molecule_chembl_id,canonical_smiles,standard_type,standard_value,pchembl_value,assay_chembl_id,assay_description,target_chembl_id,target_pref_name,target_organism,standard_units_norm,IC50_nM,pIC50
CHEMBL304722,O=C(CC(O)CCc1ccc(O)c(O)c1)O[C@H]1Cc2cc(O)c(O)cc2O[C@H]1c1ccc(O)c(O)c1,IC50,1400.0,5.85,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1400.0,5.853871964321762
CHEMBL304722,O=C(CC(O)CCc1ccc(O)c(O)c1)O[C@H]1Cc2cc(O)c(O)cc2O[C@H]1c1ccc(O)c(O)c1,IC50,1000.0,6.0,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL67076,O=C(CCc1ccc(O)c(O)c1)c1ccc(O)c(O)c1O,IC50,1700.0,5.77,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL67076,O=C(CCc1ccc(O)c(O)c1)c1ccc(O)c(O)c1O,IC50,1000.0,6.0,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL177126,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,250.0,6.6,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL177126,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,460.0,6.34,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,460.0,6.337242168318426
CHEMBL145335,O=C(O)C(=O)CC(=O)c1cccc(Cc2cccc(Cl)c2)c1,IC50,100.0,,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL143614,O=C(O)C(=O)CC(=O)c1csc(Cc2ccccc2)c1,IC50,160.0,6.8,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,160.0,6.795880017344075
CHEMBL143614,O=C(O)C(=O)CC(=O)c1csc(Cc2ccccc2)c1,IC50,100.0,7.0,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL144118,O=C(O)C(=O)CC(=O)c1cccc(Cc2ccc(Cl)cc2)c1,IC50,1000.0,6.0,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL144118,O=C(O)C(=O)CC(=O)c1cccc(Cc2ccc(Cl)cc2)c1,IC50,500.0,6.3,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL286494,Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65,IC50,10000.0,5.0,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL53463,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,900.0,6.05,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL53463,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,2400.0,5.62,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2400.0,5.619788758288394
CHEMBL85802,O=C(O)C(=O)/C=C(\O)c1cccc(Cc2ccccc2F)c1,IC50,2500.0,5.6,CHEMBL701900,Evaluated for inhibition of HIV-1 integrase catalytic activity in terms of inhibition of 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL85802,O=C(O)C(=O)/C=C(\O)c1cccc(Cc2ccccc2F)c1,IC50,400.0,6.4,CHEMBL701901,Inhibition of HIV-1 integrase catalytic activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL292992,Cc1cccc2c1C(O)=C1C(=O)C3C(O)=C(C(=O)NCN4CCN(C(=N)N=C(N)N)CC4)C(=O)[C@@H](N(C)C)[C@@H]3C[C@@H]1C2(C)O,IC50,900.0,6.05,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL292992,Cc1cccc2c1C(O)=C1C(=O)C3C(O)=C(C(=O)NCN4CCN(C(=N)N=C(N)N)CC4)C(=O)[C@@H](N(C)C)[C@@H]3C[C@@H]1C2(C)O,IC50,300.0,6.52,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL86930,O=C(O)C(=O)/C=C(\O)c1cccc(OCc2ccc(COc3cccc(/C(O)=C/C(=O)C(=O)O)c3)cc2)c1,IC50,1700.0,5.77,CHEMBL701900,Evaluated for inhibition of HIV-1 integrase catalytic activity in terms of inhibition of 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL86930,O=C(O)C(=O)/C=C(\O)c1cccc(OCc2ccc(COc3cccc(/C(O)=C/C(=O)C(=O)O)c3)cc2)c1,IC50,1900.0,5.72,CHEMBL701901,Inhibition of HIV-1 integrase catalytic activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1900.0,5.721246399047171
CHEMBL87771,O=C(/C=C(\O)c1cccc(Cc2ccccc2F)c1)C(=O)NCCCCCCNC(=O)C(=O)/C=C(\O)c1cccc(Cc2ccccc2F)c1,IC50,32000.0,4.5,CHEMBL701900,Evaluated for inhibition of HIV-1 integrase catalytic activity in terms of inhibition of 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL87771,O=C(/C=C(\O)c1cccc(Cc2ccccc2F)c1)C(=O)NCCCCCCNC(=O)C(=O)/C=C(\O)c1cccc(Cc2ccccc2F)c1,IC50,2700.0,5.57,CHEMBL701901,Inhibition of HIV-1 integrase catalytic activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2700.0,5.568636235841012
CHEMBL342295,O=C(O)C(=O)CC(=O)c1cccn1Cc1ccccc1,IC50,220.0,6.66,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,220.0,6.657577319177793
CHEMBL147147,O=C(O)C(=O)CC(=O)c1cccc(Cc2ccc(F)cc2)c1,IC50,100.0,,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL86448,O=C(O)C(=O)/C=C(\O)c1cccc(OCc2cccc(COc3cccc(/C(O)=C/C(=O)C(=O)O)c3)c2)c1,IC50,7300.0,5.14,CHEMBL701900,Evaluated for inhibition of HIV-1 integrase catalytic activity in terms of inhibition of 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7300.0,5.136677139879544
CHEMBL86448,O=C(O)C(=O)/C=C(\O)c1cccc(OCc2cccc(COc3cccc(/C(O)=C/C(=O)C(=O)O)c3)c2)c1,IC50,400.0,6.4,CHEMBL701901,Inhibition of HIV-1 integrase catalytic activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL282731,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H](C(=O)O)[C@@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,200.0,,CHEMBL699305,Inhibitory activity against HIV-1 integrase; Range 0.1-0.2 uM,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL216962,COC1/C=C/OC2(C)Oc3c(C)c(O)c4c(O)c(c(C=NN5C(C)CN(Cc6ccc([N+](=O)[O-])cc6)CC5C)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C,IC50,20600.0,4.69,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20600.0,4.686132779630847
CHEMBL216962,COC1/C=C/OC2(C)Oc3c(C)c(O)c4c(O)c(c(C=NN5C(C)CN(Cc6ccc([N+](=O)[O-])cc6)CC5C)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C,IC50,19700.0,4.71,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19700.0,4.705533773838407
CHEMBL431948,O=C(/C=C\c1ccc(O)c(O)c1)OC1CC(OC(=O)/C=C\c2ccc(O)c(O)c2)(C(=O)O)CC(O)C1O,IC50,680.0,6.17,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,680.0,6.167491087293763
CHEMBL431948,O=C(/C=C\c1ccc(O)c(O)c1)OC1CC(OC(=O)/C=C\c2ccc(O)c(O)c2)(C(=O)O)CC(O)C1O,IC50,1080.0,5.97,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1080.0,5.96657624451305
CHEMBL164,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,2000.0,5.7,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL164,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,600.0,6.22,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL145280,O=C(O)C(=O)CC(=O)c1cccc(Cc2ccccc2F)c1,IC50,100.0,,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL29898,O=C1c2ccc(O)c(O)c2C(=O)c2c(O)ccc(O)c21,IC50,17000.0,,CHEMBL699306,Inhibitory activity against HIV-1 integrase; Range 2 and 17 uM,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL421353,O=C(O)C(=O)/C=C(\O)c1cccn1Cc1ccc(F)cc1,IC50,14500.0,4.84,CHEMBL701900,Evaluated for inhibition of HIV-1 integrase catalytic activity in terms of inhibition of 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14500.0,4.838631997765025
CHEMBL421353,O=C(O)C(=O)/C=C(\O)c1cccn1Cc1ccc(F)cc1,IC50,500.0,6.3,CHEMBL701901,Inhibition of HIV-1 integrase catalytic activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL67233,O=C(/C=C\c1ccc(O)c(O)c1)OC1C(O)CC(OC(=O)/C=C\c2ccc(O)c(O)c2)(C(=O)O)CC1O,IC50,9500.0,5.02,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9500.0,5.022276394711152
CHEMBL67233,O=C(/C=C\c1ccc(O)c(O)c1)OC1C(O)CC(OC(=O)/C=C\c2ccc(O)c(O)c2)(C(=O)O)CC1O,IC50,7800.0,5.11,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7800.0,5.107905397309519
CHEMBL50605,O=C(O)C(=O)CC(=O)c1cccn1Cc1ccc(F)cc1,IC50,170.0,6.77,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,170.0,6.769551078621726
CHEMBL145946,O=C(O)C(=O)CC(=O)c1ccn(Cc2ccccc2)c1,IC50,500.0,6.3,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL145946,O=C(O)C(=O)CC(=O)c1ccn(Cc2ccccc2)c1,IC50,600.0,6.22,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL541123,C[C@@H]1O[C@@H](OC2C[C@](O)(C(=O)CO)Cc3c(O)c4c(c(O)c32)C(=O)c2c(O)cccc2C4=O)C[C@H](N)[C@@H]1O.Cl,IC50,2300.0,5.64,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2300.0,5.638272163982407
CHEMBL541123,C[C@@H]1O[C@@H](OC2C[C@](O)(C(=O)CO)Cc3c(O)c4c(c(O)c32)C(=O)c2c(O)cccc2C4=O)C[C@H](N)[C@@H]1O.Cl,IC50,4100.0,5.39,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4100.0,5.3872161432802645
CHEMBL66854,Oc1cccc(/C=N/N=C/c2cccc(O)c2O)c1O,IC50,23900.0,4.62,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23900.0,4.621602099051862
CHEMBL66854,Oc1cccc(/C=N/N=C/c2cccc(O)c2O)c1O,IC50,14000.0,4.85,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL430786,Cc1cccc2c1C(O)=C1C(=O)C3C(O)=C(C(=O)NNC4(C(=O)[O-])CCCC4)C(=O)[C@@H](N(C)C)[C@@H]3C[C@@H]1C2(C)O.[Na+],IC50,1200.0,5.92,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL430786,Cc1cccc2c1C(O)=C1C(=O)C3C(O)=C(C(=O)NNC4(C(=O)[O-])CCCC4)C(=O)[C@@H](N(C)C)[C@@H]3C[C@@H]1C2(C)O.[Na+],IC50,3600.0,5.44,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3600.0,5.443697499232712
CHEMBL147209,O=C(O)C(=O)CC(=O)c1ccccc1Cc1ccccc1,IC50,5670.0,5.25,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5670.0,5.246416941107094
CHEMBL85597,O=C(/C=C(\O)c1cccc(Cc2ccccc2F)c1)C(=O)N1CCN(C(=O)C(=O)/C=C(\O)c2cccc(Cc3ccccc3F)c2)CC1,IC50,2500.0,5.6,CHEMBL844406,Evaluated for inhibition of HIV-1 integrase catalytic activity in terms of inhibition of 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL85597,O=C(/C=C(\O)c1cccc(Cc2ccccc2F)c1)C(=O)N1CCN(C(=O)C(=O)/C=C(\O)c2cccc(Cc3ccccc3F)c2)CC1,IC50,300.0,6.52,CHEMBL701901,Inhibition of HIV-1 integrase catalytic activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL63592,O=C(/C=C/c1ccc(O)c(O)c1)OC(C(=O)O)C(OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,150.0,6.82,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,150.0,6.823908740944319
CHEMBL63592,O=C(/C=C/c1ccc(O)c(O)c1)OC(C(=O)O)C(OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,130.0,6.89,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL144727,O=C(O)C(=O)CC(=O)c1cccc(Cc2cccc(F)c2)c1,IC50,250.0,6.6,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL146777,COc1ccc(C(=O)CC(=O)C(=O)O)cc1Cc1ccccc1,IC50,150.0,6.82,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,150.0,6.823908740944319
CHEMBL29898,O=C1c2ccc(O)c(O)c2C(=O)c2c(O)ccc(O)c21,IC50,4000.0,5.4,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL29898,O=C1c2ccc(O)c(O)c2C(=O)c2c(O)ccc(O)c21,IC50,1000.0,6.0,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL147317,COc1cc(Cc2ccccc2)cc(C(=O)CC(=O)C(=O)O)c1,IC50,140.0,6.85,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,140.0,6.853871964321762
CHEMBL148241,CCOc1ccc(Cc2ccccc2)cc1C(=O)CC(=O)C(=O)O,IC50,100.0,,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL413552,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)c(O)c(O)c12,IC50,1300.0,5.89,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL413552,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)c(O)c(O)c12,IC50,600.0,6.22,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL357909,O=C(O)C(=O)CC(=O)c1cccc(Cc2ccccc2Cl)c1,IC50,100.0,,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL86133,O=C(O)C(=O)/C=C(\O)c1cccc(C(c2cccc(/C(O)=C/C(=O)C(=O)O)c2)c2ccccc2F)c1,IC50,1800.0,5.75,CHEMBL701900,Evaluated for inhibition of HIV-1 integrase catalytic activity in terms of inhibition of 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL86133,O=C(O)C(=O)/C=C(\O)c1cccc(C(c2cccc(/C(O)=C/C(=O)C(=O)O)c2)c2ccccc2F)c1,IC50,200.0,6.7,CHEMBL701901,Inhibition of HIV-1 integrase catalytic activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL441250,O=C(/C=C\c1ccc(O)c(O)c1)OC1CC(O)(C(=O)O)CC(OC(=O)/C=C\c2ccc(O)c(O)c2)C1O,IC50,640.0,6.19,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,640.0,6.1938200260161125
CHEMBL441250,O=C(/C=C\c1ccc(O)c(O)c1)OC1CC(O)(C(=O)O)CC(OC(=O)/C=C\c2ccc(O)c(O)c2)C1O,IC50,660.0,6.18,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,660.0,6.180456064458131
CHEMBL67535,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCNC(=O)/C(C#N)=C/c1ccc(O)c(O)c1,IC50,10000.0,5.0,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL67535,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCNC(=O)/C(C#N)=C/c1ccc(O)c(O)c1,IC50,3000.0,5.52,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL358506,O=C(O)C(=O)CC(=O)c1ccc(Cc2ccccc2)s1,IC50,500.0,6.3,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL145705,COc1ccc(Cc2ccccc2)cc1C(=O)CC(=O)C(=O)O,IC50,100.0,,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL343646,CC(C)Oc1ccc(Cc2ccccc2)cc1C(=O)CC(=O)C(=O)O,IC50,100.0,,CHEMBL873216,Inhibitory activity was determined against recombinant HIV-1 Integrase (0.1 uM) in strand transfer enzyme assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL35109,O=C(/C=C(\O)c1c[nH]c2ccc(Cl)cc12)c1nn[nH]n1,IC50,17000.0,,CHEMBL699306,Inhibitory activity against HIV-1 integrase; Range 2 and 17 uM,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL6246,O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23,IC50,5100.0,5.29,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5100.0,5.292429823902063
CHEMBL553067,Cc1cccc2c1C(O)=C1C(=O)C3C(O)=C(C(=O)NCNC(CO)(CO)CO)C(=O)[C@@H](N(C)C)[C@@H]3C[C@@H]1C2(C)O.Cl,IC50,1100.0,5.96,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1100.0,5.958607314841775
CHEMBL553067,Cc1cccc2c1C(O)=C1C(=O)C3C(O)=C(C(=O)NCNC(CO)(CO)CO)C(=O)[C@@H](N(C)C)[C@@H]3C[C@@H]1C2(C)O.Cl,IC50,500.0,6.3,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL177126,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,790.0,6.1,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,790.0,6.102372908709558
CHEMBL177126,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,540.0,6.27,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,540.0,6.267606240177031
CHEMBL66953,O=c1c(O)cccc2cc(O)c(O)c(O)c12,IC50,2100.0,5.68,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2100.0,5.6777807052660805
CHEMBL19464,O=C(O)C(=O)CC(=O)c1cccc(Cc2ccccc2)c1,IC50,100.0,,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL314866,O=C(/C=C(\O)c1cccc(Cc2ccccc2F)c1)C(=O)NCCNC(=O)C(=O)/C=C(\O)c1cccc(Cc2ccccc2F)c1,IC50,5800.0,5.24,CHEMBL701900,Evaluated for inhibition of HIV-1 integrase catalytic activity in terms of inhibition of 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5800.0,5.236572006437063
CHEMBL314866,O=C(/C=C(\O)c1cccc(Cc2ccccc2F)c1)C(=O)NCCNC(=O)C(=O)/C=C(\O)c1cccc(Cc2ccccc2F)c1,IC50,200.0,6.7,CHEMBL701901,Inhibition of HIV-1 integrase catalytic activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL304266,CC1(C)CC2(CC(C)(C)c3cc(O)c(O)cc32)c2cc(O)c(O)cc21,IC50,17000.0,,CHEMBL699306,Inhibitory activity against HIV-1 integrase; Range 2 and 17 uM,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL359212,O=C(O)C(=O)CC(=O)c1ccsc1Cc1ccccc1,IC50,180.0,6.75,CHEMBL701899,Inhibition of recombinant HIV-1 Integrase in strand transfer enzyme assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,180.0,6.7447274948966935
CHEMBL68073,C[Si](C)(C)C,IC50,17000.0,4.77,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL68073,C[Si](C)(C)C,IC50,5000.0,5.3,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL58,O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21,IC50,3800.0,5.42,CHEMBL701719,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3800.0,5.42021640338319
CHEMBL58,O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21,IC50,8000.0,5.1,CHEMBL701720,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL144613,CC(=O)Nc1cc(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(O)c12,IC50,17000.0,,CHEMBL699306,Inhibitory activity against HIV-1 integrase; Range 2 and 17 uM,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL85660,O=C(/C=C(\O)c1cccc(Cc2ccccc2F)c1)C(=O)NCCCNC(=O)C(=O)/C=C(\O)c1cccc(Cc2ccccc2F)c1,IC50,5300.0,5.28,CHEMBL701900,Evaluated for inhibition of HIV-1 integrase catalytic activity in terms of inhibition of 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5300.0,5.275724130399211
CHEMBL85660,O=C(/C=C(\O)c1cccc(Cc2ccccc2F)c1)C(=O)NCCCNC(=O)C(=O)/C=C(\O)c1cccc(Cc2ccccc2F)c1,IC50,200.0,6.7,CHEMBL701901,Inhibition of HIV-1 integrase catalytic activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL87764,O=C(O)C(=O)/C=C(\O)c1cccc(OCc2ccccc2COc2cccc(/C(O)=C/C(=O)C(=O)O)c2)c1,IC50,1800.0,5.75,CHEMBL701900,Evaluated for inhibition of HIV-1 integrase catalytic activity in terms of inhibition of 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL87764,O=C(O)C(=O)/C=C(\O)c1cccc(OCc2ccccc2COc2cccc(/C(O)=C/C(=O)C(=O)O)c2)c1,IC50,300.0,6.52,CHEMBL701901,Inhibition of HIV-1 integrase catalytic activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL83025,O=C(/C=C(\O)c1cccc(Cc2ccccc2F)c1)C(=O)NCCCCCNC(=O)C(=O)/C=C(\O)c1cccc(Cc2ccccc2F)c1,IC50,4800.0,5.32,CHEMBL701900,Evaluated for inhibition of HIV-1 integrase catalytic activity in terms of inhibition of 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4800.0,5.318758762624412
CHEMBL83025,O=C(/C=C(\O)c1cccc(Cc2ccccc2F)c1)C(=O)NCCCCCNC(=O)C(=O)/C=C(\O)c1cccc(Cc2ccccc2F)c1,IC50,700.0,6.16,CHEMBL701901,Inhibition of HIV-1 integrase catalytic activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL80488,CCCCC(C)/C=C(\C)C(=O)O[C@@H]1CC[C@H](C(=O)O)[C@@]2(C)C[C@H]3[C@H](C)CO[C@]3(O)C[C@H]12,IC50,100000.0,4.0,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL306631,CC1=C2C[C@@]3(C)C(=CCC[C@@H]3C(=O)O)C=C2OC1=O,IC50,100000.0,,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2309960,Nc1ccn([C@H]2C[C@@H](O)[C@@H](COP(=O)(O)O[C@@H]3[C@H](COP(=O)(O)O)OC[C@@H]3n3cnc4c(N)ncnc43)O2)c(=O)n1,IC50,19000.0,4.72,CHEMBL701161,Compound was tested for the inhibition HIV integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL2309960,Nc1ccn([C@H]2C[C@@H](O)[C@@H](COP(=O)(O)O[C@@H]3[C@H](COP(=O)(O)O)OC[C@@H]3n3cnc4c(N)ncnc43)O2)c(=O)n1,IC50,25000.0,4.6,CHEMBL701162,Compound was tested for the inhibition HIV integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL430624,CCCCC(C)/C=C(\C)C(=O)O[C@@H]1CC[C@H](C(=O)O)[C@@]2(C)C[C@H]3[C@@H](C)CO[C@]3(O)C[C@H]12,IC50,45000.0,4.35,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45000.0,4.346787486224656
CHEMBL79935,CCCCC(C)/C=C(\C)C(=O)O[C@@H]1CC[C@H](C(=O)O)[C@@]2(C)CC([C@H](C)C=O)C(=O)C=C12,IC50,11000.0,4.96,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL77301,CCCCC(C)/C=C(\C)C(=O)O[C@@H]1CC[C@H](C(=O)O)[C@@]2(C)CC3C(C)C(O)OC3(O)C=C12,IC50,40000.0,4.4,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL307588,C=C(C=O)[C@@H]1C[C@@]2(C)C(=CC1=O)[C@H](OC(=O)/C(C)=C/C(C)CCCC)CC[C@@H]2C(=O)OP(=O)(OCC)OCC,IC50,81000.0,4.09,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,81000.0,4.0915149811213505
CHEMBL79880,CCCCC(C)/C=C(\C)C(=O)O[C@@H]1CC[C@H](C(=O)O)[C@@]2(C)C[C@@H](C(C)C(O)O)C(=O)C=C12,IC50,40000.0,4.4,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL310339,C=C(CO)[C@@H]1C[C@@]2(C)C(=C[C@H]1O)[C@H](OC(=O)/C(C)=C/C(C)CCCC)CC[C@@H]2C(=O)O,IC50,73000.0,4.14,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,73000.0,4.136677139879544
CHEMBL80259,C=C(C=O)[C@@H]1C[C@@]2(C)C(=CC1=O)[C@H](OC(=O)/C(C)=C/C(C)CCCC)CC[C@@H]2C(=O)ON[C@H](C(=O)OC)c1ccccc1,IC50,5000.0,5.3,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL76984,C=C(C=O)[C@@H]1C[C@@]2(C)C(=CC1=O)[C@H](OC(=O)/C(C)=C/C(C)CCCC)CC[C@@H]2C(=O)O,IC50,3000.0,5.52,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL76319,C=CC(=C)[C@@H]1C[C@@]2(C)C(=CC1=O)[C@H](OC(=O)/C(C)=C/C(C)CCCC)CC[C@@H]2C(=O)O,IC50,30000.0,4.52,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL80654,CCCCC(C)/C=C(\C)C(=O)O[C@@H]1CC[C@H](C(=O)O)[C@@]2(C)CC([C@@H](C)C=O)C(=O)C=C12,IC50,11000.0,4.96,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL80385,C=C(C=O)[C@@H]1C[C@@]2(C)C(=CC1=O)[C@H](OC(=O)/C(C)=C/C(C)CCCC)CC[C@@H]2C(=O)N1CCN(C(=O)[C@H]2CC[C@@H](OC(=O)/C(C)=C/C(C)CCCC)C3=CC(=O)[C@H](C(=C)C=O)C[C@@]32C)CC1,IC50,24000.0,4.62,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL306576,C=C(C=O)[C@@H]1C[C@@]2(C)C(=CC1=O)[C@H](OC(=O)/C(C)=C/C(C)CCCC)CC[C@@H]2C(=O)O/C(=N\C1CCCCC1)NC1CCCCC1,IC50,88000.0,4.06,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,88000.0,4.055517327849832
CHEMBL80568,C=C(C=O)[C@@H]1C[C@@]2(C)C(=CC1=O)[C@H](OC(=O)/C(C)=C/C(C)CCCC)CC[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)OC,IC50,3000.0,5.52,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL308870,C=C/C(C)=C1\C[C@@]2(C)C(=CC1=O)[C@H](OC(=O)/C(C)=C/C(C)CCCC)CC[C@@H]2C(=O)O,IC50,75000.0,4.12,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75000.0,4.1249387366083
CHEMBL421139,CCCCC(C)/C=C(\C)C(=O)O,IC50,12000.0,4.92,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL307070,C=C(C=O)[C@@H]1C[C@@]2(C)C(=CC1=O)[C@H](OC(=O)/C(C)=C/C(C)CCCC)CC[C@@H]2C(=O)NCCNC(=O)[C@H]1CC[C@@H](OC(=O)/C(C)=C/C(C)CCCC)C2=CC(=O)[C@H](C(=C)C=O)C[C@@]21C,IC50,10000.0,5.0,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL80419,C=C(C=O)[C@@H]1C[C@@]2(C)C(=CC1=O)[C@H](OC(=O)/C(C)=C/C(C)CCCC)CC[C@@H]2C(=O)ON[C@@H](C(=O)OC)c1ccccc1,IC50,5000.0,5.3,CHEMBL702430,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL132058,O=C(/C=C/c1ccc(O)c(O)c1O)OCCc1ccccc1,IC50,2000.0,5.7,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL134573,O=C(Cc1ccccc1)NCCc1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL133492,O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccc2ccccc2c1,IC50,44000.0,4.36,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44000.0,4.356547323513812
CHEMBL32711,O=c1c(C(c2ccc(C(c3c(O)oc4cc(O)ccc4c3=O)c3c(O)oc4cc(O)ccc4c3=O)cc2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,370.0,6.43,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,370.0,6.431798275933005
CHEMBL32711,O=c1c(C(c2ccc(C(c3c(O)oc4cc(O)ccc4c3=O)c3c(O)oc4cc(O)ccc4c3=O)cc2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,330.0,6.48,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,330.0,6.481486060122112
CHEMBL17001,COC(=O)/C=C/c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL262114,O=c1c(C(c2ccc(O)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,75000.0,4.12,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75000.0,4.1249387366083
CHEMBL262114,O=c1c(C(c2ccc(O)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,74000.0,4.13,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,74000.0,4.130768280269024
CHEMBL84518,O=c1c(C(c2cc(OCc3ccccc3)cc(OCc3ccccc3)c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,8000.0,5.1,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL84518,O=c1c(C(c2cc(OCc3ccccc3)cc(OCc3ccccc3)c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,11000.0,4.96,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL84518,O=c1c(C(c2cc(OCc3ccccc3)cc(OCc3ccccc3)c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,12000.0,4.92,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL84518,O=c1c(C(c2cc(OCc3ccccc3)cc(OCc3ccccc3)c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,3700.0,5.43,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3700.0,5.431798275933005
CHEMBL84518,O=c1c(C(c2cc(OCc3ccccc3)cc(OCc3ccccc3)c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,10000.0,5.0,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL312727,O=c1c(Cc2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,46300.0,4.33,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,46300.0,4.334419008982047
CHEMBL312727,O=c1c(Cc2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,44900.0,4.35,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44900.0,4.347753658996677
CHEMBL84340,O=c1c(C(c2ccccn2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,94000.0,4.03,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,94000.0,4.026872146400302
CHEMBL84340,O=c1c(C(c2ccccn2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,84000.0,4.08,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,84000.0,4.075720713938118
CHEMBL84340,O=c1c(C(c2ccccn2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,49000.0,4.31,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,49000.0,4.309803919971486
CHEMBL84340,O=c1c(C(c2ccccn2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,70000.0,4.16,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL84340,O=c1c(C(c2ccccn2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,81000.0,4.09,CHEMBL701115,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,81000.0,4.0915149811213505
CHEMBL49350,O=C(NCCc1ccccc1)c1cc2ccc(O)c(O)c2cn1,IC50,40000.0,4.4,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL293914,O=c1c(C(c2ccc(C(c3c(O)oc4ccccc4c3=O)c3c(O)oc4ccccc4c3=O)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,2000.0,5.7,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL131680,COc1ccc(/C=C/C(=O)OCCc2ccccc2)cc1O,IC50,60000.0,4.22,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL314013,O=c1c(C(c2ccc(/C=C/c3ccccc3)cc2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,7000.0,5.16,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL314013,O=c1c(C(c2ccc(/C=C/c3ccccc3)cc2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,1800.0,5.75,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL18266,O=C(CCc1ccc(O)c(O)c1)NCCc1ccc(O)c(O)c1,IC50,3000.0,5.52,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL131678,O=C(/C=C/c1cc(O)ccc1O)OCCc1ccccc1,IC50,100000.0,,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL133937,N=c1oc2c(O)c(O)ccc2cc1C(N)=O,IC50,93000.0,4.03,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,93000.0,4.031517051446065
CHEMBL284384,O=c1c(C(c2ccc(/C=C/c3ccccc3)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,5500.0,5.26,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5500.0,5.259637310505756
CHEMBL284384,O=c1c(C(c2ccc(/C=C/c3ccccc3)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,9200.0,5.04,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9200.0,5.036212172654444
CHEMBL284384,O=c1c(C(c2ccc(/C=C/c3ccccc3)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,3700.0,5.43,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3700.0,5.431798275933005
CHEMBL284384,O=c1c(C(c2ccc(/C=C/c3ccccc3)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,9500.0,5.02,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9500.0,5.022276394711152
CHEMBL284384,O=c1c(C(c2ccc(/C=C/c3ccccc3)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,7000.0,5.16,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL133642,COc1ccc(/C=C/C(=O)OCCc2ccccc2)cc1OC,IC50,100000.0,,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL132194,O=C(CCc1ccccc1)NCCc1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL316387,O=c1c(C(c2ccc3ccccc3c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,19000.0,4.72,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL316387,O=c1c(C(c2ccc3ccccc3c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,20000.0,4.7,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL316387,O=c1c(C(c2ccc3ccccc3c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,16000.0,4.8,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL316387,O=c1c(C(c2ccc3ccccc3c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,9000.0,5.05,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL316387,O=c1c(C(c2ccc3ccccc3c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,20000.0,4.7,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL82742,O=c1oc2ccccc2c(O)c1C1c2c(c3ccccc3oc2=O)Oc2c1c(=O)oc1ccccc21,IC50,35700.0,4.45,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35700.0,4.447331783887806
CHEMBL82742,O=c1oc2ccccc2c(O)c1C1c2c(c3ccccc3oc2=O)Oc2c1c(=O)oc1ccccc21,IC50,22500.0,4.65,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22500.0,4.647817481888637
CHEMBL132238,O=C(OCCc1ccccc1)c1ccc2c(O)c(O)ccc2c1,IC50,18000.0,4.75,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL131749,O=C(/C=C/c1cc(O)c(O)cc1O)OCCc1ccccc1,IC50,55000.0,4.26,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55000.0,4.259637310505756
CHEMBL310293,O=c1c(C(c2ccc3c(c2)Cc2ccccc2-3)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,10000.0,5.0,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL310293,O=c1c(C(c2ccc3c(c2)Cc2ccccc2-3)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,11000.0,4.96,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL310293,O=c1c(C(c2ccc3c(c2)Cc2ccccc2-3)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,9500.0,5.02,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9500.0,5.022276394711152
CHEMBL310293,O=c1c(C(c2ccc3c(c2)Cc2ccccc2-3)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,7800.0,5.11,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7800.0,5.107905397309519
CHEMBL310293,O=c1c(C(c2ccc3c(c2)Cc2ccccc2-3)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,10000.0,5.0,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL133828,COC(=O)c1cc2cc(O)c(O)cc2cn1,IC50,100000.0,,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL337498,O=C(/C=C/c1ccc(F)c(F)c1)OCCc1ccccc1,IC50,100000.0,,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL131733,O=C(/C=C/c1cc(O)c(O)c(O)c1)OCCc1ccccc1,IC50,2000.0,5.7,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL17347,CCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL131689,O=C(OCCc1ccccc1)c1ccc2cc(O)c(O)cc2c1,IC50,68000.0,4.17,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68000.0,4.167491087293763
CHEMBL48436,O=C(NCc1ccccc1)c1cc2ccc(O)c(O)c2cn1,IC50,75000.0,4.12,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75000.0,4.1249387366083
CHEMBL80104,O=c1c(C(c2ccc(-c3ccccc3)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,14000.0,4.85,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL80104,O=c1c(C(c2ccc(-c3ccccc3)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,16000.0,4.8,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL80104,O=c1c(C(c2ccc(-c3ccccc3)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,13000.0,4.89,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL80104,O=c1c(C(c2ccc(-c3ccccc3)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,28000.0,4.55,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL80104,O=c1c(C(c2ccc(-c3ccccc3)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,15000.0,4.82,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL442022,COc1cc(/C=C/C(=O)OCCc2ccccc2)ccc1O,IC50,100000.0,,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL301141,O=c1cc(O)c2ccccc2o1,IC50,100000.0,,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL301141,O=c1cc(O)c2ccccc2o1,IC50,100000.0,,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL132024,O=C(CCc1ccc(O)c(O)c1)NCCc1ccccc1,IC50,100000.0,,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL82974,O=c1c(Cc2cccc(Cc3c(O)oc4ccccc4c3=O)c2)c(O)oc2ccccc12,IC50,34000.0,4.47,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34000.0,4.468521082957745
CHEMBL82974,O=c1c(Cc2cccc(Cc3c(O)oc4ccccc4c3=O)c2)c(O)oc2ccccc12,IC50,40000.0,4.4,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL82974,O=c1c(Cc2cccc(Cc3c(O)oc4ccccc4c3=O)c2)c(O)oc2ccccc12,IC50,11100.0,4.96,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11100.0,4.954677021213342
CHEMBL82974,O=c1c(Cc2cccc(Cc3c(O)oc4ccccc4c3=O)c2)c(O)oc2ccccc12,IC50,27500.0,4.56,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27500.0,4.560667306169737
CHEMBL83786,,IC50,11000.0,4.96,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL83786,,IC50,3600.0,5.44,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3600.0,5.443697499232712
CHEMBL83786,,IC50,7000.0,5.16,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL83786,,IC50,5000.0,5.3,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL133714,O=C(/C=C/c1ccc(O)c(O)c1)OCc1ccccc1,IC50,9000.0,5.05,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL413118,COC(=O)c1cc2ccc(O)c(O)c2cn1,IC50,14000.0,4.85,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL132379,N=c1oc2cc(O)c(O)cc2cc1C(N)=O,IC50,48000.0,4.32,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48000.0,4.318758762624412
CHEMBL296407,N#C/C(=C\c1ccc(O)c(O)c1)C(N)=O,IC50,100000.0,,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL315955,O=c1c(C(c2cccc(C(c3c(O)oc4ccccc4c3=O)c3c(O)oc4ccccc4c3=O)c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,3000.0,5.52,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL315955,O=c1c(C(c2cccc(C(c3c(O)oc4ccccc4c3=O)c3c(O)oc4ccccc4c3=O)c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,2900.0,5.54,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2900.0,5.537602002101044
CHEMBL315955,O=c1c(C(c2cccc(C(c3c(O)oc4ccccc4c3=O)c3c(O)oc4ccccc4c3=O)c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,1200.0,5.92,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL315955,O=c1c(C(c2cccc(C(c3c(O)oc4ccccc4c3=O)c3c(O)oc4ccccc4c3=O)c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,2000.0,5.7,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL133491,O=C(/C=C/c1ccc(O)c(O)c1)OCCc1cccc2ccccc12,IC50,15000.0,4.82,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL81935,O=c1c(C(c2ccc([N+](=O)[O-])cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,58000.0,4.24,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58000.0,4.236572006437063
CHEMBL81935,O=c1c(C(c2ccc([N+](=O)[O-])cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,50000.0,4.3,CHEMBL701117,Inhibitory activity against 3'-processing of DNA byHIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL81935,O=c1c(C(c2ccc([N+](=O)[O-])cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,12000.0,4.92,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL81935,O=c1c(C(c2ccc([N+](=O)[O-])cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,24000.0,4.62,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL81935,O=c1c(C(c2ccc([N+](=O)[O-])cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,54000.0,4.27,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54000.0,4.267606240177032
CHEMBL133992,O=C(CCc1ccc(O)c(O)c1)OCCc1ccccc1,IC50,11000.0,4.96,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL296582,O=C(NCc1ccccc1)c1cc2cc(O)c(O)cc2cn1,IC50,100000.0,,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL82228,O=c1c(C(c2cccs2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,100000.0,4.0,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL80018,O=c1c(Cc2ccccc2Cc2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,46000.0,4.34,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,46000.0,4.337242168318426
CHEMBL80018,O=c1c(Cc2ccccc2Cc2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,45000.0,4.35,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45000.0,4.346787486224656
CHEMBL80018,O=c1c(Cc2ccccc2Cc2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,20500.0,4.69,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20500.0,4.688246138944246
CHEMBL80018,O=c1c(Cc2ccccc2Cc2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,33200.0,4.48,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33200.0,4.478861916295964
CHEMBL310585,O=c1c(C(c2cccnc2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,62000.0,4.21,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,62000.0,4.2076083105017466
CHEMBL310585,O=c1c(C(c2cccnc2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,25000.0,4.6,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL310585,O=c1c(C(c2cccnc2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,97000.0,4.01,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,97000.0,4.013228265733755
CHEMBL310585,O=c1c(C(c2cccnc2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,89000.0,4.05,CHEMBL701115,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,89000.0,4.050609993355088
CHEMBL1466,O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O,IC50,100000.0,,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1466,O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O,IC50,100000.0,,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL312008,CN(C)c1ccc(C(c2c(O)oc3ccccc3c2=O)c2c(O)oc3ccccc3c2=O)cc1,IC50,100000.0,4.0,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL312008,CN(C)c1ccc(C(c2c(O)oc3ccccc3c2=O)c2c(O)oc3ccccc3c2=O)cc1,IC50,88000.0,4.06,CHEMBL701117,Inhibitory activity against 3'-processing of DNA byHIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,88000.0,4.055517327849832
CHEMBL312008,CN(C)c1ccc(C(c2c(O)oc3ccccc3c2=O)c2c(O)oc3ccccc3c2=O)cc1,IC50,50000.0,4.3,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL312008,CN(C)c1ccc(C(c2c(O)oc3ccccc3c2=O)c2c(O)oc3ccccc3c2=O)cc1,IC50,88000.0,4.06,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,88000.0,4.055517327849832
CHEMBL310188,O=c1c(C(c2ccccc2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,17200.0,4.76,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17200.0,4.764471553092451
CHEMBL310188,O=c1c(C(c2ccccc2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,22200.0,4.65,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22200.0,4.653647025549361
CHEMBL131982,O=C(/C=C/c1ccc(O)c(O)c1)OCCCc1ccccc1,IC50,8000.0,5.1,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL131904,O=C(CCc1ccc(O)c(O)c1)NCCc1cc(O)c(O)c(O)c1,IC50,4000.0,5.4,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL82696,O=C(O)c1ccc(C(c2c(O)oc3ccccc3c2=O)c2c(O)oc3ccccc3c2=O)cc1,IC50,66000.0,4.18,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,66000.0,4.180456064458132
CHEMBL82696,O=C(O)c1ccc(C(c2c(O)oc3ccccc3c2=O)c2c(O)oc3ccccc3c2=O)cc1,IC50,48000.0,4.32,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48000.0,4.318758762624412
CHEMBL82696,O=C(O)c1ccc(C(c2c(O)oc3ccccc3c2=O)c2c(O)oc3ccccc3c2=O)cc1,IC50,54000.0,4.27,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54000.0,4.267606240177032
CHEMBL82696,O=C(O)c1ccc(C(c2c(O)oc3ccccc3c2=O)c2c(O)oc3ccccc3c2=O)cc1,IC50,49000.0,4.31,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,49000.0,4.309803919971486
CHEMBL309505,O=c1c(C(c2ccco2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,75000.0,4.12,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75000.0,4.1249387366083
CHEMBL309505,O=c1c(C(c2ccco2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,34000.0,4.47,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34000.0,4.468521082957745
CHEMBL309505,O=c1c(C(c2ccco2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,54000.0,4.27,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54000.0,4.267606240177032
CHEMBL319244,O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1,IC50,7000.0,5.16,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL313509,O=c1c(C(c2ccccc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,43400.0,4.36,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43400.0,4.36251027048749
CHEMBL313509,O=c1c(C(c2ccccc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,38800.0,4.41,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38800.0,4.411168274405793
CHEMBL313509,O=c1c(C(c2ccccc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,43000.0,4.37,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43000.0,4.366531544420414
CHEMBL18276,COC(=O)c1ccc2c(O)c(O)ccc2c1,IC50,8000.0,5.1,CHEMBL701724,In vitro inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL82828,O=c1c(Cc2ccc(Cc3c(O)oc4ccccc4c3=O)cc2)c(O)oc2ccccc12,IC50,80600.0,4.09,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80600.0,4.09366495819491
CHEMBL82828,O=c1c(Cc2ccc(Cc3c(O)oc4ccccc4c3=O)cc2)c(O)oc2ccccc12,IC50,69200.0,4.16,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69200.0,4.1598939055432425
CHEMBL81797,O=c1c(C(c2ccc(OCc3ccccc3)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,19000.0,4.72,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL81797,O=c1c(C(c2ccc(OCc3ccccc3)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,8500.0,5.07,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8500.0,5.070581074285707
CHEMBL81797,O=c1c(C(c2ccc(OCc3ccccc3)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,14000.0,4.85,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL81797,O=c1c(C(c2ccc(OCc3ccccc3)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,24000.0,4.62,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL81797,O=c1c(C(c2ccc(OCc3ccccc3)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,20000.0,4.7,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL309502,O=c1c(C(c2ccc3ccccc3c2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,4200.0,5.38,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4200.0,5.376750709602099
CHEMBL309502,O=c1c(C(c2ccc3ccccc3c2)c2c(O)oc3cc(O)ccc3c2=O)c(O)oc2cc(O)ccc12,IC50,3550.0,5.45,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3550.0,5.449771646944906
CHEMBL83968,COc1cc(C(c2c(O)oc3ccccc3c2=O)c2c(O)oc3ccccc3c2=O)ccc1O,IC50,76000.0,4.12,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,76000.0,4.119186407719209
CHEMBL81144,O=c1c(C(c2cnc3ccccc3c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,40000.0,4.4,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL81144,O=c1c(C(c2cnc3ccccc3c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,29000.0,4.54,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,29000.0,4.537602002101044
CHEMBL81144,O=c1c(C(c2cnc3ccccc3c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,23000.0,4.64,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL81144,O=c1c(C(c2cnc3ccccc3c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,14000.0,4.85,CHEMBL701718,Integration of DNA by HIV -1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL81144,O=c1c(C(c2cnc3ccccc3c2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,35000.0,4.46,CHEMBL701116,Inhibitory activity against 3'-processing of DNA by HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL20592,[N-]=[N+]=NC1CC(N=[N+]=[N-])c2cc(C(=O)CC(=O)C(=O)O)ccc21,IC50,100000.0,,CHEMBL699987,Inhibitory concentration against Recombinant HIV-1 integrase (3'processing),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL20592,[N-]=[N+]=NC1CC(N=[N+]=[N-])c2cc(C(=O)CC(=O)C(=O)O)ccc21,IC50,360.0,6.44,CHEMBL699988,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,360.0,6.443697499232712
CHEMBL278545,[N-]=[N+]=NC1CCC(N=[N+]=[N-])c2cc(C(=O)CC(=O)C(=O)O)ccc21,IC50,70000.0,4.16,CHEMBL699987,Inhibitory concentration against Recombinant HIV-1 integrase (3'processing),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL278545,[N-]=[N+]=NC1CCC(N=[N+]=[N-])c2cc(C(=O)CC(=O)C(=O)O)ccc21,IC50,320.0,6.5,CHEMBL699988,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,320.0,6.494850021680094
CHEMBL19977,O=C(O)C(=O)CC(=O)c1cc(OCc2ccccc2)cc(OCc2ccccc2)c1,IC50,100000.0,,CHEMBL699987,Inhibitory concentration against Recombinant HIV-1 integrase (3'processing),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL19977,O=C(O)C(=O)CC(=O)c1cc(OCc2ccccc2)cc(OCc2ccccc2)c1,IC50,480.0,6.32,CHEMBL699988,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,480.0,6.318758762624412
CHEMBL105350,O=C(/C=C/c1ccc(O)cc1)CC(=O)/C=C/c1ccc(O)cc1,IC50,80000.0,4.1,CHEMBL701113,Inhibition of strand transfer activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL20091,N#CCCc1cccc(C(=O)CC(=O)C(=O)O)c1,IC50,100000.0,,CHEMBL699987,Inhibitory concentration against Recombinant HIV-1 integrase (3'processing),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL20091,N#CCCc1cccc(C(=O)CC(=O)C(=O)O)c1,IC50,1500.0,5.82,CHEMBL691412,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1500.0,5.823908740944319
CHEMBL20091,N#CCCc1cccc(C(=O)CC(=O)C(=O)O)c1,IC50,1800.0,5.75,CHEMBL699988,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL103410,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(O)c2)ccc1O,IC50,18000.0,4.75,CHEMBL873207,Inhibition of 3'- processing activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL103410,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(O)c2)ccc1O,IC50,9000.0,5.05,CHEMBL701113,Inhibition of strand transfer activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL18927,O=C(O)C(=O)CC(=O)c1cccc(OCc2ccccc2)c1,IC50,85000.0,4.07,CHEMBL699987,Inhibitory concentration against Recombinant HIV-1 integrase (3'processing),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,85000.0,4.070581074285707
CHEMBL18927,O=C(O)C(=O)CC(=O)c1cccc(OCc2ccccc2)c1,IC50,100000.0,4.0,CHEMBL691411,Inhibitory concentration against Recombinant HIV-1 integrase (3'processing),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL18927,O=C(O)C(=O)CC(=O)c1cccc(OCc2ccccc2)c1,IC50,350.0,6.46,CHEMBL699988,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,350.0,6.455931955649724
CHEMBL20117,COc1ccc(CN=[N+]=[N-])cc1C(=O)CC(=O)C(=O)O,IC50,100000.0,,CHEMBL699987,Inhibitory concentration against Recombinant HIV-1 integrase (3'processing),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL20117,COc1ccc(CN=[N+]=[N-])cc1C(=O)CC(=O)C(=O)O,IC50,24000.0,4.62,CHEMBL691412,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL20117,COc1ccc(CN=[N+]=[N-])cc1C(=O)CC(=O)C(=O)O,IC50,18000.0,4.75,CHEMBL699988,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL20586,[N-]=[N+]=NCc1ccc(C(=O)CC(=O)C(=O)O)cc1,IC50,100000.0,,CHEMBL699987,Inhibitory concentration against Recombinant HIV-1 integrase (3'processing),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL20586,[N-]=[N+]=NCc1ccc(C(=O)CC(=O)C(=O)O)cc1,IC50,6100.0,5.21,CHEMBL691412,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6100.0,5.214670164989233
CHEMBL20586,[N-]=[N+]=NCc1ccc(C(=O)CC(=O)C(=O)O)cc1,IC50,7100.0,5.15,CHEMBL699988,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7100.0,5.1487416512809245
CHEMBL20758,CC(C)Oc1ccc(CN=[N+]=[N-])cc1C(=O)CC(=O)C(=O)O,IC50,100000.0,,CHEMBL699987,Inhibitory concentration against Recombinant HIV-1 integrase (3'processing),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL20758,CC(C)Oc1ccc(CN=[N+]=[N-])cc1C(=O)CC(=O)C(=O)O,IC50,25000.0,4.6,CHEMBL691412,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL20758,CC(C)Oc1ccc(CN=[N+]=[N-])cc1C(=O)CC(=O)C(=O)O,IC50,23000.0,4.64,CHEMBL699988,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL324842,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,IC50,9000.0,5.05,CHEMBL873207,Inhibition of 3'- processing activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL324842,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,IC50,4000.0,5.4,CHEMBL701113,Inhibition of strand transfer activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL20342,[N-]=[N+]=NCc1ccc(C(=O)CC(=O)C(=O)O)cc1CN=[N+]=[N-],IC50,100000.0,,CHEMBL699987,Inhibitory concentration against Recombinant HIV-1 integrase (3'processing),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL20342,[N-]=[N+]=NCc1ccc(C(=O)CC(=O)C(=O)O)cc1CN=[N+]=[N-],IC50,260.0,6.58,CHEMBL691412,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,260.0,6.585026652029182
CHEMBL20342,[N-]=[N+]=NCc1ccc(C(=O)CC(=O)C(=O)O)cc1CN=[N+]=[N-],IC50,150.0,6.82,CHEMBL699988,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,150.0,6.823908740944319
CHEMBL20378,[N-]=[N+]=NCc1cccc(C(=O)CC(=O)C(=O)O)c1,IC50,100000.0,,CHEMBL699987,Inhibitory concentration against Recombinant HIV-1 integrase (3'processing),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL20378,[N-]=[N+]=NCc1cccc(C(=O)CC(=O)C(=O)O)c1,IC50,1530.0,5.82,CHEMBL699988,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1530.0,5.815308569182401
CHEMBL1160386,Nc1ccn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3OC[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]3O)[C@@H](COP(=O)(O)O)O2)c(=O)n1,IC50,7500.0,5.12,CHEMBL701182,Inhibitory concentration required against recombinant wild type HIV integrase by reproducible assay (3' processing),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7500.0,5.1249387366083
CHEMBL1160386,Nc1ccn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3OC[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]3O)[C@@H](COP(=O)(O)O)O2)c(=O)n1,IC50,5900.0,5.23,CHEMBL701183,Inhibitory concentration required against recombinant wild type HIV integrase by reproducible assay (Strand transfer),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5900.0,5.229147988357855
CHEMBL319488,O=C(/C=C/c1ccc(O)c(O)c1)CC(=O)/C=C/c1ccc(O)c(O)c1,IC50,6000.0,5.22,CHEMBL873207,Inhibition of 3'- processing activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL319488,O=C(/C=C/c1ccc(O)c(O)c1)CC(=O)/C=C/c1ccc(O)c(O)c1,IC50,3100.0,5.51,CHEMBL701113,Inhibition of strand transfer activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3100.0,5.508638306165727
CHEMBL20702,COc1ccc(C(=O)CC(=O)C(=O)O)cc1CN=[N+]=[N-],IC50,100000.0,,CHEMBL699987,Inhibitory concentration against Recombinant HIV-1 integrase (3'processing),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL20702,COc1ccc(C(=O)CC(=O)C(=O)O)cc1CN=[N+]=[N-],IC50,8500.0,5.07,CHEMBL691412,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8500.0,5.070581074285707
CHEMBL20702,COc1ccc(C(=O)CC(=O)C(=O)O)cc1CN=[N+]=[N-],IC50,9000.0,5.05,CHEMBL699988,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL20633,[N-]=[N+]=NCc1cc(CN=[N+]=[N-])cc(C(=O)CC(=O)C(=O)O)c1,IC50,100000.0,,CHEMBL699987,Inhibitory concentration against Recombinant HIV-1 integrase (3'processing),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL20633,[N-]=[N+]=NCc1cc(CN=[N+]=[N-])cc(C(=O)CC(=O)C(=O)O)c1,IC50,2800.0,5.55,CHEMBL691412,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL20633,[N-]=[N+]=NCc1cc(CN=[N+]=[N-])cc(C(=O)CC(=O)C(=O)O)c1,IC50,2000.0,5.7,CHEMBL699988,Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL110831,O=C(NNC(=O)c1ccccc1F)c1ccccc1F,IC50,100000.0,,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL110831,O=C(NNC(=O)c1ccccc1F)c1ccccc1F,IC50,100000.0,,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL320075,O=C(NNC(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1,IC50,100000.0,,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL320075,O=C(NNC(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1,IC50,100000.0,,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108311,O=C(NNC(=O)c1ccc(Br)cc1)c1ccc(Br)cc1,IC50,100000.0,,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108311,O=C(NNC(=O)c1ccc(Br)cc1)c1ccc(Br)cc1,IC50,100000.0,,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108310,COc1cc(C(=O)NNC(=O)c2ccc(Cl)cc2)cc(OC)c1OC,IC50,100000.0,,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108310,COc1cc(C(=O)NNC(=O)c2ccc(Cl)cc2)cc(OC)c1OC,IC50,100000.0,,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108302,O=C(O)c1ccccc1C(=O)NNC(=O)c1ccccc1C(=O)O,IC50,100000.0,,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108302,O=C(O)c1ccccc1C(=O)NNC(=O)c1ccccc1C(=O)O,IC50,100000.0,,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL412570,CC1=NN(C(=O)c2ccccc2O)C(=O)/C1=C/c1cccc(O)c1,IC50,900.0,6.05,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL412570,CC1=NN(C(=O)c2ccccc2O)C(=O)/C1=C/c1cccc(O)c1,IC50,7400.0,5.13,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7400.0,5.130768280269024
CHEMBL107778,O=C(NN1C(=O)C(Cl)C1c1ccc([N+](=O)[O-])cc1)c1ccccc1O,IC50,83000.0,4.08,CHEMBL701180,Inhibitory concentration was evaluated as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration in experiment II,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,83000.0,4.080921907623926
CHEMBL321391,COc1ccc(/C=C2/C(=O)N(C(=O)c3ccccc3O)N=C2C)cc1OC,IC50,500.0,6.3,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL321391,COc1ccc(/C=C2/C(=O)N(C(=O)c3ccccc3O)N=C2C)cc1OC,IC50,500.0,6.3,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL108652,O=C(NNC(=O)c1cccc2ccccc12)c1ccccc1Br,IC50,100000.0,,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108652,O=C(NNC(=O)c1cccc2ccccc12)c1ccccc1Br,IC50,100000.0,,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL110782,O=C(NNC(=O)c1ccccc1Br)c1ccccc1Br,IC50,100000.0,,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL110782,O=C(NNC(=O)c1ccccc1Br)c1ccccc1Br,IC50,100000.0,,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108888,O=C(NNC(=O)c1ccccc1F)c1ccc2ccccc2c1,IC50,100000.0,,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108888,O=C(NNC(=O)c1ccccc1F)c1ccc2ccccc2c1,IC50,100000.0,,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL111182,CC1=NN(C(=O)c2ccccc2O)C(=O)/C1=C/c1ccccc1O,IC50,600.0,6.22,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL111182,CC1=NN(C(=O)c2ccccc2O)C(=O)/C1=C/c1ccccc1O,IC50,2800.0,5.55,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL109077,CC1=NN(C(=O)c2ccccc2O)C(=O)/C1=C/c1ccc(O)cc1,IC50,600.0,6.22,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL109077,CC1=NN(C(=O)c2ccccc2O)C(=O)/C1=C/c1ccc(O)cc1,IC50,900.0,6.05,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL421416,O=C(NNC(=O)c1ccc(Cl)c(Cl)c1)c1ccc(Cl)c(Cl)c1,IC50,100000.0,,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL421416,O=C(NNC(=O)c1ccc(Cl)c(Cl)c1)c1ccc(Cl)c(Cl)c1,IC50,100000.0,,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108653,O=C(NNC(=O)c1cccc2ccccc12)c1ccc(Cl)c(Cl)c1,IC50,100000.0,,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108653,O=C(NNC(=O)c1cccc2ccccc12)c1ccc(Cl)c(Cl)c1,IC50,100000.0,,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108031,COc1ccc(/C=C2/C(=O)N(C(=O)c3ccccc3O)N=C2C)cc1,IC50,900.0,6.05,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL108031,COc1ccc(/C=C2/C(=O)N(C(=O)c3ccccc3O)N=C2C)cc1,IC50,600.0,6.22,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL321850,O=C(NNC(=O)c1ccc(Cl)cc1Cl)c1ccc2ccccc2c1,IC50,100000.0,,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL321850,O=C(NNC(=O)c1ccc(Cl)cc1Cl)c1ccc2ccccc2c1,IC50,100000.0,,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108500,O=C(NNC(=O)c1cccc2ccccc12)c1ccccc1F,IC50,100000.0,,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108500,O=C(NNC(=O)c1cccc2ccccc12)c1ccccc1F,IC50,100000.0,,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL325111,COc1cc(/C=C2/C(=O)N(C(=O)c3ccccc3O)N=C2C)ccc1O,IC50,800.0,6.1,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL325111,COc1cc(/C=C2/C(=O)N(C(=O)c3ccccc3O)N=C2C)ccc1O,IC50,600.0,6.22,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL322336,CCOc1ccccc1C(=O)NNC(=O)c1ccccc1OCC,IC50,100000.0,,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL322336,CCOc1ccccc1C(=O)NNC(=O)c1ccccc1OCC,IC50,100000.0,,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL321212,COc1cc(/C=C2/C(=O)N(C(=O)c3ccccc3O)N=C2C)cc(OC)c1OC,IC50,2000.0,5.7,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL321212,COc1cc(/C=C2/C(=O)N(C(=O)c3ccccc3O)N=C2C)cc(OC)c1OC,IC50,2000.0,5.7,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL109788,O=C(NN1C(=O)C(Cl)C1c1cccc(O)c1)c1ccccc1O,IC50,99000.0,4.0,CHEMBL701180,Inhibitory concentration was evaluated as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration in experiment II,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,99000.0,4.00436480540245
CHEMBL110315,CC1=NN(C(=O)c2ccccc2O)C(=O)/C1=C/c1ccc([N+](=O)[O-])cc1,IC50,800.0,6.1,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL110315,CC1=NN(C(=O)c2ccccc2O)C(=O)/C1=C/c1ccc([N+](=O)[O-])cc1,IC50,600.0,6.22,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL432207,CC1=NN(C(=O)c2ccccc2O)C(=O)/C1=C/c1cccc([N+](=O)[O-])c1,IC50,1400.0,5.85,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1400.0,5.853871964321762
CHEMBL432207,CC1=NN(C(=O)c2ccccc2O)C(=O)/C1=C/c1cccc([N+](=O)[O-])c1,IC50,2600.0,5.58,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2600.0,5.585026652029182
CHEMBL108773,O=C(NN1C(=O)C(Cl)C1c1ccccc1Cl)c1ccccc1O,IC50,94000.0,4.03,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,94000.0,4.026872146400302
CHEMBL109453,COc1cc(C2C(Cl)C(=O)N2NC(=O)c2ccccc2O)cc(OC)c1OC,IC50,68800.0,4.16,CHEMBL701177,Inhibitory concentration was evaluated as 50% inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration in experiment I,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68800.0,4.162411561764489
CHEMBL109453,COc1cc(C2C(Cl)C(=O)N2NC(=O)c2ccccc2O)cc(OC)c1OC,IC50,75700.0,4.12,CHEMBL879148,Inhibitory concentration was evaluated as 50% inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration in experiment II,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75700.0,4.120904120499927
CHEMBL109453,COc1cc(C2C(Cl)C(=O)N2NC(=O)c2ccccc2O)cc(OC)c1OC,IC50,73700.0,4.13,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,73700.0,4.132532512140949
CHEMBL108824,O=C(NNC(=O)c1ccc2ccccc2c1)c1ccc(Cl)c(Cl)c1,IC50,100000.0,,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108824,O=C(NNC(=O)c1ccc2ccccc2c1)c1ccc(Cl)c(Cl)c1,IC50,100000.0,,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL321846,CC1=NN(C(=O)c2ccccc2O)C(=O)/C1=C/c1ccco1,IC50,2700.0,5.57,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2700.0,5.568636235841012
CHEMBL321846,CC1=NN(C(=O)c2ccccc2O)C(=O)/C1=C/c1ccco1,IC50,2000.0,5.7,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL111238,COc1cc(C(=O)NNC(=O)c2ccc(Cl)c(Cl)c2)cc(OC)c1OC,IC50,100000.0,,CHEMBL701178,Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL111238,COc1cc(C(=O)NNC(=O)c2ccc(Cl)c(Cl)c2)cc(OC)c1OC,IC50,100000.0,,CHEMBL701181,Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL430776,COc1ccc(-c2c3c4cc(OC)c(OS(=O)(=O)[O-])cc4oc(=O)c3n3ccc4cc(OC)c(OC)cc4c23)cc1O.[Na+],IC50,16000.0,4.8,CHEMBL701726,Inhibitory activity against integrase as yield of terminal cleavage products,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL430776,COc1ccc(-c2c3c4cc(OC)c(OS(=O)(=O)[O-])cc4oc(=O)c3n3ccc4cc(OC)c(OC)cc4c23)cc1O.[Na+],IC50,22000.0,4.66,CHEMBL701726,Inhibitory activity against integrase as yield of terminal cleavage products,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL430776,COc1ccc(-c2c3c4cc(OC)c(OS(=O)(=O)[O-])cc4oc(=O)c3n3ccc4cc(OC)c(OC)cc4c23)cc1O.[Na+],IC50,8000.0,5.1,CHEMBL878464,The compound was tested in vitro for inhibition of HIV-1 replication,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL297923,COc1ccc(-c2c3n(c4c(=O)oc5cc(OS(=O)(=O)[O-])c(OC)cc5c24)C(O)Cc2c-3cc(OC)c(OC)c2OC)cc1O.[Na+],IC50,73000.0,4.14,CHEMBL701726,Inhibitory activity against integrase as yield of terminal cleavage products,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,73000.0,4.136677139879544
CHEMBL297923,COc1ccc(-c2c3n(c4c(=O)oc5cc(OS(=O)(=O)[O-])c(OC)cc5c24)C(O)Cc2c-3cc(OC)c(OC)c2OC)cc1O.[Na+],IC50,51000.0,4.29,CHEMBL701726,Inhibitory activity against integrase as yield of terminal cleavage products,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,51000.0,4.292429823902063
CHEMBL297923,COc1ccc(-c2c3n(c4c(=O)oc5cc(OS(=O)(=O)[O-])c(OC)cc5c24)C(O)Cc2c-3cc(OC)c(OC)c2OC)cc1O.[Na+],IC50,20000.0,4.7,CHEMBL878464,The compound was tested in vitro for inhibition of HIV-1 replication,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL174039,O=C(NNC(=O)c1ccccc1O)c1ccccc1O.O=C(NNCC(O)COc1ccccc1)c1ccccc1O,IC50,2000.0,5.7,CHEMBL699312,Inhibitory concentration against purified recombinant integrase by 3'-processing in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL174039,O=C(NNC(=O)c1ccccc1O)c1ccccc1O.O=C(NNCC(O)COc1ccccc1)c1ccccc1O,IC50,1500.0,5.82,CHEMBL699317,Inhibitory concentration against purified recombinant integrase by strand transfer in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1500.0,5.823908740944319
CHEMBL174039,O=C(NNC(=O)c1ccccc1O)c1ccccc1O.O=C(NNCC(O)COc1ccccc1)c1ccccc1O,IC50,0.6,,CHEMBL699309,Inhibitory concentration against purified recombinant integrase by 3'-processing in 3D search,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,1044.2228371534482,5.981206813001122
CHEMBL174039,O=C(NNC(=O)c1ccccc1O)c1ccccc1O.O=C(NNCC(O)COc1ccccc1)c1ccccc1O,IC50,0.46,,CHEMBL699314,Inhibitory concentration against purified recombinant integrase by strand transfer 3D search,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,800.5708418176436,6.096600231703191
CHEMBL173854,O=C(NCO)NCOCn1c(=O)n(CO)c(=O)n(CO)c1=O,IC50,5300.0,5.28,CHEMBL699312,Inhibitory concentration against purified recombinant integrase by 3'-processing in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5300.0,5.275724130399211
CHEMBL173854,O=C(NCO)NCOCn1c(=O)n(CO)c(=O)n(CO)c1=O,IC50,5000.0,5.3,CHEMBL699317,Inhibitory concentration against purified recombinant integrase by strand transfer in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL173854,O=C(NCO)NCOCn1c(=O)n(CO)c(=O)n(CO)c1=O,IC50,1.7,,CHEMBL699309,Inhibitory concentration against purified recombinant integrase by 3'-processing in 3D search,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,5291.894685070008,5.27638880736966
CHEMBL173854,O=C(NCO)NCOCn1c(=O)n(CO)c(=O)n(CO)c1=O,IC50,1.6,,CHEMBL699314,Inhibitory concentration against purified recombinant integrase by strand transfer 3D search,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,4980.606762418831,5.302717746092009
CHEMBL172072,C[C@H]1C(=O)c2c(cc(O)c(C3OC(CO)C(O)C(O)C3O)c2O)OC1c1ccc(O)c(O)c1,IC50,47600.0,4.32,CHEMBL696660,Inhibitory concentration against purified recombinant integrase by strand transfer in vitro assay (experiment 2),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47600.0,4.3223930472795065
CHEMBL172072,C[C@H]1C(=O)c2c(cc(O)c(C3OC(CO)C(O)C(O)C3O)c2O)OC1c1ccc(O)c(O)c1,IC50,48.0,,CHEMBL699315,Inhibitory concentration against purified recombinant integrase by strand transfer 3D search (experiment 1),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,103354.05438576467,3.985672482144305
CHEMBL172072,C[C@H]1C(=O)c2c(cc(O)c(C3OC(CO)C(O)C(O)C3O)c2O)OC1c1ccc(O)c(O)c1,IC50,22.0,,CHEMBL699316,Inhibitory concentration against purified recombinant integrase by strand transfer 3D search (experiment 2),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,47370.60826014214,4.324491038697686
CHEMBL367001,CCC/C=C/C=C/[C@@H]1C[C@@H](O)[C@@H](O)C(=O)[C@H]1CO,IC50,34.0,,CHEMBL699316,Inhibitory concentration against purified recombinant integrase by strand transfer 3D search (experiment 2),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,133686.68559250725,3.873911843760002
CHEMBL57138,COc1ccc(-c2c3n(c4c(=O)oc5cc(O)c(OC)cc5c24)CCc2c-3cc(OC)c(OC)c2OC)cc1O,IC50,27000.0,4.57,CHEMBL701726,Inhibitory activity against integrase as yield of terminal cleavage products,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27000.0,4.568636235841013
CHEMBL57138,COc1ccc(-c2c3n(c4c(=O)oc5cc(O)c(OC)cc5c24)CCc2c-3cc(OC)c(OC)c2OC)cc1O,IC50,24000.0,4.62,CHEMBL701726,Inhibitory activity against integrase as yield of terminal cleavage products,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL57138,COc1ccc(-c2c3n(c4c(=O)oc5cc(O)c(OC)cc5c24)CCc2c-3cc(OC)c(OC)c2OC)cc1O,IC50,18000.0,4.75,CHEMBL878464,The compound was tested in vitro for inhibition of HIV-1 replication,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL56784,COc1ccc(-c2c3n(c4c(=O)oc5cc(OS(=O)(=O)[O-])c(OC)cc5c24)CCc2cc(OC)c(OC)cc2-3)cc1O.[Na+],IC50,34000.0,4.47,CHEMBL701726,Inhibitory activity against integrase as yield of terminal cleavage products,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34000.0,4.468521082957745
CHEMBL56784,COc1ccc(-c2c3n(c4c(=O)oc5cc(OS(=O)(=O)[O-])c(OC)cc5c24)CCc2cc(OC)c(OC)cc2-3)cc1O.[Na+],IC50,25000.0,4.6,CHEMBL701726,Inhibitory activity against integrase as yield of terminal cleavage products,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL56784,COc1ccc(-c2c3n(c4c(=O)oc5cc(OS(=O)(=O)[O-])c(OC)cc5c24)CCc2cc(OC)c(OC)cc2-3)cc1O.[Na+],IC50,12000.0,4.92,CHEMBL878464,The compound was tested in vitro for inhibition of HIV-1 replication,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL301410,COc1ccc(-c2c3c4cc(OC)c(O)cc4oc(=O)c3n3ccc4c(OC)c(OC)c(OC)cc4c23)cc1O,IC50,19000.0,4.72,CHEMBL701726,Inhibitory activity against integrase as yield of terminal cleavage products,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL301410,COc1ccc(-c2c3c4cc(OC)c(O)cc4oc(=O)c3n3ccc4c(OC)c(OC)c(OC)cc4c23)cc1O,IC50,14000.0,4.85,CHEMBL701726,Inhibitory activity against integrase as yield of terminal cleavage products,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL301410,COc1ccc(-c2c3c4cc(OC)c(O)cc4oc(=O)c3n3ccc4c(OC)c(OC)c(OC)cc4c23)cc1O,IC50,20000.0,4.7,CHEMBL878464,The compound was tested in vitro for inhibition of HIV-1 replication,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL369267,O=C(N/N=C/c1ccc(O)cc1O)N/N=C/c1ccc(O)cc1O,IC50,26000.0,4.58,CHEMBL699312,Inhibitory concentration against purified recombinant integrase by 3'-processing in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26000.0,4.585026652029182
CHEMBL369267,O=C(N/N=C/c1ccc(O)cc1O)N/N=C/c1ccc(O)cc1O,IC50,20600.0,4.69,CHEMBL697788,Inhibitory concentration against purified recombinant integrase by strand transferrin vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20600.0,4.686132779630847
CHEMBL369267,O=C(N/N=C/c1ccc(O)cc1O)N/N=C/c1ccc(O)cc1O,IC50,8.7,,CHEMBL699309,Inhibitory concentration against purified recombinant integrase by 3'-processing in 3D search,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,26339.691189827423,4.579389321072796
CHEMBL369267,O=C(N/N=C/c1ccc(O)cc1O)N/N=C/c1ccc(O)cc1O,IC50,6.8,,CHEMBL872967,Inhibitory concentration against purified recombinant integrase by strand transfer 3D search,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,20587.344838026034,4.686399660985178
CHEMBL301226,COc1ccc(-c2c3c4cc(OC)c(O)cc4oc(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O,IC50,18000.0,4.75,CHEMBL701726,Inhibitory activity against integrase as yield of terminal cleavage products,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL301226,COc1ccc(-c2c3c4cc(OC)c(O)cc4oc(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O,IC50,19000.0,4.72,CHEMBL701726,Inhibitory activity against integrase as yield of terminal cleavage products,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL301226,COc1ccc(-c2c3c4cc(OC)c(O)cc4oc(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O,IC50,1000.0,6.0,CHEMBL878464,The compound was tested in vitro for inhibition of HIV-1 replication,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL174455,O=C(CC(O)(c1ccccc1)c1ccc(Cl)cc1)NC(=O)c1ccccc1O,IC50,40.0,,CHEMBL699315,Inhibitory concentration against purified recombinant integrase by strand transfer 3D search (experiment 1),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,101050.41910661322,3.9954618809085787
CHEMBL174172,O=C(NO)/C(CC(=O)c1ccc(O)cc1O)=N\O,IC50,29900.0,4.52,CHEMBL878458,Inhibitory concentration against purified recombinant integrase by 3'-processing in vitro assay (experiment 1),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,29900.0,4.52432881167557
CHEMBL174172,O=C(NO)/C(CC(=O)c1ccc(O)cc1O)=N\O,IC50,71300.0,4.15,CHEMBL699313,Inhibitory concentration against purified recombinant integrase by 3'-processing in vitro assay (experiment 2),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,71300.0,4.146910470148135
CHEMBL174172,O=C(NO)/C(CC(=O)c1ccc(O)cc1O)=N\O,IC50,16500.0,4.78,CHEMBL696659,Inhibitory concentration against purified recombinant integrase by strand transfer in vitro assay (experiment 1),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16500.0,4.782516055786093
CHEMBL174172,O=C(NO)/C(CC(=O)c1ccc(O)cc1O)=N\O,IC50,35800.0,4.45,CHEMBL696660,Inhibitory concentration against purified recombinant integrase by strand transfer in vitro assay (experiment 2),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35800.0,4.446116973356125
CHEMBL174172,O=C(NO)/C(CC(=O)c1ccc(O)cc1O)=N\O,IC50,7.6,,CHEMBL699310,Inhibitory concentration against purified recombinant integrase by 3'-processing in 3D search (experiment 1),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,29897.953563757383,4.524358536972679
CHEMBL174172,O=C(NO)/C(CC(=O)c1ccc(O)cc1O)=N\O,IC50,18.0,,CHEMBL699311,Inhibitory concentration against purified recombinant integrase by 3'-processing in 3D search (experiment 2),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,70810.94265100433,4.149899624150164
CHEMBL174172,O=C(NO)/C(CC(=O)c1ccc(O)cc1O)=N\O,IC50,4.2,,CHEMBL699315,Inhibitory concentration against purified recombinant integrase by strand transfer 3D search (experiment 1),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,16522.553285234342,4.78192283885557
CHEMBL174172,O=C(NO)/C(CC(=O)c1ccc(O)cc1O)=N\O,IC50,9.1,,CHEMBL699316,Inhibitory concentration against purified recombinant integrase by strand transfer 3D search (experiment 2),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,35798.86545134107,4.446130736932377
CHEMBL173281,O=C1Oc2ccccc2C(O)C1C(c1ccccc1)C1C(=O)Oc2ccccc2C1O,IC50,43400.0,4.36,CHEMBL699312,Inhibitory concentration against purified recombinant integrase by 3'-processing in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43400.0,4.36251027048749
CHEMBL173281,O=C1Oc2ccccc2C(O)C1C(c1ccccc1)C1C(=O)Oc2ccccc2C1O,IC50,38800.0,4.41,CHEMBL699317,Inhibitory concentration against purified recombinant integrase by strand transfer in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38800.0,4.411168274405793
CHEMBL141281,O=C(O)c1cc(C(=CCC23CC4CC(CC(C4)C2)C3)c2cc(Cl)c(O)c(C(=O)O)c2)cc(Cl)c1O,IC50,7000.0,5.16,CHEMBL702105,Inhibition of HIV -1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL3137943,CC(CCC=C(c1cc(Cl)c(O)c(C(=O)O)c1)c1cc(Cl)c(O)c(C(=O)O)c1)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4CCCC[C@]4(C)[C@H]3CC[C@]12C,IC50,2200.0,5.66,CHEMBL702105,Inhibition of HIV -1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2200.0,5.657577319177793
CHEMBL3138187,CC(C)CCCC(C)[C@H]1CC[C@H]2[C@@H]3CCC4C[C@@H](CCC=C(c5cc(Cl)c(O)c(C(=O)O)c5)c5cc(Cl)c(O)c(C(=O)O)c5)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,25000.0,4.6,CHEMBL702105,Inhibition of HIV -1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL3138268,CC(CCC=C(c1cc(Cl)c(O)c(C(=O)O)c1)c1cc(Cl)c(O)c(C(=O)O)c1)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4CC(F)(F)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,2200.0,5.66,CHEMBL702105,Inhibition of HIV -1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2200.0,5.657577319177793
CHEMBL113197,CCCCCC=C(c1cc(Cl)c(O)c(C(=O)NO)c1)c1cc(Cl)c(O)c(C(=O)NO)c1,IC50,4000.0,5.4,CHEMBL702105,Inhibition of HIV -1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL3138267,CC(C)CCCC(C)[C@H]1CC[C@H]2[C@@H]3CCC4CC(=C(c5cc(Cl)c(O)c(C(=O)O)c5)c5cc(Cl)c(O)c(C(=O)O)c5)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,100000.0,,CHEMBL702105,Inhibition of HIV -1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL152850,O=C1NNC(=O)c2ccccc2SSc2ccccc2C(=O)NNC(=O)c2ccccc2SSc2ccccc21,IC50,2400.0,5.62,CHEMBL699298,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and drug for 30 min followed by DNA for 1h) in 3''-processing of preassemble",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2400.0,5.619788758288394
CHEMBL152850,O=C1NNC(=O)c2ccccc2SSc2ccccc2C(=O)NNC(=O)c2ccccc2SSc2ccccc21,IC50,7200.0,5.14,CHEMBL699299,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and drug for 30 min followed by DNA for 1h) in strand transfer of preassemble",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7200.0,5.142667503568731
CHEMBL152850,O=C1NNC(=O)c2ccccc2SSc2ccccc2C(=O)NNC(=O)c2ccccc2SSc2ccccc21,IC50,5000.0,5.3,CHEMBL699296,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and DNA on ice for 15 min followed by drug for 1h) in 3'' processing of postassembly",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL152850,O=C1NNC(=O)c2ccccc2SSc2ccccc2C(=O)NNC(=O)c2ccccc2SSc2ccccc21,IC50,5000.0,5.3,CHEMBL699297,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and DNA on ice for 15 min followed by drug for 1h) in strand transfer of postassembly",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL152850,O=C1NNC(=O)c2ccccc2SSc2ccccc2C(=O)NNC(=O)c2ccccc2SSc2ccccc21,IC50,11000.0,4.96,CHEMBL701287,"Inhibitory activity against HIV-1 integrase (preincubated with Mg+2, and drug for 30 min followed by DNA for 1h) in 3''-processing of preassemble",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL152850,O=C1NNC(=O)c2ccccc2SSc2ccccc2C(=O)NNC(=O)c2ccccc2SSc2ccccc21,IC50,11000.0,4.96,CHEMBL701288,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mg+2, and drug for 30 min followed by DNA for 1h) in strand transfer of preassemble",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL152850,O=C1NNC(=O)c2ccccc2SSc2ccccc2C(=O)NNC(=O)c2ccccc2SSc2ccccc21,IC50,7000.0,5.16,CHEMBL878593,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mg+2, and DNA on ice for 15 min followed by drug for 1h) in 3'' processing of postassembly",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL152850,O=C1NNC(=O)c2ccccc2SSc2ccccc2C(=O)NNC(=O)c2ccccc2SSc2ccccc21,IC50,5000.0,5.3,CHEMBL701286,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mg+2, and DNA on ice for 15 min followed by drug for 1h) in strand transfer of postassembly",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL157428,O=C(NNC(=O)c1ccccc1S)c1ccccc1S,IC50,5100.0,5.29,CHEMBL699298,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and drug for 30 min followed by DNA for 1h) in 3''-processing of preassemble",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5100.0,5.292429823902063
CHEMBL157428,O=C(NNC(=O)c1ccccc1S)c1ccccc1S,IC50,5000.0,5.3,CHEMBL699299,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and drug for 30 min followed by DNA for 1h) in strand transfer of preassemble",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL157428,O=C(NNC(=O)c1ccccc1S)c1ccccc1S,IC50,35000.0,4.46,CHEMBL699296,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and DNA on ice for 15 min followed by drug for 1h) in 3'' processing of postassembly",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL157428,O=C(NNC(=O)c1ccccc1S)c1ccccc1S,IC50,12000.0,4.92,CHEMBL699297,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and DNA on ice for 15 min followed by drug for 1h) in strand transfer of postassembly",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL157428,O=C(NNC(=O)c1ccccc1S)c1ccccc1S,IC50,20000.0,4.7,CHEMBL701287,"Inhibitory activity against HIV-1 integrase (preincubated with Mg+2, and drug for 30 min followed by DNA for 1h) in 3''-processing of preassemble",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL157428,O=C(NNC(=O)c1ccccc1S)c1ccccc1S,IC50,11000.0,4.96,CHEMBL701288,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mg+2, and drug for 30 min followed by DNA for 1h) in strand transfer of preassemble",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL157428,O=C(NNC(=O)c1ccccc1S)c1ccccc1S,IC50,20000.0,4.7,CHEMBL878593,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mg+2, and DNA on ice for 15 min followed by drug for 1h) in 3'' processing of postassembly",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL157428,O=C(NNC(=O)c1ccccc1S)c1ccccc1S,IC50,18000.0,4.75,CHEMBL701286,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mg+2, and DNA on ice for 15 min followed by drug for 1h) in strand transfer of postassembly",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL157373,O=C(NNC(=O)c1ccccc1SSc1ccccc1C(=O)NNC(=O)c1ccccc1S)c1ccccc1S,IC50,3200.0,5.5,CHEMBL699298,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and drug for 30 min followed by DNA for 1h) in 3''-processing of preassemble",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3200.0,5.494850021680094
CHEMBL157373,O=C(NNC(=O)c1ccccc1SSc1ccccc1C(=O)NNC(=O)c1ccccc1S)c1ccccc1S,IC50,3700.0,5.43,CHEMBL699299,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and drug for 30 min followed by DNA for 1h) in strand transfer of preassemble",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3700.0,5.431798275933005
CHEMBL157373,O=C(NNC(=O)c1ccccc1SSc1ccccc1C(=O)NNC(=O)c1ccccc1S)c1ccccc1S,IC50,8000.0,5.1,CHEMBL699296,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and DNA on ice for 15 min followed by drug for 1h) in 3'' processing of postassembly",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL157373,O=C(NNC(=O)c1ccccc1SSc1ccccc1C(=O)NNC(=O)c1ccccc1S)c1ccccc1S,IC50,9000.0,5.05,CHEMBL699297,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and DNA on ice for 15 min followed by drug for 1h) in strand transfer of postassembly",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL157373,O=C(NNC(=O)c1ccccc1SSc1ccccc1C(=O)NNC(=O)c1ccccc1S)c1ccccc1S,IC50,15000.0,4.82,CHEMBL701287,"Inhibitory activity against HIV-1 integrase (preincubated with Mg+2, and drug for 30 min followed by DNA for 1h) in 3''-processing of preassemble",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL157373,O=C(NNC(=O)c1ccccc1SSc1ccccc1C(=O)NNC(=O)c1ccccc1S)c1ccccc1S,IC50,11000.0,4.96,CHEMBL701288,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mg+2, and drug for 30 min followed by DNA for 1h) in strand transfer of preassemble",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL157373,O=C(NNC(=O)c1ccccc1SSc1ccccc1C(=O)NNC(=O)c1ccccc1S)c1ccccc1S,IC50,20000.0,4.7,CHEMBL878593,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mg+2, and DNA on ice for 15 min followed by drug for 1h) in 3'' processing of postassembly",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL157373,O=C(NNC(=O)c1ccccc1SSc1ccccc1C(=O)NNC(=O)c1ccccc1S)c1ccccc1S,IC50,18000.0,4.75,CHEMBL701286,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mg+2, and DNA on ice for 15 min followed by drug for 1h) in strand transfer of postassembly",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL36303,O=C(NNC(=O)c1ccccc1O)c1ccccc1O,IC50,700.0,6.16,CHEMBL699299,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and drug for 30 min followed by DNA for 1h) in strand transfer of preassemble",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL36303,O=C(NNC(=O)c1ccccc1O)c1ccccc1O,IC50,12000.0,4.92,CHEMBL699296,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and DNA on ice for 15 min followed by drug for 1h) in 3'' processing of postassembly",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL36303,O=C(NNC(=O)c1ccccc1O)c1ccccc1O,IC50,10000.0,5.0,CHEMBL699297,"Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and DNA on ice for 15 min followed by drug for 1h) in strand transfer of postassembly",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL40148,O=C(O)c1ccc2ccc(/C=C/c3ccccc3)nc2c1O,IC50,5300.0,5.28,CHEMBL701281,Inhibitory activity against HIV-1 Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5300.0,5.275724130399211
CHEMBL40148,O=C(O)c1ccc2ccc(/C=C/c3ccccc3)nc2c1O,IC50,2100.0,5.68,CHEMBL701283,Inhibitory activity against HIV-1 Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2100.0,5.6777807052660805
CHEMBL129073,O=C(/C=C/c1ccc(O)c(O)c1)/C=C/c1ccc(O)c(O)c1,IC50,600.0,6.22,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL129148,O=C1/C(=C/c2ccc(O)c(O)c2)CCC/C1=C\c1ccc(O)c(O)c1,IC50,900.0,6.05,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL40170,COc1cc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)ccc1O,IC50,2800.0,5.55,CHEMBL701281,Inhibitory activity against HIV-1 Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL40170,COc1cc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)ccc1O,IC50,3700.0,5.43,CHEMBL701283,Inhibitory activity against HIV-1 Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3700.0,5.431798275933005
CHEMBL159251,COc1cc(OC)c2c(OC)c3c(cc2c1-c1c(OC)cc(OC)c2c(OC)c4c(cc12)OC(C)C(C)C4=O)OC(C)C(C)C3=O,IC50,60000.0,4.22,CHEMBL702112,Inhibition of HIV-1 integrase in coupled transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL159251,COc1cc(OC)c2c(OC)c3c(cc2c1-c1c(OC)cc(OC)c2c(OC)c4c(cc12)OC(C)C(C)C4=O)OC(C)C(C)C3=O,IC50,100000.0,,CHEMBL702113,Inhibition of HIV-1 integrase in strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL350391,COc1cc(O)c2c(O)c3c(cc2c1-c1c(OC)cc(OC)c2c(OC)c4c(cc12)OC(C)C(C)C4=O)OC(C)C(C)C3=O,IC50,80000.0,4.1,CHEMBL702112,Inhibition of HIV-1 integrase in coupled transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL350391,COc1cc(O)c2c(O)c3c(cc2c1-c1c(OC)cc(OC)c2c(OC)c4c(cc12)OC(C)C(C)C4=O)OC(C)C(C)C3=O,IC50,100000.0,,CHEMBL702113,Inhibition of HIV-1 integrase in strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL44657,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,100000.0,,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL38420,O=C(O)c1ccc2ccc(/C=C/c3ccco3)nc2c1O,IC50,1900.0,5.72,CHEMBL701282,Inhibitory activity against HIV-1 Integrase in 3'-end- processing was tested in CEM cells,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1900.0,5.721246399047171
CHEMBL38420,O=C(O)c1ccc2ccc(/C=C/c3ccco3)nc2c1O,IC50,5100.0,5.29,CHEMBL701284,Inhibitory activity against HIV-1 Integrase in strand transfer (integration) was tested in CEM cells,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5100.0,5.292429823902063
CHEMBL129134,O=C(/C=C/c1ccc(O)cc1)/C=C/c1ccc(O)cc1,IC50,100000.0,,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL159546,C[C@@H]1Oc2cc3c(-c4c(O)cc(O)c5c(O)c6c(cc45)O[C@H](C)[C@@H](C)C(=O)O6)c(O)cc(O)c3c(O)c2C(=O)[C@@H]1C,IC50,3000.0,5.52,CHEMBL702112,Inhibition of HIV-1 integrase in coupled transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL159546,C[C@@H]1Oc2cc3c(-c4c(O)cc(O)c5c(O)c6c(cc45)O[C@H](C)[C@@H](C)C(=O)O6)c(O)cc(O)c3c(O)c2C(=O)[C@@H]1C,IC50,9000.0,5.05,CHEMBL702113,Inhibition of HIV-1 integrase in strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL162235,COc1cc(O)c2c(OC)c3c(cc2c1-c1c(OC)cc(OC)c2c(OC)c4c(cc12)OC(C)C(C)C4=O)OC(C)C(C)C3=O,IC50,40000.0,4.4,CHEMBL702112,Inhibition of HIV-1 integrase in coupled transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL162235,COc1cc(O)c2c(OC)c3c(cc2c1-c1c(OC)cc(OC)c2c(OC)c4c(cc12)OC(C)C(C)C4=O)OC(C)C(C)C3=O,IC50,100000.0,,CHEMBL702113,Inhibition of HIV-1 integrase in strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL126625,O=C1/C(=C/c2ccc(O)c(O)c2)Cc2ccccc21,IC50,86000.0,4.07,CHEMBL701800,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,86000.0,4.0655015487564325
CHEMBL431508,O=C(O)c1ccc2ccc(/C=C/c3ccc([N+](=O)[O-])cc3)nc2c1O,IC50,1200.0,5.92,CHEMBL701281,Inhibitory activity against HIV-1 Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL431508,O=C(O)c1ccc2ccc(/C=C/c3ccc([N+](=O)[O-])cc3)nc2c1O,IC50,1700.0,5.77,CHEMBL701283,Inhibitory activity against HIV-1 Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL37845,O=C(O)c1ccc2ccc(/C=C/c3cc(O)c(O)c(I)c3)nc2c1O,IC50,4000.0,5.4,CHEMBL699300,Inhibitory activity against Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL37845,O=C(O)c1ccc2ccc(/C=C/c3cc(O)c(O)c(I)c3)nc2c1O,IC50,4900.0,5.31,CHEMBL872965,Inhibitory activity against Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4900.0,5.309803919971486
CHEMBL127028,O=C(/C=C/c1ccc(O)c(O)c1)CCc1ccccc1,IC50,100000.0,,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL105350,O=C(/C=C/c1ccc(O)cc1)CC(=O)/C=C/c1ccc(O)cc1,IC50,100000.0,,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL39481,CC(=O)Nc1ccc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc1,IC50,1400.0,5.85,CHEMBL701281,Inhibitory activity against HIV-1 Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1400.0,5.853871964321762
CHEMBL39481,CC(=O)Nc1ccc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc1,IC50,1200.0,5.92,CHEMBL701283,Inhibitory activity against HIV-1 Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL37139,COc1ccc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc1O,IC50,900.0,6.05,CHEMBL701281,Inhibitory activity against HIV-1 Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL37139,COc1ccc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc1O,IC50,3300.0,5.48,CHEMBL701283,Inhibitory activity against HIV-1 Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3300.0,5.481486060122112
CHEMBL129795,O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O,IC50,100000.0,,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL39301,O=C(O)c1ccc2ccc(/C=C/c3cc(Br)c(O)c(Br)c3)nc2c1O,IC50,1300.0,5.89,CHEMBL701281,Inhibitory activity against HIV-1 Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL39301,O=C(O)c1ccc2ccc(/C=C/c3cc(Br)c(O)c(Br)c3)nc2c1O,IC50,1200.0,5.92,CHEMBL701283,Inhibitory activity against HIV-1 Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL340775,Cl.O=C1/C(=C/c2ccc(O)c(O)c2)CNC/C1=C\c1ccc(O)c(O)c1,IC50,200.0,6.7,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL128000,O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(O)cc1O,IC50,20000.0,4.7,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL129510,O=C(/C=C/c1ccc(O)c(O)c1)c1ccccc1,IC50,2300.0,5.64,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2300.0,5.638272163982407
CHEMBL39958,O=C(O)c1ccc2ccc(/C=C/c3cc(O)cc(O)c3)nc2c1O,IC50,3200.0,5.5,CHEMBL699300,Inhibitory activity against Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3200.0,5.494850021680094
CHEMBL39958,O=C(O)c1ccc2ccc(/C=C/c3cc(O)cc(O)c3)nc2c1O,IC50,3200.0,5.5,CHEMBL878457,Inhibitory activity against Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3200.0,5.494850021680094
CHEMBL39725,Oc1ccc(/C=C/c2ccc3c(Cl)cc(Cl)c(O)c3n2)cc1O,IC50,100000.0,,CHEMBL699300,Inhibitory activity against Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL39725,Oc1ccc(/C=C/c2ccc3c(Cl)cc(Cl)c(O)c3n2)cc1O,IC50,100000.0,,CHEMBL872965,Inhibitory activity against Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL289303,O=C(O)c1ccc2ccc(CCc3ccc(O)c(O)c3)nc2c1O,IC50,2300.0,5.64,CHEMBL699300,Inhibitory activity against Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2300.0,5.638272163982407
CHEMBL289303,O=C(O)c1ccc2ccc(CCc3ccc(O)c(O)c3)nc2c1O,IC50,1500.0,5.82,CHEMBL872965,Inhibitory activity against Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1500.0,5.823908740944319
CHEMBL287903,O=C(O)c1ccc2ccc(/C=C/c3ccsc3)nc2c1O,IC50,3400.0,5.47,CHEMBL701281,Inhibitory activity against HIV-1 Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3400.0,5.468521082957745
CHEMBL287903,O=C(O)c1ccc2ccc(/C=C/c3ccsc3)nc2c1O,IC50,3000.0,5.52,CHEMBL701283,Inhibitory activity against HIV-1 Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL349925,Cc1oc2cc3c(-c4c(O)cc(O)c5c(O)c6c(cc45)O[C@H](C)[C@H](C)C6=O)c(O)cc(O)c3c(O)c2c(=O)c1C,IC50,1000.0,6.0,CHEMBL702112,Inhibition of HIV-1 integrase in coupled transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL349925,Cc1oc2cc3c(-c4c(O)cc(O)c5c(O)c6c(cc45)O[C@H](C)[C@H](C)C6=O)c(O)cc(O)c3c(O)c2c(=O)c1C,IC50,4000.0,5.4,CHEMBL702113,Inhibition of HIV-1 integrase in strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL39883,Nc1ccc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc1,IC50,3500.0,5.46,CHEMBL701281,Inhibitory activity against HIV-1 Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3500.0,5.455931955649724
CHEMBL39883,Nc1ccc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc1,IC50,2200.0,5.66,CHEMBL701283,Inhibitory activity against HIV-1 Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2200.0,5.657577319177793
CHEMBL17205,COc1cc(/C=C2\CCC/C(=C\c3ccc(O)c(OC)c3)C2=O)ccc1O,IC50,100000.0,,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL341135,O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(O)cc1,IC50,1300.0,5.89,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL162783,CC1Oc2cc3c(-c4c(O)cc(O)c5c(O)c6c(cc45)OC(C)C(C)C6=O)c(O)cc(O)c3c(O)c2C(=O)C1C,IC50,2000.0,5.7,CHEMBL702112,Inhibition of HIV-1 integrase in coupled transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL162783,CC1Oc2cc3c(-c4c(O)cc(O)c5c(O)c6c(cc45)OC(C)C(C)C6=O)c(O)cc(O)c3c(O)c2C(=O)C1C,IC50,12000.0,4.92,CHEMBL702113,Inhibition of HIV-1 integrase in strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL232801,Nc1nc[nH]n1,IC50,170.0,6.77,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,170.0,6.769551078621726
CHEMBL128748,COc1ccc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OC)c(OC)c2)cc1OC,IC50,100000.0,,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL340202,O=C(/C=C/c1ccc(O)cc1)c1cccc(C(=O)/C=C/c2ccc(O)cc2)c1,IC50,30000.0,4.52,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL65,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,100000.0,,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL349452,CC(=O)Oc1cc(OC(C)=O)c2c(OC(C)=O)c3c(cc2c1-c1c(OC(C)=O)cc(OC(C)=O)c2c(OC(C)=O)c4c(cc12)OC(C)C(C)C4=O)OC(C)C(C)C3=O,IC50,50000.0,4.3,CHEMBL702112,Inhibition of HIV-1 integrase in coupled transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL349452,CC(=O)Oc1cc(OC(C)=O)c2c(OC(C)=O)c3c(cc2c1-c1c(OC(C)=O)cc(OC(C)=O)c2c(OC(C)=O)c4c(cc12)OC(C)C(C)C4=O)OC(C)C(C)C3=O,IC50,100000.0,,CHEMBL702113,Inhibition of HIV-1 integrase in strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL129913,O=C(/C=C(O)/C=C/c1ccccc1)/C=C/c1ccccc1,IC50,100000.0,,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL83598,O=C1C(=Cc2ccc(O)c(O)c2)C(=O)c2ccccc21,IC50,3000.0,5.52,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL129964,O=C(/C=C(O)/C=C/c1ccc(O)c(O)c1)/C=C/c1ccc(O)c(O)c1,IC50,700.0,6.16,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL419981,O=C1/C(=C/c2ccc(O)c(O)c2)COC/C1=C\c1ccc(O)c(O)c1,IC50,200.0,6.7,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL36585,COC(=O)c1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O,IC50,100000.0,,CHEMBL699300,Inhibitory activity against Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL36585,COC(=O)c1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O,IC50,100000.0,,CHEMBL872965,Inhibitory activity against Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,IC50,30000.0,4.52,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL276080,O=C1/C(=C/c2ccc(O)c(O)c2)CC/C1=C\c1ccc(O)c(O)c1,IC50,1000.0,6.0,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL423698,COc1ccc(/C=C/C(=O)/C=C/c2ccc(OC)c(OC)c2)cc1OC,IC50,100000.0,,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL350391,COc1cc(O)c2c(O)c3c(cc2c1-c1c(OC)cc(OC)c2c(OC)c4c(cc12)OC(C)C(C)C4=O)OC(C)C(C)C3=O,IC50,40000.0,4.4,CHEMBL702112,Inhibition of HIV-1 integrase in coupled transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL350391,COc1cc(O)c2c(O)c3c(cc2c1-c1c(OC)cc(OC)c2c(OC)c4c(cc12)OC(C)C(C)C4=O)OC(C)C(C)C3=O,IC50,100000.0,,CHEMBL702113,Inhibition of HIV-1 integrase in strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL37431,COc1cc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc(OC)c1O,IC50,4900.0,5.31,CHEMBL701281,Inhibitory activity against HIV-1 Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4900.0,5.309803919971486
CHEMBL37431,COc1cc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc(OC)c1O,IC50,4500.0,5.35,CHEMBL701283,Inhibitory activity against HIV-1 Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4500.0,5.346787486224656
CHEMBL39143,O=C(O)c1ccc2ccc(/C=C/c3cccnc3)nc2c1O,IC50,4100.0,5.39,CHEMBL701281,Inhibitory activity against HIV-1 Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4100.0,5.3872161432802645
CHEMBL39143,O=C(O)c1ccc2ccc(/C=C/c3cccnc3)nc2c1O,IC50,11000.0,4.96,CHEMBL701283,Inhibitory activity against HIV-1 Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL339815,O=C(/C=C/c1ccc(O)c(O)c1)c1cccc(C(=O)/C=C/c2ccc(O)c(O)c2)c1,IC50,800.0,6.1,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL162783,CC1Oc2cc3c(-c4c(O)cc(O)c5c(O)c6c(cc45)OC(C)C(C)C6=O)c(O)cc(O)c3c(O)c2C(=O)C1C,IC50,2000.0,5.7,CHEMBL702112,Inhibition of HIV-1 integrase in coupled transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL162783,CC1Oc2cc3c(-c4c(O)cc(O)c5c(O)c6c(cc45)OC(C)C(C)C6=O)c(O)cc(O)c3c(O)c2C(=O)C1C,IC50,12000.0,4.92,CHEMBL702113,Inhibition of HIV-1 integrase in strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL36640,COc1cc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc(O)c1O,IC50,700.0,6.16,CHEMBL699300,Inhibitory activity against Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL36640,COc1cc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc(O)c1O,IC50,1700.0,5.77,CHEMBL872965,Inhibitory activity against Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL349440,COc1cc(O)c2c(OC)c3c(cc2c1-c1c(O)cc(OC)c2c(OC)c4c(cc12)OC(C)C(C)C4=O)OC(C)C(C)C3=O,IC50,8000.0,5.1,CHEMBL702112,Inhibition of HIV-1 integrase in coupled transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL349440,COc1cc(O)c2c(OC)c3c(cc2c1-c1c(O)cc(OC)c2c(OC)c4c(cc12)OC(C)C(C)C4=O)OC(C)C(C)C3=O,IC50,100000.0,,CHEMBL702113,Inhibition of HIV-1 integrase in strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL418613,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)cc3)nc2c1O,IC50,1600.0,5.8,CHEMBL701281,Inhibitory activity against HIV-1 Integrase in 3'-end- processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL418613,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)cc3)nc2c1O,IC50,1600.0,5.8,CHEMBL701283,Inhibitory activity against HIV-1 Integrase in strand transfer (integration),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL130911,O=C1/C(=C/c2ccc(O)c(O)c2)CSC/C1=C\c1ccc(O)c(O)c1,IC50,200.0,6.7,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL128729,COc1cc(/C=C/C(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,IC50,37000.0,4.43,CHEMBL702428,Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50%,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL137024,O=C1NC(=O)C(c2ccc(O)c(O)c2)=C1c1ccc(O)c(O)c1,IC50,15500.0,4.81,CHEMBL702338,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15500.0,4.809668301829708
CHEMBL420299,O=C1Sc2ccc(Br)cc2C(=O)N2CSCC12,IC50,87000.0,4.06,CHEMBL699513,Inhibition of the 3'-processing activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,87000.0,4.060480747381382
CHEMBL420299,O=C1Sc2ccc(Br)cc2C(=O)N2CSCC12,IC50,74000.0,4.13,CHEMBL699512,Inhibition of the 3'-end joining activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,74000.0,4.130768280269024
CHEMBL323255,O=C1Sc2ccc(Br)cc2C(=O)N2CCSC12,IC50,58000.0,4.24,CHEMBL699513,Inhibition of the 3'-processing activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58000.0,4.236572006437063
CHEMBL323255,O=C1Sc2ccc(Br)cc2C(=O)N2CCSC12,IC50,48000.0,4.32,CHEMBL699512,Inhibition of the 3'-end joining activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48000.0,4.318758762624412
CHEMBL112046,Cc1ccc2c(c1)C(=O)N1CCSC1C(=O)S2,IC50,64000.0,4.19,CHEMBL699513,Inhibition of the 3'-processing activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,64000.0,4.1938200260161125
CHEMBL112046,Cc1ccc2c(c1)C(=O)N1CCSC1C(=O)S2,IC50,55000.0,4.26,CHEMBL699512,Inhibition of the 3'-end joining activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55000.0,4.259637310505756
CHEMBL422992,O=C(O)C(c1ccc(O)c(O)c1)C(C(=O)O)c1ccc(O)c(O)c1,IC50,23600.0,4.63,CHEMBL702338,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23600.0,4.627087997029894
CHEMBL120931,O=C(O)C(Cc1ccc(O)c(O)c1)C(Cc1ccc(O)c(O)c1)C(=O)O,IC50,19100.0,4.72,CHEMBL702338,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19100.0,4.718966632752273
CHEMBL139149,O=C1OC(=O)C(c2ccc(O)c(O)c2)=C1c1ccc(O)c(O)c1,IC50,3800.0,5.42,CHEMBL702338,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3800.0,5.42021640338319
CHEMBL326800,Cc1ccc2c(c1)C(=O)N1CSCC1C(=O)S2,IC50,52000.0,4.28,CHEMBL699513,Inhibition of the 3'-processing activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52000.0,4.2839966563652006
CHEMBL326800,Cc1ccc2c(c1)C(=O)N1CSCC1C(=O)S2,IC50,63000.0,4.2,CHEMBL699512,Inhibition of the 3'-end joining activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,63000.0,4.200659450546418
CHEMBL326050,O=C1Sc2cc3ccccc3cc2C(=O)N2CSCC12,IC50,92000.0,4.04,CHEMBL699513,Inhibition of the 3'-processing activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,92000.0,4.036212172654444
CHEMBL326050,O=C1Sc2cc3ccccc3cc2C(=O)N2CSCC12,IC50,100000.0,4.0,CHEMBL699512,Inhibition of the 3'-end joining activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL327047,O=C1Sc2cc([N+](=O)[O-])ccc2C(=O)N2CSCC12,IC50,90000.0,4.05,CHEMBL699513,Inhibition of the 3'-processing activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL327047,O=C1Sc2cc([N+](=O)[O-])ccc2C(=O)N2CSCC12,IC50,100000.0,4.0,CHEMBL699512,Inhibition of the 3'-end joining activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL282731,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H](C(=O)O)[C@@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,13700.0,4.86,CHEMBL702338,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13700.0,4.863279432843593
CHEMBL342488,O=C(O)c1[nH]c(C(=O)O)c(-c2ccc(O)c(O)c2)c1-c1ccc(O)c(O)c1,IC50,5300.0,5.28,CHEMBL702338,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5300.0,5.275724130399211
CHEMBL442011,COc1ccc2c(c1)C(=O)N1C[S+]([O-])CC1C(=O)S2,IC50,84500.0,4.07,CHEMBL699513,Inhibition of the 3'-processing activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,84500.0,4.073143291050307
CHEMBL33475,O=C1Sc2cc3ccccc3cc2C(=O)N2CCSC12,IC50,40000.0,4.4,CHEMBL699513,Inhibition of the 3'-processing activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL33475,O=C1Sc2cc3ccccc3cc2C(=O)N2CCSC12,IC50,47000.0,4.33,CHEMBL699512,Inhibition of the 3'-end joining activity of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47000.0,4.327902142064283
CHEMBL31607,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1CCCC[C@@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,24800.0,,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24800.0,4.605548319173784
CHEMBL31607,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1CCCC[C@@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,7600.0,5.12,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7600.0,5.119186407719209
CHEMBL31044,O=C(/C=C/c1ccc(O)c(O)c1)NCCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,27500.0,,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27500.0,4.560667306169737
CHEMBL31044,O=C(/C=C/c1ccc(O)c(O)c1)NCCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,6500.0,5.19,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6500.0,5.187086643357144
CHEMBL30522,CC(=O)Oc1ccc(/C=C/C(=O)OCCOC(=O)/C=C/c2ccc(OC(C)=O)c(OC(C)=O)c2)cc1OC(C)=O,IC50,100000.0,,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL30522,CC(=O)Oc1ccc(/C=C/C(=O)OCCOC(=O)/C=C/c2ccc(OC(C)=O)c(OC(C)=O)c2)cc1OC(C)=O,IC50,100000.0,,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL29831,CC(=O)Oc1ccc(/C=C/C(=O)NCC(NC(=O)/C=C/c2ccc(OC(C)=O)c(OC(C)=O)c2)C(=O)O)cc1OC(C)=O,IC50,4100.0,5.39,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4100.0,5.3872161432802645
CHEMBL29831,CC(=O)Oc1ccc(/C=C/C(=O)NCC(NC(=O)/C=C/c2ccc(OC(C)=O)c(OC(C)=O)c2)C(=O)O)cc1OC(C)=O,IC50,4100.0,5.39,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4100.0,5.3872161432802645
CHEMBL29660,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](C(=O)O)[C@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,1100.0,5.96,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1100.0,5.958607314841775
CHEMBL29660,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](C(=O)O)[C@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,500.0,6.3,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL286477,O=C(/C=C/c1ccc(O)c(O)c1)OCCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,400.0,6.4,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL286477,O=C(/C=C/c1ccc(O)c(O)c1)OCCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,400.0,6.4,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL32133,COC(=O)C(COC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1)OC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1,IC50,10100.0,5.0,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10100.0,4.995678626217358
CHEMBL32133,COC(=O)C(COC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1)OC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1,IC50,10100.0,5.0,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10100.0,4.995678626217358
CHEMBL31026,O=C(/C=C/c1ccc(O)c(O)c1)OCCCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,27500.0,4.56,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27500.0,4.560667306169737
CHEMBL31026,O=C(/C=C/c1ccc(O)c(O)c1)OCCCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,7500.0,5.12,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7500.0,5.1249387366083
CHEMBL284749,CC(=O)Oc1ccc(/C=C/C(=O)OCC(OC(=O)/C=C/c2ccc(OC(C)=O)c(OC(C)=O)c2)C(=O)O)cc1OC(C)=O,IC50,2100.0,5.68,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2100.0,5.6777807052660805
CHEMBL284749,CC(=O)Oc1ccc(/C=C/C(=O)OCC(OC(=O)/C=C/c2ccc(OC(C)=O)c(OC(C)=O)c2)C(=O)O)cc1OC(C)=O,IC50,2800.0,5.55,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL30455,CC(=O)Oc1ccc(/C=C/C(=O)O[C@H](C(=O)O)[C@H](OC(=O)/C=C/c2ccc(OC(C)=O)c(OC(C)=O)c2)C(=O)O)cc1OC(C)=O,IC50,33300.0,4.48,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33300.0,4.47755576649368
CHEMBL30455,CC(=O)Oc1ccc(/C=C/C(=O)O[C@H](C(=O)O)[C@H](OC(=O)/C=C/c2ccc(OC(C)=O)c(OC(C)=O)c2)C(=O)O)cc1OC(C)=O,IC50,4600.0,5.34,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4600.0,5.337242168318426
CHEMBL36586,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)cc3O)nc2c1O,IC50,2500.0,5.6,CHEMBL701163,Inhibition of human immunodeficiency virus-1 (HIV-1) integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL30868,O=C(/C=C/c1ccc(O)c(O)c1)OCC(OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,4200.0,5.38,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4200.0,5.376750709602099
CHEMBL30868,O=C(/C=C/c1ccc(O)c(O)c1)OCC(OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,1700.0,5.77,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL31883,C[C@H](OC(=O)/C=C/c1ccc(O)c(O)c1)[C@H](C)OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,38400.0,,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38400.0,4.4156687756324695
CHEMBL31883,C[C@H](OC(=O)/C=C/c1ccc(O)c(O)c1)[C@H](C)OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,7800.0,5.11,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7800.0,5.107905397309519
CHEMBL30922,COC(=O)[C@H](COC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1)NC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1,IC50,2800.0,5.55,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL30922,COC(=O)[C@H](COC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1)NC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1,IC50,3800.0,5.42,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3800.0,5.42021640338319
CHEMBL34400,COC(=O)[C@@H](COC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1)NC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1,IC50,2800.0,5.55,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL34400,COC(=O)[C@@H](COC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1)NC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1,IC50,3200.0,5.5,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3200.0,5.494850021680094
CHEMBL416582,CC(=O)Oc1ccc(/C=C/C(=O)NCCOC(=O)/C=C/c2ccc(OC(C)=O)c(OC(C)=O)c2)cc1OC(C)=O,IC50,100000.0,4.0,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL282731,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H](C(=O)O)[C@@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,1100.0,5.96,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1100.0,5.958607314841775
CHEMBL282731,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H](C(=O)O)[C@@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,800.0,6.1,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL30434,COC(=O)C(COC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1)NC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1,IC50,2500.0,5.6,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL30434,COC(=O)C(COC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1)NC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1,IC50,3200.0,5.5,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3200.0,5.494850021680094
CHEMBL416207,O=C(/C=C/c1ccc(O)c(O)c1)NC(COC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,3300.0,5.48,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3300.0,5.481486060122112
CHEMBL416207,O=C(/C=C/c1ccc(O)c(O)c1)NC(COC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,1700.0,5.77,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL281929,COC(=O)[C@@H](CNC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1)NC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1,IC50,10900.0,4.96,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10900.0,4.962573502059376
CHEMBL281929,COC(=O)[C@@H](CNC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1)NC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1,IC50,10000.0,5.0,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL29369,CC(=O)Oc1ccc(/C=C/C(=O)O[C@@H](C(=O)O)[C@@H](OC(=O)/C=C/c2ccc(OC(C)=O)c(OC(C)=O)c2)C(=O)O)cc1OC(C)=O,IC50,9800.0,5.01,CHEMBL702431,Compound was evaluated for the inhibitory concentration against HIV-1 integrase by radiolabeled oligonucleotide-based assay 3''-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9800.0,5.008773924307505
CHEMBL29369,CC(=O)Oc1ccc(/C=C/C(=O)O[C@@H](C(=O)O)[C@@H](OC(=O)/C=C/c2ccc(OC(C)=O)c(OC(C)=O)c2)C(=O)O)cc1OC(C)=O,IC50,6200.0,5.21,CHEMBL701159,Inhibition of HIV-1 integrase by radiolabeled oligonucleotide-based assay integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6200.0,5.207608310501746
CHEMBL108423,O=C(O)C(=O)/C=C(\O)c1ccc(Oc2ccccc2)cc1,IC50,100000.0,,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108423,O=C(O)C(=O)/C=C(\O)c1ccc(Oc2ccccc2)cc1,IC50,7800.0,5.11,CHEMBL701716,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7800.0,5.107905397309519
CHEMBL108423,O=C(O)C(=O)/C=C(\O)c1ccc(Oc2ccccc2)cc1,IC50,15000.0,4.82,CHEMBL701717,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL128740,NNS(=O)(=O)c1ccc(OCC(=O)O)cc1,IC50,8200.0,5.09,CHEMBL701186,Inhibitory concentration to inhibit HIV-1 integrase by 3' -processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8200.0,5.086186147616283
CHEMBL128740,NNS(=O)(=O)c1ccc(OCC(=O)O)cc1,IC50,8800.0,5.06,CHEMBL699308,Inhibitory concentration against HIV-1 integrase by strand transfer method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8800.0,5.055517327849831
CHEMBL338145,CC1=NN(c2ccccc2)C(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2nccc(C)n2)cc1,IC50,49000.0,4.31,CHEMBL701186,Inhibitory concentration to inhibit HIV-1 integrase by 3' -processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,49000.0,4.309803919971486
CHEMBL338145,CC1=NN(c2ccccc2)C(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2nccc(C)n2)cc1,IC50,23600.0,4.63,CHEMBL699308,Inhibitory concentration against HIV-1 integrase by strand transfer method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23600.0,4.627087997029894
CHEMBL108240,COc1cc(Cn2nnnc2C(=O)/C=C(\O)c2c[nH]c3ccccc23)cc(OC)c1,IC50,100000.0,,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108240,COc1cc(Cn2nnnc2C(=O)/C=C(\O)c2c[nH]c3ccccc23)cc(OC)c1,IC50,100000.0,,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL324018,COc1ccc(Cn2nnnc2C(=O)/C=C(\O)c2c[nH]c3ccc(Cl)cc23)cc1,IC50,100000.0,,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL324018,COc1ccc(Cn2nnnc2C(=O)/C=C(\O)c2c[nH]c3ccc(Cl)cc23)cc1,IC50,34000.0,4.47,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34000.0,4.468521082957745
CHEMBL440016,O=C1NC(=S)SC1c1ccc(S(=O)(=O)Nc2ncccn2)cc1,IC50,28600.0,4.54,CHEMBL701186,Inhibitory concentration to inhibit HIV-1 integrase by 3' -processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28600.0,4.543633966870957
CHEMBL440016,O=C1NC(=S)SC1c1ccc(S(=O)(=O)Nc2ncccn2)cc1,IC50,14000.0,4.85,CHEMBL699308,Inhibitory concentration against HIV-1 integrase by strand transfer method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL108511,O=C(O)C(=O)/C=C(\O)c1cccc(/C(O)=C/C(=O)C(=O)O)c1,IC50,7800.0,5.11,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7800.0,5.107905397309519
CHEMBL108511,O=C(O)C(=O)/C=C(\O)c1cccc(/C(O)=C/C(=O)C(=O)O)c1,IC50,1830.0,5.74,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1830.0,5.73754891026957
CHEMBL3348566,O=C(CC(=O)c1c[nH]c2ccc(F)cc12)c1nnn[nH]1,IC50,79000.0,4.1,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,79000.0,4.102372908709558
CHEMBL3348566,O=C(CC(=O)c1c[nH]c2ccc(F)cc12)c1nnn[nH]1,IC50,1800.0,5.75,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL611459,,IC50,11500.0,4.94,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11500.0,4.939302159646388
CHEMBL611459,,IC50,810.0,6.09,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,810.0,6.0915149811213505
CHEMBL108253,O=C(O)C(=O)/C=C(\O)c1cccc(OCc2ccccc2)c1,IC50,65000.0,4.19,CHEMBL701713,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL108253,O=C(O)C(=O)/C=C(\O)c1cccc(OCc2ccccc2)c1,IC50,100000.0,4.0,CHEMBL701714,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108253,O=C(O)C(=O)/C=C(\O)c1cccc(OCc2ccccc2)c1,IC50,350.0,6.46,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,350.0,6.455931955649724
CHEMBL432788,O=C(O)C(=O)/C=C(\O)c1ccnc2ccccc12,IC50,100000.0,,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL432788,O=C(O)C(=O)/C=C(\O)c1ccnc2ccccc12,IC50,100000.0,,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3348565,O=C(CC(=O)c1c[nH]c2ccccc12)c1nnn[nH]1,IC50,100000.0,,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3348565,O=C(CC(=O)c1c[nH]c2ccccc12)c1nnn[nH]1,IC50,1900.0,5.72,CHEMBL701716,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1900.0,5.721246399047171
CHEMBL3348565,O=C(CC(=O)c1c[nH]c2ccccc12)c1nnn[nH]1,IC50,2000.0,5.7,CHEMBL701717,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL322472,O=C(O)C(=O)/C=C(\O)c1cccc(NC(=O)c2ccccc2)c1,IC50,100000.0,,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL322472,O=C(O)C(=O)/C=C(\O)c1cccc(NC(=O)c2ccccc2)c1,IC50,35000.0,4.46,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL108150,CCOC(=O)C(=O)/C=C(\O)c1c[nH]c2ccc(Cl)cc12,IC50,100000.0,,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL108150,CCOC(=O)C(=O)/C=C(\O)c1c[nH]c2ccc(Cl)cc12,IC50,6900.0,5.16,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6900.0,5.161150909262744
CHEMBL22197,O=C(O)C(=O)/C=C(\O)c1cccc(Br)c1,IC50,100000.0,,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL22197,O=C(O)C(=O)/C=C(\O)c1cccc(Br)c1,IC50,2000.0,5.7,CHEMBL701716,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL22197,O=C(O)C(=O)/C=C(\O)c1cccc(Br)c1,IC50,3000.0,5.52,CHEMBL701717,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL172888,Cc1nnc(NS(=O)(=O)c2ccc(C3SC(=S)NC3=O)cc2)s1,IC50,24000.0,4.62,CHEMBL701186,Inhibitory concentration to inhibit HIV-1 integrase by 3' -processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL172888,Cc1nnc(NS(=O)(=O)c2ccc(C3SC(=S)NC3=O)cc2)s1,IC50,19000.0,4.72,CHEMBL699308,Inhibitory concentration against HIV-1 integrase by strand transfer method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL421450,CC(=O)C1(/N=N/c2ccc(S(=O)(=O)Nc3nccc(C)n3)cc2)CCOC1=O,IC50,70000.0,4.16,CHEMBL701186,Inhibitory concentration to inhibit HIV-1 integrase by 3' -processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL421450,CC(=O)C1(/N=N/c2ccc(S(=O)(=O)Nc3nccc(C)n3)cc2)CCOC1=O,IC50,65000.0,4.19,CHEMBL699308,Inhibitory concentration against HIV-1 integrase by strand transfer method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL111081,COc1ccc(Cn2nnnc2C(=O)/C=C(\O)c2c[nH]c3ccccc23)cc1,IC50,100000.0,,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL111081,COc1ccc(Cn2nnnc2C(=O)/C=C(\O)c2c[nH]c3ccccc23)cc1,IC50,100000.0,,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3348567,O=C(O)c1ccc2[nH]cc(C(=O)CC(=O)c3nnn[nH]3)c2c1,IC50,40000.0,4.4,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL3348567,O=C(O)c1ccc2[nH]cc(C(=O)CC(=O)c3nnn[nH]3)c2c1,IC50,40000.0,4.4,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL16326,O=C(O)C(=O)/C=C(\O)c1ccccc1,IC50,100000.0,,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL16326,O=C(O)C(=O)/C=C(\O)c1ccccc1,IC50,24200.0,4.62,CHEMBL701716,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24200.0,4.616184634019569
CHEMBL16326,O=C(O)C(=O)/C=C(\O)c1ccccc1,IC50,25000.0,4.6,CHEMBL701717,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL107490,COc1ccc(Cn2nnnc2C(=O)/C=C(\O)c2cc(OCc3ccccc3)cc(OCc3ccccc3)c2)cc1,IC50,100000.0,,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL107490,COc1ccc(Cn2nnnc2C(=O)/C=C(\O)c2cc(OCc3ccccc3)cc(OCc3ccccc3)c2)cc1,IC50,100000.0,,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL367939,CC(=O)Nc1ccc(N)c2cc(S(=O)(=O)O)ccc12,IC50,3400.0,5.47,CHEMBL701186,Inhibitory concentration to inhibit HIV-1 integrase by 3' -processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3400.0,5.468521082957745
CHEMBL367939,CC(=O)Nc1ccc(N)c2cc(S(=O)(=O)O)ccc12,IC50,2700.0,5.57,CHEMBL699308,Inhibitory concentration against HIV-1 integrase by strand transfer method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2700.0,5.568636235841012
CHEMBL128547,O=C1c2ccccc2C(=O)c2c(Nc3ccc(S(=O)(=O)N(CCO)CCO)cc3)ccc(O)c21,IC50,5000.0,5.3,CHEMBL699307,Inhibitory concentration against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL176619,Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=O)c3cccc4c(N)c5ccccc5nc34)cc2)n1,IC50,48300.0,4.32,CHEMBL701186,Inhibitory concentration to inhibit HIV-1 integrase by 3' -processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48300.0,4.316052869248487
CHEMBL176619,Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=O)c3cccc4c(N)c5ccccc5nc34)cc2)n1,IC50,13700.0,4.86,CHEMBL699308,Inhibitory concentration against HIV-1 integrase by strand transfer method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13700.0,4.863279432843593
CHEMBL421441,CC1=NN(c2ccccc2)C(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2scc(C)c2C)cc1,IC50,97000.0,4.01,CHEMBL701184,Inhibitory concentration required to inhibit HIV-1 integrase by strand transfer method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,97000.0,4.013228265733755
CHEMBL323204,O=C(O)C(=O)/C=C(\O)c1c[nH]c2ccccc12,IC50,100000.0,,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL323204,O=C(O)C(=O)/C=C(\O)c1c[nH]c2ccccc12,IC50,1430.0,5.84,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1430.0,5.844663962534938
CHEMBL340865,Nc1nc(N)c(/N=N/c2ccc(S(=O)(=O)NC(=O)c3ccccc3)cc2)c(O)n1,IC50,96000.0,4.02,CHEMBL699308,Inhibitory concentration against HIV-1 integrase by strand transfer method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,96000.0,4.017728766960432
CHEMBL108760,O=C(O)C(=O)/C=C(\O)c1c[nH]c2ccc(Cl)cc12,IC50,65000.0,4.19,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL108760,O=C(O)C(=O)/C=C(\O)c1c[nH]c2ccc(Cl)cc12,IC50,520.0,6.28,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,520.0,6.2839966563652006
CHEMBL366434,CC(=O)Nc1cccc2cc(S(=O)(=O)O)ccc12,IC50,27900.0,4.55,CHEMBL701186,Inhibitory concentration to inhibit HIV-1 integrase by 3' -processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27900.0,4.554395796726403
CHEMBL366434,CC(=O)Nc1cccc2cc(S(=O)(=O)O)ccc12,IC50,14300.0,4.84,CHEMBL699308,Inhibitory concentration against HIV-1 integrase by strand transfer method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14300.0,4.844663962534939
CHEMBL127388,CC1=NN(c2ccccc2)C(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2nnc(C)s2)cc1,IC50,77000.0,4.11,CHEMBL699308,Inhibitory concentration against HIV-1 integrase by strand transfer method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,77000.0,4.113509274827518
CHEMBL368800,NC1=NNC(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2nccs2)cc1,IC50,71000.0,4.15,CHEMBL701186,Inhibitory concentration to inhibit HIV-1 integrase by 3' -processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,71000.0,4.1487416512809245
CHEMBL368800,NC1=NNC(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2nccs2)cc1,IC50,61000.0,4.21,CHEMBL699308,Inhibitory concentration against HIV-1 integrase by strand transfer method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61000.0,4.214670164989233
CHEMBL108775,O=C(O)C(=O)/C=C(\O)c1ccc(/C(O)=C/C(=O)C(=O)O)cc1,IC50,7200.0,5.14,CHEMBL701713,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7200.0,5.142667503568731
CHEMBL108775,O=C(O)C(=O)/C=C(\O)c1ccc(/C(O)=C/C(=O)C(=O)O)cc1,IC50,7500.0,5.12,CHEMBL701714,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7500.0,5.1249387366083
CHEMBL108775,O=C(O)C(=O)/C=C(\O)c1ccc(/C(O)=C/C(=O)C(=O)O)cc1,IC50,1280.0,5.89,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1280.0,5.892790030352131
CHEMBL432793,O=C(O)C(=O)/C=C(\O)c1cc(/C(O)=C/C(=O)C(=O)O)c2ccccc2n1,IC50,82000.0,4.09,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,82000.0,4.086186147616283
CHEMBL432793,O=C(O)C(=O)/C=C(\O)c1cc(/C(O)=C/C(=O)C(=O)O)c2ccccc2n1,IC50,6500.0,5.19,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6500.0,5.187086643357144
CHEMBL174460,Cc1ccnc(NS(=O)(=O)c2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)n1,IC50,80000.0,4.1,CHEMBL699308,Inhibitory concentration against HIV-1 integrase by strand transfer method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL173234,Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=O)c3cccn4c(=O)c5ccccc5nc34)cc2)n1,IC50,75500.0,4.12,CHEMBL701186,Inhibitory concentration to inhibit HIV-1 integrase by 3' -processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75500.0,4.1220530483708115
CHEMBL173234,Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=O)c3cccn4c(=O)c5ccccc5nc34)cc2)n1,IC50,44600.0,4.35,CHEMBL699308,Inhibitory concentration against HIV-1 integrase by strand transfer method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44600.0,4.350665141287858
CHEMBL35109,O=C(/C=C(\O)c1c[nH]c2ccc(Cl)cc12)c1nn[nH]n1,IC50,35000.0,4.46,CHEMBL873101,Inhibitory effect on 3'-processing(3'-P) of proximal DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL35109,O=C(/C=C(\O)c1c[nH]c2ccc(Cl)cc12)c1nn[nH]n1,IC50,650.0,6.19,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,650.0,6.187086643357144
CHEMBL320261,O=C(O)C(=O)/C=C(\O)c1cc(OCc2ccccc2)cc(OCc2ccccc2)c1,IC50,480.0,6.32,CHEMBL701715,Inhibitory effect on strand transfer of proximal DNA into host DNA in an extracellular HIV-1 integrase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,480.0,6.318758762624412
CHEMBL319244,O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1,IC50,42000.0,4.38,CHEMBL701186,Inhibitory concentration to inhibit HIV-1 integrase by 3' -processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42000.0,4.376750709602099
CHEMBL319244,O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1,IC50,10000.0,5.0,CHEMBL699308,Inhibitory concentration against HIV-1 integrase by strand transfer method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL144613,CC(=O)Nc1cc(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(O)c12,IC50,470.0,6.33,CHEMBL701186,Inhibitory concentration to inhibit HIV-1 integrase by 3' -processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,470.0,6.327902142064282
CHEMBL144613,CC(=O)Nc1cc(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(O)c12,IC50,290.0,6.54,CHEMBL699308,Inhibitory concentration against HIV-1 integrase by strand transfer method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,290.0,6.537602002101044
CHEMBL96959,Oc1cccc2ccc(/C=C/c3ccc4cccc(O)c4n3)nc12,IC50,100000.0,,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL58923,CC(=O)Oc1ccc(/C=C/c2ccc3cccc(OC(C)=O)c3n2)cc1OC(C)=O,IC50,100000.0,,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL58923,CC(=O)Oc1ccc(/C=C/c2ccc3cccc(OC(C)=O)c3n2)cc1OC(C)=O,IC50,100000.0,,CHEMBL702101,In vitro anti-HIV integrase activity against integration (strand transfer) of target plasmid.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL105883,Cc1cc2cc(O)c(O)cc2c(C)c1-c1ccccc1C(F)(F)F,IC50,22000.0,4.66,CHEMBL701721,Inhibition of human immunodeficiency virus - 1 (HIV-1) integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL108617,Cc1cc2cc(O)c(O)cc2c(C)c1-c1ccc(C(F)(F)F)cc1,IC50,21000.0,4.68,CHEMBL701721,Inhibition of human immunodeficiency virus - 1 (HIV-1) integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL97679,Oc1ccc(/C=C/c2ccc3ccccc3n2)cc1O,IC50,100000.0,,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL106044,Cc1ccc(-c2c(C)cc3cc(O)c(O)cc3c2C)cc1,IC50,84000.0,4.08,CHEMBL701721,Inhibition of human immunodeficiency virus - 1 (HIV-1) integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,84000.0,4.075720713938118
CHEMBL316892,Cc1ccc2cccc(O)c2n1,IC50,100000.0,,CHEMBL702100,In vitro anti-HIV integrase activity against 3' processing of target plasmid.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL316892,Cc1ccc2cccc(O)c2n1,IC50,100000.0,,CHEMBL702101,In vitro anti-HIV integrase activity against integration (strand transfer) of target plasmid.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL320509,NCCCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,90000.0,4.05,CHEMBL702104,In vitro inhibitory activity against HIV-1 integrase enzyme strand transfer process,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL58191,Nc1cccc2ccc(/C=C/c3ccc(O)c(O)c3)nc12,IC50,100000.0,,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL58191,Nc1cccc2ccc(/C=C/c3ccc(O)c(O)c3)nc12,IC50,100000.0,,CHEMBL702101,In vitro anti-HIV integrase activity against integration (strand transfer) of target plasmid.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2370429,NCCCC[C@H](NC(=O)[C@H](CSCC[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,77000.0,4.11,CHEMBL702103,In vitro inhibitory activity against HIV-1 integrase enzyme 3'-end processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,77000.0,4.113509274827518
CHEMBL2370429,NCCCC[C@H](NC(=O)[C@H](CSCC[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,87000.0,4.06,CHEMBL702104,In vitro inhibitory activity against HIV-1 integrase enzyme strand transfer process,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,87000.0,4.060480747381382
CHEMBL106455,Cc1cc2cc(O)c(O)cc2c(C)c1-c1cccc(C(F)(F)F)c1,IC50,13000.0,4.89,CHEMBL701721,Inhibition of human immunodeficiency virus - 1 (HIV-1) integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL108672,Oc1ccc(-c2ccc3cc(O)c(O)cc3c2)cc1O,IC50,2100.0,5.68,CHEMBL701721,Inhibition of human immunodeficiency virus - 1 (HIV-1) integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2100.0,5.6777807052660805
CHEMBL109167,Cc1cc2cc(O)c(O)cc2c(C)c1-c1ccccc1,IC50,76000.0,4.12,CHEMBL701721,Inhibition of human immunodeficiency virus - 1 (HIV-1) integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,76000.0,4.119186407719209
CHEMBL2370434,NCCCC[C@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,81000.0,4.09,CHEMBL702103,In vitro inhibitory activity against HIV-1 integrase enzyme 3'-end processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,81000.0,4.0915149811213505
CHEMBL2370434,NCCCC[C@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,58000.0,4.24,CHEMBL702104,In vitro inhibitory activity against HIV-1 integrase enzyme strand transfer process,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58000.0,4.236572006437063
CHEMBL2370433,NCCCC[C@H](NC(=O)[C@H](CSCSC[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,5300.0,5.28,CHEMBL702103,In vitro inhibitory activity against HIV-1 integrase enzyme 3'-end processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5300.0,5.275724130399211
CHEMBL2370433,NCCCC[C@H](NC(=O)[C@H](CSCSC[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,6500.0,5.19,CHEMBL702104,In vitro inhibitory activity against HIV-1 integrase enzyme strand transfer process,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6500.0,5.187086643357144
CHEMBL37869,O=C(O)c1ccc2ccc(/C=C/c3cc(O)c(O)c(O)c3)nc2c1O,IC50,300.0,6.52,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL37869,O=C(O)c1ccc2ccc(/C=C/c3cc(O)c(O)c(O)c3)nc2c1O,IC50,400.0,6.4,CHEMBL702101,In vitro anti-HIV integrase activity against integration (strand transfer) of target plasmid.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL432775,COc1ccc(/C=C/C(=O)Oc2cccc3ccc(C)nc23)cc1OC,IC50,100000.0,,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL432775,COc1ccc(/C=C/C(=O)Oc2cccc3ccc(C)nc23)cc1OC,IC50,100000.0,,CHEMBL702101,In vitro anti-HIV integrase activity against integration (strand transfer) of target plasmid.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL100082,O=C([O-])c1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O.[Na+],IC50,800.0,6.1,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL61800,O=[N+]([O-])c1cccc2ccc(/C=C/c3ccc(O)c(O)c3)nc12,IC50,100000.0,,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL61800,O=[N+]([O-])c1cccc2ccc(/C=C/c3ccc(O)c(O)c3)nc12,IC50,100000.0,,CHEMBL702101,In vitro anti-HIV integrase activity against integration (strand transfer) of target plasmid.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2370428,NCCCC[C@H](NC(=O)[C@H](CSC[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,67000.0,4.17,CHEMBL702103,In vitro inhibitory activity against HIV-1 integrase enzyme 3'-end processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,67000.0,4.173925197299174
CHEMBL2370428,NCCCC[C@H](NC(=O)[C@H](CSC[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,19000.0,4.72,CHEMBL702104,In vitro inhibitory activity against HIV-1 integrase enzyme strand transfer process,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL58057,Oc1ccc(/C=C/c2ccc3cccc(O)c3n2)cc1O,IC50,7400.0,5.13,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7400.0,5.130768280269024
CHEMBL58057,Oc1ccc(/C=C/c2ccc3cccc(O)c3n2)cc1O,IC50,2400.0,5.62,CHEMBL702101,In vitro anti-HIV integrase activity against integration (strand transfer) of target plasmid.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2400.0,5.619788758288394
CHEMBL416364,O=C(O)C(=O)CC(=O)c1cccc(OCc2ccc(C(=O)c3ccccc3)cc2)c1,IC50,100000.0,,CHEMBL701110,Inhibition of Integrase (3'-processing) as measured in an in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL416364,O=C(O)C(=O)CC(=O)c1cccc(OCc2ccc(C(=O)c3ccccc3)cc2)c1,IC50,19000.0,4.72,CHEMBL701111,Inhibition of Integrase catalyzed strand transfer (ST) as measured in an in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL416364,O=C(O)C(=O)CC(=O)c1cccc(OCc2ccc(C(=O)c3ccccc3)cc2)c1,IC50,29000.0,4.54,CHEMBL701111,Inhibition of Integrase catalyzed strand transfer (ST) as measured in an in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,29000.0,4.537602002101044
CHEMBL39823,Cc1ccc2ccc(C(=O)O)c(O)c2n1,IC50,100000.0,,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL106446,Oc1cc2c(cc1O)C1Cc3cc(O)c(O)cc3C(C2)O1,IC50,1300.0,5.89,CHEMBL701721,Inhibition of human immunodeficiency virus - 1 (HIV-1) integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL329488,O=C([O-])c1ccc2ccc(/C=C/c3cc(O)c(O)c(O)c3)nc2c1O.[Na+],IC50,260.0,6.58,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,260.0,6.585026652029182
CHEMBL439962,Cc1cc2cc(O)c(O)cc2c(C)c1-c1ccc(O)c(O)c1,IC50,23000.0,4.64,CHEMBL701721,Inhibition of human immunodeficiency virus - 1 (HIV-1) integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL36586,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)cc3O)nc2c1O,IC50,3700.0,5.43,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3700.0,5.431798275933005
CHEMBL36586,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)cc3O)nc2c1O,IC50,2800.0,5.55,CHEMBL702101,In vitro anti-HIV integrase activity against integration (strand transfer) of target plasmid.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL418303,Cc1ccc2cccc(OC(=O)/C=C/c3ccc(O)c(O)c3)c2n1,IC50,100000.0,,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL418303,Cc1ccc2cccc(OC(=O)/C=C/c3ccc(O)c(O)c3)c2n1,IC50,100000.0,,CHEMBL702101,In vitro anti-HIV integrase activity against integration (strand transfer) of target plasmid.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL19574,O=C(O)C(=O)CC(=O)c1cccc(C(=O)c2ccccc2)c1,IC50,100000.0,,CHEMBL701110,Inhibition of Integrase (3'-processing) as measured in an in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL19574,O=C(O)C(=O)CC(=O)c1cccc(C(=O)c2ccccc2)c1,IC50,2700.0,5.57,CHEMBL701112,Inhibition of integrase catalyzed strand transfer (ST) as measured in an in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2700.0,5.568636235841012
CHEMBL19574,O=C(O)C(=O)CC(=O)c1cccc(C(=O)c2ccccc2)c1,IC50,2100.0,5.68,CHEMBL701806,Inhibition of Integrase catalyzed strand transfer (ST) as measured in an in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2100.0,5.6777807052660805
CHEMBL293788,CC(=O)Oc1cccc2ccc(/C=C/c3ccccc3)nc12,IC50,100000.0,,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL293788,CC(=O)Oc1cccc2ccc(/C=C/c3ccccc3)nc12,IC50,100000.0,,CHEMBL702101,In vitro anti-HIV integrase activity against integration (strand transfer) of target plasmid.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL97641,Oc1ccc(/C=C/c2ccc3ccc(/C=C/c4ccc(O)c(O)c4)c(O)c3n2)cc1O,IC50,2200.0,5.66,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2200.0,5.657577319177793
CHEMBL97641,Oc1ccc(/C=C/c2ccc3ccc(/C=C/c4ccc(O)c(O)c4)c(O)c3n2)cc1O,IC50,3400.0,5.47,CHEMBL702101,In vitro anti-HIV integrase activity against integration (strand transfer) of target plasmid.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3400.0,5.468521082957745
CHEMBL59446,N#Cc1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O,IC50,3000.0,5.52,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL19332,O=C(O)C(=O)CC(=O)c1ccccc1,IC50,25000.0,4.6,CHEMBL701111,Inhibition of Integrase catalyzed strand transfer (ST) as measured in an in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL59548,O=C(O)c1cc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)ccc1O,IC50,2700.0,5.57,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2700.0,5.568636235841012
CHEMBL59548,O=C(O)c1cc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)ccc1O,IC50,600.0,6.22,CHEMBL702101,In vitro anti-HIV integrase activity against integration (strand transfer) of target plasmid.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL39092,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O,IC50,2400.0,5.62,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2400.0,5.619788758288394
CHEMBL39092,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O,IC50,1000.0,6.0,CHEMBL702101,In vitro anti-HIV integrase activity against integration (strand transfer) of target plasmid.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL280299,[N-]=[N+]=Nc1cccc(C(=O)CC(=O)C(=O)O)c1,IC50,100000.0,,CHEMBL701110,Inhibition of Integrase (3'-processing) as measured in an in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL280299,[N-]=[N+]=Nc1cccc(C(=O)CC(=O)C(=O)O)c1,IC50,5300.0,5.28,CHEMBL701111,Inhibition of Integrase catalyzed strand transfer (ST) as measured in an in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5300.0,5.275724130399211
CHEMBL280299,[N-]=[N+]=Nc1cccc(C(=O)CC(=O)C(=O)O)c1,IC50,5200.0,5.28,CHEMBL701111,Inhibition of Integrase catalyzed strand transfer (ST) as measured in an in vitro assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5200.0,5.2839966563652006
CHEMBL2370430,NCCCC[C@H](NC(=O)[C@@H](CCSCC[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,59000.0,4.23,CHEMBL702103,In vitro inhibitory activity against HIV-1 integrase enzyme 3'-end processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,59000.0,4.229147988357856
CHEMBL2370430,NCCCC[C@H](NC(=O)[C@@H](CCSCC[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,63000.0,4.2,CHEMBL702104,In vitro inhibitory activity against HIV-1 integrase enzyme strand transfer process,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,63000.0,4.200659450546418
CHEMBL61203,Oc1cccc2ccc(/C=C/c3ccccc3)nc12,IC50,100000.0,,CHEMBL702097,HIV integrase inhibitory potency was evaluated as IC50 on 3' processing of target DNA.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL61203,Oc1cccc2ccc(/C=C/c3ccccc3)nc12,IC50,100000.0,,CHEMBL702101,In vitro anti-HIV integrase activity against integration (strand transfer) of target plasmid.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL267578,O=C(NCCCNC(=O)c1ccc2cc(O)c(O)cc2c1)c1ccc2cc(O)c(O)cc2c1,IC50,980.0,6.01,CHEMBL702114,Inhibition of HIV-1 integrase-mediated 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,980.0,6.008773924307505
CHEMBL267578,O=C(NCCCNC(=O)c1ccc2cc(O)c(O)cc2c1)c1ccc2cc(O)c(O)cc2c1,IC50,810.0,6.09,CHEMBL701109,Inhibition of HIV-1 integrase-mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,810.0,6.0915149811213505
CHEMBL18635,O=C(NCCCNC(=O)c1ccc2c(O)c(O)ccc2c1)c1ccc2c(O)c(O)ccc2c1,IC50,230.0,6.64,CHEMBL702114,Inhibition of HIV-1 integrase-mediated 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,230.0,6.638272163982407
CHEMBL18635,O=C(NCCCNC(=O)c1ccc2c(O)c(O)ccc2c1)c1ccc2c(O)c(O)ccc2c1,IC50,110.0,6.96,CHEMBL701109,Inhibition of HIV-1 integrase-mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL18630,O=C(O)c1ccc2cc(O)c(O)cc2c1,IC50,5400.0,5.27,CHEMBL702114,Inhibition of HIV-1 integrase-mediated 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5400.0,5.267606240177031
CHEMBL18630,O=C(O)c1ccc2cc(O)c(O)cc2c1,IC50,4700.0,5.33,CHEMBL701109,Inhibition of HIV-1 integrase-mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4700.0,5.327902142064282
CHEMBL18276,COC(=O)c1ccc2c(O)c(O)ccc2c1,IC50,58400.0,4.23,CHEMBL702114,Inhibition of HIV-1 integrase-mediated 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58400.0,4.2335871528876
CHEMBL18276,COC(=O)c1ccc2c(O)c(O)ccc2c1,IC50,52700.0,4.28,CHEMBL701109,Inhibition of HIV-1 integrase-mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52700.0,4.278189384787454
CHEMBL18266,O=C(CCc1ccc(O)c(O)c1)NCCc1ccc(O)c(O)c1,IC50,33000.0,4.48,CHEMBL702114,Inhibition of HIV-1 integrase-mediated 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL18550,O=C(O)c1ccc2c(O)c(O)ccc2c1,IC50,53300.0,4.27,CHEMBL702114,Inhibition of HIV-1 integrase-mediated 3'-processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53300.0,4.273272790973428
CHEMBL18550,O=C(O)c1ccc2c(O)c(O)ccc2c1,IC50,62400.0,4.21,CHEMBL701109,Inhibition of HIV-1 integrase-mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,62400.0,4.204815410317576
CHEMBL49201,O=C(/C=C/c1cccn1Cc1ccccc1)CC(=O)C(=O)O,IC50,7900.0,5.1,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7900.0,5.102372908709558
CHEMBL49201,O=C(/C=C/c1cccn1Cc1ccccc1)CC(=O)C(=O)O,IC50,7000.0,5.16,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL301161,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(C)cc1,IC50,73000.0,4.14,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,73000.0,4.136677139879544
CHEMBL301161,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(C)cc1,IC50,88000.0,4.06,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,88000.0,4.055517327849832
CHEMBL49363,Cc1ccc(Cn2cccc2/C=C/C(=O)CC(=O)C(=O)O)cc1,IC50,56000.0,4.25,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL49363,Cc1ccc(Cn2cccc2/C=C/C(=O)CC(=O)C(=O)O)cc1,IC50,67000.0,4.17,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,67000.0,4.173925197299174
CHEMBL301183,O=C(/C=C/c1cccn1Cc1ccc([N+](=O)[O-])cc1)CC(=O)C(=O)O,IC50,76000.0,4.12,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,76000.0,4.119186407719209
CHEMBL301183,O=C(/C=C/c1cccn1Cc1ccc([N+](=O)[O-])cc1)CC(=O)C(=O)O,IC50,92000.0,4.04,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,92000.0,4.036212172654444
CHEMBL48381,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccccc1,IC50,8900.0,5.05,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8900.0,5.050609993355087
CHEMBL48381,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccccc1,IC50,7500.0,5.12,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7500.0,5.1249387366083
CHEMBL417356,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(Cl)cc1,IC50,50000.0,4.3,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL417356,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(Cl)cc1,IC50,65000.0,4.19,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL48573,O=C(/C=C/c1cccn1Cc1ccc(F)cc1)CC(=O)C(=O)O,IC50,61000.0,4.21,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61000.0,4.214670164989233
CHEMBL48573,O=C(/C=C/c1cccn1Cc1ccc(F)cc1)CC(=O)C(=O)O,IC50,72000.0,4.14,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,72000.0,4.142667503568732
CHEMBL49387,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc([N+](=O)[O-])cc1,IC50,57000.0,4.24,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57000.0,4.2441251443275085
CHEMBL49387,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc([N+](=O)[O-])cc1,IC50,45000.0,4.35,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45000.0,4.346787486224656
CHEMBL50605,O=C(O)C(=O)CC(=O)c1cccn1Cc1ccc(F)cc1,IC50,2000.0,5.7,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL50605,O=C(O)C(=O)CC(=O)c1cccn1Cc1ccc(F)cc1,IC50,300.0,6.52,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL49473,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(OC)cc1,IC50,38000.0,4.42,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38000.0,4.42021640338319
CHEMBL49473,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(OC)cc1,IC50,50000.0,4.3,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL299873,O=C(/C=C/c1cccn1Cc1ccc(Cl)cc1)CC(=O)C(=O)O,IC50,50000.0,4.3,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL299873,O=C(/C=C/c1cccn1Cc1ccc(Cl)cc1)CC(=O)C(=O)O,IC50,65000.0,4.19,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL46032,COc1ccc(Cn2cccc2/C=C/C(=O)CC(=O)C(=O)O)cc1,IC50,22000.0,4.66,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL46032,COc1ccc(Cn2cccc2/C=C/C(=O)CC(=O)C(=O)O)cc1,IC50,41000.0,4.39,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41000.0,4.3872161432802645
CHEMBL45578,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(F)cc1,IC50,87000.0,4.06,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,87000.0,4.060480747381382
CHEMBL45578,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(F)cc1,IC50,95000.0,4.02,CHEMBL699301,Inhibitory activity against HIV-1 integrase.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,95000.0,4.022276394711152
CHEMBL282731,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H](C(=O)O)[C@@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,24900.0,4.6,CHEMBL702429,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24900.0,4.603800652904264
CHEMBL55888,CO[C@@H]1O[C@H](COC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,89600.0,4.05,CHEMBL702429,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,89600.0,4.047691990337875
CHEMBL59321,CO[C@H]1O[C@H](COC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H](O)[C@H](O)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,70000.0,4.16,CHEMBL702429,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL293573,CO[C@@H]1O[C@H](COC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H](O)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1O,IC50,35100.0,4.46,CHEMBL702429,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35100.0,4.454692883534176
CHEMBL418300,COC1O[C@H](CO)[C@@H](O)[C@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@H]1OC(=O)c1cc(O)c(O)c(O)c1,IC50,5400.0,5.27,CHEMBL702429,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5400.0,5.267606240177031
CHEMBL54536,CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,31800.0,4.5,CHEMBL702429,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31800.0,4.497572880015567
CHEMBL299686,CO[C@@H]1O[C@H](COC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H](O)[C@H](O)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,30500.0,4.52,CHEMBL702429,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30500.0,4.515700160653214
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,IC50,57500.0,4.24,CHEMBL702429,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57500.0,4.2403321553103694
CHEMBL301656,CO[C@H]1O[C@H](COC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H](O)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1O,IC50,82400.0,4.08,CHEMBL702429,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,82400.0,4.084072788302884
CHEMBL300032,CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,29100.0,4.54,CHEMBL702429,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,29100.0,4.536107011014093
CHEMBL444478,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O,IC50,7800.0,5.11,CHEMBL702429,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7800.0,5.107905397309519
CHEMBL3037876,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(N)=O,IC50,35000.0,4.46,CHEMBL699302,Inhibitory activity of compound against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL129120,Cc1cc(S(=O)(=O)Nc2n[nH]c(-c3ccc(Cl)cn3)n2)c(S)cc1Cl,IC50,8912.51,5.05,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8912.51,5.049999969853415
CHEMBL129120,Cc1cc(S(=O)(=O)Nc2n[nH]c(-c3ccc(Cl)cn3)n2)c(S)cc1Cl,IC50,10232.93,4.99,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10232.93,4.989999996723885
CHEMBL338373,Cc1cc(S(=O)(=O)Nc2nnc3c(Cl)cc(C(F)(F)F)cn23)c(S)cc1Cl,IC50,17782.79,4.75,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17782.79,4.750000100140428
CHEMBL338373,Cc1cc(S(=O)(=O)Nc2nnc3c(Cl)cc(C(F)(F)F)cn23)c(S)cc1Cl,IC50,20892.96,4.68,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20892.96,4.68000002720016
CHEMBL128249,Cc1cc(S(=O)(=O)Nc2nnc3c(C(F)(F)F)cc(Cl)cn23)c(S)cc1Cl,IC50,10715.19,4.97,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10715.19,4.970000123715015
CHEMBL128249,Cc1cc(S(=O)(=O)Nc2nnc3c(C(F)(F)F)cc(Cl)cn23)c(S)cc1Cl,IC50,23988.33,4.62,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23988.33,4.619999985338959
CHEMBL129286,Cc1cc(S(=O)(=O)Nc2nnc3cc(C(F)(F)F)cc(C)n23)c(S)cc1Cl,IC50,18620.87,4.73,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18620.87,4.730000031873875
CHEMBL129286,Cc1cc(S(=O)(=O)Nc2nnc3cc(C(F)(F)F)cc(C)n23)c(S)cc1Cl,IC50,10964.78,4.96,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10964.78,4.96000007768865
CHEMBL433666,Cc1cc(S(=O)(=O)Nc2nc(N)nc3nc4ccccc4n23)c(S)cc1Cl,IC50,9772.37,5.01,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9772.37,5.010000098195093
CHEMBL433666,Cc1cc(S(=O)(=O)Nc2nc(N)nc3nc4ccccc4n23)c(S)cc1Cl,IC50,7762.47,5.11,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7762.47,5.110000065251387
CHEMBL128231,O=C(Nc1ccc(Cl)cc1)c1cc(S(=O)(=O)Nc2nncn2-c2ccc(F)cc2)c(S)cc1Cl,IC50,37153.52,4.43,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37153.52,4.430000034012231
CHEMBL128231,O=C(Nc1ccc(Cl)cc1)c1cc(S(=O)(=O)Nc2nncn2-c2ccc(F)cc2)c(S)cc1Cl,IC50,37153.52,4.43,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37153.52,4.430000034012231
CHEMBL2370473,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O,IC50,3000.0,5.52,CHEMBL699302,Inhibitory activity of compound against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL130134,Cc1ccc(NC(=O)c2cc(S(=O)(=O)Nc3nncn3Cc3ccccc3)c(S)cc2Cl)cc1,IC50,8912.51,5.05,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8912.51,5.049999969853415
CHEMBL130134,Cc1ccc(NC(=O)c2cc(S(=O)(=O)Nc3nncn3Cc3ccccc3)c(S)cc2Cl)cc1,IC50,7943.28,5.1,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7943.28,5.100000128334196
CHEMBL128856,Cc1cc(S(=O)(=O)Nc2nc3ccccc3nc2-c2cccc([N+](=O)[O-])c2)c(S)cc1Cl,IC50,15135.61,4.82,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15135.61,4.820000071285178
CHEMBL128856,Cc1cc(S(=O)(=O)Nc2nc3ccccc3nc2-c2cccc([N+](=O)[O-])c2)c(S)cc1Cl,IC50,7943.28,5.1,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7943.28,5.100000128334196
CHEMBL128376,Cc1ccc(-n2cnnc2NS(=O)(=O)c2cc(C(=O)Nc3ccccc3)c(Cl)cc2S)cc1,IC50,6025.6,5.22,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6025.6,5.219999701663429
CHEMBL128376,Cc1ccc(-n2cnnc2NS(=O)(=O)c2cc(C(=O)Nc3ccccc3)c(Cl)cc2S)cc1,IC50,10000.0,5.0,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL265887,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,2000.0,5.7,CHEMBL699302,Inhibitory activity of compound against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL129287,Cc1cc2c(cc1Cl)SC(C1C(=O)NC(=S)NC1=O)NS2(=O)=O,IC50,60255.96,4.22,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60255.96,4.219999989963101
CHEMBL129287,Cc1cc2c(cc1Cl)SC(C1C(=O)NC(=S)NC1=O)NS2(=O)=O,IC50,50118.72,4.3,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50118.72,4.300000029139088
CHEMBL129147,Cc1cc2nc3nc(N)nc(NS(=O)(=O)c4cc(C)c(Cl)cc4S)n3c2cc1C,IC50,5495.41,5.26,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5495.41,5.259999900311453
CHEMBL129147,Cc1cc2nc3nc(N)nc(NS(=O)(=O)c4cc(C)c(Cl)cc4S)n3c2cc1C,IC50,4265.8,5.37,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4265.8,5.369999510099088
CHEMBL338228,Cc1ccc(-n2cnnc2NS(=O)(=O)c2cc(C(=O)Nc3ccc(Cl)cc3)c(Cl)cc2S)cc1,IC50,3981.07,5.4,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3981.07,5.40000018605658
CHEMBL338228,Cc1ccc(-n2cnnc2NS(=O)(=O)c2cc(C(=O)Nc3ccc(Cl)cc3)c(Cl)cc2S)cc1,IC50,3981.07,5.4,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3981.07,5.40000018605658
CHEMBL128868,Cc1cc(S(=O)(=O)Nc2nc(Nc3ccccc3)nn2C)c(S)cc1Cl,IC50,27542.29,4.56,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27542.29,4.559999953221535
CHEMBL128868,Cc1cc(S(=O)(=O)Nc2nc(Nc3ccccc3)nn2C)c(S)cc1Cl,IC50,15848.93,4.8,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15848.93,4.800000052738446
CHEMBL128850,Cc1cc(S(=O)(=O)Nc2nc3ccccc3[nH]2)c(S)cc1Cl,IC50,38904.51,4.41,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38904.51,4.41000005022751
CHEMBL128850,Cc1cc(S(=O)(=O)Nc2nc3ccccc3[nH]2)c(S)cc1Cl,IC50,43651.58,4.36,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43651.58,4.360000032076103
CHEMBL128608,Cc1cc(C(F)(F)F)cc(-n2nc(NS(=O)(=O)c3cc(C)c(Cl)cc3S)nc2N)n1,IC50,9332.54,5.03,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9332.54,5.030000139977383
CHEMBL128608,Cc1cc(C(F)(F)F)cc(-n2nc(NS(=O)(=O)c3cc(C)c(Cl)cc3S)nc2N)n1,IC50,6309.57,5.2,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6309.57,5.200000237109354
CHEMBL129598,Cc1cc(S(=O)(=O)Nc2nnc3cnc4ccccc4n23)c(S)cc1Cl,IC50,31622.78,4.5,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31622.78,4.499999953328896
CHEMBL129598,Cc1cc(S(=O)(=O)Nc2nnc3cnc4ccccc4n23)c(S)cc1Cl,IC50,8317.64,5.08,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8317.64,5.079999880484295
CHEMBL339576,COc1ccc(Nc2n[nH]c(NS(=O)(=O)c3cc(C)c(Cl)cc3S)n2)cc1,IC50,15488.17,4.81,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15488.17,4.809999893141522
CHEMBL339576,COc1ccc(Nc2n[nH]c(NS(=O)(=O)c3cc(C)c(Cl)cc3S)n2)cc1,IC50,14125.38,4.85,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14125.38,4.849999859991125
CHEMBL340697,Cc1cc(S(=O)(=O)Nc2nnc3c4c(C)csc4ncn23)c(S)cc1Cl,IC50,3630.78,5.44,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3630.78,5.440000065513061
CHEMBL340697,Cc1cc(S(=O)(=O)Nc2nnc3c4c(C)csc4ncn23)c(S)cc1Cl,IC50,3467.37,5.46,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3467.37,5.459999812689
CHEMBL337606,Cc1cc(S(=O)(=O)Nc2nnc3ccc4ccccc4n23)c(S)cc1Cl,IC50,12882.5,4.89,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12882.5,4.889999848866887
CHEMBL337606,Cc1cc(S(=O)(=O)Nc2nnc3ccc4ccccc4n23)c(S)cc1Cl,IC50,7413.1,5.13,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7413.1,5.130000141365475
CHEMBL127330,O=C(Nc1ccccc1)c1cc(S(=O)(=O)Nc2nncn2-c2ccc(Cl)cc2)c(S)cc1Cl,IC50,6025.6,5.22,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6025.6,5.219999701663429
CHEMBL127330,O=C(Nc1ccccc1)c1cc(S(=O)(=O)Nc2nncn2-c2ccc(Cl)cc2)c(S)cc1Cl,IC50,12022.64,4.92,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12022.64,4.920000156997057
CHEMBL338178,O=S(=O)(Nc1nnc2c3ccccc3ccn12)c1ccc(F)cc1S,IC50,51286.14,4.29,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,51286.14,4.28999998644378
CHEMBL338178,O=S(=O)(Nc1nnc2c3ccccc3ccn12)c1ccc(F)cc1S,IC50,47863.01,4.32,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47863.01,4.319999993033794
CHEMBL132166,Cc1cc(S(=O)(=O)Nc2nc(N)nc(N(C)C)n2)c(S)cc1Cl,IC50,77624.71,4.11,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,77624.71,4.110000009303415
CHEMBL132166,Cc1cc(S(=O)(=O)Nc2nc(N)nc(N(C)C)n2)c(S)cc1Cl,IC50,41686.94,4.38,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41686.94,4.379999982779397
CHEMBL422790,O=C(O)c1cc2ccccc2c(/N=N/c2ccc(S(=O)(=O)Nc3nccs3)cc2)c1O,IC50,21379.62,4.67,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21379.62,4.6700000181810175
CHEMBL422790,O=C(O)c1cc2ccccc2c(/N=N/c2ccc(S(=O)(=O)Nc3nccs3)cc2)c1O,IC50,42657.95,4.37,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42657.95,4.3700000191416315
CHEMBL339551,CC(=O)C(/N=N/c1ccc(S(=O)(=O)Nc2ccccn2)cc1)C(=O)Nc1ccccc1C,IC50,66069.34,4.18,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,66069.34,4.180000031556896
CHEMBL339551,CC(=O)C(/N=N/c1ccc(S(=O)(=O)Nc2ccccn2)cc1)C(=O)Nc1ccccc1C,IC50,72443.6,4.14,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,72443.6,4.1399999760652255
CHEMBL338005,O=C(Nc1ccccc1)c1cc(S(=O)(=O)Nc2nncn2-c2ccc(F)cc2)c(S)cc1Cl,IC50,45708.82,4.34,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45708.82,4.339999990132752
CHEMBL338005,O=C(Nc1ccccc1)c1cc(S(=O)(=O)Nc2nncn2-c2ccc(F)cc2)c(S)cc1Cl,IC50,50118.72,4.3,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50118.72,4.300000029139088
CHEMBL338144,Cc1ccc(Nc2nc(NS(=O)(=O)c3cc(C)c(Cl)cc3S)n(C)n2)cc1,IC50,23442.29,4.63,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23442.29,4.629999965785961
CHEMBL338144,Cc1ccc(Nc2nc(NS(=O)(=O)c3cc(C)c(Cl)cc3S)n(C)n2)cc1,IC50,19054.61,4.72,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19054.61,4.719999935717911
CHEMBL130024,Cc1cc(S(=O)(=O)/N=C(\NN)Nc2ccc(Cl)cc2)c(S)cc1Cl,IC50,3548.13,5.45,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3548.13,5.450000476425332
CHEMBL130024,Cc1cc(S(=O)(=O)/N=C(\NN)Nc2ccc(Cl)cc2)c(S)cc1Cl,IC50,3548.13,5.45,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3548.13,5.450000476425332
CHEMBL128927,O=S(=O)(Nc1nnc2c3ccccc3cnn12)c1ccc(Cl)cc1S,IC50,28840.32,4.54,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28840.32,4.539999925177879
CHEMBL128927,O=S(=O)(Nc1nnc2c3ccccc3cnn12)c1ccc(Cl)cc1S,IC50,38904.51,4.41,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38904.51,4.41000005022751
CHEMBL129812,CCCn1cnnc1NS(=O)(=O)c1cc(C(=O)Nc2ccc(C)cc2)c(Cl)cc1SCC(=O)O,IC50,43651.58,4.36,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43651.58,4.360000032076103
CHEMBL129812,CCCn1cnnc1NS(=O)(=O)c1cc(C(=O)Nc2ccc(C)cc2)c(Cl)cc1SCC(=O)O,IC50,43651.58,4.36,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43651.58,4.360000032076103
CHEMBL129119,Cc1cc(S(=O)(=O)Nc2n[nH]c(Nc3ccccc3)n2)c(S)cc1Cl,IC50,16218.1,4.79,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16218.1,4.790000026071146
CHEMBL129119,Cc1cc(S(=O)(=O)Nc2n[nH]c(Nc3ccccc3)n2)c(S)cc1Cl,IC50,12589.25,4.9,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12589.25,4.900000142057633
CHEMBL128177,Cc1ccc(Nc2n[nH]c(NS(=O)(=O)c3cc(C)c(Cl)cc3S)n2)cc1,IC50,22387.21,4.65,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22387.21,4.65000002688118
CHEMBL128177,Cc1ccc(Nc2n[nH]c(NS(=O)(=O)c3cc(C)c(Cl)cc3S)n2)cc1,IC50,23988.33,4.62,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23988.33,4.619999985338959
CHEMBL128508,CCCCn1cnnc1NS(=O)(=O)c1cc(C(=O)Nc2ccc(Cl)cc2)c(Cl)cc1S,IC50,36307.81,4.44,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36307.81,4.4399999458984265
CHEMBL128508,CCCCn1cnnc1NS(=O)(=O)c1cc(C(=O)Nc2ccc(Cl)cc2)c(Cl)cc1S,IC50,43651.58,4.36,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43651.58,4.360000032076103
CHEMBL419983,O=S(=O)(Nc1nccs1)c1ccc(/N=N/c2cnc(O)c(O)c2)cc1,IC50,22908.68,4.64,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22908.68,4.639999934172963
CHEMBL419983,O=S(=O)(Nc1nccs1)c1ccc(/N=N/c2cnc(O)c(O)c2)cc1,IC50,20892.96,4.68,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20892.96,4.68000002720016
CHEMBL132328,CCCCn1cnnc1NS(=O)(=O)c1cc(C(=O)Nc2ccc(C)cc2)c(Cl)cc1S,IC50,60255.96,4.22,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60255.96,4.219999989963101
CHEMBL132328,CCCCn1cnnc1NS(=O)(=O)c1cc(C(=O)Nc2ccc(C)cc2)c(Cl)cc1S,IC50,33884.42,4.47,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33884.42,4.469999943783888
CHEMBL128540,CC(=O)Oc1cc(S(=O)(=O)Nc2n[nH]c(Nc3ccc(C)cc3)n2)c(S)cc1Cl,IC50,7585.78,5.12,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7585.78,5.119999756699334
CHEMBL128540,CC(=O)Oc1cc(S(=O)(=O)Nc2n[nH]c(Nc3ccc(C)cc3)n2)c(S)cc1Cl,IC50,10000.0,5.0,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL334547,Cc1cc(S(=O)(=O)Nc2nc(N)n(-c3ccccn3)n2)c(S)cc1Cl,IC50,14454.4,4.84,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14454.4,4.8399999311187
CHEMBL334547,Cc1cc(S(=O)(=O)Nc2nc(N)n(-c3ccccn3)n2)c(S)cc1Cl,IC50,22908.68,4.64,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22908.68,4.639999934172963
CHEMBL339463,Cc1ccnc(NS(=O)(=O)c2ccc(/N=N/c3cc4ccccc4c(C(=O)O)c3O)cc2)n1,IC50,19498.45,4.71,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19498.45,4.709999910852971
CHEMBL339463,Cc1ccnc(NS(=O)(=O)c2ccc(/N=N/c3cc4ccccc4c(C(=O)O)c3O)cc2)n1,IC50,32359.37,4.49,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32359.37,4.489999942195333
CHEMBL129911,Cc1cc2c(cc1Cl)SC(C1C(=O)NC(=O)NC1=O)NS2(=O)=O,IC50,60255.96,4.22,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60255.96,4.219999989963101
CHEMBL129911,Cc1cc2c(cc1Cl)SC(C1C(=O)NC(=O)NC1=O)NS2(=O)=O,IC50,60255.96,4.22,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60255.96,4.219999989963101
CHEMBL128090,Cc1cnc(NS(=O)(=O)c2ccc(/N=N/c3cc4ccccc4cc3O)cc2)s1,IC50,38904.51,4.41,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38904.51,4.41000005022751
CHEMBL128090,Cc1cnc(NS(=O)(=O)c2ccc(/N=N/c3cc4ccccc4cc3O)cc2)s1,IC50,50118.72,4.3,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50118.72,4.300000029139088
CHEMBL339829,O=S(=O)(Nc1ccccn1)c1ccc(/N=N/c2cnc(O)c(O)c2)cc1,IC50,60255.96,4.22,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60255.96,4.219999989963101
CHEMBL339829,O=S(=O)(Nc1ccccn1)c1ccc(/N=N/c2cnc(O)c(O)c2)cc1,IC50,58884.37,4.23,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58884.37,4.229999967073058
CHEMBL131451,CCCCn1cnnc1NS(=O)(=O)c1cc(C(=O)NCc2ccccc2)c(Cl)cc1S,IC50,89125.09,4.05,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,89125.09,4.050000018582057
CHEMBL131451,CCCCn1cnnc1NS(=O)(=O)c1cc(C(=O)NCc2ccccc2)c(Cl)cc1S,IC50,70794.58,4.15,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70794.58,4.149999990420336
CHEMBL128670,CC1=NNC(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2nccs2)cc1,IC50,70794.58,4.15,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70794.58,4.149999990420336
CHEMBL128670,CC1=NNC(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2nccs2)cc1,IC50,61659.5,4.21,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61659.5,4.210000001311123
CHEMBL128792,Cc1ccc(NC(=O)c2cc(S(=O)(=O)Nc3nncn3CC(C)C)c(S)cc2Cl)cc1,IC50,75857.76,4.12,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75857.76,4.119999985703918
CHEMBL128792,Cc1ccc(NC(=O)c2cc(S(=O)(=O)Nc3nncn3CC(C)C)c(S)cc2Cl)cc1,IC50,100000.0,4.0,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL335480,Cc1cc(S(=O)(=O)/N=C(\NN)NNc2cccc(C(F)(F)F)n2)c(S)cc1Cl,IC50,87096.36,4.06,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,87096.36,4.059999994991732
CHEMBL335480,Cc1cc(S(=O)(=O)/N=C(\NN)NNc2cccc(C(F)(F)F)n2)c(S)cc1Cl,IC50,100000.0,4.0,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL129778,COc1cccc(Nc2n[nH]c(NS(=O)(=O)c3cc(C)c(Cl)cc3S)n2)c1,IC50,6309.57,5.2,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6309.57,5.200000237109354
CHEMBL129778,COc1cccc(Nc2n[nH]c(NS(=O)(=O)c3cc(C)c(Cl)cc3S)n2)c1,IC50,20892.96,4.68,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20892.96,4.68000002720016
CHEMBL131113,CCCn1cnnc1NS(=O)(=O)c1cc(C(=O)Nc2ccc(C)cc2)c(Cl)cc1S,IC50,40738.03,4.39,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40738.03,4.389999976337708
CHEMBL131113,CCCn1cnnc1NS(=O)(=O)c1cc(C(=O)Nc2ccc(C)cc2)c(Cl)cc1S,IC50,39810.72,4.4,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39810.72,4.399999967876858
CHEMBL406261,CC[C@@H](C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C,IC50,30000.0,4.52,CHEMBL699302,Inhibitory activity of compound against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL128293,COc1cc(Nc2n[nH]c(NS(=O)(=O)c3cc(C)c(Cl)cc3S)n2)cc(OC)c1OC,IC50,15488.17,4.81,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15488.17,4.809999893141522
CHEMBL128293,COc1cc(Nc2n[nH]c(NS(=O)(=O)c3cc(C)c(Cl)cc3S)n2)cc(OC)c1OC,IC50,16595.87,4.78,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16595.87,4.779999975777493
CHEMBL128247,Cc1cc(S(=O)(=O)Nc2nc(Nc3ccc(Cl)cc3)nn2C)c(S)cc1Cl,IC50,16218.1,4.79,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16218.1,4.790000026071146
CHEMBL128247,Cc1cc(S(=O)(=O)Nc2nc(Nc3ccc(Cl)cc3)nn2C)c(S)cc1Cl,IC50,17782.79,4.75,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17782.79,4.750000100140428
CHEMBL338902,Cc1cc(S(=O)(=O)Nc2nnc3c4ccccc4ccn23)c(S)cc1Cl,IC50,13182.57,4.88,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13182.57,4.879999913868448
CHEMBL338902,Cc1cc(S(=O)(=O)Nc2nnc3c4ccccc4ccn23)c(S)cc1Cl,IC50,10715.19,4.97,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10715.19,4.970000123715015
CHEMBL130882,Cc1cc(S(=O)(=O)Nc2nc(N)n(-c3ccccc3)n2)c(S)cc1Cl,IC50,10715.19,4.97,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10715.19,4.970000123715015
CHEMBL130882,Cc1cc(S(=O)(=O)Nc2nc(N)n(-c3ccccc3)n2)c(S)cc1Cl,IC50,13182.57,4.88,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13182.57,4.879999913868448
CHEMBL340425,CCN(c1ccccc1)c1nc(N)nc(NS(=O)(=O)c2cc(C)c(Cl)cc2S)n1,IC50,17378.01,4.76,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17378.01,4.759999957202692
CHEMBL340425,CCN(c1ccccc1)c1nc(N)nc(NS(=O)(=O)c2cc(C)c(Cl)cc2S)n1,IC50,24547.09,4.61,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24547.09,4.609999985082743
CHEMBL128487,O=S(=O)(Nc1nnc2n1-c1ccccc1CC2)c1ccc(Cl)cc1S,IC50,21877.62,4.66,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21877.62,4.659999925349902
CHEMBL128487,O=S(=O)(Nc1nnc2n1-c1ccccc1CC2)c1ccc(Cl)cc1S,IC50,19498.45,4.71,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19498.45,4.709999910852971
CHEMBL339572,CC1N=NC(c2ccc(S(=O)(=O)NC3SC(=S)NC3=O)cc2)S1,IC50,23988.33,4.62,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23988.33,4.619999985338959
CHEMBL339572,CC1N=NC(c2ccc(S(=O)(=O)NC3SC(=S)NC3=O)cc2)S1,IC50,19054.61,4.72,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19054.61,4.719999935717911
CHEMBL129486,O=C1NC(=S)SC1NS(=O)(=O)c1ccc(-c2ncccn2)cc1,IC50,28840.32,4.54,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28840.32,4.539999925177879
CHEMBL129486,O=C1NC(=S)SC1NS(=O)(=O)c1ccc(-c2ncccn2)cc1,IC50,1412.54,5.85,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1412.54,5.849999245077862
CHEMBL129376,O=C(Nc1ccc(F)cc1)c1cc(S(=O)(=O)Nc2nncn2-c2ccc(F)cc2)c(S)cc1Cl,IC50,79432.82,4.1,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,79432.82,4.100000018985305
CHEMBL129376,O=C(Nc1ccc(F)cc1)c1cc(S(=O)(=O)Nc2nncn2-c2ccc(F)cc2)c(S)cc1Cl,IC50,37153.52,4.43,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37153.52,4.430000034012231
CHEMBL339347,Cc1cc(S(=O)(=O)Nc2nc3ccccc3nc2-c2ccc(Cl)cc2)c(S)cc1Cl,IC50,19952.62,4.7,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19952.62,4.70000006855703
CHEMBL339347,Cc1cc(S(=O)(=O)Nc2nc3ccccc3nc2-c2ccc(Cl)cc2)c(S)cc1Cl,IC50,12022.64,4.92,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12022.64,4.920000156997057
CHEMBL131784,Cc1cc(S(=O)(=O)Nc2nnc3c4scc(C)c4ncn23)c(S)cc1Cl,IC50,9332.54,5.03,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9332.54,5.030000139977383
CHEMBL131784,Cc1cc(S(=O)(=O)Nc2nnc3c4scc(C)c4ncn23)c(S)cc1Cl,IC50,7413.1,5.13,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7413.1,5.130000141365475
CHEMBL129173,Cc1cc(S(=O)(=O)Nc2nc3ccccc3nc2-c2ccc(Br)cc2)c(S)cc1Cl,IC50,12302.69,4.91,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12302.69,4.909999919094989
CHEMBL129173,Cc1cc(S(=O)(=O)Nc2nc3ccccc3nc2-c2ccc(Br)cc2)c(S)cc1Cl,IC50,7943.28,5.1,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7943.28,5.100000128334196
CHEMBL131063,CC(C)Cn1cnnc1NS(=O)(=O)c1cc(C(=O)Nc2ccc(Cl)cc2)c(Cl)cc1S,IC50,38018.94,4.42,CHEMBL701802,Inhibitory activity against 3' processing by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38018.94,4.419999995796937
CHEMBL131063,CC(C)Cn1cnnc1NS(=O)(=O)c1cc(C(=O)Nc2ccc(Cl)cc2)c(Cl)cc1S,IC50,39810.72,4.4,CHEMBL701803,Inhibitory activity against DNA strand transfer by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39810.72,4.399999967876858
CHEMBL150,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,IC50,97800.0,4.01,CHEMBL702098,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,97800.0,4.009661145212399
CHEMBL150,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,IC50,64700.0,4.19,CHEMBL702099,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,64700.0,4.189095719331299
CHEMBL149674,O=C(/C=C/c1ccc(O)c(O)c1)OC1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,600.0,6.22,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL403498,CC1C=C(NC(=O)C2=CC(NC(=O)C3=CC(NC(=O)c4ccc(C(=O)NC5=CC(C)C(C(=O)NC6=CC(C)C(C(=O)NC7=CC(C)C(C(=O)NCCC(=N)N)=C7)=C6)=C5)nc4)=CC3C)=CC2C)C=C1C(=O)NCCC(=N)N,IC50,100.0,7.0,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL415678,O=C(OC(C(=O)O)C(OC(=O)c1ccc(O)c(O)c1)C(=O)O)c1ccc(O)c(O)c1,IC50,430.0,6.37,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,430.0,6.366531544420413
CHEMBL348709,O=C(/C=C/c1ccc(O)c(O)c1)OC1CCCCC1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,10000.0,,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL487258,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@@H](O)[C@@H]1O,IC50,1600.0,5.8,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL8260,O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12,IC50,1200.0,5.92,CHEMBL702098,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL8260,O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12,IC50,4300.0,5.37,CHEMBL702099,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4300.0,5.366531544420413
CHEMBL149826,O=C(/C=C/c1ccc(O)c(O)c1)OC1CCC(OC(=O)/C=C/c2ccc(O)c(O)c2)CC1,IC50,1030.0,5.99,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1030.0,5.987162775294828
CHEMBL149306,O=C(/C=C/c1ccc(O)c(O)c1)OCCCCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,10000.0,,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL146179,O=C(/C=C/c1ccc(O)c(O)c1)Oc1cc(OC(=O)/C=C/c2ccc(O)c(O)c2)cc(C(=O)O)c1,IC50,6900.0,5.16,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6900.0,5.161150909262744
CHEMBL164,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,7600.0,5.12,CHEMBL702098,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7600.0,5.119186407719209
CHEMBL164,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,2500.0,5.6,CHEMBL702099,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL286477,O=C(/C=C/c1ccc(O)c(O)c1)OCCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,10000.0,,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL31026,O=C(/C=C/c1ccc(O)c(O)c1)OCCCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,10000.0,,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL148364,O=C(Cc1ccc(O)c(O)c1)OC(C(=O)O)C(OC(=O)Cc1ccc(O)c(O)c1)C(=O)O,IC50,880.0,6.06,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,880.0,6.055517327849831
CHEMBL285696,CCCCCc1cc(O)cc2c1Oc1c(C=O)c(O)c(Cl)c(C(=O)CCCC)c1C(=O)O2,IC50,33600.0,4.47,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33600.0,4.473660722610156
CHEMBL171315,CC1OC(O)C(O)C(O)C1Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O,IC50,60000.0,4.22,CHEMBL702098,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL171315,CC1OC(O)C(O)C(O)C1Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O,IC50,38500.0,4.42,CHEMBL702099,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38500.0,4.414539270491499
CHEMBL149305,O=C(/C=C\c1ccc(O)c(O)c1)OC1CCCCC1OC(=O)/C=C\c1ccc(O)c(O)c1,IC50,8360.0,5.08,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8360.0,5.077793722560983
CHEMBL29660,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](C(=O)O)[C@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,70.0,7.16,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL63592,O=C(/C=C/c1ccc(O)c(O)c1)OC(C(=O)O)C(OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,80.0,7.1,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL36463,COc1cc(C(C2=C(O)C(=O)c3ccccc3C2=O)C2C(=O)c3ccccc3C(=O)C2O)cc(Br)c1O,IC50,20000.0,4.7,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL31574,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12,IC50,28400.0,4.55,CHEMBL702098,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28400.0,4.546681659952962
CHEMBL31574,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12,IC50,8500.0,5.07,CHEMBL702099,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8500.0,5.070581074285707
CHEMBL433434,COc1ccc(/C=C2\C(=O)N(C(=O)c3ccccc3O)N=C2C)cc1,IC50,600.0,6.22,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL409132,CC1C=C(NC(=O)C2=CC(NC(=O)C3=CC(N(C)C(=O)c4ccc(C(=O)N(C)C5=CC(C)C(C(=O)NC6=CC(C)C(C(=O)NC7=CC(C)C(C(=O)NCCCN(C)C)=C7)=C6)=C5)cc4)=CC3C)=CC2C)C=C1C(=O)NCCCN(C)C,IC50,70.0,7.16,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL413552,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)c(O)c(O)c12,IC50,800.0,6.1,CHEMBL702098,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL413552,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)c(O)c(O)c12,IC50,100.0,7.0,CHEMBL702099,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL285489,CC1=NN(C(=O)c2ccccc2O)C(=O)/C1=C\c1cccc(O)c1,IC50,7400.0,5.13,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7400.0,5.130768280269024
CHEMBL472863,O=C(/C=C/c1ccc(O)c(O)c1)NCC(OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,370.0,6.43,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,370.0,6.431798275933005
CHEMBL1159990,CC(Cc1ccc(O)c(O)c1)(C(=O)O)C(C)(Cc1ccc(O)c(O)c1)C(=O)O,IC50,230.0,6.64,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,230.0,6.638272163982407
CHEMBL216058,CC1C=C(NC(=O)C2=CC(NC(=O)C3=CC(NC(=O)c4ccc(C(=O)NC5=CC(C)C(C(=O)NC6=CC(C)C(C(=O)NC7=CC(C)C(C(=O)NCCC(=N)N)=C7)=C6)=C5)cc4)=CC3C)=CC2C)C=C1C(=O)NCCC(=N)N,IC50,90.0,7.05,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90.0,7.045757490560675
CHEMBL358821,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@@](O)(C(=O)O)CC(O)[C@@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,1400.0,5.85,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1400.0,5.853871964321762
CHEMBL357646,O=C(OC(C(=O)O)C(OC(=O)c1cc(O)c(O)c(O)c1)C(=O)O)c1cc(O)c(O)c(O)c1,IC50,970.0,6.01,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,970.0,6.013228265733755
CHEMBL249447,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1O,IC50,1300.0,5.89,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL1159990,CC(Cc1ccc(O)c(O)c1)(C(=O)O)C(C)(Cc1ccc(O)c(O)c1)C(=O)O,IC50,440.0,6.36,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,440.0,6.356547323513812
CHEMBL1159988,[N-]=[N+]=NC1CC(N=[N+]=[N-])c2cc(/C(O)=C\C(=O)C(=O)O)ccc21,IC50,360.0,6.44,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,360.0,6.443697499232712
CHEMBL312163,COc1cc(O)c2c(=O)c(O)c(-c3ccc(O)c(O)c3)oc2c1,IC50,61600.0,4.21,CHEMBL702098,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61600.0,4.210419287835575
CHEMBL312163,COc1cc(O)c2c(=O)c(O)c(-c3ccc(O)c(O)c3)oc2c1,IC50,28700.0,4.54,CHEMBL702099,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28700.0,4.542118103266008
CHEMBL357831,O=C(OC(C(=O)O)C(OC(=O)c1cccc(O)c1O)C(=O)O)c1cccc(O)c1O,IC50,1070.0,5.97,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1070.0,5.97061622231479
CHEMBL3138501,CC(CCC(=O)O)C1CC[C@H]2[C@@H]3C(OC(=O)/C=C/c4ccc(O)c(O)c4)CC4CC(OC(=O)/C=C/c5ccc(O)c(O)c5)CC[C@]4(C)[C@H]3CC(OC(=O)/C=C/c3ccc(O)c(O)c3)[C@]12C,IC50,970.0,6.01,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,970.0,6.013228265733755
CHEMBL440354,O=C(/C=C\c1ccc(O)c(O)c1)OC1CCCC(OC(=O)/C=C\c2ccc(O)c(O)c2)C1,IC50,1630.0,5.79,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1630.0,5.787812395596042
CHEMBL30868,O=C(/C=C/c1ccc(O)c(O)c1)OCC(OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,520.0,6.28,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,520.0,6.2839966563652006
CHEMBL63592,O=C(/C=C/c1ccc(O)c(O)c1)OC(C(=O)O)C(OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,180.0,6.75,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,180.0,6.7447274948966935
CHEMBL320261,O=C(O)C(=O)/C=C(\O)c1cc(OCc2ccccc2)cc(OCc2ccccc2)c1,IC50,59.0,7.23,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,59.0,7.229147988357855
CHEMBL149475,O=C(CCc1ccc(O)c(O)c1)OC(C(=O)O)C(OC(=O)CCc1ccc(O)c(O)c1)C(=O)O,IC50,2380.0,5.62,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2380.0,5.623423042943488
CHEMBL1159644,C[C@@H]1O[C@@H](O)[C@H](O)[C@H](O)[C@H]1Oc1c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c2c1=O,IC50,39600.0,4.4,CHEMBL702098,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39600.0,4.402304814074488
CHEMBL1159644,C[C@@H]1O[C@@H](O)[C@H](O)[C@H](O)[C@H]1Oc1c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c2c1=O,IC50,10300.0,4.99,CHEMBL702099,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10300.0,4.987162775294828
CHEMBL149178,O=C(/C=C/c1ccc(O)c(O)c1)OC1CCCC(OC(=O)/C=C/c2ccc(O)c(O)c2)C1,IC50,1800.0,5.75,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL1159993,[N-]=[N+]=NCc1ccc(/C(O)=C\C(=O)C(=O)O)cc1CN=[N+]=[N-],IC50,260.0,6.58,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,260.0,6.585026652029182
CHEMBL1159989,[N-]=[N+]=NC1CCC(N=[N+]=[N-])c2cc(/C(O)=C\C(=O)C(=O)O)ccc21,IC50,320.0,6.5,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,320.0,6.494850021680094
CHEMBL421353,O=C(O)C(=O)/C=C(\O)c1cccn1Cc1ccc(F)cc1,IC50,126.0,6.9,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,126.0,6.899629454882437
CHEMBL170405,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)ccc12,IC50,5900.0,5.23,CHEMBL702098,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5900.0,5.229147988357855
CHEMBL170405,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)ccc12,IC50,1600.0,5.8,CHEMBL702099,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL151,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,32900.0,4.48,CHEMBL702098,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32900.0,4.482804102050026
CHEMBL151,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,25000.0,4.6,CHEMBL702099,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL146489,O=C(/C=C\c1ccc(O)c(O)c1)OC1CCC(OC(=O)/C=C\c2ccc(O)c(O)c2)CC1,IC50,1010.0,6.0,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1010.0,5.995678626217357
CHEMBL2029094,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2c(O[C@@H]3O[C@@H](O)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc(O)c12,IC50,69700.0,4.16,CHEMBL702098,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69700.0,4.15676722190199
CHEMBL2029094,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2c(O[C@@H]3O[C@@H](O)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc(O)c12,IC50,22500.0,4.65,CHEMBL702099,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22500.0,4.647817481888637
CHEMBL285415,COc1cc(C)c2c(c1C)OC(=O)c1c(C)c(Cl)c(O)c(C=O)c1O2,IC50,2100.0,5.68,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2100.0,5.6777807052660805
CHEMBL353450,O=c1c(OC2COC(O)C(O)C2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,66300.0,4.18,CHEMBL702098,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,66300.0,4.178486471595227
CHEMBL353450,O=c1c(OC2COC(O)C(O)C2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,25100.0,4.6,CHEMBL702099,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25100.0,4.600326278518962
CHEMBL50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,23600.0,4.63,CHEMBL702098,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23600.0,4.627087997029894
CHEMBL50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,13600.0,4.87,CHEMBL702099,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13600.0,4.866461091629782
CHEMBL172350,COc1c(O)cc2oc(-c3ccc(O)c(O)c3)cc(=O)c2c1O,IC50,94300.0,4.03,CHEMBL702098,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,94300.0,4.0254883072626715
CHEMBL172350,COc1c(O)cc2oc(-c3ccc(O)c(O)c3)cc(=O)c2c1O,IC50,39100.0,4.41,CHEMBL702099,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39100.0,4.407823242604133
CHEMBL1159991,N#CCCc1cccc(/C(O)=C\C(=O)C(=O)O)c1,IC50,1500.0,5.82,CHEMBL699303,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1500.0,5.823908740944319
CHEMBL28626,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,IC50,76500.0,4.12,CHEMBL702098,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,76500.0,4.116338564846382
CHEMBL28626,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,IC50,31700.0,4.5,CHEMBL702099,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31700.0,4.498940737782249
CHEMBL149893,COC(=O)O[C@]1(C(=O)O)CC(OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1,IC50,800.0,6.1,CHEMBL701725,Inhibitory activity against Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL368810,CCCCCc1cc(O)cc2c1Oc1cc(O)cc(C(=O)CCCC)c1C(=O)O2,IC50,59900.0,4.22,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,59900.0,4.2225731776106885
CHEMBL368810,CCCCCc1cc(O)cc2c1Oc1cc(O)cc(C(=O)CCCC)c1C(=O)O2,IC50,42200.0,4.38,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42200.0,4.374687549038326
CHEMBL368810,CCCCCc1cc(O)cc2c1Oc1cc(O)cc(C(=O)CCCC)c1C(=O)O2,IC50,39200.0,4.41,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39200.0,4.406713932979542
CHEMBL368810,CCCCCc1cc(O)cc2c1Oc1cc(O)cc(C(=O)CCCC)c1C(=O)O2,IC50,28100.0,4.55,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28100.0,4.55129368009492
CHEMBL177126,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,1300.0,5.89,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL177126,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,700.0,6.16,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL177126,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,600.0,6.22,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL177126,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,700.0,6.16,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL131678,O=C(/C=C/c1cc(O)ccc1O)OCCc1ccccc1,IC50,100000.0,4.0,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL172418,CCOC(=O)c1cnc(NCCCNc2ncc(C(=O)OCC)c(O)n2)nc1O,IC50,12800.0,4.89,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12800.0,4.892790030352131
CHEMBL172418,CCOC(=O)c1cnc(NCCCNc2ncc(C(=O)OCC)c(O)n2)nc1O,IC50,11600.0,4.94,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11600.0,4.935542010773082
CHEMBL172418,CCOC(=O)c1cnc(NCCCNc2ncc(C(=O)OCC)c(O)n2)nc1O,IC50,16700.0,4.78,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16700.0,4.777283528852417
CHEMBL172418,CCOC(=O)c1cnc(NCCCNc2ncc(C(=O)OCC)c(O)n2)nc1O,IC50,7900.0,5.1,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7900.0,5.102372908709558
CHEMBL174366,O=C(NO)c1cc(O)c(O)c(O)c1,IC50,1100.0,5.96,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1100.0,5.958607314841775
CHEMBL174366,O=C(NO)c1cc(O)c(O)c(O)c1,IC50,3200.0,5.5,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3200.0,5.494850021680094
CHEMBL174366,O=C(NO)c1cc(O)c(O)c(O)c1,IC50,500.0,6.3,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL174366,O=C(NO)c1cc(O)c(O)c(O)c1,IC50,1600.0,5.8,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL17347,CCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,100000.0,4.0,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL168284,COOC(=O)c1cc2ccc(O)c(O)c2cn1,IC50,14125.38,4.85,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14125.38,4.849999859991125
CHEMBL175266,Cc1c2cc(O)c(=O)cc-2oc2cc(O)c(O)cc12,IC50,1100.0,5.96,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1100.0,5.958607314841775
CHEMBL175266,Cc1c2cc(O)c(=O)cc-2oc2cc(O)c(O)cc12,IC50,1500.0,5.82,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1500.0,5.823908740944319
CHEMBL175266,Cc1c2cc(O)c(=O)cc-2oc2cc(O)c(O)cc12,IC50,1100.0,5.96,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1100.0,5.958607314841775
CHEMBL175266,Cc1c2cc(O)c(=O)cc-2oc2cc(O)c(O)cc12,IC50,900.0,6.05,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL170850,COOC(=O)c1cc2cc(O)c(O)cc2cn1,IC50,100000.0,4.0,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL177021,COC(=O)c1c(C)c2c(c(C)c1O)OC(=O)c1c(C)cc(O)c(C=O)c1O2,IC50,5400.0,5.27,CHEMBL701791,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1&2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5400.0,5.267606240177031
CHEMBL177021,COC(=O)c1c(C)c2c(c(C)c1O)OC(=O)c1c(C)cc(O)c(C=O)c1O2,IC50,4400.0,5.36,CHEMBL699509,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1&2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4400.0,5.356547323513812
CHEMBL177021,COC(=O)c1c(C)c2c(c(C)c1O)OC(=O)c1c(C)cc(O)c(C=O)c1O2,IC50,26000.0,4.58,CHEMBL701793,Inhibitory concentration of compound against disintegration (reversal of strand transfer)of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26000.0,4.585026652029182
CHEMBL172018,CC(=O)C1=C(NNC(=O)c2ccccn2)[C@@]2(C)C(=CC1=O)Oc1c(C(C)=O)c(O)c(C)c(O)c12,IC50,73000.0,4.14,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,73000.0,4.136677139879544
CHEMBL172018,CC(=O)C1=C(NNC(=O)c2ccccn2)[C@@]2(C)C(=CC1=O)Oc1c(C(C)=O)c(O)c(C)c(O)c12,IC50,60800.0,4.22,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60800.0,4.216096420727265
CHEMBL172018,CC(=O)C1=C(NNC(=O)c2ccccn2)[C@@]2(C)C(=CC1=O)Oc1c(C(C)=O)c(O)c(C)c(O)c12,IC50,48500.0,4.31,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48500.0,4.314258261397736
CHEMBL172018,CC(=O)C1=C(NNC(=O)c2ccccn2)[C@@]2(C)C(=CC1=O)Oc1c(C(C)=O)c(O)c(C)c(O)c12,IC50,55000.0,4.26,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55000.0,4.259637310505756
CHEMBL172018,CC(=O)C1=C(NNC(=O)c2ccccn2)[C@@]2(C)C(=CC1=O)Oc1c(C(C)=O)c(O)c(C)c(O)c12,IC50,39000.0,4.41,CHEMBL701793,Inhibitory concentration of compound against disintegration (reversal of strand transfer)of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39000.0,4.4089353929735005
CHEMBL171896,CCCCCc1cc2cc(O)cc(Oc3c(O)cc(O)c(C(=O)O)c3CCCCC)c2c(=O)o1,IC50,52200.0,4.28,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52200.0,4.282329496997738
CHEMBL171896,CCCCCc1cc2cc(O)cc(Oc3c(O)cc(O)c(C(=O)O)c3CCCCC)c2c(=O)o1,IC50,45700.0,4.34,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45700.0,4.34008379993015
CHEMBL171896,CCCCCc1cc2cc(O)cc(Oc3c(O)cc(O)c(C(=O)O)c3CCCCC)c2c(=O)o1,IC50,35000.0,4.46,CHEMBL701793,Inhibitory concentration of compound against disintegration (reversal of strand transfer)of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL284616,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O,IC50,87800.0,4.06,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,87800.0,4.056505484093897
CHEMBL284616,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O,IC50,58200.0,4.24,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58200.0,4.235077015350112
CHEMBL284616,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O,IC50,45800.0,4.34,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45800.0,4.339134521996131
CHEMBL284616,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O,IC50,31300.0,4.5,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31300.0,4.504455662453552
CHEMBL173117,O=[N+]([O-])c1cc(Cc2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O,IC50,49700.0,4.3,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,49700.0,4.303643611266668
CHEMBL173117,O=[N+]([O-])c1cc(Cc2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O,IC50,61800.0,4.21,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61800.0,4.209011524911184
CHEMBL173117,O=[N+]([O-])c1cc(Cc2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O,IC50,43900.0,4.36,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43900.0,4.357535479757878
CHEMBL173117,O=[N+]([O-])c1cc(Cc2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O,IC50,40500.0,4.39,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40500.0,4.392544976785332
CHEMBL366410,Cc1cc(O)c(C=O)c2c1C(=O)Oc1c(C)c(O)c(C(=O)O)c(C)c1O2,IC50,4600.0,5.34,CHEMBL701791,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1&2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4600.0,5.337242168318426
CHEMBL366410,Cc1cc(O)c(C=O)c2c1C(=O)Oc1c(C)c(O)c(C(=O)O)c(C)c1O2,IC50,6500.0,5.19,CHEMBL699509,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1&2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6500.0,5.187086643357144
CHEMBL366410,Cc1cc(O)c(C=O)c2c1C(=O)Oc1c(C)c(O)c(C(=O)O)c(C)c1O2,IC50,33500.0,4.47,CHEMBL701793,Inhibitory concentration of compound against disintegration (reversal of strand transfer)of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33500.0,4.474955192963154
CHEMBL368859,O=C1C(O)=C(c2ccccc2)C12CSC1(CS2)C(=O)C(O)=C1c1ccccc1,IC50,60000.0,4.22,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL368859,O=C1C(O)=C(c2ccccc2)C12CSC1(CS2)C(=O)C(O)=C1c1ccccc1,IC50,54800.0,4.26,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54800.0,4.261219441515631
CHEMBL173395,COC(=O)c1c(C)cc(OC(=O)c2c(C)cc(O)c(C=O)c2O)c(C)c1O,IC50,61000.0,4.21,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61000.0,4.214670164989233
CHEMBL173395,COC(=O)c1c(C)cc(OC(=O)c2c(C)cc(O)c(C=O)c2O)c(C)c1O,IC50,62400.0,4.21,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,62400.0,4.204815410317576
CHEMBL173395,COC(=O)c1c(C)cc(OC(=O)c2c(C)cc(O)c(C=O)c2O)c(C)c1O,IC50,36000.0,4.44,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36000.0,4.443697499232713
CHEMBL173395,COC(=O)c1c(C)cc(OC(=O)c2c(C)cc(O)c(C=O)c2O)c(C)c1O,IC50,44000.0,4.36,CHEMBL699511,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44000.0,4.356547323513812
CHEMBL296582,O=C(NCc1ccccc1)c1cc2cc(O)c(O)cc2cn1,IC50,100000.0,4.0,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL176570,COc1cc(C(=O)O)c2c(c1C)OC(=O)c1c(C)cc(O)c(C=O)c1O2,IC50,17000.0,4.77,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL176570,COc1cc(C(=O)O)c2c(c1C)OC(=O)c1c(C)cc(O)c(C=O)c1O2,IC50,15100.0,4.82,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15100.0,4.82102305270683
CHEMBL176570,COc1cc(C(=O)O)c2c(c1C)OC(=O)c1c(C)cc(O)c(C=O)c1O2,IC50,5300.0,5.28,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5300.0,5.275724130399211
CHEMBL176570,COc1cc(C(=O)O)c2c(c1C)OC(=O)c1c(C)cc(O)c(C=O)c1O2,IC50,12300.0,4.91,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12300.0,4.910094888560602
CHEMBL113891,Cc1cc(C(c2cc(C)c(O)c(C(=O)O)c2)c2cc(C)c(O)c(C(=O)O)c2)cc(C(=O)O)c1O,IC50,20400.0,4.69,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20400.0,4.690369832574102
CHEMBL113891,Cc1cc(C(c2cc(C)c(O)c(C(=O)O)c2)c2cc(C)c(O)c(C(=O)O)c2)cc(C(=O)O)c1O,IC50,23400.0,,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23400.0,4.6307841425898575
CHEMBL113891,Cc1cc(C(c2cc(C)c(O)c(C(=O)O)c2)c2cc(C)c(O)c(C(=O)O)c2)cc(C(=O)O)c1O,IC50,16700.0,4.78,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16700.0,4.777283528852417
CHEMBL113891,Cc1cc(C(c2cc(C)c(O)c(C(=O)O)c2)c2cc(C)c(O)c(C(=O)O)c2)cc(C(=O)O)c1O,IC50,23400.0,,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23400.0,4.6307841425898575
CHEMBL355757,Cc1ncc(COP(=O)(O)O)c(C2NC(C(=O)O)CS2)c1O,IC50,91700.0,4.04,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,91700.0,4.037630664329979
CHEMBL355757,Cc1ncc(COP(=O)(O)O)c(C2NC(C(=O)O)CS2)c1O,IC50,75100.0,4.12,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75100.0,4.124360062995832
CHEMBL355757,Cc1ncc(COP(=O)(O)O)c(C2NC(C(=O)O)CS2)c1O,IC50,93400.0,4.03,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,93400.0,4.029653123769907
CHEMBL355757,Cc1ncc(COP(=O)(O)O)c(C2NC(C(=O)O)CS2)c1O,IC50,31700.0,4.5,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31700.0,4.498940737782249
CHEMBL105350,O=C(/C=C/c1ccc(O)cc1)CC(=O)/C=C/c1ccc(O)cc1,IC50,100000.0,4.0,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL113835,Cc1cc(Cc2cc(C)c(O)c(C(=O)O)c2)cc(C(=O)O)c1O,IC50,61800.0,4.21,CHEMBL701791,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1&2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61800.0,4.209011524911184
CHEMBL113835,Cc1cc(Cc2cc(C)c(O)c(C(=O)O)c2)cc(C(=O)O)c1O,IC50,68500.0,4.16,CHEMBL699509,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1&2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68500.0,4.164309428507575
CHEMBL368123,O=C1OC2C(O)COC2(O)C1(O)Cc1cc(O)c(O)c(Br)c1Br,IC50,64700.0,4.19,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,64700.0,4.189095719331299
CHEMBL368123,O=C1OC2C(O)COC2(O)C1(O)Cc1cc(O)c(O)c(Br)c1Br,IC50,28700.0,4.54,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28700.0,4.542118103266008
CHEMBL368123,O=C1OC2C(O)COC2(O)C1(O)Cc1cc(O)c(O)c(Br)c1Br,IC50,50200.0,4.3,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50200.0,4.29929628285498
CHEMBL368123,O=C1OC2C(O)COC2(O)C1(O)Cc1cc(O)c(O)c(Br)c1Br,IC50,24300.0,4.61,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24300.0,4.614393726401688
CHEMBL366861,Cc1cc(O)c(C=O)c2c1C(=O)Oc1c(COC(=O)/C=C/C(=O)O)c(O)c(C(=O)O)c(C)c1O2,IC50,4900.0,5.31,CHEMBL701791,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1&2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4900.0,5.309803919971486
CHEMBL366861,Cc1cc(O)c(C=O)c2c1C(=O)Oc1c(COC(=O)/C=C/C(=O)O)c(O)c(C(=O)O)c(C)c1O2,IC50,4600.0,5.34,CHEMBL699509,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1&2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4600.0,5.337242168318426
CHEMBL366861,Cc1cc(O)c(C=O)c2c1C(=O)Oc1c(COC(=O)/C=C/C(=O)O)c(O)c(C(=O)O)c(C)c1O2,IC50,7300.0,5.14,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7300.0,5.136677139879544
CHEMBL17001,COC(=O)/C=C/c1ccc(O)c(O)c1,IC50,100000.0,4.0,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL129134,O=C(/C=C/c1ccc(O)cc1)/C=C/c1ccc(O)cc1,IC50,100000.0,4.0,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL353069,COOC(=O)c1ccc2c(O)c(O)ccc2c1,IC50,7943.28,5.1,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7943.28,5.100000128334196
CHEMBL366356,O=C(O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1,IC50,900.0,6.05,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL366356,O=C(O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1,IC50,1500.0,5.82,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1500.0,5.823908740944319
CHEMBL366356,O=C(O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1,IC50,600.0,6.22,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL366356,O=C(O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1,IC50,600.0,6.22,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL366356,O=C(O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1,IC50,2200.0,5.66,CHEMBL699438,Inhibitory concentration of compound against strand transfer of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2200.0,5.657577319177793
CHEMBL337498,O=C(/C=C/c1ccc(F)c(F)c1)OCCc1ccccc1,IC50,100000.0,4.0,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL17377,C[C@@](O)(/C=C/[C@H]1CC=CC(=O)O1)[C@@H](C[C@@H](O)/C=C\C=C/C=C/CO)OP(=O)(O)O,IC50,41300.0,4.38,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41300.0,4.384049948343599
CHEMBL17377,C[C@@](O)(/C=C/[C@H]1CC=CC(=O)O1)[C@@H](C[C@@H](O)/C=C\C=C/C=C/CO)OP(=O)(O)O,IC50,12800.0,4.89,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12800.0,4.892790030352131
CHEMBL17377,C[C@@](O)(/C=C/[C@H]1CC=CC(=O)O1)[C@@H](C[C@@H](O)/C=C\C=C/C=C/CO)OP(=O)(O)O,IC50,52700.0,4.28,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52700.0,4.278189384787454
CHEMBL175052,O=C(NC(Cc1ccc(O)c(O)c1)C(=O)OCc1ccccc1)c1ccc([N+](=O)[O-])cc1,IC50,55400.0,4.26,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55400.0,4.2564902352715706
CHEMBL175052,O=C(NC(Cc1ccc(O)c(O)c1)C(=O)OCc1ccccc1)c1ccc([N+](=O)[O-])cc1,IC50,76600.0,4.12,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,76600.0,4.115771230367396
CHEMBL173698,O=C(O)c1c([N+](=O)[O-])cc([N+](=O)[O-])c(-c2c([N+](=O)[O-])cc([N+](=O)[O-])c(C(=O)O)c2[N+](=O)[O-])c1[N+](=O)[O-],IC50,18200.0,4.74,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18200.0,4.739928612014925
CHEMBL173698,O=C(O)c1c([N+](=O)[O-])cc([N+](=O)[O-])c(-c2c([N+](=O)[O-])cc([N+](=O)[O-])c(C(=O)O)c2[N+](=O)[O-])c1[N+](=O)[O-],IC50,46100.0,4.34,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,46100.0,4.336299074610352
CHEMBL173698,O=C(O)c1c([N+](=O)[O-])cc([N+](=O)[O-])c(-c2c([N+](=O)[O-])cc([N+](=O)[O-])c(C(=O)O)c2[N+](=O)[O-])c1[N+](=O)[O-],IC50,15000.0,4.82,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL173698,O=C(O)c1c([N+](=O)[O-])cc([N+](=O)[O-])c(-c2c([N+](=O)[O-])cc([N+](=O)[O-])c(C(=O)O)c2[N+](=O)[O-])c1[N+](=O)[O-],IC50,43300.0,4.36,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43300.0,4.363512103646634
CHEMBL129795,O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O,IC50,100000.0,4.0,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL115145,O=C(O)c1cc(Cc2ccc(O)c(C(=O)O)c2)ccc1O,IC50,91300.0,4.04,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,91300.0,4.039529222465701
CHEMBL115145,O=C(O)c1cc(Cc2ccc(O)c(C(=O)O)c2)ccc1O,IC50,51800.0,4.29,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,51800.0,4.285670240254767
CHEMBL115145,O=C(O)c1cc(Cc2ccc(O)c(C(=O)O)c2)ccc1O,IC50,60400.0,4.22,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60400.0,4.218963061378868
CHEMBL115145,O=C(O)c1cc(Cc2ccc(O)c(C(=O)O)c2)ccc1O,IC50,57800.0,4.24,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57800.0,4.2380721615794705
CHEMBL174150,O=[N+]([O-])c1c(Cl)c(O)c(Cl)c([N+](=O)[O-])c1Nc1c([N+](=O)[O-])c(Cl)c(O)c(Cl)c1[N+](=O)[O-],IC50,11000.0,4.96,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL174150,O=[N+]([O-])c1c(Cl)c(O)c(Cl)c([N+](=O)[O-])c1Nc1c([N+](=O)[O-])c(Cl)c(O)c(Cl)c1[N+](=O)[O-],IC50,8300.0,5.08,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8300.0,5.080921907623926
CHEMBL174150,O=[N+]([O-])c1c(Cl)c(O)c(Cl)c([N+](=O)[O-])c1Nc1c([N+](=O)[O-])c(Cl)c(O)c(Cl)c1[N+](=O)[O-],IC50,4400.0,5.36,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4400.0,5.356547323513812
CHEMBL174150,O=[N+]([O-])c1c(Cl)c(O)c(Cl)c([N+](=O)[O-])c1Nc1c([N+](=O)[O-])c(Cl)c(O)c(Cl)c1[N+](=O)[O-],IC50,4000.0,5.4,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL285415,COc1cc(C)c2c(c1C)OC(=O)c1c(C)c(Cl)c(O)c(C=O)c1O2,IC50,2200.0,5.66,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2200.0,5.657577319177793
CHEMBL285415,COc1cc(C)c2c(c1C)OC(=O)c1c(C)c(Cl)c(O)c(C=O)c1O2,IC50,2700.0,5.57,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2700.0,5.568636235841012
CHEMBL285415,COc1cc(C)c2c(c1C)OC(=O)c1c(C)c(Cl)c(O)c(C=O)c1O2,IC50,1600.0,5.8,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL285415,COc1cc(C)c2c(c1C)OC(=O)c1c(C)c(Cl)c(O)c(C=O)c1O2,IC50,2700.0,5.57,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2700.0,5.568636235841012
CHEMBL285415,COc1cc(C)c2c(c1C)OC(=O)c1c(C)c(Cl)c(O)c(C=O)c1O2,IC50,12800.0,4.89,CHEMBL701793,Inhibitory concentration of compound against disintegration (reversal of strand transfer)of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12800.0,4.892790030352131
CHEMBL177054,O=C(O)C(CSSCC(Nc1ccc([N+](=O)[O-])cc1[N+](=O)[O-])C(=O)O)Nc1ccc([N+](=O)[O-])cc1[N+](=O)[O-],IC50,45100.0,4.35,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45100.0,4.345823458122039
CHEMBL177054,O=C(O)C(CSSCC(Nc1ccc([N+](=O)[O-])cc1[N+](=O)[O-])C(=O)O)Nc1ccc([N+](=O)[O-])cc1[N+](=O)[O-],IC50,82000.0,4.09,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,82000.0,4.086186147616283
CHEMBL177054,O=C(O)C(CSSCC(Nc1ccc([N+](=O)[O-])cc1[N+](=O)[O-])C(=O)O)Nc1ccc([N+](=O)[O-])cc1[N+](=O)[O-],IC50,43000.0,4.37,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43000.0,4.366531544420414
CHEMBL177054,O=C(O)C(CSSCC(Nc1ccc([N+](=O)[O-])cc1[N+](=O)[O-])C(=O)O)Nc1ccc([N+](=O)[O-])cc1[N+](=O)[O-],IC50,51000.0,4.29,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,51000.0,4.292429823902063
CHEMBL133642,COc1ccc(/C=C/C(=O)OCCc2ccccc2)cc1OC,IC50,100000.0,4.0,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL176916,O=[N+]([O-])c1cc(-c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O,IC50,61700.0,4.21,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61700.0,4.209714835966758
CHEMBL176916,O=[N+]([O-])c1cc(-c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O,IC50,65000.0,4.19,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL176916,O=[N+]([O-])c1cc(-c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O,IC50,57300.0,4.24,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57300.0,4.24184537803261
CHEMBL176916,O=[N+]([O-])c1cc(-c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O,IC50,35800.0,4.45,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35800.0,4.446116973356125
CHEMBL173530,COc1cc(C)c2c(c1C=O)Oc1c(c(C)c(O)c3c1C(O)OC3=O)OC2=O,IC50,4400.0,5.36,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4400.0,5.356547323513812
CHEMBL173530,COc1cc(C)c2c(c1C=O)Oc1c(c(C)c(O)c3c1C(O)OC3=O)OC2=O,IC50,2900.0,5.54,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2900.0,5.537602002101044
CHEMBL173530,COc1cc(C)c2c(c1C=O)Oc1c(c(C)c(O)c3c1C(O)OC3=O)OC2=O,IC50,2600.0,5.58,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2600.0,5.585026652029182
CHEMBL173530,COc1cc(C)c2c(c1C=O)Oc1c(c(C)c(O)c3c1C(O)OC3=O)OC2=O,IC50,1900.0,5.72,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1900.0,5.721246399047171
CHEMBL173530,COc1cc(C)c2c(c1C=O)Oc1c(c(C)c(O)c3c1C(O)OC3=O)OC2=O,IC50,11700.0,4.93,CHEMBL701793,Inhibitory concentration of compound against disintegration (reversal of strand transfer)of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11700.0,4.931814138253839
CHEMBL442022,COc1cc(/C=C/C(=O)OCCc2ccccc2)ccc1O,IC50,100000.0,4.0,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL116973,Cc1cc(C(O)(c2cc(C)c(O)c(C(=O)O)c2)c2cc(C)c(O)c(C(=O)O)c2)cc(C(=O)O)c1O,IC50,35800.0,4.45,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35800.0,4.446116973356125
CHEMBL116973,Cc1cc(C(O)(c2cc(C)c(O)c(C(=O)O)c2)c2cc(C)c(O)c(C(=O)O)c2)cc(C(=O)O)c1O,IC50,32800.0,4.48,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32800.0,4.484126156288321
CHEMBL116973,Cc1cc(C(O)(c2cc(C)c(O)c(C(=O)O)c2)c2cc(C)c(O)c(C(=O)O)c2)cc(C(=O)O)c1O,IC50,21800.0,4.66,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21800.0,4.661543506395395
CHEMBL116973,Cc1cc(C(O)(c2cc(C)c(O)c(C(=O)O)c2)c2cc(C)c(O)c(C(=O)O)c2)cc(C(=O)O)c1O,IC50,23000.0,4.64,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL170358,CCN(CC)c1ccc(Cc2ccc(N(C)C)c(Cl)c2)cc1.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O,IC50,61800.0,4.21,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61800.0,4.209011524911184
CHEMBL170358,CCN(CC)c1ccc(Cc2ccc(N(C)C)c(Cl)c2)cc1.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O,IC50,78600.0,4.11,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,78600.0,4.104577453960592
CHEMBL170358,CCN(CC)c1ccc(Cc2ccc(N(C)C)c(Cl)c2)cc1.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O,IC50,45800.0,4.34,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45800.0,4.339134521996131
CHEMBL170358,CCN(CC)c1ccc(Cc2ccc(N(C)C)c(Cl)c2)cc1.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O,IC50,38600.0,4.41,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38600.0,4.413412695328245
CHEMBL173978,O=[N+]([O-])c1cccc(/C=N/CCN2CCN(CC/N=C/c3cccc([N+](=O)[O-])c3O)C2c2cccc([N+](=O)[O-])c2O)c1O,IC50,52700.0,4.28,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52700.0,4.278189384787454
CHEMBL173978,O=[N+]([O-])c1cccc(/C=N/CCN2CCN(CC/N=C/c3cccc([N+](=O)[O-])c3O)C2c2cccc([N+](=O)[O-])c2O)c1O,IC50,60800.0,4.22,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60800.0,4.216096420727265
CHEMBL173978,O=[N+]([O-])c1cccc(/C=N/CCN2CCN(CC/N=C/c3cccc([N+](=O)[O-])c3O)C2c2cccc([N+](=O)[O-])c2O)c1O,IC50,36700.0,4.43,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36700.0,4.43533393574791
CHEMBL173978,O=[N+]([O-])c1cccc(/C=N/CCN2CCN(CC/N=C/c3cccc([N+](=O)[O-])c3O)C2c2cccc([N+](=O)[O-])c2O)c1O,IC50,49500.0,4.3,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,49500.0,4.305394801066432
CHEMBL176754,O=C(c1ccc(O)cc1O)c1c([N+](=O)[O-])cc([N+](=O)[O-])cc1[N+](=O)[O-],IC50,66200.0,4.18,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,66200.0,4.1791420105603
CHEMBL176754,O=C(c1ccc(O)cc1O)c1c([N+](=O)[O-])cc([N+](=O)[O-])cc1[N+](=O)[O-],IC50,67000.0,4.17,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,67000.0,4.173925197299174
CHEMBL176754,O=C(c1ccc(O)cc1O)c1c([N+](=O)[O-])cc([N+](=O)[O-])cc1[N+](=O)[O-],IC50,88200.0,4.05,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,88200.0,4.054531414868181
CHEMBL176754,O=C(c1ccc(O)cc1O)c1c([N+](=O)[O-])cc([N+](=O)[O-])cc1[N+](=O)[O-],IC50,54400.0,4.26,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54400.0,4.2644011003018205
CHEMBL172439,Cc1cc(O)c(C=O)c2c1C(=O)Oc1c(CO)c(O)c3c(c1O2)C(O)OC3=O,IC50,19000.0,4.72,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL172439,Cc1cc(O)c(C=O)c2c1C(=O)Oc1c(CO)c(O)c3c(c1O2)C(O)OC3=O,IC50,16000.0,4.8,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL172439,Cc1cc(O)c(C=O)c2c1C(=O)Oc1c(CO)c(O)c3c(c1O2)C(O)OC3=O,IC50,12600.0,4.9,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12600.0,4.8996294548824375
CHEMBL172439,Cc1cc(O)c(C=O)c2c1C(=O)Oc1c(CO)c(O)c3c(c1O2)C(O)OC3=O,IC50,6200.0,5.21,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6200.0,5.207608310501746
CHEMBL17205,COc1cc(/C=C2\CCC/C(=C\c3ccc(O)c(OC)c3)C2=O)ccc1O,IC50,100000.0,4.0,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL129913,O=C(/C=C(O)/C=C/c1ccccc1)/C=C/c1ccccc1,IC50,100000.0,4.0,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL174041,O=C(Nc1ccc(C(=O)O)c(O)c1)c1ccc(C(=O)Nc2ccc(O)c(C(=O)O)c2)cc1,IC50,23600.0,4.63,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23600.0,4.627087997029894
CHEMBL174041,O=C(Nc1ccc(C(=O)O)c(O)c1)c1ccc(C(=O)Nc2ccc(O)c(C(=O)O)c2)cc1,IC50,25200.0,4.6,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25200.0,4.598599459218456
CHEMBL174041,O=C(Nc1ccc(C(=O)O)c(O)c1)c1ccc(C(=O)Nc2ccc(O)c(C(=O)O)c2)cc1,IC50,16300.0,4.79,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16300.0,4.787812395596042
CHEMBL174041,O=C(Nc1ccc(C(=O)O)c(O)c1)c1ccc(C(=O)Nc2ccc(O)c(C(=O)O)c2)cc1,IC50,20000.0,4.7,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL128748,COc1ccc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OC)c(OC)c2)cc1OC,IC50,100000.0,4.0,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL354416,O=C(O)c1ccccc1C(c1cc(Br)c(O)c(Br)c1)c1ccc(Br)c(O)c1Br,IC50,43700.0,4.36,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43700.0,4.359518563029578
CHEMBL354416,O=C(O)c1ccccc1C(c1cc(Br)c(O)c(Br)c1)c1ccc(Br)c(O)c1Br,IC50,25600.0,4.59,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25600.0,4.59176003468815
CHEMBL354416,O=C(O)c1ccccc1C(c1cc(Br)c(O)c(Br)c1)c1ccc(Br)c(O)c1Br,IC50,38800.0,4.41,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38800.0,4.411168274405793
CHEMBL354416,O=C(O)c1ccccc1C(c1cc(Br)c(O)c(Br)c1)c1ccc(Br)c(O)c1Br,IC50,27200.0,4.57,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27200.0,4.565431095965801
CHEMBL369379,O=C(O)c1cnc2c(ccc3ncc(C(=O)O)c(O)c32)c1O,IC50,7600.0,5.12,CHEMBL697789,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7600.0,5.119186407719209
CHEMBL369379,O=C(O)c1cnc2c(ccc3ncc(C(=O)O)c(O)c32)c1O,IC50,6100.0,5.21,CHEMBL701792,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6100.0,5.214670164989233
CHEMBL369379,O=C(O)c1cnc2c(ccc3ncc(C(=O)O)c(O)c32)c1O,IC50,9800.0,5.01,CHEMBL699508,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9800.0,5.008773924307505
CHEMBL369379,O=C(O)c1cnc2c(ccc3ncc(C(=O)O)c(O)c32)c1O,IC50,6100.0,5.21,CHEMBL699510,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6100.0,5.214670164989233
CHEMBL127028,O=C(/C=C/c1ccc(O)c(O)c1)CCc1ccccc1,IC50,100000.0,4.0,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1161516,O=C1/C(=C/c2ccc(O)c(O)c2)CNC/C1=C\c1ccc(O)c(O)c1,IC50,199.53,6.7,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,199.53,6.699991797446187
CHEMBL423698,COc1ccc(/C=C/C(=O)/C=C/c2ccc(OC)c(OC)c2)cc1OC,IC50,100000.0,4.0,CHEMBL857173,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL171637,CCCCCC(=O)Cc1cc(O)cc2c1C(=O)Oc1cc(O)c(C(=O)O)c(CCCCC)c1O2,IC50,38500.0,4.42,CHEMBL701791,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1&2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38500.0,4.414539270491499
CHEMBL171637,CCCCCC(=O)Cc1cc(O)cc2c1C(=O)Oc1cc(O)c(C(=O)O)c(CCCCC)c1O2,IC50,30900.0,4.51,CHEMBL699509,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1&2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30900.0,4.510041520575165
CHEMBL171637,CCCCCC(=O)Cc1cc(O)cc2c1C(=O)Oc1cc(O)c(C(=O)O)c(CCCCC)c1O2,IC50,32500.0,4.49,CHEMBL701793,Inhibitory concentration of compound against disintegration (reversal of strand transfer)of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32500.0,4.488116639021126
CHEMBL35842,O=C(c1cccc(Cc2ccccc2)c1)c1ccc2cccnc2c1O,IC50,370.0,6.43,CHEMBL701160,Compound was tested for its ability to inhibit the strand transfer of the integration process catalyzed by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,370.0,6.431798275933005
CHEMBL288097,O=c1c2cc(Cc3ccccc3)ccc2oc2ccc(O)c(O)c12,IC50,600.0,6.22,CHEMBL701160,Compound was tested for its ability to inhibit the strand transfer of the integration process catalyzed by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL173334,Nc1ccccc1C(=O)NNC(=O)c1ccccc1O,IC50,100000.0,,CHEMBL702106,Inhibition of HIV-1 integrase enzyme by 3'-processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL173334,Nc1ccccc1C(=O)NNC(=O)c1ccccc1O,IC50,100000.0,,CHEMBL702109,Inhibition of HIV-1 integrase enzyme,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL369060,CC(=O)NNC(=O)c1ccccc1O,IC50,100000.0,,CHEMBL702106,Inhibition of HIV-1 integrase enzyme by 3'-processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL369060,CC(=O)NNC(=O)c1ccccc1O,IC50,100000.0,,CHEMBL702109,Inhibition of HIV-1 integrase enzyme,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL142072,O=C(c1cc(Cc2ccccc2)ccn1)c1ccc2cccnc2c1O,IC50,50.0,7.3,CHEMBL701160,Compound was tested for its ability to inhibit the strand transfer of the integration process catalyzed by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL126038,NNC(=O)c1ccccc1N,IC50,100000.0,,CHEMBL702106,Inhibition of HIV-1 integrase enzyme by 3'-processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL126038,NNC(=O)c1ccccc1N,IC50,100000.0,,CHEMBL702109,Inhibition of HIV-1 integrase enzyme,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL36303,O=C(NNC(=O)c1ccccc1O)c1ccccc1O,IC50,2070.0,5.68,CHEMBL702106,Inhibition of HIV-1 integrase enzyme by 3'-processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2070.0,5.684029654543082
CHEMBL36303,O=C(NNC(=O)c1ccccc1O)c1ccccc1O,IC50,730.0,6.14,CHEMBL702109,Inhibition of HIV-1 integrase enzyme,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,730.0,6.136677139879544
CHEMBL353337,O=C(NNC(=O)c1ccccc1O)c1ccccc1,IC50,100000.0,,CHEMBL702106,Inhibition of HIV-1 integrase enzyme by 3'-processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL353337,O=C(NNC(=O)c1ccccc1O)c1ccccc1,IC50,100000.0,,CHEMBL702109,Inhibition of HIV-1 integrase enzyme,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL425852,O=C(NNC(=O)c1ccccc1S)c1ccccc1O,IC50,9100.0,5.04,CHEMBL702106,Inhibition of HIV-1 integrase enzyme by 3'-processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9100.0,5.040958607678906
CHEMBL425852,O=C(NNC(=O)c1ccccc1S)c1ccccc1O,IC50,5800.0,5.24,CHEMBL702109,Inhibition of HIV-1 integrase enzyme,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5800.0,5.236572006437063
CHEMBL174074,NNC(=O)c1ccccc1S,IC50,70000.0,4.16,CHEMBL702107,Inhibition of HIV-1 integrase enzyme by 3'-processing method (experiment 1),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL174074,NNC(=O)c1ccccc1S,IC50,57500.0,4.24,CHEMBL702110,Inhibition of HIV-1 integrase enzyme by integration method (experiment 1),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57500.0,4.2403321553103694
CHEMBL174074,NNC(=O)c1ccccc1S,IC50,79600.0,4.1,CHEMBL702108,Inhibition of HIV-1 integrase enzyme by 3'-processing method (experiment 2),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,79600.0,4.099086932262331
CHEMBL174074,NNC(=O)c1ccccc1S,IC50,50000.0,4.3,CHEMBL702111,Inhibition of HIV-1 integrase enzyme by integration method (experiment 2),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL36070,O=C(c1cccc(Cc2ccccc2)c1)c1ncc2cccnc2c1O,IC50,40.0,7.4,CHEMBL701160,Compound was tested for its ability to inhibit the strand transfer of the integration process catalyzed by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL140319,O=C(c1cccc(Cc2ccccc2)c1)c1oc2cccnc2c1O,IC50,1000.0,6.0,CHEMBL701160,Compound was tested for its ability to inhibit the strand transfer of the integration process catalyzed by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL366798,O=C(NNC(=O)c1cc2ccccc2cc1O)c1ccccc1O,IC50,2300.0,5.64,CHEMBL702106,Inhibition of HIV-1 integrase enzyme by 3'-processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2300.0,5.638272163982407
CHEMBL366798,O=C(NNC(=O)c1cc2ccccc2cc1O)c1ccccc1O,IC50,1100.0,5.96,CHEMBL702109,Inhibition of HIV-1 integrase enzyme,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1100.0,5.958607314841775
CHEMBL115405,O=C(NNC(=O)c1ccccc1)c1ccccc1,IC50,100000.0,,CHEMBL702106,Inhibition of HIV-1 integrase enzyme by 3'-processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL115405,O=C(NNC(=O)c1ccccc1)c1ccccc1,IC50,100000.0,,CHEMBL702109,Inhibition of HIV-1 integrase enzyme,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL433983,O=C(NNCc1ccccc1O)c1ccccc1O,IC50,6700.0,5.17,CHEMBL702106,Inhibition of HIV-1 integrase enzyme by 3'-processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6700.0,5.173925197299173
CHEMBL433983,O=C(NNCc1ccccc1O)c1ccccc1O,IC50,5200.0,5.28,CHEMBL702109,Inhibition of HIV-1 integrase enzyme,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5200.0,5.2839966563652006
CHEMBL19464,O=C(O)C(=O)CC(=O)c1cccc(Cc2ccccc2)c1,IC50,10.0,8.0,CHEMBL701160,Compound was tested for its ability to inhibit the strand transfer of the integration process catalyzed by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL172968,O=C(NNC(=O)c1ccccn1)c1ccccn1,IC50,100000.0,,CHEMBL702106,Inhibition of HIV-1 integrase enzyme by 3'-processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL172968,O=C(NNC(=O)c1ccccn1)c1ccccn1,IC50,100000.0,,CHEMBL702109,Inhibition of HIV-1 integrase enzyme,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL27577,NC(=O)c1ccccc1O,IC50,100000.0,,CHEMBL702106,Inhibition of HIV-1 integrase enzyme by 3'-processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL27577,NC(=O)c1ccccc1O,IC50,100000.0,,CHEMBL702109,Inhibition of HIV-1 integrase enzyme,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL110954,Nc1ccccc1C(=O)NNC(=O)c1ccccc1N,IC50,100000.0,,CHEMBL702106,Inhibition of HIV-1 integrase enzyme by 3'-processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL110954,Nc1ccccc1C(=O)NNC(=O)c1ccccc1N,IC50,100000.0,,CHEMBL702109,Inhibition of HIV-1 integrase enzyme,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL32865,O=C(c1cc(Cc2ccccc2)cc(CN2CCCS2(=O)=O)c1)c1ncc2cccnc2c1O,IC50,10.0,8.0,CHEMBL701160,Compound was tested for its ability to inhibit the strand transfer of the integration process catalyzed by HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL354261,O=C(N/N=C/c1ccccc1O)c1ccccc1O,IC50,100000.0,,CHEMBL702106,Inhibition of HIV-1 integrase enzyme by 3'-processing method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL354261,O=C(N/N=C/c1ccccc1O)c1ccccc1O,IC50,100000.0,,CHEMBL702109,Inhibition of HIV-1 integrase enzyme,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL170058,NNC(=O)c1ccccc1O,IC50,46000.0,4.34,CHEMBL702107,Inhibition of HIV-1 integrase enzyme by 3'-processing method (experiment 1),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,46000.0,4.337242168318426
CHEMBL170058,NNC(=O)c1ccccc1O,IC50,33000.0,4.48,CHEMBL702110,Inhibition of HIV-1 integrase enzyme by integration method (experiment 1),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL170058,NNC(=O)c1ccccc1O,IC50,43000.0,4.37,CHEMBL702111,Inhibition of HIV-1 integrase enzyme by integration method (experiment 2),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43000.0,4.366531544420414
CHEMBL369471,O=C1OC[C@H](Cc2ccc(O)c(O)c2)[C@H]1Cc1ccc(O)c(O)c1,IC50,21400.0,4.67,CHEMBL699985,Inhibitory concentration against 3'-processing by HIV -1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21400.0,4.669586226650809
CHEMBL369471,O=C1OC[C@H](Cc2ccc(O)c(O)c2)[C@H]1Cc1ccc(O)c(O)c1,IC50,5400.0,5.27,CHEMBL699986,Inhibitory concentration against Strand transfer by HIV -1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5400.0,5.267606240177031
CHEMBL64802,CCCCCCc1cc2c(cc1O)OC(=O)C(C(c1ccccc1)c1c(O)oc3cc(O)c(CCCCCC)cc3c1=O)C2O,IC50,10500.0,4.98,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10500.0,4.978810700930062
CHEMBL64802,CCCCCCc1cc2c(cc1O)OC(=O)C(C(c1ccccc1)c1c(O)oc3cc(O)c(CCCCCC)cc3c1=O)C2O,IC50,12000.0,4.92,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL431195,Cc1ccc(S(=O)(=O)N/N=C(/CCN2CCCC2)CC(c2ccccc2)c2c(O)oc3ccccc3c2=O)cc1,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL431195,Cc1ccc(S(=O)(=O)N/N=C(/CCN2CCCC2)CC(c2ccccc2)c2c(O)oc3ccccc3c2=O)cc1,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL84356,O=C(c1ccc(Cl)cc1)c1c(O)c2ccccc2oc1=O,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL84356,O=C(c1ccc(Cl)cc1)c1c(O)c2ccccc2oc1=O,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL81686,O=C(NNc1ccccc1)c1ccc2ccc(C(=O)O)c(O)c2n1,IC50,100000.0,,CHEMBL699441,In vitro inhibition of recombinant integrase activity in a standard 3'-processing assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL84281,O=C(SCc1c(O)c2ccccc2oc1=O)c1ccccc1,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL84281,O=C(SCc1c(O)c2ccccc2oc1=O)c1ccccc1,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL82359,O=C(Nc1ccc2ccc(C(=O)O)c(O)c2n1)c1ccccc1,IC50,100000.0,,CHEMBL699441,In vitro inhibition of recombinant integrase activity in a standard 3'-processing assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL81875,O=C1C(=O)c2ccccc2C(O)=C1CCCC1CCC2CCCCC2C1,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL81875,O=C1C(=O)c2ccccc2C(O)=C1CCCC1CCC2CCCCC2C1,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL81182,O=C(NCc1ccc(O)c(O)c1)c1ccc2ccc(C(=O)O)c(O)c2n1,IC50,5000.0,5.3,CHEMBL699441,In vitro inhibition of recombinant integrase activity in a standard 3'-processing assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL312608,O=C(Nc1ccc(O)c(O)c1)c1ccc2ccc(C(=O)O)c(O)c2n1,IC50,900.0,6.05,CHEMBL699441,In vitro inhibition of recombinant integrase activity in a standard 3'-processing assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL64213,O=c1c(C(c2ccc3c(c2)OCO3)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,47000.0,4.33,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47000.0,4.327902142064283
CHEMBL64213,O=c1c(C(c2ccc3c(c2)OCO3)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,18000.0,4.75,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL84307,COc1cc(C(C2=C(O)C(=O)c3ccccc3C2=O)C2=C(O)C(=O)c3ccccc3C2=O)cc(OC)c1OC,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL84307,COc1cc(C(C2=C(O)C(=O)c3ccccc3C2=O)C2=C(O)C(=O)c3ccccc3C2=O)cc(OC)c1OC,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL294714,Nc1ncnc2cc3c(cc12)ncn3C1COC(COP(=O)([O-])[O-])C1.[Na+].[Na+],IC50,68000.0,4.17,CHEMBL873209,Inhibitory activity against HIV integrase in the strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68000.0,4.167491087293763
CHEMBL420026,O=C(/C=C(\O)c1ccccc1)c1ccc2ccc(C(=O)O)c(O)c2n1,IC50,30000.0,4.52,CHEMBL699441,In vitro inhibition of recombinant integrase activity in a standard 3'-processing assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL55906,Nc1ncnc2c1ccc1ncn(C3COC(COP(=O)([O-])[O-])C3)c12.[Na+].[Na+],IC50,53000.0,4.28,CHEMBL873209,Inhibitory activity against HIV integrase in the strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53000.0,4.275724130399211
CHEMBL55906,Nc1ncnc2c1ccc1ncn(C3COC(COP(=O)([O-])[O-])C3)c12.[Na+].[Na+],IC50,75000.0,4.12,CHEMBL701118,Inhibitory activity against HIV integrase in the 3' processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75000.0,4.1249387366083
CHEMBL418131,O=c1oc2c(-c3ccccc3)cccc2c(O)c1-c1ccccc1,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL418131,O=c1oc2c(-c3ccccc3)cccc2c(O)c1-c1ccccc1,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL64744,O=c1oc2ccccc2c(O)c1-c1ccccc1,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL64744,O=c1oc2ccccc2c(O)c1-c1ccccc1,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL313215,COc1ccc2c(O)c(S(=O)(=O)c3ccc(Cl)cc3)c(=O)oc2c1,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL313215,COc1ccc2c(O)c(S(=O)(=O)c3ccc(Cl)cc3)c(=O)oc2c1,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL79687,O=C1C(=O)c2ccccc2C(O)=C1Cc1ccc(Cl)cc1,IC50,92000.0,4.04,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,92000.0,4.036212172654444
CHEMBL79687,O=C1C(=O)c2ccccc2C(O)=C1Cc1ccc(Cl)cc1,IC50,56000.0,4.25,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL82633,O=C(NCc1cccc(O)c1O)c1ccc2ccc(C(=O)O)c(O)c2n1,IC50,5000.0,5.3,CHEMBL699441,In vitro inhibition of recombinant integrase activity in a standard 3'-processing assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL83730,O=C1C(=O)c2ccccc2C(O)=C1CSc1ccc(Cl)cc1,IC50,100000.0,4.0,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL83730,O=C1C(=O)c2ccccc2C(O)=C1CSc1ccc(Cl)cc1,IC50,100000.0,4.0,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL310321,O=C(NNc1ccc([N+](=O)[O-])cc1[N+](=O)[O-])c1ccc2ccc(C(=O)O)c(O)c2n1,IC50,3000.0,5.52,CHEMBL699441,In vitro inhibition of recombinant integrase activity in a standard 3'-processing assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL2106261,CCOC(=O)C(c1c(O)c2ccccc2oc1=O)c1c(O)c2ccccc2oc1=O,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2106261,CCOC(=O)C(c1c(O)c2ccccc2oc1=O)c1c(O)c2ccccc2oc1=O,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL309885,COc1ccc(CNC(=O)Nc2ccc3ccc(C(=O)O)c(O)c3n2)cc1,IC50,100000.0,,CHEMBL699441,In vitro inhibition of recombinant integrase activity in a standard 3'-processing assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL81284,O=C(NCc1ccc(O)c(O)c1)Nc1ccc2ccc(C(=O)O)c(O)c2n1,IC50,100000.0,,CHEMBL699441,In vitro inhibition of recombinant integrase activity in a standard 3'-processing assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL64588,O=c1oc2cccc(O)c2c(O)c1Cc1ccccc1,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL64588,O=c1oc2cccc(O)c2c(O)c1Cc1ccccc1,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL84199,O=C1C(=O)c2ccccc2C(O)=C1Sc1ccccc1,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL84199,O=C1C(=O)c2ccccc2C(O)=C1Sc1ccccc1,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL82986,O=C(NCc1ccc(O)c(O)c1O)c1ccc2ccc(C(=O)O)c(O)c2n1,IC50,1500.0,5.82,CHEMBL699441,In vitro inhibition of recombinant integrase activity in a standard 3'-processing assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1500.0,5.823908740944319
CHEMBL80008,COc1cc(CNC(=O)c2ccc3ccc(C(=O)O)c(O)c3n2)cc(O)c1O,IC50,6500.0,5.19,CHEMBL699441,In vitro inhibition of recombinant integrase activity in a standard 3'-processing assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6500.0,5.187086643357144
CHEMBL311489,O=C1C(O)=C(C(CCc2ccccc2)C2=C(O)C(=O)c3ccccc3C2=O)C(=O)c2ccccc21,IC50,83000.0,4.08,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,83000.0,4.080921907623926
CHEMBL311489,O=C1C(O)=C(C(CCc2ccccc2)C2=C(O)C(=O)c3ccccc3C2=O)C(=O)c2ccccc21,IC50,90000.0,4.05,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL83419,O=C(NCc1cc(O)cc(O)c1)c1ccc2ccc(C(=O)O)c(O)c2n1,IC50,100000.0,,CHEMBL699441,In vitro inhibition of recombinant integrase activity in a standard 3'-processing assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL83651,O=C1C(O)=C(C(C2=C(O)C(=O)c3ccccc3C2=O)c2ccccc2)C(=O)c2ccccc21,IC50,68000.0,4.17,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68000.0,4.167491087293763
CHEMBL83651,O=C1C(O)=C(C(C2=C(O)C(=O)c3ccccc3C2=O)c2ccccc2)C(=O)c2ccccc21,IC50,48000.0,4.32,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48000.0,4.318758762624412
CHEMBL81788,CN(C)c1ccc(C(C2=C(O)C(=O)c3ccccc3C2=O)C2=C(O)C(=O)c3ccccc3C2=O)cc1,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL81788,CN(C)c1ccc(C(C2=C(O)C(=O)c3ccccc3C2=O)C2=C(O)C(=O)c3ccccc3C2=O)cc1,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL310437,COc1ccc2c(O)c(S(=O)(=O)c3ccc(C)cc3)c(=O)oc2c1,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL310437,COc1ccc2c(O)c(S(=O)(=O)c3ccc(C)cc3)c(=O)oc2c1,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL312699,CC(=O)c1cccc(NC(=O)C(=O)c2c(O)oc3ccccc3c2=O)c1,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL312699,CC(=O)c1cccc(NC(=O)C(=O)c2c(O)oc3ccccc3c2=O)c1,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL287689,O=C1C(O)=C(C(C2=C(O)C(=O)c3ccccc3C2=O)c2ccc(Cl)cc2)C(=O)c2ccccc21,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL287689,O=C1C(O)=C(C(C2=C(O)C(=O)c3ccccc3C2=O)c2ccc(Cl)cc2)C(=O)c2ccccc21,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL83742,CCOC(=O)C(C1=C(O)C(=O)c2ccccc2C1=O)C1=C(O)C(=O)c2ccccc2C1=O,IC50,92000.0,4.04,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,92000.0,4.036212172654444
CHEMBL83742,CCOC(=O)C(C1=C(O)C(=O)c2ccccc2C1=O)C1=C(O)C(=O)c2ccccc2C1=O,IC50,60000.0,4.22,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL66033,O=C1C(O)=C(C(C2=C(O)C(=O)c3ccccc3C2=O)c2ccc(C(C3=C(O)C(=O)c4ccccc4C3=O)C3=C(O)C(=O)c4ccccc4C3=O)cc2)C(=O)c2ccccc21,IC50,7500.0,5.12,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7500.0,5.1249387366083
CHEMBL66033,O=C1C(O)=C(C(C2=C(O)C(=O)c3ccccc3C2=O)c2ccc(C(C3=C(O)C(=O)c4ccccc4C3=O)C3=C(O)C(=O)c4ccccc4C3=O)cc2)C(=O)c2ccccc21,IC50,2700.0,5.57,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2700.0,5.568636235841012
CHEMBL310847,CC(C1=C(O)C(=O)c2ccccc2C1=O)C1=C(O)C(=O)c2ccccc2C1=O,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL310847,CC(C1=C(O)C(=O)c2ccccc2C1=O)C1=C(O)C(=O)c2ccccc2C1=O,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL82029,O=C(Nc1ccc(O)c(O)c1)Nc1ccc2ccc(C(=O)O)c(O)c2n1,IC50,100000.0,,CHEMBL699441,In vitro inhibition of recombinant integrase activity in a standard 3'-processing assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL293914,O=c1c(C(c2ccc(C(c3c(O)oc4ccccc4c3=O)c3c(O)oc4ccccc4c3=O)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,1500.0,5.82,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1500.0,5.823908740944319
CHEMBL293914,O=c1c(C(c2ccc(C(c3c(O)oc4ccccc4c3=O)c3c(O)oc4ccccc4c3=O)cc2)c2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12,IC50,800.0,6.1,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL303093,O=C1Oc2ccccc2C(O)C1Sc1c(O)oc2ccccc2c1=O,IC50,80000.0,4.1,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL303093,O=C1Oc2ccccc2C(O)C1Sc1c(O)oc2ccccc2c1=O,IC50,100000.0,4.0,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL309934,CC(=O)Nc1ccc(C(C2=C(O)C(=O)c3ccccc3C2=O)C2=C(O)C(=O)c3ccccc3C2=O)cc1,IC50,86000.0,4.07,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,86000.0,4.0655015487564325
CHEMBL309934,CC(=O)Nc1ccc(C(C2=C(O)C(=O)c3ccccc3C2=O)C2=C(O)C(=O)c3ccccc3C2=O)cc1,IC50,78000.0,4.11,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,78000.0,4.107905397309519
CHEMBL82611,CCCCCCC/N=C1/C(=O)c2ccccc2C(O)=C1O,IC50,100000.0,4.0,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL82611,CCCCCCC/N=C1/C(=O)c2ccccc2C(O)=C1O,IC50,100000.0,4.0,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL83746,COc1cc(NC(=O)c2ccc3ccc(C(=O)O)c(O)c3n2)cc(O)c1O,IC50,6500.0,5.19,CHEMBL699441,In vitro inhibition of recombinant integrase activity in a standard 3'-processing assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6500.0,5.187086643357144
CHEMBL79480,O=C(NC1=C(Cl)C(=O)c2ccccc2C1=O)C(=O)c1c(O)c2ccccc2oc1=O,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL79480,O=C(NC1=C(Cl)C(=O)c2ccccc2C1=O)C(=O)c1c(O)c2ccccc2oc1=O,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL79884,O=C1C(O)=C(C(C#Cc2ccccc2)C2=C(O)C(=O)c3ccccc3C2=O)C(=O)c2ccccc21,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL79884,O=C1C(O)=C(C(C#Cc2ccccc2)C2=C(O)C(=O)c3ccccc3C2=O)C(=O)c2ccccc21,IC50,72000.0,4.14,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,72000.0,4.142667503568732
CHEMBL312902,O=C1Oc2ccccc2C(O)C1Cc1c(O)oc2ccccc2c1=O,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL312902,O=C1Oc2ccccc2C(O)C1Cc1c(O)oc2ccccc2c1=O,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL81714,O=C(NCc1ccc(O)cc1O)c1ccc2ccc(C(=O)O)c(O)c2n1,IC50,5000.0,5.3,CHEMBL699441,In vitro inhibition of recombinant integrase activity in a standard 3'-processing assay.,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL550020,O=C(c1cccc([N+](=O)[O-])c1)c1c(O)oc2ccccc2c1=O,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL550020,O=C(c1cccc([N+](=O)[O-])c1)c1c(O)oc2ccccc2c1=O,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL291663,O=C1C(O)=C(C(C2=C(O)C(=O)c3ccccc3C2=O)c2ccc(Cl)cc2Cl)C(=O)c2ccccc21,IC50,37000.0,4.43,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL291663,O=C1C(O)=C(C(C2=C(O)C(=O)c3ccccc3C2=O)c2ccc(Cl)cc2Cl)C(=O)c2ccccc21,IC50,40000.0,4.4,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL79938,COc1cc(C(C2=C(O)C(=O)c3ccccc3C2=O)C2=C(O)C(=O)c3ccccc3C2=O)cc(Br)c1O,IC50,32000.0,4.5,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL79938,COc1cc(C(C2=C(O)C(=O)c3ccccc3C2=O)C2=C(O)C(=O)c3ccccc3C2=O)cc(Br)c1O,IC50,20000.0,4.7,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL62658,CC(C)c1cccc(C(C)C)c1NC(=O)C(=O)CC(=O)CC(c1ccccc1)c1c(O)oc2ccccc2c1=O,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL62658,CC(C)c1cccc(C(C)C)c1NC(=O)C(=O)CC(=O)CC(c1ccccc1)c1c(O)oc2ccccc2c1=O,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL312984,O=C1C(O)=C(C(C2=C(O)C(=O)c3ccccc3C2=O)c2ccc(Cl)c(Cl)c2)C(=O)c2ccccc21,IC50,90000.0,4.05,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL312984,O=C1C(O)=C(C(C2=C(O)C(=O)c3ccccc3C2=O)c2ccc(Cl)c(Cl)c2)C(=O)c2ccccc21,IC50,52000.0,4.28,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52000.0,4.2839966563652006
CHEMBL312587,CCOc1ccc(C(C2=C(O)C(=O)c3ccccc3C2=O)C2=C(O)C(=O)c3ccccc3C2=O)cc1OC,IC50,100000.0,4.0,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL312587,CCOc1ccc(C(C2=C(O)C(=O)c3ccccc3C2=O)C2=C(O)C(=O)c3ccccc3C2=O)cc1OC,IC50,100000.0,4.0,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL240963,O=C1C=C(O)C(=O)c2ccccc21,IC50,100000.0,,CHEMBL701285,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL240963,O=C1C=C(O)C(=O)c2ccccc21,IC50,100000.0,,CHEMBL701114,Inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL177547,COc1cccc(OC)c1CN1C(=O)c2c(c(O)c3nccnc3c2O)C1=O,IC50,1995.26,5.7,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1995.26,5.700000503883016
CHEMBL177515,COc1cccc(CN2C(=O)c3c(c(O)c4nccnc4c3O)C2=O)c1OC,IC50,426.58,6.37,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,426.58,6.369999510099088
CHEMBL177215,COc1ccc(CN2C(=O)c3c(c(O)c4nccnc4c3O)C2=O)c(OC)c1,IC50,426.58,6.37,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,426.58,6.369999510099088
CHEMBL177405,COc1ccc(OC)c(CN2C(=O)c3c(c(O)c4nccnc4c3O)C2=O)c1,IC50,776.25,6.11,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,776.25,6.109998386815363
CHEMBL177704,Cc1ccc(CN2C(=O)c3c(c(O)c4nccnc4c3O)C2=O)cc1,IC50,1584.89,5.8,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1584.89,5.800000874803203
CHEMBL177705,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1,IC50,2041.74,5.69,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2041.74,5.689999562814496
CHEMBL177622,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1cccc(C(F)(F)F)c1,IC50,426.58,6.37,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,426.58,6.369999510099088
CHEMBL177690,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1cccc(F)c1,IC50,562.34,6.25,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,562.34,6.250001023441651
CHEMBL360274,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1ccc(F)cc1,IC50,416.87,6.38,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,416.87,6.379999357699932
CHEMBL424780,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1ccc(Br)cc1F,IC50,436.52,6.36,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,436.52,6.35999585346894
CHEMBL414654,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1cc(Br)ccc1F,IC50,354.81,6.45,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,354.81,6.450004148469349
CHEMBL362252,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1cc(F)cc(F)c1,IC50,371.54,6.43,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,371.54,6.429994423238211
CHEMBL368301,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1ccc(F)c(Cl)c1,IC50,177.83,6.75,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,177.83,6.749994971513104
CHEMBL367104,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1cccc(Cl)c1,IC50,218.78,6.66,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,218.78,6.6599923820033275
CHEMBL369841,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1ccc(Cl)cc1,IC50,416.87,6.38,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,416.87,6.379999357699932
CHEMBL424782,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1ccc(Cl)c(Cl)c1,IC50,112.2,6.95,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,112.2,6.950007143079858
CHEMBL360752,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1cc(Cl)cc(Cl)c1,IC50,186.21,6.73,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,186.21,6.72999699989494
CHEMBL177380,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1ccccc1Br,IC50,630.96,6.2,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,630.96,6.199998172182031
CHEMBL369808,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1ccncc1,IC50,6760.83,5.17,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6760.83,5.169999984192582
CHEMBL175404,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1cccc2ccccc12,IC50,1412.54,5.85,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1412.54,5.849999245077862
CHEMBL368424,Cc1csc(-c2cccc(CN3C(=O)c4c(c(O)c5nccnc5c4O)C3=O)c2)c1,IC50,676.08,6.17,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,676.08,6.17000191130262
CHEMBL174793,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1cccc(-c2ccccc2F)c1,IC50,501.19,6.3,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,501.19,6.299997602857746
CHEMBL174851,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1ccc(-c2ccccc2F)cc1,IC50,1000.0,6.0,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL367945,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1ccc(-c2ccccc2)cc1,IC50,1445.44,5.84,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1445.44,5.839999931118699
CHEMBL435337,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1CCc1ccccc1,IC50,2041.74,5.69,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2041.74,5.689999562814496
CHEMBL2068731,CC(C)Oc1ccc(Cc2ccccc2)cc1/C([O-])=C/C(=O)C(=O)[O-].[Mg+2],IC50,50.0,7.3,CHEMBL829517,Inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL2079773,O=S1(=O)CCCCN1c1nc(/C([O-])=N/Cc2ccc(F)cc2)c([O-])c2ncccc12.[Mg+2],IC50,10.0,8.0,CHEMBL829517,Inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL370020,O=C1c2c(c(O)c3ccccc3c2O)C(=O)N1Cc1ccc(F)cc1,IC50,100000.0,,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL366982,O=C1c2c(c(O)c3ncccc3c2O)C(=O)N1Cc1cccc(Br)c1,IC50,380.19,6.42,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,380.19,6.41999931041096
CHEMBL177640,Cc1ccc2c(O)c3c(c(O)c2n1)C(=O)N(Cc1cccc(Br)c1)C3=O,IC50,257.04,6.59,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,257.04,6.589999287456538
CHEMBL360065,O=C1c2c(c(O)c3nnccc3c2O)C(=O)N1Cc1cccc(Br)c1,IC50,3630.78,5.44,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3630.78,5.440000065513061
CHEMBL425516,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1cccc(Br)c1,IC50,208.93,6.68,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,208.93,6.679999195735272
CHEMBL177451,CN1C(=O)c2c(c(O)c3nccnc3c2O)C1=O,IC50,48977.88,4.31,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48977.88,4.3100000171743025
CHEMBL177562,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1C1CCCC1,IC50,10471.29,4.98,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10471.29,4.97999981255505
CHEMBL369834,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1C1CCNCC1,IC50,100000.0,,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL176023,O=C(c1ccccc1)N1CCC(N2C(=O)c3c(c(O)c4nccnc4c3O)C2=O)CC1,IC50,2398.83,5.62,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2398.83,5.620000528471499
CHEMBL367772,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1CC1CCCCC1,IC50,2187.76,5.66,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2187.76,5.660000322371772
CHEMBL368509,C[C@H](c1ccccc1)N1C(=O)c2c(c(O)c3nccnc3c2O)C1=O,IC50,1047.13,5.98,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1047.13,5.979999397807417
CHEMBL366712,C[C@@H](c1ccccc1)N1C(=O)c2c(c(O)c3nccnc3c2O)C1=O,IC50,2041.74,5.69,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2041.74,5.689999562814496
CHEMBL177673,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1c1ccc2c(c1)OCO2,IC50,10000.0,5.0,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL177724,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1Cc1ccc2c(c1)OCO2,IC50,562.34,6.25,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,562.34,6.250001023441651
CHEMBL175671,O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1CCc1ccc2c(c1)OCO2,IC50,1412.54,5.85,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1412.54,5.849999245077862
CHEMBL177311,COc1ccccc1CN1C(=O)c2c(c(O)c3nccnc3c2O)C1=O,IC50,812.83,6.09,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,812.83,6.090000275786018
CHEMBL174001,COc1ccc(CN2C(=O)c3c(c(O)c4nccnc4c3O)C2=O)cc1,IC50,562.34,6.25,CHEMBL831653,Log of inhibitory concentration against human immunodeficiency virus type 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,562.34,6.250001023441651
CHEMBL369650,COc1ccc2[nH]c(SCC(=O)Nc3ccc(O)c(C(=O)O)c3)nc2c1,IC50,100000.0,,CHEMBL833587,Concentration to inhibit 3' processing of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL369650,COc1ccc2[nH]c(SCC(=O)Nc3ccc(O)c(C(=O)O)c3)nc2c1,IC50,100000.0,,CHEMBL830061,Concentration to inhibit strand transfer of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL177001,CCOC(=O)c1cc(C(=O)OCC)c(SCC(=O)Nc2ccc(Br)cc2)nc1O,IC50,100000.0,,CHEMBL833587,Concentration to inhibit 3' processing of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL177001,CCOC(=O)c1cc(C(=O)OCC)c(SCC(=O)Nc2ccc(Br)cc2)nc1O,IC50,100000.0,,CHEMBL830061,Concentration to inhibit strand transfer of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL179185,O=C(c1ccccc1)c1ccc(OCC(O)COc2ccc(C(=O)c3ccccc3)c(O)c2)cc1O,IC50,100000.0,,CHEMBL833587,Concentration to inhibit 3' processing of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL179185,O=C(c1ccccc1)c1ccc(OCC(O)COc2ccc(C(=O)c3ccccc3)c(O)c2)cc1O,IC50,100000.0,,CHEMBL830061,Concentration to inhibit strand transfer of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL176127,O=C(O)c1cc(NS(=O)(=O)c2ccc(NCCCN3CCOCC3)c([N+](=O)[O-])c2)cc(C(=O)O)c1,IC50,100000.0,4.0,CHEMBL830061,Concentration to inhibit strand transfer of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL180164,O=C(NCc1ccco1)c1cc(C(=O)NCc2ccco2)cc(C(=O)NCc2ccco2)c1,IC50,37000.0,4.43,CHEMBL833587,Concentration to inhibit 3' processing of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL180164,O=C(NCc1ccco1)c1cc(C(=O)NCc2ccco2)cc(C(=O)NCc2ccco2)c1,IC50,8000.0,5.1,CHEMBL830061,Concentration to inhibit strand transfer of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL2251917,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,60000.0,4.22,CHEMBL832730,Concentration required for inhibition of HIV-1 integrase mediated 3'-end processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL2251917,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,57000.0,4.24,CHEMBL833506,Concentration required for inhibition of HIV-1 integrase mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57000.0,4.2441251443275085
CHEMBL407700,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(N)=O,IC50,16000.0,4.8,CHEMBL832730,Concentration required for inhibition of HIV-1 integrase mediated 3'-end processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL407700,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(N)=O,IC50,13000.0,4.89,CHEMBL833506,Concentration required for inhibition of HIV-1 integrase mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL413133,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(N)=O,IC50,80000.0,4.1,CHEMBL833506,Concentration required for inhibition of HIV-1 integrase mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL437477,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O,IC50,49000.0,4.31,CHEMBL832730,Concentration required for inhibition of HIV-1 integrase mediated 3'-end processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,49000.0,4.309803919971486
CHEMBL437477,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O,IC50,19000.0,4.72,CHEMBL833506,Concentration required for inhibition of HIV-1 integrase mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL414660,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(N)=O,IC50,54000.0,4.27,CHEMBL832730,Concentration required for inhibition of HIV-1 integrase mediated 3'-end processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54000.0,4.267606240177032
CHEMBL414660,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(N)=O,IC50,41000.0,4.39,CHEMBL833506,Concentration required for inhibition of HIV-1 integrase mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41000.0,4.3872161432802645
CHEMBL440629,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCCCCC(NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(N)=O,IC50,2800.0,5.55,CHEMBL832730,Concentration required for inhibition of HIV-1 integrase mediated 3'-end processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL440629,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCCCCC(NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(N)=O,IC50,4900.0,5.31,CHEMBL833506,Concentration required for inhibition of HIV-1 integrase mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4900.0,5.309803919971486
CHEMBL428673,CC[C@H](C)[C@@H](N)C(=O)N[C@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@@H]1C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@@H]1C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)NCCCCC(NC(=O)[C@H]1CCCN1C(=O)[C@H]1CCCN1C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H]1CCCN1C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H]1CCCN1C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H]1CCCN1C(=O)[C@@H](CC(C)C)NC(=O)[C@H](N)[C@@H](C)CC)C(N)=O,IC50,2300.0,5.64,CHEMBL832730,Concentration required for inhibition of HIV-1 integrase mediated 3'-end processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2300.0,5.638272163982407
CHEMBL428673,CC[C@H](C)[C@@H](N)C(=O)N[C@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@@H]1C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@@H]1C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)NCCCCC(NC(=O)[C@H]1CCCN1C(=O)[C@H]1CCCN1C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H]1CCCN1C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H]1CCCN1C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H]1CCCN1C(=O)[C@@H](CC(C)C)NC(=O)[C@H](N)[C@@H](C)CC)C(N)=O,IC50,2300.0,5.64,CHEMBL833506,Concentration required for inhibition of HIV-1 integrase mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2300.0,5.638272163982407
CHEMBL3143741,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCCCCC(NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)NCCCCC(NC(=O)C(CCCCNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](N)[C@@H](C)CC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(N)=O,IC50,600.0,6.22,CHEMBL832730,Concentration required for inhibition of HIV-1 integrase mediated 3'-end processing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL3143741,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCCCCC(NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)NCCCCC(NC(=O)C(CCCCNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](N)[C@@H](C)CC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(N)=O,IC50,600.0,6.22,CHEMBL833506,Concentration required for inhibition of HIV-1 integrase mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL186914,COC(=O)C(=O)CC(=O)c1cc2cc3c(cc2n1Cc1ccccc1)OCO3,IC50,14000.0,4.85,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL188190,COC(=O)C(=O)CC(=O)c1cn(C)c2cc3c(cc12)OCO3,IC50,100000.0,,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL188190,COC(=O)C(=O)CC(=O)c1cn(C)c2cc3c(cc12)OCO3,IC50,60000.0,4.22,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL364097,CCn1cc(C(=O)CC(=O)C(=O)OC)c2ccccc21,IC50,100000.0,,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL364097,CCn1cc(C(=O)CC(=O)C(=O)OC)c2ccccc21,IC50,26000.0,4.58,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26000.0,4.585026652029182
CHEMBL365421,Cn1c(/C(O)=C/C(=O)C(=O)O)cc2ccccc21,IC50,50000.0,4.3,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL365421,Cn1c(/C(O)=C/C(=O)C(=O)O)cc2ccccc21,IC50,6000.0,5.22,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL189718,Cn1c(/C(O)=C/C(=O)C(=O)O)cc2cc3c(cc21)OCO3,IC50,11000.0,4.96,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL189718,Cn1c(/C(O)=C/C(=O)C(=O)O)cc2cc3c(cc21)OCO3,IC50,2000.0,5.7,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL188302,CCn1c(/C(O)=C/C(=O)C(=O)O)cc2ccccc21,IC50,16000.0,4.8,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL188302,CCn1c(/C(O)=C/C(=O)C(=O)O)cc2ccccc21,IC50,1600.0,5.8,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL183469,CCn1c(/C(O)=C/C(=O)C(=O)O)cc2cc3c(cc21)OCO3,IC50,55000.0,4.26,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55000.0,4.259637310505756
CHEMBL183469,CCn1c(/C(O)=C/C(=O)C(=O)O)cc2cc3c(cc21)OCO3,IC50,5000.0,5.3,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL363333,O=C(O)C(=O)/C=C(\O)c1cc2ccccc2n1Cc1ccccc1,IC50,20000.0,4.7,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL363333,O=C(O)C(=O)/C=C(\O)c1cc2ccccc2n1Cc1ccccc1,IC50,1000.0,6.0,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL188145,O=C(O)C(=O)/C=C(\O)c1cc2cc3c(cc2n1Cc1ccccc1)OCO3,IC50,35000.0,4.46,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL188145,O=C(O)C(=O)/C=C(\O)c1cc2cc3c(cc2n1Cc1ccccc1)OCO3,IC50,2000.0,5.7,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL187821,Cn1cc(/C(O)=C/C(=O)C(=O)O)c2ccccc21,IC50,100000.0,4.0,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL187821,Cn1cc(/C(O)=C/C(=O)C(=O)O)c2ccccc21,IC50,2000.0,5.7,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL188631,Cn1cc(/C(O)=C/C(=O)C(=O)O)c2cc3c(cc21)OCO3,IC50,100000.0,4.0,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL188631,Cn1cc(/C(O)=C/C(=O)C(=O)O)c2cc3c(cc21)OCO3,IC50,3000.0,5.52,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL186055,CCn1cc(/C(O)=C/C(=O)C(=O)O)c2ccccc21,IC50,93000.0,4.03,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,93000.0,4.031517051446065
CHEMBL186055,CCn1cc(/C(O)=C/C(=O)C(=O)O)c2ccccc21,IC50,3000.0,5.52,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL361659,CCn1cc(/C(O)=C/C(=O)C(=O)O)c2cc3c(cc21)OCO3,IC50,45000.0,4.35,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45000.0,4.346787486224656
CHEMBL361659,CCn1cc(/C(O)=C/C(=O)C(=O)O)c2cc3c(cc21)OCO3,IC50,3000.0,5.52,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL186820,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c2ccccc12,IC50,12000.0,4.92,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL186820,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c2ccccc12,IC50,1000.0,6.0,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL188686,COC(=O)C(=O)CC(=O)c1cc2ccccc2n1C,IC50,100000.0,4.0,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL188686,COC(=O)C(=O)CC(=O)c1cc2ccccc2n1C,IC50,45000.0,4.35,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45000.0,4.346787486224656
CHEMBL442414,COC(=O)C(=O)CC(=O)c1cc2cc3c(cc2n1C)OCO3,IC50,100000.0,4.0,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL442414,COC(=O)C(=O)CC(=O)c1cc2cc3c(cc2n1C)OCO3,IC50,50000.0,4.3,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL187971,CCn1c(C(=O)CC(=O)C(=O)OC)cc2cc3c(cc21)OCO3,IC50,85000.0,4.07,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,85000.0,4.070581074285707
CHEMBL187971,CCn1c(C(=O)CC(=O)C(=O)OC)cc2cc3c(cc21)OCO3,IC50,65000.0,4.19,CHEMBL827976,Inhibitory concentration against HIV-1 integrase mediated strand transfer reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL186914,COC(=O)C(=O)CC(=O)c1cc2cc3c(cc2n1Cc1ccccc1)OCO3,IC50,100000.0,4.0,CHEMBL829529,Inhibitory concentration against HIV-1 integrase mediated 3' processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL440562,O=C(O)c1nc(-c2ccccc2)nc(O)c1O,IC50,50000.0,,CHEMBL827840,Inhibitory concentration required to inhibit HIV-integrase is determined,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL188448,O=C(O)c1nc(-c2ccc(Cl)cc2)nc(O)c1O,IC50,50000.0,,CHEMBL827840,Inhibitory concentration required to inhibit HIV-integrase is determined,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL188307,O=C(O)c1nc(-c2cccc(OCc3ccccc3)c2)nc(O)c1O,IC50,50000.0,,CHEMBL827840,Inhibitory concentration required to inhibit HIV-integrase is determined,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL364321,O=C(O)c1nc(-c2cccc(O)c2)nc(O)c1O,IC50,50000.0,,CHEMBL827840,Inhibitory concentration required to inhibit HIV-integrase is determined,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL373133,CC(=O)c1ccc(/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c2ccc(C(C)=O)c(C(C)=O)c2)cc1C(C)=O,IC50,70000.0,4.16,CHEMBL832484,Inhibitory concentration against 3'processing of HIV-1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL373133,CC(=O)c1ccc(/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c2ccc(C(C)=O)c(C(C)=O)c2)cc1C(C)=O,IC50,70000.0,4.16,CHEMBL832469,Inhibitory concentration against integration of HIV-1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL191020,O=S(=O)(/C=C/c1ccc(O)c(O)c1)CS(=O)(=O)/C=C/c1ccc(O)c(O)c1,IC50,4000.0,5.4,CHEMBL832484,Inhibitory concentration against 3'processing of HIV-1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL191020,O=S(=O)(/C=C/c1ccc(O)c(O)c1)CS(=O)(=O)/C=C/c1ccc(O)c(O)c1,IC50,5000.0,5.3,CHEMBL832469,Inhibitory concentration against integration of HIV-1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL191445,CC(=O)c1cc(/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c2cc(C(C)=O)c(C(C)=O)c(C(C)=O)c2)cc(C(C)=O)c1C(C)=O,IC50,50000.0,4.3,CHEMBL832484,Inhibitory concentration against 3'processing of HIV-1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL191445,CC(=O)c1cc(/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c2cc(C(C)=O)c(C(C)=O)c(C(C)=O)c2)cc(C(C)=O)c1C(C)=O,IC50,5000.0,5.3,CHEMBL832469,Inhibitory concentration against integration of HIV-1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL190009,O=S(=O)(/C=C/c1cc(O)c(O)c(O)c1)CS(=O)(=O)/C=C/c1cc(O)c(O)c(O)c1,IC50,1800.0,5.75,CHEMBL832484,Inhibitory concentration against 3'processing of HIV-1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL190009,O=S(=O)(/C=C/c1cc(O)c(O)c(O)c1)CS(=O)(=O)/C=C/c1cc(O)c(O)c(O)c1,IC50,900.0,6.05,CHEMBL832469,Inhibitory concentration against integration of HIV-1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL189892,COc1cc(/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c2cc(OC)c(C(C)=O)c(C(C)=O)c2)cc(C(C)=O)c1C(C)=O,IC50,30000.0,4.52,CHEMBL832484,Inhibitory concentration against 3'processing of HIV-1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL189892,COc1cc(/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c2cc(OC)c(C(C)=O)c(C(C)=O)c2)cc(C(C)=O)c1C(C)=O,IC50,30000.0,4.52,CHEMBL832469,Inhibitory concentration against integration of HIV-1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL188746,COc1cc(/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c2cc(O)c(O)c(OC)c2)cc(O)c1O,IC50,50000.0,4.3,CHEMBL832484,Inhibitory concentration against 3'processing of HIV-1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL188746,COc1cc(/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c2cc(O)c(O)c(OC)c2)cc(O)c1O,IC50,50000.0,4.3,CHEMBL832469,Inhibitory concentration against integration of HIV-1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL189982,COc1cc(/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c2ccccc2)cc(C(C)=O)c1C(C)=O,IC50,80000.0,4.1,CHEMBL832484,Inhibitory concentration against 3'processing of HIV-1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL189982,COc1cc(/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c2ccccc2)cc(C(C)=O)c1C(C)=O,IC50,80000.0,4.1,CHEMBL832469,Inhibitory concentration against integration of HIV-1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL191022,COc1cc(/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c2ccccc2)cc(O)c1O,IC50,80000.0,4.1,CHEMBL832484,Inhibitory concentration against 3'processing of HIV-1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL191022,COc1cc(/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c2ccccc2)cc(O)c1O,IC50,80000.0,4.1,CHEMBL832469,Inhibitory concentration against integration of HIV-1 Integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL194550,O=C(N/N=C/c1ccc(O)cc1O)c1cc(C2CC2)[nH]n1,IC50,43000.0,4.37,CHEMBL830061,Concentration to inhibit strand transfer of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43000.0,4.366531544420414
CHEMBL195166,O=C(NCc1cccc(CNC(=O)C(=O)NCc2ccco2)c1)C(=O)NCc1ccco1,IC50,100000.0,,CHEMBL833587,Concentration to inhibit 3' processing of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL195166,O=C(NCc1cccc(CNC(=O)C(=O)NCc2ccco2)c1)C(=O)NCc1ccco1,IC50,100000.0,,CHEMBL830061,Concentration to inhibit strand transfer of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL195166,O=C(NCc1cccc(CNC(=O)C(=O)NCc2ccco2)c1)C(=O)NCc1ccco1,IC50,40000.0,4.4,CHEMBL825246,"Concentration to inhibit strand transfer of soluble mutant (F185K, C280S) of wild type Human immunodeficiency virus-1 integrase",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL193930,COC(=O)c1cc(NS(=O)(=O)c2ccc(NCc3cccnc3)c(N)c2)cc(C(=O)OC)c1,IC50,100000.0,,CHEMBL833587,Concentration to inhibit 3' processing of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL193930,COC(=O)c1cc(NS(=O)(=O)c2ccc(NCc3cccnc3)c(N)c2)cc(C(=O)OC)c1,IC50,100000.0,,CHEMBL830061,Concentration to inhibit strand transfer of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL444357,COc1cc(/C=N/NC(=O)c2cc(C3CC3)[nH]n2)ccc1O,IC50,100000.0,,CHEMBL833587,Concentration to inhibit 3' processing of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL444357,COc1cc(/C=N/NC(=O)c2cc(C3CC3)[nH]n2)ccc1O,IC50,100000.0,,CHEMBL830061,Concentration to inhibit strand transfer of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL195705,CCOC(=O)C(=O)NCc1ccc(/C=C2/N=C(C)C(C(=O)OCC)=C2O)o1,IC50,100000.0,,CHEMBL832198,Concentration to inhibit 3' processing of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL195705,CCOC(=O)C(=O)NCc1ccc(/C=C2/N=C(C)C(C(=O)OCC)=C2O)o1,IC50,100000.0,,CHEMBL833588,Concentration to inhibit strand transfer of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL193927,CCOc1ccc2[nH]c(SCC(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)nc2c1,IC50,100000.0,,CHEMBL832958,Concentration to inhibit 3' processing of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL193927,CCOc1ccc2[nH]c(SCC(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)nc2c1,IC50,100000.0,,CHEMBL832677,Concentration to inhibit strand transfer of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL195455,COC(=O)C1=C(O)/C(=C\c2ccc(CNC(=O)C(=O)Nc3ccc(C)cc3)o2)N=C1C,IC50,100000.0,,CHEMBL832958,Concentration to inhibit 3' processing of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL195455,COC(=O)C1=C(O)/C(=C\c2ccc(CNC(=O)C(=O)Nc3ccc(C)cc3)o2)N=C1C,IC50,81000.0,4.09,CHEMBL832677,Concentration to inhibit strand transfer of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,81000.0,4.0915149811213505
CHEMBL195502,COC(=O)c1sccc1NC(=O)c1ccc(C(=O)Nc2ccsc2C(=O)OC)cc1,IC50,100000.0,,CHEMBL832198,Concentration to inhibit 3' processing of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL195502,COC(=O)c1sccc1NC(=O)c1ccc(C(=O)Nc2ccsc2C(=O)OC)cc1,IC50,97000.0,4.01,CHEMBL833588,Concentration to inhibit strand transfer of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,97000.0,4.013228265733755
CHEMBL193769,O=C(O)c1cc(NS(=O)(=O)c2ccc(NCc3ccccc3)c([N+](=O)[O-])c2)cc(C(=O)O)c1,IC50,100000.0,,CHEMBL832198,Concentration to inhibit 3' processing of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL193769,O=C(O)c1cc(NS(=O)(=O)c2ccc(NCc3ccccc3)c([N+](=O)[O-])c2)cc(C(=O)O)c1,IC50,66000.0,4.18,CHEMBL833588,Concentration to inhibit strand transfer of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,66000.0,4.180456064458132
CHEMBL195244,O=C(Nc1ccc(Cc2ccc(NC(=O)c3cccs3)c(C(=O)O)c2)cc1C(=O)O)c1cccs1,IC50,63000.0,4.2,CHEMBL832198,Concentration to inhibit 3' processing of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,63000.0,4.200659450546418
CHEMBL195244,O=C(Nc1ccc(Cc2ccc(NC(=O)c3cccs3)c(C(=O)O)c2)cc1C(=O)O)c1cccs1,IC50,38000.0,4.42,CHEMBL833588,Concentration to inhibit strand transfer of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38000.0,4.42021640338319
CHEMBL365182,O=C(Nc1ccc(Cc2ccc(NC(=O)c3cccc([N+](=O)[O-])c3)c(C(=O)O)c2)cc1C(=O)O)c1cccc([N+](=O)[O-])c1,IC50,15000.0,4.82,CHEMBL832198,Concentration to inhibit 3' processing of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL365182,O=C(Nc1ccc(Cc2ccc(NC(=O)c3cccc([N+](=O)[O-])c3)c(C(=O)O)c2)cc1C(=O)O)c1cccc([N+](=O)[O-])c1,IC50,13000.0,4.89,CHEMBL833588,Concentration to inhibit strand transfer of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL373353,CCN(CC)c1ccc(/C=N/Nc2nonc2N)c(O)c1,IC50,100000.0,,CHEMBL832198,Concentration to inhibit 3' processing of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL373353,CCN(CC)c1ccc(/C=N/Nc2nonc2N)c(O)c1,IC50,100000.0,,CHEMBL833588,Concentration to inhibit strand transfer of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL193783,CCc1cc(/C=N/CC/N=C/c2cc(CC)sc2S)c(S)s1,IC50,100000.0,,CHEMBL833587,Concentration to inhibit 3' processing of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL193783,CCc1cc(/C=N/CC/N=C/c2cc(CC)sc2S)c(S)s1,IC50,21000.0,4.68,CHEMBL830061,Concentration to inhibit strand transfer of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL193783,CCc1cc(/C=N/CC/N=C/c2cc(CC)sc2S)c(S)s1,IC50,100000.0,,CHEMBL825245,"Concentration to inhibit 3' processing of soluble mutant (F185K, C280S) of wild type Human immunodeficiency virus-1 integrase",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL193783,CCc1cc(/C=N/CC/N=C/c2cc(CC)sc2S)c(S)s1,IC50,6000.0,5.22,CHEMBL825246,"Concentration to inhibit strand transfer of soluble mutant (F185K, C280S) of wild type Human immunodeficiency virus-1 integrase",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL195104,O=C(Nc1ccc(Cc2ccc(O)c(NC(=O)c3ccccc3F)c2)cc1O)c1ccccc1F,IC50,100000.0,,CHEMBL832198,Concentration to inhibit 3' processing of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL195104,O=C(Nc1ccc(Cc2ccc(O)c(NC(=O)c3ccccc3F)c2)cc1O)c1ccccc1F,IC50,100000.0,,CHEMBL833588,Concentration to inhibit strand transfer of wild type Human immunodeficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL195104,O=C(Nc1ccc(Cc2ccc(O)c(NC(=O)c3ccccc3F)c2)cc1O)c1ccccc1F,IC50,33000.0,4.48,CHEMBL825246,"Concentration to inhibit strand transfer of soluble mutant (F185K, C280S) of wild type Human immunodeficiency virus-1 integrase",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL193505,COc1ccc(C(=O)Nc2ccc(Cc3ccc(NC(=O)c4ccc(OC)cc4)c(O)c3)cc2O)cc1,IC50,100000.0,,CHEMBL833587,Concentration to inhibit 3' processing of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL193505,COc1ccc(C(=O)Nc2ccc(Cc3ccc(NC(=O)c4ccc(OC)cc4)c(O)c3)cc2O)cc1,IC50,100000.0,,CHEMBL830061,Concentration to inhibit strand transfer of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL191854,Cc1ccc(NC(=O)C(=O)NCc2ccc(/C=N\NC(=O)C(=O)Nc3cc(Cl)ccc3C)o2)cc1C,IC50,100000.0,,CHEMBL833587,Concentration to inhibit 3' processing of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL191854,Cc1ccc(NC(=O)C(=O)NCc2ccc(/C=N\NC(=O)C(=O)Nc3cc(Cl)ccc3C)o2)cc1C,IC50,100000.0,,CHEMBL830061,Concentration to inhibit strand transfer of wild type Human immuno deficiency virus-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL191854,Cc1ccc(NC(=O)C(=O)NCc2ccc(/C=N\NC(=O)C(=O)Nc3cc(Cl)ccc3C)o2)cc1C,IC50,70000.0,4.16,CHEMBL825246,"Concentration to inhibit strand transfer of soluble mutant (F185K, C280S) of wild type Human immunodeficiency virus-1 integrase",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL414850,O=C(NCc1ccc(F)cc1)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,10.0,8.0,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL414850,O=C(NCc1ccc(F)cc1)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,0.5,9.3,CHEMBL880241,In vitro concentration required to inhibit the overall HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,0.5,9.301029995663981
CHEMBL414850,O=C(NCc1ccc(F)cc1)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,120.0,6.92,CHEMBL881942,In vitro concentration required to inhibit the HIV-1 integrase 3' strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,120.0,6.920818753952375
CHEMBL414850,O=C(NCc1ccc(F)cc1)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,2.5,8.6,CHEMBL880629,In vitro concentration required to inhibit the HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.5,8.602059991327963
CHEMBL421353,O=C(O)C(=O)/C=C(\O)c1cccn1Cc1ccc(F)cc1,IC50,50.0,7.3,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL320261,O=C(O)C(=O)/C=C(\O)c1cc(OCc2ccccc2)cc(OCc2ccccc2)c1,IC50,100.0,7.0,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL371471,COc1cc(Cc2ccccc2)cc(/C(O)=C/C(=O)C(=O)O)c1,IC50,140.0,6.85,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,140.0,6.853871964321762
CHEMBL198000,O=C(O)C(=O)/C=C(\O)c1cccc(Cc2cccc(F)c2)c1,IC50,250.0,6.6,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL22197,O=C(O)C(=O)/C=C(\O)c1cccc(Br)c1,IC50,2500.0,5.6,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL371519,CCC(=O)C(=O)/C=C(\O)c1c[nH]c2ccc(Cl)cc12,IC50,6900.0,5.16,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6900.0,5.161150909262744
CHEMBL108423,O=C(O)C(=O)/C=C(\O)c1ccc(Oc2ccccc2)cc1,IC50,11400.0,4.94,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11400.0,4.943095148663527
CHEMBL371473,CC(C)OC(=O)C(=O)/C=C(\O)c1cccn1Cc1ccc(F)cc1,IC50,100000.0,4.0,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL193758,CCCCOC(=O)C(=O)/C=C(\O)c1cccn1Cc1ccc(F)cc1,IC50,100000.0,4.0,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL193759,O=C(O)C(=O)/C=C(\O)c1cccc(Cc2ccccc2)c1,IC50,10.0,8.0,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL368084,O=C(/C=C(\O)c1ccc(Cc2ccc(F)cc2)o1)c1nc[nH]n1,IC50,20.0,7.7,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL380588,NC(=O)C(=O)Nc1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,40.0,7.4,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL194833,COc1ccc(Cc2ccccc2)cc1/C(O)=C/C(=O)C(=O)O,IC50,100.0,7.0,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL197584,COc1ccc(/C(O)=C/C(=O)C(=O)O)cc1Cc1ccccc1,IC50,150.0,6.82,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,150.0,6.823908740944319
CHEMBL197638,O=C(O)C(=O)/C=C(\O)c1ccsc1Cc1ccccc1,IC50,180.0,6.75,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,180.0,6.7447274948966935
CHEMBL371867,O=C(O)C(=O)/C=C(\O)c1cccn1Cc1ccccc1,IC50,220.0,6.66,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,220.0,6.657577319177793
CHEMBL196421,O=C(O)C(=O)/C=C(\O)c1ccc(Cc2ccccc2)s1,IC50,500.0,6.3,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL438262,O=C(/C=C(\O)c1c[nH]c2ccc(Cl)cc12)c1nc[nH]n1,IC50,2000.0,5.7,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL432788,O=C(O)C(=O)/C=C(\O)c1ccnc2ccccc12,IC50,100000.0,4.0,CHEMBL881407,Strand transfer inhibitory activity against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL362916,CCOC(=O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c2ccccc12,IC50,760.0,6.12,CHEMBL880241,In vitro concentration required to inhibit the overall HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,760.0,6.119186407719209
CHEMBL362916,CCOC(=O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c2ccccc12,IC50,5400.0,5.27,CHEMBL880629,In vitro concentration required to inhibit the HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5400.0,5.267606240177031
CHEMBL197554,CCOC(=O)C(=O)/C=C(\O)c1cn(Cc2ccc(F)cc2)c2ccccc12,IC50,1200.0,5.92,CHEMBL880241,In vitro concentration required to inhibit the overall HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL197554,CCOC(=O)C(=O)/C=C(\O)c1cn(Cc2ccc(F)cc2)c2ccccc12,IC50,1500.0,5.82,CHEMBL880629,In vitro concentration required to inhibit the HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1500.0,5.823908740944319
CHEMBL197001,CCOC(=O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c2ccc(Cl)cc12,IC50,220.0,6.66,CHEMBL880241,In vitro concentration required to inhibit the overall HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,220.0,6.657577319177793
CHEMBL197001,CCOC(=O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c2ccc(Cl)cc12,IC50,10190.0,4.99,CHEMBL881942,In vitro concentration required to inhibit the HIV-1 integrase 3' strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10190.0,4.991825815993574
CHEMBL197001,CCOC(=O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c2ccc(Cl)cc12,IC50,30.0,7.52,CHEMBL880629,In vitro concentration required to inhibit the HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL365604,CCOC(=O)C(=O)/C=C(\O)c1cn(Cc2ccc(F)cc2)c2ccc(Cl)cc12,IC50,390.0,6.41,CHEMBL880241,In vitro concentration required to inhibit the overall HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,390.0,6.4089353929735005
CHEMBL365604,CCOC(=O)C(=O)/C=C(\O)c1cn(Cc2ccc(F)cc2)c2ccc(Cl)cc12,IC50,11470.0,4.94,CHEMBL881942,In vitro concentration required to inhibit the HIV-1 integrase 3' strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11470.0,4.940436582098732
CHEMBL365604,CCOC(=O)C(=O)/C=C(\O)c1cn(Cc2ccc(F)cc2)c2ccc(Cl)cc12,IC50,70.0,7.16,CHEMBL880629,In vitro concentration required to inhibit the HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL194241,CCOC(=O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c2ccc(OC)cc12,IC50,150.0,6.82,CHEMBL880241,In vitro concentration required to inhibit the overall HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,150.0,6.823908740944319
CHEMBL194241,CCOC(=O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c2ccc(OC)cc12,IC50,680.0,6.17,CHEMBL880629,In vitro concentration required to inhibit the HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,680.0,6.167491087293763
CHEMBL372325,CCOC(=O)C(=O)/C=C(\O)c1cn(Cc2ccc(F)cc2)c2ccc(OC)cc12,IC50,220.0,6.66,CHEMBL880241,In vitro concentration required to inhibit the overall HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,220.0,6.657577319177793
CHEMBL372325,CCOC(=O)C(=O)/C=C(\O)c1cn(Cc2ccc(F)cc2)c2ccc(OC)cc12,IC50,800.0,6.1,CHEMBL880629,In vitro concentration required to inhibit the HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL186820,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c2ccccc12,IC50,20.0,7.7,CHEMBL880241,In vitro concentration required to inhibit the overall HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL186820,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c2ccccc12,IC50,8280.0,5.08,CHEMBL881942,In vitro concentration required to inhibit the HIV-1 integrase 3' strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8280.0,5.081969663215119
CHEMBL186820,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c2ccccc12,IC50,30.0,7.52,CHEMBL880629,In vitro concentration required to inhibit the HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL198001,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccc(F)cc2)c2ccccc12,IC50,2.0,8.7,CHEMBL880241,In vitro concentration required to inhibit the overall HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL198001,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccc(F)cc2)c2ccccc12,IC50,5300.0,5.28,CHEMBL881942,In vitro concentration required to inhibit the HIV-1 integrase 3' strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5300.0,5.275724130399211
CHEMBL198001,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccc(F)cc2)c2ccccc12,IC50,15.0,7.82,CHEMBL880629,In vitro concentration required to inhibit the HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL194735,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c2ccc(Cl)cc12,IC50,10.0,8.0,CHEMBL880241,In vitro concentration required to inhibit the overall HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL194735,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c2ccc(Cl)cc12,IC50,970.0,6.01,CHEMBL881942,In vitro concentration required to inhibit the HIV-1 integrase 3' strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,970.0,6.013228265733755
CHEMBL194735,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c2ccc(Cl)cc12,IC50,100.0,7.0,CHEMBL880629,In vitro concentration required to inhibit the HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL363170,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccc(F)cc2)c2ccc(Cl)cc12,IC50,200.0,6.7,CHEMBL880241,In vitro concentration required to inhibit the overall HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL363170,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccc(F)cc2)c2ccc(Cl)cc12,IC50,1590.0,5.8,CHEMBL881942,In vitro concentration required to inhibit the HIV-1 integrase 3' strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1590.0,5.798602875679549
CHEMBL363170,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccc(F)cc2)c2ccc(Cl)cc12,IC50,10.0,8.0,CHEMBL880629,In vitro concentration required to inhibit the HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL196689,COc1ccc2c(c1)c(/C(O)=C/C(=O)C(=O)O)cn2Cc1ccccc1,IC50,17.0,7.77,CHEMBL880241,In vitro concentration required to inhibit the overall HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17.0,7.769551078621726
CHEMBL196689,COc1ccc2c(c1)c(/C(O)=C/C(=O)C(=O)O)cn2Cc1ccccc1,IC50,2160.0,5.67,CHEMBL881942,In vitro concentration required to inhibit the HIV-1 integrase 3' strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2160.0,5.665546248849069
CHEMBL196689,COc1ccc2c(c1)c(/C(O)=C/C(=O)C(=O)O)cn2Cc1ccccc1,IC50,21.0,7.68,CHEMBL880629,In vitro concentration required to inhibit the HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL196391,COc1ccc2c(c1)c(/C(O)=C/C(=O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,19.0,7.72,CHEMBL880241,In vitro concentration required to inhibit the overall HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19.0,7.721246399047171
CHEMBL196391,COc1ccc2c(c1)c(/C(O)=C/C(=O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,2710.0,5.57,CHEMBL881942,In vitro concentration required to inhibit the HIV-1 integrase 3' strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2710.0,5.567030709125595
CHEMBL196391,COc1ccc2c(c1)c(/C(O)=C/C(=O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,4.0,8.4,CHEMBL880629,In vitro concentration required to inhibit the HIV-1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL199145,O=C(NCc1ccc(F)cc1)c1ncc2cccnc2c1O,IC50,32.8,7.48,CHEMBL872199,Inhibition of strand transfer for HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32.8,7.484126156288321
CHEMBL371007,O=C1CC(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)NC(=O)N1,IC50,10.0,8.0,CHEMBL872199,Inhibition of strand transfer for HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL425924,CN1C(=O)NC(=O)CC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,12.5,7.9,CHEMBL872199,Inhibition of strand transfer for HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.5,7.903089986991944
CHEMBL382965,CN1C(=O)CC(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)NC1=O,IC50,12.8,7.89,CHEMBL872199,Inhibition of strand transfer for HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.8,7.892790030352131
CHEMBL198160,CN1C(=O)CC(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)N(C)C1=O,IC50,8.7,8.06,CHEMBL872199,Inhibition of strand transfer for HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.7,8.060480747381382
CHEMBL371007,O=C1CC(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)NC(=O)N1,IC50,11.0,7.96,CHEMBL872199,Inhibition of strand transfer for HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL371007,O=C1CC(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)NC(=O)N1,IC50,13.3,7.88,CHEMBL872199,Inhibition of strand transfer for HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.3,7.876148359032914
CHEMBL198160,CN1C(=O)CC(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)N(C)C1=O,IC50,11.3,7.95,CHEMBL872199,Inhibition of strand transfer for HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.3,7.94692155651658
CHEMBL198160,CN1C(=O)CC(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)N(C)C1=O,IC50,35.0,7.46,CHEMBL872199,Inhibition of strand transfer for HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35.0,7.455931955649724
CHEMBL198160,CN1C(=O)CC(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)N(C)C1=O,IC50,27.5,7.56,CHEMBL872199,Inhibition of strand transfer for HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27.5,7.560667306169737
CHEMBL197251,O=c1oc2cc(O)c(O)cc2cc1O,IC50,2000.0,5.7,CHEMBL881770,Inhibitory concentration against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL197036,O=C(O)/C=C/c1ccc(Oc2cc3cc(O)c(O)cc3oc2=O)c(O)c1,IC50,2000.0,5.7,CHEMBL881770,Inhibitory concentration against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL196272,O=C(O)/C=C/c1ccc(O)c(Oc2cc3cc(O)c(O)cc3oc2=O)c1,IC50,1000.0,6.0,CHEMBL881770,Inhibitory concentration against HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL264263,O=C(Nc1ccc(O)c(-c2nc3ccccc3o2)c1)c1cccc2ccccc12,IC50,14000.0,4.85,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL264263,O=C(Nc1ccc(O)c(-c2nc3ccccc3o2)c1)c1cccc2ccccc12,IC50,6000.0,5.22,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL381234,COc1ccc(C(=O)Nc2ccc(O)c(-c3nc4ccccc4o3)c2)cc1[N+](=O)[O-],IC50,6000.0,5.22,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL381234,COc1ccc(C(=O)Nc2ccc(O)c(-c3nc4ccccc4o3)c2)cc1[N+](=O)[O-],IC50,7000.0,5.16,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL198572,O=C(/C=C/c1ccc(-c2ccccc2[N+](=O)[O-])o1)Nc1ccc(O)c(-c2nc3ccccc3o2)c1,IC50,23000.0,4.64,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL198572,O=C(/C=C/c1ccc(-c2ccccc2[N+](=O)[O-])o1)Nc1ccc(O)c(-c2nc3ccccc3o2)c1,IC50,63000.0,4.2,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,63000.0,4.200659450546418
CHEMBL425205,O=C(Nc1ccc(O)c(-c2nc3cc(Cl)ccc3o2)c1)c1cccnc1,IC50,61000.0,4.21,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61000.0,4.214670164989233
CHEMBL425205,O=C(Nc1ccc(O)c(-c2nc3cc(Cl)ccc3o2)c1)c1cccnc1,IC50,10000.0,5.0,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL198591,COc1ccc2oc(=O)c(-c3csc(N/N=C/c4ccccc4O)n3)cc2c1,IC50,30000.0,4.52,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL198591,COc1ccc2oc(=O)c(-c3csc(N/N=C/c4ccccc4O)n3)cc2c1,IC50,10000.0,5.0,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL197014,CC(C)Cn1c(=O)c(C(=O)Nc2ccccc2S(N)(=O)=O)c(O)c2ccccc21,IC50,40000.0,4.4,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL197014,CC(C)Cn1c(=O)c(C(=O)Nc2ccccc2S(N)(=O)=O)c(O)c2ccccc21,IC50,16000.0,4.8,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL198442,O=C(Cc1ccccc1)Nc1cc(C(=O)O)c(NC(=O)Cc2ccccc2)cc1C(=O)O,IC50,9000.0,5.05,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL198442,O=C(Cc1ccccc1)Nc1cc(C(=O)O)c(NC(=O)Cc2ccccc2)cc1C(=O)O,IC50,7000.0,5.16,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL373035,O=C(O)c1cc(NC(=O)c2cccc3ccccc23)c(C(=O)O)cc1NC(=O)c1cccc2ccccc12,IC50,28000.0,4.55,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL373035,O=C(O)c1cc(NC(=O)c2cccc3ccccc23)c(C(=O)O)cc1NC(=O)c1cccc2ccccc12,IC50,21000.0,4.68,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL382489,O=C(c1ccccc1)c1cc(Br)ccc1NC(=O)c1nc[nH]c1C(=O)O,IC50,16000.0,4.8,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL382489,O=C(c1ccccc1)c1cc(Br)ccc1NC(=O)c1nc[nH]c1C(=O)O,IC50,17000.0,4.77,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL200669,O=C(O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccccc1[N+](=O)[O-],IC50,88000.0,4.06,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,88000.0,4.055517327849832
CHEMBL200669,O=C(O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccccc1[N+](=O)[O-],IC50,56000.0,4.25,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL373258,O=C(N/N=C/c1cc(Br)ccc1O)/C(=C/C=C/c1ccccc1)NC(=O)c1ccccc1,IC50,90000.0,4.05,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL373258,O=C(N/N=C/c1cc(Br)ccc1O)/C(=C/C=C/c1ccccc1)NC(=O)c1ccccc1,IC50,23000.0,4.64,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL427015,O=C(/N=N/c1c(O)[nH]c2ccc(F)cc12)/C(=C/C=C/c1ccccc1)NC(=O)c1ccccc1,IC50,60000.0,4.22,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL427015,O=C(/N=N/c1c(O)[nH]c2ccc(F)cc12)/C(=C/C=C/c1ccccc1)NC(=O)c1ccccc1,IC50,38000.0,4.42,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38000.0,4.42021640338319
CHEMBL198894,O=C(CSc1nc(O)cc(CSc2ccc(Cl)cc2)n1)Nc1ccc(Cl)cc1Cl,IC50,34000.0,4.47,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34000.0,4.468521082957745
CHEMBL198894,O=C(CSc1nc(O)cc(CSc2ccc(Cl)cc2)n1)Nc1ccc(Cl)cc1Cl,IC50,24000.0,4.62,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL371492,O=C(/C=C(\O)c1ccc(Cl)cc1)C(=O)/N=N/c1c(O)[nH]c2ccc(Br)cc12,IC50,42000.0,4.38,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42000.0,4.376750709602099
CHEMBL371492,O=C(/C=C(\O)c1ccc(Cl)cc1)C(=O)/N=N/c1c(O)[nH]c2ccc(Br)cc12,IC50,28000.0,4.55,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL426104,COc1ccc(CCNC(=O)CC(=O)N/N=C/c2ccco2)cc1OC,IC50,100000.0,,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL426104,COc1ccc(CCNC(=O)CC(=O)N/N=C/c2ccco2)cc1OC,IC50,90000.0,4.05,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL198594,O=C(/C=C/c1ccco1)NC(=S)Nc1ccccc1O,IC50,57000.0,4.24,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57000.0,4.2441251443275085
CHEMBL198594,O=C(/C=C/c1ccco1)NC(=S)Nc1ccccc1O,IC50,28000.0,4.55,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL3144704,Cc1[nH]n(-c2ccccc2)c(=O)c1C(c1ccc(O)c(O)c1)c1c(C)n(C)n(-c2ccccc2)c1=O,IC50,89000.0,4.05,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,89000.0,4.050609993355088
CHEMBL3144704,Cc1[nH]n(-c2ccccc2)c(=O)c1C(c1ccc(O)c(O)c1)c1c(C)n(C)n(-c2ccccc2)c1=O,IC50,31000.0,4.51,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31000.0,4.508638306165727
CHEMBL275657,COc1cc(/C=N/NC2=NC(=O)C(CC(=O)Nc3ccc(Cl)c(Cl)c3)S2)ccc1O,IC50,89000.0,4.05,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,89000.0,4.050609993355088
CHEMBL275657,COc1cc(/C=N/NC2=NC(=O)C(CC(=O)Nc3ccc(Cl)c(Cl)c3)S2)ccc1O,IC50,38000.0,4.42,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38000.0,4.42021640338319
CHEMBL196822,O=C(CSc1nc2ccccc2n1Cc1ccccc1)N/N=C/c1cc(Br)ccc1O,IC50,60000.0,4.22,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL196822,O=C(CSc1nc2ccccc2n1Cc1ccccc1)N/N=C/c1cc(Br)ccc1O,IC50,51000.0,4.29,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,51000.0,4.292429823902063
CHEMBL198855,COc1ccc(N(CC(=O)N/N=C/c2c(O)ccc3ccccc23)S(C)(=O)=O)cc1Cl,IC50,95000.0,4.02,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,95000.0,4.022276394711152
CHEMBL198855,COc1ccc(N(CC(=O)N/N=C/c2c(O)ccc3ccccc23)S(C)(=O)=O)cc1Cl,IC50,59000.0,4.23,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,59000.0,4.229147988357856
CHEMBL198840,O=C(N/N=C/c1ccc(/C=N/NC(=O)c2cc(O)cc(O)c2)cc1)c1cc(O)cc(O)c1,IC50,76000.0,4.12,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,76000.0,4.119186407719209
CHEMBL198840,O=C(N/N=C/c1ccc(/C=N/NC(=O)c2cc(O)cc(O)c2)cc1)c1cc(O)cc(O)c1,IC50,56000.0,4.25,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL196968,Oc1ccccc1/C=N/CC(O)C/N=C/c1ccccc1O,IC50,97000.0,4.01,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,97000.0,4.013228265733755
CHEMBL196968,Oc1ccccc1/C=N/CC(O)C/N=C/c1ccccc1O,IC50,61000.0,4.21,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61000.0,4.214670164989233
CHEMBL370855,Cc1ccc(C(=O)C2=C(O)C(=O)N(CCCc3c[nH]cn3)C2c2ccc(Cl)cc2)cc1,IC50,93000.0,4.03,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,93000.0,4.031517051446065
CHEMBL370855,Cc1ccc(C(=O)C2=C(O)C(=O)N(CCCc3c[nH]cn3)C2c2ccc(Cl)cc2)cc1,IC50,67000.0,4.17,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,67000.0,4.173925197299174
CHEMBL199109,Cc1ccc(S(=O)(=O)Nc2ccccc2/N=C/c2sc3ccccc3c2O)cc1,IC50,88000.0,4.06,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,88000.0,4.055517327849832
CHEMBL199109,Cc1ccc(S(=O)(=O)Nc2ccccc2/N=C/c2sc3ccccc3c2O)cc1,IC50,68000.0,4.17,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68000.0,4.167491087293763
CHEMBL197167,CCOC(=O)c1c(-c2ccccc2)csc1NC(NC(=O)c1ccco1)C(=O)c1ccc(C)cc1,IC50,100000.0,,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL197167,CCOC(=O)c1c(-c2ccccc2)csc1NC(NC(=O)c1ccco1)C(=O)c1ccc(C)cc1,IC50,79000.0,4.1,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,79000.0,4.102372908709558
CHEMBL198596,O=C(/C=C/c1ccc(Cl)cc1)Nc1ccc(NC(=O)c2ccco2)cc1,IC50,90000.0,4.05,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL198596,O=C(/C=C/c1ccc(Cl)cc1)Nc1ccc(NC(=O)c2ccco2)cc1,IC50,91000.0,4.04,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,91000.0,4.040958607678906
CHEMBL197122,Cc1ccc(C(=O)N/C(=C/c2ccc(-c3ccc(Cl)cc3Cl)o2)C(=O)NCCCO)cc1,IC50,85000.0,4.07,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,85000.0,4.070581074285707
CHEMBL371917,CC(=O)c1cc(C(=O)CC(=O)Nc2ccc([N+](=O)[O-])cc2)sc1Nc1ccccc1,IC50,80000.0,4.1,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL371917,CC(=O)c1cc(C(=O)CC(=O)Nc2ccc([N+](=O)[O-])cc2)sc1Nc1ccccc1,IC50,28000.0,4.55,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL199162,CC(=O)c1cc(C(=O)CC(=O)Nc2cccc([N+](=O)[O-])c2)sc1Nc1ccccc1,IC50,97000.0,4.01,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,97000.0,4.013228265733755
CHEMBL199162,CC(=O)c1cc(C(=O)CC(=O)Nc2cccc([N+](=O)[O-])c2)sc1Nc1ccccc1,IC50,29000.0,4.54,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,29000.0,4.537602002101044
CHEMBL198540,CC(=O)c1cc(C(=O)CC(=O)Nc2ccccc2)sc1Nc1ccccc1,IC50,100000.0,,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL198540,CC(=O)c1cc(C(=O)CC(=O)Nc2ccccc2)sc1Nc1ccccc1,IC50,100000.0,,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL370109,CCSc1nnc(N2C(=O)c3ccc(C(=O)c4ccc(C(=O)O)cc4)cc3C2=O)s1,IC50,98000.0,4.01,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,98000.0,4.008773924307505
CHEMBL370109,CCSc1nnc(N2C(=O)c3ccc(C(=O)c4ccc(C(=O)O)cc4)cc3C2=O)s1,IC50,65000.0,4.19,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL199764,CCOC(=O)CCc1cc(C(=O)OCC)c(CCC(=O)OCC)cc1C(=O)OCC,IC50,100000.0,,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL199764,CCOC(=O)CCc1cc(C(=O)OCC)c(CCC(=O)OCC)cc1C(=O)OCC,IC50,94000.0,4.03,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,94000.0,4.026872146400302
CHEMBL373248,COC(=O)c1ccc(C(=O)OC)c(NC(=O)c2ccc(C)c([N+](=O)[O-])c2)c1,IC50,92000.0,4.04,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,92000.0,4.036212172654444
CHEMBL373248,COC(=O)c1ccc(C(=O)OC)c(NC(=O)c2ccc(C)c([N+](=O)[O-])c2)c1,IC50,100000.0,,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL370611,O=C(CC1Sc2ccccc2NC1=O)Nc1cccc(C(=O)O)c1,IC50,79000.0,4.1,CHEMBL867583,Inhibition of 3'-processing catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,79000.0,4.102372908709558
CHEMBL370611,O=C(CC1Sc2ccccc2NC1=O)Nc1cccc(C(=O)O)c1,IC50,71000.0,4.15,CHEMBL867584,Inhibition of strand transfer catalytic activity HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,71000.0,4.1487416512809245
CHEMBL370620,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c(=O)n(Cc2ccccc2)c1=O,IC50,3700.0,5.43,CHEMBL865134,Inhibition of 3' processing step of wt HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3700.0,5.431798275933005
CHEMBL370620,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c(=O)n(Cc2ccccc2)c1=O,IC50,200.0,6.7,CHEMBL865136,Inhibition of strand transfer step of wt HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL202166,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccccc2F)c(=O)n(Cc2ccccc2F)c1=O,IC50,4100.0,5.39,CHEMBL865134,Inhibition of 3' processing step of wt HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4100.0,5.3872161432802645
CHEMBL202166,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccccc2F)c(=O)n(Cc2ccccc2F)c1=O,IC50,600.0,,CHEMBL865136,Inhibition of strand transfer step of wt HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL199874,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c(=O)[nH]c1=O,IC50,10000.0,5.0,CHEMBL865134,Inhibition of 3' processing step of wt HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL380548,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccc(F)cc2)c(=O)n(Cc2ccc(F)cc2)c1=O,IC50,3900.0,5.41,CHEMBL865134,Inhibition of 3' processing step of wt HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3900.0,5.4089353929735005
CHEMBL199874,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccccc2)c(=O)[nH]c1=O,IC50,500.0,6.3,CHEMBL865136,Inhibition of strand transfer step of wt HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL380548,O=C(O)C(=O)/C=C(\O)c1cn(Cc2ccc(F)cc2)c(=O)n(Cc2ccc(F)cc2)c1=O,IC50,700.0,,CHEMBL865136,Inhibition of strand transfer step of wt HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL383505,CCOC(=O)C(=O)/C=C(\O)c1ccc2ncc(/C(O)=C/C(=O)C(=O)OCC)c(O)c2c1,IC50,77000.0,4.11,CHEMBL868323,Inhibition of HIV1 integrase strand transfer activity in presence of MgCl2 by plate-based electrochemiluminescent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,77000.0,4.113509274827518
CHEMBL383505,CCOC(=O)C(=O)/C=C(\O)c1ccc2ncc(/C(O)=C/C(=O)C(=O)OCC)c(O)c2c1,IC50,39000.0,4.41,CHEMBL868325,Inhibition of HIV1 integrase strand transfer activity in presence of MgCl2 by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39000.0,4.4089353929735005
CHEMBL383505,CCOC(=O)C(=O)/C=C(\O)c1ccc2ncc(/C(O)=C/C(=O)C(=O)OCC)c(O)c2c1,IC50,80000.0,4.1,CHEMBL868326,Inhibition of HIV1 integrase strand transfer activity in presence of MnCl2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL383505,CCOC(=O)C(=O)/C=C(\O)c1ccc2ncc(/C(O)=C/C(=O)C(=O)OCC)c(O)c2c1,IC50,28000.0,4.55,CHEMBL868328,Inhibition of HIV1 integrase 3'-processing activity in presence of MgCl2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL377501,O=C(O)C(=O)/C=C(\O)c1ccc2c(c1)c(=O)c(/C(O)=C/C(=O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,16.0,7.8,CHEMBL868323,Inhibition of HIV1 integrase strand transfer activity in presence of MgCl2 by plate-based electrochemiluminescent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16.0,7.795880017344075
CHEMBL204751,CCOC(=O)C(=O)/C=C(\O)c1ccc2c(c1)c(=O)c(/C(O)=C/C(=O)C(=O)OCC)cn2Cc1ccc(F)cc1,IC50,380.0,6.42,CHEMBL868323,Inhibition of HIV1 integrase strand transfer activity in presence of MgCl2 by plate-based electrochemiluminescent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,380.0,6.42021640338319
CHEMBL378373,O=C(O)C(=O)/C=C(\O)c1ccc2ncc(/C(O)=C/C(=O)C(=O)O)c(O)c2c1,IC50,9100.0,5.04,CHEMBL868323,Inhibition of HIV1 integrase strand transfer activity in presence of MgCl2 by plate-based electrochemiluminescent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9100.0,5.040958607678906
CHEMBL377501,O=C(O)C(=O)/C=C(\O)c1ccc2c(c1)c(=O)c(/C(O)=C/C(=O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,17.0,7.77,CHEMBL868325,Inhibition of HIV1 integrase strand transfer activity in presence of MgCl2 by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17.0,7.769551078621726
CHEMBL204751,CCOC(=O)C(=O)/C=C(\O)c1ccc2c(c1)c(=O)c(/C(O)=C/C(=O)C(=O)OCC)cn2Cc1ccc(F)cc1,IC50,290.0,6.54,CHEMBL868325,Inhibition of HIV1 integrase strand transfer activity in presence of MgCl2 by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,290.0,6.537602002101044
CHEMBL378373,O=C(O)C(=O)/C=C(\O)c1ccc2ncc(/C(O)=C/C(=O)C(=O)O)c(O)c2c1,IC50,2900.0,5.54,CHEMBL868325,Inhibition of HIV1 integrase strand transfer activity in presence of MgCl2 by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2900.0,5.537602002101044
CHEMBL377501,O=C(O)C(=O)/C=C(\O)c1ccc2c(c1)c(=O)c(/C(O)=C/C(=O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,12.0,7.92,CHEMBL868326,Inhibition of HIV1 integrase strand transfer activity in presence of MnCl2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL204751,CCOC(=O)C(=O)/C=C(\O)c1ccc2c(c1)c(=O)c(/C(O)=C/C(=O)C(=O)OCC)cn2Cc1ccc(F)cc1,IC50,250.0,6.6,CHEMBL868326,Inhibition of HIV1 integrase strand transfer activity in presence of MnCl2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL378373,O=C(O)C(=O)/C=C(\O)c1ccc2ncc(/C(O)=C/C(=O)C(=O)O)c(O)c2c1,IC50,430.0,6.37,CHEMBL868326,Inhibition of HIV1 integrase strand transfer activity in presence of MnCl2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,430.0,6.366531544420413
CHEMBL377501,O=C(O)C(=O)/C=C(\O)c1ccc2c(c1)c(=O)c(/C(O)=C/C(=O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,440.0,6.36,CHEMBL868328,Inhibition of HIV1 integrase 3'-processing activity in presence of MgCl2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,440.0,6.356547323513812
CHEMBL204751,CCOC(=O)C(=O)/C=C(\O)c1ccc2c(c1)c(=O)c(/C(O)=C/C(=O)C(=O)OCC)cn2Cc1ccc(F)cc1,IC50,21000.0,4.68,CHEMBL868328,Inhibition of HIV1 integrase 3'-processing activity in presence of MgCl2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL378373,O=C(O)C(=O)/C=C(\O)c1ccc2ncc(/C(O)=C/C(=O)C(=O)O)c(O)c2c1,IC50,22000.0,4.66,CHEMBL868328,Inhibition of HIV1 integrase 3'-processing activity in presence of MgCl2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL377501,O=C(O)C(=O)/C=C(\O)c1ccc2c(c1)c(=O)c(/C(O)=C/C(=O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,200.0,6.7,CHEMBL867146,Inhibition of HIV1 integrase 3'-processing activity in presence of MnCl2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL204751,CCOC(=O)C(=O)/C=C(\O)c1ccc2c(c1)c(=O)c(/C(O)=C/C(=O)C(=O)OCC)cn2Cc1ccc(F)cc1,IC50,40000.0,4.4,CHEMBL867146,Inhibition of HIV1 integrase 3'-processing activity in presence of MnCl2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL378373,O=C(O)C(=O)/C=C(\O)c1ccc2ncc(/C(O)=C/C(=O)C(=O)O)c(O)c2c1,IC50,4100.0,,CHEMBL867146,Inhibition of HIV1 integrase 3'-processing activity in presence of MnCl2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4100.0,5.3872161432802645
CHEMBL382680,O=C(O)c1cnc2ccc(Cc3ccccc3)cc2c1O,IC50,1600.0,5.8,CHEMBL865324,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL8,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,IC50,100000.0,,CHEMBL865324,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL414850,O=C(NCc1ccc(F)cc1)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,22.8,7.64,CHEMBL865324,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22.8,7.642065152999546
CHEMBL204656,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C,IC50,7.2,8.14,CHEMBL865324,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.2,8.142667503568731
CHEMBL206604,CC(C)[C@@H](CO)n1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3F)ccc21,IC50,8.2,8.09,CHEMBL865324,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.2,8.086186147616283
CHEMBL203443,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2CCO,IC50,9.1,8.04,CHEMBL865324,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.1,8.040958607678906
CHEMBL379664,O=C(O)c1cn(CCO)c2ccc(Cc3cccc(Cl)c3F)cc2c1=O,IC50,24.2,7.62,CHEMBL865324,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24.2,7.616184634019569
CHEMBL270717,O=C(O)c1c[nH]c2ccc(Cc3cccc(Cl)c3F)cc2c1=O,IC50,43.5,7.36,CHEMBL865324,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43.5,7.361510743045363
CHEMBL203666,NCCCNc1ccc2c3c(nn2CCNCCO)-c2c(O)ccc(O)c2C(=O)c13,IC50,18000.0,4.75,CHEMBL862554,Inhibition of 3'-processing activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL203666,NCCCNc1ccc2c3c(nn2CCNCCO)-c2c(O)ccc(O)c2C(=O)c13,IC50,9000.0,5.05,CHEMBL862555,Inhibition of strand transfer activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL205077,CN(C)CCCN1C(=O)C(O)=C(C(=O)c2cccs2)C1c1cccs1,IC50,100000.0,,CHEMBL862554,Inhibition of 3'-processing activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL205116,NCCCCCCNC(=O)c1c(O)oc2ccccc2c1=O,IC50,100000.0,,CHEMBL862554,Inhibition of 3'-processing activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL379037,COc1cc(C(c2c[nH]c3ccccc23)c2c[nH]c3ccccc23)ccc1OCC(=O)O,IC50,100000.0,,CHEMBL862554,Inhibition of 3'-processing activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL444623,CCOC(=O)c1c(NC(=O)c2cc3ccccc3oc2=O)sc(C(N)=O)c1C,IC50,90000.0,4.05,CHEMBL862554,Inhibition of 3'-processing activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL380528,Oc1ccc(C(c2c[nH]c3ccccc23)c2c[nH]c3ccccc23)cc1O,IC50,53000.0,4.28,CHEMBL862554,Inhibition of 3'-processing activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53000.0,4.275724130399211
CHEMBL203749,COc1cccc2cc(-c3csc(Nc4cccc(O)c4)n3)c(=O)oc12,IC50,100000.0,,CHEMBL862554,Inhibition of 3'-processing activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL205921,O=C(NCCCO)c1ccc(CSc2nc(O)c3c4c(sc3n2)CCC4)cc1,IC50,100000.0,,CHEMBL862554,Inhibition of 3'-processing activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL206621,CCOC(=O)c1c(NC(=O)CC2Sc3ccc(C(F)(F)F)cc3NC2=O)sc2c1CCCC2,IC50,100000.0,,CHEMBL862554,Inhibition of 3'-processing activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL382220,COC(=O)c1c(NC(=O)CC2Nc3ccccc3NC2=O)sc2c1CCCC2,IC50,100000.0,,CHEMBL862554,Inhibition of 3'-processing activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL206381,O=C(O)CCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(F)cc2)cc1,IC50,100000.0,,CHEMBL862554,Inhibition of 3'-processing activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL377295,CCOC(=O)C1=C(O)/C(=C\c2ccc(CNC(=O)C(=O)Nc3ccccc3)o2)N=C1C,IC50,100000.0,,CHEMBL862554,Inhibition of 3'-processing activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL203881,O=C(O)CCC(=O)Nc1ccc(Cl)c(NC(=O)Cc2ccccc2)c1,IC50,100000.0,,CHEMBL862554,Inhibition of 3'-processing activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL204026,COc1ccc(C2C(C(=O)c3ccccc3)=C(O)C(=O)N2CCCO)cc1OC,IC50,100000.0,,CHEMBL862554,Inhibition of 3'-processing activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL202815,COCCCNS(=O)(=O)c1ccc(Oc2cc(O)c3c(c2O)C(=O)c2ccccc2C3=O)cc1,IC50,100000.0,4.0,CHEMBL862554,Inhibition of 3'-processing activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL205077,CN(C)CCCN1C(=O)C(O)=C(C(=O)c2cccs2)C1c1cccs1,IC50,100000.0,,CHEMBL862555,Inhibition of strand transfer activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL205116,NCCCCCCNC(=O)c1c(O)oc2ccccc2c1=O,IC50,100000.0,,CHEMBL862555,Inhibition of strand transfer activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL379037,COc1cc(C(c2c[nH]c3ccccc23)c2c[nH]c3ccccc23)ccc1OCC(=O)O,IC50,100000.0,,CHEMBL862555,Inhibition of strand transfer activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL444623,CCOC(=O)c1c(NC(=O)c2cc3ccccc3oc2=O)sc(C(N)=O)c1C,IC50,56000.0,4.25,CHEMBL862555,Inhibition of strand transfer activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL380528,Oc1ccc(C(c2c[nH]c3ccccc23)c2c[nH]c3ccccc23)cc1O,IC50,10000.0,5.0,CHEMBL862555,Inhibition of strand transfer activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL203749,COc1cccc2cc(-c3csc(Nc4cccc(O)c4)n3)c(=O)oc12,IC50,100000.0,,CHEMBL862555,Inhibition of strand transfer activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL205921,O=C(NCCCO)c1ccc(CSc2nc(O)c3c4c(sc3n2)CCC4)cc1,IC50,100000.0,,CHEMBL862555,Inhibition of strand transfer activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL206621,CCOC(=O)c1c(NC(=O)CC2Sc3ccc(C(F)(F)F)cc3NC2=O)sc2c1CCCC2,IC50,100000.0,,CHEMBL862555,Inhibition of strand transfer activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL382220,COC(=O)c1c(NC(=O)CC2Nc3ccccc3NC2=O)sc2c1CCCC2,IC50,100000.0,,CHEMBL862555,Inhibition of strand transfer activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL206381,O=C(O)CCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(F)cc2)cc1,IC50,100000.0,,CHEMBL862555,Inhibition of strand transfer activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL377295,CCOC(=O)C1=C(O)/C(=C\c2ccc(CNC(=O)C(=O)Nc3ccccc3)o2)N=C1C,IC50,40000.0,4.4,CHEMBL862555,Inhibition of strand transfer activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL203881,O=C(O)CCC(=O)Nc1ccc(Cl)c(NC(=O)Cc2ccccc2)c1,IC50,100000.0,,CHEMBL862555,Inhibition of strand transfer activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL204026,COc1ccc(C2C(C(=O)c3ccccc3)=C(O)C(=O)N2CCCO)cc1OC,IC50,100000.0,,CHEMBL862555,Inhibition of strand transfer activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL202815,COCCCNS(=O)(=O)c1ccc(Oc2cc(O)c3c(c2O)C(=O)c2ccccc2C3=O)cc1,IC50,23000.0,4.64,CHEMBL862555,Inhibition of strand transfer activity of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL382139,O=C(O)C(=O)/C=C(\O)c1nc2c(ncn2Cc2ccccc2)c(=O)n1Cc1ccccc1,IC50,30000.0,4.52,CHEMBL862315,Inhibition of HIV1 integrase 3'-processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL206981,O=C(O)C(=O)/C=C(/O)c1nc2c(=O)n(Cc3ccccc3)cnc2n1Cc1ccccc1,IC50,31500.0,4.5,CHEMBL862315,Inhibition of HIV1 integrase 3'-processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31500.0,4.501689446210399
CHEMBL206980,O=C(O)C(=O)/C=C(/O)c1nc2cncnc2n1Cc1ccccc1,IC50,100000.0,4.0,CHEMBL862315,Inhibition of HIV1 integrase 3'-processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL382139,O=C(O)C(=O)/C=C(\O)c1nc2c(ncn2Cc2ccccc2)c(=O)n1Cc1ccccc1,IC50,2700.0,5.57,CHEMBL862316,Inhibition of HIV1 integrase strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2700.0,5.568636235841012
CHEMBL206981,O=C(O)C(=O)/C=C(/O)c1nc2c(=O)n(Cc3ccccc3)cnc2n1Cc1ccccc1,IC50,4100.0,5.39,CHEMBL862316,Inhibition of HIV1 integrase strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4100.0,5.3872161432802645
CHEMBL206980,O=C(O)C(=O)/C=C(/O)c1nc2cncnc2n1Cc1ccccc1,IC50,10000.0,5.0,CHEMBL862316,Inhibition of HIV1 integrase strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL379658,CCN1CCN(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)C(=O)C1=O,IC50,10.0,8.0,CHEMBL861104,Inhibition of strand transfer process of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL209307,CN(C(=O)C(=O)N1CCCC1)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,40.0,7.4,CHEMBL861104,Inhibition of strand transfer process of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL210234,CN(C(=O)C(=O)N1CCCCC1)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,7.0,8.15,CHEMBL861104,Inhibition of strand transfer process of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL210233,CN(C(=O)C(N)=O)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,20.0,7.7,CHEMBL861104,Inhibition of strand transfer process of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL378029,CNC(=O)C(=O)N(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,15.0,7.82,CHEMBL861104,Inhibition of strand transfer process of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL426686,CN(C)C(=O)C(=O)N(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,40.0,7.4,CHEMBL861104,Inhibition of strand transfer process of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL377759,CC(=O)N(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,25.0,7.6,CHEMBL861104,Inhibition of strand transfer process of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25.0,7.6020599913279625
CHEMBL208776,CN(C)C(=O)CN(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,58.0,7.24,CHEMBL861104,Inhibition of strand transfer process of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58.0,7.236572006437063
CHEMBL379132,CC(=O)N(C)CCN(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,156.0,6.81,CHEMBL861104,Inhibition of strand transfer process of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,156.0,6.806875401645538
CHEMBL441683,CN1CCN(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)CC1,IC50,40.0,7.4,CHEMBL861104,Inhibition of strand transfer process of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL209872,CC(=O)N1CCN(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)CC1,IC50,25.0,7.6,CHEMBL861104,Inhibition of strand transfer process of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25.0,7.6020599913279625
CHEMBL211014,O=C(CC(=O)C(=O)O)CC(=O)c1ccccc1Cl,IC50,1000.0,6.0,CHEMBL871193,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL210977,O=C(/C=C(\O)C(=O)O)CCc1ccccc1Br,IC50,5000.0,5.3,CHEMBL871193,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL210996,O=C(/C=C(\O)C(=O)O)CCc1ccccc1,IC50,30000.0,4.52,CHEMBL871193,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL108760,O=C(O)C(=O)/C=C(\O)c1c[nH]c2ccc(Cl)cc12,IC50,400.0,6.4,CHEMBL871193,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL210374,O=C(CC(=O)C(=O)O)CC(=O)c1ccc(-c2ccccc2)cc1,IC50,2000.0,5.7,CHEMBL871193,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL210373,O=C(CC(=O)C(=O)O)CC(=O)c1ccc2ccccc2c1,IC50,6000.0,5.22,CHEMBL871193,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL209614,O=C(CC(=O)C(=O)O)CC(=O)c1cccc2ccccc12,IC50,600.0,6.22,CHEMBL871193,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL210962,O=C(CC(=O)C(=O)O)CC(=O)c1ccccn1,IC50,100000.0,4.0,CHEMBL871193,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL210870,O=C(CC(=O)C(=O)O)CC(=O)c1cccc(Cl)c1,IC50,8000.0,5.1,CHEMBL871193,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL377263,O=C(CC(=O)C(=O)O)CC(=O)c1ccccc1OCc1ccccc1,IC50,7000.0,5.16,CHEMBL871193,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL208806,COc1ccccc1C(=O)CC(=O)CC(=O)C(=O)O,IC50,4000.0,5.4,CHEMBL871193,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL209879,O=C(CC(=O)C(=O)O)CC(=O)c1ccccc1C(F)(F)F,IC50,6000.0,5.22,CHEMBL871193,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL209827,O=C(CC(=O)C(=O)O)CC(=O)c1ccccc1F,IC50,3000.0,5.52,CHEMBL871193,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL448424,O=C(CC(=O)C(=O)O)CC(=O)c1ccccc1,IC50,80000.0,4.1,CHEMBL871193,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL209205,O=C(CCc1ccccc1Cl)CC(=O)C(=O)O,IC50,9000.0,5.05,CHEMBL871193,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL211014,O=C(CC(=O)C(=O)O)CC(=O)c1ccccc1Cl,IC50,600.0,6.22,CHEMBL871194,Inhibition of HIV1 recombinant integrase in pre-integration complex,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL211014,O=C(CC(=O)C(=O)O)CC(=O)c1ccccc1Cl,IC50,200.0,6.7,CHEMBL863032,Inhibition of HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL50605,O=C(O)C(=O)CC(=O)c1cccn1Cc1ccc(F)cc1,IC50,20.0,7.7,CHEMBL863032,Inhibition of HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL211028,O=C(/C=C(\O)C(=O)O)CCc1ccc(Cl)c(Cl)c1,IC50,10.0,8.0,CHEMBL863032,Inhibition of HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL108760,O=C(O)C(=O)/C=C(\O)c1c[nH]c2ccc(Cl)cc12,IC50,80.0,7.1,CHEMBL863032,Inhibition of HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL209713,O=C(/C=C(\O)C(=O)O)CCc1ccccc1Cl,IC50,26000.0,4.58,CHEMBL871193,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26000.0,4.585026652029182
CHEMBL208722,COC(=O)C(=O)/C=C(\O)c1cccn1Cc1ccc(F)cc1,IC50,48000.0,4.32,CHEMBL862914,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48000.0,4.318758762624412
CHEMBL16326,O=C(O)C(=O)/C=C(\O)c1ccccc1,IC50,80000.0,4.1,CHEMBL869711,Inhibition of HIV1 integrase strand transfer activity in presence of exogenous cobalt ion,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL16326,O=C(O)C(=O)/C=C(\O)c1ccccc1,IC50,82000.0,4.09,CHEMBL869710,Inhibition of HIV1 integrase 3' processing activity in presence of exogenous cobalt ion,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,82000.0,4.086186147616283
CHEMBL16326,O=C(O)C(=O)/C=C(\O)c1ccccc1,IC50,69000.0,4.16,CHEMBL862914,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69000.0,4.161150909262744
CHEMBL421353,O=C(O)C(=O)/C=C(\O)c1cccn1Cc1ccc(F)cc1,IC50,540.0,6.27,CHEMBL862914,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,540.0,6.267606240177031
CHEMBL267212,CC(C)C[C@@H](NC(=O)[C@@H](C)NC(=O)CNC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](C)C(=O)N[C@@H](C(=O)O)[C@H](C)O,IC50,4000.0,5.4,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL267212,CC(C)C[C@@H](NC(=O)[C@@H](C)NC(=O)CNC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](C)C(=O)N[C@@H](C(=O)O)[C@H](C)O,IC50,3500.0,5.46,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3500.0,5.455931955649724
CHEMBL384894,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](C)NC(=O)[C@H](N)[C@H](C)O)C(=O)N[C@H](C)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,16000.0,4.8,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL384894,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](C)NC(=O)[C@H](N)[C@H](C)O)C(=O)N[C@H](C)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,96000.0,4.02,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,96000.0,4.017728766960432
CHEMBL219255,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](C)NC(=O)[C@H](N)[C@H](C)O)C(=O)N[C@H](C)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,13000.0,4.89,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL219255,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](C)NC(=O)[C@H](N)[C@H](C)O)C(=O)N[C@H](C)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,65000.0,4.19,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL377022,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,IC50,100000.0,,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL377022,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,IC50,100000.0,,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL211491,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,100000.0,,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL211491,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,100000.0,,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL211490,C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)NCC(N)=O,IC50,60000.0,4.22,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL211490,C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)NCC(N)=O,IC50,100000.0,,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL378468,CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,100000.0,,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL378468,CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,100000.0,,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL377971,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(N)=O,IC50,20000.0,4.7,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL377971,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(N)=O,IC50,20000.0,4.7,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL438244,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,IC50,16000.0,4.8,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL438244,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,IC50,46000.0,4.34,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,46000.0,4.337242168318426
CHEMBL374671,CC(C)C[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(N)=O,IC50,38000.0,4.42,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38000.0,4.42021640338319
CHEMBL373670,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,3000.0,5.52,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL373670,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,4100.0,5.39,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4100.0,5.3872161432802645
CHEMBL427057,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,11000.0,4.96,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL414784,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,IC50,55000.0,4.26,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55000.0,4.259637310505756
CHEMBL414784,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,IC50,62000.0,4.21,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,62000.0,4.2076083105017466
CHEMBL434367,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,IC50,43000.0,4.37,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43000.0,4.366531544420414
CHEMBL434367,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,IC50,90000.0,4.05,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL406897,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,IC50,34000.0,4.47,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34000.0,4.468521082957745
CHEMBL406897,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,IC50,33000.0,4.48,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL374420,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,80000.0,4.1,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL374420,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,83000.0,4.08,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,83000.0,4.080921907623926
CHEMBL424924,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,19000.0,4.72,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL413479,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,56000.0,4.25,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL409975,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,51000.0,4.29,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,51000.0,4.292429823902063
CHEMBL412938,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,47000.0,4.33,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47000.0,4.327902142064283
CHEMBL412938,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,100000.0,4.0,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL436489,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,IC50,56000.0,4.25,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL436489,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,IC50,95000.0,4.02,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,95000.0,4.022276394711152
CHEMBL427235,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,2700.0,5.57,CHEMBL869096,Inhibition of wild type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2700.0,5.568636235841012
CHEMBL427235,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,IC50,21000.0,4.68,CHEMBL869095,Inhibition of wild type HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL209440,COc1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C2,IC50,60.0,7.22,CHEMBL867996,Inhibition of HIV1 integrase strand transfer activity in MT4 cell line,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL377267,COc1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C2C,IC50,88.0,7.06,CHEMBL867996,Inhibition of HIV1 integrase strand transfer activity in MT4 cell line,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,88.0,7.055517327849831
CHEMBL213852,C=C1c2c(c(O)c3ncccc3c2OC)C(=O)N1Cc1ccc(F)cc1,IC50,150.0,6.82,CHEMBL867996,Inhibition of HIV1 integrase strand transfer activity in MT4 cell line,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,150.0,6.823908740944319
CHEMBL212412,COc1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C21CC1,IC50,7.0,8.15,CHEMBL867996,Inhibition of HIV1 integrase strand transfer activity in MT4 cell line,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL384158,COc1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C2(C)C,IC50,210.0,6.68,CHEMBL867996,Inhibition of HIV1 integrase strand transfer activity in MT4 cell line,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,210.0,6.6777807052660805
CHEMBL212000,COc1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C2O,IC50,36.0,7.44,CHEMBL867996,Inhibition of HIV1 integrase strand transfer activity in MT4 cell line,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36.0,7.443697499232712
CHEMBL384912,COc1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C2OC,IC50,64.0,7.19,CHEMBL867996,Inhibition of HIV1 integrase strand transfer activity in MT4 cell line,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,64.0,7.1938200260161125
CHEMBL209641,COC(=O)CCSC1c2c(c(O)c3ncccc3c2OC)C(=O)N1Cc1ccc(F)cc1,IC50,310.0,6.51,CHEMBL867996,Inhibition of HIV1 integrase strand transfer activity in MT4 cell line,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,310.0,6.508638306165727
CHEMBL213467,COc1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C2SCCC(=O)O,IC50,295.0,6.53,CHEMBL867996,Inhibition of HIV1 integrase strand transfer activity in MT4 cell line,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,295.0,6.530177984021837
CHEMBL385825,COc1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C2SCCC(=O)N1CCNCC1.O=C(O)C(F)(F)F,IC50,59.0,7.23,CHEMBL867996,Inhibition of HIV1 integrase strand transfer activity in MT4 cell line,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,59.0,7.229147988357855
CHEMBL378117,CC1c2c(c(O)c3ncccc3c2OS(=O)(=O)N(C)C)C(=O)N1Cc1ccc(F)cc1,IC50,815.0,6.09,CHEMBL867996,Inhibition of HIV1 integrase strand transfer activity in MT4 cell line,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,815.0,6.088842391260023
CHEMBL377621,C=C1c2c(c(O)c3ncccc3c2OS(=O)(=O)N(C)C)C(=O)N1Cc1ccc(F)cc1,IC50,420.0,6.38,CHEMBL867996,Inhibition of HIV1 integrase strand transfer activity in MT4 cell line,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,420.0,6.376750709602099
CHEMBL209958,O=C1c2c(c(O)c3ncccc3c2O)C(=O)N1Cc1ccc(F)cc1,IC50,80.0,7.1,CHEMBL867996,Inhibition of HIV1 integrase strand transfer activity in MT4 cell line,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL379974,CN(C)S(=O)(=O)Oc1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C21CC1,IC50,357.0,6.45,CHEMBL867996,Inhibition of HIV1 integrase strand transfer activity in MT4 cell line,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,357.0,6.447331783887806
CHEMBL212213,COc1c2c(c(O)c3ncc(F)cc13)C(=O)N(Cc1ccc(F)cc1)C2,IC50,7.2,8.14,CHEMBL869776,Inhibition of strand transfer activity in HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.2,8.142667503568731
CHEMBL386055,COc1cnc2c(O)c3c(c(OC)c2c1)CN(Cc1ccc(F)cc1)C3=O,IC50,93.0,7.03,CHEMBL869776,Inhibition of strand transfer activity in HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,93.0,7.031517051446065
CHEMBL214371,CN(C)S(=O)(=O)Oc1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C2,IC50,255.0,6.59,CHEMBL869776,Inhibition of strand transfer activity in HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,255.0,6.5934598195660445
CHEMBL212982,CN(C)S(=O)(=O)Oc1c2c(c(O)c3nccnc13)C(=O)N(Cc1ccc(F)cc1)C2,IC50,33.0,7.48,CHEMBL869776,Inhibition of strand transfer activity in HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33.0,7.481486060122112
CHEMBL214066,COc1c2c(c(O)c3ncn(Cc4ccccc4)c13)C(=O)N(Cc1ccc(F)cc1)C2,IC50,24000.0,4.62,CHEMBL869776,Inhibition of strand transfer activity in HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL380034,COc1c2c(c(O)c3c1NCCN3)C(=O)N(Cc1ccc(F)cc1)C2,IC50,850.0,6.07,CHEMBL869776,Inhibition of strand transfer activity in HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,850.0,6.070581074285707
CHEMBL209488,COc1c2c(c(O)c3nccnc13)C(=O)N(Cc1ccc(F)cc1)C2,IC50,210.0,6.68,CHEMBL869776,Inhibition of strand transfer activity in HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,210.0,6.6777807052660805
CHEMBL209440,COc1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C2,IC50,50.0,7.3,CHEMBL869776,Inhibition of strand transfer activity in HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL414850,O=C(NCc1ccc(F)cc1)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,50.0,7.3,CHEMBL869770,Inhibition of strand transfer activity of HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL209854,O=C1c2c(c(C(=O)N3CCOCC3)c3cccnc3c2O)CN1Cc1ccc(F)cc1,IC50,36.0,7.44,CHEMBL869770,Inhibition of strand transfer activity of HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36.0,7.443697499232712
CHEMBL211110,O=C(NCc1ccccn1)c1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C2,IC50,190.0,6.72,CHEMBL869770,Inhibition of strand transfer activity of HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,190.0,6.721246399047171
CHEMBL379382,O=C1c2c(c(-c3c(F)cccc3F)c3cccnc3c2O)CN1Cc1ccc(F)cc1,IC50,335.0,6.47,CHEMBL869770,Inhibition of strand transfer activity of HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,335.0,6.474955192963154
CHEMBL378395,CCOC(=O)c1ccccc1-c1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C2,IC50,350.0,6.46,CHEMBL869770,Inhibition of strand transfer activity of HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,350.0,6.455931955649724
CHEMBL211275,CCOC(=O)c1cccc(-c2c3c(c(O)c4ncccc24)C(=O)N(Cc2ccc(F)cc2)C3)c1,IC50,2100.0,5.68,CHEMBL869770,Inhibition of strand transfer activity of HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2100.0,5.6777807052660805
CHEMBL377693,CCOc1ccc(-c2c3c(c(O)c4ncccc24)C(=O)N(Cc2ccc(F)cc2)C3)cc1,IC50,1200.0,5.92,CHEMBL869770,Inhibition of strand transfer activity of HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL210396,CN(C)C(=O)Oc1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C2,IC50,760.0,6.12,CHEMBL869770,Inhibition of strand transfer activity of HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,760.0,6.119186407719209
CHEMBL212320,CN(C)C(=O)Oc1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C2=O,IC50,2400.0,5.62,CHEMBL869770,Inhibition of strand transfer activity of HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2400.0,5.619788758288394
CHEMBL211634,O=C1c2c(cc3cccnc3c2O)CN1Cc1ccc(F)cc1,IC50,70.0,7.16,CHEMBL869770,Inhibition of strand transfer activity of HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL209591,O=C(NCc1ccc(F)cc1)c1ccc2cccnc2c1O,IC50,2000.0,5.7,CHEMBL869770,Inhibition of strand transfer activity of HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL212921,COc1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C2=O,IC50,80.0,7.1,CHEMBL869770,Inhibition of strand transfer activity of HIV integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL414737,CC[C@H](C)C(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O,IC50,6000.0,5.22,CHEMBL909168,Inhibition of wild type HIV1 integrase 3' processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL414737,CC[C@H](C)C(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O,IC50,10000.0,5.0,CHEMBL909169,Inhibition of wild type HIV1 integrase strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL414737,CC[C@H](C)C(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O,IC50,23000.0,4.64,CHEMBL909170,Inhibition of soluble HIV1 integrase F185K/C280S mutant strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL414737,CC[C@H](C)C(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O,IC50,28000.0,4.55,CHEMBL909171,Inhibition of soluble HIV1 integrase F182K/ C280S mutant 3' processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL414737,CC[C@H](C)C(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O,IC50,2000.0,5.7,CHEMBL909172,Inhibition of HIV1 integrase C130S mutant strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL412074,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C,IC50,15000.0,4.82,CHEMBL909168,Inhibition of wild type HIV1 integrase 3' processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL414737,CC[C@H](C)C(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O,IC50,20000.0,4.7,CHEMBL909175,Inhibition of mutant HIV1 integrase C130A mutant 3' processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL414737,CC[C@H](C)C(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O,IC50,5000.0,5.3,CHEMBL909174,Inhibition of HIV1 integrase C130A mutant strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL414737,CC[C@H](C)C(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O,IC50,41000.0,4.39,CHEMBL909173,Inhibition of HIV1 integrase C130S mutant 3' processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41000.0,4.3872161432802645
CHEMBL437239,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(=O)O,IC50,11000.0,4.96,CHEMBL909168,Inhibition of wild type HIV1 integrase 3' processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL412522,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O,IC50,6000.0,5.22,CHEMBL909168,Inhibition of wild type HIV1 integrase 3' processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL265159,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C,IC50,7000.0,5.16,CHEMBL909168,Inhibition of wild type HIV1 integrase 3' processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL412074,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C,IC50,14000.0,4.85,CHEMBL909169,Inhibition of wild type HIV1 integrase strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL437239,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(=O)O,IC50,2000.0,5.7,CHEMBL909169,Inhibition of wild type HIV1 integrase strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL412522,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O,IC50,2000.0,5.7,CHEMBL909169,Inhibition of wild type HIV1 integrase strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL265159,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C,IC50,4000.0,5.4,CHEMBL909169,Inhibition of wild type HIV1 integrase strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL412074,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C,IC50,83000.0,4.08,CHEMBL909170,Inhibition of soluble HIV1 integrase F185K/C280S mutant strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,83000.0,4.080921907623926
CHEMBL437239,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(=O)O,IC50,36000.0,4.44,CHEMBL909170,Inhibition of soluble HIV1 integrase F185K/C280S mutant strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36000.0,4.443697499232713
CHEMBL412522,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O,IC50,9000.0,5.05,CHEMBL909170,Inhibition of soluble HIV1 integrase F185K/C280S mutant strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL265159,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C,IC50,31000.0,4.51,CHEMBL909170,Inhibition of soluble HIV1 integrase F185K/C280S mutant strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31000.0,4.508638306165727
CHEMBL412074,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C,IC50,7000.0,5.16,CHEMBL909172,Inhibition of HIV1 integrase C130S mutant strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL437239,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(=O)O,IC50,4000.0,5.4,CHEMBL909172,Inhibition of HIV1 integrase C130S mutant strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL412522,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O,IC50,27000.0,4.57,CHEMBL909172,Inhibition of HIV1 integrase C130S mutant strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27000.0,4.568636235841013
CHEMBL265159,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C,IC50,2000.0,5.7,CHEMBL909172,Inhibition of HIV1 integrase C130S mutant strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL437239,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(=O)O,IC50,18000.0,4.75,CHEMBL909173,Inhibition of HIV1 integrase C130S mutant 3' processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL265159,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C,IC50,29000.0,4.54,CHEMBL909173,Inhibition of HIV1 integrase C130S mutant 3' processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,29000.0,4.537602002101044
CHEMBL412074,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C,IC50,15000.0,4.82,CHEMBL909174,Inhibition of HIV1 integrase C130A mutant strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL437239,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(=O)O,IC50,20000.0,4.7,CHEMBL909174,Inhibition of HIV1 integrase C130A mutant strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL412522,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O,IC50,5000.0,5.3,CHEMBL909174,Inhibition of HIV1 integrase C130A mutant strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL265159,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C,IC50,10000.0,5.0,CHEMBL909174,Inhibition of HIV1 integrase C130A mutant strand transfer step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL412522,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O,IC50,13000.0,4.89,CHEMBL909171,Inhibition of soluble HIV1 integrase F182K/ C280S mutant 3' processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL265159,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C,IC50,51000.0,4.29,CHEMBL909171,Inhibition of soluble HIV1 integrase F182K/ C280S mutant 3' processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,51000.0,4.292429823902063
CHEMBL412074,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C,IC50,45000.0,4.35,CHEMBL909175,Inhibition of mutant HIV1 integrase C130A mutant 3' processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45000.0,4.346787486224656
CHEMBL412522,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O,IC50,25000.0,4.6,CHEMBL909175,Inhibition of mutant HIV1 integrase C130A mutant 3' processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL265159,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C,IC50,15000.0,4.82,CHEMBL909175,Inhibition of mutant HIV1 integrase C130A mutant 3' processing step,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL437708,O=C(NCc1ccccc1)c1nc(-c2cccs2)nc(O)c1O,IC50,85.0,7.07,CHEMBL907140,Inhibition of HIV integrase by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,85.0,7.070581074285707
CHEMBL216874,O=C(NCc1ccc(F)cc1)c1nc(-c2cccs2)nc(O)c1O,IC50,10.0,8.0,CHEMBL907140,Inhibition of HIV integrase by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL407451,CN1CCCCC1c1nc(O)c(O)c(C(=O)NCc2ccc(F)cc2)n1,IC50,200.0,6.7,CHEMBL907140,Inhibition of HIV integrase by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL386515,CN(C)C(C)(C)c1nc(O)c(O)c(C(=O)NCc2ccc(F)cc2)n1,IC50,50.0,7.3,CHEMBL907140,Inhibition of HIV integrase by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL216373,CN(C)Cc1nc(O)c(O)c(C(=O)NCc2ccc(F)cc2)n1,IC50,200.0,6.7,CHEMBL907140,Inhibition of HIV integrase by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL216317,CC(c1nc(O)c(O)c(C(=O)NCc2ccc(F)cc2)n1)N(C)C,IC50,80.0,7.1,CHEMBL907140,Inhibition of HIV integrase by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL217776,CN(C)C(c1ccccc1)c1nc(O)c(O)c(C(=O)NCc2ccc(F)cc2)n1,IC50,200.0,6.7,CHEMBL907140,Inhibition of HIV integrase by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL217020,O=C(NCc1ccc(F)cc1)c1nc(Cc2ccccc2)nc(O)c1O,IC50,50.0,7.3,CHEMBL907140,Inhibition of HIV integrase by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL385951,O=C(NCc1ccccc1)c1nc(-c2ccccc2)nc(O)c1O,IC50,70.0,7.16,CHEMBL907140,Inhibition of HIV integrase by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL217285,Cc1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)[nH]1,IC50,60.0,7.22,CHEMBL907140,Inhibition of HIV integrase by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL217566,O=C(NCc1ccc(F)cc1)c1ncnc(O)c1O,IC50,60.0,7.22,CHEMBL907140,Inhibition of HIV integrase by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL386710,CN1CCOCC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,25.0,7.6,CHEMBL907140,Inhibition of HIV integrase by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25.0,7.6020599913279625
CHEMBL386710,CN1CCOCC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,20.0,7.7,CHEMBL907140,Inhibition of HIV integrase by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL386710,CN1CCOCC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,60.0,7.22,CHEMBL907140,Inhibition of HIV integrase by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL216389,CN1CCCCC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,210.0,6.68,CHEMBL907140,Inhibition of HIV integrase by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,210.0,6.6777807052660805
CHEMBL224993,COc1ccc(Br)cc1/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c1cc(Br)ccc1OC,IC50,100000.0,,CHEMBL915571,Inhibition of HIV1 integrase-mediated 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL224992,O=S(=O)(/C=C/c1ccc2c(c1)OCCO2)CS(=O)(=O)/C=C/c1ccc2c(c1)OCCO2,IC50,100000.0,,CHEMBL915571,Inhibition of HIV1 integrase-mediated 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL225394,O=S(=O)(/C=C/c1cc(OCc2ccccc2)c(OCc2ccccc2)c(OCc2ccccc2)c1)CS(=O)(=O)/C=C/c1cc(OCc2ccccc2)c(OCc2ccccc2)c(OCc2ccccc2)c1,IC50,100000.0,,CHEMBL915571,Inhibition of HIV1 integrase-mediated 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL374171,O=S(=O)(/C=C/c1cc(Cl)ccc1Cl)CS(=O)(=O)/C=C/c1cc(Cl)ccc1Cl,IC50,100000.0,,CHEMBL915571,Inhibition of HIV1 integrase-mediated 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL373310,O=S(=O)(/C=C/c1ccc(OCc2ccccc2)c(OCc2ccccc2)c1)CS(=O)(=O)/C=C/c1ccc(OCc2ccccc2)c(OCc2ccccc2)c1,IC50,100000.0,,CHEMBL915571,Inhibition of HIV1 integrase-mediated 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL375883,O=S(=O)(/C=C/c1ccccc1OCc1ccccc1)CS(=O)(=O)/C=C/c1ccccc1OCc1ccccc1,IC50,100000.0,,CHEMBL915571,Inhibition of HIV1 integrase-mediated 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL224123,O=S(=O)(CCc1ccccc1)CS(=O)(=O)CCc1ccccc1,IC50,100000.0,,CHEMBL915571,Inhibition of HIV1 integrase-mediated 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL225598,COc1cc(/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c2cc(Br)c(OC)c(OC)c2)cc(Br)c1OC,IC50,100000.0,,CHEMBL915571,Inhibition of HIV1 integrase-mediated 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL225597,O=S(=O)(/C=C/c1ccccc1)CS(=O)(=O)/C=C/c1ccccc1,IC50,100000.0,,CHEMBL915571,Inhibition of HIV1 integrase-mediated 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL223062,O=S(=O)(/C=C/c1ccc2[nH]ccc2c1)CS(=O)(=O)/C=C/c1ccc2[nH]ccc2c1,IC50,100000.0,,CHEMBL915571,Inhibition of HIV1 integrase-mediated 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL439018,O=S(=O)(/C=C/c1cc(F)c(F)c(F)c1)CS(=O)(=O)/C=C/c1cc(F)c(F)c(F)c1,IC50,100000.0,,CHEMBL915571,Inhibition of HIV1 integrase-mediated 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL388725,O=S(=O)(CCc1ccc(O)c(O)c1)CS(=O)(=O)CCc1ccc(O)c(O)c1,IC50,40000.0,4.4,CHEMBL915571,Inhibition of HIV1 integrase-mediated 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL223909,O=C(O)c1ccc(/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c2ccc(C(=O)O)cc2)cc1,IC50,33000.0,4.48,CHEMBL915571,Inhibition of HIV1 integrase-mediated 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL224993,COc1ccc(Br)cc1/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c1cc(Br)ccc1OC,IC50,100000.0,,CHEMBL915572,Inhibition of HIV1 integrase-mediated integration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL224992,O=S(=O)(/C=C/c1ccc2c(c1)OCCO2)CS(=O)(=O)/C=C/c1ccc2c(c1)OCCO2,IC50,100000.0,,CHEMBL915572,Inhibition of HIV1 integrase-mediated integration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL225394,O=S(=O)(/C=C/c1cc(OCc2ccccc2)c(OCc2ccccc2)c(OCc2ccccc2)c1)CS(=O)(=O)/C=C/c1cc(OCc2ccccc2)c(OCc2ccccc2)c(OCc2ccccc2)c1,IC50,100000.0,,CHEMBL915572,Inhibition of HIV1 integrase-mediated integration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL374171,O=S(=O)(/C=C/c1cc(Cl)ccc1Cl)CS(=O)(=O)/C=C/c1cc(Cl)ccc1Cl,IC50,100000.0,,CHEMBL915572,Inhibition of HIV1 integrase-mediated integration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL373310,O=S(=O)(/C=C/c1ccc(OCc2ccccc2)c(OCc2ccccc2)c1)CS(=O)(=O)/C=C/c1ccc(OCc2ccccc2)c(OCc2ccccc2)c1,IC50,100000.0,,CHEMBL915572,Inhibition of HIV1 integrase-mediated integration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL375883,O=S(=O)(/C=C/c1ccccc1OCc1ccccc1)CS(=O)(=O)/C=C/c1ccccc1OCc1ccccc1,IC50,100000.0,,CHEMBL915572,Inhibition of HIV1 integrase-mediated integration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL224123,O=S(=O)(CCc1ccccc1)CS(=O)(=O)CCc1ccccc1,IC50,100000.0,,CHEMBL915572,Inhibition of HIV1 integrase-mediated integration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL225598,COc1cc(/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c2cc(Br)c(OC)c(OC)c2)cc(Br)c1OC,IC50,100000.0,,CHEMBL915572,Inhibition of HIV1 integrase-mediated integration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL225597,O=S(=O)(/C=C/c1ccccc1)CS(=O)(=O)/C=C/c1ccccc1,IC50,100000.0,,CHEMBL915572,Inhibition of HIV1 integrase-mediated integration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL223062,O=S(=O)(/C=C/c1ccc2[nH]ccc2c1)CS(=O)(=O)/C=C/c1ccc2[nH]ccc2c1,IC50,95000.0,4.02,CHEMBL915572,Inhibition of HIV1 integrase-mediated integration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,95000.0,4.022276394711152
CHEMBL439018,O=S(=O)(/C=C/c1cc(F)c(F)c(F)c1)CS(=O)(=O)/C=C/c1cc(F)c(F)c(F)c1,IC50,100000.0,,CHEMBL915572,Inhibition of HIV1 integrase-mediated integration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL388725,O=S(=O)(CCc1ccc(O)c(O)c1)CS(=O)(=O)CCc1ccc(O)c(O)c1,IC50,17000.0,4.77,CHEMBL915572,Inhibition of HIV1 integrase-mediated integration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL223909,O=C(O)c1ccc(/C=C/S(=O)(=O)CS(=O)(=O)/C=C/c2ccc(C(=O)O)cc2)cc1,IC50,33000.0,4.48,CHEMBL915572,Inhibition of HIV1 integrase-mediated integration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL389931,Cc1nc2oc3ccccc3c(=O)c2cc1C(=O)CC(=O)C(=O)O,IC50,100000.0,,CHEMBL903664,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL389881,O=C(O)C(=O)CC(=O)c1ccc(N2CCOCC2)cc1,IC50,100000.0,,CHEMBL903664,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL389931,Cc1nc2oc3ccccc3c(=O)c2cc1C(=O)CC(=O)C(=O)O,IC50,35000.0,4.46,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL389881,O=C(O)C(=O)CC(=O)c1ccc(N2CCOCC2)cc1,IC50,23000.0,4.64,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL3706873,N#Cc1ccc(CN(Cc2ccc(C#N)cc2)c2ccc3[nH]c(=O)c4ccccc4c3c2)cc1,IC50,62000.0,4.21,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,62000.0,4.2076083105017466
CHEMBL387679,O=c1[nH]c2ccc(Cl)cc2c2ccccc12,IC50,100000.0,4.0,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL225682,Cc1ccc2oc3nc(C)c(C(=O)CC(=O)C(=O)O)cc3c(=O)c2c1,IC50,16000.0,4.8,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL225681,O=C(O)C(=O)CC(=O)c1ccc2ccc3cccc4ccc1c2c34,IC50,530.0,6.28,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,530.0,6.275724130399211
CHEMBL226490,O=C(O)C(=O)CC(=O)c1c2ccccc2cc2ccccc12,IC50,1700.0,5.77,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL226489,O=C(O)C(=O)CC(=O)c1ccc2cc3ccccc3cc2c1,IC50,13000.0,4.89,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL389930,O=C(O)C(=O)CC(=O)c1cc2ccccc2c2ccccc12,IC50,380.0,6.42,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,380.0,6.42021640338319
CHEMBL375484,O=C(O)C(=O)CC(=O)c1ccc2c(ccc3ccccc32)c1,IC50,4800.0,5.32,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4800.0,5.318758762624412
CHEMBL226485,O=C(O)C(=O)CC(=O)c1ccc2ccc3ccccc3c2c1,IC50,2700.0,5.57,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2700.0,5.568636235841012
CHEMBL226484,Cc1ccc2cc(C(=O)CC(=O)C(=O)O)ccc2c1,IC50,3000.0,5.52,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL375956,O=C(O)C(=O)CC(=O)c1ccc2ccccc2c1,IC50,7000.0,5.16,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL226434,COC(=O)c1ccccc1-c1ccc(C(=O)CC(=O)C(=O)O)cc1[N+](=O)[O-],IC50,7000.0,5.16,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL226433,COC(=O)C(=O)CC(=O)c1ccc(-c2ccccc2C(=O)OC)c([N+](=O)[O-])c1,IC50,27000.0,4.57,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27000.0,4.568636235841013
CHEMBL226374,O=C(O)C(=O)CC(=O)c1ccc2c(c1)[nH]c(=O)c1ccccc12,IC50,65000.0,4.19,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL225669,O=c1[nH]c2ccc(Br)cc2c2ccccc12,IC50,78000.0,4.11,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,78000.0,4.107905397309519
CHEMBL225682,Cc1ccc2oc3nc(C)c(C(=O)CC(=O)C(=O)O)cc3c(=O)c2c1,IC50,92000.0,4.04,CHEMBL903664,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,92000.0,4.036212172654444
CHEMBL225681,O=C(O)C(=O)CC(=O)c1ccc2ccc3cccc4ccc1c2c34,IC50,7000.0,5.16,CHEMBL903664,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL226490,O=C(O)C(=O)CC(=O)c1c2ccccc2cc2ccccc12,IC50,54000.0,4.27,CHEMBL903664,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54000.0,4.267606240177032
CHEMBL226489,O=C(O)C(=O)CC(=O)c1ccc2cc3ccccc3cc2c1,IC50,32000.0,4.5,CHEMBL903664,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL389930,O=C(O)C(=O)CC(=O)c1cc2ccccc2c2ccccc12,IC50,9000.0,5.05,CHEMBL903664,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL375484,O=C(O)C(=O)CC(=O)c1ccc2c(ccc3ccccc32)c1,IC50,23000.0,4.64,CHEMBL903664,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL226485,O=C(O)C(=O)CC(=O)c1ccc2ccc3ccccc3c2c1,IC50,25000.0,4.6,CHEMBL903664,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL226484,Cc1ccc2cc(C(=O)CC(=O)C(=O)O)ccc2c1,IC50,11000.0,4.96,CHEMBL903664,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL375956,O=C(O)C(=O)CC(=O)c1ccc2ccccc2c1,IC50,54000.0,4.27,CHEMBL903664,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54000.0,4.267606240177032
CHEMBL226434,COC(=O)c1ccccc1-c1ccc(C(=O)CC(=O)C(=O)O)cc1[N+](=O)[O-],IC50,26000.0,4.58,CHEMBL903664,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26000.0,4.585026652029182
CHEMBL218227,O=C(/C=C(\O)c1nc[nH]n1)c1ccc(Cc2ccc(F)cc2)o1,IC50,11000.0,4.96,CHEMBL903664,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL218227,O=C(/C=C(\O)c1nc[nH]n1)c1ccc(Cc2ccc(F)cc2)o1,IC50,600.0,6.22,CHEMBL903665,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL265377,CCc1c(Cc2ccccc2)n(COCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c(=O)[nH]c1=O,IC50,1820.0,5.74,CHEMBL888534,Inhibition of HIV1 integrase expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1820.0,5.739928612014925
CHEMBL1161970,O=C(Nc1ccc2c(O)c(/N=N/c3ccc(C(=O)O)cc3)c(S(=O)(=O)O)cc2c1)Nc1ccc2c(O)c(/N=N/c3ccc(C(=O)O)cc3)c(S(=O)(=O)O)cc2c1,IC50,700.0,6.16,CHEMBL888534,Inhibition of HIV1 integrase expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL390489,O=Cc1ccc(-c2cc(-c3cccc(C=O)c3)c(O)c(O)c(=O)c2O)cc1,IC50,1100.0,5.96,CHEMBL888534,Inhibition of HIV1 integrase expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1100.0,5.958607314841775
CHEMBL178865,O=[N+]([O-])c1ccc(C2c3c(O)nc(S)nc3Oc3nc(S)nc(O)c32)cc1,IC50,300.0,6.52,CHEMBL888534,Inhibition of HIV1 integrase expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL242883,O=C(O)/C(O)=C/C(=O)c1cccc(Cc2ccccc2)c1,IC50,93.0,7.03,CHEMBL888534,Inhibition of HIV1 integrase expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,93.0,7.031517051446065
CHEMBL436546,CC(C)c1c(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]c1=O,IC50,100000.0,,CHEMBL888534,Inhibition of HIV1 integrase expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL243536,Cc1cc(C)cc(Cc2c(C(C)C)c(=O)[nH]c(=O)n2COCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1,IC50,7670.0,5.12,CHEMBL888534,Inhibition of HIV1 integrase expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7670.0,5.115204636051019
CHEMBL388707,CC(C)c1c(Cc2ccccc2)n(COCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c(=O)[nH]c1=O,IC50,2410.0,5.62,CHEMBL888534,Inhibition of HIV1 integrase expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2410.0,5.617982957425132
CHEMBL244167,CCc1c(Cc2cc(C)cc(C)c2)n(COCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c(=O)[nH]c1=O,IC50,4440.0,5.35,CHEMBL888534,Inhibition of HIV1 integrase expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4440.0,5.35261702988538
CHEMBL442795,O=C(/C=C/c1ccc(O)c(O)c1)NC(Cc1ccc(O)c(O)c1)C(=O)O,IC50,12000.0,4.92,CHEMBL893264,Inhibition of recombinant HIV1 integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL396065,O=C(O)COC(=O)/C=C/c1ccc(O)c(O)c1,IC50,10500.0,4.98,CHEMBL893264,Inhibition of recombinant HIV1 integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10500.0,4.978810700930062
CHEMBL226764,CN1CCCC1c1nc(O)c(O)c(C(=O)NCc2ccc(F)cc2)n1,IC50,120.0,6.92,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,120.0,6.920818753952375
CHEMBL395819,CN1CCOCC1c1nc(C(=O)NCc2ccc(F)c(Br)c2)c(O)c(=O)n1C,IC50,44.0,7.36,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44.0,7.356547323513812
CHEMBL394610,CN1CCOCC1c1nc(C(=O)NCc2ccc(F)c(Cl)c2)c(O)c(=O)n1C,IC50,28.0,7.55,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28.0,7.552841968657781
CHEMBL244236,Cc1cc(CNC(=O)c2nc(C3COCCN3C)n(C)c(=O)c2O)ccc1F,IC50,86.0,7.07,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,86.0,7.0655015487564325
CHEMBL394353,CN1CCOCC1c1nc(C(=O)NCc2ccc(F)c(F)c2)c(O)c(=O)n1C,IC50,21.0,7.68,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL244235,COc1cccc(CNC(=O)c2nc(C3COCCN3C)n(C)c(=O)c2O)c1,IC50,140.0,6.85,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,140.0,6.853871964321762
CHEMBL244863,CN1CCOCC1c1nc(C(=O)NCc2cccc(Br)c2)c(O)c(=O)n1C,IC50,19.0,7.72,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19.0,7.721246399047171
CHEMBL389142,CN1CCOCC1c1nc(C(=O)NCc2cccc(Cl)c2)c(O)c(=O)n1C,IC50,62.0,7.21,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,62.0,7.207608310501746
CHEMBL244651,CN1CCOCC1c1nc(C(=O)NCc2cccc(F)c2)c(O)c(=O)n1C,IC50,62.0,7.21,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,62.0,7.207608310501746
CHEMBL389141,CN1CCOCC1c1nc(C(=O)NCc2ccccc2F)c(O)c(=O)n1C,IC50,175.0,6.76,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,175.0,6.756961951313706
CHEMBL242076,CN(Cc1ccccc1)C(=O)c1nc(C2COCCN2C)n(C)c(=O)c1O,IC50,5000.0,,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL428215,CN1CCOCC1c1nc(C(=O)NCCc2ccccc2)c(O)c(=O)n1C,IC50,71.0,7.15,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,71.0,7.1487416512809245
CHEMBL428570,CN1CCOCC1c1nc(C(=O)NCc2ccccc2)c(O)c(=O)n1C,IC50,66.0,7.18,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,66.0,7.180456064458131
CHEMBL243377,Cn1c(C2COCCN2C(=O)OC(C)(C)C)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,20.0,7.7,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL389829,CC(=O)N1CCOCC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,15.0,7.82,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL243366,CCN1CCOCC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,33.0,7.48,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33.0,7.481486060122112
CHEMBL394782,Cn1c(C2COCCN2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,50.0,7.3,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL216683,CN1CCOCC1c1nc(O)c(O)c(C(=O)NCc2ccc(F)cc2)n1,IC50,30.0,7.52,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL243365,CN1CCN(S(=O)(=O)N(C)C)CC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,8.0,8.1,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL243151,CN1CCN(S(=O)(=O)c2ccccc2)CC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,7.0,8.15,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL243150,CN1CCN(S(C)(=O)=O)CC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,11.0,7.96,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL394781,CCNC(=O)N1CCN(C)C(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)C1,IC50,52.0,7.28,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52.0,7.2839966563652006
CHEMBL242926,CN(C)CC(=O)N1CCN(C)C(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)C1,IC50,4.0,8.4,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL242924,CN1CCN(C(=O)c2ccccc2)CC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,12.0,7.92,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL242139,CC(=O)N1CCN(C)CC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,4000.0,5.4,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL394786,CC(=O)N1CCN(C)C(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)C1,IC50,32.0,7.5,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32.0,7.494850021680094
CHEMBL394537,CN1CCN(C(=O)OC(C)(C)C)CC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,41.0,7.39,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41.0,7.3872161432802645
CHEMBL242609,CC(C)N1CCN(C)C(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)C1,IC50,130.0,6.89,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL394536,CCN1CCN(C)C(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)C1,IC50,250.0,6.6,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL427698,CN1CCNCC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,200.0,6.7,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL430194,CN1CC(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)N(C)CC1=O,IC50,50.0,7.3,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL244754,CN1CCN(C)C(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)C1,IC50,100.0,7.0,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL397268,CN1CCS(=O)(=O)CC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,140.0,6.85,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,140.0,6.853871964321762
CHEMBL389566,CN1CC[S+]([O-])CC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,37.0,7.43,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37.0,7.431798275933005
CHEMBL244904,CN1CCSCC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,70.0,7.16,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL243655,CN1CC[C@@H](OCc2ccccc2)C[C@H]1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,62.0,7.21,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,62.0,7.207608310501746
CHEMBL243265,CN1CC[C@@H](O)C[C@H]1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,21.0,7.68,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL244520,CN1CC(F)(F)C[C@H]1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,30.0,7.52,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL394847,CN1C[C@H](F)C[C@H]1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,20.0,7.7,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL388908,CN1C[C@@H](F)C[C@H]1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,20.0,7.7,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL244700,CC(=O)N[C@H]1C[C@@H](c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)N(C)C1,IC50,61.0,7.21,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61.0,7.214670164989233
CHEMBL242561,CN1C[C@@H](NS(C)(=O)=O)C[C@H]1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,30.0,7.52,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL389332,CN1C[C@H](OCc2ccccc2)C[C@H]1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,130.0,6.89,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL242353,CCO[C@@H]1C[C@@H](c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)N(C)C1,IC50,200.0,6.7,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL389331,CO[C@@H]1C[C@@H](c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)N(C)C1,IC50,180.0,6.75,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,180.0,6.7447274948966935
CHEMBL242137,CN1C[C@H](O)C[C@H]1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,100.0,7.0,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL241924,CC1CCC(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)N1C,IC50,690.0,6.16,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,690.0,6.161150909262744
CHEMBL390225,C[C@@H]1C[C@@H](c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)N(C)C1,IC50,190.0,6.72,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,190.0,6.721246399047171
CHEMBL390027,C[C@H]1C[C@@H](c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)N(C)C1,IC50,10.0,8.0,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL244051,CC1CCN(C)C1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,710.0,6.15,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,710.0,6.1487416512809245
CHEMBL244964,CN1CCC[C@H]1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,62.0,7.21,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,62.0,7.207608310501746
CHEMBL216389,CN1CCCCC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,440.0,6.36,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,440.0,6.356547323513812
CHEMBL244963,CN1CCCC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,100.0,7.0,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL407451,CN1CCCCC1c1nc(O)c(O)c(C(=O)NCc2ccc(F)cc2)n1,IC50,220.0,6.66,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,220.0,6.657577319177793
CHEMBL1161980,CN1CCOCC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C.O=C(O)C(F)(F)F,IC50,60.0,7.22,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL538587,CN1CCOCC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C.Cl,IC50,25.0,7.6,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25.0,7.6020599913279625
CHEMBL538587,CN1CCOCC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C.Cl,IC50,20.0,7.7,CHEMBL894220,Inhibition of HIV integrase activity by HIV strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL243183,O=C(/C=C/c1ccc(O)c(O)c1)NC(Cc1ccccc1)C(=O)O,IC50,95000.0,4.02,CHEMBL893264,Inhibition of recombinant HIV1 integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,95000.0,4.022276394711152
CHEMBL397730,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](C(=O)O)[C@@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,15700.0,4.8,CHEMBL893264,Inhibition of recombinant HIV1 integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15700.0,4.804100347590766
CHEMBL232446,O=C(NCc1ccc(Cl)c(Cl)c1)c1nc(-c2cccs2)nc(O)c1O,IC50,10.0,8.0,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL398211,O=C(NCc1cccc(F)c1)c1nc(-c2cccs2)nc(O)c1O,IC50,70.0,7.16,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL232445,O=C(NCc1ccccc1F)c1nc(-c2cccs2)nc(O)c1O,IC50,160.0,6.8,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,160.0,6.795880017344075
CHEMBL232444,O=C(NCc1ccc(Cl)cc1)c1nc(-c2cccs2)nc(O)c1O,IC50,20.0,7.7,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL398210,O=C(NCc1ccc(-c2ccccc2)cc1)c1nc(-c2cccs2)nc(O)c1O,IC50,50000.0,4.3,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL232630,O=C(NCc1cccc(-c2ccccc2)c1)c1nc(-c2cccs2)nc(O)c1O,IC50,50.0,7.3,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL389093,O=C(NCc1ccccc1-c1ccccc1)c1nc(-c2cccs2)nc(O)c1O,IC50,130.0,6.89,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL277754,Cc1ccc(CNC(=O)c2nc(-c3cccs3)nc(O)c2O)cc1,IC50,70.0,7.16,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL232629,Cc1cccc(CNC(=O)c2nc(-c3cccs3)nc(O)c2O)c1,IC50,40.0,7.4,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL232437,Cc1ccccc1CNC(=O)c1nc(-c2cccs2)nc(O)c1O,IC50,110.0,6.96,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL232436,COc1ccc(CNC(=O)c2nc(-c3cccs3)nc(O)c2O)cc1,IC50,550.0,6.26,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,550.0,6.259637310505756
CHEMBL438113,COc1cccc(CNC(=O)c2nc(-c3cccs3)nc(O)c2O)c1,IC50,50.0,7.3,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL232435,COc1ccccc1CNC(=O)c1nc(-c2cccs2)nc(O)c1O,IC50,90.0,7.05,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90.0,7.045757490560675
CHEMBL232228,O=C(NCc1c[nH]c2ccccc12)c1nc(-c2cccs2)nc(O)c1O,IC50,20.0,7.7,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL232227,O=C(Nc1csc2ccccc12)c1nc(-c2cccs2)nc(O)c1O,IC50,50.0,7.3,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL232226,O=C(Nc1cc2ccccc2s1)c1nc(-c2cccs2)nc(O)c1O,IC50,10.0,8.0,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL388420,O=C(Nc1cncs1)c1nc(-c2cccs2)nc(O)c1O,IC50,2500.0,5.6,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL232025,O=C(Nc1nccs1)c1nc(-c2cccs2)nc(O)c1O,IC50,200.0,6.7,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL388419,O=C(Nc1cccs1)c1nc(-c2cccs2)nc(O)c1O,IC50,100.0,7.0,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL232024,O=C(NCc1ccncc1)c1nc(-c2cccs2)nc(O)c1O,IC50,16600.0,4.78,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16600.0,4.779891911959945
CHEMBL234923,O=C(N[C@@H]1CCc2ccccc21)c1nc(-c2cccs2)nc(O)c1O,IC50,610.0,6.21,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,610.0,6.214670164989233
CHEMBL390433,O=C(N[C@H]1CCc2ccccc21)c1nc(-c2cccs2)nc(O)c1O,IC50,20.0,7.7,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL234922,CN(C(=O)c1nc(-c2cccs2)nc(O)c1O)c1cccc2ccccc12,IC50,210.0,6.68,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,210.0,6.6777807052660805
CHEMBL234921,C[C@@H](NC(=O)c1nc(-c2cccs2)nc(O)c1O)c1ccc2ccccc2c1,IC50,610.0,6.21,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,610.0,6.214670164989233
CHEMBL437361,C[C@H](NC(=O)c1nc(-c2cccs2)nc(O)c1O)c1ccc2ccccc2c1,IC50,40.0,7.4,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL234707,O=C(Nc1cccc2ccccc12)c1nc(-c2cccs2)nc(O)c1O,IC50,30.0,7.52,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL373760,O=C(Nc1ccccc1)c1nc(-c2cccs2)nc(O)c1O,IC50,1000.0,6.0,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL226916,O=C(NCCc1ccccc1)c1nc(-c2cccs2)nc(O)c1O,IC50,20.0,7.7,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL373761,O=C(NCC1CCCCC1)c1nc(-c2cccs2)nc(O)c1O,IC50,50000.0,4.3,CHEMBL890063,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL391894,N#C/C(=C\c1ccc(-c2cc(C(F)(F)F)ccc2Cl)o1)c1nc2ccccc2[nH]1,IC50,31320.0,4.5,CHEMBL899229,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31320.0,4.504178246614094
CHEMBL235550,O=[N+]([O-])c1cccc(-c2ccc(/C=C/c3nc4ccccc4[nH]3)o2)c1,IC50,12020.0,4.92,CHEMBL899229,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12020.0,4.92009553233328
CHEMBL237871,Cc1c(-c2ccc(/C=C(\C#N)c3nc4ccccc4[nH]3)o2)cccc1[N+](=O)[O-],IC50,85840.0,4.07,CHEMBL899229,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,85840.0,4.066310291042106
CHEMBL236792,N#C/C(=C\c1ccc(-c2ccc(O)c(C(=O)O)c2)o1)c1nc2ccccc2[nH]1,IC50,68690.0,4.16,CHEMBL899229,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68690.0,4.163106483623566
CHEMBL236791,Cc1ccc(C(=O)O)cc1-c1ccc(/C=C(\C#N)c2nc3ccccc3[nH]2)o1,IC50,39800.0,4.4,CHEMBL899229,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39800.0,4.400116927926312
CHEMBL392938,Cc1ccc2[nH]c(/C(C#N)=C/c3ccc(-c4ccc(Cl)cc4C(=O)O)o3)nc2c1,IC50,36160.0,4.44,CHEMBL899229,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36160.0,4.441771578196675
CHEMBL236614,N#C/C(=C\c1ccc(-c2ccc(Cl)c(C(=O)O)c2)o1)c1nc2ccccc2[nH]1,IC50,90360.0,4.04,CHEMBL899229,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90360.0,4.044023777751675
CHEMBL391867,N#C/C(=C\c1ccc(-c2ccc(C(=O)O)c(O)c2)o1)c1nc2ccccc2[nH]1,IC50,70280.0,4.15,CHEMBL899229,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70280.0,4.153168247176743
CHEMBL235547,N#C/C(=C\c1ccc(-c2cc([N+](=O)[O-])ccc2Cl)o1)c1nc2ccccc2[nH]1,IC50,58680.0,4.23,CHEMBL899229,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58680.0,4.231509894828755
CHEMBL237292,O=C(O)CCC(=O)Nc1ccccc1-c1ccccc1NC(=O)CCC(=O)O,IC50,37000.0,4.43,CHEMBL899295,Inhibition of HIV1 integrase by BioVeris assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL237503,C=C(NNC(=O)C1CC1c1ccccc1)c1cccc(NC(=O)C2CCCCC2C(=O)O)c1,IC50,65000.0,4.19,CHEMBL899296,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL394197,Cc1n[nH]c(O)c1C(c1ccc(-c2ccc(Cl)c(C(=O)O)c2)o1)c1c(C)n[nH]c1O,IC50,87000.0,4.06,CHEMBL899296,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,87000.0,4.060480747381382
CHEMBL237503,C=C(NNC(=O)C1CC1c1ccccc1)c1cccc(NC(=O)C2CCCCC2C(=O)O)c1,IC50,49000.0,4.31,CHEMBL899297,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,49000.0,4.309803919971486
CHEMBL427847,Cc1[nH]nc(O)c1CC(=O)N/N=C/c1ccccc1OCC(=O)O,IC50,54000.0,4.27,CHEMBL899297,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54000.0,4.267606240177032
CHEMBL394197,Cc1n[nH]c(O)c1C(c1ccc(-c2ccc(Cl)c(C(=O)O)c2)o1)c1c(C)n[nH]c1O,IC50,57000.0,4.24,CHEMBL899297,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57000.0,4.2441251443275085
CHEMBL237713,C=C(NNC(=O)c1c[nH]c2ccccc12)c1cccc(NC(=O)CCCC(=O)O)c1,IC50,70000.0,4.16,CHEMBL899297,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL236241,O=C1c2c(O)c(O)cc(=O)n2CCCN1Cc1ccc(F)cc1,IC50,1040.0,5.98,CHEMBL899781,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1040.0,5.982966660701219
CHEMBL237942,O=C1c2c(O)c(O)c(I)c(=O)n2CCN1Cc1ccc(F)cc1,IC50,20.0,7.7,CHEMBL899781,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL394905,O=C1c2c(O)c(O)c(Br)c(=O)n2CCN1Cc1ccc(F)cc1,IC50,30.0,7.52,CHEMBL899781,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL237728,N#Cc1c(O)c(O)c2n(c1=O)CCN(Cc1ccc(F)cc1)C2=O,IC50,20.0,7.7,CHEMBL899781,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL237727,O=C1c2c(O)c(O)cc(=O)n2CCN1Cc1ccc(F)c(Cl)c1,IC50,40.0,7.4,CHEMBL899781,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL394890,O=C1c2c(O)c(O)cc(=O)n2CCN1Cc1ccc(Cl)cc1,IC50,380.0,6.42,CHEMBL899781,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,380.0,6.42021640338319
CHEMBL237726,O=C1c2c(O)c(O)cc(=O)n2CCN1Cc1cccc(Cl)c1,IC50,40.0,7.4,CHEMBL899781,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL268633,O=C1c2c(O)c(O)cc(=O)n2CCN1Cc1ccccc1Cl,IC50,370.0,6.43,CHEMBL899781,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,370.0,6.431798275933005
CHEMBL237083,O=C1c2c(O)c(O)cc(=O)n2CCN1Cc1ccccc1,IC50,230.0,6.64,CHEMBL899781,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,230.0,6.638272163982407
CHEMBL237725,O=c1c2c(O)c(O)cc(=O)n2ccn1Cc1ccc(F)cc1,IC50,40.0,7.4,CHEMBL899781,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL237724,O=C1c2c(O)c(O)cc(=O)n2CCN1Cc1ccc(F)cc1,IC50,100.0,7.0,CHEMBL899781,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL237537,Cc1ccc(C(=O)C2=C(O)C(=O)N(CCCn3ccnc3)C2c2ccc(Cl)cc2)cc1,IC50,93000.0,4.03,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,93000.0,4.031517051446065
CHEMBL429082,O=C(C1=C(O)C(=O)N(c2nc3ccccc3s2)C1c1ccccn1)c1ccc(Cl)cc1,IC50,100000.0,,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL236067,O=C(C1=C(O)C(=O)N(c2nc3ccccc3s2)C1c1cccnc1)c1ccc(Cl)cc1,IC50,100000.0,,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL438489,O=C(C1=C(O)C(=O)N(c2nc3ccccc3s2)C1c1ccc2c(c1)OCO2)c1ccccc1,IC50,57000.0,4.24,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57000.0,4.2441251443275085
CHEMBL236066,Cc1ccc(C(=O)C2=C(O)C(=O)N(c3ncc(S(=O)(=O)c4ccc([N+](=O)[O-])cc4)s3)C2c2cccc(Cl)c2)cc1,IC50,27000.0,4.57,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27000.0,4.568636235841013
CHEMBL235848,CCOC(=O)c1sc(N2C(=O)C(O)=C(C(=O)c3ccc(C)cc3)C2c2ccc(F)cc2)nc1C,IC50,100000.0,,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL235847,CCOC(=O)c1sc(N2C(=O)C(O)=C(C(=O)c3ccccc3)C2c2ccc(F)cc2)nc1C,IC50,44000.0,4.36,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44000.0,4.356547323513812
CHEMBL391949,CCOc1ccc(C(=O)C2=C(O)C(=O)N(c3nccs3)C2c2ccc(OC)cc2)cc1,IC50,100000.0,,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL235846,Cc1ccc(C(=O)C2=C(O)C(=O)N(c3nccs3)C2c2ccc(F)cc2)cc1,IC50,100000.0,,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL235639,Cc1ccc(C(=O)C2=C(O)C(=O)N(c3nccs3)C2c2ccc(Cl)cc2)cc1,IC50,56000.0,4.25,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL235638,CCOc1ccc(C(=O)C2=C(O)C(=O)N(c3nnc(C)s3)C2c2ccc(F)cc2)cc1,IC50,100000.0,,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL392359,CC(C)(C)c1ccc(C2C(C(=O)c3ccc(F)cc3)=C(O)C(=O)N2c2nncs2)cc1,IC50,64000.0,4.19,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,64000.0,4.1938200260161125
CHEMBL235637,COc1ccc(C2C(C(=O)c3ccc(Br)cc3)=C(O)C(=O)N2c2cc(C(C)(C)C)on2)cc1OC,IC50,45000.0,4.35,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45000.0,4.346787486224656
CHEMBL430168,CCOc1ccc(C(=O)C2=C(O)C(=O)N(c3nccs3)C2c2ccc(O)c(OC)c2)cc1,IC50,57000.0,4.24,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57000.0,4.2441251443275085
CHEMBL235418,COc1ccc(C2C(C(=O)c3ccc(Br)cc3)=C(O)C(=O)N2c2cccc(C(F)(F)F)c2)cc1OC,IC50,47000.0,4.33,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47000.0,4.327902142064283
CHEMBL392358,COc1ccc(C(=O)C2=C(O)C(=O)N(CCc3ccccc3)C2c2ccc(Br)cc2)cc1OC,IC50,60000.0,4.22,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL235417,COc1ccc(OC)c(C(=O)C2=C(O)C(=O)N(CCCCCC(=O)O)C2c2ccc(Cl)cc2)c1,IC50,88000.0,4.06,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,88000.0,4.055517327849832
CHEMBL235200,Cc1ccc(C2C(C(=O)c3ccc(Cl)cc3)=C(O)C(=O)N2CC(=O)O)cc1,IC50,84000.0,4.08,CHEMBL899545,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,84000.0,4.075720713938118
CHEMBL237537,Cc1ccc(C(=O)C2=C(O)C(=O)N(CCCn3ccnc3)C2c2ccc(Cl)cc2)cc1,IC50,67000.0,4.17,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,67000.0,4.173925197299174
CHEMBL429082,O=C(C1=C(O)C(=O)N(c2nc3ccccc3s2)C1c1ccccn1)c1ccc(Cl)cc1,IC50,83000.0,4.08,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,83000.0,4.080921907623926
CHEMBL236067,O=C(C1=C(O)C(=O)N(c2nc3ccccc3s2)C1c1cccnc1)c1ccc(Cl)cc1,IC50,90000.0,4.05,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL438489,O=C(C1=C(O)C(=O)N(c2nc3ccccc3s2)C1c1ccc2c(c1)OCO2)c1ccccc1,IC50,21000.0,4.68,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL236066,Cc1ccc(C(=O)C2=C(O)C(=O)N(c3ncc(S(=O)(=O)c4ccc([N+](=O)[O-])cc4)s3)C2c2cccc(Cl)c2)cc1,IC50,8000.0,5.1,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL235848,CCOC(=O)c1sc(N2C(=O)C(O)=C(C(=O)c3ccc(C)cc3)C2c2ccc(F)cc2)nc1C,IC50,33000.0,4.48,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL235847,CCOC(=O)c1sc(N2C(=O)C(O)=C(C(=O)c3ccccc3)C2c2ccc(F)cc2)nc1C,IC50,21000.0,4.68,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL391949,CCOc1ccc(C(=O)C2=C(O)C(=O)N(c3nccs3)C2c2ccc(OC)cc2)cc1,IC50,90000.0,4.05,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL235846,Cc1ccc(C(=O)C2=C(O)C(=O)N(c3nccs3)C2c2ccc(F)cc2)cc1,IC50,78000.0,4.11,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,78000.0,4.107905397309519
CHEMBL235639,Cc1ccc(C(=O)C2=C(O)C(=O)N(c3nccs3)C2c2ccc(Cl)cc2)cc1,IC50,39000.0,4.41,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39000.0,4.4089353929735005
CHEMBL235638,CCOc1ccc(C(=O)C2=C(O)C(=O)N(c3nnc(C)s3)C2c2ccc(F)cc2)cc1,IC50,100000.0,,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL392359,CC(C)(C)c1ccc(C2C(C(=O)c3ccc(F)cc3)=C(O)C(=O)N2c2nncs2)cc1,IC50,43000.0,4.37,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43000.0,4.366531544420414
CHEMBL235637,COc1ccc(C2C(C(=O)c3ccc(Br)cc3)=C(O)C(=O)N2c2cc(C(C)(C)C)on2)cc1OC,IC50,43000.0,4.37,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43000.0,4.366531544420414
CHEMBL430168,CCOc1ccc(C(=O)C2=C(O)C(=O)N(c3nccs3)C2c2ccc(O)c(OC)c2)cc1,IC50,30000.0,4.52,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL235418,COc1ccc(C2C(C(=O)c3ccc(Br)cc3)=C(O)C(=O)N2c2cccc(C(F)(F)F)c2)cc1OC,IC50,26000.0,4.58,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26000.0,4.585026652029182
CHEMBL392358,COc1ccc(C(=O)C2=C(O)C(=O)N(CCc3ccccc3)C2c2ccc(Br)cc2)cc1OC,IC50,42000.0,4.38,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42000.0,4.376750709602099
CHEMBL235417,COc1ccc(OC)c(C(=O)C2=C(O)C(=O)N(CCCCCC(=O)O)C2c2ccc(Cl)cc2)c1,IC50,40000.0,4.4,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL235200,Cc1ccc(C2C(C(=O)c3ccc(Cl)cc3)=C(O)C(=O)N2CC(=O)O)cc1,IC50,69000.0,4.16,CHEMBL899547,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69000.0,4.161150909262744
CHEMBL235417,COc1ccc(OC)c(C(=O)C2=C(O)C(=O)N(CCCCCC(=O)O)C2c2ccc(Cl)cc2)c1,IC50,100000.0,,CHEMBL899546,Inhibition of HIV1 integrase 3'-end processing activity in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL236066,Cc1ccc(C(=O)C2=C(O)C(=O)N(c3ncc(S(=O)(=O)c4ccc([N+](=O)[O-])cc4)s3)C2c2cccc(Cl)c2)cc1,IC50,100000.0,,CHEMBL899546,Inhibition of HIV1 integrase 3'-end processing activity in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL235417,COc1ccc(OC)c(C(=O)C2=C(O)C(=O)N(CCCCCC(=O)O)C2c2ccc(Cl)cc2)c1,IC50,10000.0,5.0,CHEMBL900653,Inhibition of HIV1 integrase strand transfer activity in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL236066,Cc1ccc(C(=O)C2=C(O)C(=O)N(c3ncc(S(=O)(=O)c4ccc([N+](=O)[O-])cc4)s3)C2c2cccc(Cl)c2)cc1,IC50,6100.0,5.21,CHEMBL900653,Inhibition of HIV1 integrase strand transfer activity in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6100.0,5.214670164989233
CHEMBL240056,CCOC(=O)c1cn2c(c1O)C(=O)N(Cc1ccc(F)cc1)CCC2,IC50,5000.0,,CHEMBL899921,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL239413,CCOC(=O)c1cn2c(c1O)C(=O)N(Cc1ccc(F)cc1)CC2,IC50,40.0,7.4,CHEMBL899921,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL236581,O=C1c2c(O)c3n(c2CCN1Cc1ccc(F)cc1)CCN(Cc1ccc(F)cc1)C3=O,IC50,10.0,,CHEMBL899921,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL391431,CN1CCn2c3c(c(O)c2C1=O)C(=O)N(Cc1ccc(F)cc1)CC3,IC50,10.0,,CHEMBL899921,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL436631,CN1CCc2c(c(O)c3n2CCN(Cc2ccc(F)cc2)C3=O)C1=O,IC50,10.0,,CHEMBL899921,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL236409,CNC(=O)c1cn2c(c1O)C(=O)N(Cc1ccc(Cl)c(Cl)c1)CC2,IC50,40.0,7.4,CHEMBL899921,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL236408,CNC(=O)c1cn2c(c1O)C(=O)N(Cc1ccc(Cl)cc1)CC2,IC50,60.0,7.22,CHEMBL899921,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL396890,CNC(=O)c1cn2c(c1O)C(=O)N(Cc1ccc(F)cc1)CC2,IC50,80.0,7.1,CHEMBL899921,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL428565,O=C(O)c1cn2c(c1O)C(=O)N(Cc1cccc(Cl)c1)CC2,IC50,10.0,8.0,CHEMBL899921,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL240694,O=C(O)c1cn2c(c1O)C(=O)N(Cc1ccccc1)CC2,IC50,80.0,7.1,CHEMBL899921,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL240692,CCOC(=O)c1cn2c(c1O)C(=O)N(Cc1ccc(Cl)c(Cl)c1)CC2,IC50,10.0,8.0,CHEMBL899921,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL240481,CCOC(=O)c1cn2c(c1O)C(=O)N(Cc1ccc(F)c(Cl)c1)CC2,IC50,20.0,7.7,CHEMBL899921,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL240479,CCOC(=O)c1cn2c(c1O)C(=O)N(Cc1cccc(Cl)c1)CC2,IC50,30.0,7.52,CHEMBL899921,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL240272,CCOC(=O)c1cn2c(c1O)C(=O)N(Cc1cccc(F)c1)CC2,IC50,110.0,6.96,CHEMBL899921,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL240058,CCOC(=O)c1cn2c(c1O)C(=O)N(Cc1ccc(Cl)cc1)CC2,IC50,40.0,7.4,CHEMBL899921,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL240057,CCOC(=O)c1cn2c(c1O)C(=O)N(Cc1ccccc1)CC2,IC50,220.0,6.66,CHEMBL899921,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,220.0,6.657577319177793
CHEMBL396335,CC1(C)OC(=O)C2(C(=O)O1)[C@@H](c1ccco1)CC(=O)C[C@H]2c1c[nH]c2ccccc12,IC50,11100.0,4.96,CHEMBL885904,Inhibition of recombinant HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11100.0,4.954677021213342
CHEMBL396335,CC1(C)OC(=O)C2(C(=O)O1)[C@@H](c1ccco1)CC(=O)C[C@H]2c1c[nH]c2ccccc12,IC50,9600.0,5.02,CHEMBL885905,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9600.0,5.017728766960431
CHEMBL264109,CCOC(=O)C1=C(O)CCC2(C(=O)OC(C)(C)OC2=O)[C@H]1c1ccco1,IC50,67800.0,4.17,CHEMBL885904,Inhibition of recombinant HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,67800.0,4.168770306132937
CHEMBL394249,COc1cccc([C@@H]2CC(=O)C[C@H](c3ccco3)C23C(=O)OC(C)(C)OC3=O)c1OC,IC50,44800.0,4.35,CHEMBL885904,Inhibition of recombinant HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44800.0,4.3487219860018556
CHEMBL427703,CC1(C)OC(=O)C2(C(=O)O1)[C@@H](c1ccco1)CC(=O)C[C@H]2c1ccco1,IC50,32900.0,4.48,CHEMBL885904,Inhibition of recombinant HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32900.0,4.482804102050026
CHEMBL246950,COc1ccc([C@H]2CC(=O)CCC23C(=O)OC(C)(C)OC3=O)cc1,IC50,97500.0,4.01,CHEMBL885905,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,97500.0,4.010995384301463
CHEMBL247961,COc1ccc([C@@H]2CC(=O)C[C@H](c3ccco3)C23C(=O)OC(C)(C)OC3=O)cc1,IC50,36300.0,4.44,CHEMBL885905,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36300.0,4.440093374963888
CHEMBL247960,COc1ccc([C@@H]2CC(=O)C[C@H](c3ccco3)C23C(=O)OC(C)(C)OC3=O)cc1OC,IC50,91500.0,4.04,CHEMBL885905,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,91500.0,4.0385789059335515
CHEMBL264109,CCOC(=O)C1=C(O)CCC2(C(=O)OC(C)(C)OC2=O)[C@H]1c1ccco1,IC50,35700.0,4.45,CHEMBL885905,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35700.0,4.447331783887806
CHEMBL394249,COc1cccc([C@@H]2CC(=O)C[C@H](c3ccco3)C23C(=O)OC(C)(C)OC3=O)c1OC,IC50,44200.0,4.36,CHEMBL885905,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44200.0,4.354577730650908
CHEMBL427703,CC1(C)OC(=O)C2(C(=O)O1)[C@@H](c1ccco1)CC(=O)C[C@H]2c1ccco1,IC50,13700.0,4.86,CHEMBL885905,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13700.0,4.863279432843593
CHEMBL427703,CC1(C)OC(=O)C2(C(=O)O1)[C@@H](c1ccco1)CC(=O)C[C@H]2c1ccco1,IC50,81400.0,4.09,CHEMBL885906,Inhibition of recombinant HIV1 integrase mediated-disintegration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,81400.0,4.089375595110798
CHEMBL396335,CC1(C)OC(=O)C2(C(=O)O1)[C@@H](c1ccco1)CC(=O)C[C@H]2c1c[nH]c2ccccc12,IC50,19200.0,4.72,CHEMBL885906,Inhibition of recombinant HIV1 integrase mediated-disintegration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19200.0,4.716698771296451
CHEMBL394251,CN(C)C(=O)Cc1ccccc1CNC(=O)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,14.0,7.85,CHEMBL885920,Inhibition of HIV1 recombinant integrase catalyzed strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL247570,CN(C)S(=O)(=O)c1cc(F)ccc1CNC(=O)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,30.0,7.52,CHEMBL885920,Inhibition of HIV1 recombinant integrase catalyzed strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL245519,NS(=O)(=O)c1cc(F)ccc1CNC(=O)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,10.0,8.0,CHEMBL885920,Inhibition of HIV1 recombinant integrase catalyzed strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL245719,CNC(=O)c1cc(F)ccc1CNC(=O)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,10.0,8.0,CHEMBL885920,Inhibition of HIV1 recombinant integrase catalyzed strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL245717,CN(C)C(=O)c1cc(F)ccc1CNC(=O)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,110.0,6.96,CHEMBL885920,Inhibition of HIV1 recombinant integrase catalyzed strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL437940,CNS(=O)(=O)c1cc(F)ccc1CNC(=O)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,45.0,7.35,CHEMBL885920,Inhibition of HIV1 recombinant integrase catalyzed strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45.0,7.346787486224656
CHEMBL246744,CNC(=O)Cc1ccccc1CNC(=O)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,7.0,8.15,CHEMBL885920,Inhibition of HIV1 recombinant integrase catalyzed strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL246535,O=C(NCc1ccccc1)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,10.0,8.0,CHEMBL885920,Inhibition of HIV1 recombinant integrase catalyzed strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL246774,CNC(=O)c1cc(F)ccc1CNC(=O)c1ncc2cccnc2c1O,IC50,51.0,7.29,CHEMBL885920,Inhibition of HIV1 recombinant integrase catalyzed strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,51.0,7.292429823902063
CHEMBL396907,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(CNC(=O)C4=C(O)[C@@H](N(C)C)[C@@H]5C[C@H]6C(=C(O)[C@]5(O)C4=O)C(=O)c4c(O)cccc4[C@@]6(C)O)CC3)cc21,IC50,20000.0,4.7,CHEMBL887177,Inhibition of HIV1 recombinant integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL396907,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(CNC(=O)C4=C(O)[C@@H](N(C)C)[C@@H]5C[C@H]6C(=C(O)[C@]5(O)C4=O)C(=O)c4c(O)cccc4[C@@]6(C)O)CC3)cc21,IC50,13000.0,4.89,CHEMBL887178,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL1237046,CN(C)[C@@H]1C(O)=C(C(=O)NCN2CCCC2)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,IC50,28000.0,4.55,CHEMBL887177,Inhibition of HIV1 recombinant integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL239177,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(CNC(=O)C4=C(O)[C@@H](N(C)C)[C@@H]5C[C@@H]6Cc7c(N(C)C)ccc(O)c7C(=O)C6=C(O)[C@]5(O)C4=O)C(C)C3)c(F)c21,IC50,20000.0,4.7,CHEMBL887177,Inhibition of HIV1 recombinant integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL392565,COc1c(N2CCN(CNC(=O)C3=C(O)[C@@H](N(C)C)[C@@H]4[C@@H](O)[C@H]5C(=C(O)[C@]4(O)C3=O)C(=O)c3c(O)cccc3[C@@]5(C)O)C(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,28000.0,4.55,CHEMBL887177,Inhibition of HIV1 recombinant integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL239176,CN(C)[C@@H]1C(O)=C(C(=O)NCN2CCN(c3cc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)CC2)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12,IC50,38000.0,4.42,CHEMBL887177,Inhibition of HIV1 recombinant integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38000.0,4.42021640338319
CHEMBL396688,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(CNC(=O)C4=C(O)[C@@H](N(C)C)[C@@H]5[C@@H](O)[C@H]6C(=C(O)[C@]5(O)C4=O)C(=O)c4c(O)cccc4[C@@]6(C)O)CC3)cc21,IC50,21000.0,4.68,CHEMBL887177,Inhibition of HIV1 recombinant integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL241495,CN(C)[C@@H]1C(O)=C(C(=O)NCN2CCN(c3cc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)CC2)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,IC50,20000.0,4.7,CHEMBL887177,Inhibition of HIV1 recombinant integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL396686,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(CNC(=O)C4=C(O)[C@@H](N(C)C)[C@@H]5C[C@H]6C(=C(O)[C@]5(O)C4=O)C(=O)c4c(O)cccc4[C@@]6(C)O)C(C)C3)c(F)c21,IC50,65000.0,4.19,CHEMBL887177,Inhibition of HIV1 recombinant integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL1237046,CN(C)[C@@H]1C(O)=C(C(=O)NCN2CCCC2)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,IC50,34000.0,4.47,CHEMBL887178,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34000.0,4.468521082957745
CHEMBL239177,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(CNC(=O)C4=C(O)[C@@H](N(C)C)[C@@H]5C[C@@H]6Cc7c(N(C)C)ccc(O)c7C(=O)C6=C(O)[C@]5(O)C4=O)C(C)C3)c(F)c21,IC50,18000.0,4.75,CHEMBL887178,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL392565,COc1c(N2CCN(CNC(=O)C3=C(O)[C@@H](N(C)C)[C@@H]4[C@@H](O)[C@H]5C(=C(O)[C@]4(O)C3=O)C(=O)c3c(O)cccc3[C@@]5(C)O)C(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,13500.0,4.87,CHEMBL887178,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13500.0,4.8696662315049934
CHEMBL239176,CN(C)[C@@H]1C(O)=C(C(=O)NCN2CCN(c3cc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)CC2)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12,IC50,17000.0,4.77,CHEMBL887178,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL396688,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(CNC(=O)C4=C(O)[C@@H](N(C)C)[C@@H]5[C@@H](O)[C@H]6C(=C(O)[C@]5(O)C4=O)C(=O)c4c(O)cccc4[C@@]6(C)O)CC3)cc21,IC50,12000.0,4.92,CHEMBL887178,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL241495,CN(C)[C@@H]1C(O)=C(C(=O)NCN2CCN(c3cc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)CC2)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,IC50,12000.0,4.92,CHEMBL887178,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL396686,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(CNC(=O)C4=C(O)[C@@H](N(C)C)[C@@H]5C[C@H]6C(=C(O)[C@]5(O)C4=O)C(=O)c4c(O)cccc4[C@@]6(C)O)C(C)C3)c(F)c21,IC50,44000.0,4.36,CHEMBL887178,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44000.0,4.356547323513812
CHEMBL182653,COc1ccc(/C=C/C(=O)c2ccc(O)cc2O)cc1,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL238849,COc1cc(OC)c(C(=O)/C=C/c2cccc([N+](=O)[O-])c2)cc1OC,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL276600,COc1cc(C(=O)/C=C/c2ccc3c(c2)OCO3)cc(OC)c1OC,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL394397,COc1cc(C(=O)/C=C/c2ccc3c(c2)OCO3)ccc1O,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL244458,O=C(/C=C/c1ccc2c(c1)OCO2)c1ccccc1O,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL238634,COc1ccc(OC)c(C(=O)/C=C/c2ccc3c(c2)OCO3)c1,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL227400,O=C(/C=C/c1ccc2c(c1)OCO2)c1ccccc1,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL238633,O=C(/C=C/c1ccccc1OC(=O)c1cc2ccccc2oc1=O)c1ccccc1,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL238632,O=C(/C=C/c1cccc(NC(=O)c2cccs2)c1)c1ccccc1,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL182653,COc1ccc(/C=C/C(=O)c2ccc(O)cc2O)cc1,IC50,39000.0,4.41,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39000.0,4.4089353929735005
CHEMBL238849,COc1cc(OC)c(C(=O)/C=C/c2cccc([N+](=O)[O-])c2)cc1OC,IC50,100000.0,,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL276600,COc1cc(C(=O)/C=C/c2ccc3c(c2)OCO3)cc(OC)c1OC,IC50,100000.0,,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL394397,COc1cc(C(=O)/C=C/c2ccc3c(c2)OCO3)ccc1O,IC50,100000.0,,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL244458,O=C(/C=C/c1ccc2c(c1)OCO2)c1ccccc1O,IC50,100000.0,,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL238634,COc1ccc(OC)c(C(=O)/C=C/c2ccc3c(c2)OCO3)c1,IC50,100000.0,,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL227400,O=C(/C=C/c1ccc2c(c1)OCO2)c1ccccc1,IC50,100000.0,,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL238633,O=C(/C=C/c1ccccc1OC(=O)c1cc2ccccc2oc1=O)c1ccccc1,IC50,92000.0,4.04,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,92000.0,4.036212172654444
CHEMBL238632,O=C(/C=C/c1cccc(NC(=O)c2cccs2)c1)c1ccccc1,IC50,89000.0,4.05,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,89000.0,4.050609993355088
CHEMBL239056,CCCn1c(=O)c(C(=O)NNC(=O)c2ccccc2)c(O)c2ccccc21,IC50,100000.0,4.0,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL241183,CCCn1c(N/N=C/c2cc(Br)ccc2O)nc2c1c(=O)[nH]c(=O)n2C,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL401050,O=C(CSc1nc(SCC(=O)NCc2ccco2)nc(SCC(=O)NCc2ccco2)n1)NCc1ccco1,IC50,28000.0,4.55,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL240975,CCCCCCc1nc2ccccc2c(=O)n1NC(=O)c1c(O)c2ccccc2n(CC)c1=O,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL240974,O=C(Nc1cccc(O)c1)c1cc(C(=O)Nc2cccc(O)c2)cc(N2C(=O)c3ccccc3C2=O)c1,IC50,100000.0,4.0,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL240973,Cn1c(=O)[nH]c(=O)c2c1nc(SCC(O)CCl)n2CC(O)COc1ccc(Cl)cc1,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL401049,Oc1ccc(Br)cc1/C=N/Nc1nc2nonc2nc1Nc1ccc(F)cc1,IC50,16000.0,4.8,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL240754,COc1cc(C(NC(=O)c2ccco2)NC(=O)c2ccco2)ccc1OCc1ccccc1,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL239684,O=C(NC1CCCCC1)C(c1ccco1)N(C(=O)Cn1nnc2ccccc21)c1ccc(S(=O)(=O)NCC2CCCO2)cc1,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL240753,CCCn1c(=O)c(C(=O)NNC(=O)COc2ccccc2)c(O)c2ccccc21,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL399412,Cn1c(SCC(=O)NNC(=O)c2cccc(O)c2)nc2sc3c(c2c1=O)CCC3,IC50,87000.0,4.06,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,87000.0,4.060480747381382
CHEMBL240752,NC(=O)NN=C1c2cc(S(=O)(=O)NCc3ccco3)ccc2-c2ccc(S(=O)(=O)NCc3ccco3)cc21,IC50,92000.0,4.04,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,92000.0,4.036212172654444
CHEMBL240548,Cc1nc(SCC(=O)c2ccc(O)c(O)c2)c(C#N)c(CC(C)C)c1C(N)=O,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL240547,COc1ccc(C(=O)Nc2ccccc2C(=O)NC(C(=O)NNC(=O)c2ccccc2O)C(C)C)cc1,IC50,19000.0,4.72,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL399211,COc1ccc(NC(=O)CSc2nc(-c3ccncc3)nn2CC(=O)NCc2ccco2)cc1,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL240546,CCCc1nc2ccccc2c(=O)n1NC(=O)c1c(O)c2cccc3c2n(c1=O)CCC3,IC50,64000.0,4.19,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,64000.0,4.1938200260161125
CHEMBL240334,O=C1Nc2ccccc2/C1=N\NC(=O)c1ccc(O)cc1O,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL394683,O=C1Nc2ccccc2/C1=N/NC(=O)c1ccccc1O,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL240331,O=C(CSc1nc(O)c2ccccc2n1)c1ccc(O)c(O)c1,IC50,87000.0,4.06,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,87000.0,4.060480747381382
CHEMBL240543,O=C(CSc1nnc(-c2ccncc2)[nH]1)c1ccc(O)cc1O,IC50,91000.0,4.04,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,91000.0,4.040958607678906
CHEMBL391411,O=C(N/N=C/c1ccc(O)c(O)c1)c1ccccc1O,IC50,70000.0,4.16,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL239484,O=C(Nc1nccs1)/C(O)=C/C(=O)c1ccc(Cl)cc1,IC50,95000.0,4.02,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,95000.0,4.022276394711152
CHEMBL240330,CCCn1c(=O)c(C(=O)NNC(=O)CC(=O)OCC)c(O)c2ccccc21,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL240329,COc1cccc(C(=O)NNC(=O)c2ccc3ccccc3c2O)c1,IC50,42000.0,4.38,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42000.0,4.376750709602099
CHEMBL241804,COc1ccc(C(=O)NNC(=O)c2cc3ccccc3cc2O)cc1,IC50,49000.0,4.31,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,49000.0,4.309803919971486
CHEMBL395448,O=C(NNC(=O)c1c(O)c2ccccc2[nH]c1=O)c1ccccc1F,IC50,52000.0,4.28,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52000.0,4.2839966563652006
CHEMBL241598,O=C(NNC(=O)c1c(O)c2ccccc2[nH]c1=O)c1ccccc1,IC50,100000.0,4.0,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL241597,O=C(NNC(=O)c1c(O)c2ccccc2[nH]c1=O)c1cccc([N+](=O)[O-])c1,IC50,3300.0,5.48,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3300.0,5.481486060122112
CHEMBL241596,O=C(NNC(=O)c1c(O)c2ccccc2[nH]c1=O)c1ccccc1[N+](=O)[O-],IC50,54000.0,4.27,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54000.0,4.267606240177032
CHEMBL399006,O=C(CSc1nc2ccccc2c(=O)n1CC1CCCO1)NNC(=O)c1ccccc1O,IC50,85000.0,4.07,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,85000.0,4.070581074285707
CHEMBL392160,CCn1c(=O)c(C(=O)NNC(=O)c2cccc([N+](=O)[O-])c2)c(O)c2ccccc21,IC50,37000.0,4.43,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL239696,CCn1c(=O)c(C(=O)NNC(=O)c2ccc([N+](=O)[O-])cc2)c(O)c2ccccc21,IC50,32000.0,4.5,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL239485,O=C(COc1ccc2ccccc2c1)NNC(=O)c1cc2ccccc2cc1O,IC50,18000.0,4.75,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL394650,O=C(COc1ccc2ccccc2c1)NNC(=O)c1ccccc1O,IC50,29000.0,4.54,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,29000.0,4.537602002101044
CHEMBL239483,Cc1cc(C)cc(OCC(=O)NNC(=O)c2cc3ccccc3oc2=O)c1,IC50,74000.0,4.13,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,74000.0,4.130768280269024
CHEMBL239482,CCn1c(=O)c(C(=O)NNC(=O)c2ccccc2[N+](=O)[O-])c(O)c2ccccc21,IC50,36000.0,4.44,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36000.0,4.443697499232713
CHEMBL239275,CCCC(=O)NC(c1ccc(OC)c(OC)c1)c1cc(Cl)c2cccnc2c1O,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL239274,O=c1nc2n(-c3ccc(Cl)cc3)c3ccc([N+](=O)[O-])cc3cc-2c(=O)[nH]1,IC50,78000.0,4.11,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,78000.0,4.107905397309519
CHEMBL239057,CCOc1ccc(-c2c(C#N)c(N)nc(SCC(=O)c3cc4cc(Br)cc(Br)c4oc3=O)c2C#N)cc1,IC50,6000.0,5.22,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL241184,CCc1nc2sc3c(c2c2nnc(SCC(=O)NNC(=O)c4ccc(OC)cc4)n12)CCCC3,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL239244,CCCOc1ccc(/C=N/NC2=NC(c3ccccc3O)CC(c3ccccc3)=N2)c(O)c1,IC50,64000.0,4.19,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,64000.0,4.1938200260161125
CHEMBL240513,CNc1nc(N/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3OC)o2)nc(Nc2ccccc2)n1,IC50,81000.0,4.09,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,81000.0,4.0915149811213505
CHEMBL240511,Cc1ccc(NC(=O)CN2C(=O)/C(=N\NC(=O)c3ccc4ccccc4n3)c3ccccc32)cc1,IC50,84000.0,4.08,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,84000.0,4.075720713938118
CHEMBL240299,Nc1ccc(C(=O)CC(=O)Nc2cc(C(=O)O)cc(C(=O)O)c2)cc1,IC50,41000.0,4.39,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41000.0,4.3872161432802645
CHEMBL241359,COc1ccc(Nc2nc(NCc3ccco3)nc(N/N=C/c3ccc(Br)cc3)n2)cc1,IC50,18000.0,4.75,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL391423,COc1ccc(NC(=O)c2cccc(S(=O)(=O)Nc3ccc(C(=O)O)cc3)c2)cc1,IC50,80000.0,4.1,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL240506,O=[N+]([O-])c1cc(Br)cc(/C=N/Nc2nc(Nc3ccccc3)nc(Nc3ccccc3)n2)c1O,IC50,1900.0,5.72,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1900.0,5.721246399047171
CHEMBL391519,COc1cc([N+](=O)[O-])cc(/C=N/Nc2nc(Nc3ccccc3)nc(Nc3ccccc3)n2)c1O,IC50,29000.0,4.54,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,29000.0,4.537602002101044
CHEMBL241606,O=C(Nc1ccccc1C(=O)O)c1ccc(C(=O)Nc2ccccc2C(=O)O)cc1,IC50,67000.0,4.17,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,67000.0,4.173925197299174
CHEMBL241397,O=C(O)c1cc(-c2ccc(/C=N/Nc3nc4nonc4nc3Nc3ccccc3F)o2)ccc1Cl,IC50,7000.0,5.16,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL241396,CC(C)CN1C(N/N=C/c2cc(Br)ccc2O)=NC2C1C(=O)NC(=O)N2C,IC50,65000.0,4.19,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL401051,Cc1ccc(O)c(/C=N/Nc2nc3c(c(=O)[nH]c(=O)n3C)n2Cc2ccccc2)c1,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL241185,CCc1cccc2c(SCC(=O)NNC(=O)c3ccccc3[N+](=O)[O-])nc(-c3ccc(F)cc3)nc12,IC50,100000.0,,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL239057,CCOc1ccc(-c2c(C#N)c(N)nc(SCC(=O)c3cc4cc(Br)cc(Br)c4oc3=O)c2C#N)cc1,IC50,17000.0,4.77,CHEMBL888083,Inhibition of HIV1 integrase 3'-end processing activity in presence of magnesium cofactor,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL239057,CCOc1ccc(-c2c(C#N)c(N)nc(SCC(=O)c3cc4cc(Br)cc(Br)c4oc3=O)c2C#N)cc1,IC50,9600.0,5.02,CHEMBL888082,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium cofactor,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9600.0,5.017728766960431
CHEMBL239056,CCCn1c(=O)c(C(=O)NNC(=O)c2ccccc2)c(O)c2ccccc21,IC50,66000.0,4.18,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,66000.0,4.180456064458132
CHEMBL241183,CCCn1c(N/N=C/c2cc(Br)ccc2O)nc2c1c(=O)[nH]c(=O)n2C,IC50,80000.0,4.1,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL401050,O=C(CSc1nc(SCC(=O)NCc2ccco2)nc(SCC(=O)NCc2ccco2)n1)NCc1ccco1,IC50,12000.0,4.92,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL240975,CCCCCCc1nc2ccccc2c(=O)n1NC(=O)c1c(O)c2ccccc2n(CC)c1=O,IC50,100000.0,,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL240974,O=C(Nc1cccc(O)c1)c1cc(C(=O)Nc2cccc(O)c2)cc(N2C(=O)c3ccccc3C2=O)c1,IC50,100000.0,4.0,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL240973,Cn1c(=O)[nH]c(=O)c2c1nc(SCC(O)CCl)n2CC(O)COc1ccc(Cl)cc1,IC50,100000.0,,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL401049,Oc1ccc(Br)cc1/C=N/Nc1nc2nonc2nc1Nc1ccc(F)cc1,IC50,11000.0,4.96,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL240754,COc1cc(C(NC(=O)c2ccco2)NC(=O)c2ccco2)ccc1OCc1ccccc1,IC50,100000.0,,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL239684,O=C(NC1CCCCC1)C(c1ccco1)N(C(=O)Cn1nnc2ccccc21)c1ccc(S(=O)(=O)NCC2CCCO2)cc1,IC50,100000.0,,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL240753,CCCn1c(=O)c(C(=O)NNC(=O)COc2ccccc2)c(O)c2ccccc21,IC50,100000.0,,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL399412,Cn1c(SCC(=O)NNC(=O)c2cccc(O)c2)nc2sc3c(c2c1=O)CCC3,IC50,100000.0,4.0,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL240752,NC(=O)NN=C1c2cc(S(=O)(=O)NCc3ccco3)ccc2-c2ccc(S(=O)(=O)NCc3ccco3)cc21,IC50,20000.0,4.7,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL240548,Cc1nc(SCC(=O)c2ccc(O)c(O)c2)c(C#N)c(CC(C)C)c1C(N)=O,IC50,85000.0,4.07,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,85000.0,4.070581074285707
CHEMBL240547,COc1ccc(C(=O)Nc2ccccc2C(=O)NC(C(=O)NNC(=O)c2ccccc2O)C(C)C)cc1,IC50,16000.0,4.8,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL399211,COc1ccc(NC(=O)CSc2nc(-c3ccncc3)nn2CC(=O)NCc2ccco2)cc1,IC50,100000.0,,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL240546,CCCc1nc2ccccc2c(=O)n1NC(=O)c1c(O)c2cccc3c2n(c1=O)CCC3,IC50,58000.0,4.24,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58000.0,4.236572006437063
CHEMBL240334,O=C1Nc2ccccc2/C1=N\NC(=O)c1ccc(O)cc1O,IC50,36000.0,4.44,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36000.0,4.443697499232713
CHEMBL394683,O=C1Nc2ccccc2/C1=N/NC(=O)c1ccccc1O,IC50,57000.0,4.24,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57000.0,4.2441251443275085
CHEMBL240333,Oc1ccc(-c2csc(Nc3ncccn3)n2)cc1O,IC50,83000.0,4.08,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,83000.0,4.080921907623926
CHEMBL240331,O=C(CSc1nc(O)c2ccccc2n1)c1ccc(O)c(O)c1,IC50,77000.0,4.11,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,77000.0,4.113509274827518
CHEMBL240544,Nc1cc(O)nc(SCC(=O)c2ccc(O)c(O)c2)n1,IC50,89000.0,4.05,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,89000.0,4.050609993355088
CHEMBL240543,O=C(CSc1nnc(-c2ccncc2)[nH]1)c1ccc(O)cc1O,IC50,25000.0,4.6,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL391411,O=C(N/N=C/c1ccc(O)c(O)c1)c1ccccc1O,IC50,26000.0,4.58,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26000.0,4.585026652029182
CHEMBL240542,CCOc1cc(Br)cc(/C=N/c2ncccc2O)c1O,IC50,81000.0,4.09,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,81000.0,4.0915149811213505
CHEMBL239484,O=C(Nc1nccs1)/C(O)=C/C(=O)c1ccc(Cl)cc1,IC50,70000.0,4.16,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL240330,CCCn1c(=O)c(C(=O)NNC(=O)CC(=O)OCC)c(O)c2ccccc21,IC50,48000.0,4.32,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48000.0,4.318758762624412
CHEMBL240329,COc1cccc(C(=O)NNC(=O)c2ccc3ccccc3c2O)c1,IC50,33000.0,4.48,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL241804,COc1ccc(C(=O)NNC(=O)c2cc3ccccc3cc2O)cc1,IC50,18000.0,4.75,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL395448,O=C(NNC(=O)c1c(O)c2ccccc2[nH]c1=O)c1ccccc1F,IC50,30000.0,4.52,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL241598,O=C(NNC(=O)c1c(O)c2ccccc2[nH]c1=O)c1ccccc1,IC50,28000.0,4.55,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL241597,O=C(NNC(=O)c1c(O)c2ccccc2[nH]c1=O)c1cccc([N+](=O)[O-])c1,IC50,1000.0,6.0,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL241596,O=C(NNC(=O)c1c(O)c2ccccc2[nH]c1=O)c1ccccc1[N+](=O)[O-],IC50,46000.0,4.34,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,46000.0,4.337242168318426
CHEMBL399006,O=C(CSc1nc2ccccc2c(=O)n1CC1CCCO1)NNC(=O)c1ccccc1O,IC50,60000.0,4.22,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL392160,CCn1c(=O)c(C(=O)NNC(=O)c2cccc([N+](=O)[O-])c2)c(O)c2ccccc21,IC50,17000.0,4.77,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL239696,CCn1c(=O)c(C(=O)NNC(=O)c2ccc([N+](=O)[O-])cc2)c(O)c2ccccc21,IC50,20000.0,4.7,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL239485,O=C(COc1ccc2ccccc2c1)NNC(=O)c1cc2ccccc2cc1O,IC50,12000.0,4.92,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL394650,O=C(COc1ccc2ccccc2c1)NNC(=O)c1ccccc1O,IC50,18000.0,4.75,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL239483,Cc1cc(C)cc(OCC(=O)NNC(=O)c2cc3ccccc3oc2=O)c1,IC50,72000.0,4.14,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,72000.0,4.142667503568732
CHEMBL239482,CCn1c(=O)c(C(=O)NNC(=O)c2ccccc2[N+](=O)[O-])c(O)c2ccccc21,IC50,30000.0,4.52,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL239275,CCCC(=O)NC(c1ccc(OC)c(OC)c1)c1cc(Cl)c2cccnc2c1O,IC50,90000.0,4.05,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL239274,O=c1nc2n(-c3ccc(Cl)cc3)c3ccc([N+](=O)[O-])cc3cc-2c(=O)[nH]1,IC50,49000.0,4.31,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,49000.0,4.309803919971486
CHEMBL239057,CCOc1ccc(-c2c(C#N)c(N)nc(SCC(=O)c3cc4cc(Br)cc(Br)c4oc3=O)c2C#N)cc1,IC50,4000.0,5.4,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL241184,CCc1nc2sc3c(c2c2nnc(SCC(=O)NNC(=O)c4ccc(OC)cc4)n12)CCCC3,IC50,100000.0,4.0,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL239244,CCCOc1ccc(/C=N/NC2=NC(c3ccccc3O)CC(c3ccccc3)=N2)c(O)c1,IC50,60000.0,4.22,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL240513,CNc1nc(N/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3OC)o2)nc(Nc2ccccc2)n1,IC50,37000.0,4.43,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL240511,Cc1ccc(NC(=O)CN2C(=O)/C(=N\NC(=O)c3ccc4ccccc4n3)c3ccccc32)cc1,IC50,84000.0,4.08,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,84000.0,4.075720713938118
CHEMBL240299,Nc1ccc(C(=O)CC(=O)Nc2cc(C(=O)O)cc(C(=O)O)c2)cc1,IC50,43000.0,4.37,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43000.0,4.366531544420414
CHEMBL241359,COc1ccc(Nc2nc(NCc3ccco3)nc(N/N=C/c3ccc(Br)cc3)n2)cc1,IC50,13000.0,4.89,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL391423,COc1ccc(NC(=O)c2cccc(S(=O)(=O)Nc3ccc(C(=O)O)cc3)c2)cc1,IC50,70000.0,4.16,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL240506,O=[N+]([O-])c1cc(Br)cc(/C=N/Nc2nc(Nc3ccccc3)nc(Nc3ccccc3)n2)c1O,IC50,600.0,6.22,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL391519,COc1cc([N+](=O)[O-])cc(/C=N/Nc2nc(Nc3ccccc3)nc(Nc3ccccc3)n2)c1O,IC50,29000.0,4.54,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,29000.0,4.537602002101044
CHEMBL241606,O=C(Nc1ccccc1C(=O)O)c1ccc(C(=O)Nc2ccccc2C(=O)O)cc1,IC50,32000.0,4.5,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL241397,O=C(O)c1cc(-c2ccc(/C=N/Nc3nc4nonc4nc3Nc3ccccc3F)o2)ccc1Cl,IC50,4000.0,5.4,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL241396,CC(C)CN1C(N/N=C/c2cc(Br)ccc2O)=NC2C1C(=O)NC(=O)N2C,IC50,53000.0,4.28,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53000.0,4.275724130399211
CHEMBL401051,Cc1ccc(O)c(/C=N/Nc2nc3c(c(=O)[nH]c(=O)n3C)n2Cc2ccccc2)c1,IC50,100000.0,,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL241185,CCc1cccc2c(SCC(=O)NNC(=O)c3ccccc3[N+](=O)[O-])nc(-c3ccc(F)cc3)nc12,IC50,100000.0,4.0,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL148472,O=C(/C=C/c1ccccc1O)c1ccc(O)cc1O,IC50,53000.0,4.28,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53000.0,4.275724130399211
CHEMBL148472,O=C(/C=C/c1ccccc1O)c1ccc(O)cc1O,IC50,47000.0,4.33,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47000.0,4.327902142064283
CHEMBL388276,COc1cccc(/C=C/C(=O)c2ccccc2)c1O,IC50,2000.0,5.7,CHEMBL888081,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL388276,COc1cccc(/C=C/C(=O)c2ccccc2)c1O,IC50,2000.0,5.7,CHEMBL888080,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL249349,Cc1ccc(-n2c(SCC(=O)NNC(=O)c3ccccc3O)nnc2-c2ccccc2O)cc1,IC50,5000.0,5.3,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL249349,Cc1ccc(-n2c(SCC(=O)NNC(=O)c3ccccc3O)nnc2-c2ccccc2O)cc1,IC50,3000.0,5.52,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL398558,O=C(CSc1nnnn1-c1ccccc1)NNC(=O)c1ccc(O)cc1O,IC50,68000.0,4.17,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68000.0,4.167491087293763
CHEMBL251379,Cc1cc(C)nc(SCc2nnc(SCC(=O)NNC(=O)c3ccccc3O)n2C)n1,IC50,100000.0,,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL251378,Cc1cc(C)nc(SCc2nnc(SCC(=O)NNC(=O)c3ccccc3O)n2-c2ccccc2)n1,IC50,51000.0,4.29,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,51000.0,4.292429823902063
CHEMBL251172,Cn1c(SCC(=O)NNC(=O)c2ccccc2O)nnc1-c1ccccc1,IC50,64000.0,4.19,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,64000.0,4.1938200260161125
CHEMBL399560,O=C(CSc1nnc(-c2ccncc2)n1-c1ccc(F)cc1)NNC(=O)c1ccccc1O,IC50,49000.0,4.31,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,49000.0,4.309803919971486
CHEMBL250977,Cc1ccc(-n2c(SCC(=O)NNC(=O)c3ccccc3O)nnc2-c2ccccc2)cc1,IC50,23000.0,4.64,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL399559,COc1ccc(-c2nnc(SCC(=O)NNC(=O)c3ccccc3O)n2-c2ccccc2)cc1OC,IC50,22000.0,4.66,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL250975,O=C(CSc1nnc(-c2ccc(Cl)cc2)n1-c1ccccc1)NNC(=O)c1ccccc1O,IC50,11000.0,4.96,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL250779,O=C(CSc1nnc(Cc2ccccc2)n1C1CCCCC1)NNC(=O)c1ccccc1O,IC50,21000.0,4.68,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL398970,COc1ccc(-n2c(Cc3ccccc3)nnc2SCC(=O)NNC(=O)c2ccccc2O)cc1,IC50,18000.0,4.75,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL250777,O=C(CSc1nnc(Cc2ccccc2)n1-c1cccc(Cl)c1)NNC(=O)c1ccccc1O,IC50,9000.0,5.05,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL250574,O=C(CSc1nnc(-c2ccccc2)n1Cc1ccccc1)NNC(=O)c1ccccc1O,IC50,21000.0,4.68,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL398969,O=C(CSc1nnc(-c2ccccc2O)n1Cc1ccccc1)NNC(=O)c1ccccc1O,IC50,15000.0,4.82,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL250367,COc1ccccc1-n1c(SCC(=O)NNC(=O)c2ccccc2O)nnc1-c1ccccc1O,IC50,8000.0,5.1,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL398558,O=C(CSc1nnnn1-c1ccccc1)NNC(=O)c1ccc(O)cc1O,IC50,61000.0,4.21,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61000.0,4.214670164989233
CHEMBL251379,Cc1cc(C)nc(SCc2nnc(SCC(=O)NNC(=O)c3ccccc3O)n2C)n1,IC50,100000.0,,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL251378,Cc1cc(C)nc(SCc2nnc(SCC(=O)NNC(=O)c3ccccc3O)n2-c2ccccc2)n1,IC50,27000.0,4.57,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27000.0,4.568636235841013
CHEMBL251172,Cn1c(SCC(=O)NNC(=O)c2ccccc2O)nnc1-c1ccccc1,IC50,58000.0,4.24,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58000.0,4.236572006437063
CHEMBL399560,O=C(CSc1nnc(-c2ccncc2)n1-c1ccc(F)cc1)NNC(=O)c1ccccc1O,IC50,31000.0,4.51,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31000.0,4.508638306165727
CHEMBL250977,Cc1ccc(-n2c(SCC(=O)NNC(=O)c3ccccc3O)nnc2-c2ccccc2)cc1,IC50,12000.0,4.92,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL399559,COc1ccc(-c2nnc(SCC(=O)NNC(=O)c3ccccc3O)n2-c2ccccc2)cc1OC,IC50,21000.0,4.68,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL250975,O=C(CSc1nnc(-c2ccc(Cl)cc2)n1-c1ccccc1)NNC(=O)c1ccccc1O,IC50,5000.0,5.3,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL250779,O=C(CSc1nnc(Cc2ccccc2)n1C1CCCCC1)NNC(=O)c1ccccc1O,IC50,17000.0,4.77,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL398970,COc1ccc(-n2c(Cc3ccccc3)nnc2SCC(=O)NNC(=O)c2ccccc2O)cc1,IC50,17000.0,4.77,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL250777,O=C(CSc1nnc(Cc2ccccc2)n1-c1cccc(Cl)c1)NNC(=O)c1ccccc1O,IC50,8000.0,5.1,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL250574,O=C(CSc1nnc(-c2ccccc2)n1Cc1ccccc1)NNC(=O)c1ccccc1O,IC50,9000.0,5.05,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL398969,O=C(CSc1nnc(-c2ccccc2O)n1Cc1ccccc1)NNC(=O)c1ccccc1O,IC50,9000.0,5.05,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL250367,COc1ccccc1-n1c(SCC(=O)NNC(=O)c2ccccc2O)nnc1-c1ccccc1O,IC50,6000.0,5.22,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL248957,O=C(CSc1nnc(-c2ccc(Cl)cc2)n1-c1ccccc1)N/N=C/c1ccccc1C(=O)O,IC50,100000.0,,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL248763,O=C(CSc1nnc(-c2ccncc2)n1-c1ccccc1)N/N=C/c1ccccc1O,IC50,100000.0,,CHEMBL941965,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL248957,O=C(CSc1nnc(-c2ccc(Cl)cc2)n1-c1ccccc1)N/N=C/c1ccccc1C(=O)O,IC50,100000.0,,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL248763,O=C(CSc1nnc(-c2ccncc2)n1-c1ccccc1)N/N=C/c1ccccc1O,IC50,100000.0,,CHEMBL941966,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL267855,O=C(O)c1cc2cc(O)c(O)cc2[nH]1,IC50,10000.0,,CHEMBL925061,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL401579,O=C1C(O)=C(O)C(O)=C2CC(O)=CC=CC12,IC50,2100.0,5.68,CHEMBL925061,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2100.0,5.6777807052660805
CHEMBL19977,O=C(O)C(=O)CC(=O)c1cc(OCc2ccccc2)cc(OCc2ccccc2)c1,IC50,200.0,6.7,CHEMBL925063,Inhibition of HIV1 integrase-mediated 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL19977,O=C(O)C(=O)CC(=O)c1cc(OCc2ccccc2)cc(OCc2ccccc2)c1,IC50,3500.0,5.46,CHEMBL925064,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3500.0,5.455931955649724
CHEMBL254527,N#C/C(=C(/O)C(=O)O)c1cn(-c2ccc(F)cc2)c2ccccc12,IC50,10000.0,5.0,CHEMBL925064,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL252700,COc1cccc(CN(Cc2cccc(OC)c2)c2ccc3nc(N)[nH]c3c2)c1,IC50,1800.0,5.75,CHEMBL925064,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL252905,N=C(N)c1ccc2cc(C#Cc3cccc(OCc4ccccc4)c3)ccc2c1,IC50,2100.0,5.68,CHEMBL925064,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2100.0,5.6777807052660805
CHEMBL404423,CC(C)(C)C1CCC(C2=NCCc3ccc([C@H]4CC4c4ccc5cc(C(=N)N)ccc5c4)cc32)CC1,IC50,3400.0,5.47,CHEMBL925064,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3400.0,5.468521082957745
CHEMBL254727,CC(C)S(=O)(=O)Nc1ccc2nc(N)[nH]c2c1,IC50,2600.0,5.58,CHEMBL925064,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2600.0,5.585026652029182
CHEMBL218227,O=C(/C=C(\O)c1nc[nH]n1)c1ccc(Cc2ccc(F)cc2)o1,IC50,20.0,7.7,CHEMBL925128,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL254438,O=C(/C=C(\O)c1cc[nH]c1)c1ccc(Cc2ccc(F)cc2)o1,IC50,1000.0,,CHEMBL925128,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL254230,O=C(/C=C(\O)c1nc[nH]n1)c1ccc(Cc2ccc(F)cc2)[nH]1,IC50,1000.0,,CHEMBL925128,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL36303,O=C(NNC(=O)c1ccccc1O)c1ccccc1O,IC50,3600.0,5.44,CHEMBL927584,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3600.0,5.443697499232712
CHEMBL36303,O=C(NNC(=O)c1ccccc1O)c1ccccc1O,IC50,1800.0,5.75,CHEMBL927586,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL254632,O=C(NNC(=O)c1cccc(O)c1O)c1cccc(O)c1O,IC50,6900.0,5.16,CHEMBL927583,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6900.0,5.161150909262744
CHEMBL254632,O=C(NNC(=O)c1cccc(O)c1O)c1cccc(O)c1O,IC50,1600.0,5.8,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL254853,COc1cccc(C(=O)NNC(=O)c2cc3ccccc3cc2O)c1O,IC50,12000.0,4.92,CHEMBL927584,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL254852,COc1cccc(C(=O)NNC(=O)c2cccc(OC)c2O)c1O,IC50,26000.0,4.58,CHEMBL927584,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26000.0,4.585026652029182
CHEMBL399581,O=C(N/N=C/c1cccc(O)c1O)c1cccc(O)c1O,IC50,11000.0,4.96,CHEMBL927584,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL428588,O=C(NNC(=O)c1cccc(O)c1O)c1cc2ccccc2cc1O,IC50,19000.0,4.72,CHEMBL927584,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL252551,COc1cccc(C(=O)NNC(=O)c2cccc(O)c2O)c1O,IC50,11000.0,4.96,CHEMBL927584,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL254632,O=C(NNC(=O)c1cccc(O)c1O)c1cccc(O)c1O,IC50,8900.0,5.05,CHEMBL927584,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8900.0,5.050609993355087
CHEMBL403574,O=C(NNC(=O)c1cccc(O)c1O)c1ccccc1O,IC50,2800.0,5.55,CHEMBL927584,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL254853,COc1cccc(C(=O)NNC(=O)c2cc3ccccc3cc2O)c1O,IC50,8000.0,5.1,CHEMBL927586,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL254852,COc1cccc(C(=O)NNC(=O)c2cccc(OC)c2O)c1O,IC50,22000.0,4.66,CHEMBL927586,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL254646,COc1cccc(/C=N/NC(=O)c2cccc(O)c2O)c1OC,IC50,18000.0,4.75,CHEMBL927586,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL399581,O=C(N/N=C/c1cccc(O)c1O)c1cccc(O)c1O,IC50,1300.0,5.89,CHEMBL927586,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL428588,O=C(NNC(=O)c1cccc(O)c1O)c1cc2ccccc2cc1O,IC50,16000.0,4.8,CHEMBL927586,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL252551,COc1cccc(C(=O)NNC(=O)c2cccc(O)c2O)c1O,IC50,9000.0,5.05,CHEMBL927586,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL254632,O=C(NNC(=O)c1cccc(O)c1O)c1cccc(O)c1O,IC50,5000.0,5.3,CHEMBL927586,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL403574,O=C(NNC(=O)c1cccc(O)c1O)c1ccccc1O,IC50,500.0,6.3,CHEMBL927586,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL254646,COc1cccc(/C=N/NC(=O)c2cccc(O)c2O)c1OC,IC50,68000.0,4.17,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68000.0,4.167491087293763
CHEMBL399581,O=C(N/N=C/c1cccc(O)c1O)c1cccc(O)c1O,IC50,54000.0,4.27,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54000.0,4.267606240177032
CHEMBL399480,O=C(NCCCNC(=O)c1cccc(O)c1O)c1cccc(O)c1O,IC50,31000.0,4.51,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31000.0,4.508638306165727
CHEMBL399272,O=C(NCCNC(=O)c1cccc(O)c1O)c1cccc(O)c1O,IC50,50000.0,4.3,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL428588,O=C(NNC(=O)c1cccc(O)c1O)c1cc2ccccc2cc1O,IC50,32000.0,4.5,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL252551,COc1cccc(C(=O)NNC(=O)c2cccc(O)c2O)c1O,IC50,44000.0,4.36,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44000.0,4.356547323513812
CHEMBL398846,O=C1c2c(ccc(O)c2O)CN1Cc1cccc(CBr)c1,IC50,13000.0,4.89,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL253342,O=C1c2c(ccc(O)c2O)CN1Cc1ccc(F)c(Cl)c1,IC50,160.0,6.8,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,160.0,6.795880017344075
CHEMBL253138,O=C1c2c(ccc(O)c2O)CN1Cc1ccc(F)cc1,IC50,10000.0,5.0,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL443502,O=C1c2c(ccc(O)c2O)CN1Cc1cccc2ccccc12,IC50,740.0,6.13,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,740.0,6.130768280269024
CHEMBL252831,O=C1c2c(ccc(O)c2O)CN1CCc1ccccc1,IC50,28000.0,4.55,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL253137,O=C1c2c(ccc(O)c2O)CN1Cc1ccccc1,IC50,12300.0,4.91,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12300.0,4.910094888560602
CHEMBL253395,O=C1c2c(ccc(O)c2O)CN1/N=C/c1cccc(O)c1O,IC50,54000.0,4.27,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54000.0,4.267606240177032
CHEMBL404420,O=C1c2c(ccc(O)c2O)CN1N1C(=O)c2ccc(F)cc2C1=O,IC50,53000.0,4.28,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53000.0,4.275724130399211
CHEMBL402709,O=C1c2c(ccc(O)c2O)CN1N1C(=O)c2cc(O)c(O)cc2C1=O,IC50,810.0,6.09,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,810.0,6.0915149811213505
CHEMBL253394,O=C1c2c(ccc(O)c2O)CN1N1C(=O)c2ccc(O)c(O)c2C1=O,IC50,600.0,6.22,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL252775,O=C1c2c(ccc(O)c2O)CN1N1C(=O)c2cccc(O)c2C1=O,IC50,11000.0,4.96,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL252570,O=C1c2c(ccc(O)c2O)CN1N1Cc2ccc(O)c(O)c2S1(=O)=O,IC50,1200.0,5.92,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL253609,O=C1c2c(ccc(O)c2O)CN1N1Cc2ccc(O)c(O)c2C1=O,IC50,41000.0,4.39,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41000.0,4.3872161432802645
CHEMBL427715,O=C1c2c(ccc(O)c2O)CN1N(S(=O)(=O)c1ccc(O)c(O)c1)S(=O)(=O)c1ccc(O)c(O)c1,IC50,210.0,6.68,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,210.0,6.6777807052660805
CHEMBL400246,O=C1c2c(ccc(O)c2O)CN1N(S(=O)(=O)c1ccc(F)cc1)S(=O)(=O)c1ccc(F)cc1,IC50,33000.0,4.48,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL252161,O=C1c2c(ccc(O)c2O)CN1NS(=O)(=O)c1ccc(F)cc1,IC50,21000.0,4.68,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL400055,O=C(NN1Cc2ccc(O)c(O)c2C1=O)c1cccc(O)c1O,IC50,6000.0,5.22,CHEMBL927585,Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL398846,O=C1c2c(ccc(O)c2O)CN1Cc1cccc(CBr)c1,IC50,37000.0,4.43,CHEMBL927583,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL253342,O=C1c2c(ccc(O)c2O)CN1Cc1ccc(F)c(Cl)c1,IC50,13000.0,4.89,CHEMBL927583,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL443502,O=C1c2c(ccc(O)c2O)CN1Cc1cccc2ccccc12,IC50,61000.0,4.21,CHEMBL927583,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61000.0,4.214670164989233
CHEMBL253395,O=C1c2c(ccc(O)c2O)CN1/N=C/c1cccc(O)c1O,IC50,87000.0,4.06,CHEMBL927583,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,87000.0,4.060480747381382
CHEMBL402709,O=C1c2c(ccc(O)c2O)CN1N1C(=O)c2cc(O)c(O)cc2C1=O,IC50,6700.0,5.17,CHEMBL927583,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6700.0,5.173925197299173
CHEMBL253394,O=C1c2c(ccc(O)c2O)CN1N1C(=O)c2ccc(O)c(O)c2C1=O,IC50,78000.0,4.11,CHEMBL927583,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,78000.0,4.107905397309519
CHEMBL252775,O=C1c2c(ccc(O)c2O)CN1N1C(=O)c2cccc(O)c2C1=O,IC50,42000.0,4.38,CHEMBL927583,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42000.0,4.376750709602099
CHEMBL252570,O=C1c2c(ccc(O)c2O)CN1N1Cc2ccc(O)c(O)c2S1(=O)=O,IC50,7000.0,5.16,CHEMBL927583,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL427715,O=C1c2c(ccc(O)c2O)CN1N(S(=O)(=O)c1ccc(O)c(O)c1)S(=O)(=O)c1ccc(O)c(O)c1,IC50,1600.0,5.8,CHEMBL927583,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL252161,O=C1c2c(ccc(O)c2O)CN1NS(=O)(=O)c1ccc(F)cc1,IC50,69000.0,4.16,CHEMBL927583,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69000.0,4.161150909262744
CHEMBL399581,O=C(N/N=C/c1cccc(O)c1O)c1cccc(O)c1O,IC50,61000.0,4.21,CHEMBL927583,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61000.0,4.214670164989233
CHEMBL399480,O=C(NCCCNC(=O)c1cccc(O)c1O)c1cccc(O)c1O,IC50,33000.0,4.48,CHEMBL927583,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL399272,O=C(NCCNC(=O)c1cccc(O)c1O)c1cccc(O)c1O,IC50,85000.0,4.07,CHEMBL927583,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,85000.0,4.070581074285707
CHEMBL428588,O=C(NNC(=O)c1cccc(O)c1O)c1cc2ccccc2cc1O,IC50,72000.0,4.14,CHEMBL927583,Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,72000.0,4.142667503568732
CHEMBL408699,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@@H](CO)C(C)C,IC50,7.2,8.14,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.2,8.142667503568731
CHEMBL273128,CC(C)[C@H](CO)n1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3F)ccc21,IC50,8.2,8.09,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.2,8.086186147616283
CHEMBL272420,COc1ccc(/C=C2\C(=O)N(c3nnn[nH]3)N=C2C)cc1OCc1ccccc1Cl,IC50,14.0,7.85,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL272420,COc1ccc(/C=C2\C(=O)N(c3nnn[nH]3)N=C2C)cc1OCc1ccccc1Cl,IC50,5.0,8.3,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL405927,N#Cc1c(-c2ccc(Cl)cc2)cc(-c2ccccc2)nc1SCC(=O)O,IC50,60.0,7.22,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL272193,CCOc1cc(N(CC)CC)ccc1/C=C1\C(=O)N(c2nnn[nH]2)N=C1C,IC50,65.0,7.19,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65.0,7.187086643357144
CHEMBL272194,CC1=NN(c2nnn[nH]2)C(=O)/C1=C\c1cc(Cl)c(O)c(Cl)c1,IC50,13.0,7.89,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL260096,CCOc1cc(/C=C2\C(=O)N(c3nnn[nH]3)N=C2C)ccc1OC,IC50,59.0,7.23,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,59.0,7.229147988357855
CHEMBL429327,CCOc1cc(/C=C2\C(=O)N(c3nnn[nH]3)N=C2C)cc(Cl)c1OCC,IC50,4.0,8.4,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL412149,COc1cc(/C=C2\C(=O)N(c3nnn[nH]3)N=C2C)cc(Cl)c1OC,IC50,4.0,8.4,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL260960,COc1cccc(NC(=O)c2sc3[nH]c(=O)c(C(=O)O)cc3c2N)c1,IC50,43.0,7.37,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43.0,7.366531544420413
CHEMBL406595,Nc1c(C(=O)Nc2ccc(Cl)c(Cl)c2)sc2[nH]c(=O)c(C(=O)O)cc12,IC50,5.0,8.3,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL406596,Cc1ccc(C(=O)O)cc1NC(=O)CSc1nc2ccccc2s1,IC50,17.0,7.77,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17.0,7.769551078621726
CHEMBL409315,O=C(O)CN1C(=O)/C(=C2\SC(=S)N(C(Cc3ccccc3)C(=O)O)C2=O)c2ccccc21,IC50,66.0,7.18,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,66.0,7.180456064458131
CHEMBL272642,Cc1ccc2nc(-c3ccc(NC(=O)/C=C/C(=O)O)cc3)sc2c1,IC50,23.0,7.64,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23.0,7.638272163982407
CHEMBL261833,O=C(O)c1ccccc1NC(=O)c1ccccc1S(=O)(=O)Nc1ccc(Oc2ccccc2)cc1,IC50,18.0,7.75,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL272418,CCOc1cc(CNc2nn[nH]n2)cc(Cl)c1OCc1ccc(Cl)cc1,IC50,52.0,7.28,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52.0,7.2839966563652006
CHEMBL407352,O=C(O)CSc1nnc(-c2ccco2)c(-c2ccco2)n1,IC50,5.0,8.3,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL405927,N#Cc1c(-c2ccc(Cl)cc2)cc(-c2ccccc2)nc1SCC(=O)O,IC50,98.0,7.01,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,98.0,7.008773924307505
CHEMBL272193,CCOc1cc(N(CC)CC)ccc1/C=C1\C(=O)N(c2nnn[nH]2)N=C1C,IC50,61.0,7.21,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61.0,7.214670164989233
CHEMBL272194,CC1=NN(c2nnn[nH]2)C(=O)/C1=C\c1cc(Cl)c(O)c(Cl)c1,IC50,11.0,7.96,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL260096,CCOc1cc(/C=C2\C(=O)N(c3nnn[nH]3)N=C2C)ccc1OC,IC50,75.0,7.12,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75.0,7.1249387366083
CHEMBL429327,CCOc1cc(/C=C2\C(=O)N(c3nnn[nH]3)N=C2C)cc(Cl)c1OCC,IC50,7.0,8.15,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL412149,COc1cc(/C=C2\C(=O)N(c3nnn[nH]3)N=C2C)cc(Cl)c1OC,IC50,5.0,8.3,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL260960,COc1cccc(NC(=O)c2sc3[nH]c(=O)c(C(=O)O)cc3c2N)c1,IC50,82.0,7.09,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,82.0,7.086186147616283
CHEMBL406595,Nc1c(C(=O)Nc2ccc(Cl)c(Cl)c2)sc2[nH]c(=O)c(C(=O)O)cc12,IC50,14.0,7.85,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL406596,Cc1ccc(C(=O)O)cc1NC(=O)CSc1nc2ccccc2s1,IC50,63.0,7.2,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,63.0,7.200659450546418
CHEMBL409315,O=C(O)CN1C(=O)/C(=C2\SC(=S)N(C(Cc3ccccc3)C(=O)O)C2=O)c2ccccc21,IC50,92.0,7.04,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,92.0,7.036212172654444
CHEMBL272642,Cc1ccc2nc(-c3ccc(NC(=O)/C=C/C(=O)O)cc3)sc2c1,IC50,48.0,7.32,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48.0,7.318758762624412
CHEMBL261833,O=C(O)c1ccccc1NC(=O)c1ccccc1S(=O)(=O)Nc1ccc(Oc2ccccc2)cc1,IC50,42.0,7.38,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42.0,7.376750709602099
CHEMBL272418,CCOc1cc(CNc2nn[nH]n2)cc(Cl)c1OCc1ccc(Cl)cc1,IC50,100.0,,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL407352,O=C(O)CSc1nnc(-c2ccco2)c(-c2ccco2)n1,IC50,18.0,7.75,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL272204,O=C(O)CSc1nc(Nc2ccccc2)nc(N2CCOCC2)n1,IC50,100.0,,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL258815,O=C(O)CSc1nc(-c2cccs2)cc(C(F)(F)F)n1,IC50,100.0,,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL258814,O=C(O)CSc1nc(-c2ccccc2)cc(C(F)(F)F)n1,IC50,100.0,,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL272448,O=C(O)C1CCCCC1C(=O)Nc1ccc(Oc2cccc3ccccc23)cc1,IC50,100.0,,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL272419,O=C(O)C(O)C(O)c1nc2cc3ccccc3cc2[nH]1,IC50,100.0,,CHEMBL932798,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL272204,O=C(O)CSc1nc(Nc2ccccc2)nc(N2CCOCC2)n1,IC50,100.0,,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL258815,O=C(O)CSc1nc(-c2cccs2)cc(C(F)(F)F)n1,IC50,100.0,,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL258814,O=C(O)CSc1nc(-c2ccccc2)cc(C(F)(F)F)n1,IC50,100.0,,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL272448,O=C(O)C1CCCCC1C(=O)Nc1ccc(Oc2cccc3ccccc23)cc1,IC50,34.0,7.47,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34.0,7.468521082957745
CHEMBL272419,O=C(O)C(O)C(O)c1nc2cc3ccccc3cc2[nH]1,IC50,46.0,7.34,CHEMBL932796,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,46.0,7.337242168318426
CHEMBL324842,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,IC50,63500.0,4.2,CHEMBL926887,Inhibition of HIV1 integrase using labelled oligonucleotide substrate in presence of bovine serum albumin by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,63500.0,4.197226274708024
CHEMBL261703,O=C(/C=C/c1cc(O)c(O)cc1[N+](=O)[O-])O[C@H](Cc1cc(O)c(O)cc1[N+](=O)[O-])C(=O)O,IC50,70.0,7.16,CHEMBL926891,Inhibition of HIV1 integrase strand transfer activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL260778,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1cc(O)c(O)cc1[N+](=O)[O-])C(=O)O,IC50,3700.0,5.43,CHEMBL926891,Inhibition of HIV1 integrase strand transfer activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3700.0,5.431798275933005
CHEMBL261703,O=C(/C=C/c1cc(O)c(O)cc1[N+](=O)[O-])O[C@H](Cc1cc(O)c(O)cc1[N+](=O)[O-])C(=O)O,IC50,52200.0,4.28,CHEMBL926890,Inhibition of HIV1 integrase 3'-processing activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52200.0,4.282329496997738
CHEMBL261703,O=C(/C=C/c1cc(O)c(O)cc1[N+](=O)[O-])O[C@H](Cc1cc(O)c(O)cc1[N+](=O)[O-])C(=O)O,IC50,30.0,7.52,CHEMBL926889,Inhibition of HIV1 integrase using labelled U5A/U5B double stranded DNA substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL260778,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1cc(O)c(O)cc1[N+](=O)[O-])C(=O)O,IC50,26.0,7.58,CHEMBL926889,Inhibition of HIV1 integrase using labelled U5A/U5B double stranded DNA substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26.0,7.585026652029182
CHEMBL261703,O=C(/C=C/c1cc(O)c(O)cc1[N+](=O)[O-])O[C@H](Cc1cc(O)c(O)cc1[N+](=O)[O-])C(=O)O,IC50,150.0,6.82,CHEMBL926888,Inhibition of HIV1 integrase using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,150.0,6.823908740944319
CHEMBL260778,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1cc(O)c(O)cc1[N+](=O)[O-])C(=O)O,IC50,1400.0,5.85,CHEMBL926888,Inhibition of HIV1 integrase using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1400.0,5.853871964321762
CHEMBL261703,O=C(/C=C/c1cc(O)c(O)cc1[N+](=O)[O-])O[C@H](Cc1cc(O)c(O)cc1[N+](=O)[O-])C(=O)O,IC50,20800.0,4.68,CHEMBL926887,Inhibition of HIV1 integrase using labelled oligonucleotide substrate in presence of bovine serum albumin by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20800.0,4.681936665037238
CHEMBL260778,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1cc(O)c(O)cc1[N+](=O)[O-])C(=O)O,IC50,54700.0,4.26,CHEMBL926887,Inhibition of HIV1 integrase using labelled oligonucleotide substrate in presence of bovine serum albumin by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54700.0,4.262012673666569
CHEMBL259780,CC(C)(C)c1nc(O)c(O)c(C(=O)NCc2ccc(F)cc2)n1,IC50,10.0,8.0,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL401801,CN1CCN(C(=O)c2cc(F)ccc2CNC(=O)c2nc(C(C)(C)C)n(C)c(=O)c2O)CC1,IC50,490.0,6.31,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,490.0,6.309803919971486
CHEMBL261106,Cn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2C(=O)N2CCCC2)c(O)c1=O,IC50,230.0,6.64,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,230.0,6.638272163982407
CHEMBL410444,CN(C)C(=O)c1cc(F)ccc1CNC(=O)c1nc(C(C)(C)C)n(C)c(=O)c1O,IC50,180.0,6.75,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,180.0,6.7447274948966935
CHEMBL260913,Cn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2C(=O)NCC(F)(F)F)c(O)c1=O,IC50,90.0,7.05,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90.0,7.045757490560675
CHEMBL260082,CC(C)NC(=O)c1cc(F)ccc1CNC(=O)c1nc(C(C)(C)C)n(C)c(=O)c1O,IC50,90.0,7.05,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90.0,7.045757490560675
CHEMBL430049,CCCNC(=O)c1cc(F)ccc1CNC(=O)c1nc(C(C)(C)C)n(C)c(=O)c1O,IC50,70.0,7.16,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL408938,CCNC(=O)c1cc(F)ccc1CNC(=O)c1nc(C(C)(C)C)n(C)c(=O)c1O,IC50,70.0,7.16,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL258681,Cn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2C(N)=O)c(O)c1=O,IC50,20.0,7.7,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL258682,Cn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2S(C)(=O)=O)c(O)c1=O,IC50,20.0,7.7,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL260665,Cc1noc(-c2cc(F)ccc2CNC(=O)c2nc(C(C)(C)C)n(C)c(=O)c2O)n1,IC50,20.0,7.7,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL411299,CNC(=O)c1cc(F)ccc1CNC(=O)c1nc(C(C)(C)C)n(C)c(=O)c1O,IC50,20.0,7.7,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL408075,Cn1c(C(C)(C)C)nc(C(=O)NCc2cccc3cc[nH]c23)c(O)c1=O,IC50,20.0,7.7,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL259125,CCOc1ccccc1CNC(=O)c1nc(C(C)(C)C)n(C)c(=O)c1O,IC50,20.0,7.7,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL407651,Cn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,10.0,8.0,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL259336,CC(C)(C)c1nc(O)c(O)c(C(=O)NCc2ccc(F)cc2S(C)(=O)=O)n1,IC50,60.0,7.22,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL262067,Cc1noc(-c2cc(F)ccc2CNC(=O)c2nc(C(C)(C)C)nc(O)c2O)n1,IC50,20.0,7.7,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL408076,CNC(=O)c1cc(F)ccc1CNC(=O)c1nc(C(C)(C)C)nc(O)c1O,IC50,20.0,7.7,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL259779,CC(C)(C)c1nc(O)c(O)c(C(=O)NCc2cccc3cc[nH]c23)n1,IC50,10.0,8.0,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL259573,CCOc1ccccc1CNC(=O)c1nc(C(C)(C)C)nc(O)c1O,IC50,10.0,8.0,CHEMBL927106,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL259011,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,80.0,7.1,CHEMBL921483,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL259012,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccccc12,IC50,860.0,6.07,CHEMBL921483,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,860.0,6.065501548756432
CHEMBL259012,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccccc12,IC50,2330.0,5.63,CHEMBL921484,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2330.0,5.632644078973981
CHEMBL526172,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)[C@@H](C)CC,IC50,25000.0,4.6,CHEMBL942373,Inhibition of HIV1 integrase by quantitative ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL510353,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O,IC50,25000.0,4.6,CHEMBL942373,Inhibition of HIV1 integrase by quantitative ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL506605,CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](NC(=O)C(=O)c3cc(Cl)c(O)c(Cl)c3)Cc3c[nH]c4cc(ccc34)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)N[C@@H](C(=O)O)c1ccc(O)cc1,IC50,200.0,6.7,CHEMBL990225,Inhibition of HIV1 integrase 3' processing/strand transfer coupled activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL525803,CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](NC(=O)C(=O)c3cc(Cl)c(O)c(Cl)c3)Cc3c[nH]c4c(cccc34)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)N[C@@H](C(=O)O)c1ccc(O)cc1,IC50,400.0,6.4,CHEMBL990225,Inhibition of HIV1 integrase 3' processing/strand transfer coupled activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL448564,CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](N)Cc3c[nH]c4c(cccc34)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)O,IC50,500.0,6.3,CHEMBL990225,Inhibition of HIV1 integrase 3' processing/strand transfer coupled activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL506605,CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](NC(=O)C(=O)c3cc(Cl)c(O)c(Cl)c3)Cc3c[nH]c4cc(ccc34)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)N[C@@H](C(=O)O)c1ccc(O)cc1,IC50,500.0,6.3,CHEMBL990227,Inhibition of disintegration activity of HIV1 intact integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL506605,CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](NC(=O)C(=O)c3cc(Cl)c(O)c(Cl)c3)Cc3c[nH]c4cc(ccc34)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)N[C@@H](C(=O)O)c1ccc(O)cc1,IC50,500.0,6.3,CHEMBL990228,Inhibition of disintegration activity of HIV1 integrase catalytic core domain (50 to 212),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL507121,CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](NC(=O)C(=O)c3cc(Cl)c(O)c(Cl)c3)Cc3c[nH]c4c(cccc34)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)O,IC50,600.0,6.22,CHEMBL990225,Inhibition of HIV1 integrase 3' processing/strand transfer coupled activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL524665,CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](NC(=O)C(=O)c3cc(Cl)c(O)c(Cl)c3)CC3C(=O)Nc4cc(ccc43)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)N[C@@H](C(=O)O)c1ccc(O)cc1,IC50,800.0,6.1,CHEMBL990225,Inhibition of HIV1 integrase 3' processing/strand transfer coupled activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL524869,CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](NC(=O)C(=O)c3cc(Cl)c(O)c(Cl)c3)CC3(O)C(=O)Nc4cc(ccc43)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)N[C@@H](C(=O)O)c1ccc(O)cc1,IC50,1700.0,5.77,CHEMBL990225,Inhibition of HIV1 integrase 3' processing/strand transfer coupled activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL506605,CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](NC(=O)C(=O)c3cc(Cl)c(O)c(Cl)c3)Cc3c[nH]c4cc(ccc34)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)N[C@@H](C(=O)O)c1ccc(O)cc1,IC50,3000.0,5.52,CHEMBL990229,Inhibition of integration activity of HIV1 intact integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL505739,CN[C@@H](Cc1ccc(Oc2cc3cc(c2O)-c2cccc4c(c[nH]c24)C[C@@H](N)C(=O)N[C@H](c2cc(Cl)c(O)c(Cl)c2)C(=O)N[C@H]3C(=O)N[C@@H](C(=O)O)c2cc(Cl)c(O)c(Cl)c2)cc1)C(=O)O,IC50,3800.0,5.42,CHEMBL990225,Inhibition of HIV1 integrase 3' processing/strand transfer coupled activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3800.0,5.42021640338319
CHEMBL506605,CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](NC(=O)C(=O)c3cc(Cl)c(O)c(Cl)c3)Cc3c[nH]c4cc(ccc34)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)N[C@@H](C(=O)O)c1ccc(O)cc1,IC50,4000.0,5.4,CHEMBL990226,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL525803,CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](NC(=O)C(=O)c3cc(Cl)c(O)c(Cl)c3)Cc3c[nH]c4c(cccc34)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)N[C@@H](C(=O)O)c1ccc(O)cc1,IC50,5000.0,5.3,CHEMBL990226,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL448564,CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](N)Cc3c[nH]c4c(cccc34)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)O,IC50,6000.0,5.22,CHEMBL990226,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL448271,CN(C(=O)[C@H](N)c1cc(Cl)c(O)c(Cl)c1)[C@@H](Cc1ccc(Oc2cc3cc(c2O)-c2cccc4c(c[nH]c24)C[C@@H](N)C(=O)N[C@H](c2cc(Cl)c(O)c(Cl)c2)C(=O)N[C@H]3C(=O)O)cc1)C(=O)O,IC50,7800.0,5.11,CHEMBL990225,Inhibition of HIV1 integrase 3' processing/strand transfer coupled activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7800.0,5.107905397309519
CHEMBL507121,CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](NC(=O)C(=O)c3cc(Cl)c(O)c(Cl)c3)Cc3c[nH]c4c(cccc34)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)O,IC50,8000.0,5.1,CHEMBL990226,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL524869,CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](NC(=O)C(=O)c3cc(Cl)c(O)c(Cl)c3)CC3(O)C(=O)Nc4cc(ccc43)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)N[C@@H](C(=O)O)c1ccc(O)cc1,IC50,12500.0,4.9,CHEMBL990226,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12500.0,4.903089986991944
CHEMBL524665,CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](NC(=O)C(=O)c3cc(Cl)c(O)c(Cl)c3)CC3C(=O)Nc4cc(ccc43)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)N[C@@H](C(=O)O)c1ccc(O)cc1,IC50,12500.0,4.9,CHEMBL990226,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12500.0,4.903089986991944
CHEMBL506051,CN[C@@H](Cc1ccc(Oc2cc3cc(c2O)-c2cccc4c(c[nH]c24)C[C@@H](N)C(=O)N[C@H](c2cc(Cl)c(O)c(Cl)c2)C(=O)N[C@H]3C(=O)O)cc1)C(=O)O,IC50,28000.0,4.55,CHEMBL990225,Inhibition of HIV1 integrase 3' processing/strand transfer coupled activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL505739,CN[C@@H](Cc1ccc(Oc2cc3cc(c2O)-c2cccc4c(c[nH]c24)C[C@@H](N)C(=O)N[C@H](c2cc(Cl)c(O)c(Cl)c2)C(=O)N[C@H]3C(=O)N[C@@H](C(=O)O)c2cc(Cl)c(O)c(Cl)c2)cc1)C(=O)O,IC50,45000.0,4.35,CHEMBL990226,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45000.0,4.346787486224656
CHEMBL448271,CN(C(=O)[C@H](N)c1cc(Cl)c(O)c(Cl)c1)[C@@H](Cc1ccc(Oc2cc3cc(c2O)-c2cccc4c(c[nH]c24)C[C@@H](N)C(=O)N[C@H](c2cc(Cl)c(O)c(Cl)c2)C(=O)N[C@H]3C(=O)O)cc1)C(=O)O,IC50,86000.0,4.07,CHEMBL990226,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,86000.0,4.0655015487564325
CHEMBL506051,CN[C@@H](Cc1ccc(Oc2cc3cc(c2O)-c2cccc4c(c[nH]c24)C[C@@H](N)C(=O)N[C@H](c2cc(Cl)c(O)c(Cl)c2)C(=O)N[C@H]3C(=O)O)cc1)C(=O)O,IC50,100000.0,,CHEMBL990226,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL509561,CC1=C[C@@H]2CC[C@@H](O)[C@H](C)[C@@H]2[C@@H](C(=O)C2=C(O)C(O)NC2=O)[C@@H]1C[C@H]1O[C@@]2(CC[C@H](C)[C@@H](c3cc(O)cc(O)c3)O2)[C@@H](C)C[C@@H]1C,IC50,4000.0,5.4,CHEMBL974034,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL145,O=C(O)/C=C/c1ccc(O)c(O)c1,IC50,2800.0,5.55,CHEMBL1004835,Inhibition of HIV1 integrase in presence of Mn2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL507259,O=C(O)/C=C/c1ccc(O)c(O)c1CC(=O)O,IC50,1340.0,5.87,CHEMBL1004829,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1340.0,5.872895201635192
CHEMBL507259,O=C(O)/C=C/c1ccc(O)c(O)c1CC(=O)O,IC50,1090.0,5.96,CHEMBL1004830,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1090.0,5.962573502059376
CHEMBL524273,O=C(O)/C=C/c1ccc(O)c(O)c1/C(=C/c1ccc(O)c(O)c1)C(=O)O,IC50,560.0,6.25,CHEMBL1004829,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,560.0,6.251811972993799
CHEMBL524273,O=C(O)/C=C/c1ccc(O)c(O)c1/C(=C/c1ccc(O)c(O)c1)C(=O)O,IC50,730.0,6.14,CHEMBL1004830,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,730.0,6.136677139879544
CHEMBL497672,O=C(O)/C=C/c1ccc(O)c2c1C1C(=O)c3cc(O)c(O)cc3C1O2,IC50,150.0,6.82,CHEMBL1004829,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,150.0,6.823908740944319
CHEMBL497672,O=C(O)/C=C/c1ccc(O)c2c1C1C(=O)c3cc(O)c(O)cc3C1O2,IC50,300.0,6.52,CHEMBL1004830,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL249447,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1O,IC50,640.0,6.19,CHEMBL1004834,Inhibition of HIV1 integrase catalyzed reactions,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,640.0,6.1938200260161125
CHEMBL145,O=C(O)/C=C/c1ccc(O)c(O)c1,IC50,2800.0,5.55,CHEMBL1004829,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL145,O=C(O)/C=C/c1ccc(O)c(O)c1,IC50,24000.0,4.62,CHEMBL1004830,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL486871,O=C1OC(c2cc(OCc3ccccc3)cc(OCc3ccccc3)c2)C(c2ccc(F)cc2)=C1O,IC50,30000.0,4.52,CHEMBL1006480,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL487034,O=C1OC(c2ccc(OCc3ccccc3)c(OCc3ccccc3)c2)C(c2ccc(F)cc2)=C1O,IC50,10000.0,5.0,CHEMBL1006480,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL520072,O=C1OC(c2ccc(OCc3ccccc3)c(OCc3ccccc3)c2)C(c2ccc(O)cc2)=C1O,IC50,1000.0,6.0,CHEMBL1006480,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL487884,O=C1OC(c2cc(O)cc(O)c2)C(c2ccc(O)cc2)=C1O,IC50,22000.0,4.66,CHEMBL1006480,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL487885,O=C1OC(c2ccc(O)c(O)c2)C(c2ccc(O)cc2)=C1O,IC50,9200.0,5.04,CHEMBL1006480,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9200.0,5.036212172654444
CHEMBL521053,O=C1OC(c2cc(O)cc(O)c2)C(c2ccc(F)cc2)=C1O,IC50,92000.0,4.04,CHEMBL1006480,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,92000.0,4.036212172654444
CHEMBL505145,O=C1OCC(c2ccc(O)cc2)=C1O,IC50,3600.0,5.44,CHEMBL1006480,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3600.0,5.443697499232712
CHEMBL453857,Cc1cc(S(=O)(=O)Nc2nc3ccccc3c(=O)n2N)c(S)cc1Cl,IC50,100000.0,,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL453857,Cc1cc(S(=O)(=O)Nc2nc3ccccc3c(=O)n2N)c(S)cc1Cl,IC50,100000.0,,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL471330,Cc1cc(S(=O)(=O)Nc2nc3ccsc3c(=O)[nH]2)c(SCc2ccccc2)cc1Cl,IC50,100000.0,,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL513058,Cc1cc(S(=O)(=O)Nc2nc3cscc3c(=O)[nH]2)c(SCc2ccccc2)cc1Cl,IC50,100000.0,,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL479348,O=C(Nc1ccc(Cl)cc1)c1cc(S(=O)(=O)Nc2nc3ccccc3c(=O)[nH]2)c(SCc2ccccc2)cc1Cl,IC50,100000.0,,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL455050,COc1ccc(NC(=O)c2cc(S(=O)(=O)Nc3nc4ccccc4c(=O)[nH]3)c(SCc3ccccc3)cc2Cl)cc1,IC50,100000.0,,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL479347,Cc1ccc(NC(=O)c2cc(S(=O)(=O)Nc3nc4ccccc4c(=O)[nH]3)c(SCc3ccccc3)cc2Cl)cc1,IC50,100000.0,,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL479537,O=C(Nc1ccccc1)c1cc(S(=O)(=O)Nc2nc3ccccc3c(=O)[nH]2)c(SCc2ccccc2)cc1Cl,IC50,73000.0,4.14,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,73000.0,4.136677139879544
CHEMBL471328,NC(=O)c1cc(S(=O)(=O)Nc2nc3ccccc3c(=O)[nH]2)c(SCc2ccccc2)cc1Cl,IC50,100000.0,,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL471327,Cc1cc(S(=O)(=O)Nc2nc3cc(Cl)ccc3c(=O)[nH]2)c(SCc2ccccc2)cc1Cl,IC50,47000.0,4.33,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47000.0,4.327902142064283
CHEMBL513057,Cc1cc(S(=O)(=O)Nc2nc3ccccc3c(=O)[nH]2)c(SCc2ccccc2)cc1Cl,IC50,100000.0,,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL459891,Cc1cc(S(=O)(=O)Nc2nc3cc(-c4ccsc4)sc3c(=O)n2Cc2ccco2)c(S)cc1Cl,IC50,8000.0,5.1,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL459890,Cc1cc(S(=O)(=O)Nc2nc3cc(-c4ccc(Cl)cc4)sc3c(=O)n2Cc2ccccc2)c(S)cc1Cl,IC50,6000.0,5.22,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL461997,Cc1cc(S(=O)(=O)Nc2nc3cc(-c4ccccc4)sc3c(=O)n2Cc2ccccc2)c(S)cc1Cl,IC50,9000.0,5.05,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL461996,Cc1cc(S(=O)(=O)Nc2nc3cc(C(C)(C)C)sc3c(=O)n2Cc2ccccc2)c(S)cc1Cl,IC50,22000.0,4.66,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL460943,Cc1cc(S(=O)(=O)Nc2nc3ccsc3c(=O)n2Cc2ccco2)c(S)cc1Cl,IC50,62000.0,4.21,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,62000.0,4.2076083105017466
CHEMBL518799,Cc1cc(S(=O)(=O)Nc2nc3ccsc3c(=O)n2Cc2ccccc2)c(S)cc1Cl,IC50,53000.0,4.28,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53000.0,4.275724130399211
CHEMBL462344,Cc1cc(S(=O)(=O)Nc2nc3cscc3c(=O)n2Cc2ccccc2)c(S)cc1Cl,IC50,80000.0,4.1,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL518513,Cc1cc(S(=O)(=O)Nc2nc3ccccc3c(=O)n2Cc2ccco2)c(S)cc1Cl,IC50,78000.0,4.11,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,78000.0,4.107905397309519
CHEMBL449305,Cc1cc(S(=O)(=O)Nc2nc3n[nH]cc3c(=O)n2N)c(S)cc1Cl,IC50,100000.0,,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL518478,Cc1cc(S(=O)(=O)Nc2nc3sc(C)c(C)c3c(=O)n2N)c(S)cc1Cl,IC50,55000.0,4.26,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55000.0,4.259637310505756
CHEMBL459878,Cc1cc(S(=O)(=O)Nc2nc3scc(C)c3c(=O)n2N)c(S)cc1Cl,IC50,100000.0,,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL462561,Cc1cc(S(=O)(=O)Nc2nc3cc(C(C)(C)C)sc3c(=O)n2N)c(S)cc1Cl,IC50,60000.0,4.22,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL516661,Cc1cc(S(=O)(=O)Nc2nc3ccsc3c(=O)n2N)c(S)cc1Cl,IC50,65000.0,4.19,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL459879,Cc1cc(S(=O)(=O)Nc2nc3cscc3c(=O)n2N)c(S)cc1Cl,IC50,69000.0,4.16,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69000.0,4.161150909262744
CHEMBL453356,COc1cc2nc(NS(=O)(=O)c3cc(C)c(Cl)cc3S)n(N)c(=O)c2cc1OC,IC50,100000.0,,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL471330,Cc1cc(S(=O)(=O)Nc2nc3ccsc3c(=O)[nH]2)c(SCc2ccccc2)cc1Cl,IC50,70000.0,4.16,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL513058,Cc1cc(S(=O)(=O)Nc2nc3cscc3c(=O)[nH]2)c(SCc2ccccc2)cc1Cl,IC50,78000.0,4.11,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,78000.0,4.107905397309519
CHEMBL479348,O=C(Nc1ccc(Cl)cc1)c1cc(S(=O)(=O)Nc2nc3ccccc3c(=O)[nH]2)c(SCc2ccccc2)cc1Cl,IC50,52000.0,4.28,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52000.0,4.2839966563652006
CHEMBL455050,COc1ccc(NC(=O)c2cc(S(=O)(=O)Nc3nc4ccccc4c(=O)[nH]3)c(SCc3ccccc3)cc2Cl)cc1,IC50,93000.0,4.03,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,93000.0,4.031517051446065
CHEMBL479347,Cc1ccc(NC(=O)c2cc(S(=O)(=O)Nc3nc4ccccc4c(=O)[nH]3)c(SCc3ccccc3)cc2Cl)cc1,IC50,77000.0,4.11,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,77000.0,4.113509274827518
CHEMBL479537,O=C(Nc1ccccc1)c1cc(S(=O)(=O)Nc2nc3ccccc3c(=O)[nH]2)c(SCc2ccccc2)cc1Cl,IC50,36000.0,4.44,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36000.0,4.443697499232713
CHEMBL471328,NC(=O)c1cc(S(=O)(=O)Nc2nc3ccccc3c(=O)[nH]2)c(SCc2ccccc2)cc1Cl,IC50,100000.0,,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL471327,Cc1cc(S(=O)(=O)Nc2nc3cc(Cl)ccc3c(=O)[nH]2)c(SCc2ccccc2)cc1Cl,IC50,33000.0,4.48,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL513057,Cc1cc(S(=O)(=O)Nc2nc3ccccc3c(=O)[nH]2)c(SCc2ccccc2)cc1Cl,IC50,83000.0,4.08,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,83000.0,4.080921907623926
CHEMBL459891,Cc1cc(S(=O)(=O)Nc2nc3cc(-c4ccsc4)sc3c(=O)n2Cc2ccco2)c(S)cc1Cl,IC50,6000.0,5.22,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL459890,Cc1cc(S(=O)(=O)Nc2nc3cc(-c4ccc(Cl)cc4)sc3c(=O)n2Cc2ccccc2)c(S)cc1Cl,IC50,4000.0,5.4,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL461997,Cc1cc(S(=O)(=O)Nc2nc3cc(-c4ccccc4)sc3c(=O)n2Cc2ccccc2)c(S)cc1Cl,IC50,6000.0,5.22,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL461996,Cc1cc(S(=O)(=O)Nc2nc3cc(C(C)(C)C)sc3c(=O)n2Cc2ccccc2)c(S)cc1Cl,IC50,4000.0,5.4,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL460943,Cc1cc(S(=O)(=O)Nc2nc3ccsc3c(=O)n2Cc2ccco2)c(S)cc1Cl,IC50,53000.0,4.28,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53000.0,4.275724130399211
CHEMBL518799,Cc1cc(S(=O)(=O)Nc2nc3ccsc3c(=O)n2Cc2ccccc2)c(S)cc1Cl,IC50,29000.0,4.54,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,29000.0,4.537602002101044
CHEMBL462344,Cc1cc(S(=O)(=O)Nc2nc3cscc3c(=O)n2Cc2ccccc2)c(S)cc1Cl,IC50,31000.0,4.51,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31000.0,4.508638306165727
CHEMBL518513,Cc1cc(S(=O)(=O)Nc2nc3ccccc3c(=O)n2Cc2ccco2)c(S)cc1Cl,IC50,42000.0,4.38,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42000.0,4.376750709602099
CHEMBL449305,Cc1cc(S(=O)(=O)Nc2nc3n[nH]cc3c(=O)n2N)c(S)cc1Cl,IC50,100000.0,,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL518478,Cc1cc(S(=O)(=O)Nc2nc3sc(C)c(C)c3c(=O)n2N)c(S)cc1Cl,IC50,39000.0,4.41,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39000.0,4.4089353929735005
CHEMBL459878,Cc1cc(S(=O)(=O)Nc2nc3scc(C)c3c(=O)n2N)c(S)cc1Cl,IC50,81000.0,4.09,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,81000.0,4.0915149811213505
CHEMBL462561,Cc1cc(S(=O)(=O)Nc2nc3cc(C(C)(C)C)sc3c(=O)n2N)c(S)cc1Cl,IC50,35000.0,4.46,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL516661,Cc1cc(S(=O)(=O)Nc2nc3ccsc3c(=O)n2N)c(S)cc1Cl,IC50,53000.0,4.28,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53000.0,4.275724130399211
CHEMBL459879,Cc1cc(S(=O)(=O)Nc2nc3cscc3c(=O)n2N)c(S)cc1Cl,IC50,43000.0,4.37,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43000.0,4.366531544420414
CHEMBL453356,COc1cc2nc(NS(=O)(=O)c3cc(C)c(Cl)cc3S)n(N)c(=O)c2cc1OC,IC50,100000.0,,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL472374,Cc1cc(S(=O)(=O)Nc2nc(N)n[nH]2)c(S)cc1Cl,IC50,4790.0,5.32,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4790.0,5.319664486585436
CHEMBL472204,Cc1cc(S(=O)(=O)Nc2nc(=O)c3ccccc3n2C)c(SCc2ccccc2)cc1Cl,IC50,100000.0,,CHEMBL1006488,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL472374,Cc1cc(S(=O)(=O)Nc2nc(N)n[nH]2)c(S)cc1Cl,IC50,4900.0,5.31,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4900.0,5.309803919971486
CHEMBL472204,Cc1cc(S(=O)(=O)Nc2nc(=O)c3ccccc3n2C)c(SCc2ccccc2)cc1Cl,IC50,90000.0,4.05,CHEMBL1006489,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL458494,O=C(O)c1cc(-c2cccc(OCc3ccccc3)c2)on1,IC50,100000.0,,CHEMBL972695,Inhibition of HIV1 wild type integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL458494,O=C(O)c1cc(-c2cccc(OCc3ccccc3)c2)on1,IC50,68000.0,4.17,CHEMBL972696,Inhibition of HIV1 wild type integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68000.0,4.167491087293763
CHEMBL455952,O=C(O)c1cc(-c2cccc(OCc3ccccc3)c2)[nH]n1,IC50,100000.0,4.0,CHEMBL972696,Inhibition of HIV1 wild type integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL455820,O=C(O)c1cc(-c2cccc(OCc3ccccc3)c2)no1,IC50,81000.0,4.09,CHEMBL972696,Inhibition of HIV1 wild type integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,81000.0,4.0915149811213505
CHEMBL512205,O=C(NO)c1cc(-c2cccc(OCc3ccccc3)c2)on1,IC50,27000.0,4.57,CHEMBL972696,Inhibition of HIV1 wild type integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27000.0,4.568636235841013
CHEMBL450074,O=C(O)c1cc(-c2ccc([N+](=O)[O-])cc2)on1,IC50,97000.0,4.01,CHEMBL972696,Inhibition of HIV1 wild type integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,97000.0,4.013228265733755
CHEMBL509967,O=C(O)c1csnc1-c1cccc(OCc2ccccc2)c1,IC50,100000.0,,CHEMBL972695,Inhibition of HIV1 wild type integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL455955,O=C(O)c1cc(-c2cccc(OCc3ccccc3)c2)ns1,IC50,100000.0,,CHEMBL972695,Inhibition of HIV1 wild type integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL455954,COC(=O)c1cc(-c2ccc([N+](=O)[O-])cc2)[nH]n1,IC50,100000.0,,CHEMBL972695,Inhibition of HIV1 wild type integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL455953,O=C(O)c1cc(-c2ccc([N+](=O)[O-])cc2)[nH]n1,IC50,100000.0,,CHEMBL972695,Inhibition of HIV1 wild type integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL455952,O=C(O)c1cc(-c2cccc(OCc3ccccc3)c2)[nH]n1,IC50,100000.0,,CHEMBL972695,Inhibition of HIV1 wild type integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL455820,O=C(O)c1cc(-c2cccc(OCc3ccccc3)c2)no1,IC50,100000.0,,CHEMBL972695,Inhibition of HIV1 wild type integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL512205,O=C(NO)c1cc(-c2cccc(OCc3ccccc3)c2)on1,IC50,100000.0,,CHEMBL972695,Inhibition of HIV1 wild type integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL450074,O=C(O)c1cc(-c2ccc([N+](=O)[O-])cc2)on1,IC50,100000.0,,CHEMBL972695,Inhibition of HIV1 wild type integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL509967,O=C(O)c1csnc1-c1cccc(OCc2ccccc2)c1,IC50,100000.0,,CHEMBL972696,Inhibition of HIV1 wild type integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL455955,O=C(O)c1cc(-c2cccc(OCc3ccccc3)c2)ns1,IC50,100000.0,,CHEMBL972696,Inhibition of HIV1 wild type integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL455954,COC(=O)c1cc(-c2ccc([N+](=O)[O-])cc2)[nH]n1,IC50,100000.0,,CHEMBL972696,Inhibition of HIV1 wild type integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL455953,O=C(O)c1cc(-c2ccc([N+](=O)[O-])cc2)[nH]n1,IC50,100000.0,,CHEMBL972696,Inhibition of HIV1 wild type integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL458483,O=C(O)c1cn(CCO)c2ccc(Oc3ccc(F)c(Cl)c3)cc2c1=O,IC50,86900.0,4.06,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,86900.0,4.060980223551334
CHEMBL458483,O=C(O)c1cn(CCO)c2ccc(Oc3ccc(F)c(Cl)c3)cc2c1=O,IC50,100000.0,,CHEMBL998726,Inhibition of HIV1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL204656,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C,IC50,50.0,7.3,CHEMBL998726,Inhibition of HIV1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL204656,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C,IC50,2.0,8.7,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL498504,CCn1cc(C(=O)O)c(=O)c2c1C(=O)C=CC2=O,IC50,43700.0,4.36,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43700.0,4.359518563029578
CHEMBL497661,CCn1cc(C(=O)O)c(=O)c2c1C(=O)C=C(Sc1ccccc1)C2=O,IC50,4600.0,5.34,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4600.0,5.337242168318426
CHEMBL497490,CCn1cc(C(=O)O)c(=O)c2c1C(=O)C=C(Nc1ccc(F)c(Cl)c1)C2=O,IC50,1000.0,6.0,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL497489,CCn1cc(C(=O)O)c(=O)c2c1C(=O)C=C(Nc1cccc(Cl)c1F)C2=O,IC50,9700.0,5.01,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9700.0,5.013228265733755
CHEMBL526269,O=C(O)c1cn(CCO)c2ccc(-c3ccncc3)cc2c1=O,IC50,77600.0,4.11,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,77600.0,4.110138278741812
CHEMBL444410,O=C(O)c1cn(CCO)c2ccc(-c3ccccc3)cc2c1=O,IC50,100000.0,,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL498491,CCn1cc(C(=O)O)c(=O)c2cc(Nc3cccc(Cl)c3F)ccc21,IC50,38000.0,4.42,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38000.0,4.42021640338319
CHEMBL498490,O=C(O)c1cn(CCO)c2ccc(Nc3cccc(Cl)c3F)cc2c1=O,IC50,100000.0,,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL498321,O=C(Nc1ccc2c(c1)c(=O)c(C(=O)O)cn2CCO)c1ccccc1,IC50,100000.0,,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL497476,O=C(Nc1ccccc1)c1ccc2c(c1)c(=O)c(C(=O)O)cn2CCO,IC50,100000.0,,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL497475,O=C(O)c1cn(CCO)c2ccc(/C=C/c3ccccc3)cc2c1=O,IC50,71900.0,4.14,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,71900.0,4.1432711096171175
CHEMBL496491,O=C(c1ccc2c(c1)c(=O)c(C(=O)O)cn2CCCCO)c1ccc(Cl)cc1Cl,IC50,54900.0,4.26,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54900.0,4.2604276555499085
CHEMBL496476,O=C(c1ccc2c(c1)c(=O)c(C(=O)O)cn2CCCO)c1ccc(Cl)cc1Cl,IC50,73900.0,4.13,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,73900.0,4.131355561605174
CHEMBL497506,O=C(c1ccc2c(c1)c(=O)c(C(=O)O)cn2CCO)c1ccc(Cl)cc1Cl,IC50,18700.0,4.73,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18700.0,4.728158393463501
CHEMBL526642,COCCn1cc(C(=O)O)c(=O)c2cc(Cc3ccc(Cl)cc3Cl)ccc21,IC50,5600.0,5.25,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5600.0,5.251811972993799
CHEMBL497505,CN(C)CCn1cc(C(=O)O)c(=O)c2cc(Cc3ccc(Cl)cc3Cl)ccc21,IC50,10800.0,4.97,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10800.0,4.966576244513051
CHEMBL522229,O=C(O)c1cn(CCCCO)c2ccc(Cc3ccc(Cl)cc3Cl)cc2c1=O,IC50,50.0,7.3,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL458280,O=C(O)c1cn(CCCO)c2ccc(Cc3ccc(Cl)cc3Cl)cc2c1=O,IC50,900.0,6.05,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL458279,O=C(O)c1cn(CCO)c2ccc(Cc3ccc(Cl)cc3Cl)cc2c1=O,IC50,70.0,7.16,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL511508,O=C(O)c1cn(CCO)c2ccc(Sc3ccccc3)cc2c1=O,IC50,4800.0,5.32,CHEMBL998725,Inhibition of HIV1 integrase by overall integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4800.0,5.318758762624412
CHEMBL497489,CCn1cc(C(=O)O)c(=O)c2c1C(=O)C=C(Nc1cccc(Cl)c1F)C2=O,IC50,100000.0,,CHEMBL998726,Inhibition of HIV1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL526269,O=C(O)c1cn(CCO)c2ccc(-c3ccncc3)cc2c1=O,IC50,100000.0,,CHEMBL998726,Inhibition of HIV1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL498491,CCn1cc(C(=O)O)c(=O)c2cc(Nc3cccc(Cl)c3F)ccc21,IC50,100000.0,,CHEMBL998726,Inhibition of HIV1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL496491,O=C(c1ccc2c(c1)c(=O)c(C(=O)O)cn2CCCCO)c1ccc(Cl)cc1Cl,IC50,100000.0,,CHEMBL998726,Inhibition of HIV1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL496476,O=C(c1ccc2c(c1)c(=O)c(C(=O)O)cn2CCCO)c1ccc(Cl)cc1Cl,IC50,100000.0,,CHEMBL998726,Inhibition of HIV1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL497506,O=C(c1ccc2c(c1)c(=O)c(C(=O)O)cn2CCO)c1ccc(Cl)cc1Cl,IC50,100000.0,,CHEMBL998726,Inhibition of HIV1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL522229,O=C(O)c1cn(CCCCO)c2ccc(Cc3ccc(Cl)cc3Cl)cc2c1=O,IC50,16600.0,4.78,CHEMBL998726,Inhibition of HIV1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16600.0,4.779891911959945
CHEMBL458483,O=C(O)c1cn(CCO)c2ccc(Oc3ccc(F)c(Cl)c3)cc2c1=O,IC50,100000.0,,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL498504,CCn1cc(C(=O)O)c(=O)c2c1C(=O)C=CC2=O,IC50,58700.0,4.23,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58700.0,4.231361898752386
CHEMBL497661,CCn1cc(C(=O)O)c(=O)c2c1C(=O)C=C(Sc1ccccc1)C2=O,IC50,1600.0,5.8,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL497490,CCn1cc(C(=O)O)c(=O)c2c1C(=O)C=C(Nc1ccc(F)c(Cl)c1)C2=O,IC50,2100.0,5.68,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2100.0,5.6777807052660805
CHEMBL497489,CCn1cc(C(=O)O)c(=O)c2c1C(=O)C=C(Nc1cccc(Cl)c1F)C2=O,IC50,100000.0,,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL526269,O=C(O)c1cn(CCO)c2ccc(-c3ccncc3)cc2c1=O,IC50,100000.0,,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL444410,O=C(O)c1cn(CCO)c2ccc(-c3ccccc3)cc2c1=O,IC50,100000.0,,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL498491,CCn1cc(C(=O)O)c(=O)c2cc(Nc3cccc(Cl)c3F)ccc21,IC50,100000.0,,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL498490,O=C(O)c1cn(CCO)c2ccc(Nc3cccc(Cl)c3F)cc2c1=O,IC50,100000.0,,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL498321,O=C(Nc1ccc2c(c1)c(=O)c(C(=O)O)cn2CCO)c1ccccc1,IC50,100000.0,,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL497476,O=C(Nc1ccccc1)c1ccc2c(c1)c(=O)c(C(=O)O)cn2CCO,IC50,100000.0,,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL497475,O=C(O)c1cn(CCO)c2ccc(/C=C/c3ccccc3)cc2c1=O,IC50,100000.0,,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL496491,O=C(c1ccc2c(c1)c(=O)c(C(=O)O)cn2CCCCO)c1ccc(Cl)cc1Cl,IC50,100000.0,,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL496476,O=C(c1ccc2c(c1)c(=O)c(C(=O)O)cn2CCCO)c1ccc(Cl)cc1Cl,IC50,100000.0,,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL497506,O=C(c1ccc2c(c1)c(=O)c(C(=O)O)cn2CCO)c1ccc(Cl)cc1Cl,IC50,100000.0,,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL526642,COCCn1cc(C(=O)O)c(=O)c2cc(Cc3ccc(Cl)cc3Cl)ccc21,IC50,16500.0,4.78,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16500.0,4.782516055786093
CHEMBL497505,CN(C)CCn1cc(C(=O)O)c(=O)c2cc(Cc3ccc(Cl)cc3Cl)ccc21,IC50,24100.0,4.62,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24100.0,4.617982957425132
CHEMBL522229,O=C(O)c1cn(CCCCO)c2ccc(Cc3ccc(Cl)cc3Cl)cc2c1=O,IC50,600.0,6.22,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL458280,O=C(O)c1cn(CCCO)c2ccc(Cc3ccc(Cl)cc3Cl)cc2c1=O,IC50,1300.0,5.89,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL458279,O=C(O)c1cn(CCO)c2ccc(Cc3ccc(Cl)cc3Cl)cc2c1=O,IC50,200.0,6.7,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL511508,O=C(O)c1cn(CCO)c2ccc(Sc3ccccc3)cc2c1=O,IC50,18500.0,4.73,CHEMBL998727,Inhibition of HIV1 integrase DNA strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18500.0,4.732828271596986
CHEMBL503254,O=C(O)CCc1ccc(-c2ccc(Cl)cc2)n1CC(=O)O,IC50,100000.0,,CHEMBL1021381,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL517724,O=C(O)Cc1cc(S(=O)(=O)c2ccc(Sc3ccc(C(=O)O)cc3)cc2)ccc1C(=O)O,IC50,100000.0,,CHEMBL1021381,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL462690,O=C(O)CCN1C(=O)/C(=C2/C(=O)N(CC(=O)O)c3ccccc32)SC1=S,IC50,100000.0,,CHEMBL1021381,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL467436,Cc1oc(C)c(C(=O)O)c1COc1ccccc1C(=O)O,IC50,100000.0,,CHEMBL1021381,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL512260,O=C(O)CN1C(=O)/C(=C\c2ccc(-c3cccc(C(=O)O)c3)o2)SC1=S,IC50,100000.0,,CHEMBL1021381,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL467435,O=C(O)Cn1c(CCCCc2nc3ccccc3n2CC(=O)O)nc2ccccc21,IC50,100000.0,,CHEMBL1021381,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL496565,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccccc2F)c2cccc(OC)c12,IC50,380.0,6.42,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,380.0,6.42021640338319
CHEMBL495970,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cccc(F)c2)c2cccc(OC)c12,IC50,300.0,6.52,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL521567,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cccc(F)c2F)c2cccc(OC)c12,IC50,5.0,8.3,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL496580,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2F)c2cccc(OC)c12,IC50,110.0,6.96,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL496379,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cc(F)ccc2F)c2cccc(OC)c12,IC50,1410.0,5.85,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1410.0,5.85078088734462
CHEMBL496380,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2c(F)cccc2F)c2cccc(OC)c12,IC50,360.0,6.44,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,360.0,6.443697499232712
CHEMBL496142,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)c(F)c2)c2cccc(OC)c12,IC50,26450.0,4.58,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26450.0,4.577574323628795
CHEMBL496143,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cc(F)cc(F)c2)c2cccc(OC)c12,IC50,1520.0,5.82,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1520.0,5.818156412055227
CHEMBL496346,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)c(F)c2F)c2cccc(OC)c12,IC50,3010.0,5.52,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3010.0,5.521433504406156
CHEMBL498204,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2c(F)ccc(F)c2F)c2cccc(OC)c12,IC50,170.0,6.77,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,170.0,6.769551078621726
CHEMBL497394,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cc(F)c(F)c(F)c2)c2cccc(OC)c12,IC50,2000.0,5.7,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL497605,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccccc1F,IC50,70.0,7.16,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL525898,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cccc(F)c1,IC50,30.0,7.52,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL495952,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cccc(F)c1F,IC50,10.0,8.0,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL523901,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1F,IC50,10.0,8.0,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL499475,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cc(F)ccc1F,IC50,50.0,7.3,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL495540,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1c(F)cccc1F,IC50,130.0,6.89,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL495960,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)c(F)c1,IC50,420.0,6.38,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,420.0,6.376750709602099
CHEMBL524066,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cc(F)cc(F)c1,IC50,440.0,6.36,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,440.0,6.356547323513812
CHEMBL521569,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)c(F)c1F,IC50,140.0,6.85,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,140.0,6.853871964321762
CHEMBL498202,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cc(F)c(F)c(F)c1,IC50,60.0,7.22,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL496565,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccccc2F)c2cccc(OC)c12,IC50,720.0,6.14,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,720.0,6.142667503568731
CHEMBL495970,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cccc(F)c2)c2cccc(OC)c12,IC50,2260.0,5.65,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2260.0,5.645891560852599
CHEMBL521567,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cccc(F)c2F)c2cccc(OC)c12,IC50,12.0,7.92,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL496580,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2F)c2cccc(OC)c12,IC50,670.0,6.17,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,670.0,6.173925197299173
CHEMBL496379,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cc(F)ccc2F)c2cccc(OC)c12,IC50,400.0,6.4,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL496380,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2c(F)cccc2F)c2cccc(OC)c12,IC50,70.0,7.16,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL496142,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)c(F)c2)c2cccc(OC)c12,IC50,1560.0,5.81,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1560.0,5.806875401645538
CHEMBL496143,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cc(F)cc(F)c2)c2cccc(OC)c12,IC50,2740.0,5.56,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2740.0,5.562249437179612
CHEMBL496346,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)c(F)c2F)c2cccc(OC)c12,IC50,1150.0,5.94,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1150.0,5.939302159646388
CHEMBL498204,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2c(F)ccc(F)c2F)c2cccc(OC)c12,IC50,820.0,6.09,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,820.0,6.086186147616283
CHEMBL497394,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cc(F)c(F)c(F)c2)c2cccc(OC)c12,IC50,1410.0,5.85,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1410.0,5.85078088734462
CHEMBL497605,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccccc1F,IC50,40.0,7.4,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL525898,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cccc(F)c1,IC50,30.0,7.52,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL495952,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cccc(F)c1F,IC50,120.0,6.92,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,120.0,6.920818753952375
CHEMBL523901,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1F,IC50,20.0,7.7,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL499475,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cc(F)ccc1F,IC50,20.0,7.7,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL495540,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1c(F)cccc1F,IC50,80.0,7.1,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL495960,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)c(F)c1,IC50,600.0,6.22,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL524066,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cc(F)cc(F)c1,IC50,240.0,6.62,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,240.0,6.619788758288394
CHEMBL521569,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)c(F)c1F,IC50,280.0,6.55,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,280.0,6.552841968657781
CHEMBL526283,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1c(F)ccc(F)c1F,IC50,160.0,6.8,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,160.0,6.795880017344075
CHEMBL498202,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cc(F)c(F)c(F)c1,IC50,100.0,7.0,CHEMBL1020689,Inhibition of HIV1 integrase strand transfer activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL526283,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1c(F)ccc(F)c1F,IC50,130.0,6.89,CHEMBL1020688,Inhibition of HIV1 integrase activity by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL464213,CCCCCn1c(=O)c(C(=O)Nc2cc([N+](=O)[O-])ccc2O)c(O)c2ccccc21,IC50,9000.0,5.05,CHEMBL1014187,Inhibition of HIV1 integrase 3' processing activity by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL464212,Cn1c(=O)c(C(=O)O)c(O)c2cc(Cc3ccccc3)ccc21,IC50,45000.0,4.35,CHEMBL1014187,Inhibition of HIV1 integrase 3' processing activity by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45000.0,4.346787486224656
CHEMBL464215,Cn1c(=O)c(C(=O)O)c(O)c2cc(Cc3ccc(F)cc3)ccc21,IC50,23000.0,4.64,CHEMBL1014187,Inhibition of HIV1 integrase 3' processing activity by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL464216,Cn1c(=O)c(C(=O)O)c(O)c2cc(Oc3ccccc3)ccc21,IC50,34000.0,4.47,CHEMBL1014187,Inhibition of HIV1 integrase 3' processing activity by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34000.0,4.468521082957745
CHEMBL511191,CCCCCn1c(=O)c(C(=O)O)c(O)c2cc(Cc3ccc(F)cc3)ccc21,IC50,92000.0,4.04,CHEMBL1014187,Inhibition of HIV1 integrase 3' processing activity by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,92000.0,4.036212172654444
CHEMBL50605,O=C(O)C(=O)CC(=O)c1cccn1Cc1ccc(F)cc1,IC50,15000.0,4.82,CHEMBL1014187,Inhibition of HIV1 integrase 3' processing activity by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL464213,CCCCCn1c(=O)c(C(=O)Nc2cc([N+](=O)[O-])ccc2O)c(O)c2ccccc21,IC50,9000.0,5.05,CHEMBL1014188,Inhibition of HIV1 integrase strand transfer activity by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL464212,Cn1c(=O)c(C(=O)O)c(O)c2cc(Cc3ccccc3)ccc21,IC50,6000.0,5.22,CHEMBL1014188,Inhibition of HIV1 integrase strand transfer activity by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL464215,Cn1c(=O)c(C(=O)O)c(O)c2cc(Cc3ccc(F)cc3)ccc21,IC50,900.0,6.05,CHEMBL1014188,Inhibition of HIV1 integrase strand transfer activity by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL464216,Cn1c(=O)c(C(=O)O)c(O)c2cc(Oc3ccccc3)ccc21,IC50,14000.0,4.85,CHEMBL1014188,Inhibition of HIV1 integrase strand transfer activity by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL511191,CCCCCn1c(=O)c(C(=O)O)c(O)c2cc(Cc3ccc(F)cc3)ccc21,IC50,5000.0,5.3,CHEMBL1014188,Inhibition of HIV1 integrase strand transfer activity by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL50605,O=C(O)C(=O)CC(=O)c1cccn1Cc1ccc(F)cc1,IC50,540.0,6.27,CHEMBL1014188,Inhibition of HIV1 integrase strand transfer activity by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,540.0,6.267606240177031
CHEMBL499839,Oc1c(-c2noc(-c3ccccc3)n2)ncc2cccnc12,IC50,100000.0,,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL510677,Oc1c(-c2noc(Cc3ccccc3)n2)ncc2cccnc12,IC50,950.0,6.02,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,950.0,6.022276394711152
CHEMBL455437,Oc1c(-c2noc(Cc3ccc(F)cc3)n2)ncc2cccnc12,IC50,130.0,6.89,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL455438,Oc1c(-c2nnc(Cc3ccccc3)[nH]2)ncc2cccnc12,IC50,360.0,6.44,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,360.0,6.443697499232712
CHEMBL522630,Oc1c(-c2nnc(Cc3ccc(F)cc3)[nH]2)ncc2cccnc12,IC50,130.0,6.89,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL523303,Oc1c(-c2nnc(Cc3ccc(Cl)cc3)[nH]2)ncc2cccnc12,IC50,640.0,6.19,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,640.0,6.1938200260161125
CHEMBL490971,Oc1c(-c2nnc(Cc3cccc(Cl)c3)[nH]2)ncc2cccnc12,IC50,1030.0,5.99,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1030.0,5.987162775294828
CHEMBL490972,COc1cccc(Cc2nnc(-c3ncc4cccnc4c3O)[nH]2)c1,IC50,2800.0,5.55,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL523468,COc1ccc(Cc2nnc(-c3ncc4cccnc4c3O)[nH]2)cc1OC,IC50,6300.0,5.2,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6300.0,5.200659450546418
CHEMBL491149,Oc1c(-c2nnc(CCc3ccccc3)[nH]2)ncc2cccnc12,IC50,2400.0,5.62,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2400.0,5.619788758288394
CHEMBL490970,Oc1c(-c2nnc(Cc3ccncc3)[nH]2)ncc2cccnc12,IC50,4600.0,5.34,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4600.0,5.337242168318426
CHEMBL523302,Oc1c(-c2nnc(Cc3cccnc3)[nH]2)ncc2cccnc12,IC50,3500.0,5.46,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3500.0,5.455931955649724
CHEMBL523974,Oc1c(-c2nnc(Cc3ccccc3)o2)ncc2cccnc12,IC50,130.0,6.89,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL491150,Oc1c(-c2nnc(Cc3ccc(F)cc3)o2)ncc2cccnc12,IC50,42.0,7.38,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42.0,7.376750709602099
CHEMBL491685,Cn1nc(-c2ncc3cccnc3c2O)nc1Cc1ccc(F)cc1,IC50,7900.0,5.1,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7900.0,5.102372908709558
CHEMBL199145,O=C(NCc1ccc(F)cc1)c1ncc2cccnc2c1O,IC50,12.0,7.92,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL453400,O=S1(=O)CCCCN1c1nc(-c2noc(Cc3ccc(F)cc3)n2)c(O)c2ncccc12,IC50,100000.0,,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL452588,O=S1(=O)CCCCN1c1nc(-c2nnc(Cc3ccc(F)cc3)[nH]2)c(O)c2ncccc12,IC50,11.0,7.96,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL454633,O=S1(=O)CCCCN1c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12,IC50,2.0,8.7,CHEMBL1015285,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL501858,O=C(O)/C(O)=C/C(=O)c1cccc(NC(=O)c2ccc(O)cc2)c1,IC50,81000.0,4.09,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,81000.0,4.0915149811213505
CHEMBL501858,O=C(O)/C(O)=C/C(=O)c1cccc(NC(=O)c2ccc(O)cc2)c1,IC50,13000.0,4.89,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL516404,O=C(/C=C/c1ccc(O)cc1)Nc1cccc(C(=O)/C=C(\O)C(=O)O)c1,IC50,26000.0,4.58,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26000.0,4.585026652029182
CHEMBL516404,O=C(/C=C/c1ccc(O)cc1)Nc1cccc(C(=O)/C=C(\O)C(=O)O)c1,IC50,7000.0,5.16,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL475819,O=C(/C=C/c1ccc(F)cc1)Nc1cccc(C(=O)/C=C(\O)C(=O)O)c1,IC50,22000.0,4.66,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL475819,O=C(/C=C/c1ccc(F)cc1)Nc1cccc(C(=O)/C=C(\O)C(=O)O)c1,IC50,7000.0,5.16,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL475828,O=C(/C=C/c1ccc(Cl)cc1)Nc1cccc(C(=O)/C=C(\O)C(=O)O)c1,IC50,18000.0,4.75,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL475828,O=C(/C=C/c1ccc(Cl)cc1)Nc1cccc(C(=O)/C=C(\O)C(=O)O)c1,IC50,4000.0,5.4,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL506796,COc1ccc(/C=C/C(=O)Nc2cccc(C(=O)/C=C(\O)C(=O)O)c2)cc1,IC50,30000.0,4.52,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL506796,COc1ccc(/C=C/C(=O)Nc2cccc(C(=O)/C=C(\O)C(=O)O)c2)cc1,IC50,11000.0,4.96,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL475661,COc1cc(/C=C/C(=O)Nc2cccc(C(=O)/C=C(\O)C(=O)O)c2)ccc1O,IC50,42000.0,4.38,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42000.0,4.376750709602099
CHEMBL475661,COc1cc(/C=C/C(=O)Nc2cccc(C(=O)/C=C(\O)C(=O)O)c2)ccc1O,IC50,11000.0,4.96,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL514990,O=C(O)/C(O)=C/C(=O)c1cccc(NC(=O)c2ccccc2)c1,IC50,100000.0,,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL514990,O=C(O)/C(O)=C/C(=O)c1cccc(NC(=O)c2ccccc2)c1,IC50,31000.0,4.51,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31000.0,4.508638306165727
CHEMBL500308,O=C(Cc1ccccc1)Nc1cccc(C(=O)/C=C(\O)C(=O)O)c1,IC50,56000.0,4.25,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL500308,O=C(Cc1ccccc1)Nc1cccc(C(=O)/C=C(\O)C(=O)O)c1,IC50,7000.0,5.16,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL475852,O=C(O)/C(O)=C/C(=O)c1cccc(NC(=O)c2ccco2)c1,IC50,100000.0,,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL475852,O=C(O)/C(O)=C/C(=O)c1cccc(NC(=O)c2ccco2)c1,IC50,33000.0,4.48,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL475853,O=C(O)/C(O)=C/C(=O)c1cccc(NC(=O)c2ccccc2O)c1,IC50,41000.0,4.39,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41000.0,4.3872161432802645
CHEMBL475853,O=C(O)/C(O)=C/C(=O)c1cccc(NC(=O)c2ccccc2O)c1,IC50,11000.0,4.96,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL475854,O=C(O)/C(O)=C/C(=O)c1cccc(NC(=O)c2cc([N+](=O)[O-])cc([N+](=O)[O-])c2O)c1,IC50,8000.0,5.1,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL475854,O=C(O)/C(O)=C/C(=O)c1cccc(NC(=O)c2cc([N+](=O)[O-])cc([N+](=O)[O-])c2O)c1,IC50,2000.0,5.7,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL474027,Cc1cccc(C(=O)Nc2cccc(C(=O)/C=C(\O)C(=O)O)c2)c1O,IC50,48000.0,4.32,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48000.0,4.318758762624412
CHEMBL474027,Cc1cccc(C(=O)Nc2cccc(C(=O)/C=C(\O)C(=O)O)c2)c1O,IC50,10000.0,5.0,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL474861,COc1ccccc1C(=O)Nc1cccc(C(=O)/C=C(\O)C(=O)O)c1,IC50,73000.0,4.14,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,73000.0,4.136677139879544
CHEMBL474861,COc1ccccc1C(=O)Nc1cccc(C(=O)/C=C(\O)C(=O)O)c1,IC50,13000.0,4.89,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL474862,COc1cccc(C(=O)Nc2cccc(C(=O)/C=C(\O)C(=O)O)c2)c1,IC50,69000.0,4.16,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69000.0,4.161150909262744
CHEMBL474862,COc1cccc(C(=O)Nc2cccc(C(=O)/C=C(\O)C(=O)O)c2)c1,IC50,12000.0,4.92,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL474034,COc1ccc(C(=O)Nc2cccc(C(=O)/C=C(\O)C(=O)O)c2)cc1,IC50,95000.0,4.02,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,95000.0,4.022276394711152
CHEMBL474034,COc1ccc(C(=O)Nc2cccc(C(=O)/C=C(\O)C(=O)O)c2)cc1,IC50,19000.0,4.72,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL474035,O=C(O)/C(O)=C/C(=O)c1cccc(NC(=O)c2ccccc2Cl)c1,IC50,92000.0,4.04,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,92000.0,4.036212172654444
CHEMBL474035,O=C(O)/C(O)=C/C(=O)c1cccc(NC(=O)c2ccccc2Cl)c1,IC50,18000.0,4.75,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL510239,O=C(O)/C(O)=C/C(=O)c1cccc(NC(=O)c2cccc(Cl)c2)c1,IC50,57000.0,4.24,CHEMBL1030755,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57000.0,4.2441251443275085
CHEMBL510239,O=C(O)/C(O)=C/C(=O)c1cccc(NC(=O)c2cccc(Cl)c2)c1,IC50,15000.0,4.82,CHEMBL1030756,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL492526,O=C(NCc1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12)c1ccccc1,IC50,24.0,7.62,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24.0,7.619788758288394
CHEMBL492525,CC(=O)N1CCN(Cc2cccn3c(=O)c(O)c(C(=O)NCc4ccc(F)cc4)nc23)CC1,IC50,185.0,6.73,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,185.0,6.732828271596986
CHEMBL492524,O=C(NCc1ccc(F)cc1)c1nc2c(CN3CCOCC3)cccn2c(=O)c1O,IC50,170.0,6.77,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,170.0,6.769551078621726
CHEMBL523678,Cc1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,9.0,8.05,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL492930,O=C(Nc1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12)c1ccccc1,IC50,18.0,7.75,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL493531,CN(C)c1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,70.0,7.16,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL493335,CCNc1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,36.0,7.44,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36.0,7.443697499232712
CHEMBL492727,CNc1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,130.0,6.89,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL499184,O=C(NCc1ccc(F)cc1)c1nc2ccccn2c(=O)c1O,IC50,22.0,7.66,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22.0,7.657577319177793
CHEMBL494946,CCN(C(=O)CN(C)C)c1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,185.0,6.73,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,185.0,6.732828271596986
CHEMBL492932,CCN(C(=O)CN1CCOCC1)c1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,23.0,7.64,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23.0,7.638272163982407
CHEMBL492328,CCN(C(=O)c1ccncc1)c1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,50.0,7.3,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL492329,CCN(C(=O)c1ccccn1)c1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,21.0,7.68,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL495144,CCN(C(=O)c1nnc(C)o1)c1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,50.0,7.3,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL495145,CCN(C(=O)c1cscn1)c1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,21.0,7.68,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL523833,CCN(C(=O)c1ccno1)c1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,18.0,7.75,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL492537,CN(C)C(=O)C(=O)N(C)c1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,26.0,7.58,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26.0,7.585026652029182
CHEMBL522534,CCN(C(=O)C(=O)N(C)C)c1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,36.0,7.44,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36.0,7.443697499232712
CHEMBL494944,CCCN(C(=O)C(=O)N(C)C)c1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,18.0,7.75,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL494945,CC(C)N(C(=O)C(=O)N(C)C)c1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,21.0,7.68,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL492538,CCN(CC)C(=O)C(=O)N(CC)c1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,19.0,7.72,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19.0,7.721246399047171
CHEMBL522653,CCN(C(=O)C(=O)N1CCOCC1)c1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,25.0,7.6,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25.0,7.6020599913279625
CHEMBL492350,CCN(C(=O)C(=O)N1CCCC1)c1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,21.0,7.68,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL492543,CCN(C(=O)C(=O)N1CCN(C)CC1)c1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,21.0,7.68,CHEMBL957610,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL249447,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1O,IC50,0.66,,CHEMBL1033271,Inhibition of HIV1 integrase-catalyzed disintegration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,1277.942899187731,5.893488550811183
CHEMBL498876,COC(=O)C(=O)O[C@]1(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1,IC50,0.57,,CHEMBL1033271,Inhibition of HIV1 integrase-catalyzed disintegration activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,946.0565210680145,6.0240829163945335
CHEMBL513386,CCCCCC[C@H]1OC(=O)C2=C1[C@@H](O)[C@@H]1O[C@@H]1[C@@H]2O,IC50,41000.0,4.39,CHEMBL996421,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41000.0,4.3872161432802645
CHEMBL443442,O=C(OC[C@H]1O[C@@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@@H](O)[C@H]1O)c1cc(O)c(O)c(O)c1,IC50,24.2,,CHEMBL1026710,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,31486.268994221853,4.501878798595613
CHEMBL382408,O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,IC50,28.0,,CHEMBL1026710,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,29765.66976477678,4.5262843408335725
CHEMBL447974,O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@@H](O)[C@@H]1O)c1cc(O)c(O)c(O)c1,IC50,28.3,,CHEMBL1026710,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,44463.926871766336,4.351992184834751
CHEMBL65675,COC(=O)c1cc(O)c(O)c(O)c1,IC50,28.5,,CHEMBL1026710,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,154767.65844678436,3.81031978800426
CHEMBL505880,O=C(O[C@H]1[C@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)O[C@H](CO)[C@H](O)[C@@H]1O)c1cc(O)c(O)c(O)c1,IC50,27.9,,CHEMBL1026710,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,45256.6489965676,4.34431760628446
CHEMBL501837,O=C(O[C@H]1[C@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)OC[C@H](O)[C@@H]1O)c1cc(O)c(O)c(O)c1,IC50,18.1,,CHEMBL1026710,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,30863.250224227464,4.510558340096637
CHEMBL493291,CN(C)C(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,230.0,6.64,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,230.0,6.638272163982407
CHEMBL517136,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)[nH]1,IC50,4.0,8.4,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,15.0,7.82,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL462045,Cn1c(C(C)(C)NC(=O)c2c[nH]cn2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,6.0,8.22,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL460977,Cn1c(C(C)(C)NC(=O)c2cscn2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,8.0,8.1,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL460771,Cn1c(C(C)(C)NC(=O)c2cnco2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,7.0,8.15,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL518491,Cn1c(C(C)(C)NC(=O)c2ncccn2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,7.0,8.15,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL460770,Cn1c(C(C)(C)NC(=O)c2cccnn2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,15.0,7.82,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL461406,Cn1c(C(C)(C)NC(=O)c2ccccn2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,20.0,7.7,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL461405,CN(C)C(=O)C(=O)NC(C)(C)c1nc(C(=O)NCc2ccc(F)c(Cl)c2)c(O)c(=O)n1C,IC50,9.0,8.05,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL517428,CN(C)C(=O)C(=O)NC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2S(C)(=O)=O)c(O)c(=O)n1C,IC50,4.0,8.4,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL461652,COc1cccc(CNC(=O)c2nc(C(C)(C)NC(=O)C(=O)N(C)C)n(C)c(=O)c2O)c1OC,IC50,21.0,7.68,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL492683,CNC(=O)c1nc(C(C)(C)NC(=O)C(=O)N(C)C)n(C)c(=O)c1O,IC50,5000.0,,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL492682,CN1CCN(C(=O)C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)CC1,IC50,26.0,7.58,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26.0,7.585026652029182
CHEMBL510093,Cn1c(C(C)(C)NC(=O)C(=O)N2CCOCC2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,20.0,7.7,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL493920,CN(C)C(=O)C(=O)N(C)C(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,15.0,7.82,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL522374,Cn1c(C(C)(C)NC(=O)C(=O)O)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,4.0,8.4,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL495332,COC(=O)C(=O)NC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,15.0,7.82,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL495331,CN(C)C(=O)C(=O)NC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,10.0,8.0,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL493295,CN(C)S(=O)(=O)NC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,12.0,7.92,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL505332,CN(C)C(=O)NC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,18.0,7.75,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL524164,Cn1c(C(C)(C)NS(C)(=O)=O)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,8.0,8.1,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL492667,CC(=O)NC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,7.0,8.15,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL492465,CN(C)C1(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)CCOCC1,IC50,2.0,8.7,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL492464,Cn1c(C(C)(C)N2CCOCC2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,3.0,8.52,CHEMBL968064,Inhibition of HIV1 recombinant integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL464128,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,82000.0,4.09,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,82000.0,4.086186147616283
CHEMBL446297,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](OS(=O)(=O)O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,4000.0,5.4,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL503991,C=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=C([C@@H](O)[C@H](OC(C)=O)[C@]12C)[C@@]1(C)C[C@@H](O)[C@H](OS(=O)(=O)O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,5000.0,5.3,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL501254,CC(=O)O[C@H]1[C@H](O)C2=C(CC[C@H]3C(C)(C)[C@@H](OS(=O)(=O)O)[C@H](OC(=O)CCCCCCCCCCCCCCCO)C[C@]23C)C2=CC[C@H]([C@H](C)CCC3(C(C)(C)O)CO3)[C@]21C,IC50,5000.0,5.3,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL454134,CC(=O)O[C@H]1[C@H](O)C2=C(CC[C@H]3C(C)(C)[C@@H](OS(=O)(=O)O)[C@H](OC(=O)CCCCCCCCCCCCCCCO)C[C@]23C)[C@@H]2CC[C@H]([C@H](C)CCC3(C(C)(C)O)CO3)[C@]21C,IC50,5600.0,5.25,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5600.0,5.251811972993799
CHEMBL453488,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)CC[C@H](OS(=O)(=O)O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,3100.0,5.51,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3100.0,5.508638306165727
CHEMBL452658,C[C@H](CCC(O)C(C)(C)O)[C@H]1CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)C[C@@H](OC(=O)CC(C)(O)CC(=O)O)C(=O)C(C)(C)[C@@H]1CC3,IC50,47000.0,4.33,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47000.0,4.327902142064283
CHEMBL500469,COC(=O)CC(C)(O)CC(=O)O[C@@H]1C[C@]2(C)C3=C(CC[C@H]2C(C)(C)C1=O)[C@]1(C)CC[C@H]([C@H](C)CCC(O)C(C)(C)O)[C@@]1(C)CC3,IC50,70000.0,4.16,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL513686,C[C@H](CCC(O)C(C)(C)O)[C@H]1CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)C[C@@H](O)C(=O)C(C)(C)[C@@H]1CC3,IC50,68000.0,4.17,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68000.0,4.167491087293763
CHEMBL468450,C=C(CC[C@@H](C)[C@H]1C[C@H](OC)c2c3c(cc(C)c21)[C@@]1(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,4.3,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL468451,C=C(CC[C@@H](C)[C@H]1C[C@@H](OC)c2c3c(cc(C)c21)[C@@]1(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,4.3,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL467410,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C(C(=O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,75000.0,4.12,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75000.0,4.1249387366083
CHEMBL468459,C=C(CC[C@@H](C)[C@H]1CC(=O)C2=C3CC[C@H]4C(C)(C)[C@@H](O)[C@H](O)C[C@]4(C)C3=C[C@H](OC(C)=O)[C@@]21C)C(C)C,IC50,25000.0,4.6,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL510011,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(C)=O)[C@H](OC(C)=O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL518806,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,48000.0,4.32,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48000.0,4.318758762624412
CHEMBL455285,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@H]2OC(C)(C)O[C@@H]2C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL468668,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H]2O[C@@H]2C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL449270,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)C(C)(C)[C@@H]1CC3)C(C)C,IC50,69000.0,,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69000.0,4.161150909262744
CHEMBL507912,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](OC(=O)c2ccccc2)C(C)(C)[C@@H]1CC3)C(C)C,IC50,80000.0,,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL510890,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)c2ccccc2)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,80000.0,,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL511014,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OCOC)[C@H](OCOC)C(C)(C)[C@@H]1CC3)C(C)C,IC50,80000.0,,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL505723,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](OCOC)C(C)(C)[C@@H]1CC3)C(C)C,IC50,80000.0,,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL503134,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OCOC)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,80000.0,,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL506797,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](OC(=O)CCC(=O)O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,3000.0,5.52,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL391925,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CCC(=O)O)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,3000.0,5.52,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL449147,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](OC(=O)CCC(=O)OC)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL431685,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CCC(=O)OC)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL507659,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CCC(=O)NO)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,8000.0,5.1,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL447895,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CNC(=O)OC(C)(C)C)[C@H](OC(=O)CNC(=O)OC(C)(C)C)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL455501,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CNC(=O)OC(C)(C)C)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL447061,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CNC(=O)OCC2c4ccccc4-c4ccccc42)[C@H](OC(=O)CNC(=O)OCC2c4ccccc4-c4ccccc42)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL446808,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CNC(=O)OCC2c4ccccc4-c4ccccc42)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL443983,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CN)[C@H](OC(=O)CN)C(C)(C)[C@@H]1CC3)C(C)C.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,IC50,1700.0,5.77,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL501573,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CN)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C.O=C(O)C(F)(F)F,IC50,23000.0,4.64,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL444993,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](OC(=O)CN)C(C)(C)[C@@H]1CC3)C(C)C.O=C(O)C(F)(F)F,IC50,18000.0,4.75,CHEMBL993786,Inhibition of recombinant HIV1 integrase using unprocessed donor DNA by coupled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL446297,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](OS(=O)(=O)O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,9000.0,5.05,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL464128,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,100000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL503991,C=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=C([C@@H](O)[C@H](OC(C)=O)[C@]12C)[C@@]1(C)C[C@@H](O)[C@H](OS(=O)(=O)O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,15000.0,4.82,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL501254,CC(=O)O[C@H]1[C@H](O)C2=C(CC[C@H]3C(C)(C)[C@@H](OS(=O)(=O)O)[C@H](OC(=O)CCCCCCCCCCCCCCCO)C[C@]23C)C2=CC[C@H]([C@H](C)CCC3(C(C)(C)O)CO3)[C@]21C,IC50,14000.0,4.85,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL454134,CC(=O)O[C@H]1[C@H](O)C2=C(CC[C@H]3C(C)(C)[C@@H](OS(=O)(=O)O)[C@H](OC(=O)CCCCCCCCCCCCCCCO)C[C@]23C)[C@@H]2CC[C@H]([C@H](C)CCC3(C(C)(C)O)CO3)[C@]21C,IC50,5600.0,5.25,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5600.0,5.251811972993799
CHEMBL453488,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)CC[C@H](OS(=O)(=O)O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,4800.0,5.32,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4800.0,5.318758762624412
CHEMBL452658,C[C@H](CCC(O)C(C)(C)O)[C@H]1CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)C[C@@H](OC(=O)CC(C)(O)CC(=O)O)C(=O)C(C)(C)[C@@H]1CC3,IC50,85000.0,4.07,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,85000.0,4.070581074285707
CHEMBL500469,COC(=O)CC(C)(O)CC(=O)O[C@@H]1C[C@]2(C)C3=C(CC[C@H]2C(C)(C)C1=O)[C@]1(C)CC[C@H]([C@H](C)CCC(O)C(C)(C)O)[C@@]1(C)CC3,IC50,100000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL513686,C[C@H](CCC(O)C(C)(C)O)[C@H]1CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)C[C@@H](O)C(=O)C(C)(C)[C@@H]1CC3,IC50,100000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL468450,C=C(CC[C@@H](C)[C@H]1C[C@H](OC)c2c3c(cc(C)c21)[C@@]1(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,100000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL468451,C=C(CC[C@@H](C)[C@H]1C[C@@H](OC)c2c3c(cc(C)c21)[C@@]1(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,100000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL467410,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C(C(=O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,100000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL468459,C=C(CC[C@@H](C)[C@H]1CC(=O)C2=C3CC[C@H]4C(C)(C)[C@@H](O)[C@H](O)C[C@]4(C)C3=C[C@H](OC(C)=O)[C@@]21C)C(C)C,IC50,40000.0,4.4,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL510011,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(C)=O)[C@H](OC(C)=O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL518806,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL455285,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@H]2OC(C)(C)O[C@@H]2C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL468668,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H]2O[C@@H]2C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL449270,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)C(C)(C)[C@@H]1CC3)C(C)C,IC50,69000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69000.0,4.161150909262744
CHEMBL507912,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](OC(=O)c2ccccc2)C(C)(C)[C@@H]1CC3)C(C)C,IC50,80000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL510890,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)c2ccccc2)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,80000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL511014,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OCOC)[C@H](OCOC)C(C)(C)[C@@H]1CC3)C(C)C,IC50,80000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL505723,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](OCOC)C(C)(C)[C@@H]1CC3)C(C)C,IC50,80000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL503134,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OCOC)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,80000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL506797,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](OC(=O)CCC(=O)O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,12000.0,4.92,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL391925,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CCC(=O)O)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,12000.0,4.92,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL449147,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](OC(=O)CCC(=O)OC)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL431685,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CCC(=O)OC)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL507659,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CCC(=O)NO)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL447895,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CNC(=O)OC(C)(C)C)[C@H](OC(=O)CNC(=O)OC(C)(C)C)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL455501,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CNC(=O)OC(C)(C)C)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL447061,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CNC(=O)OCC2c4ccccc4-c4ccccc42)[C@H](OC(=O)CNC(=O)OCC2c4ccccc4-c4ccccc42)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL446808,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CNC(=O)OCC2c4ccccc4-c4ccccc42)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL443983,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CN)[C@H](OC(=O)CN)C(C)(C)[C@@H]1CC3)C(C)C.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,IC50,11500.0,4.94,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11500.0,4.939302159646388
CHEMBL501573,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CN)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C.O=C(O)C(F)(F)F,IC50,50000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL444993,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](OC(=O)CN)C(C)(C)[C@@H]1CC3)C(C)C.O=C(O)C(F)(F)F,IC50,50000.0,,CHEMBL993787,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA treated after washing excess enzyme by strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL446297,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](OS(=O)(=O)O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,5000.0,5.3,CHEMBL993788,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL503991,C=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=C([C@@H](O)[C@H](OC(C)=O)[C@]12C)[C@@]1(C)C[C@@H](O)[C@H](OS(=O)(=O)O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,5000.0,5.3,CHEMBL993788,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL501254,CC(=O)O[C@H]1[C@H](O)C2=C(CC[C@H]3C(C)(C)[C@@H](OS(=O)(=O)O)[C@H](OC(=O)CCCCCCCCCCCCCCCO)C[C@]23C)C2=CC[C@H]([C@H](C)CCC3(C(C)(C)O)CO3)[C@]21C,IC50,10000.0,5.0,CHEMBL993788,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL454134,CC(=O)O[C@H]1[C@H](O)C2=C(CC[C@H]3C(C)(C)[C@@H](OS(=O)(=O)O)[C@H](OC(=O)CCCCCCCCCCCCCCCO)C[C@]23C)[C@@H]2CC[C@H]([C@H](C)CCC3(C(C)(C)O)CO3)[C@]21C,IC50,2000.0,5.7,CHEMBL993788,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL506797,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](OC(=O)CCC(=O)O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,5000.0,5.3,CHEMBL993788,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing reaction,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL503991,C=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=C([C@@H](O)[C@H](OC(C)=O)[C@]12C)[C@@]1(C)C[C@@H](O)[C@H](OS(=O)(=O)O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,10000.0,5.0,CHEMBL993791,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA by assembly assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL454134,CC(=O)O[C@H]1[C@H](O)C2=C(CC[C@H]3C(C)(C)[C@@H](OS(=O)(=O)O)[C@H](OC(=O)CCCCCCCCCCCCCCCO)C[C@]23C)[C@@H]2CC[C@H]([C@H](C)CCC3(C(C)(C)O)CO3)[C@]21C,IC50,12000.0,4.92,CHEMBL993791,Inhibition of recombinant HIV1 integrase using preprocessed donor DNA by assembly assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL446297,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](OS(=O)(=O)O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,50000.0,4.3,CHEMBL993792,Inhibition of HIV1 integrase-mediated preintegration complex formation by Southern blotting,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL503991,C=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=C([C@@H](O)[C@H](OC(C)=O)[C@]12C)[C@@]1(C)C[C@@H](O)[C@H](OS(=O)(=O)O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,30000.0,4.52,CHEMBL993792,Inhibition of HIV1 integrase-mediated preintegration complex formation by Southern blotting,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL454134,CC(=O)O[C@H]1[C@H](O)C2=C(CC[C@H]3C(C)(C)[C@@H](OS(=O)(=O)O)[C@H](OC(=O)CCCCCCCCCCCCCCCO)C[C@]23C)[C@@H]2CC[C@H]([C@H](C)CCC3(C(C)(C)O)CO3)[C@]21C,IC50,50000.0,4.3,CHEMBL993792,Inhibition of HIV1 integrase-mediated preintegration complex formation by Southern blotting,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL506797,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](O)[C@H](OC(=O)CCC(=O)O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,12500.0,4.9,CHEMBL993792,Inhibition of HIV1 integrase-mediated preintegration complex formation by Southern blotting,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12500.0,4.903089986991944
CHEMBL391925,C=C(CC[C@@H](C)[C@H]1CC=C2C3=C([C@@H](O)[C@H](OC(C)=O)[C@@]21C)[C@@]1(C)C[C@@H](OC(=O)CCC(=O)O)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C,IC50,6000.0,5.22,CHEMBL993792,Inhibition of HIV1 integrase-mediated preintegration complex formation by Southern blotting,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL468656,CCCC[C@@H](C)C1=C(O)C(=O)[C@@H]2C[C@H](C)C[C@H](C(=O)O)[C@H]2[C@]1(C)C(=O)CCO,IC50,20000.0,4.7,CHEMBL992093,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL512638,CCCCCC[C@@H](C)C1=C(O)C(=O)[C@@H]2[C@H](O)[C@H](C)C[C@H](O)[C@H]2[C@]1(C)C(=O)/C=C\O,IC50,20000.0,4.7,CHEMBL992093,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL444968,OCC(O)C#CC#CCCCCCCC#C/C=C/Br,IC50,50.0,,CHEMBL982279,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,154688.61182439752,3.8105416578835305
CHEMBL451305,OCC(O)C#CC#CCCCC/C=C/C#C/C=C/Br,IC50,50.0,,CHEMBL982279,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,155659.4668974578,3.807824461256442
CHEMBL447447,OCC(O)C#CC#CCCCCC#CC#C/C=C/Br,IC50,50.0,,CHEMBL982279,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,156642.5854798589,3.8050901571907776
CHEMBL499451,OCC(O)C#CC#CCCCCCCCC/C=C/Br,IC50,50.0,,CHEMBL982279,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,152782.78565797437,3.815925575831721
CHEMBL467406,OCC(O)C#CC#CCCCCCCC#C/C=C\Br,IC50,50.0,,CHEMBL982279,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,154688.61182439752,3.8105416578835305
CHEMBL468667,O=S(=O)(O)OCC(O)C#CC#CCCCCCCC#C/C=C/Br,IC50,30.0,,CHEMBL982279,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,74387.41959959731,4.128500506126848
CHEMBL468248,O=S(=O)(O)OCCC#CC#CCCCCC#CC#C/C=C/Br,IC50,30.0,,CHEMBL982279,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,78275.23136853806,4.106375640007044
CHEMBL512823,O=S(=O)(O)OCC(O)C#CC#CCCCCCCCC/C=C/Br,IC50,30.0,,CHEMBL982279,Inhibition of HIV1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,73651.08046135036,4.132820877674568
CHEMBL476357,CN1CC(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)CC1=O,IC50,20.0,7.7,CHEMBL987043,Inhibition of recombinant HIV1 integrase strand transfer activity using immobilized DNA substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL514555,CCN1CC(c2nc(C(=O)NCc3ccc(F)cc3S(C)(=O)=O)c(O)c3ncccc23)CC1=O,IC50,26.0,7.58,CHEMBL987043,Inhibition of recombinant HIV1 integrase strand transfer activity using immobilized DNA substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26.0,7.585026652029182
CHEMBL478452,CN1CC(c2nc(C(=O)NCc3ccc(F)cc3S(C)(=O)=O)c(O)c3ncccc23)CC1=O,IC50,123.0,6.91,CHEMBL987043,Inhibition of recombinant HIV1 integrase strand transfer activity using immobilized DNA substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,123.0,6.910094888560602
CHEMBL478239,CN(C)C(=O)CN1CC(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)CC1=O,IC50,33.0,7.48,CHEMBL987043,Inhibition of recombinant HIV1 integrase strand transfer activity using immobilized DNA substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33.0,7.481486060122112
CHEMBL514836,O=C1CC(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)CN1,IC50,24.0,7.62,CHEMBL987043,Inhibition of recombinant HIV1 integrase strand transfer activity using immobilized DNA substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24.0,7.619788758288394
CHEMBL476565,CC(C)N1CC(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)CC1=O,IC50,40.0,7.4,CHEMBL987043,Inhibition of recombinant HIV1 integrase strand transfer activity using immobilized DNA substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL476564,CCN1CC(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)CC1=O,IC50,14.0,7.85,CHEMBL987043,Inhibition of recombinant HIV1 integrase strand transfer activity using immobilized DNA substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL520039,CC[NH+](CC)CC.Cc1cc2c(c(=O)o1)C(/C=C/C=C1\O[B-](F)(F)Oc3cc(C)oc(=O)c31)=[O+][B-](F)(F)O2,IC50,13000.0,4.89,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL520039,CC[NH+](CC)CC.Cc1cc2c(c(=O)o1)C(/C=C/C=C1\O[B-](F)(F)Oc3cc(C)oc(=O)c31)=[O+][B-](F)(F)O2,IC50,7000.0,5.16,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL490208,COc1ccc(Br)cc1/C=C/C(=O)c1c(O)cc(/C=C/c2ccc(N(C)C)cc2)oc1=O,IC50,100000.0,4.0,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL523454,COc1ccc(Br)cc1/C=C/C1=[O+][B-](F)(F)Oc2cc(/C=C/c3ccc(N(C)C)cc3)oc(=O)c21,IC50,100000.0,,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL490207,COc1ccc(/C=C/C(=O)c2c(O)cc(/C=C/c3ccc(N(C)C)cc3)oc2=O)cc1,IC50,100000.0,,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL522103,COc1ccc(/C=C/C2=[O+][B-](F)(F)Oc3cc(/C=C/c4ccc(N(C)C)cc4)oc(=O)c32)cc1,IC50,100000.0,,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL490003,CN(C)c1ccc(/C=C/C(=O)c2c(O)cc(/C=C/c3ccc(N(C)C)cc3)oc2=O)cc1,IC50,100000.0,,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL491024,CN(C)c1ccc(/C=C/C2=[O+][B-](F)(F)Oc3cc(/C=C/c4ccc(N(C)C)cc4)oc(=O)c32)cc1,IC50,100000.0,,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL478042,Cc1cc(O)c(C(=O)/C=C/C=C/c2ccc(N(C)C)cc2)c(=O)o1,IC50,100000.0,,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL478041,Cc1cc2c(c(=O)o1)C(/C=C/C=C/c1ccc(N(C)C)cc1)=[O+][B-](F)(F)O2,IC50,100000.0,4.0,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL515646,Cc1cc(O)c(C(=O)/C=C/C=C2/N(C)c3ccccc3C2(C)C)c(=O)o1,IC50,100000.0,,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL514856,Cc1cc2c(c(=O)o1)C(/C=C/C=C1/N(C)c3ccccc3C1(C)C)=[O+][B-](F)(F)O2,IC50,100000.0,,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL507575,Cc1cc2c(c(=O)o1)C(/C=C/c1ccc(N(C)C)s1)=[O+][B-](F)(F)O2,IC50,100000.0,,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL479088,Cc1cc(O)c(C(=O)/C=C/c2ccc(F)cc2)c(=O)o1,IC50,100000.0,,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL449287,Cc1cc(O)c(C(=O)/C=C/c2ccc(Br)cc2)c(=O)o1,IC50,100000.0,,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL490818,COc1ccc(/C=C/C=C/C(=O)c2c(O)cc(C)oc2=O)cc1,IC50,39000.0,4.41,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39000.0,4.4089353929735005
CHEMBL516726,COc1ccc(/C=C/C=C/C2=[O+][B-](F)(F)Oc3cc(C)oc(=O)c32)cc1,IC50,4000.0,5.4,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL445242,Cc1cc(O)c(C(=O)/C=C/c2ccc(Br)s2)c(=O)o1,IC50,23000.0,4.64,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL478459,Cc1cc2c(c(=O)o1)C(/C=C/c1ccc(Br)s1)=[O+][B-](F)(F)O2,IC50,3000.0,5.52,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL478246,Cc1cc(O)c(C(=O)/C=C/c2ccc(N(C)C)s2)c(=O)o1,IC50,11000.0,4.96,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL490817,Cc1cc2c(c(=O)o1)C(/C=C/c1ccc(F)cc1)=[O+][B-](F)(F)O2,IC50,16000.0,4.8,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL492032,Cc1cc2c(c(=O)o1)C(/C=C/c1ccc(Br)cc1)=[O+][B-](F)(F)O2,IC50,4000.0,5.4,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL491828,Cc1cc2c(c(=O)o1)C(/C=C/c1ccc(N(C)C)cc1)=[O+][B-](F)(F)O2,IC50,56000.0,4.25,CHEMBL994256,Inhibition of wild-type HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL491828,Cc1cc2c(c(=O)o1)C(/C=C/c1ccc(N(C)C)cc1)=[O+][B-](F)(F)O2,IC50,100000.0,,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL492032,Cc1cc2c(c(=O)o1)C(/C=C/c1ccc(Br)cc1)=[O+][B-](F)(F)O2,IC50,12000.0,4.92,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL449287,Cc1cc(O)c(C(=O)/C=C/c2ccc(Br)cc2)c(=O)o1,IC50,100000.0,,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL490817,Cc1cc2c(c(=O)o1)C(/C=C/c1ccc(F)cc1)=[O+][B-](F)(F)O2,IC50,9000.0,5.05,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL479088,Cc1cc(O)c(C(=O)/C=C/c2ccc(F)cc2)c(=O)o1,IC50,64000.0,4.19,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,64000.0,4.1938200260161125
CHEMBL507575,Cc1cc2c(c(=O)o1)C(/C=C/c1ccc(N(C)C)s1)=[O+][B-](F)(F)O2,IC50,100000.0,,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL478246,Cc1cc(O)c(C(=O)/C=C/c2ccc(N(C)C)s2)c(=O)o1,IC50,19000.0,4.72,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL478459,Cc1cc2c(c(=O)o1)C(/C=C/c1ccc(Br)s1)=[O+][B-](F)(F)O2,IC50,9000.0,5.05,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL445242,Cc1cc(O)c(C(=O)/C=C/c2ccc(Br)s2)c(=O)o1,IC50,65000.0,4.19,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL514856,Cc1cc2c(c(=O)o1)C(/C=C/C=C1/N(C)c3ccccc3C1(C)C)=[O+][B-](F)(F)O2,IC50,100000.0,,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL515646,Cc1cc(O)c(C(=O)/C=C/C=C2/N(C)c3ccccc3C2(C)C)c(=O)o1,IC50,100000.0,,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL478041,Cc1cc2c(c(=O)o1)C(/C=C/C=C/c1ccc(N(C)C)cc1)=[O+][B-](F)(F)O2,IC50,100000.0,,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL478042,Cc1cc(O)c(C(=O)/C=C/C=C/c2ccc(N(C)C)cc2)c(=O)o1,IC50,100000.0,,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL516726,COc1ccc(/C=C/C=C/C2=[O+][B-](F)(F)Oc3cc(C)oc(=O)c32)cc1,IC50,11000.0,4.96,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL490818,COc1ccc(/C=C/C=C/C(=O)c2c(O)cc(C)oc2=O)cc1,IC50,100000.0,,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL491024,CN(C)c1ccc(/C=C/C2=[O+][B-](F)(F)Oc3cc(/C=C/c4ccc(N(C)C)cc4)oc(=O)c32)cc1,IC50,100000.0,,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL490003,CN(C)c1ccc(/C=C/C(=O)c2c(O)cc(/C=C/c3ccc(N(C)C)cc3)oc2=O)cc1,IC50,100000.0,,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL522103,COc1ccc(/C=C/C2=[O+][B-](F)(F)Oc3cc(/C=C/c4ccc(N(C)C)cc4)oc(=O)c32)cc1,IC50,100000.0,,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL490207,COc1ccc(/C=C/C(=O)c2c(O)cc(/C=C/c3ccc(N(C)C)cc3)oc2=O)cc1,IC50,100000.0,,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL523454,COc1ccc(Br)cc1/C=C/C1=[O+][B-](F)(F)Oc2cc(/C=C/c3ccc(N(C)C)cc3)oc(=O)c21,IC50,100000.0,,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL490208,COc1ccc(Br)cc1/C=C/C(=O)c1c(O)cc(/C=C/c2ccc(N(C)C)cc2)oc1=O,IC50,100000.0,,CHEMBL993494,Inhibition of wild-type HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL145,O=C(O)/C=C/c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL17362,CCCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL481890,CC(C)OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL481891,C=CCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL481892,C#CCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL29489,CCCCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL452394,CCC(C)OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL467808,CC(C)(C)OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL481573,CC(C)(COC(=O)/C=C/c1ccc(O)c(O)c1)[N+](=O)[O-],IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL472582,O=C(/C=C/c1ccc(O)c(O)c1)OC1CCCCC1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL118111,CCCCCCCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL450591,CCCCCCCCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL471796,CCCCCCC(C)OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL471797,CCCCCCCCCCCCCCCCCCOC(=O)/C=C/c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL471973,O=C(/C=C/c1ccc(O)c(O)c1)Oc1ccccc1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL133714,O=C(/C=C/c1ccc(O)c(O)c1)OCc1ccccc1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL319244,O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL482353,O=C(/C=C/c1ccc(O)c(O)c1)Oc1ccc2ccccc2c1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL482354,CC1(C)C2CCC1(C)C(OC(=O)/C=C/c1ccc(O)c(O)c1)C2,IC50,19900.0,4.7,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19900.0,4.701146923590294
CHEMBL480394,COc1cc(/C=C/C(=O)O)cc([N+](=O)[O-])c1O,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL480395,COc1cc(/C=C/C(=O)OCCc2ccccc2)cc([N+](=O)[O-])c1O,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL480396,COc1cc(/C=C/C(=O)OC2CC3CCC2(C)C3(C)C)cc([N+](=O)[O-])c1O,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL137555,O=C(O)/C=C/c1cc(O)c(O)c([N+](=O)[O-])c1,IC50,26800.0,4.57,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26800.0,4.5718652059712115
CHEMBL481644,O=C(/C=C/c1cc(O)c(O)c([N+](=O)[O-])c1)OCCc1ccccc1,IC50,25000.0,4.6,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL519766,CC1(C)C2CCC1(C)C(OC(=O)/C=C/c1cc(O)c(O)c([N+](=O)[O-])c1)C2,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL32749,COc1cc(/C=C/C(=O)O)ccc1O,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL480747,COc1cc(/C=C/C(=O)O)cc(Cl)c1O,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL480748,COc1cc(/C=C/C(=O)OCCc2ccccc2)cc(Cl)c1O,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL448543,COc1cc(/C=C/C(=O)OC2CC3CCC2(C)C3(C)C)cc(Cl)c1O,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL450003,COc1cc(/C=C/C(=O)O)cc(Br)c1O,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL480927,COc1cc(/C=C/C(=O)OCCc2ccccc2)cc(Br)c1O,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL480928,COc1cc(/C=C/C(=O)OC2CC3CCC2(C)C3(C)C)cc(Br)c1O,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL450032,COc1c(O)ccc(/C=C/C(=O)O)c1[N+](=O)[O-],IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL474594,COc1c(O)ccc(/C=C/C(=O)OCCc2ccccc2)c1[N+](=O)[O-],IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL474595,COc1c(O)ccc(/C=C/C(=O)OC2CC3CCC2(C)C3(C)C)c1[N+](=O)[O-],IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL137762,O=C(O)/C=C/c1ccc(O)c(O)c1[N+](=O)[O-],IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL482316,O=C(/C=C/c1ccc(O)c(O)c1[N+](=O)[O-])OCCc1ccccc1,IC50,100000.0,,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL482317,CC1(C)C2CCC1(C)C(OC(=O)/C=C/c1ccc(O)c(O)c1[N+](=O)[O-])C2,IC50,13500.0,4.87,CHEMBL946684,Inhibition of HIV1 integrase by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13500.0,4.8696662315049934
CHEMBL505948,COc1ccc(-c2c3c4cc(OC)c(OS(=O)(=O)O)cc4oc(=O)c3n3ccc4cc(OC)c(OC)cc4c23)cc1O,IC50,16000.0,4.8,CHEMBL1013067,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL505948,COc1ccc(-c2c3c4cc(OC)c(OS(=O)(=O)O)cc4oc(=O)c3n3ccc4cc(OC)c(OC)cc4c23)cc1O,IC50,22000.0,4.66,CHEMBL1013068,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL474262,COC(=O)[C@]1(O)C[C@@H](O)[C@@H](OC(=O)/C=C/c2cc(OC)c(O)c(OC)c2)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1,IC50,19.4,,CHEMBL977607,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,33766.43720574028,4.471514760611685
CHEMBL282731,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H](C(=O)O)[C@@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,7.4,,CHEMBL977607,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,15599.505875111192,4.8068891579988255
CHEMBL177126,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,IC50,5.4,,CHEMBL977607,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,10455.896447899619,4.980638726530083
CHEMBL249447,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1O,IC50,5.9,,CHEMBL977607,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,11424.035007890323,4.9421804747109075
CHEMBL482232,CCOC(=O)[C@]1(O)C[C@@H](O)[C@@H](O)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1,IC50,44.5,,CHEMBL977607,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,116380.94490866053,3.9341181210474776
CHEMBL446012,COC(=O)[C@]1(O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H](OC(=O)C(C)(O)CC(=O)O)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1,IC50,20.1,,CHEMBL977607,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,30427.759805383426,4.5167300206938785
CHEMBL445715,CCOC(=O)[C@@]1(O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](OC(=O)/C=C/c2cc(OC)c(O)c(OC)c2)C1,IC50,47.4,,CHEMBL977607,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,80535.2707106473,4.094013877144454
CHEMBL475065,COC(=O)[C@@]1(O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](OC(=O)/C=C/c2cc(OC)c(O)c(OC)c2)C1,IC50,23.6,,CHEMBL977607,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,41076.696806983025,4.386404487571804
CHEMBL448070,CCOC(=O)[C@]1(O)C[C@@H](O)[C@@H](OC(=O)/C=C/c2cc(OC)c(O)c(OC)c2)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1,IC50,43.5,,CHEMBL977607,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,ug/mL,73908.95096863198,4.131302961863902
CHEMBL458064,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccccc2c1=O,IC50,670.0,6.17,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,670.0,6.173925197299173
CHEMBL458064,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccccc2c1=O,IC50,440.0,6.36,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,440.0,6.356547323513812
CHEMBL504621,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(F)cc2c1=O,IC50,580.0,6.24,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,580.0,6.236572006437063
CHEMBL504621,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(F)cc2c1=O,IC50,230.0,6.64,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,230.0,6.638272163982407
CHEMBL497501,O=C(O)/C(O)=C/C(=O)c1ccc2c(c1)c(=O)c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,16.0,7.8,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16.0,7.795880017344075
CHEMBL50605,O=C(O)C(=O)CC(=O)c1cccn1Cc1ccc(F)cc1,IC50,50.0,7.3,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL473489,O=C(/C=C(\O)c1nnn[nH]1)c1c[nH]c2ccc(Cl)cc12,IC50,2100.0,5.68,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2100.0,5.6777807052660805
CHEMBL492335,O=C(O)/C(O)=C/C(=O)c1c[nH]c2cc(Cl)ccc2c1=O,IC50,37000.0,4.43,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL496455,CCOC(=O)/C(O)=C/C(=O)c1c[nH]c2ccc(Cl)cc2c1=O,IC50,3300.0,5.48,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3300.0,5.481486060122112
CHEMBL496454,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCCC3)ccc2c1=O,IC50,28.0,7.55,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28.0,7.552841968657781
CHEMBL498713,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(Cl)c(Cl)cc2c1=O,IC50,33.0,7.48,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33.0,7.481486060122112
CHEMBL524807,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2c(Cl)cccc2c1=O,IC50,230.0,6.64,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,230.0,6.638272163982407
CHEMBL497688,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(Cl)ccc2c1=O,IC50,19.0,7.72,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19.0,7.721246399047171
CHEMBL496652,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(Cl)cc2c1=O,IC50,28.0,7.55,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28.0,7.552841968657781
CHEMBL498698,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2c(F)cccc2c1=O,IC50,18.0,7.75,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL498697,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(F)ccc2c1=O,IC50,20.0,7.7,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL456580,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(F)cc2c1=O,IC50,300.0,6.52,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL512195,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccccc2c1=O,IC50,40.0,7.4,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL456365,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCCC3)ccc2c1=O,IC50,2300.0,5.64,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2300.0,5.638272163982407
CHEMBL456158,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(Cl)c(Cl)cc2c1=O,IC50,3900.0,5.41,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3900.0,5.4089353929735005
CHEMBL456991,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2c(Cl)cccc2c1=O,IC50,32000.0,4.5,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL456791,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(Cl)ccc2c1=O,IC50,14000.0,4.85,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL457850,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(Cl)cc2c1=O,IC50,21000.0,4.68,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL514422,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2c(F)cccc2c1=O,IC50,26000.0,4.58,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26000.0,4.585026652029182
CHEMBL458275,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(F)ccc2c1=O,IC50,1300.0,5.89,CHEMBL1004781,Inhibition of recombinant HIV1 integrase strand transfer activity by high throughput electrochemiluminescent assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL497501,O=C(O)/C(O)=C/C(=O)c1ccc2c(c1)c(=O)c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,17.0,7.77,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17.0,7.769551078621726
CHEMBL492335,O=C(O)/C(O)=C/C(=O)c1c[nH]c2cc(Cl)ccc2c1=O,IC50,17000.0,4.77,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL497314,O=C(O)/C(O)=C/C(=O)c1c[nH]c2ccc(Cl)cc2c1=O,IC50,56000.0,4.25,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL496455,CCOC(=O)/C(O)=C/C(=O)c1c[nH]c2ccc(Cl)cc2c1=O,IC50,2100.0,5.68,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2100.0,5.6777807052660805
CHEMBL496454,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCCC3)ccc2c1=O,IC50,180.0,6.75,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,180.0,6.7447274948966935
CHEMBL498713,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(Cl)c(Cl)cc2c1=O,IC50,75.0,7.12,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75.0,7.1249387366083
CHEMBL524807,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2c(Cl)cccc2c1=O,IC50,510.0,6.29,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,510.0,6.292429823902063
CHEMBL497688,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(Cl)ccc2c1=O,IC50,110.0,6.96,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL496652,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(Cl)cc2c1=O,IC50,400.0,6.4,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL498698,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2c(F)cccc2c1=O,IC50,160.0,6.8,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,160.0,6.795880017344075
CHEMBL498697,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(F)ccc2c1=O,IC50,50.0,7.3,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL456580,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(F)cc2c1=O,IC50,2300.0,5.64,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2300.0,5.638272163982407
CHEMBL512195,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccccc2c1=O,IC50,60.0,7.22,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL456365,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCCC3)ccc2c1=O,IC50,2700.0,5.57,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2700.0,5.568636235841012
CHEMBL456158,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(Cl)c(Cl)cc2c1=O,IC50,1800.0,5.75,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL456991,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2c(Cl)cccc2c1=O,IC50,5200.0,5.28,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5200.0,5.2839966563652006
CHEMBL456791,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(Cl)ccc2c1=O,IC50,3600.0,5.44,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3600.0,5.443697499232712
CHEMBL457850,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(Cl)cc2c1=O,IC50,3000.0,5.52,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL514422,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2c(F)cccc2c1=O,IC50,5200.0,5.28,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5200.0,5.2839966563652006
CHEMBL458275,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(F)ccc2c1=O,IC50,1200.0,5.92,CHEMBL1004782,Inhibition of recombinant HIV1 integrase strand transfer activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL497501,O=C(O)/C(O)=C/C(=O)c1ccc2c(c1)c(=O)c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,440.0,6.36,CHEMBL1004783,Inhibition of recombinant HIV1 integrase 3'-end processing activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,440.0,6.356547323513812
CHEMBL496454,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCCC3)ccc2c1=O,IC50,14000.0,4.85,CHEMBL1004783,Inhibition of recombinant HIV1 integrase 3'-end processing activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL498713,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(Cl)c(Cl)cc2c1=O,IC50,11000.0,4.96,CHEMBL1004783,Inhibition of recombinant HIV1 integrase 3'-end processing activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL524807,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2c(Cl)cccc2c1=O,IC50,44000.0,4.36,CHEMBL1004783,Inhibition of recombinant HIV1 integrase 3'-end processing activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44000.0,4.356547323513812
CHEMBL497688,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(Cl)ccc2c1=O,IC50,4000.0,5.4,CHEMBL1004783,Inhibition of recombinant HIV1 integrase 3'-end processing activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL496652,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(Cl)cc2c1=O,IC50,6400.0,5.19,CHEMBL1004783,Inhibition of recombinant HIV1 integrase 3'-end processing activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6400.0,5.1938200260161125
CHEMBL498698,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2c(F)cccc2c1=O,IC50,16000.0,4.8,CHEMBL1004783,Inhibition of recombinant HIV1 integrase 3'-end processing activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL498697,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(F)ccc2c1=O,IC50,4400.0,5.36,CHEMBL1004783,Inhibition of recombinant HIV1 integrase 3'-end processing activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4400.0,5.356547323513812
CHEMBL456580,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(F)cc2c1=O,IC50,2300.0,5.64,CHEMBL1004783,Inhibition of recombinant HIV1 integrase 3'-end processing activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2300.0,5.638272163982407
CHEMBL512195,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccccc2c1=O,IC50,14000.0,4.85,CHEMBL1004783,Inhibition of recombinant HIV1 integrase 3'-end processing activity by gel-based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL456356,Cc1nn(Cc2ccc(F)cc2)c(=O)c2c(O)c3n(c12)[C@@H](C)CN(C(C)C)C3=O,IC50,10.0,,CHEMBL972607,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL457616,CC(C)N1C[C@H](C)n2c(c(O)c3c(=O)n(Cc4ccc(F)cc4)ncc32)C1=O,IC50,10.0,,CHEMBL972607,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL476930,COC(=O)/C(O)=C/C(=O)c1cccc(OCc2ccccc2)c1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL476930,COC(=O)/C(O)=C/C(=O)c1cccc(OCc2ccccc2)c1,IC50,14000.0,4.85,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL467389,O=C(O)/C(O)=C/C(=O)c1ccccc1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL511423,CCCCCC12CCC(C(=O)Nc3cccc(C(=O)CC(=O)C(=O)O)c3)(CC1)CC2,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL468235,O=C(O)/C(O)=C/C(=O)c1ccc([N+](=O)[O-])cc1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL468234,COc1cccc(C(=O)CC(=O)C(=O)N2CCN(C(=O)C(=O)CC(=O)c3cccc(OC)c3)CC2)c1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL512106,COc1cccc(C(=O)CC(=O)C(=O)NC2CCN(C(=O)C(=O)CC(=O)c3cccc(OC)c3)CC2)c1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL468233,COc1cccc(C(=O)CC(=O)C(=O)NC2CCC(NC(=O)C(=O)CC(=O)c3cccc(OC)c3)CC2)c1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL502238,COc1cccc(C(=O)/C=C(\O)C(=O)O)c1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL464340,O=C(CC(=O)c1ccc(C(F)(F)F)cc1)C(=O)N1CCN(C(=O)C(=O)CC(=O)c2ccc(C(F)(F)F)cc2)CC1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL505776,O=C(CC(=O)c1ccc(C(F)(F)F)cc1)C(=O)NC1CCC(NC(=O)C(=O)CC(=O)c2ccc(C(F)(F)F)cc2)CC1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL465864,O=C(O)/C(O)=C/C(=O)c1ccc(C(F)(F)F)cc1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL467351,O=C(CC(=O)c1ccccc1Cl)C(=O)N1CCN(C(=O)C(=O)CC(=O)c2ccccc2Cl)CC1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL469071,O=C(CC(=O)c1ccccc1Cl)C(=O)NC1CCN(C(=O)C(=O)CC(=O)c2ccccc2Cl)CC1,IC50,99000.0,4.0,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,99000.0,4.00436480540245
CHEMBL513666,O=C(CC(=O)c1ccccc1Cl)C(=O)NC1CCC(NC(=O)C(=O)CC(=O)c2ccccc2Cl)CC1,IC50,92000.0,4.04,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,92000.0,4.036212172654444
CHEMBL448880,O=C(O)/C(O)=C/C(=O)c1ccccc1Cl,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL444974,Cc1cc(C(=O)/C=C(\O)C(=O)O)ccc1Cl,IC50,94000.0,4.03,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,94000.0,4.026872146400302
CHEMBL467381,COC(=O)/C(O)=C/C(=O)c1cccc(N(Cc2ccccc2)Cc2ccccc2)c1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL467380,COC(=O)/C(O)=C/C(=O)c1cccc(Cc2ccccc2F)c1,IC50,26000.0,4.58,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26000.0,4.585026652029182
CHEMBL467361,COC(=O)/C(O)=C/C(=O)c1cccc(NC(=O)OCc2ccccc2)c1,IC50,99000.0,4.0,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,99000.0,4.00436480540245
CHEMBL513321,CC(C)(C)OC(=O)N1CCC(NC(=O)/C(O)=C/C(=O)c2ccc(F)cc2)CC1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL467360,O=C(CC(=O)c1ccc(F)cc1)C(=O)N1CCN(C(=O)C(=O)CC(=O)c2ccc(F)cc2)CC1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL467359,O=C(CC(=O)c1ccc(F)cc1)C(=O)NC1CCN(C(=O)C(=O)CC(=O)c2ccc(F)cc2)CC1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL469070,O=C(CC(=O)c1ccc(F)cc1)C(=O)NC1CCC(NC(=O)C(=O)CC(=O)c2ccc(F)cc2)CC1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL469069,COC(=O)/C(O)=C/C(=O)c1ccc(F)cc1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL467169,O=C(CC(=O)c1ccccc1F)C(=O)NC1CCC(NC(=O)C(=O)CC(=O)c2ccccc2F)CC1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL449221,O=C(O)/C(O)=C/C(=O)c1ccccc1F,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL467159,COC(=O)/C(O)=C/C(=O)c1ccccc1F,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL467149,COc1ccc(C(=O)/C=C(\O)C(=O)O)cc1OCc1ccccc1,IC50,55000.0,4.26,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55000.0,4.259637310505756
CHEMBL452111,COC(=O)/C(O)=C/C(=O)c1ccc(OC)c(OCc2ccccc2)c1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL452223,O=C(CC(=O)c1cccc(OCc2ccccc2)c1)C(=O)OC1CCN(C(=O)C(=O)CC(=O)c2cccc(OCc3ccccc3)c2)CC1,IC50,91000.0,4.04,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,91000.0,4.040958607678906
CHEMBL443890,O=C(CC(=O)c1cccc(OCc2ccccc2)c1)C(=O)N1CCN(C(=O)C(=O)CC(=O)c2cccc(OCc3ccccc3)c2)CC1,IC50,56000.0,4.25,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL454190,O=C(CC(=O)c1cccc(OCc2ccccc2)c1)C(=O)NC1CCN(C(=O)C(=O)CC(=O)c2cccc(OCc3ccccc3)c2)CC1,IC50,23000.0,4.64,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL452876,O=C(CC(=O)c1cccc(OCc2ccccc2)c1)C(=O)NC1CCC(NC(=O)C(=O)CC(=O)c2cccc(OCc3ccccc3)c2)CC1,IC50,100000.0,,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL492770,O=C(O)/C(O)=C/C(=O)c1cccc(OCc2ccccc2)c1,IC50,19000.0,4.72,CHEMBL1003960,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL467389,O=C(O)/C(O)=C/C(=O)c1ccccc1,IC50,24200.0,4.62,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24200.0,4.616184634019569
CHEMBL511423,CCCCCC12CCC(C(=O)Nc3cccc(C(=O)CC(=O)C(=O)O)c3)(CC1)CC2,IC50,14000.0,4.85,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL468235,O=C(O)/C(O)=C/C(=O)c1ccc([N+](=O)[O-])cc1,IC50,45000.0,4.35,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45000.0,4.346787486224656
CHEMBL468234,COc1cccc(C(=O)CC(=O)C(=O)N2CCN(C(=O)C(=O)CC(=O)c3cccc(OC)c3)CC2)c1,IC50,26000.0,4.58,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26000.0,4.585026652029182
CHEMBL512106,COc1cccc(C(=O)CC(=O)C(=O)NC2CCN(C(=O)C(=O)CC(=O)c3cccc(OC)c3)CC2)c1,IC50,53000.0,4.28,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53000.0,4.275724130399211
CHEMBL468233,COc1cccc(C(=O)CC(=O)C(=O)NC2CCC(NC(=O)C(=O)CC(=O)c3cccc(OC)c3)CC2)c1,IC50,26000.0,4.58,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26000.0,4.585026652029182
CHEMBL502238,COc1cccc(C(=O)/C=C(\O)C(=O)O)c1,IC50,27000.0,4.57,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27000.0,4.568636235841013
CHEMBL464340,O=C(CC(=O)c1ccc(C(F)(F)F)cc1)C(=O)N1CCN(C(=O)C(=O)CC(=O)c2ccc(C(F)(F)F)cc2)CC1,IC50,25000.0,4.6,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL505776,O=C(CC(=O)c1ccc(C(F)(F)F)cc1)C(=O)NC1CCC(NC(=O)C(=O)CC(=O)c2ccc(C(F)(F)F)cc2)CC1,IC50,41000.0,4.39,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41000.0,4.3872161432802645
CHEMBL465864,O=C(O)/C(O)=C/C(=O)c1ccc(C(F)(F)F)cc1,IC50,33000.0,4.48,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL467351,O=C(CC(=O)c1ccccc1Cl)C(=O)N1CCN(C(=O)C(=O)CC(=O)c2ccccc2Cl)CC1,IC50,100000.0,,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL469071,O=C(CC(=O)c1ccccc1Cl)C(=O)NC1CCN(C(=O)C(=O)CC(=O)c2ccccc2Cl)CC1,IC50,31000.0,4.51,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31000.0,4.508638306165727
CHEMBL513666,O=C(CC(=O)c1ccccc1Cl)C(=O)NC1CCC(NC(=O)C(=O)CC(=O)c2ccccc2Cl)CC1,IC50,30000.0,4.52,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL448880,O=C(O)/C(O)=C/C(=O)c1ccccc1Cl,IC50,17000.0,4.77,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL444974,Cc1cc(C(=O)/C=C(\O)C(=O)O)ccc1Cl,IC50,4700.0,5.33,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4700.0,5.327902142064282
CHEMBL467381,COC(=O)/C(O)=C/C(=O)c1cccc(N(Cc2ccccc2)Cc2ccccc2)c1,IC50,100000.0,,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL467380,COC(=O)/C(O)=C/C(=O)c1cccc(Cc2ccccc2F)c1,IC50,600.0,6.22,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL467361,COC(=O)/C(O)=C/C(=O)c1cccc(NC(=O)OCc2ccccc2)c1,IC50,7000.0,5.16,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL513321,CC(C)(C)OC(=O)N1CCC(NC(=O)/C(O)=C/C(=O)c2ccc(F)cc2)CC1,IC50,100000.0,4.0,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL467360,O=C(CC(=O)c1ccc(F)cc1)C(=O)N1CCN(C(=O)C(=O)CC(=O)c2ccc(F)cc2)CC1,IC50,29000.0,4.54,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,29000.0,4.537602002101044
CHEMBL467359,O=C(CC(=O)c1ccc(F)cc1)C(=O)NC1CCN(C(=O)C(=O)CC(=O)c2ccc(F)cc2)CC1,IC50,88000.0,4.06,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,88000.0,4.055517327849832
CHEMBL469070,O=C(CC(=O)c1ccc(F)cc1)C(=O)NC1CCC(NC(=O)C(=O)CC(=O)c2ccc(F)cc2)CC1,IC50,35500.0,4.45,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35500.0,4.449771646944906
CHEMBL469069,COC(=O)/C(O)=C/C(=O)c1ccc(F)cc1,IC50,100000.0,,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL467169,O=C(CC(=O)c1ccccc1F)C(=O)NC1CCC(NC(=O)C(=O)CC(=O)c2ccccc2F)CC1,IC50,55000.0,4.26,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55000.0,4.259637310505756
CHEMBL449221,O=C(O)/C(O)=C/C(=O)c1ccccc1F,IC50,58000.0,4.24,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58000.0,4.236572006437063
CHEMBL467159,COC(=O)/C(O)=C/C(=O)c1ccccc1F,IC50,100000.0,,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL467149,COc1ccc(C(=O)/C=C(\O)C(=O)O)cc1OCc1ccccc1,IC50,400.0,,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL452111,COC(=O)/C(O)=C/C(=O)c1ccc(OC)c(OCc2ccccc2)c1,IC50,16000.0,4.8,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL452223,O=C(CC(=O)c1cccc(OCc2ccccc2)c1)C(=O)OC1CCN(C(=O)C(=O)CC(=O)c2cccc(OCc3ccccc3)c2)CC1,IC50,3000.0,5.52,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL443890,O=C(CC(=O)c1cccc(OCc2ccccc2)c1)C(=O)N1CCN(C(=O)C(=O)CC(=O)c2cccc(OCc3ccccc3)c2)CC1,IC50,1800.0,5.75,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL454190,O=C(CC(=O)c1cccc(OCc2ccccc2)c1)C(=O)NC1CCN(C(=O)C(=O)CC(=O)c2cccc(OCc3ccccc3)c2)CC1,IC50,400.0,,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL452876,O=C(CC(=O)c1cccc(OCc2ccccc2)c1)C(=O)NC1CCC(NC(=O)C(=O)CC(=O)c2cccc(OCc3ccccc3)c2)CC1,IC50,7000.0,5.16,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL492770,O=C(O)/C(O)=C/C(=O)c1cccc(OCc2ccccc2)c1,IC50,400.0,,CHEMBL1003961,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL481279,O=C(NCc1ccc(F)cc1)C1=C(O)C(=O)N(Cc2ccccc2)C1,IC50,100.0,7.0,CHEMBL991040,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL481296,O=C(NCc1ccc(F)cc1)C1=C(O)C(=O)N2CCCCC12,IC50,18.0,7.75,CHEMBL991040,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL480717,O=C(NCc1ccc(F)cc1)C1=C(O)C(=O)N(CCN2CCOCC2)C1C(=O)NCc1ccc(F)cc1,IC50,1000.0,,CHEMBL991040,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL520744,CN1C(=O)C(O)=C(C(=O)NCc2ccc(F)cc2)C1c1ccccc1,IC50,1000.0,,CHEMBL991040,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL480532,O=C(NCc1ccc(F)cc1)C1=C(O)C(=O)N(CCN2CCCCC2)C1,IC50,1000.0,,CHEMBL991040,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL480531,O=C(NCc1ccc(F)cc1)C1=C(O)C(=O)N(Cc2ccccn2)C1,IC50,94.0,7.03,CHEMBL991040,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,94.0,7.026872146400302
CHEMBL481094,O=C(NCc1ccc(F)cc1)C1=C(O)C(=O)N(CCCc2ccccc2)C1,IC50,5.0,8.3,CHEMBL991040,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL480904,COc1ccccc1CCN1CC(C(=O)NCc2ccc(F)cc2)=C(O)C1=O,IC50,4.0,8.4,CHEMBL991040,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL519936,Cc1cccc(CN2CC(C(=O)NCc3ccc(F)cc3)=C(O)C2=O)c1,IC50,6.0,8.22,CHEMBL991040,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL16755,O=C1Cc2ccccc2C(=O)N1O,IC50,6320.0,5.2,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6320.0,5.199282921717614
CHEMBL443423,O=C1Cc2ccc([N+](=O)[O-])cc2C(=O)N1O,IC50,8500.0,5.07,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8500.0,5.070581074285707
CHEMBL446740,O=C1Cc2ccc(Cl)cc2C(=O)N1O,IC50,800.0,6.1,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL444646,O=C1Cc2ccc(Br)cc2C(=O)N1O,IC50,580.0,6.24,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,580.0,6.236572006437063
CHEMBL461036,O=C1Cc2ccc(I)cc2C(=O)N1O,IC50,1220.0,5.91,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1220.0,5.913640169325252
CHEMBL455061,O=C1Cc2ccc(O)cc2C(=O)N1O,IC50,2220.0,5.65,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2220.0,5.653647025549361
CHEMBL461247,CC(=O)Nc1ccc2c(c1)C(=O)N(O)C(=O)C2,IC50,590.0,6.23,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,590.0,6.229147988357855
CHEMBL446644,CCCCC(=O)Nc1ccc2c(c1)C(=O)N(O)C(=O)C2,IC50,18800.0,4.73,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18800.0,4.72584215073632
CHEMBL502584,O=C(Nc1ccc2c(c1)C(=O)N(O)C(=O)C2)c1ccccc1,IC50,1240.0,5.91,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1240.0,5.906578314837764
CHEMBL444813,O=C(Nc1ccc2c(c1)C(=O)N(O)C(=O)C2)c1ccc(F)cc1,IC50,410.0,6.39,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,410.0,6.3872161432802645
CHEMBL456325,O=C(Nc1ccc2c(c1)C(=O)N(O)C(=O)C2)c1cccc([N+](=O)[O-])c1,IC50,8900.0,5.05,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8900.0,5.050609993355087
CHEMBL512021,O=C(Cc1ccccc1)Nc1ccc2c(c1)C(=O)N(O)C(=O)C2,IC50,90.0,7.05,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90.0,7.045757490560675
CHEMBL456326,O=C(Cc1ccc(F)cc1)Nc1ccc2c(c1)C(=O)N(O)C(=O)C2,IC50,130.0,6.89,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL509261,O=C1Cc2ccc(-c3ccc(F)cc3)cc2C(=O)N1O,IC50,1470.0,5.83,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1470.0,5.8326826652518236
CHEMBL526563,O=C1Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2C(=O)N1O,IC50,1800.0,5.75,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL456120,O=C1Cc2ccc(-c3ccccc3)cc2C(=O)N1O,IC50,1730.0,5.76,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1730.0,5.761953896871205
CHEMBL456337,O=C1Cc2ccc(-c3ccc(O)cc3)cc2C(=O)N1O,IC50,5420.0,5.27,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5420.0,5.266000713461613
CHEMBL456338,O=C1Cc2ccc(-c3ccc(O)c(O)c3)cc2C(=O)N1O,IC50,560.0,6.25,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,560.0,6.251811972993799
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,9.0,8.05,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL204656,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C,IC50,4.0,8.4,CHEMBL1016223,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL444646,O=C1Cc2ccc(Br)cc2C(=O)N1O,IC50,1400.0,5.85,CHEMBL1016229,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1400.0,5.853871964321762
CHEMBL512021,O=C(Cc1ccccc1)Nc1ccc2c(c1)C(=O)N(O)C(=O)C2,IC50,7790.0,5.11,CHEMBL1016229,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7790.0,5.108462542327436
CHEMBL456326,O=C(Cc1ccc(F)cc1)Nc1ccc2c(c1)C(=O)N(O)C(=O)C2,IC50,750.0,6.12,CHEMBL1016229,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,750.0,6.1249387366083
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,900.0,6.05,CHEMBL1016229,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL444646,O=C1Cc2ccc(Br)cc2C(=O)N1O,IC50,900.0,6.05,CHEMBL1016230,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL512021,O=C(Cc1ccccc1)Nc1ccc2c(c1)C(=O)N(O)C(=O)C2,IC50,100.0,7.0,CHEMBL1016230,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL456326,O=C(Cc1ccc(F)cc1)Nc1ccc2c(c1)C(=O)N(O)C(=O)C2,IC50,20.0,7.7,CHEMBL1016230,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,7.0,8.15,CHEMBL1016230,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL460632,COc1c2c(c(O)c3ncc(Cc4ccc(F)cc4)cc13)C(=O)N(C)C2,IC50,100.0,7.0,CHEMBL1026554,Inhibition of HIV1 HXB2 integrase strand transfer activity by microtiter assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL461259,COc1c2c(c(O)c3ncc(Cc4ccc(F)cc4)cc13)C(=O)NC2,IC50,14.0,7.85,CHEMBL1026554,Inhibition of HIV1 HXB2 integrase strand transfer activity by microtiter assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL459381,COc1c2c(c(O)c3ncc(Cc4ccc(F)cc4)cc13)C(=O)N(Cc1ccc(F)cc1)C2,IC50,600.0,6.22,CHEMBL1026554,Inhibition of HIV1 HXB2 integrase strand transfer activity by microtiter assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL459382,CN1Cc2c(c(O)c3ncc(Cc4ccc(F)cc4)cc3c2N(C)S(C)(=O)=O)C1=O,IC50,80.0,7.1,CHEMBL1026554,Inhibition of HIV1 HXB2 integrase strand transfer activity by microtiter assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL517854,CN1Cc2c(c(O)c3ncc(Cc4ccc(F)c(Cl)c4)cc3c2N(C)S(C)(=O)=O)C1=O,IC50,265.0,6.58,CHEMBL1026554,Inhibition of HIV1 HXB2 integrase strand transfer activity by microtiter assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,265.0,6.576754126063192
CHEMBL282731,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H](C(=O)O)[C@@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,200.0,6.7,CHEMBL1033121,Inhibition of HIV1 integrase using U5A/U5B double-stranded DNA as substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL29660,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](C(=O)O)[C@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,300.0,6.52,CHEMBL1033121,Inhibition of HIV1 integrase using U5A/U5B double-stranded DNA as substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL445821,O=C(O)C(O)C(O)(Cc1ccc(O)c(O)c1)C(=O)O,IC50,250.0,6.6,CHEMBL1033121,Inhibition of HIV1 integrase using U5A/U5B double-stranded DNA as substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL445821,O=C(O)C(O)C(O)(Cc1ccc(O)c(O)c1)C(=O)O,IC50,17000.0,4.77,CHEMBL1033124,Inhibition of HIV1 integrase using U5A/U5B double-stranded DNA as substrate by ELISA in presence of BSA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL449723,Cc1cc2c(cc1Cl)SC(C(=O)c1ccccc1)=NS2(=O)=O,IC50,12000.0,4.92,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL459074,COc1ccc(C(=O)C2=NS(=O)(=O)c3cc(C)c(Cl)cc3S2)cc1,IC50,30000.0,4.52,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL513773,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Br)cc1)=NS2(=O)=O,IC50,30000.0,4.52,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL457554,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)cc1)=NS2(=O)=O,IC50,30000.0,4.52,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL457777,Cc1cc2c(cc1Cl)SC(C(=O)c1cccc([N+](=O)[O-])c1)=NS2(=O)=O,IC50,57000.0,4.24,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57000.0,4.2441251443275085
CHEMBL457778,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)c(Cl)c1)=NS2(=O)=O,IC50,15000.0,4.82,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL457779,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc3ccccc3c1)=NS2(=O)=O,IC50,28000.0,4.55,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL456475,Cc1cc(Cl)cc2c1S(=O)(=O)N=C(C(=O)c1ccc(Cl)cc1)S2,IC50,22000.0,4.66,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL456476,Cc1cc(Cl)cc2c1S(=O)(=O)N=C(C(=O)c1ccc(Cl)c(Cl)c1)S2,IC50,17000.0,4.77,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL458432,Cc1cc(Cl)cc2c1S(=O)(=O)N=C(C(=O)c1ccc3ccccc3c1)S2,IC50,22000.0,4.66,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL512918,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc(Cl)cc1,IC50,100000.0,4.0,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL458652,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc(Cl)c(Cl)c1,IC50,61200.0,4.21,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61200.0,4.213248577854439
CHEMBL458653,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc2ccccc2c1,IC50,8000.0,5.1,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL444733,Cc1cc2c(cc1Cl)SC(C(=O)c1ccccc1)NS2(=O)=O,IC50,7000.0,5.16,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL456482,COc1ccc(C(=O)C2NS(=O)(=O)c3cc(C)c(Cl)cc3S2)cc1,IC50,38000.0,4.42,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38000.0,4.42021640338319
CHEMBL458228,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Br)cc1)NS2(=O)=O,IC50,4000.0,5.4,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL510036,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)cc1)NS2(=O)=O,IC50,6000.0,5.22,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL458229,Cc1cc2c(cc1Cl)SC(C(=O)c1cccc([N+](=O)[O-])c1)NS2(=O)=O,IC50,32000.0,4.5,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL457536,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)c(Cl)c1)NS2(=O)=O,IC50,20000.0,4.7,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL510455,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc3ccccc3c1)NS2(=O)=O,IC50,57000.0,4.24,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57000.0,4.2441251443275085
CHEMBL453267,Cc1cc(Cl)cc2c1S(=O)(=O)NC(C(=O)c1ccc(Cl)cc1)S2,IC50,23000.0,4.64,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL456030,Cc1cc(Cl)cc2c1S(=O)(=O)NC(C(=O)c1ccc(Cl)c(Cl)c1)S2,IC50,20000.0,4.7,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL456031,Cc1cc(Cl)cc2c1S(=O)(=O)NC(C(=O)c1ccc3ccccc3c1)S2,IC50,9000.0,5.05,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL456024,O=C(c1ccc(Cl)cc1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,8000.0,5.1,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL457106,O=C(c1ccc(Cl)c(Cl)c1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,9000.0,5.05,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL462081,O=C(c1ccc2ccccc2c1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,8000.0,5.1,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL462288,O=C(c1ccc(Cl)c(Cl)c1)C1NS(=O)(=O)c2ccccc2S1,IC50,22000.0,4.66,CHEMBL1016883,Inhibition of HIV1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL449723,Cc1cc2c(cc1Cl)SC(C(=O)c1ccccc1)=NS2(=O)=O,IC50,12000.0,4.92,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL459074,COc1ccc(C(=O)C2=NS(=O)(=O)c3cc(C)c(Cl)cc3S2)cc1,IC50,33000.0,4.48,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL513773,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Br)cc1)=NS2(=O)=O,IC50,30000.0,4.52,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL457554,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)cc1)=NS2(=O)=O,IC50,65000.0,4.19,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL457777,Cc1cc2c(cc1Cl)SC(C(=O)c1cccc([N+](=O)[O-])c1)=NS2(=O)=O,IC50,50000.0,4.3,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL457778,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)c(Cl)c1)=NS2(=O)=O,IC50,7000.0,5.16,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL457779,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc3ccccc3c1)=NS2(=O)=O,IC50,3000.0,5.52,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL456475,Cc1cc(Cl)cc2c1S(=O)(=O)N=C(C(=O)c1ccc(Cl)cc1)S2,IC50,25000.0,4.6,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL456476,Cc1cc(Cl)cc2c1S(=O)(=O)N=C(C(=O)c1ccc(Cl)c(Cl)c1)S2,IC50,25000.0,4.6,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL458432,Cc1cc(Cl)cc2c1S(=O)(=O)N=C(C(=O)c1ccc3ccccc3c1)S2,IC50,7000.0,5.16,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL512918,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc(Cl)cc1,IC50,90000.0,4.05,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL458653,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc2ccccc2c1,IC50,8000.0,5.1,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL444733,Cc1cc2c(cc1Cl)SC(C(=O)c1ccccc1)NS2(=O)=O,IC50,5000.0,5.3,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL456482,COc1ccc(C(=O)C2NS(=O)(=O)c3cc(C)c(Cl)cc3S2)cc1,IC50,17000.0,4.77,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL458228,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Br)cc1)NS2(=O)=O,IC50,3000.0,5.52,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL510036,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)cc1)NS2(=O)=O,IC50,4000.0,5.4,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL458229,Cc1cc2c(cc1Cl)SC(C(=O)c1cccc([N+](=O)[O-])c1)NS2(=O)=O,IC50,28000.0,4.55,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL457536,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)c(Cl)c1)NS2(=O)=O,IC50,10000.0,5.0,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL510455,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc3ccccc3c1)NS2(=O)=O,IC50,30000.0,4.52,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL453267,Cc1cc(Cl)cc2c1S(=O)(=O)NC(C(=O)c1ccc(Cl)cc1)S2,IC50,14000.0,4.85,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL456030,Cc1cc(Cl)cc2c1S(=O)(=O)NC(C(=O)c1ccc(Cl)c(Cl)c1)S2,IC50,14000.0,4.85,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL456031,Cc1cc(Cl)cc2c1S(=O)(=O)NC(C(=O)c1ccc3ccccc3c1)S2,IC50,6000.0,5.22,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL456024,O=C(c1ccc(Cl)cc1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,4000.0,5.4,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL457106,O=C(c1ccc(Cl)c(Cl)c1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,5000.0,5.3,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL462081,O=C(c1ccc2ccccc2c1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,3000.0,5.52,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL462288,O=C(c1ccc(Cl)c(Cl)c1)C1NS(=O)(=O)c2ccccc2S1,IC50,15000.0,4.82,CHEMBL1016884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL449723,Cc1cc2c(cc1Cl)SC(C(=O)c1ccccc1)=NS2(=O)=O,IC50,90000.0,4.05,CHEMBL1016885,Inhibition of HIV1 integrase Y99S mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL457554,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)cc1)=NS2(=O)=O,IC50,90000.0,4.05,CHEMBL1016885,Inhibition of HIV1 integrase Y99S mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL458432,Cc1cc(Cl)cc2c1S(=O)(=O)N=C(C(=O)c1ccc3ccccc3c1)S2,IC50,70000.0,4.16,CHEMBL1016885,Inhibition of HIV1 integrase Y99S mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL512918,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc(Cl)cc1,IC50,100000.0,4.0,CHEMBL1016885,Inhibition of HIV1 integrase Y99S mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL458652,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc(Cl)c(Cl)c1,IC50,90000.0,4.05,CHEMBL1016885,Inhibition of HIV1 integrase Y99S mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL458653,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc2ccccc2c1,IC50,100000.0,4.0,CHEMBL1016885,Inhibition of HIV1 integrase Y99S mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL444733,Cc1cc2c(cc1Cl)SC(C(=O)c1ccccc1)NS2(=O)=O,IC50,90000.0,4.05,CHEMBL1016885,Inhibition of HIV1 integrase Y99S mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL510036,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)cc1)NS2(=O)=O,IC50,90000.0,4.05,CHEMBL1016885,Inhibition of HIV1 integrase Y99S mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL456031,Cc1cc(Cl)cc2c1S(=O)(=O)NC(C(=O)c1ccc3ccccc3c1)S2,IC50,70000.0,4.16,CHEMBL1016885,Inhibition of HIV1 integrase Y99S mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL456024,O=C(c1ccc(Cl)cc1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,100000.0,4.0,CHEMBL1016885,Inhibition of HIV1 integrase Y99S mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL457106,O=C(c1ccc(Cl)c(Cl)c1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,90000.0,4.05,CHEMBL1016885,Inhibition of HIV1 integrase Y99S mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL462081,O=C(c1ccc2ccccc2c1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,100000.0,4.0,CHEMBL1016885,Inhibition of HIV1 integrase Y99S mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL449723,Cc1cc2c(cc1Cl)SC(C(=O)c1ccccc1)=NS2(=O)=O,IC50,18000.0,4.75,CHEMBL1016886,Inhibition of HIV1 integrase Y99S mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL457554,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)cc1)=NS2(=O)=O,IC50,20000.0,4.7,CHEMBL1016886,Inhibition of HIV1 integrase Y99S mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL458432,Cc1cc(Cl)cc2c1S(=O)(=O)N=C(C(=O)c1ccc3ccccc3c1)S2,IC50,23000.0,4.64,CHEMBL1016886,Inhibition of HIV1 integrase Y99S mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL512918,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc(Cl)cc1,IC50,20000.0,4.7,CHEMBL1016886,Inhibition of HIV1 integrase Y99S mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL458652,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc(Cl)c(Cl)c1,IC50,20000.0,4.7,CHEMBL1016886,Inhibition of HIV1 integrase Y99S mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL458653,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc2ccccc2c1,IC50,15000.0,4.82,CHEMBL1016886,Inhibition of HIV1 integrase Y99S mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL444733,Cc1cc2c(cc1Cl)SC(C(=O)c1ccccc1)NS2(=O)=O,IC50,18000.0,4.75,CHEMBL1016886,Inhibition of HIV1 integrase Y99S mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL510036,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)cc1)NS2(=O)=O,IC50,20000.0,4.7,CHEMBL1016886,Inhibition of HIV1 integrase Y99S mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL456031,Cc1cc(Cl)cc2c1S(=O)(=O)NC(C(=O)c1ccc3ccccc3c1)S2,IC50,23000.0,4.64,CHEMBL1016886,Inhibition of HIV1 integrase Y99S mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL456024,O=C(c1ccc(Cl)cc1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,20000.0,4.7,CHEMBL1016886,Inhibition of HIV1 integrase Y99S mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL457106,O=C(c1ccc(Cl)c(Cl)c1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,20000.0,4.7,CHEMBL1016886,Inhibition of HIV1 integrase Y99S mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL462081,O=C(c1ccc2ccccc2c1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,15000.0,4.82,CHEMBL1016886,Inhibition of HIV1 integrase Y99S mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL449723,Cc1cc2c(cc1Cl)SC(C(=O)c1ccccc1)=NS2(=O)=O,IC50,15000.0,4.82,CHEMBL1016887,Inhibition of HIV1 integrase H114A mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL457554,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)cc1)=NS2(=O)=O,IC50,18000.0,4.75,CHEMBL1016887,Inhibition of HIV1 integrase H114A mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL458432,Cc1cc(Cl)cc2c1S(=O)(=O)N=C(C(=O)c1ccc3ccccc3c1)S2,IC50,33000.0,4.48,CHEMBL1016887,Inhibition of HIV1 integrase H114A mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL512918,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc(Cl)cc1,IC50,20000.0,4.7,CHEMBL1016887,Inhibition of HIV1 integrase H114A mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL458652,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc(Cl)c(Cl)c1,IC50,18000.0,4.75,CHEMBL1016887,Inhibition of HIV1 integrase H114A mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL458653,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc2ccccc2c1,IC50,9000.0,5.05,CHEMBL1016887,Inhibition of HIV1 integrase H114A mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL444733,Cc1cc2c(cc1Cl)SC(C(=O)c1ccccc1)NS2(=O)=O,IC50,15000.0,4.82,CHEMBL1016887,Inhibition of HIV1 integrase H114A mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL510036,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)cc1)NS2(=O)=O,IC50,18000.0,4.75,CHEMBL1016887,Inhibition of HIV1 integrase H114A mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL456031,Cc1cc(Cl)cc2c1S(=O)(=O)NC(C(=O)c1ccc3ccccc3c1)S2,IC50,33000.0,4.48,CHEMBL1016887,Inhibition of HIV1 integrase H114A mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL456024,O=C(c1ccc(Cl)cc1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,20000.0,4.7,CHEMBL1016887,Inhibition of HIV1 integrase H114A mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL457106,O=C(c1ccc(Cl)c(Cl)c1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,18000.0,4.75,CHEMBL1016887,Inhibition of HIV1 integrase H114A mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL462081,O=C(c1ccc2ccccc2c1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,9000.0,5.05,CHEMBL1016887,Inhibition of HIV1 integrase H114A mutant 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL449723,Cc1cc2c(cc1Cl)SC(C(=O)c1ccccc1)=NS2(=O)=O,IC50,9000.0,5.05,CHEMBL1016888,Inhibition of HIV1 integrase H114A mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL457554,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)cc1)=NS2(=O)=O,IC50,16000.0,4.8,CHEMBL1016888,Inhibition of HIV1 integrase H114A mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL458432,Cc1cc(Cl)cc2c1S(=O)(=O)N=C(C(=O)c1ccc3ccccc3c1)S2,IC50,23000.0,4.64,CHEMBL1016888,Inhibition of HIV1 integrase H114A mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL512918,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc(Cl)cc1,IC50,18000.0,4.75,CHEMBL1016888,Inhibition of HIV1 integrase H114A mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL458652,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc(Cl)c(Cl)c1,IC50,18000.0,4.75,CHEMBL1016888,Inhibition of HIV1 integrase H114A mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL458653,O=C(C1=NS(=O)(=O)c2ccc(Cl)cc2S1)c1ccc2ccccc2c1,IC50,15000.0,4.82,CHEMBL1016888,Inhibition of HIV1 integrase H114A mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL444733,Cc1cc2c(cc1Cl)SC(C(=O)c1ccccc1)NS2(=O)=O,IC50,9000.0,5.05,CHEMBL1016888,Inhibition of HIV1 integrase H114A mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL510036,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)cc1)NS2(=O)=O,IC50,16000.0,4.8,CHEMBL1016888,Inhibition of HIV1 integrase H114A mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL456031,Cc1cc(Cl)cc2c1S(=O)(=O)NC(C(=O)c1ccc3ccccc3c1)S2,IC50,23000.0,4.64,CHEMBL1016888,Inhibition of HIV1 integrase H114A mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL456024,O=C(c1ccc(Cl)cc1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,18000.0,4.75,CHEMBL1016888,Inhibition of HIV1 integrase H114A mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL457106,O=C(c1ccc(Cl)c(Cl)c1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,18000.0,4.75,CHEMBL1016888,Inhibition of HIV1 integrase H114A mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL462081,O=C(c1ccc2ccccc2c1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,15000.0,4.82,CHEMBL1016888,Inhibition of HIV1 integrase H114A mutant strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL444733,Cc1cc2c(cc1Cl)SC(C(=O)c1ccccc1)NS2(=O)=O,IC50,60000.0,4.22,CHEMBL1016889,Inhibition of HIV1 integrase 3'-end processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL444733,Cc1cc2c(cc1Cl)SC(C(=O)c1ccccc1)NS2(=O)=O,IC50,27000.0,4.57,CHEMBL1016890,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27000.0,4.568636235841013
CHEMBL510036,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)cc1)NS2(=O)=O,IC50,63000.0,4.2,CHEMBL1016889,Inhibition of HIV1 integrase 3'-end processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,63000.0,4.200659450546418
CHEMBL510036,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(Cl)cc1)NS2(=O)=O,IC50,40000.0,4.4,CHEMBL1016890,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL456031,Cc1cc(Cl)cc2c1S(=O)(=O)NC(C(=O)c1ccc3ccccc3c1)S2,IC50,83000.0,4.08,CHEMBL1016889,Inhibition of HIV1 integrase 3'-end processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,83000.0,4.080921907623926
CHEMBL456031,Cc1cc(Cl)cc2c1S(=O)(=O)NC(C(=O)c1ccc3ccccc3c1)S2,IC50,51000.0,4.29,CHEMBL1016890,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,51000.0,4.292429823902063
CHEMBL456024,O=C(c1ccc(Cl)cc1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,51000.0,4.29,CHEMBL1016889,Inhibition of HIV1 integrase 3'-end processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,51000.0,4.292429823902063
CHEMBL456024,O=C(c1ccc(Cl)cc1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,25000.0,4.6,CHEMBL1016890,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL457106,O=C(c1ccc(Cl)c(Cl)c1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,58000.0,4.24,CHEMBL1016889,Inhibition of HIV1 integrase 3'-end processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58000.0,4.236572006437063
CHEMBL457106,O=C(c1ccc(Cl)c(Cl)c1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,25000.0,4.6,CHEMBL1016890,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL462081,O=C(c1ccc2ccccc2c1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,55000.0,4.26,CHEMBL1016889,Inhibition of HIV1 integrase 3'-end processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55000.0,4.259637310505756
CHEMBL462081,O=C(c1ccc2ccccc2c1)C1NS(=O)(=O)c2ccc(Cl)cc2S1,IC50,28000.0,4.55,CHEMBL1016890,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL496412,O=C1NC(=S)NC(=O)C1=Cc1ccc(-c2ccc(C(=O)O)c(O)c2)o1,IC50,8940.0,5.05,CHEMBL997213,Inhibition of HIV1 integrase using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8940.0,5.048662481204082
CHEMBL496413,O=C1NC(=S)NC(=O)C1=Cc1ccc(-c2ccc(O)c(C(=O)O)c2)o1,IC50,33400.0,4.48,CHEMBL997213,Inhibition of HIV1 integrase using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33400.0,4.476253533188435
CHEMBL497423,O=C1NC(=S)NC(=O)C1=Cc1ccc(-c2ccc(Cl)c(C(=O)O)c2)o1,IC50,41700.0,4.38,CHEMBL997213,Inhibition of HIV1 integrase using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41700.0,4.379863945026242
CHEMBL497028,COc1cc(-c2ccc(C=C3C(=O)NC(=S)NC3=O)o2)c(Cl)cc1C(=O)O,IC50,43200.0,4.37,CHEMBL997213,Inhibition of HIV1 integrase using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43200.0,4.364516253185088
CHEMBL497029,O=C1NC(=S)NC(=O)C1=Cc1ccc(-c2cc(C(=O)O)cc(O)c2O)o1,IC50,5060.0,5.3,CHEMBL997213,Inhibition of HIV1 integrase using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5060.0,5.2958494831602
CHEMBL497226,Cc1ccc(C(=O)O)cc1-c1ccc(C=C2C(=O)NC(=S)NC2=O)o1,IC50,46350.0,4.33,CHEMBL997213,Inhibition of HIV1 integrase using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,46350.0,4.333950261519484
CHEMBL526099,Cc1c(-c2ccc(C=C3C(=O)NC(=S)NC3=O)o2)cccc1[N+](=O)[O-],IC50,58400.0,4.23,CHEMBL997213,Inhibition of HIV1 integrase using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58400.0,4.2335871528876
CHEMBL498634,O=C1NC(=S)NC(=O)C1=Cc1ccc(-c2cc(C(=O)O)cc3c2OCO3)o1,IC50,56500.0,4.25,CHEMBL997213,Inhibition of HIV1 integrase using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56500.0,4.247951552180561
CHEMBL525558,Cc1cc(-c2ccc(C(=O)O)c(O)c2)oc1C=C1C(=O)NC(=S)NC1=O,IC50,90870.0,4.04,CHEMBL997213,Inhibition of HIV1 integrase using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90870.0,4.041579471947482
CHEMBL525175,O=C1NC(=S)S/C1=C\c1ccc(-c2cc(C(=O)O)cc(O)c2O)o1,IC50,15470.0,4.81,CHEMBL997213,Inhibition of HIV1 integrase using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15470.0,4.810509686300633
CHEMBL487512,O=C1NC(=S)N/C1=C\c1ccc(-c2ccc(O)c(C(=O)O)c2)o1,IC50,50900.0,4.29,CHEMBL997213,Inhibition of HIV1 integrase using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50900.0,4.293282217663242
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,80.0,7.1,CHEMBL997213,Inhibition of HIV1 integrase using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL496412,O=C1NC(=S)NC(=O)C1=Cc1ccc(-c2ccc(C(=O)O)c(O)c2)o1,IC50,2740.0,5.56,CHEMBL997214,Inhibition of HIV1 integrase 3'-processing activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2740.0,5.562249437179612
CHEMBL496413,O=C1NC(=S)NC(=O)C1=Cc1ccc(-c2ccc(O)c(C(=O)O)c2)o1,IC50,53000.0,4.28,CHEMBL997214,Inhibition of HIV1 integrase 3'-processing activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53000.0,4.275724130399211
CHEMBL497225,O=C1NC(=S)NC(=O)C1=Cc1ccc(-c2ccc(F)cc2C(=O)O)o1,IC50,47100.0,4.33,CHEMBL997214,Inhibition of HIV1 integrase 3'-processing activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47100.0,4.326979092871104
CHEMBL497423,O=C1NC(=S)NC(=O)C1=Cc1ccc(-c2ccc(Cl)c(C(=O)O)c2)o1,IC50,12860.0,4.89,CHEMBL997214,Inhibition of HIV1 integrase 3'-processing activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12860.0,4.890759031411797
CHEMBL497028,COc1cc(-c2ccc(C=C3C(=O)NC(=S)NC3=O)o2)c(Cl)cc1C(=O)O,IC50,35300.0,4.45,CHEMBL997214,Inhibition of HIV1 integrase 3'-processing activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35300.0,4.452225294612178
CHEMBL497029,O=C1NC(=S)NC(=O)C1=Cc1ccc(-c2cc(C(=O)O)cc(O)c2O)o1,IC50,5790.0,5.24,CHEMBL997214,Inhibition of HIV1 integrase 3'-processing activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5790.0,5.237321436272564
CHEMBL497226,Cc1ccc(C(=O)O)cc1-c1ccc(C=C2C(=O)NC(=S)NC2=O)o1,IC50,25400.0,4.59,CHEMBL997214,Inhibition of HIV1 integrase 3'-processing activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25400.0,4.5951662833800615
CHEMBL526099,Cc1c(-c2ccc(C=C3C(=O)NC(=S)NC3=O)o2)cccc1[N+](=O)[O-],IC50,40800.0,4.39,CHEMBL997214,Inhibition of HIV1 integrase 3'-processing activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40800.0,4.38933983691012
CHEMBL498634,O=C1NC(=S)NC(=O)C1=Cc1ccc(-c2cc(C(=O)O)cc3c2OCO3)o1,IC50,71570.0,4.14,CHEMBL997214,Inhibition of HIV1 integrase 3'-processing activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,71570.0,4.145268982786058
CHEMBL525175,O=C1NC(=S)S/C1=C\c1ccc(-c2cc(C(=O)O)cc(O)c2O)o1,IC50,22300.0,4.65,CHEMBL997214,Inhibition of HIV1 integrase 3'-processing activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22300.0,4.651695136951839
CHEMBL525357,O=C1NC(=S)N/C1=C\c1ccc(-c2ccc(C(=O)O)c(O)c2)o1,IC50,74000.0,4.13,CHEMBL997214,Inhibition of HIV1 integrase 3'-processing activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,74000.0,4.130768280269024
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,67.0,7.17,CHEMBL997214,Inhibition of HIV1 integrase 3'-processing activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,67.0,7.173925197299173
CHEMBL496412,O=C1NC(=S)NC(=O)C1=Cc1ccc(-c2ccc(C(=O)O)c(O)c2)o1,IC50,69160.0,4.16,CHEMBL1008275,Inhibition of HIV1 integrase strand transfer activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69160.0,4.160145015398115
CHEMBL498635,O=C1NC(=S)S/C1=C\c1ccc(-c2ccc(C(=O)O)c(O)c2)o1,IC50,97720.0,4.01,CHEMBL1008275,Inhibition of HIV1 integrase strand transfer activity using labelled oligonucleotide substrate by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,97720.0,4.010016541698601
CHEMBL242883,O=C(O)/C(O)=C/C(=O)c1cccc(Cc2ccccc2)c1,IC50,50.0,7.3,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL560235,Cn1cc(C(=O)C(=O)O)c(=O)c2cc(Cc3ccccc3)ccc21,IC50,100000.0,,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL557480,Cn1cc(C(=O)O)c(=O)c2cc(Cc3ccccc3)ccc21,IC50,2300.0,5.64,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2300.0,5.638272163982407
CHEMBL381059,CCOC(=O)c1c[nH]c2ccc(Cc3ccccc3)cc2c1=O,IC50,100000.0,,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL560436,NC(=O)c1c[nH]c2ccc(Cc3ccccc3)cc2c1=O,IC50,100000.0,,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL537947,O=C(O)c1c[nH]c2ccc(Cc3ccc(Cl)cc3)cc2c1=O,IC50,100000.0,,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL560960,O=C(O)c1c[nH]c2ccc(Cc3cccc(Cl)c3)cc2c1=O,IC50,800.0,6.1,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL559704,O=C(O)c1c[nH]c2ccc(Cc3ccccc3Cl)cc2c1=O,IC50,410.0,6.39,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,410.0,6.3872161432802645
CHEMBL561423,O=C(O)c1c[nH]c2ccc(Cc3ccccc3F)cc2c1=O,IC50,500.0,6.3,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL560761,Cc1ccccc1Cc1ccc2[nH]cc(C(=O)O)c(=O)c2c1,IC50,1080.0,5.97,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1080.0,5.96657624451305
CHEMBL549404,COc1ccccc1Cc1ccc2[nH]cc(C(=O)O)c(=O)c2c1,IC50,1170.0,5.93,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1170.0,5.931814138253838
CHEMBL549338,O=C(O)c1c[nH]c2ccc(Cc3ccccc3C(F)(F)F)cc2c1=O,IC50,720.0,6.14,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,720.0,6.142667503568731
CHEMBL559705,O=C(O)c1c[nH]c2ccc(Cc3c(Cl)cccc3Cl)cc2c1=O,IC50,370.0,6.43,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,370.0,6.431798275933005
CHEMBL549405,O=C(O)c1c[nH]c2ccc(Cc3cc(Cl)ccc3Cl)cc2c1=O,IC50,250.0,6.6,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL560234,O=C(O)c1c[nH]c2ccc(Cc3cccc(Cl)c3Cl)cc2c1=O,IC50,70.0,7.16,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL550691,Cn1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3Cl)ccc21,IC50,83.0,7.08,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,83.0,7.080921907623926
CHEMBL561099,CCn1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3Cl)ccc21,IC50,31.0,7.51,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31.0,7.508638306165727
CHEMBL551437,CCCn1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3Cl)ccc21,IC50,55.0,7.26,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55.0,7.259637310505756
CHEMBL562360,CC(C)n1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3Cl)ccc21,IC50,26.0,7.58,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26.0,7.585026652029182
CHEMBL561827,CCCCn1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3Cl)ccc21,IC50,65.0,7.19,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65.0,7.187086643357144
CHEMBL558481,O=C(O)Cn1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3Cl)ccc21,IC50,32.0,7.5,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32.0,7.494850021680094
CHEMBL561100,O=C(O)CCn1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3Cl)ccc21,IC50,38.0,7.42,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38.0,7.42021640338319
CHEMBL563162,NC(=O)Cn1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3Cl)ccc21,IC50,35.0,7.46,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35.0,7.455931955649724
CHEMBL551235,NC(=O)CCn1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3Cl)ccc21,IC50,116.0,6.94,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,116.0,6.935542010773082
CHEMBL561437,NCCn1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3Cl)ccc21,IC50,215.0,6.67,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,215.0,6.667561540084394
CHEMBL550893,O=C(O)c1cn(CCO)c2ccc(Cc3cccc(Cl)c3Cl)cc2c1=O,IC50,21.0,7.68,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL558286,O=C(O)c1cn(CCCO)c2ccc(Cc3cccc(Cl)c3Cl)cc2c1=O,IC50,77.0,7.11,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,77.0,7.113509274827518
CHEMBL550895,O=C(O)c1cn(CCO)c2ccc(Cc3cccc(F)c3Cl)cc2c1=O,IC50,44.0,7.36,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44.0,7.356547323513812
CHEMBL558287,O=C(O)c1cn(CCO)c2ccc(Cc3cccc(Cl)c3Cl)c(F)c2c1=O,IC50,84.0,7.08,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,84.0,7.075720713938118
CHEMBL549546,O=C(O)c1cn(CCO)c2cc(F)c(Cc3cccc(Cl)c3Cl)cc2c1=O,IC50,25.0,7.6,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25.0,7.6020599913279625
CHEMBL560439,O=C(O)c1cn(CCO)c2c(F)cc(Cc3cccc(Cl)c3Cl)cc2c1=O,IC50,34.0,7.47,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34.0,7.468521082957745
CHEMBL549549,COc1cc2c(cc1Cc1cccc(Cl)c1Cl)c(=O)c(C(=O)O)cn2CCO,IC50,12.0,7.92,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL559903,O=C(O)c1cn(CCO)c2cc(Cl)c(Cc3cccc(Cl)c3Cl)cc2c1=O,IC50,43.0,7.37,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43.0,7.366531544420413
CHEMBL549611,Cc1cc2c(cc1Cc1cccc(Cl)c1Cl)c(=O)c(C(=O)O)cn2CCO,IC50,41.0,7.39,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41.0,7.3872161432802645
CHEMBL554504,O=C(O)c1cn(CCO)c2cc(C(F)(F)F)c(Cc3cccc(Cl)c3Cl)cc2c1=O,IC50,674.0,6.17,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,674.0,6.17134010346468
CHEMBL549750,N#Cc1cc2c(cc1Cc1cccc(Cl)c1Cl)c(=O)c(C(=O)O)cn2CCO,IC50,50.0,7.3,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL563525,C[C@@H](CO)n1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3F)ccc21,IC50,14800.0,4.83,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14800.0,4.8297382846050425
CHEMBL554722,C[C@H](CO)n1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3F)ccc21,IC50,38300.0,4.42,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38300.0,4.416801226031377
CHEMBL549816,CC[C@@H](CO)n1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3F)ccc21,IC50,9000.0,5.05,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL563677,CCC[C@@H](CO)n1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3F)ccc21,IC50,8200.0,5.09,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8200.0,5.086186147616283
CHEMBL565125,CC(C)(C)[C@@H](CO)n1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3F)ccc21,IC50,6000.0,5.22,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL561619,O=C(O)c1cn([C@H](CO)C2CCCCC2)c2ccc(Cc3cccc(Cl)c3F)cc2c1=O,IC50,5600.0,5.25,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5600.0,5.251811972993799
CHEMBL557891,O=C(O)c1cn([C@H](CO)c2ccccc2)c2ccc(Cc3cccc(Cl)c3F)cc2c1=O,IC50,9800.0,5.01,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9800.0,5.008773924307505
CHEMBL550080,CCC[C@@H](CO)n1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3F)c(OC)cc21,IC50,5800.0,5.24,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5800.0,5.236572006437063
CHEMBL408699,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@@H](CO)C(C)C,IC50,14400.0,4.84,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14400.0,4.841637507904751
CHEMBL550220,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)(C)C,IC50,5800.0,5.24,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5800.0,5.236572006437063
CHEMBL560836,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C1CCCCC1,IC50,6700.0,5.17,CHEMBL1033786,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6700.0,5.173925197299173
CHEMBL541701,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc3c(c1O)C(=O)N1c4ccccc4SC31)CC2,IC50,96000.0,4.02,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,96000.0,4.017728766960432
CHEMBL549679,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc3c(c1O)C(=O)N1CCCNC31)CC2,IC50,56000.0,4.25,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL554975,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc3c(c1O)C(=O)N1C(C(=O)O)CSC31)CC2,IC50,20000.0,4.7,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL550839,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc3c(c1O)C(=O)N(N(C)C)C3O)CC2,IC50,7700.0,5.11,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7700.0,5.113509274827518
CHEMBL538879,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc(C3NCc4ccccc4N3)c(C(=O)O)c1O)CC2,IC50,40000.0,4.4,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL552987,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc(/C=N/C34CC5CC(CC(C5)C3)C4)c(C(=O)O)c1O)CC2,IC50,37000.0,4.43,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL538947,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc(/C=N/NS(=O)(=O)c3ccc(C)cc3)c(C(=O)O)c1O)CC2,IC50,22000.0,4.66,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL538878,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc(/C=N/NC(=O)c3ccccc3)c(C(=O)O)c1O)CC2,IC50,14600.0,4.84,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14600.0,4.835647144215563
CHEMBL554301,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc(C(=O)O)c(C(=O)O)c1O)CC2,IC50,13200.0,4.88,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13200.0,4.87942606879415
CHEMBL561566,CO/N=C/c1cc2c(c(O)c1C(=O)O)-c1c(O)c3c(c(OC)c1CC2)C(=O)c1c(cc(O)c(C)c1O)C3=O,IC50,12500.0,4.9,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12500.0,4.903089986991944
CHEMBL538448,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc(/C=N/NC(=O)c3ccccc3O)c(C(=O)O)c1O)CC2,IC50,6090.0,5.21,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6090.0,5.215382707367125
CHEMBL562741,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc(/C=N/NC(=N)N)c(C(=O)O)c1O)CC2,IC50,3150.0,5.5,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3150.0,5.501689446210399
CHEMBL555736,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc(/C=N/Nc3ccc([N+](=O)[O-])cc3)c(C(=O)O)c1O)CC2,IC50,2200.0,5.66,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2200.0,5.657577319177793
CHEMBL557286,CCCn1ncc2cc3c(c(O)c2c1=O)-c1c(O)c2c(c(OC)c1CC3)C(=O)c1c(cc(O)c(C)c1O)C2=O,IC50,6340.0,5.2,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6340.0,5.1979107421182675
CHEMBL554095,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc3cnn(CCOC(C)=O)c(=O)c3c1O)CC2,IC50,6280.0,5.2,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6280.0,5.202040356262804
CHEMBL564339,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc3cnn(CC(=O)O)c(=O)c3c1O)CC2,IC50,4620.0,5.33,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4620.0,5.335358024443874
CHEMBL552100,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc3cn[nH]c(=O)c3c1O)CC2,IC50,4060.0,5.39,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4060.0,5.391473966422806
CHEMBL540405,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc3cnn(-c4ccc(C(=O)O)cc4)c(=O)c3c1O)CC2,IC50,3450.0,5.46,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3450.0,5.462180904926726
CHEMBL562425,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc3cnn(C(=N)N)c(=O)c3c1O)CC2,IC50,3020.0,5.52,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3020.0,5.51999305704285
CHEMBL555734,CCOC(=O)Cn1ncc2cc3c(c(O)c2c1=O)-c1c(O)c2c(c(OC)c1CC3)C(=O)c1c(cc(O)c(C)c1O)C2=O,IC50,2670.0,5.57,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2670.0,5.573488738635424
CHEMBL541369,COc1c2c(c(O)c3c1C(=O)c1c(cc(O)c(C)c1O)C3=O)-c1c(cc3cnn(-c4ccccc4)c(=O)c3c1O)CC2,IC50,410.0,6.39,CHEMBL1030329,Inhibition of HIV1 recombinant integrase by electrochemiluminescent-based high-throughput strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,410.0,6.3872161432802645
CHEMBL540719,O=C1c2c(ccc(O)c2O)CN1Cc1cccc(Cl)c1,IC50,72000.0,4.14,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,72000.0,4.142667503568732
CHEMBL563507,O=C1c2c(ccc(O)c2O)CN1Cc1ccc(F)c(F)c1,IC50,72000.0,4.14,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,72000.0,4.142667503568732
CHEMBL539708,O=C1c2c(ccc(O)c2O)CN1Cc1cccc(F)c1F,IC50,72000.0,4.14,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,72000.0,4.142667503568732
CHEMBL560202,O=C1c2c(ccc(O)c2O)CN1Cc1ccc(F)cc1F,IC50,37000.0,4.43,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL560218,O=C1c2c(ccc(O)c2O)CN1Cc1c(F)cccc1F,IC50,71000.0,4.15,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,71000.0,4.1487416512809245
CHEMBL557898,O=C1c2c(ccc(O)c2O)CN1Cc1ccc(F)c(Br)c1,IC50,34000.0,4.47,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34000.0,4.468521082957745
CHEMBL561770,Cc1cc(CN2Cc3ccc(O)c(O)c3C2=O)ccc1F,IC50,17000.0,4.77,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL540720,O=C1c2c(ccc(O)c2O)CN1Cc1ccc(Cl)c(F)c1,IC50,97000.0,4.01,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,97000.0,4.013228265733755
CHEMBL557899,O=C1c2c(ccc(O)c2O)CN1Cc1ccc(Cl)c(Cl)c1,IC50,89000.0,4.05,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,89000.0,4.050609993355088
CHEMBL550838,O=C1c2c(ccc(O)c2O)CN1Cc1cc(Cl)ccc1F,IC50,18000.0,4.75,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL549886,O=C1c2c(ccc(O)c2O)CN1Cc1cccc(Cl)c1F,IC50,36000.0,4.44,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36000.0,4.443697499232713
CHEMBL561849,O=C1c2c(ccc(O)c2O)CN1Cc1cc(F)c(F)c(F)c1,IC50,99000.0,4.0,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,99000.0,4.00436480540245
CHEMBL550494,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccccc1,IC50,72000.0,4.14,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,72000.0,4.142667503568732
CHEMBL551241,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(F)cc1,IC50,8000.0,5.1,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL564630,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cccc(F)c1,IC50,11000.0,4.96,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL561709,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccccc1F,IC50,68000.0,4.17,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68000.0,4.167491087293763
CHEMBL549966,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cccc(Cl)c1,IC50,14000.0,4.85,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL569375,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cccc(Br)c1,IC50,16000.0,4.8,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL572338,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cccc(I)c1,IC50,85000.0,4.07,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,85000.0,4.070581074285707
CHEMBL562366,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(F)c(F)c1,IC50,27000.0,4.57,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27000.0,4.568636235841013
CHEMBL551559,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cc(F)cc(F)c1,IC50,48000.0,4.32,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48000.0,4.318758762624412
CHEMBL564147,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cc(F)ccc1F,IC50,60000.0,4.22,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL559852,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cccc(F)c1F,IC50,24000.0,4.62,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL552566,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(F)cc1F,IC50,16000.0,4.8,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL559284,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(F)c(Cl)c1,IC50,14000.0,4.85,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL563783,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(F)c(Br)c1,IC50,11000.0,4.96,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL550574,Cc1cc(CN2C(=O)c3ccc(O)c(O)c3C2=O)ccc1F,IC50,11000.0,4.96,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL569376,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(Cl)c(F)c1,IC50,58000.0,4.24,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58000.0,4.236572006437063
CHEMBL550776,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(Cl)c(Cl)c1,IC50,18000.0,4.75,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL564499,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(F)cc1Cl,IC50,90000.0,4.05,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL551568,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cc(Cl)ccc1F,IC50,9000.0,5.05,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL556473,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cccc(Cl)c1F,IC50,25000.0,4.6,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL562110,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1c(F)cccc1Cl,IC50,54000.0,4.27,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54000.0,4.267606240177032
CHEMBL572334,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cc(F)c(F)c(F)c1,IC50,10000.0,5.0,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL553173,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(F)c(F)c1F,IC50,18000.0,4.75,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL563552,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cc(F)c(F)cc1F,IC50,54000.0,4.27,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54000.0,4.267606240177032
CHEMBL550978,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1c(F)ccc(F)c1Cl,IC50,34000.0,4.47,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34000.0,4.468521082957745
CHEMBL560644,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cc(Cl)c(F)cc1F,IC50,79000.0,4.1,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,79000.0,4.102372908709558
CHEMBL560769,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1c(F)c(F)c(F)c(F)c1F,IC50,41000.0,4.39,CHEMBL1036448,Inhibition of HIV1 integrase 3'-processing activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41000.0,4.3872161432802645
CHEMBL561164,O=C1c2c(ccc(O)c2O)CN1Cc1cccc(F)c1,IC50,21000.0,4.68,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL554974,O=C1c2c(ccc(O)c2O)CN1Cc1ccccc1F,IC50,25000.0,4.6,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL540719,O=C1c2c(ccc(O)c2O)CN1Cc1cccc(Cl)c1,IC50,4000.0,5.4,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL564594,O=C1c2c(ccc(O)c2O)CN1Cc1cccc(Br)c1,IC50,3000.0,5.52,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL560706,O=C1c2c(ccc(O)c2O)CN1Cc1cccc(I)c1,IC50,4000.0,5.4,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL563507,O=C1c2c(ccc(O)c2O)CN1Cc1ccc(F)c(F)c1,IC50,900.0,6.05,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL563256,O=C1c2c(ccc(O)c2O)CN1Cc1cc(F)cc(F)c1,IC50,300.0,6.52,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL561565,O=C1c2c(ccc(O)c2O)CN1Cc1cc(F)ccc1F,IC50,27000.0,4.57,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27000.0,4.568636235841013
CHEMBL539708,O=C1c2c(ccc(O)c2O)CN1Cc1cccc(F)c1F,IC50,700.0,6.16,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL560202,O=C1c2c(ccc(O)c2O)CN1Cc1ccc(F)cc1F,IC50,500.0,6.3,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL560218,O=C1c2c(ccc(O)c2O)CN1Cc1c(F)cccc1F,IC50,20000.0,4.7,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL557898,O=C1c2c(ccc(O)c2O)CN1Cc1ccc(F)c(Br)c1,IC50,1000.0,6.0,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL561770,Cc1cc(CN2Cc3ccc(O)c(O)c3C2=O)ccc1F,IC50,900.0,6.05,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL540720,O=C1c2c(ccc(O)c2O)CN1Cc1ccc(Cl)c(F)c1,IC50,6000.0,5.22,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL557899,O=C1c2c(ccc(O)c2O)CN1Cc1ccc(Cl)c(Cl)c1,IC50,100.0,7.0,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL561646,O=C1c2c(ccc(O)c2O)CN1Cc1ccc(F)cc1Cl,IC50,2500.0,5.6,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL550838,O=C1c2c(ccc(O)c2O)CN1Cc1cc(Cl)ccc1F,IC50,1200.0,5.92,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL549886,O=C1c2c(ccc(O)c2O)CN1Cc1cccc(Cl)c1F,IC50,2000.0,5.7,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL561848,O=C1c2c(ccc(O)c2O)CN1Cc1c(F)cccc1Cl,IC50,18000.0,4.75,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL561849,O=C1c2c(ccc(O)c2O)CN1Cc1cc(F)c(F)c(F)c1,IC50,4000.0,5.4,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL569135,O=C1c2c(ccc(O)c2O)CN1Cc1ccc(F)c(F)c1F,IC50,2700.0,5.57,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2700.0,5.568636235841012
CHEMBL550086,O=C1c2c(ccc(O)c2O)CN1Cc1cc(F)c(F)cc1F,IC50,3700.0,5.43,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3700.0,5.431798275933005
CHEMBL565197,O=C1c2c(ccc(O)c2O)CN1Cc1c(F)ccc(F)c1F,IC50,25000.0,4.6,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL569371,O=C1c2c(ccc(O)c2O)CN1Cc1c(F)ccc(F)c1Cl,IC50,8900.0,5.05,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8900.0,5.050609993355087
CHEMBL555979,O=C1c2c(ccc(O)c2O)CN1Cc1cc(Cl)c(F)cc1F,IC50,4400.0,5.36,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4400.0,5.356547323513812
CHEMBL562442,O=C1c2c(ccc(O)c2O)CN1Cc1c(F)c(F)c(F)c(F)c1F,IC50,8000.0,5.1,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL550494,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccccc1,IC50,400.0,6.4,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL551241,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(F)cc1,IC50,5000.0,5.3,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL564630,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cccc(F)c1,IC50,300.0,6.52,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL561709,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccccc1F,IC50,2000.0,5.7,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL549966,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cccc(Cl)c1,IC50,400.0,6.4,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL569375,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cccc(Br)c1,IC50,400.0,6.4,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL572338,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cccc(I)c1,IC50,1000.0,6.0,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL562366,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(F)c(F)c1,IC50,100.0,7.0,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL551559,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cc(F)cc(F)c1,IC50,400.0,6.4,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL564147,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cc(F)ccc1F,IC50,230.0,6.64,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,230.0,6.638272163982407
CHEMBL559852,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cccc(F)c1F,IC50,200.0,6.7,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL552566,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(F)cc1F,IC50,300.0,6.52,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL551560,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1c(F)cccc1F,IC50,2000.0,5.7,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL559284,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(F)c(Cl)c1,IC50,170.0,6.77,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,170.0,6.769551078621726
CHEMBL563783,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(F)c(Br)c1,IC50,900.0,6.05,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL550574,Cc1cc(CN2C(=O)c3ccc(O)c(O)c3C2=O)ccc1F,IC50,800.0,6.1,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL569376,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(Cl)c(F)c1,IC50,900.0,6.05,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL550776,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(Cl)c(Cl)c1,IC50,120.0,6.92,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,120.0,6.920818753952375
CHEMBL564499,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(F)cc1Cl,IC50,1300.0,5.89,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL551568,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cc(Cl)ccc1F,IC50,310.0,6.51,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,310.0,6.508638306165727
CHEMBL556473,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cccc(Cl)c1F,IC50,2000.0,5.7,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL562110,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1c(F)cccc1Cl,IC50,3500.0,5.46,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3500.0,5.455931955649724
CHEMBL572334,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cc(F)c(F)c(F)c1,IC50,600.0,6.22,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL553173,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(F)c(F)c1F,IC50,800.0,6.1,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL563552,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cc(F)c(F)cc1F,IC50,500.0,6.3,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL549415,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1c(F)ccc(F)c1F,IC50,1800.0,5.75,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL550978,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1c(F)ccc(F)c1Cl,IC50,4000.0,5.4,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL560644,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cc(Cl)c(F)cc1F,IC50,400.0,6.4,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL560769,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1c(F)c(F)c(F)c(F)c1F,IC50,1300.0,5.89,CHEMBL1024560,Inhibition of HIV1 integrase strand transfer activity in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL554745,CN1Cn2c(nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)C1(C)C,IC50,30.0,7.52,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL563963,CC1(C)NC(=O)n2c1nc(C(=O)NCc1ccc(F)cc1)c(O)c2=O,IC50,32.0,7.5,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32.0,7.494850021680094
CHEMBL552065,CC1(C)NC(=O)Cn2c1nc(C(=O)NCc1ccc(F)cc1)c(O)c2=O,IC50,5.0,8.3,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL561987,CC1(C)NS(=O)(=O)Cn2c1nc(C(=O)NCc1ccc(F)cc1)c(O)c2=O,IC50,7.0,8.15,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL550394,CC1(C)NCCn2c1nc(C(=O)NCc1ccc(F)cc1)c(O)c2=O,IC50,16.0,7.8,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16.0,7.795880017344075
CHEMBL559306,CN1CCn2c(nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)C1(C)C,IC50,6.0,8.22,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL563270,CC1(C)NCCCn2c1nc(C(=O)NCc1ccc(F)cc1)c(O)c2=O,IC50,20.0,7.7,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL557854,CC(=O)N1CCn2c(nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)C1(C)C,IC50,5.0,8.3,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL564212,CN(C)C(=O)C(=O)N1CCn2c(nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)C1(C)C,IC50,6.0,8.22,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL554737,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1S(C)(=O)=O,IC50,10.0,8.0,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL550108,CCNC(=O)N1CCn2c(nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)C1(C)C,IC50,15.0,7.82,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL550997,CN(C)S(=O)(=O)N1CCn2c(nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)C1(C)C,IC50,8.0,8.1,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL560265,CN(C)CCN1CCn2c(nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)C1(C)C,IC50,62.0,7.21,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,62.0,7.207608310501746
CHEMBL551401,CCN(CC)CCN1CCn2c(nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)C1(C)C,IC50,76.0,7.12,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,76.0,7.119186407719209
CHEMBL550051,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1CCN1CCOCC1,IC50,3.0,8.52,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL558641,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1CC(N)=O,IC50,5.0,8.3,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL551402,CNC(=O)CN1CCn2c(nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)C1(C)C,IC50,21.0,7.68,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL551808,CN(C)C(=O)CN1CCn2c(nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)C1(C)C,IC50,8.0,8.1,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL561729,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1CC(=O)N1CCOCC1,IC50,7.0,8.15,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL557308,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1CC(=O)N1CCCC1,IC50,7.0,8.15,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL560185,CN1CCN(C(=O)CN2CCn3c(nc(C(=O)NCc4ccc(F)cc4)c(O)c3=O)C2(C)C)CC1,IC50,21.0,7.68,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL562327,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1CC(=O)O,IC50,8.0,8.1,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL560387,C=C(CCc1ccc(C)cc1)C1=C(C)C(=C)C2CCC(CC#N)C(C)(C)C2=C1,IC50,5.0,8.3,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL563502,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1Cc1ccccc1,IC50,5.0,8.3,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL552202,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1Cc1ccccn1,IC50,9.0,8.05,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL551325,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1CCc1ccccn1,IC50,12.0,7.92,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL561467,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1Cc1cnccn1,IC50,6.0,8.22,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL559537,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1Cc1ccn[nH]1,IC50,5.0,8.3,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL558121,Cn1nccc1CN1CCn2c(nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)C1(C)C,IC50,7.0,8.15,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL552264,Cn1ccc(CN2CCn3c(nc(C(=O)NCc4ccc(F)cc4)c(O)c3=O)C2(C)C)n1,IC50,9.0,8.05,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL560322,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1Cc1cnn[nH]1,IC50,6.0,8.22,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL557646,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1Cc1cn[nH]c1,IC50,7.0,8.15,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL559395,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1Cc1cocn1,IC50,3.0,8.52,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL564823,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1Cc1cscn1,IC50,9.0,8.05,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL558051,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1Cc1cnco1,IC50,4.0,8.4,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL550590,Cn1cnc(CN2CCn3c(nc(C(=O)NCc4ccc(F)cc4)c(O)c3=O)C2(C)C)n1,IC50,25.0,7.6,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25.0,7.6020599913279625
CHEMBL552327,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1Cc1nnco1,IC50,21.0,7.68,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL554284,Cc1nnc(CN2CCn3c(nc(C(=O)NCc4ccc(F)cc4)c(O)c3=O)C2(C)C)o1,IC50,5.0,8.3,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL563631,Cc1cnc(CN2CCn3c(nc(C(=O)NCc4ccc(F)cc4)c(O)c3=O)C2(C)C)o1,IC50,8.0,8.1,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL552176,Cc1cc(CN2CCn3c(nc(C(=O)NCc4ccc(F)cc4)c(O)c3=O)C2(C)C)on1,IC50,62.0,7.21,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,62.0,7.207608310501746
CHEMBL552177,Cc1noc(CN2CCn3c(nc(C(=O)NCc4ccc(F)cc4)c(O)c3=O)C2(C)C)n1,IC50,13.0,7.89,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL550784,Cc1nc(CN2CCn3c(nc(C(=O)NCc4ccc(F)cc4)c(O)c3=O)C2(C)C)no1,IC50,6.0,8.22,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL556894,Cn1cc(CN2CCn3c(nc(C(=O)NCc4ccc(F)cc4)c(O)c3=O)C2(C)C)nn1,IC50,2.0,8.7,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL560251,Cn1nncc1CN1CCn2c(nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)C1(C)C,IC50,6.0,8.22,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL549422,CC1(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2CCN1Cc1nnn[nH]1,IC50,2.0,8.7,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL550985,Cn1nnnc1CN1CCn2c(nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)C1(C)C,IC50,5.0,8.3,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL549831,Cn1nnc(CN2CCn3c(nc(C(=O)NCc4ccc(F)cc4)c(O)c3=O)C2(C)C)n1,IC50,6.0,8.22,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL518520,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c([O-])c(=O)n2C)o1.[K+],IC50,15.0,7.82,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL562760,CN(C)[C@@H]1CCCn2c1nc(C(=O)NCc1ccc(F)cc1)c(O)c2=O,IC50,69.0,7.16,CHEMBL1062363,Inhibition of HIV1 recombinant integrase strand transfer activity treated after enzyme assembly and washing,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69.0,7.161150909262744
CHEMBL556071,O=C(Nc1ccc(S(=O)(=O)Nc2ccc(F)cc2)cc1)c1cc(O)c(O)c(O)c1,IC50,900.0,6.05,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL549713,O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2)cc1)c1cc(O)c(O)c(O)c1,IC50,1500.0,5.82,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1500.0,5.823908740944319
CHEMBL552413,O=C(Nc1ccc(S(=O)(=O)Nc2ccc([N+](=O)[O-])cc2)cc1)c1cc(O)c(O)c(O)c1,IC50,3000.0,5.52,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL549298,O=C(Nc1ccc(S(=O)(=O)Nc2ccc(Br)cc2)cc1)c1cc(O)c(O)c(O)c1,IC50,700.0,6.16,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL549299,O=C(Nc1ccc(S(=O)(=O)Nc2cccc(Br)c2)cc1)c1cc(O)c(O)c(O)c1,IC50,700.0,6.16,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL556642,CCCCc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3cc(O)c(O)c(O)c3)cc2)cc1,IC50,2500.0,5.6,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL557319,Cc1cc(C)cc(NS(=O)(=O)c2ccc(NC(=O)c3cc(O)c(O)c(O)c3)cc2)c1,IC50,2500.0,5.6,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL562273,O=C(Nc1ccc(S(=O)(=O)NCc2ccc(Cl)cc2)cc1)c1cc(O)c(O)c(O)c1,IC50,2000.0,5.7,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL561593,O=C(Nc1ccc(S(=O)(=O)NCc2ccc(F)cc2)cc1)c1cc(O)c(O)c(O)c1,IC50,2000.0,5.7,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL559681,Cc1ccccc1NS(=O)(=O)c1ccc(NC(=O)c2cc(O)c(O)c(O)c2)cc1,IC50,2000.0,5.7,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL564228,O=C(Nc1ccc(S(=O)(=O)Nc2ccc(Cl)cc2)cc1)c1cc(O)c(O)c(O)c1,IC50,2000.0,5.7,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL549299,O=C(Nc1ccc(S(=O)(=O)Nc2cccc(Br)c2)cc1)c1cc(O)c(O)c(O)c1,IC50,2000.0,5.7,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL557865,NS(=O)(=O)c1ccc(NC(=O)c2cc(O)c(O)c(O)c2)cc1,IC50,2000.0,5.7,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL556642,CCCCc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3cc(O)c(O)c(O)c3)cc2)cc1,IC50,3000.0,5.52,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL562335,O=C(Nc1ccc(S(=O)(=O)Nc2ccc(Cl)c(Cl)c2)cc1)c1cc(O)c(O)c(O)c1,IC50,5000.0,5.3,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL551736,Cc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3cc(O)c(O)c(O)c3)cc2)cc1C,IC50,8000.0,5.1,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL549298,O=C(Nc1ccc(S(=O)(=O)Nc2ccc(Br)cc2)cc1)c1cc(O)c(O)c(O)c1,IC50,3000.0,5.52,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL558132,O=C(Nc1ccc(S(=O)(=O)Nc2ccc(F)c(F)c2F)cc1)c1cc(O)c(O)c(O)c1,IC50,3000.0,5.52,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL552413,O=C(Nc1ccc(S(=O)(=O)Nc2ccc([N+](=O)[O-])cc2)cc1)c1cc(O)c(O)c(O)c1,IC50,4000.0,5.4,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL562196,O=C(Nc1ccc(S(=O)(=O)Nc2ccc(F)c(F)c2)cc1)c1cc(O)c(O)c(O)c1,IC50,4000.0,5.4,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL562273,O=C(Nc1ccc(S(=O)(=O)NCc2ccc(Cl)cc2)cc1)c1cc(O)c(O)c(O)c1,IC50,5000.0,5.3,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL564228,O=C(Nc1ccc(S(=O)(=O)Nc2ccc(Cl)cc2)cc1)c1cc(O)c(O)c(O)c1,IC50,6000.0,5.22,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL558132,O=C(Nc1ccc(S(=O)(=O)Nc2ccc(F)c(F)c2F)cc1)c1cc(O)c(O)c(O)c1,IC50,7000.0,5.16,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL557319,Cc1cc(C)cc(NS(=O)(=O)c2ccc(NC(=O)c3cc(O)c(O)c(O)c3)cc2)c1,IC50,8000.0,5.1,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL561593,O=C(Nc1ccc(S(=O)(=O)NCc2ccc(F)cc2)cc1)c1cc(O)c(O)c(O)c1,IC50,7000.0,5.16,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL559681,Cc1ccccc1NS(=O)(=O)c1ccc(NC(=O)c2cc(O)c(O)c(O)c2)cc1,IC50,7000.0,5.16,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL549713,O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2)cc1)c1cc(O)c(O)c(O)c1,IC50,7000.0,5.16,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL551736,Cc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3cc(O)c(O)c(O)c3)cc2)cc1C,IC50,8000.0,5.1,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL559410,O=C(/C=C/c1ccc(O)c(O)c1)Nc1ccc(S(=O)(=O)Nc2ccccc2)cc1,IC50,12000.0,4.92,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL559410,O=C(/C=C/c1ccc(O)c(O)c1)Nc1ccc(S(=O)(=O)Nc2ccccc2)cc1,IC50,16000.0,4.8,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL559409,O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2)cc1)c1ccc(O)c(O)c1,IC50,50000.0,4.3,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL557865,NS(=O)(=O)c1ccc(NC(=O)c2cc(O)c(O)c(O)c2)cc1,IC50,22000.0,4.66,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL557046,CCOc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3cc(O)c(O)c(O)c3)cc2)cc1,IC50,1300.0,5.89,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL562196,O=C(Nc1ccc(S(=O)(=O)Nc2ccc(F)c(F)c2)cc1)c1cc(O)c(O)c(O)c1,IC50,1500.0,5.82,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1500.0,5.823908740944319
CHEMBL549995,CC(=O)Oc1cc(C(=O)Nc2ccc(S(=O)(=O)Nc3ccccc3C)cc2)cc(OC(C)=O)c1OC(C)=O,IC50,1600.0,5.8,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL560002,CC(=O)Oc1cc(C(=O)Nc2ccc(S(=O)(=O)Nc3ccccc3)cc2)cc(OC(C)=O)c1OC(C)=O,IC50,1600.0,5.8,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL562335,O=C(Nc1ccc(S(=O)(=O)Nc2ccc(Cl)c(Cl)c2)cc1)c1cc(O)c(O)c(O)c1,IC50,1700.0,5.77,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL562871,COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3cc(O)c(O)c(O)c3)cc2)cc1,IC50,4500.0,5.35,CHEMBL1057308,Inhibition of HIV1 integrase assessed as inhibition of strand transfer activity by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4500.0,5.346787486224656
CHEMBL562871,COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3cc(O)c(O)c(O)c3)cc2)cc1,IC50,5000.0,5.3,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL557046,CCOc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3cc(O)c(O)c(O)c3)cc2)cc1,IC50,6000.0,5.22,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL556071,O=C(Nc1ccc(S(=O)(=O)Nc2ccc(F)cc2)cc1)c1cc(O)c(O)c(O)c1,IC50,7000.0,5.16,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL560002,CC(=O)Oc1cc(C(=O)Nc2ccc(S(=O)(=O)Nc3ccccc3)cc2)cc(OC(C)=O)c1OC(C)=O,IC50,8000.0,5.1,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL559409,O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2)cc1)c1ccc(O)c(O)c1,IC50,100000.0,4.0,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL549995,CC(=O)Oc1cc(C(=O)Nc2ccc(S(=O)(=O)Nc3ccccc3C)cc2)cc(OC(C)=O)c1OC(C)=O,IC50,10000.0,,CHEMBL1057307,Inhibition of HIV1 integrase assessed as inhibition of 3'-end processing by 32P-labelled assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL559753,CCOC(=O)C(=O)CC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(Br)cc2c1=O,IC50,78000.0,4.11,CHEMBL1056712,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli BL21 (DE3) by gel based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,78000.0,4.107905397309519
CHEMBL562899,O=C(O)C(=O)CC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(Br)cc2c1=O,IC50,1600.0,5.8,CHEMBL1056712,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli BL21 (DE3) by gel based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL559753,CCOC(=O)C(=O)CC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(Br)cc2c1=O,IC50,120.0,6.92,CHEMBL1056713,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) by gel based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,120.0,6.920818753952375
CHEMBL562899,O=C(O)C(=O)CC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(Br)cc2c1=O,IC50,30.0,7.52,CHEMBL1056713,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) by gel based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL558661,O=C(O)C(=O)CC(=O)c1ccc2c(c1)c(=O)c(C(=O)CC(=O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,440.0,6.36,CHEMBL1056712,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli BL21 (DE3) by gel based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,440.0,6.356547323513812
CHEMBL558661,O=C(O)C(=O)CC(=O)c1ccc2c(c1)c(=O)c(C(=O)CC(=O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,17.0,7.77,CHEMBL1056713,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) by gel based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17.0,7.769551078621726
CHEMBL554522,C[C@@]1(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)[nH]2)CCCN1,IC50,80.0,7.1,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL549798,CN1CCC[C@@]1(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)[nH]1,IC50,90.0,7.05,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90.0,7.045757490560675
CHEMBL550674,CC(=O)N1CCC[C@@]1(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)[nH]1,IC50,20.0,7.7,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL565220,CC1(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)[nH]2)CCCCN1,IC50,20.0,7.7,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL549309,CN1CCCCC1(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)[nH]1,IC50,250.0,6.6,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL563757,CC(=O)N1CCCCC1(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)[nH]1,IC50,14.0,7.85,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL550202,Cc1nc(C)c(C(=O)N2CCCCC2(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)[nH]2)s1,IC50,20.0,7.7,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL562482,CN1CCCCC1(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,550.0,6.26,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,550.0,6.259637310505756
CHEMBL559492,CC(=O)N1CCN(C)CC1(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)[nH]1,IC50,100.0,7.0,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL551942,CN1CCN(C(=O)c2cnccn2)C(C)(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)[nH]2)C1,IC50,100.0,7.0,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL549592,CC(=O)N1CCN(C)C(C)(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)C1,IC50,4.0,8.4,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL562595,CN1CCN(S(=O)(=O)N(C)C)CC1(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,20.0,7.7,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL564267,CN1CCN(S(C)(=O)=O)CC1(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,15.0,7.82,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL564984,O=C(NCc1ccc(F)cc1)c1nc(C2CCCN2)[nH]c(=O)c1O,IC50,120.0,6.92,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,120.0,6.920818753952375
CHEMBL226764,CN1CCCC1c1nc(O)c(O)c(C(=O)NCc2ccc(F)cc2)n1,IC50,70.0,7.16,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL563628,CC(=O)N1CCCC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)[nH]1,IC50,40.0,7.4,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL227497,O=C(NCc1ccc(F)cc1)c1nc(C2CCCCN2)nc(O)c1O,IC50,130.0,6.89,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL563898,CC(=O)N1CCCCC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)[nH]1,IC50,20.0,7.7,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL559493,Cc1nc(C)c(C(=O)N2CCCCC2c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)[nH]2)s1,IC50,50.0,7.3,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL560944,CC(=O)N1CCN(C)CC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)[nH]1,IC50,30.0,7.52,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL559494,CN1CCN(C(=O)c2cnccn2)C(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)[nH]2)C1,IC50,60.0,7.22,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL394786,CC(=O)N1CCN(C)C(c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)C1,IC50,6.0,8.22,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL243365,CN1CCN(S(=O)(=O)N(C)C)CC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,20.0,7.7,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL243150,CN1CCN(S(C)(=O)=O)CC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,30.0,7.52,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL564267,CN1CCN(S(C)(=O)=O)CC1(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,20.0,7.7,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL564267,CN1CCN(S(C)(=O)=O)CC1(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,20.0,7.7,CHEMBL1060098,Inhibition of recombinant HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL516025,O=C(O)/C(O)=C/C(=O)c1cc(OCc2ccccc2)cc(OCc2ccccc2)c1,IC50,100.0,7.0,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL573605,CC(=O)N(C)c1cc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,20.0,7.7,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL575207,CC(=O)N(C)CCNc1cc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,30.0,7.52,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL572902,CC(=O)N1CCN(c2cc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)CC1,IC50,20.0,7.7,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL572901,CN1CCN(c2cc(C(=O)NCc3ccc(F)cc3)c(O)c3ncccc23)CC1,IC50,40.0,7.4,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL209591,O=C(NCc1ccc(F)cc1)c1ccc2cccnc2c1O,IC50,30.0,7.52,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL572448,CN(C)C(=O)C(=O)N(C)c1cc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,40.0,7.4,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL35842,O=C(c1cccc(Cc2ccccc2)c1)c1ccc2cccnc2c1O,IC50,50.0,7.3,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL209854,O=C1c2c(c(C(=O)N3CCOCC3)c3cccnc3c2O)CN1Cc1ccc(F)cc1,IC50,40.0,7.4,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL573638,O=C(O)/C(O)=C/C(=O)c1ccc(Oc2ccccc2)cc1,IC50,11400.0,4.94,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11400.0,4.943095148663527
CHEMBL492770,O=C(O)/C(O)=C/C(=O)c1cccc(OCc2ccccc2)c1,IC50,350.0,6.46,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,350.0,6.455931955649724
CHEMBL564494,O=C(O)/C(O)=C/C(=O)c1cccc(Br)c1,IC50,2500.0,5.6,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL574316,O=C(/C=C(\O)C(=O)O)C(=O)c1cccc(C(=O)c2ccccc2)c1,IC50,2400.0,5.62,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2400.0,5.619788758288394
CHEMBL564495,[N-]=[N+]=NCc1cccc(C(=O)/C=C(\O)C(=O)O)c1,IC50,330.0,6.48,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,330.0,6.481486060122112
CHEMBL574315,[N-]=[N+]=NCc1cc(CN=[N+]=[N-])cc(C(=O)/C=C(\O)C(=O)O)c1,IC50,460.0,6.34,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,460.0,6.337242168318426
CHEMBL574314,O=C(O)/C(O)=C/C(=O)c1cccc(Cc2cccc(Cl)c2)c1,IC50,100.0,,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL573621,O=C(O)/C(O)=C/C(=O)c1cccc(Cc2ccccc2Cl)c1,IC50,100.0,,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL584360,O=C(O)/C(O)=C/C(=O)c1cccc(Cc2ccc(F)cc2)c1,IC50,100.0,,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL572438,O=C(O)/C(O)=C/C(=O)c1cccc(Cc2ccccc2F)c1,IC50,100.0,,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL242883,O=C(O)/C(O)=C/C(=O)c1cccc(Cc2ccccc2)c1,IC50,100.0,,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL572414,COc1ccc(Cc2cccc(C(=O)/C=C(\O)C(=O)O)c2)cc1,IC50,150.0,6.82,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,150.0,6.823908740944319
CHEMBL573874,O=C(O)/C(O)=C/C(=O)c1ccc(Cc2ccccc2)s1,IC50,500.0,6.3,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL584772,O=C(O)/C(O)=C/C(=O)c1csc(Cc2ccccc2)c1,IC50,130.0,6.89,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL573873,O=C(O)/C(O)=C/C(=O)c1ccn(Cc2ccccc2)c1,IC50,550.0,6.26,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,550.0,6.259637310505756
CHEMBL573644,O=C(O)/C(O)=C/C(=O)c1cccn1Cc1ccccc1,IC50,220.0,6.66,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,220.0,6.657577319177793
CHEMBL573637,COc1cccc(Cc2cccc(C(=O)/C=C(\O)C(=O)O)c2)c1,IC50,140.0,6.85,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,140.0,6.853871964321762
CHEMBL572473,O=C(O)/C(O)=C/C(=O)c1cccc(Cc2cccc(F)c2)c1,IC50,250.0,6.6,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL572472,O=C(O)/C(O)=C/C(=O)c1cccc(Cc2ccc(Cl)cc2)c1,IC50,750.0,6.12,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,750.0,6.1249387366083
CHEMBL572471,O=C(O)/C(O)=C/C(=O)C1C=CSC1Cc1ccccc1,IC50,180.0,6.75,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,180.0,6.7447274948966935
CHEMBL583059,O=C(O)/C(O)=C/C(=O)c1ccccc1Cc1ccccc1,IC50,5670.0,5.25,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5670.0,5.246416941107094
CHEMBL573623,O=C(O)/C(O)=C/C(=O)c1cccn1Cc1ccc(-c2ccccc2)cc1,IC50,7500.0,5.12,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7500.0,5.1249387366083
CHEMBL582913,O=C(O)/C(O)=C/C(=O)c1cccn1CCCc1ccccc1,IC50,500.0,6.3,CHEMBL1040344,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL568049,O=C(O)c1cc2ccn(Cc3ccccc3F)c2cn1,IC50,50000.0,,CHEMBL1043899,Inhibition of HIV1 integrase expressed in Escherichia coli assessed as strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL568050,O=C(O)c1cc2ccn(Cc3ccc(F)cc3F)c2cn1,IC50,3500.0,5.46,CHEMBL1043899,Inhibition of HIV1 integrase expressed in Escherichia coli assessed as strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3500.0,5.455931955649724
CHEMBL585005,O=C(O)c1cc2ccn(Cc3ccc(F)cc3)c2cn1,IC50,7350.0,5.13,CHEMBL1043899,Inhibition of HIV1 integrase expressed in Escherichia coli assessed as strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7350.0,5.133712660915805
CHEMBL576026,O=C(O)c1cc2ccn(Cc3ccc(F)c(F)c3F)c2cn1,IC50,3690.0,5.43,CHEMBL1043899,Inhibition of HIV1 integrase expressed in Escherichia coli assessed as strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3690.0,5.432973633840939
CHEMBL574570,O=C(O)c1cc2ccn(Cc3cccc(Cl)c3F)c2cn1,IC50,950.0,6.02,CHEMBL1043899,Inhibition of HIV1 integrase expressed in Escherichia coli assessed as strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,950.0,6.022276394711152
CHEMBL574571,O=C(O)c1cc2ccn(Cc3c(F)cc(Cl)cc3F)c2cn1,IC50,1190.0,5.92,CHEMBL1043899,Inhibition of HIV1 integrase expressed in Escherichia coli assessed as strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1190.0,5.924453038607469
CHEMBL565266,O=C(O)c1cc2ccn(Cc3cccc(Cl)c3Cl)c2cn1,IC50,5420.0,5.27,CHEMBL1043899,Inhibition of HIV1 integrase expressed in Escherichia coli assessed as strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5420.0,5.266000713461613
CHEMBL565676,O=C(O)c1cc2ccn(Cc3cc(Cl)cs3)c2cn1,IC50,3200.0,5.5,CHEMBL1043899,Inhibition of HIV1 integrase expressed in Escherichia coli assessed as strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3200.0,5.494850021680094
CHEMBL577062,O=C(NO)c1cc2ccn(Cc3ccc(F)cc3F)c2cn1,IC50,84000.0,4.08,CHEMBL1043899,Inhibition of HIV1 integrase expressed in Escherichia coli assessed as strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,84000.0,4.075720713938118
CHEMBL578595,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cccc2ccccc12,IC50,720.0,6.14,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,720.0,6.142667503568731
CHEMBL568970,O=C1c2c(ccc(O)c2O)CN1Cc1ccc2ccccc2c1,IC50,800.0,6.1,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL579040,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc2ccccc2c1,IC50,960.0,6.02,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,960.0,6.017728766960431
CHEMBL565954,O=C1c2ccc(O)c(O)c2C(=O)N1[C@H]1CCc2ccccc21,IC50,1800.0,5.75,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL576652,O=C1c2ccc(O)c(O)c2C(=O)N1C1Cc2ccccc2C1,IC50,4000.0,5.4,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL565985,C[C@@H](c1cccc2ccccc12)N1Cc2ccc(O)c(O)c2C1=O,IC50,4000.0,5.4,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL576837,C[C@@H](c1ccc2ccccc2c1)N1Cc2ccc(O)c(O)c2C1=O,IC50,4600.0,5.34,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4600.0,5.337242168318426
CHEMBL583803,C[C@@H](C1CCc2ccccc21)N1Cc2ccc(O)c(O)c2C1=O,IC50,6000.0,5.22,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL567591,O=C1c2ccc(O)c(O)c2C(=O)N1CCc1ccccc1,IC50,6800.0,5.17,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6800.0,5.167491087293763
CHEMBL583869,C[C@@H](C1CCCc2ccccc21)N1Cc2ccc(O)c(O)c2C1=O,IC50,9000.0,5.05,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL576828,O=C1c2ccc(O)c(O)c2C(=O)N1[C@H]1CCCc2ccccc21,IC50,10000.0,5.0,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL583395,O=C1c2ccc(O)c(O)c2C(=O)N1[C@@H]1CCc2ccccc21,IC50,12000.0,4.92,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL565527,C[C@@H](c1ccc(F)cc1)N1Cc2ccc(O)c(O)c2C1=O,IC50,12100.0,4.92,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12100.0,4.91721462968355
CHEMBL579040,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc2ccccc2c1,IC50,18000.0,4.75,CHEMBL1049935,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL586817,O=C1c2c(ccc(O)c2O)CN1C1Cc2ccccc2C1,IC50,23000.0,4.64,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL568970,O=C1c2c(ccc(O)c2O)CN1Cc1ccc2ccccc2c1,IC50,24000.0,4.62,CHEMBL1049935,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL583393,C[C@H](c1ccc2ccccc2c1)N1Cc2ccc(O)c(O)c2C1=O,IC50,24000.0,4.62,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL583118,C[C@H](c1ccc(F)cc1)N1Cc2ccc(O)c(O)c2C1=O,IC50,24400.0,4.61,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24400.0,4.61261017366127
CHEMBL576652,O=C1c2ccc(O)c(O)c2C(=O)N1C1Cc2ccccc2C1,IC50,37000.0,4.43,CHEMBL1049935,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL579192,C[C@H](c1cccc2ccccc12)N1Cc2ccc(O)c(O)c2C1=O,IC50,48300.0,4.32,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48300.0,4.316052869248487
CHEMBL572179,C[C@@H](c1ccccc1)N1Cc2ccc(O)c(O)c2C1=O,IC50,49000.0,4.31,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,49000.0,4.309803919971486
CHEMBL579398,O=C1c2ccc(O)c(O)c2C(=O)N1[C@@H]1CCCc2ccccc21,IC50,81000.0,4.09,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,81000.0,4.0915149811213505
CHEMBL568462,C[C@H](C1CCc2ccccc21)N1Cc2ccc(O)c(O)c2C1=O,IC50,99000.0,4.0,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,99000.0,4.00436480540245
CHEMBL568680,C[C@H](c1ccccc1)N1Cc2ccc(O)c(O)c2C1=O,IC50,100000.0,4.0,CHEMBL1049936,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,IC50,40000.0,4.4,CHEMBL1109337,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL373761,O=C(NCC1CCCCC1)c1nc(-c2cccs2)nc(O)c1O,IC50,10.0,8.0,CHEMBL1111323,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL1087940,O=C(Nc1ccc2ccccc2c1)c1nc(-c2cccs2)nc(O)c1O,IC50,30.2,7.52,CHEMBL1111323,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.2,7.51999305704285
CHEMBL234707,O=C(Nc1cccc2ccccc12)c1nc(-c2cccs2)nc(O)c1O,IC50,213.8,6.67,CHEMBL1111323,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,213.8,6.669992299127241
CHEMBL234923,O=C(N[C@@H]1CCc2ccccc21)c1nc(-c2cccs2)nc(O)c1O,IC50,19.95,7.7,CHEMBL1111323,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19.95,7.700057099977233
CHEMBL390433,O=C(N[C@H]1CCc2ccccc21)c1nc(-c2cccs2)nc(O)c1O,IC50,616.6,6.21,CHEMBL1111323,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,616.6,6.209996479609511
CHEMBL1085426,O=C(NCn1cncn1)c1nc(-c2cccs2)nc(O)c1O,IC50,50118.72,4.3,CHEMBL1111323,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50118.72,4.300000029139088
CHEMBL1084126,O=C(NCn1ccnc1)c1nc(-c2cccs2)nc(O)c1O,IC50,16982.44,4.77,CHEMBL1111323,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16982.44,4.769999911123512
CHEMBL1088620,O=C(NCc1cccs1)c1nc(-c2cccs2)nc(O)c1O,IC50,100.0,7.0,CHEMBL1111323,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL1088621,O=C(NCc1nccs1)c1nc(-c2cccs2)nc(O)c1O,IC50,199.53,6.7,CHEMBL1111323,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,199.53,6.699991797446187
CHEMBL1087929,O=C(NCc1cncs1)c1nc(-c2cccs2)nc(O)c1O,IC50,2511.89,5.6,CHEMBL1111323,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2511.89,5.59999938302362
CHEMBL1088058,O=C(NCc1cc2ccccc2s1)c1nc(-c2cccs2)nc(O)c1O,IC50,10.0,8.0,CHEMBL1111323,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL1088059,O=C(NCc1csc2ccccc12)c1nc(-c2cccs2)nc(O)c1O,IC50,50.12,7.3,CHEMBL1111323,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.12,7.299988937677888
CHEMBL1092354,NCCCCNP(=O)(O[C@H]1C[C@H](n2ccc(N)nc2=O)O[C@@H]1CO)O[C@H]1C[C@H](n2cnc3c(N)ncnc32)O[C@@H]1CO,IC50,100000.0,4.0,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1092356,N=C(N)NCCCCNP(=O)(OC[C@H]1O[C@@H](n2ccc(N)nc2=O)C[C@@H]1O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)C[C@@H]1O,IC50,100000.0,4.0,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1092357,N=C(N)NCCCCNP(=O)(O[C@H]1C[C@H](n2ccc(N)nc2=O)O[C@@H]1CO)O[C@H]1C[C@H](n2cnc3c(N)ncnc32)O[C@@H]1CO,IC50,100000.0,4.0,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1092359,COc1ccc2nc3cc(Cl)ccc3c(NCCCCCCOP(=O)(O)OC[C@H]3O[C@@H](n4ccc(N)nc4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)C[C@@H]3OP(=O)(O)O)c2c1,IC50,13200.0,4.88,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13200.0,4.87942606879415
CHEMBL1092360,COc1ccc2nc3cc(Cl)ccc3c(NCCC[N+](C)(C)CCCSP(=O)(O)OC[C@H]3O[C@@H](n4ccc(N)nc4=O)C[C@@H]3OP(=O)([O-])OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)C[C@@H]3OP(=O)(O)O)c2c1,IC50,100000.0,,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1092361,Nc1ccn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)C[C@@H]3OP(=O)(O)O)[C@@H](COP(=O)(O)SCCCCCC(=O)Nc3cccc4c3C(=O)c3ccccc3C4=O)O2)c(=O)n1,IC50,13900.0,4.86,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13900.0,4.856985199745905
CHEMBL1092362,Nc1ccn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)C[C@@H]3OP(=O)(O)O)[C@@H](COP(=O)(O)SCCCCCC(=O)Nc3ccc(N)c4c3C(=O)c3ccccc3C4=O)O2)c(=O)n1,IC50,13400.0,4.87,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13400.0,4.872895201635193
CHEMBL1092363,Nc1ccn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)C[C@@H]3OP(=O)(O)O)[C@@H](COP(=O)(O)OCCCCCCNC(=O)c3ccc4c(c3)C(=O)c3cc(C(=O)NCCCCCCO)ccc3C4=O)O2)c(=O)n1,IC50,21000.0,4.68,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL1092363,Nc1ccn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)C[C@@H]3OP(=O)(O)O)[C@@H](COP(=O)(O)OCCCCCCNC(=O)c3ccc4c(c3)C(=O)c3cc(C(=O)NCCCCCCO)ccc3C4=O)O2)c(=O)n1,IC50,65500.0,4.18,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65500.0,4.183758700008217
CHEMBL1092364,Nc1ccn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)C[C@@H]3OP(=O)(O)O)[C@@H](COP(=O)(O)O[C@H]3C[C@H](OCCCc4ccc5c6cccc7cccc(c8cccc4c85)c76)O[C@@H]3CO)O2)c(=O)n1,IC50,30000.0,4.52,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL1092365,Nc1ccn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)C[C@@H]3OP(=O)(O)O)[C@@H](COP(=O)(O)OCCCCCCNCc3ccc4c5cccc6cccc(c7cccc3c74)c65)O2)c(=O)n1,IC50,1800.0,5.75,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL1092366,Nc1ccn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)C[C@@H]3OP(=O)(O)NCCCO)[C@@H](COP(=O)(O)O)O2)c(=O)n1,IC50,100000.0,,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1092367,Nc1ccn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)C[C@@H]3OP(=O)(O)NCCCCCCCCCCCCO)[C@@H](COP(=O)(O)O)O2)c(=O)n1,IC50,100000.0,,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1092368,NCCCCCCNP(=O)(O)O[C@H]1C[C@H](n2cnc3c(N)ncnc32)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2ccc(N)nc2=O)O[C@@H]1COP(=O)(O)O,IC50,100000.0,,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1092369,COc1ccc2nc3cc(Cl)ccc3c(NCCCCSP(=O)(O)O[C@H]3C[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(=O)(O)O)c2c1,IC50,100000.0,,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1092370,COc1ccc2nc3cc(Cl)ccc3c(NCCCCCCSP(=O)(O)O[C@H]3C[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(=O)(O)O)c2c1,IC50,100000.0,,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1092371,COc1ccc2nc3cc(Cl)ccc3c(NCCC[N+](C)(C)CCCSP(=O)(O)O[C@H]3C[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)([O-])O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(=O)(O)O)c2c1,IC50,100000.0,,CHEMBL1108869,Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1086442,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,IC50,68000.0,4.17,CHEMBL1118864,Inhibition of HIV1 integrase strand transfer activity after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68000.0,4.167491087293763
CHEMBL1086442,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,IC50,100000.0,,CHEMBL1118865,Inhibition of HIV1 integrase 3'-end processing activity after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1086443,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,6100.0,5.21,CHEMBL1118864,Inhibition of HIV1 integrase strand transfer activity after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6100.0,5.214670164989233
CHEMBL1086443,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,11000.0,,CHEMBL1118865,Inhibition of HIV1 integrase 3'-end processing activity after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL1082255,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC,IC50,700.0,6.16,CHEMBL1118864,Inhibition of HIV1 integrase strand transfer activity after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL1082255,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC,IC50,830.0,6.08,CHEMBL1118865,Inhibition of HIV1 integrase 3'-end processing activity after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,830.0,6.080921907623926
CHEMBL1082256,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,4.0,8.4,CHEMBL1118864,Inhibition of HIV1 integrase strand transfer activity after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL1082256,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,8.0,8.1,CHEMBL1118865,Inhibition of HIV1 integrase 3'-end processing activity after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL1082257,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,5.0,8.3,CHEMBL1118864,Inhibition of HIV1 integrase strand transfer activity after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL1082257,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,6.0,8.22,CHEMBL1118865,Inhibition of HIV1 integrase 3'-end processing activity after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL1164863,CC(C)c1c(Cc2ccccc2)[nH]c(=O)n(CCCCCCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1=O,IC50,100000.0,,CHEMBL1168191,Inhibition of HIV 3B integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1163802,CC(C)c1c(Cc2ccccc2)[nH]c(=O)n(CCCCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1=O,IC50,37000.0,4.43,CHEMBL1168191,Inhibition of HIV 3B integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL1163770,CC(C)c1c(Cc2ccccc2)[nH]c(=O)n(CCCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1=O,IC50,12000.0,4.92,CHEMBL1168191,Inhibition of HIV 3B integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL1165709,CC(C)c1c(Cc2ccccc2)[nH]c(=O)n(CCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1=O,IC50,8000.0,5.1,CHEMBL1168191,Inhibition of HIV 3B integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL1163769,CCc1c(Cc2ccccc2)nc(SCc2ccc(Cc3cccc(C(=O)/C=C(\O)C(=O)O)c3)cc2)[nH]c1=O,IC50,100000.0,,CHEMBL1168191,Inhibition of HIV 3B integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1163766,CCc1c(Cc2ccccc2)nc(SCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)[nH]c1=O,IC50,100000.0,,CHEMBL1168191,Inhibition of HIV 3B integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1163556,CC(C)c1c(Cc2ccccc2)n(COCCCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c(=O)[nH]c1=O,IC50,8200.0,5.09,CHEMBL1168191,Inhibition of HIV 3B integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8200.0,5.086186147616283
CHEMBL1163797,CC(C)c1c(Cc2ccccc2)n(COCCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c(=O)[nH]c1=O,IC50,7400.0,5.13,CHEMBL1168191,Inhibition of HIV 3B integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7400.0,5.130768280269024
CHEMBL1163166,CCc1c(Cc2cc(C)cc(C)c2)n(COCc2ccc(Cc3cccc(C(=O)/C=C(\O)C(=O)O)c3)cc2)c(=O)[nH]c1=O,IC50,14000.0,4.85,CHEMBL1168191,Inhibition of HIV 3B integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL1163681,CCc1c(Cc2ccccc2)n(COCc2ccc(Cc3cccc(C(=O)/C=C(\O)C(=O)O)c3)cc2)c(=O)[nH]c1=O,IC50,16000.0,4.8,CHEMBL1168191,Inhibition of HIV 3B integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL1164684,Cc1cc(C)cc(Cc2c(C(C)C)c(=O)[nH]c(=O)n2COCc2ccc(Cc3cccc(C(=O)/C=C(\O)C(=O)O)c3)cc2)c1,IC50,22000.0,4.66,CHEMBL1168191,Inhibition of HIV 3B integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL1163165,CC(C)c1c(Cc2ccccc2)n(COCc2ccc(Cc3cccc(C(=O)/C=C(\O)C(=O)O)c3)cc2)c(=O)[nH]c1=O,IC50,11000.0,4.96,CHEMBL1168191,Inhibition of HIV 3B integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL1173779,Oc1cccc(-c2ccc3c(O)c(O)ccc3c2)c1O,IC50,1000.0,6.0,CHEMBL1176632,Inhibition of HIV1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL1173780,Oc1cc(-c2ccc3cc(O)c(O)c(O)c3c2)cc(O)c1O,IC50,500.0,6.3,CHEMBL1176632,Inhibition of HIV1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL1170880,O=C1C(=O)c2cc(-c3cc(O)c(O)c(O)c3)ccc2C(Oc2c(O)cc(-c3ccc4cc(O)c(O)c(O)c4c3)cc2O)=C1O,IC50,850.0,6.07,CHEMBL1176632,Inhibition of HIV1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,850.0,6.070581074285707
CHEMBL1173010,Oc1ccc(-c2ccc3c(O)c(O)ccc3c2)cc1O,IC50,2200.0,5.66,CHEMBL1176632,Inhibition of HIV1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2200.0,5.657577319177793
CHEMBL1173011,Oc1ccc2cc(-c3ccccc3)ccc2c1O,IC50,6000.0,5.22,CHEMBL1176632,Inhibition of HIV1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL1173012,Oc1ccccc1-c1ccc2c(O)c(O)ccc2c1,IC50,10000.0,5.0,CHEMBL1176632,Inhibition of HIV1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL1173013,Oc1cccc(-c2ccc3c(O)c(O)ccc3c2)c1,IC50,4800.0,5.32,CHEMBL1176632,Inhibition of HIV1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4800.0,5.318758762624412
CHEMBL1170457,Oc1ccc(-c2ccc3c(O)c(O)ccc3c2)cc1,IC50,8100.0,5.09,CHEMBL1176632,Inhibition of HIV1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8100.0,5.0915149811213505
CHEMBL1170458,Oc1ccc2cc(-c3ccccc3C(F)(F)F)ccc2c1O,IC50,6000.0,5.22,CHEMBL1176632,Inhibition of HIV1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL1170674,Oc1ccc2cc(-c3cccc(C(F)(F)F)c3)ccc2c1O,IC50,10000.0,5.0,CHEMBL1176632,Inhibition of HIV1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL1170675,Oc1ccc2cc(-c3ccc(C(F)(F)F)cc3)ccc2c1O,IC50,10000.0,5.0,CHEMBL1176632,Inhibition of HIV1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL1170676,Oc1ccc2cc(-c3ccccc3F)ccc2c1O,IC50,7300.0,5.14,CHEMBL1176632,Inhibition of HIV1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7300.0,5.136677139879544
CHEMBL1171838,Oc1ccc2cc(-c3cccc(F)c3)ccc2c1O,IC50,9600.0,5.02,CHEMBL1176632,Inhibition of HIV1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9600.0,5.017728766960431
CHEMBL1172005,Oc1ccc2cc(-c3ccc(F)cc3)ccc2c1O,IC50,8000.0,5.1,CHEMBL1176632,Inhibition of HIV1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL563525,C[C@@H](CO)n1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3F)ccc21,IC50,14.79,7.83,CHEMBL1211287,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.79,7.830031826003108
CHEMBL554722,C[C@H](CO)n1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3F)ccc21,IC50,38.02,7.42,CHEMBL1211287,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38.02,7.419987887470576
CHEMBL549816,CC[C@@H](CO)n1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3F)ccc21,IC50,8.913,8.05,CHEMBL1211287,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.913,8.049976093476673
CHEMBL563677,CCC[C@@H](CO)n1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3F)ccc21,IC50,8.128,8.09,CHEMBL1211287,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.128,8.090016305060155
CHEMBL565125,CC(C)(C)[C@@H](CO)n1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3F)ccc21,IC50,6.026,8.22,CHEMBL1211287,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.026,8.219970872662662
CHEMBL561619,O=C(O)c1cn([C@H](CO)C2CCCCC2)c2ccc(Cc3cccc(Cl)c3F)cc2c1=O,IC50,5.623,8.25,CHEMBL1211287,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.623,8.250031916490597
CHEMBL557891,O=C(O)c1cn([C@H](CO)c2ccccc2)c2ccc(Cc3cccc(Cl)c3F)cc2c1=O,IC50,9.772,8.01,CHEMBL1211287,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.772,8.010016541698601
CHEMBL550080,CCC[C@@H](CO)n1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3F)c(OC)cc21,IC50,5.754,8.24,CHEMBL1211287,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.754,8.240030142445693
CHEMBL408699,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@@H](CO)C(C)C,IC50,14.45,7.84,CHEMBL1211287,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.45,7.840132152907433
CHEMBL550220,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)(C)C,IC50,5.754,8.24,CHEMBL1211287,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.754,8.240030142445693
CHEMBL560836,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C1CCCCC1,IC50,6.761,8.17,CHEMBL1211287,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.761,8.169989064063882
CHEMBL1214417,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccccc2Cl)c2cccc(OC)c12,IC50,13100.0,4.88,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13100.0,4.882728704344236
CHEMBL1214478,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cccc(Cl)c2)c2cccc(OC)c12,IC50,4780.0,5.32,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4780.0,5.320572103387882
CHEMBL1214479,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(Cl)cc2)c2cccc(OC)c12,IC50,5780.0,5.24,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5780.0,5.2380721615794705
CHEMBL1214480,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cccc(F)c2Cl)c2cccc(OC)c12,IC50,1390.0,5.86,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1390.0,5.856985199745905
CHEMBL1214481,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2Cl)c2cccc(OC)c12,IC50,1740.0,5.76,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1740.0,5.7594507517174005
CHEMBL1214533,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cc(F)ccc2Cl)c2cccc(OC)c12,IC50,2700.0,5.57,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2700.0,5.568636235841012
CHEMBL1214534,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2c(F)cccc2Cl)c2cccc(OC)c12,IC50,2860.0,5.54,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2860.0,5.543633966870956
CHEMBL1214535,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cccc(Cl)c2F)c2cccc(OC)c12,IC50,1370.0,5.86,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1370.0,5.863279432843593
CHEMBL1214536,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)c(Cl)c2)c2cccc(OC)c12,IC50,360.0,6.44,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,360.0,6.443697499232712
CHEMBL1214583,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cc(F)cc(Cl)c2)c2cccc(OC)c12,IC50,1300.0,5.89,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL1214584,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cc(Cl)ccc2F)c2cccc(OC)c12,IC50,1610.0,5.79,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1610.0,5.79317412396815
CHEMBL1214585,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(Cl)cc2F)c2cccc(OC)c12,IC50,1150.0,5.94,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1150.0,5.939302159646388
CHEMBL1214586,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(Cl)c(F)c2)c2cccc(OC)c12,IC50,5050.0,5.3,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5050.0,5.296708621881338
CHEMBL1214587,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccccc1Cl,IC50,710.0,6.15,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,710.0,6.1487416512809245
CHEMBL1213723,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cccc(Cl)c1,IC50,130.0,6.89,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL1213724,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(Cl)cc1,IC50,1020.0,5.99,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1020.0,5.991399828238082
CHEMBL1213725,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cccc(F)c1Cl,IC50,5240.0,5.28,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5240.0,5.280668713016274
CHEMBL1213726,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1Cl,IC50,540.0,6.27,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,540.0,6.267606240177031
CHEMBL1213727,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cc(F)ccc1Cl,IC50,420.0,6.38,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,420.0,6.376750709602099
CHEMBL1213787,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1c(F)cccc1Cl,IC50,530.0,6.28,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,530.0,6.275724130399211
CHEMBL1213788,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cccc(Cl)c1F,IC50,740.0,6.13,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,740.0,6.130768280269024
CHEMBL1213789,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)c(Cl)c1,IC50,40.0,7.4,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL1213790,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cc(F)cc(Cl)c1,IC50,240.0,6.62,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,240.0,6.619788758288394
CHEMBL1213791,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cc(Cl)ccc1F,IC50,320.0,6.5,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,320.0,6.494850021680094
CHEMBL1213849,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(Cl)cc1F,IC50,2530.0,5.6,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2530.0,5.596879478824182
CHEMBL1213850,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(Cl)c(F)c1,IC50,3330.0,5.48,CHEMBL1217312,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3330.0,5.47755576649368
CHEMBL1214417,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccccc2Cl)c2cccc(OC)c12,IC50,730.0,6.14,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,730.0,6.136677139879544
CHEMBL1214478,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cccc(Cl)c2)c2cccc(OC)c12,IC50,2890.0,5.54,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2890.0,5.539102157243452
CHEMBL1214479,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(Cl)cc2)c2cccc(OC)c12,IC50,8260.0,5.08,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8260.0,5.083019952679617
CHEMBL1214480,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cccc(F)c2Cl)c2cccc(OC)c12,IC50,9200.0,5.04,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9200.0,5.036212172654444
CHEMBL1214481,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2Cl)c2cccc(OC)c12,IC50,2560.0,5.59,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2560.0,5.59176003468815
CHEMBL1214533,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cc(F)ccc2Cl)c2cccc(OC)c12,IC50,2940.0,5.53,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2940.0,5.531652669587842
CHEMBL1214534,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2c(F)cccc2Cl)c2cccc(OC)c12,IC50,1200.0,5.92,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL1214535,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cccc(Cl)c2F)c2cccc(OC)c12,IC50,740.0,6.13,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,740.0,6.130768280269024
CHEMBL1214536,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)c(Cl)c2)c2cccc(OC)c12,IC50,70.0,7.16,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL1214583,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cc(F)cc(Cl)c2)c2cccc(OC)c12,IC50,3170.0,5.5,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3170.0,5.498940737782249
CHEMBL1214584,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cc(Cl)ccc2F)c2cccc(OC)c12,IC50,890.0,6.05,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,890.0,6.050609993355087
CHEMBL1214585,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(Cl)cc2F)c2cccc(OC)c12,IC50,3320.0,5.48,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3320.0,5.478861916295964
CHEMBL1214586,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(Cl)c(F)c2)c2cccc(OC)c12,IC50,20350.0,4.69,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20350.0,4.691435586438761
CHEMBL1214587,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccccc1Cl,IC50,520.0,6.28,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,520.0,6.2839966563652006
CHEMBL1213723,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cccc(Cl)c1,IC50,30.0,7.52,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL1213724,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(Cl)cc1,IC50,590.0,6.23,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,590.0,6.229147988357855
CHEMBL1213725,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cccc(F)c1Cl,IC50,12740.0,4.89,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12740.0,4.894830572000668
CHEMBL1213726,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1Cl,IC50,60.0,7.22,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL1213727,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cc(F)ccc1Cl,IC50,270.0,6.57,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,270.0,6.568636235841012
CHEMBL1213787,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1c(F)cccc1Cl,IC50,130.0,6.89,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL1213788,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cccc(Cl)c1F,IC50,30.0,7.52,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL1213789,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)c(Cl)c1,IC50,120.0,6.92,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,120.0,6.920818753952375
CHEMBL1213790,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cc(F)cc(Cl)c1,IC50,250.0,6.6,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL1213791,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cc(Cl)ccc1F,IC50,90.0,7.05,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90.0,7.045757490560675
CHEMBL1213849,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(Cl)cc1F,IC50,5520.0,5.26,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5520.0,5.258060922270801
CHEMBL1213850,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(Cl)c(F)c1,IC50,4580.0,5.34,CHEMBL1217313,Inhibition of HIV1 integrase strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4580.0,5.339134521996131
CHEMBL1223974,CC1(C)C=Cc2c(ccc3c2C(=O)C(O)=C(C2=C(C4=C(O)C(=O)c5c(ccc6c5C=CC(C)(C)O6)C4=O)C(=O)c4ccccc4C2=O)C3=O)O1,IC50,2500.0,5.6,CHEMBL1228503,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL1223975,COc1ccc2c(c1)C(=O)C(C1=C(O)C(=O)c3c(ccc4c3C=CC(C)(C)O4)C1=O)=C(C1=C(O)C(=O)c3c(ccc4c3C=CC(C)(C)O4)C1=O)C2=O,IC50,2300.0,5.64,CHEMBL1228503,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2300.0,5.638272163982407
CHEMBL1223976,CCCOc1ccc2c(c1)C(=O)C(C1=C(O)C(=O)c3c(ccc4c3C=CC(C)(C)O4)C1=O)=C(C1=C(O)C(=O)c3c(ccc4c3C=CC(C)(C)O4)C1=O)C2=O,IC50,2800.0,5.55,CHEMBL1228503,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL1223977,CC(C)Oc1ccc2c(c1)C(=O)C(C1=C(O)C(=O)c3c(ccc4c3C=CC(C)(C)O4)C1=O)=C(C1=C(O)C(=O)c3c(ccc4c3C=CC(C)(C)O4)C1=O)C2=O,IC50,3000.0,5.52,CHEMBL1228503,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL1223978,CC1(C)C=Cc2c(ccc3c2C(=O)C(O)=C(C2=C(C4=C(O)C(=O)c5c(ccc6c5C=CC(C)(C)O6)C4=O)C(=O)c4c(ccc5c4C=CC(C)(C)O5)C2=O)C3=O)O1,IC50,1700.0,5.77,CHEMBL1228503,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL1223980,CC1(C)C=Cc2c(ccc3c2C(=O)C(O)=C(C2=C(C4=C(O)C(=O)c5c(ccc6c5C=CC(C)(C)O6)C4=O)C(=O)c4c(ccc5c4CCC(C)(C)O5)C2=O)C3=O)O1,IC50,1800.0,5.75,CHEMBL1228503,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL1223981,CC1(C)C=Cc2c(ccc3c2C(=O)C(O)=C(C2=C(C4=C(O)C(=O)c5c(ccc6c5C=CC(C)(C)O6)C4=O)C(=O)N(Cc4ccccc4)C2=O)C3=O)O1,IC50,4500.0,5.35,CHEMBL1228503,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4500.0,5.346787486224656
CHEMBL1223974,CC1(C)C=Cc2c(ccc3c2C(=O)C(O)=C(C2=C(C4=C(O)C(=O)c5c(ccc6c5C=CC(C)(C)O6)C4=O)C(=O)c4ccccc4C2=O)C3=O)O1,IC50,2000.0,5.7,CHEMBL1228504,Inhibition of HIV1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL1223975,COc1ccc2c(c1)C(=O)C(C1=C(O)C(=O)c3c(ccc4c3C=CC(C)(C)O4)C1=O)=C(C1=C(O)C(=O)c3c(ccc4c3C=CC(C)(C)O4)C1=O)C2=O,IC50,2500.0,5.6,CHEMBL1228504,Inhibition of HIV1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL1223976,CCCOc1ccc2c(c1)C(=O)C(C1=C(O)C(=O)c3c(ccc4c3C=CC(C)(C)O4)C1=O)=C(C1=C(O)C(=O)c3c(ccc4c3C=CC(C)(C)O4)C1=O)C2=O,IC50,5000.0,5.3,CHEMBL1228504,Inhibition of HIV1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL1223977,CC(C)Oc1ccc2c(c1)C(=O)C(C1=C(O)C(=O)c3c(ccc4c3C=CC(C)(C)O4)C1=O)=C(C1=C(O)C(=O)c3c(ccc4c3C=CC(C)(C)O4)C1=O)C2=O,IC50,100000.0,,CHEMBL1228504,Inhibition of HIV1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1223978,CC1(C)C=Cc2c(ccc3c2C(=O)C(O)=C(C2=C(C4=C(O)C(=O)c5c(ccc6c5C=CC(C)(C)O6)C4=O)C(=O)c4c(ccc5c4C=CC(C)(C)O5)C2=O)C3=O)O1,IC50,3000.0,5.52,CHEMBL1228504,Inhibition of HIV1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL1223979,CC1(C)CCc2c(ccc3c2C(=O)C(O)=C(C2=C(C4=C(O)C(=O)c5c(ccc6c5CCC(C)(C)O6)C4=O)C(=O)c4c(ccc5c4CCC(C)(C)O5)C2=O)C3=O)O1,IC50,9000.0,5.05,CHEMBL1228504,Inhibition of HIV1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL1223980,CC1(C)C=Cc2c(ccc3c2C(=O)C(O)=C(C2=C(C4=C(O)C(=O)c5c(ccc6c5C=CC(C)(C)O6)C4=O)C(=O)c4c(ccc5c4CCC(C)(C)O5)C2=O)C3=O)O1,IC50,6000.0,5.22,CHEMBL1228504,Inhibition of HIV1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL1223981,CC1(C)C=Cc2c(ccc3c2C(=O)C(O)=C(C2=C(C4=C(O)C(=O)c5c(ccc6c5C=CC(C)(C)O6)C4=O)C(=O)N(Cc4ccccc4)C2=O)C3=O)O1,IC50,4000.0,5.4,CHEMBL1228504,Inhibition of HIV1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL1223983,COc1ccc2c(c1)C(=O)C(O)=C(C1=C(C3=C(O)C(=O)c4cc(OC)ccc4C3=O)C(=O)c3ccccc3C1=O)C2=O,IC50,22500.0,4.65,CHEMBL1228503,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22500.0,4.647817481888637
CHEMBL1223984,COc1cc2c(cc1OC)C(=O)C(C1=C(C3=C(O)C(=O)c4cc(OC)c(OC)cc4C3=O)C(=O)c3ccccc3C1=O)=C(O)C2=O,IC50,62000.0,4.21,CHEMBL1228503,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,62000.0,4.2076083105017466
CHEMBL1224083,O=C1C(O)=C(C2=C(C3=C(O)C(=O)c4ccccc4C3=O)C(=O)c3ccccc3C2=O)C(=O)c2ccccc21,IC50,56000.0,4.25,CHEMBL1228503,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL1223982,COc1cccc2c1C(=O)C(C1=C(C3=C(O)C(=O)c4cccc(OC)c4C3=O)C(=O)c3ccccc3C1=O)=C(O)C2=O,IC50,13000.0,4.89,CHEMBL1228504,Inhibition of HIV1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL1223983,COc1ccc2c(c1)C(=O)C(O)=C(C1=C(C3=C(O)C(=O)c4cc(OC)ccc4C3=O)C(=O)c3ccccc3C1=O)C2=O,IC50,10000.0,5.0,CHEMBL1228504,Inhibition of HIV1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL1223984,COc1cc2c(cc1OC)C(=O)C(C1=C(C3=C(O)C(=O)c4cc(OC)c(OC)cc4C3=O)C(=O)c3ccccc3C1=O)=C(O)C2=O,IC50,12000.0,4.92,CHEMBL1228504,Inhibition of HIV1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL1224083,O=C1C(O)=C(C2=C(C3=C(O)C(=O)c4ccccc4C3=O)C(=O)c3ccccc3C2=O)C(=O)c2ccccc21,IC50,13000.0,4.89,CHEMBL1228504,Inhibition of HIV1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL1224084,COc1cc2c(cc1OC)C(=O)C(C1=C(C3=C(O)C(=O)c4cc(OC)c(OC)cc4C3=O)C(=O)c3cc(OC)c(OC)cc3C1=O)=C(O)C2=O,IC50,10000.0,5.0,CHEMBL1228504,Inhibition of HIV1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL1223934,O=C(NCCCN1CCN(C(=O)/C=C/c2ccccc2)CC1)c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL1225823,Inhibition of HIV1 integrase strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1223935,Cc1ccc(/C=C/C(=O)N2CCN(CCCNC(=O)c3ccc(O)c(O)c3)CC2)cc1,IC50,100000.0,,CHEMBL1225823,Inhibition of HIV1 integrase strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1223936,O=C(NCCCN1CCN(C(=O)/C=C/c2ccc(Cl)cc2)CC1)c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL1225823,Inhibition of HIV1 integrase strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1223937,O=C(NCCCN1CCN(C(=O)/C=C/c2ccccc2Cl)CC1)c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL1225823,Inhibition of HIV1 integrase strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1224050,O=C(NCCCN1CCN(C(=O)/C=C/c2cccc(O)c2)CC1)c1ccc(O)c(O)c1,IC50,100000.0,,CHEMBL1225823,Inhibition of HIV1 integrase strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1224051,O=C(NCCCN1CCN(C(=O)/C=C/c2ccccc2)CC1)c1cc(O)c(O)c(O)c1,IC50,12830.0,4.89,CHEMBL1225823,Inhibition of HIV1 integrase strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12830.0,4.891773343625071
CHEMBL1224052,Cc1ccc(/C=C/C(=O)N2CCN(CCCNC(=O)c3cc(O)c(O)c(O)c3)CC2)cc1,IC50,17470.0,4.76,CHEMBL1225823,Inhibition of HIV1 integrase strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17470.0,4.757707095017069
CHEMBL1224053,O=C(NCCCN1CCN(C(=O)/C=C/c2ccc(Cl)cc2)CC1)c1cc(O)c(O)c(O)c1,IC50,24940.0,4.6,CHEMBL1225823,Inhibition of HIV1 integrase strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24940.0,4.603103550857476
CHEMBL1224122,O=C(NCCCN1CCN(C(=O)/C=C/c2ccccc2Cl)CC1)c1cc(O)c(O)c(O)c1,IC50,19270.0,4.71,CHEMBL1225823,Inhibition of HIV1 integrase strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19270.0,4.7151182853445475
CHEMBL1224123,O=C(NCCCN1CCN(C(=O)/C=C/c2ccccc2[N+](=O)[O-])CC1)c1cc(O)c(O)c(O)c1,IC50,31310.0,4.5,CHEMBL1225823,Inhibition of HIV1 integrase strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31310.0,4.504316932383085
CHEMBL1224124,O=C(NCCCN1CCN(C(=O)/C=C/c2cccc(O)c2)CC1)c1cc(O)c(O)c(O)c1,IC50,15410.0,4.81,CHEMBL1225823,Inhibition of HIV1 integrase strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15410.0,4.812197361281581
CHEMBL19977,O=C(O)C(=O)CC(=O)c1cc(OCc2ccccc2)cc(OCc2ccccc2)c1,IC50,770.0,6.11,CHEMBL1225823,Inhibition of HIV1 integrase strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,770.0,6.113509274827518
CHEMBL388908,CN1C[C@@H](F)C[C@H]1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,23.0,7.64,CHEMBL1227437,Inhibition of HIV 1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23.0,7.638272163982407
CHEMBL1223400,Cn1c([C@@H]2C[C@H](F)CN2C2CC2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,20.0,7.7,CHEMBL1227437,Inhibition of HIV 1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL1223469,CC(=O)N1C[C@@H](F)C[C@H]1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,15.0,7.82,CHEMBL1227437,Inhibition of HIV 1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL1223401,Cn1c([C@@H]2C[C@H](F)CN2Cc2ccon2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,10.0,8.0,CHEMBL1227437,Inhibition of HIV 1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL1223471,CN(C)C(=O)N1C[C@@H](F)C[C@H]1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,10.0,8.0,CHEMBL1227437,Inhibition of HIV 1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL1223470,COC(=O)N1C[C@@H](F)C[C@H]1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,10.0,8.0,CHEMBL1227437,Inhibition of HIV 1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL1223472,Cn1c([C@@H]2C[C@H](F)CN2S(C)(=O)=O)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,15.0,7.82,CHEMBL1227437,Inhibition of HIV 1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL1223543,CN(C)C(=O)C(=O)N1C[C@@H](F)C[C@H]1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,21.0,7.68,CHEMBL1227437,Inhibition of HIV 1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL1223542,Cn1c([C@@H]2C[C@H](F)CN2C(=O)c2cnccn2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,10.0,8.0,CHEMBL1227437,Inhibition of HIV 1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL1223541,CN(C)S(=O)(=O)N1C[C@@H](F)C[C@H]1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,9.0,8.05,CHEMBL1227437,Inhibition of HIV 1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL1222458,CC(=O)N1C[C@@H](F)C[C@H]1c1nc(C(=O)NCc2ccc(F)c(C)c2)c(O)c(=O)n1C,IC50,27.0,7.57,CHEMBL1227437,Inhibition of HIV 1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27.0,7.568636235841012
CHEMBL1223544,CC(=O)N1C[C@@H](F)C[C@H]1c1nc(C(=O)NCc2ccc(F)c(Cl)c2)c(O)c(=O)n1C,IC50,24.0,7.62,CHEMBL1227437,Inhibition of HIV 1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24.0,7.619788758288394
CHEMBL1222461,COC(=O)N1C[C@@H](F)C[C@H]1c1nc(C(=O)NCc2ccc(F)c(Cl)c2)c(O)c(=O)n1C,IC50,19.0,7.72,CHEMBL1227437,Inhibition of HIV 1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19.0,7.721246399047171
CHEMBL1222460,COC(=O)N1C[C@@H](F)C[C@H]1c1nc(C(=O)NCc2ccc(C)c(Cl)c2)c(O)c(=O)n1C,IC50,20.0,7.7,CHEMBL1227437,Inhibition of HIV 1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL1222459,CC(=O)N1C[C@@H](F)C[C@H]1c1nc(C(=O)NCc2ccc(C)c(Cl)c2)c(O)c(=O)n1C,IC50,32.0,7.5,CHEMBL1227437,Inhibition of HIV 1 recombinant integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32.0,7.494850021680094
CHEMBL1082256,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,130.0,6.89,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL1082257,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,90.0,7.05,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90.0,7.045757490560675
CHEMBL1241169,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC,IC50,100.0,7.0,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL1241170,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,130.0,6.89,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL1241171,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,260.0,6.58,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,260.0,6.585026652029182
CHEMBL1241172,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,110.0,6.96,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL1241173,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,80.0,7.1,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL1241174,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,50.0,7.3,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL1241175,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(C)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,120.0,6.92,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,120.0,6.920818753952375
CHEMBL1241176,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,140.0,6.85,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,140.0,6.853871964321762
CHEMBL1241177,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,230.0,6.64,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,230.0,6.638272163982407
CHEMBL1241178,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,40.0,7.4,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL1241179,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,710.0,6.15,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,710.0,6.1487416512809245
CHEMBL1241180,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(C)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,180.0,6.75,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,180.0,6.7447274948966935
CHEMBL1241181,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,120.0,6.92,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,120.0,6.920818753952375
CHEMBL1241182,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,130.0,6.89,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL1241183,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,100.0,7.0,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL1240540,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,120.0,6.92,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,120.0,6.920818753952375
CHEMBL1241184,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,130.0,6.89,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL1241185,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC,IC50,340.0,6.47,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,340.0,6.468521082957745
CHEMBL1241186,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,330.0,6.48,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,330.0,6.481486060122112
CHEMBL1241187,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,130.0,6.89,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL1241188,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,250.0,6.6,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL1241189,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,110.0,6.96,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL1241190,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,200.0,6.7,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL1241191,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,90.0,7.05,CHEMBL1246353,Inhibition of HIV1 integrase 3'-processing activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90.0,7.045757490560675
CHEMBL1082256,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,60.0,7.22,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL1082257,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,40.0,7.4,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL1241169,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC,IC50,70.0,7.16,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL1241170,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,110.0,6.96,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL1241171,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,110.0,6.96,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL1241172,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,70.0,7.16,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL1241173,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,50.0,7.3,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL1241174,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,10.0,8.0,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL1241175,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(C)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,47.0,7.33,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47.0,7.327902142064282
CHEMBL1241176,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,65.0,7.19,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65.0,7.187086643357144
CHEMBL1241177,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,150.0,6.82,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,150.0,6.823908740944319
CHEMBL1241178,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,31.0,7.51,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31.0,7.508638306165727
CHEMBL1241179,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC,IC50,60.0,7.22,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL1241180,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(C)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,80.0,7.1,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL1241181,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,80.0,7.1,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL1241182,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,60.0,7.22,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL1241183,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,60.0,7.22,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL1240540,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,70.0,7.16,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL1241184,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,60.0,7.22,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL1241185,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC,IC50,180.0,6.75,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,180.0,6.7447274948966935
CHEMBL1241186,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,220.0,6.66,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,220.0,6.657577319177793
CHEMBL1241187,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,60.0,7.22,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL1241188,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,120.0,6.92,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,120.0,6.920818753952375
CHEMBL1241189,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,50.0,7.3,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL1241190,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,160.0,6.8,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,160.0,6.795880017344075
CHEMBL1241191,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O,IC50,90.0,7.05,CHEMBL1246354,Inhibition of HIV1 integrase strand transfer activity expressed in Escherichia coli after 60 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90.0,7.045757490560675
CHEMBL1256978,Cn1c(=O)c(C(=O)NCCO)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,11.0,7.96,CHEMBL1262283,Displacement of 20 nM [3H]GSK304649 from Human immunodeficiency virus 1 integrase by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL414850,O=C(NCc1ccc(F)cc1)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,13.0,7.89,CHEMBL1262283,Displacement of 20 nM [3H]GSK304649 from Human immunodeficiency virus 1 integrase by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,16.0,7.8,CHEMBL1262283,Displacement of 20 nM [3H]GSK304649 from Human immunodeficiency virus 1 integrase by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16.0,7.795880017344075
CHEMBL204656,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C,IC50,11.0,7.96,CHEMBL1262283,Displacement of 20 nM [3H]GSK304649 from Human immunodeficiency virus 1 integrase by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL1256978,Cn1c(=O)c(C(=O)NCCO)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,7.8,8.11,CHEMBL1262420,Inhibition of Human immunodeficiency virus 1 integrase by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.8,8.10790539730952
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,3.3,8.48,CHEMBL1262420,Inhibition of Human immunodeficiency virus 1 integrase by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.3,8.481486060122112
CHEMBL204656,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C,IC50,6.0,8.22,CHEMBL1262420,Inhibition of Human immunodeficiency virus 1 integrase by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL518520,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c([O-])c(=O)n2C)o1.[K+],IC50,130.0,6.89,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL1258162,CC(=O)N1CCN(c2cc(Br)c3nc(C(=O)NCc4ccc(F)cc4)c(O)c(=O)n3c2)CC1,IC50,110.0,6.96,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL1258046,O=C(NCc1cc(Cl)cc(Cl)c1)c1nc2c(N3CCCS3(=O)=O)cc(N3CCOCC3)cn2c(=O)c1O,IC50,130.0,6.89,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL1258045,O=C(NCc1ccc(F)cc1)c1nc2c(N3CCCS3(=O)=O)cc(N3CCOCC3)cn2c(=O)c1O,IC50,195.0,6.71,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,195.0,6.709965388637482
CHEMBL1257936,O=C(NCc1ccc(F)cc1)c1nc2c(Cl)cc(N3CCOCC3)cn2c(=O)c1O,IC50,135.0,6.87,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,135.0,6.8696662315049934
CHEMBL1257935,O=C(NCc1ccc(F)cc1)c1nc2c(Br)cc(N3CCOCC3)cn2c(=O)c1O,IC50,130.0,6.89,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL1257819,O=C(NCc1ccc(F)cc1)c1nc2c(I)cc(N3CCOCC3)cn2c(=O)c1O,IC50,85.0,7.07,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,85.0,7.070581074285707
CHEMBL1257818,O=C(NCc1ccc(F)cc1)c1nc2c(N3CCOCC3)cc(N3CCOCC3)cn2c(=O)c1O,IC50,755.0,6.12,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,755.0,6.1220530483708115
CHEMBL1257697,O=C(NCc1ccc(F)cc1)c1nc2c(OCc3ccc(F)cc3)cc(N3CCOCC3)cn2c(=O)c1O,IC50,275.0,6.56,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,275.0,6.560667306169737
CHEMBL1257696,O=C(NCc1ccc(F)cc1)c1nc2c(OCC3CC3)cc(N3CCOCC3)cn2c(=O)c1O,IC50,429.0,6.37,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,429.0,6.367542707815276
CHEMBL1257576,CC(C)Oc1cc(N2CCOCC2)cn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,245.0,6.61,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,245.0,6.610833915635467
CHEMBL1257575,COc1cc(N2CCOCC2)cn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,170.0,6.77,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,170.0,6.769551078621726
CHEMBL1257456,O=C(NCc1ccc(F)cc1)c1nc2c3ccc(N4CCOCC4)cc3on2c(=O)c1O,IC50,10000.0,,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL1257455,O=C(NCc1ccc(F)cc1)c1nc2c3ccccc3on2c(=O)c1O,IC50,10000.0,,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL1257345,Cc1cc2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2o1,IC50,5100.0,5.29,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5100.0,5.292429823902063
CHEMBL1257344,O=C(NCc1ccc(F)cc1)c1nc2sc3ccccc3n2c(=O)c1O,IC50,30000.0,,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL1257224,COc1cccc2c1sc1nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n12,IC50,50000.0,,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL1257223,O=C(NCc1ccc(F)cc1)c1nc2sc(N3CCOCC3)cn2c(=O)c1O,IC50,1130.0,5.95,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1130.0,5.94692155651658
CHEMBL1258958,Cc1cn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc2s1,IC50,4250.0,5.37,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4250.0,5.371611069949688
CHEMBL1258957,O=C(NCc1ccc(F)cc1)c1nc2sccn2c(=O)c1O,IC50,33250.0,4.48,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33250.0,4.478208350360877
CHEMBL1258956,Cn1c2ccccc2c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n21,IC50,626.0,6.2,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,626.0,6.20342566678957
CHEMBL1258842,O=C(NCc1ccc(F)cc1)c1nc2c3ccccc3[nH]n2c(=O)c1O,IC50,10000.0,,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL1258841,Cn1ccc2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n21,IC50,30000.0,,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL1258840,N#Cc1c[nH]n2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,13650.0,4.87,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13650.0,4.864867348623225
CHEMBL1258721,O=C(NCc1ccc(F)cc1)c1nc2cc(-c3ccccc3)[nH]n2c(=O)c1O,IC50,100000.0,,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1258720,Cn1c2ccccc2n2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,20250.0,4.69,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20250.0,4.693574972449313
CHEMBL1258613,O=C(NCc1ccc(F)cc1)c1nc2[nH]c3ccccc3n2c(=O)c1O,IC50,100000.0,,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1258612,Cn1ccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12,IC50,76.8,7.12,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,76.8,7.114638779968488
CHEMBL499184,O=C(NCc1ccc(F)cc1)c1nc2ccccn2c(=O)c1O,IC50,587.0,6.23,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,587.0,6.231361898752386
CHEMBL1257580,O=C(NCc1ccc(F)cc1)c1nc2ccc(N3CCOCC3)cn2c(=O)c1O,IC50,80.0,7.1,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL1258501,O=C(NCc1ccc(F)cc1)c1nc2ccc(Br)cn2c(=O)c1O,IC50,445.0,6.35,CHEMBL1259305,Inhibition of HIV1 integrase 3'-strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,445.0,6.351639989019068
CHEMBL1222998,O=c1c(O)c(-c2ncc(Cc3ccc(F)cc3)s2)nc2ccc(N3CCOCC3)cn12,IC50,20.0,7.7,CHEMBL1259489,Inhibition of HIV-1 integrase-mediated 3'-processing and strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL1258726,O=C1OCCN1c1cc(N2CCOCC2)cn2c(=O)c(O)c(-c3ncc(Cc4ccc(F)cc4)[nH]3)nc12,IC50,35.0,7.46,CHEMBL1259489,Inhibition of HIV-1 integrase-mediated 3'-processing and strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35.0,7.455931955649724
CHEMBL1222997,O=c1c(O)c(-c2ncc(Cc3ccc(F)cc3)s2)nc2c(N3CCCS3(=O)=O)cc(N3CCOCC3)cn12,IC50,36.0,7.44,CHEMBL1259489,Inhibition of HIV-1 integrase-mediated 3'-processing and strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36.0,7.443697499232712
CHEMBL1222999,O=c1c(O)c(-c2ncc(Cc3ccc(F)cc3)s2)nc2c(Br)cc(N3CCOCC3)cn12,IC50,42.0,7.38,CHEMBL1259489,Inhibition of HIV-1 integrase-mediated 3'-processing and strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42.0,7.376750709602099
CHEMBL1258050,O=c1c(O)c(-c2ncc(Cc3ccc(F)cc3)[nH]2)nc2ccc(N3CCOCC3)cn12,IC50,45.0,7.35,CHEMBL1259489,Inhibition of HIV-1 integrase-mediated 3'-processing and strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45.0,7.346787486224656
CHEMBL1258727,O=C1CCCN1c1cc(N2CCOCC2)cn2c(=O)c(O)c(-c3ncc(Cc4ccc(F)cc4)[nH]3)nc12,IC50,47.0,7.33,CHEMBL1259489,Inhibition of HIV-1 integrase-mediated 3'-processing and strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47.0,7.327902142064282
CHEMBL1258049,O=c1c(O)c(-c2ncc(Cc3ccc(F)cc3)o2)nc2ccc(N3CCOCC3)cn12,IC50,59.0,7.23,CHEMBL1259489,Inhibition of HIV-1 integrase-mediated 3'-processing and strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,59.0,7.229147988357855
CHEMBL1258617,CN1CCN(c2cc(N3CCOCC3)cn3c(=O)c(O)c(-c4ncc(Cc5ccc(F)cc5)[nH]4)nc23)S1(=O)=O,IC50,70.0,7.16,CHEMBL1259489,Inhibition of HIV-1 integrase-mediated 3'-processing and strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL1258504,O=c1c(O)c(-c2ncc(Cc3ccc(F)cc3)[nH]2)nc2c(N3CCCS3(=O)=O)cc(N3CCOCC3)cn12,IC50,95.0,7.02,CHEMBL1259489,Inhibition of HIV-1 integrase-mediated 3'-processing and strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,95.0,7.022276394711152
CHEMBL1258167,O=c1c(O)c(-c2ncc(Cc3ccc(F)cc3)o2)nc2c(I)cc(N3CCOCC3)cn12,IC50,170.0,6.77,CHEMBL1259489,Inhibition of HIV-1 integrase-mediated 3'-processing and strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,170.0,6.769551078621726
CHEMBL1257823,O=c1c(O)c(-c2nnc(Cc3ccc(F)cc3)s2)nc2ccc(N3CCOCC3)cn12,IC50,225.0,6.65,CHEMBL1259489,Inhibition of HIV-1 integrase-mediated 3'-processing and strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,225.0,6.647817481888637
CHEMBL1257699,O=c1c(O)c(-c2nnc(Cc3ccc(F)cc3)o2)nc2ccc(N3CCOCC3)cn12,IC50,310.0,6.51,CHEMBL1259489,Inhibition of HIV-1 integrase-mediated 3'-processing and strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,310.0,6.508638306165727
CHEMBL1257700,O=c1c(O)c(-c2noc(Cc3ccc(F)cc3)n2)nc2ccc(N3CCOCC3)cn12,IC50,450.0,6.35,CHEMBL1259489,Inhibition of HIV-1 integrase-mediated 3'-processing and strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,450.0,6.346787486224656
CHEMBL1257580,O=C(NCc1ccc(F)cc1)c1nc2ccc(N3CCOCC3)cn2c(=O)c1O,IC50,775.0,6.11,CHEMBL1259489,Inhibition of HIV-1 integrase-mediated 3'-processing and strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,775.0,6.110698297493689
CHEMBL1257939,O=c1c(O)c(-c2nc(Cc3ccc(F)cc3)no2)nc2ccc(N3CCOCC3)cn12,IC50,10000.0,,CHEMBL1259489,Inhibition of HIV-1 integrase-mediated 3'-processing and strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL1270106,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2C(F)(F)F)cc1OC,IC50,34000.0,4.47,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34000.0,4.468521082957745
CHEMBL1270107,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2C(F)(F)F)c(OC)c1OC,IC50,100000.0,,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1270213,COc1cc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2C(F)(F)F)cc(OC)c1OC,IC50,15000.0,4.82,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL1270214,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2C(F)(F)F)cc1OCc1cccc(Cl)c1F,IC50,30000.0,4.52,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL1270307,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,40000.0,4.4,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL1270308,O=C1/C(=C\c2ccc(O)c(OCc3ccc(F)cc3)c2)C(C(F)(F)F)=NN1c1cccc(Br)c1,IC50,22000.0,4.66,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL1270406,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2C(F)(F)F)cc1Cc1ccc(F)cc1,IC50,11000.0,4.96,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL1270407,COc1ccc(/C=C2\C(=O)N(c3ccccc3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1270500,COc1ccc(/C=C2\C(=O)N(c3cccc(C)c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1270501,COc1ccc(/C=C2\C(=O)N(c3cccc(C(F)(F)F)c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,24000.0,4.62,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL1270602,COc1ccc(/C=C2\C(=O)N(c3cccc(-c4ccccc4)c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,16000.0,4.8,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL1270700,COc1ccc(/C=C2\C(=O)N(c3cccc([N+](=O)[O-])c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,19000.0,4.72,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL1270701,COc1ccc(/C=C2\C(=O)N(c3cccc(F)c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,60000.0,4.22,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL1270805,COc1ccc(/C=C2\C(=O)N(c3cccc(Cl)c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,30000.0,4.52,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL1270806,COc1ccc(/C=C2\C(=O)N(c3cccc(I)c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,35000.0,4.46,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL1270908,COc1ccc(/C=C2\C(=O)N(c3cc(Cl)cc(Cl)c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,12000.0,4.92,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL1270909,COc1ccc(/C=C2\C(=O)N(c3ccc(Br)cc3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,25000.0,4.6,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL1271007,COc1ccc(/C=C2\C(=O)N(c3ccc(I)cc3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,69000.0,4.16,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69000.0,4.161150909262744
CHEMBL1271008,COc1ccc(/C=C2\C(=O)N(c3ccc(C(=O)O)cc3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,41000.0,4.39,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41000.0,4.3872161432802645
CHEMBL1271113,COc1ccc(/C=C2\C(=O)N(c3ccc(NS(C)(=O)=O)cc3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1271215,COc1ccc(/C=C2\C(=O)N(c3nc4ccccc4s3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,27000.0,4.57,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27000.0,4.568636235841013
CHEMBL1271216,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2C)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1271317,CCC1=NN(c2cccc(Br)c2)C(=O)/C1=C\c1ccc(OC)c(OCc2ccc(F)cc2)c1,IC50,100000.0,,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1271318,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2NC(=O)C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1271425,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2OC(C)=O)cc1OCc1ccc(F)cc1,IC50,100000.0,4.0,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1271426,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2COC(C)=O)cc1OCc1ccc(F)cc1,IC50,57000.0,4.24,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57000.0,4.2441251443275085
CHEMBL1269892,CCC(=O)OC1=NN(c2cccc(Br)c2)C(=O)/C1=C\c1ccc(OC)c(OCc2ccc(F)cc2)c1,IC50,88000.0,4.06,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,88000.0,4.055517327849832
CHEMBL1269893,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2C(=O)O)cc1OCc1ccc(F)cc1,IC50,19000.0,4.72,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL1269999,COc1ccc(/C=C2\C(=O)N(c3cccc([N+](=O)[O-])c3)N=C2C(=O)O)cc1Cc1ccc(F)cc1,IC50,11000.0,4.96,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL1270000,COc1ccc(/C=C2\C(=O)N(c3cccc([N+](=O)[O-])c3)N=C2C(=O)O)cc1OCc1ccc(F)cc1,IC50,14000.0,4.85,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL1270108,O=C(O)C1=NN(c2cccc([N+](=O)[O-])c2)C(=O)/C1=C\c1ccc(O)c(OCc2ccc(F)cc2)c1,IC50,10000.0,5.0,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL1270109,O=C(O)C1=NN(c2cccc([N+](=O)[O-])c2)C(=O)/C1=C\c1ccc(OCc2ccc(F)cc2)c(O)c1,IC50,3000.0,5.52,CHEMBL1273470,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL1270106,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2C(F)(F)F)cc1OC,IC50,89000.0,4.05,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,89000.0,4.050609993355088
CHEMBL1270107,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2C(F)(F)F)c(OC)c1OC,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1270213,COc1cc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2C(F)(F)F)cc(OC)c1OC,IC50,61000.0,4.21,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61000.0,4.214670164989233
CHEMBL1270214,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2C(F)(F)F)cc1OCc1cccc(Cl)c1F,IC50,50000.0,4.3,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL1270307,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,83000.0,4.08,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,83000.0,4.080921907623926
CHEMBL1270308,O=C1/C(=C\c2ccc(O)c(OCc3ccc(F)cc3)c2)C(C(F)(F)F)=NN1c1cccc(Br)c1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1270406,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2C(F)(F)F)cc1Cc1ccc(F)cc1,IC50,21000.0,4.68,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL1270407,COc1ccc(/C=C2\C(=O)N(c3ccccc3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1270500,COc1ccc(/C=C2\C(=O)N(c3cccc(C)c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1270501,COc1ccc(/C=C2\C(=O)N(c3cccc(C(F)(F)F)c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,90000.0,4.05,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL1270602,COc1ccc(/C=C2\C(=O)N(c3cccc(-c4ccccc4)c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1270700,COc1ccc(/C=C2\C(=O)N(c3cccc([N+](=O)[O-])c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,52000.0,4.28,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52000.0,4.2839966563652006
CHEMBL1270701,COc1ccc(/C=C2\C(=O)N(c3cccc(F)c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1270805,COc1ccc(/C=C2\C(=O)N(c3cccc(Cl)c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,88000.0,4.06,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,88000.0,4.055517327849832
CHEMBL1270806,COc1ccc(/C=C2\C(=O)N(c3cccc(I)c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1270908,COc1ccc(/C=C2\C(=O)N(c3cc(Cl)cc(Cl)c3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1270909,COc1ccc(/C=C2\C(=O)N(c3ccc(Br)cc3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,82000.0,4.09,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,82000.0,4.086186147616283
CHEMBL1271007,COc1ccc(/C=C2\C(=O)N(c3ccc(I)cc3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1271008,COc1ccc(/C=C2\C(=O)N(c3ccc(C(=O)O)cc3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1271113,COc1ccc(/C=C2\C(=O)N(c3ccc(NS(C)(=O)=O)cc3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1271215,COc1ccc(/C=C2\C(=O)N(c3nc4ccccc4s3)N=C2C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1271216,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2C)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1271317,CCC1=NN(c2cccc(Br)c2)C(=O)/C1=C\c1ccc(OC)c(OCc2ccc(F)cc2)c1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1271318,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2NC(=O)C(F)(F)F)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1271425,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2OC(C)=O)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1271426,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2COC(C)=O)cc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1269892,CCC(=O)OC1=NN(c2cccc(Br)c2)C(=O)/C1=C\c1ccc(OC)c(OCc2ccc(F)cc2)c1,IC50,100000.0,,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1269893,COc1ccc(/C=C2\C(=O)N(c3cccc(Br)c3)N=C2C(=O)O)cc1OCc1ccc(F)cc1,IC50,55000.0,4.26,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55000.0,4.259637310505756
CHEMBL1269999,COc1ccc(/C=C2\C(=O)N(c3cccc([N+](=O)[O-])c3)N=C2C(=O)O)cc1Cc1ccc(F)cc1,IC50,15000.0,4.82,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL1270000,COc1ccc(/C=C2\C(=O)N(c3cccc([N+](=O)[O-])c3)N=C2C(=O)O)cc1OCc1ccc(F)cc1,IC50,60000.0,4.22,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60000.0,4.221848749616356
CHEMBL1270108,O=C(O)C1=NN(c2cccc([N+](=O)[O-])c2)C(=O)/C1=C\c1ccc(O)c(OCc2ccc(F)cc2)c1,IC50,95000.0,4.02,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,95000.0,4.022276394711152
CHEMBL1270109,O=C(O)C1=NN(c2cccc([N+](=O)[O-])c2)C(=O)/C1=C\c1ccc(OCc2ccc(F)cc2)c(O)c1,IC50,21000.0,4.68,CHEMBL1273471,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL1270611,NCc1ccc(-c2ccc(Cc3cc(=O)n(O)c4ncccc34)cc2)cc1,IC50,24000.0,4.62,CHEMBL1273924,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL1270511,NCc1ccc(-c2cccc(Cc3cc(=O)n(O)c4ncccc34)c2)cc1,IC50,8100.0,5.09,CHEMBL1273924,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8100.0,5.0915149811213505
CHEMBL1270510,NCc1ccc(-c2cccc(-c3cc(=O)n(O)c4ncccc34)c2)cc1,IC50,7800.0,5.11,CHEMBL1273924,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7800.0,5.107905397309519
CHEMBL1270417,NCc1cccc(-c2cccc(-c3cc(=O)n(O)c4ncccc34)c2)c1,IC50,9100.0,5.04,CHEMBL1273924,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9100.0,5.040958607678906
CHEMBL1270416,NCc1ccccc1-c1cccc(-c2cc(=O)n(O)c3ncccc23)c1,IC50,18000.0,4.75,CHEMBL1273924,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL1270317,O=c1cc(-c2cccc(-c3ccccc3)c2)c2cccnc2n1O,IC50,2400.0,5.62,CHEMBL1273924,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2400.0,5.619788758288394
CHEMBL1269478,O=c1ccc2cccnc2n1O,IC50,15000.0,4.82,CHEMBL1273924,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL1289080,CN(O)C(=O)c1cc2c(CN3CCC(O)C3)cn(Cc3ccc(F)cc3)c2cn1,IC50,1421.0,5.85,CHEMBL1291062,Inhibition of HIV1 RF integrase after 50 mins by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1421.0,5.8474059220725305
CHEMBL1289199,CN1CCN(Cc2cn(Cc3ccc(F)cc3)c3cnc(C(=O)N(C)O)cc23)CC1,IC50,534.0,6.27,CHEMBL1291062,Inhibition of HIV1 RF integrase after 50 mins by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,534.0,6.272458742971444
CHEMBL1289200,CN(O)C(=O)c1cc2c(CN3CCNC(=O)C3)cn(Cc3ccc(F)cc3)c2cn1,IC50,388.0,6.41,CHEMBL1291062,Inhibition of HIV1 RF integrase after 50 mins by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,388.0,6.411168274405792
CHEMBL1289312,CN(O)C(=O)c1cc2c(CN3CCC[C@@H]3C(N)=O)cn(Cc3ccc(F)cc3)c2cn1,IC50,466.0,6.33,CHEMBL1291062,Inhibition of HIV1 RF integrase after 50 mins by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,466.0,6.33161408331
CHEMBL1289313,CN(O)C(=O)c1cc2c(CN3CCC[C@H]3C(N)=O)cn(Cc3ccc(F)cc3)c2cn1,IC50,558.0,6.25,CHEMBL1291062,Inhibition of HIV1 RF integrase after 50 mins by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,558.0,6.253365801062421
CHEMBL1289430,CN(O)C(=O)c1cc2c(CO)cn(Cc3ccc(F)cc3)c2cn1,IC50,145.0,6.84,CHEMBL1291062,Inhibition of HIV1 RF integrase after 50 mins by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,145.0,6.838631997765026
CHEMBL1289431,COCCOCc1cn(Cc2ccc(F)cc2)c2cnc(C(=O)N(C)O)cc12,IC50,382.0,6.42,CHEMBL1291062,Inhibition of HIV1 RF integrase after 50 mins by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,382.0,6.417936637088291
CHEMBL1289542,CN(O)C(=O)c1cc2c(COC3CCOCC3)cn(Cc3ccc(F)cc3)c2cn1,IC50,313.0,6.5,CHEMBL1291062,Inhibition of HIV1 RF integrase after 50 mins by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,313.0,6.504455662453552
CHEMBL1289543,COCc1cn(Cc2ccc(F)cc2)c2cnc(C(=O)N(C)O)cc12,IC50,242.0,6.62,CHEMBL1291062,Inhibition of HIV1 RF integrase after 50 mins by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,242.0,6.616184634019569
CHEMBL1289651,CCOCCOCc1cn(Cc2ccc(F)cc2)c2cnc(C(=O)N(C)O)cc12,IC50,308.0,6.51,CHEMBL1291062,Inhibition of HIV1 RF integrase after 50 mins by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,308.0,6.511449283499555
CHEMBL1289652,CN(O)C(=O)c1cc2c(C(=O)NCCN3CCOCC3)cn(Cc3ccc(F)cc3)c2cn1,IC50,503.0,6.3,CHEMBL1291062,Inhibition of HIV1 RF integrase after 50 mins by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,503.0,6.298432014944073
CHEMBL1289756,CN(O)C(=O)c1cc2c(C(=O)N3CCC[C@@H]3CO)cn(Cc3ccc(F)cc3)c2cn1,IC50,319.0,6.5,CHEMBL1291062,Inhibition of HIV1 RF integrase after 50 mins by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,319.0,6.496209316942819
CHEMBL1289757,CC(C)NC(=O)c1cn(Cc2ccc(F)cc2)c2cnc(C(=O)N(C)O)cc12,IC50,251.0,6.6,CHEMBL1291062,Inhibition of HIV1 RF integrase after 50 mins by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,251.0,6.600326278518962
CHEMBL1289863,CN(O)C(=O)c1cc2c(CCCN3CCOCC3)cn(Cc3ccc(F)cc3)c2cn1,IC50,559.0,6.25,CHEMBL1291062,Inhibition of HIV1 RF integrase after 50 mins by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,559.0,6.252588192113577
CHEMBL1289864,CN(O)C(=O)c1cc2c(CCCO)cn(Cc3ccc(F)cc3)c2cn1,IC50,340.0,6.47,CHEMBL1291062,Inhibition of HIV1 RF integrase after 50 mins by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,340.0,6.468521082957745
CHEMBL1289981,COCCOCCCc1cn(Cc2ccc(F)cc2)c2cnc(C(=O)N(C)O)cc12,IC50,552.0,6.26,CHEMBL1291062,Inhibition of HIV1 RF integrase after 50 mins by strand transfer scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,552.0,6.258060922270801
CHEMBL1631331,COc1cc(/C=C/c2ccc3ccc(C(=O)[O-])c(O)c3n2)cc(O)c1O.[Na+],IC50,700.0,6.16,CHEMBL1634566,Inhibition of HIV 1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL1631332,COc1cc(/C=C/c2ccc3ccc(C(=O)[O-])c(O)c3n2)cc(OC)c1O.[Na+],IC50,4900.0,5.31,CHEMBL1634566,Inhibition of HIV 1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4900.0,5.309803919971486
CHEMBL513189,CN(c1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C2)S(C)(=O)=O,IC50,28.0,7.55,CHEMBL1635106,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28.0,7.552841968657781
CHEMBL408699,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@@H](CO)C(C)C,IC50,40.0,7.4,CHEMBL1635106,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL414850,O=C(NCc1ccc(F)cc1)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,44.0,7.36,CHEMBL1635106,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44.0,7.356547323513812
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,34.0,7.47,CHEMBL1635106,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34.0,7.468521082957745
CHEMBL1668660,CC1C(=O)N(O)C(=O)c2ccccc21,IC50,3300.0,5.48,CHEMBL1670581,Inhibition of HIV-1 integrase after 1 hr by immunosorbent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3300.0,5.481486060122112
CHEMBL1668661,CCC1C(=O)N(O)C(=O)c2ccccc21,IC50,15700.0,4.8,CHEMBL1670581,Inhibition of HIV-1 integrase after 1 hr by immunosorbent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15700.0,4.804100347590766
CHEMBL1668662,CCCC1C(=O)N(O)C(=O)c2ccccc21,IC50,21100.0,4.68,CHEMBL1670581,Inhibition of HIV-1 integrase after 1 hr by immunosorbent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21100.0,4.675717544702307
CHEMBL1668663,CC(C)C1C(=O)N(O)C(=O)c2ccccc21,IC50,35500.0,4.45,CHEMBL1670581,Inhibition of HIV-1 integrase after 1 hr by immunosorbent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35500.0,4.449771646944906
CHEMBL1668664,CCCCC1C(=O)N(O)C(=O)c2ccccc21,IC50,40200.0,4.4,CHEMBL1670581,Inhibition of HIV-1 integrase after 1 hr by immunosorbent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40200.0,4.39577394691553
CHEMBL1668665,CCCCCC1C(=O)N(O)C(=O)c2ccccc21,IC50,1350.0,5.87,CHEMBL1670581,Inhibition of HIV-1 integrase after 1 hr by immunosorbent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1350.0,5.8696662315049934
CHEMBL1668666,CCCCCCC1C(=O)N(O)C(=O)c2ccccc21,IC50,11400.0,4.94,CHEMBL1670581,Inhibition of HIV-1 integrase after 1 hr by immunosorbent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11400.0,4.943095148663527
CHEMBL1668658,CCCCCCc1c(O)n(O)c(=O)c2ccccc12,IC50,45400.0,4.34,CHEMBL1670581,Inhibition of HIV-1 integrase after 1 hr by immunosorbent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45400.0,4.342944147142896
CHEMBL1668667,O=C1c2ccccc2C(Cc2ccccc2)C(=O)N1O,IC50,37700.0,4.42,CHEMBL1670581,Inhibition of HIV-1 integrase after 1 hr by immunosorbent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37700.0,4.423658649794207
CHEMBL1668668,O=c1c2ccccc2c(Cc2ccccc2)c(O)n1O,IC50,39900.0,4.4,CHEMBL1670581,Inhibition of HIV-1 integrase after 1 hr by immunosorbent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39900.0,4.399027104313252
CHEMBL1668669,Cc1ccc(CC2C(=O)N(O)C(=O)c3ccccc32)cc1,IC50,3400.0,5.47,CHEMBL1670581,Inhibition of HIV-1 integrase after 1 hr by immunosorbent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3400.0,5.468521082957745
CHEMBL1668670,O=C1c2ccccc2C(Cc2ccc(C(F)(F)F)cc2)C(=O)N1O,IC50,23200.0,4.63,CHEMBL1670581,Inhibition of HIV-1 integrase after 1 hr by immunosorbent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23200.0,4.634512015109101
CHEMBL1668671,O=C1c2ccccc2C(CCc2ccccc2)C(=O)N1O,IC50,27800.0,4.56,CHEMBL1670581,Inhibition of HIV-1 integrase after 1 hr by immunosorbent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27800.0,4.555955204081924
CHEMBL1668672,O=C1c2ccccc2C(CCCc2ccccc2)C(=O)N1O,IC50,2600.0,5.58,CHEMBL1670581,Inhibition of HIV-1 integrase after 1 hr by immunosorbent assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2600.0,5.585026652029182
CHEMBL1669249,COc1cc(OC)c2c(c1)c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,251.0,6.6,CHEMBL1671032,Inhibition of HIV-1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,251.0,6.600326278518962
CHEMBL1669247,COc1cc(OC)c2c(C(=O)/C=C(\O)C(=O)O)cn(Cc3ccc(F)cc3)c2c1,IC50,470.0,6.33,CHEMBL1671032,Inhibition of HIV-1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,470.0,6.327902142064282
CHEMBL1669248,COc1cc2c(C(=O)/C=C(\O)C(=O)O)cn(Cc3ccc(F)cc3)c2cc1OC,IC50,547.0,6.26,CHEMBL1671032,Inhibition of HIV-1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,547.0,6.262012673666569
CHEMBL1669241,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OC)c(OC)c12,IC50,900.0,6.05,CHEMBL1671032,Inhibition of HIV-1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL1669246,COc1ccc2c(c(C(=O)/C=C(\O)C(=O)O)cn2Cc2ccc(F)cc2)c1OC,IC50,1450.0,5.84,CHEMBL1671032,Inhibition of HIV-1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1450.0,5.838631997765026
CHEMBL1669242,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(OC)cc(OC)c12,IC50,2790.0,5.55,CHEMBL1671032,Inhibition of HIV-1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2790.0,5.554395796726403
CHEMBL1669250,COc1ccc2c(C(=O)/C=C(\O)C(=O)O)cn(Cc3ccc(F)cc3)c2c1OC,IC50,3550.0,5.45,CHEMBL1671032,Inhibition of HIV-1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3550.0,5.449771646944906
CHEMBL1669243,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(OC)c(OC)cc12,IC50,4400.0,5.36,CHEMBL1671032,Inhibition of HIV-1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4400.0,5.356547323513812
CHEMBL1669245,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2c(OC)c(OC)ccc12,IC50,7410.0,5.13,CHEMBL1671032,Inhibition of HIV-1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7410.0,5.130181792020672
CHEMBL1669244,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2c(OC)cc(OC)cc12,IC50,18100.0,4.74,CHEMBL1671032,Inhibition of HIV-1 integrase after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18100.0,4.7423214251308154
CHEMBL89295,[N-]=[N+]=[N-].[Na+],IC50,1200.0,5.92,CHEMBL1671440,Inhibition of full-length recombinant HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL1669300,O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(NC(=O)c2ccc(F)c(F)c2)cc1,IC50,28500.0,4.54,CHEMBL1671440,Inhibition of full-length recombinant HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28500.0,4.54515513999149
CHEMBL1669301,Cc1ccc(/C=C/C(=O)c2ccc(NC(=O)c3cc(F)cc(F)c3)cc2)cc1O,IC50,39300.0,4.41,CHEMBL1671440,Inhibition of full-length recombinant HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39300.0,4.405607449624573
CHEMBL1669295,O=C(Cc1cccs1)Nc1ccc(C(=O)/C=C/c2ccc(O)c(O)c2)cc1,IC50,44600.0,4.35,CHEMBL1671440,Inhibition of full-length recombinant HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44600.0,4.350665141287858
CHEMBL1669296,O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(NC(=O)c2ccccc2)cc1,IC50,50200.0,4.3,CHEMBL1671440,Inhibition of full-length recombinant HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50200.0,4.29929628285498
CHEMBL1669298,COc1ccc(C(=O)Nc2ccc(C(=O)/C=C/c3ccc(O)c(O)c3)cc2)cc1,IC50,25200.0,4.6,CHEMBL1671440,Inhibition of full-length recombinant HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25200.0,4.598599459218456
CHEMBL1669292,O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(NC(=O)C23C[C@H]4C[C@@H](C2)C[C@@H](C3)C4)cc1,IC50,36800.0,4.43,CHEMBL1671440,Inhibition of full-length recombinant HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36800.0,4.434152181326482
CHEMBL263887,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cccc(OC)c12,IC50,86080.0,4.07,CHEMBL1675359,Inhibition of Human immunodeficiency virus 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,86080.0,4.065097741677686
CHEMBL406929,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OC)cc12,IC50,4600.0,5.34,CHEMBL1675359,Inhibition of Human immunodeficiency virus 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4600.0,5.337242168318426
CHEMBL260619,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(OC)ccc12,IC50,1960.0,5.71,CHEMBL1675359,Inhibition of Human immunodeficiency virus 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1960.0,5.707743928643524
CHEMBL405652,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2c(OC)cccc12,IC50,4760.0,5.32,CHEMBL1675359,Inhibition of Human immunodeficiency virus 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4760.0,5.3223930472795065
CHEMBL260398,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2c(OC)ccc(OC)c12,IC50,1240.0,5.91,CHEMBL1675359,Inhibition of Human immunodeficiency virus 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1240.0,5.906578314837764
CHEMBL1673089,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccccc2)c2ccccc12,IC50,860.0,6.07,CHEMBL1675359,Inhibition of Human immunodeficiency virus 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,860.0,6.065501548756432
CHEMBL259011,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,110.0,6.96,CHEMBL1675359,Inhibition of Human immunodeficiency virus 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL409643,COc1ccc2c(c1)c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,300.0,6.52,CHEMBL1675359,Inhibition of Human immunodeficiency virus 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL261541,COc1ccc2c(C(=O)/C=C(\O)C(=O)O)cn(Cc3ccc(F)cc3)c2c1,IC50,190.0,6.72,CHEMBL1675359,Inhibition of Human immunodeficiency virus 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,190.0,6.721246399047171
CHEMBL261714,COc1cccc2c(C(=O)/C=C(\O)C(=O)O)cn(Cc3ccc(F)cc3)c12,IC50,270.0,6.57,CHEMBL1675359,Inhibition of Human immunodeficiency virus 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,270.0,6.568636235841012
CHEMBL260185,COc1ccc(OC)c2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,60.0,7.22,CHEMBL1675359,Inhibition of Human immunodeficiency virus 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL414850,O=C(NCc1ccc(F)cc1)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,2.3,8.64,CHEMBL1675359,Inhibition of Human immunodeficiency virus 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.3,8.638272163982407
CHEMBL204656,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C,IC50,3.8,8.42,CHEMBL1675359,Inhibition of Human immunodeficiency virus 1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.8,8.42021640338319
CHEMBL263887,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cccc(OC)c12,IC50,92300.0,4.04,CHEMBL1675360,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,92300.0,4.034798298974088
CHEMBL406929,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OC)cc12,IC50,7550.0,5.12,CHEMBL1675360,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7550.0,5.1220530483708115
CHEMBL260619,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(OC)ccc12,IC50,2340.0,5.63,CHEMBL1675360,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2340.0,5.630784142589857
CHEMBL405652,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2c(OC)cccc12,IC50,2640.0,5.58,CHEMBL1675360,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2640.0,5.578396073130168
CHEMBL260398,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2c(OC)ccc(OC)c12,IC50,660.0,6.18,CHEMBL1675360,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,660.0,6.180456064458131
CHEMBL1673089,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccccc2)c2ccccc12,IC50,2330.0,5.63,CHEMBL1675360,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2330.0,5.632644078973981
CHEMBL259011,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,140.0,6.85,CHEMBL1675360,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,140.0,6.853871964321762
CHEMBL409643,COc1ccc2c(c1)c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,270.0,6.57,CHEMBL1675360,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,270.0,6.568636235841012
CHEMBL261541,COc1ccc2c(C(=O)/C=C(\O)C(=O)O)cn(Cc3ccc(F)cc3)c2c1,IC50,220.0,6.66,CHEMBL1675360,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,220.0,6.657577319177793
CHEMBL261714,COc1cccc2c(C(=O)/C=C(\O)C(=O)O)cn(Cc3ccc(F)cc3)c12,IC50,190.0,6.72,CHEMBL1675360,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,190.0,6.721246399047171
CHEMBL260185,COc1ccc(OC)c2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,30.0,7.52,CHEMBL1675360,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL414850,O=C(NCc1ccc(F)cc1)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,7.0,8.15,CHEMBL1675360,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL204656,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C,IC50,15.0,7.82,CHEMBL1675360,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL1682070,O=C(NCc1ccc(F)cc1)c1cc(Br)ccc1O,IC50,100000.0,,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682069,Cc1cccc(C(=O)NCc2ccc(F)cc2)c1O,IC50,100000.0,,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682068,O=C(O)c1cc(Br)cc(C(=O)NCc2ccc(F)cc2)c1O,IC50,100000.0,,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682067,O=C(O)c1cc(F)cc(C(=O)CCc2cc(Cl)ccc2Cl)c1O,IC50,100000.0,,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682066,O=Cc1cc(Br)cc(C(=O)NCc2ccc(F)cc2)c1O,IC50,100000.0,,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682063,Cc1cc(C(=O)O)c(O)c(C(=O)/C=C/c2c(Cl)ccc(Cl)c2Cl)c1,IC50,100000.0,,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682062,N#Cc1cc(Br)cc(C(=O)/C=C/c2c(Cl)ccc(Cl)c2Cl)c1O,IC50,100000.0,,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682058,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(OC(F)(F)F)c2)c1O,IC50,100000.0,,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682057,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cc3c(cc2Cl)OCO3)c1O,IC50,79000.0,4.1,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,79000.0,4.102372908709558
CHEMBL1682056,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccccc2-c2ccco2)c1O,IC50,100000.0,,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682054,COc1cccc2c(/C=C/C(=O)c3cc(Br)cc(C(=O)O)c3O)cccc12,IC50,54000.0,4.27,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54000.0,4.267606240177032
CHEMBL1682053,CCOc1ccc2ccccc2c1/C=C/C(=O)c1cc(Br)cc(C(=O)O)c1O,IC50,92000.0,4.04,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,92000.0,4.036212172654444
CHEMBL1682052,COc1ccc(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)cc1OC1CCCC1,IC50,100000.0,4.0,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682050,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(Oc3ccc(Cl)cc3)cc2)c1O,IC50,22000.0,4.66,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL1682049,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(Oc3ccc(Cl)cc3)c2)c1O,IC50,25000.0,4.6,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL1682048,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccccc2OCc2ccccc2)c1O,IC50,21000.0,4.68,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL1682047,COc1cc(F)c(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)cc1OC,IC50,100000.0,,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682046,COc1ccc(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)c(Cl)c1OC,IC50,100000.0,,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682045,Cc1cc(C)cc(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)c1,IC50,100000.0,,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682042,O=C(O)c1cc(F)cc(C(=O)/C=C/c2cc(Cl)ccc2Cl)c1O,IC50,50000.0,4.3,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL1682035,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2cc(Cl)ccc2Cl)c1O,IC50,75000.0,4.12,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75000.0,4.1249387366083
CHEMBL1682034,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2cccc(Cl)c2Cl)c1O,IC50,100000.0,4.0,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682033,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2ccc(Cl)cc2Cl)c1O,IC50,100000.0,,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1685081,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(I)cc2)c1O,IC50,69000.0,4.16,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69000.0,4.161150909262744
CHEMBL1682070,O=C(NCc1ccc(F)cc1)c1cc(Br)ccc1O,IC50,100000.0,4.0,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682069,Cc1cccc(C(=O)NCc2ccc(F)cc2)c1O,IC50,100000.0,4.0,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682068,O=C(O)c1cc(Br)cc(C(=O)NCc2ccc(F)cc2)c1O,IC50,15135.61,4.82,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15135.61,4.820000071285178
CHEMBL1682065,O=C(/C=C/c1cc(Br)cc([N+](=O)[O-])c1O)c1c(Cl)ccc(Cl)c1Cl,IC50,20892.96,4.68,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20892.96,4.68000002720016
CHEMBL1682064,O=C(/C=C/c1cc(Br)cc([N+](=O)[O-])c1O)c1cc(Cl)cc(Cl)c1Cl,IC50,69183.1,4.16,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69183.1,4.159999981744464
CHEMBL1682063,Cc1cc(C(=O)O)c(O)c(C(=O)/C=C/c2c(Cl)ccc(Cl)c2Cl)c1,IC50,50118.72,4.3,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50118.72,4.300000029139088
CHEMBL1682062,N#Cc1cc(Br)cc(C(=O)/C=C/c2c(Cl)ccc(Cl)c2Cl)c1O,IC50,39810.72,4.4,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39810.72,4.399999967876858
CHEMBL1682061,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(F)c2)c1O,IC50,58884.37,4.23,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58884.37,4.229999967073058
CHEMBL1682060,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(Br)c2)c1O,IC50,18197.01,4.74,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18197.01,4.739999966255497
CHEMBL1682059,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc([N+](=O)[O-])c2)c1O,IC50,32359.37,4.49,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32359.37,4.489999942195333
CHEMBL1682058,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(OC(F)(F)F)c2)c1O,IC50,52480.75,4.28,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52480.75,4.279999967105453
CHEMBL1682057,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cc3c(cc2Cl)OCO3)c1O,IC50,63095.73,4.2,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,63095.73,4.200000030616179
CHEMBL1682056,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccccc2-c2ccco2)c1O,IC50,15848.93,4.8,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15848.93,4.800000052738446
CHEMBL1682055,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc3sccc3c2)c1O,IC50,10964.78,4.96,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10964.78,4.96000007768865
CHEMBL1682054,COc1cccc2c(/C=C/C(=O)c3cc(Br)cc(C(=O)O)c3O)cccc12,IC50,54954.09,4.26,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54954.09,4.259999979340046
CHEMBL1682053,CCOc1ccc2ccccc2c1/C=C/C(=O)c1cc(Br)cc(C(=O)O)c1O,IC50,46773.51,4.33,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,46773.51,4.330000038335378
CHEMBL1682052,COc1ccc(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)cc1OC1CCCC1,IC50,54954.09,4.26,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54954.09,4.259999979340046
CHEMBL1682051,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccsc2)c1O,IC50,18197.01,4.74,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18197.01,4.739999966255497
CHEMBL1682050,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(Oc3ccc(Cl)cc3)cc2)c1O,IC50,16218.1,4.79,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16218.1,4.790000026071146
CHEMBL1682049,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(Oc3ccc(Cl)cc3)c2)c1O,IC50,18197.01,4.74,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18197.01,4.739999966255497
CHEMBL1682048,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccccc2OCc2ccccc2)c1O,IC50,9120.11,5.04,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9120.11,5.039999923502186
CHEMBL1682047,COc1cc(F)c(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)cc1OC,IC50,75857.76,4.12,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75857.76,4.119999985703918
CHEMBL1682046,COc1ccc(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)c(Cl)c1OC,IC50,75857.76,4.12,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75857.76,4.119999985703918
CHEMBL1682045,Cc1cc(C)cc(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)c1,IC50,58884.37,4.23,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58884.37,4.229999967073058
CHEMBL1682044,O=C(O)c1cc(F)cc(C(=O)/C=C/c2c(Cl)ccc(Cl)c2Cl)c1O,IC50,38904.51,4.41,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38904.51,4.41000005022751
CHEMBL1682043,O=C(O)c1cc(F)cc(C(=O)/C=C/c2cc(Cl)cc(Cl)c2Cl)c1O,IC50,15135.61,4.82,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15135.61,4.820000071285178
CHEMBL1682042,O=C(O)c1cc(F)cc(C(=O)/C=C/c2cc(Cl)ccc2Cl)c1O,IC50,28840.32,4.54,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28840.32,4.539999925177879
CHEMBL1682041,O=C(O)c1cc(F)cc(C(=O)/C=C/c2cccc(Cl)c2Cl)c1O,IC50,30199.52,4.52,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30199.52,4.519999959791458
CHEMBL1682040,O=C(O)c1cc(F)cc(C(=O)/C=C/c2ccc(Cl)cc2Cl)c1O,IC50,23988.33,4.62,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23988.33,4.619999985338959
CHEMBL1682039,O=C(O)c1cc(F)cc(C(=O)/C=C/c2ccc(Cl)cc2)c1O,IC50,17378.01,4.76,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17378.01,4.759999957202692
CHEMBL1682038,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2ccc(Cl)c(Cl)c2)c1O,IC50,40738.03,4.39,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40738.03,4.389999976337708
CHEMBL1682037,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2c(Cl)ccc(Cl)c2Cl)c1O,IC50,30199.52,4.52,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30199.52,4.519999959791458
CHEMBL1682036,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2cc(Cl)cc(Cl)c2Cl)c1O,IC50,16982.44,4.77,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16982.44,4.769999911123512
CHEMBL1682035,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2cc(Cl)ccc2Cl)c1O,IC50,25118.86,4.6,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25118.86,4.600000074606178
CHEMBL1682034,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2cccc(Cl)c2Cl)c1O,IC50,93325.43,4.03,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,93325.43,4.030000000370884
CHEMBL1682033,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2ccc(Cl)cc2Cl)c1O,IC50,100000.0,4.0,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682032,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2ccc(Cl)cc2)c1O,IC50,53703.18,4.27,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53703.18,4.2699999970646445
CHEMBL1682031,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2c(Cl)ccc(Cl)c2Cl)c1O,IC50,3981.07,5.4,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3981.07,5.40000018605658
CHEMBL1682030,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cc(Cl)cc(Cl)c2Cl)c1O,IC50,13182.57,4.88,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13182.57,4.879999913868448
CHEMBL1682029,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(Cl)c(Cl)c2)c1O,IC50,14125.38,4.85,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14125.38,4.849999859991125
CHEMBL1682028,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2c(Cl)cccc2Cl)c1O,IC50,16218.1,4.79,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16218.1,4.790000026071146
CHEMBL1682027,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cc(Cl)ccc2Cl)c1O,IC50,18197.01,4.74,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18197.01,4.739999966255497
CHEMBL1682026,COc1ccc(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)c(OC)c1OC,IC50,51286.14,4.29,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,51286.14,4.28999998644378
CHEMBL1685084,COc1cccc(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)c1OC,IC50,34673.69,4.46,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34673.69,4.459999937940861
CHEMBL1685083,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(Cl)c2Cl)c1O,IC50,19054.61,4.72,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19054.61,4.719999935717911
CHEMBL1685082,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(Cl)cc2Cl)c1O,IC50,7079.46,5.15,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7079.46,5.149999867728904
CHEMBL1685081,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(I)cc2)c1O,IC50,35481.34,4.45,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35481.34,4.449999986821809
CHEMBL1685080,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(Br)cc2)c1O,IC50,5011.87,5.3,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5011.87,5.300000202445418
CHEMBL1685079,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(Cl)cc2)c1O,IC50,12022.64,4.92,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12022.64,4.920000156997057
CHEMBL1685078,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(Cl)c2)c1O,IC50,9120.11,5.04,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9120.11,5.039999923502186
CHEMBL1685077,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccccc2F)c1O,IC50,32359.37,4.49,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32359.37,4.489999942195333
CHEMBL1685076,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccccc2Cl)c1O,IC50,14125.38,4.85,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14125.38,4.849999859991125
CHEMBL1685075,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccccc2)c1O,IC50,25118.86,4.6,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25118.86,4.600000074606178
CHEMBL1682070,O=C(NCc1ccc(F)cc1)c1cc(Br)ccc1O,IC50,100000.0,,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682069,Cc1cccc(C(=O)NCc2ccc(F)cc2)c1O,IC50,100000.0,,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682058,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(OC(F)(F)F)c2)c1O,IC50,52000.0,4.28,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52000.0,4.2839966563652006
CHEMBL1682057,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cc3c(cc2Cl)OCO3)c1O,IC50,63000.0,4.2,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,63000.0,4.200659450546418
CHEMBL1682053,CCOc1ccc2ccccc2c1/C=C/C(=O)c1cc(Br)cc(C(=O)O)c1O,IC50,46000.0,4.34,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,46000.0,4.337242168318426
CHEMBL1682052,COc1ccc(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)cc1OC1CCCC1,IC50,55000.0,4.26,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55000.0,4.259637310505756
CHEMBL1682050,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(Oc3ccc(Cl)cc3)cc2)c1O,IC50,16000.0,4.8,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL1682049,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(Oc3ccc(Cl)cc3)c2)c1O,IC50,18000.0,4.75,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL1682048,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccccc2OCc2ccccc2)c1O,IC50,9000.0,5.05,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL1682047,COc1cc(F)c(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)cc1OC,IC50,76000.0,4.12,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,76000.0,4.119186407719209
CHEMBL1682046,COc1ccc(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)c(Cl)c1OC,IC50,76000.0,4.12,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,76000.0,4.119186407719209
CHEMBL1682045,Cc1cc(C)cc(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)c1,IC50,58000.0,4.24,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58000.0,4.236572006437063
CHEMBL1682035,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2cc(Cl)ccc2Cl)c1O,IC50,25000.0,4.6,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL1682033,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2ccc(Cl)cc2Cl)c1O,IC50,100000.0,,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1682031,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2c(Cl)ccc(Cl)c2Cl)c1O,IC50,3700.0,,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3700.0,5.431798275933005
CHEMBL1685081,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(I)cc2)c1O,IC50,35000.0,4.46,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL1682036,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2cc(Cl)cc(Cl)c2Cl)c1O,IC50,55000.0,4.26,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55000.0,4.259637310505756
CHEMBL1685079,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(Cl)cc2)c1O,IC50,81000.0,4.09,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,81000.0,4.0915149811213505
CHEMBL1685077,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccccc2F)c1O,IC50,74000.0,4.13,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,74000.0,4.130768280269024
CHEMBL1682054,COc1cccc2c(/C=C/C(=O)c3cc(Br)cc(C(=O)O)c3O)cccc12,IC50,54000.0,4.27,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54000.0,4.267606240177032
CHEMBL1682032,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2ccc(Cl)cc2)c1O,IC50,53000.0,4.28,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53000.0,4.275724130399211
CHEMBL1682037,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2c(Cl)ccc(Cl)c2Cl)c1O,IC50,77000.0,4.11,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,77000.0,4.113509274827518
CHEMBL1682026,COc1ccc(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)c(OC)c1OC,IC50,85000.0,4.07,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,85000.0,4.070581074285707
CHEMBL1682041,O=C(O)c1cc(F)cc(C(=O)/C=C/c2cccc(Cl)c2Cl)c1O,IC50,55000.0,4.26,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55000.0,4.259637310505756
CHEMBL1682044,O=C(O)c1cc(F)cc(C(=O)/C=C/c2c(Cl)ccc(Cl)c2Cl)c1O,IC50,82000.0,4.09,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,82000.0,4.086186147616283
CHEMBL1682026,COc1ccc(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)c(OC)c1OC,IC50,51000.0,4.29,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,51000.0,4.292429823902063
CHEMBL1682043,O=C(O)c1cc(F)cc(C(=O)/C=C/c2cc(Cl)cc(Cl)c2Cl)c1O,IC50,33000.0,4.48,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33000.0,4.481486060122113
CHEMBL1682027,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cc(Cl)ccc2Cl)c1O,IC50,47000.0,4.33,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47000.0,4.327902142064283
CHEMBL1685084,COc1cccc(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)c1OC,IC50,62000.0,4.21,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,62000.0,4.2076083105017466
CHEMBL1685075,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccccc2)c1O,IC50,75000.0,4.12,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75000.0,4.1249387366083
CHEMBL1682034,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2cccc(Cl)c2Cl)c1O,IC50,92000.0,4.04,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,92000.0,4.036212172654444
CHEMBL1682040,O=C(O)c1cc(F)cc(C(=O)/C=C/c2ccc(Cl)cc2Cl)c1O,IC50,52000.0,4.28,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52000.0,4.2839966563652006
CHEMBL1682039,O=C(O)c1cc(F)cc(C(=O)/C=C/c2ccc(Cl)cc2)c1O,IC50,36000.0,4.44,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36000.0,4.443697499232713
CHEMBL1682038,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2ccc(Cl)c(Cl)c2)c1O,IC50,87000.0,4.06,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,87000.0,4.060480747381382
CHEMBL1682032,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2ccc(Cl)cc2)c1O,IC50,85000.0,4.07,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,85000.0,4.070581074285707
CHEMBL1685083,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(Cl)c2Cl)c1O,IC50,58000.0,4.24,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58000.0,4.236572006437063
CHEMBL1685076,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccccc2Cl)c1O,IC50,52000.0,4.28,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52000.0,4.2839966563652006
CHEMBL1682051,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccsc2)c1O,IC50,30000.0,4.52,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL1682031,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2c(Cl)ccc(Cl)c2Cl)c1O,IC50,23000.0,4.64,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL1682030,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cc(Cl)cc(Cl)c2Cl)c1O,IC50,20000.0,4.7,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1682028,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2c(Cl)cccc2Cl)c1O,IC50,52000.0,4.28,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52000.0,4.2839966563652006
CHEMBL1685082,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(Cl)cc2Cl)c1O,IC50,28000.0,4.55,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL1682029,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(Cl)c(Cl)c2)c1O,IC50,27000.0,4.57,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27000.0,4.568636235841013
CHEMBL1685083,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(Cl)c2Cl)c1O,IC50,19000.0,4.72,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL1685078,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(Cl)c2)c1O,IC50,45000.0,4.35,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45000.0,4.346787486224656
CHEMBL1682063,Cc1cc(C(=O)O)c(O)c(C(=O)/C=C/c2c(Cl)ccc(Cl)c2Cl)c1,IC50,50000.0,4.3,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL1682041,O=C(O)c1cc(F)cc(C(=O)/C=C/c2cccc(Cl)c2Cl)c1O,IC50,30000.0,4.52,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL1682040,O=C(O)c1cc(F)cc(C(=O)/C=C/c2ccc(Cl)cc2Cl)c1O,IC50,24000.0,4.62,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL1682038,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2ccc(Cl)c(Cl)c2)c1O,IC50,41000.0,4.39,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41000.0,4.3872161432802645
CHEMBL1682059,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc([N+](=O)[O-])c2)c1O,IC50,49000.0,4.31,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,49000.0,4.309803919971486
CHEMBL1682028,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2c(Cl)cccc2Cl)c1O,IC50,16000.0,4.8,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL1682059,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc([N+](=O)[O-])c2)c1O,IC50,32000.0,4.5,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL1682044,O=C(O)c1cc(F)cc(C(=O)/C=C/c2c(Cl)ccc(Cl)c2Cl)c1O,IC50,39000.0,4.41,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39000.0,4.4089353929735005
CHEMBL1682042,O=C(O)c1cc(F)cc(C(=O)/C=C/c2cc(Cl)ccc2Cl)c1O,IC50,29000.0,4.54,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,29000.0,4.537602002101044
CHEMBL1685084,COc1cccc(/C=C/C(=O)c2cc(Br)cc(C(=O)O)c2O)c1OC,IC50,34000.0,4.47,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34000.0,4.468521082957745
CHEMBL1682067,O=C(O)c1cc(F)cc(C(=O)CCc2cc(Cl)ccc2Cl)c1O,IC50,57000.0,4.24,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57000.0,4.2441251443275085
CHEMBL1682064,O=C(/C=C/c1cc(Br)cc([N+](=O)[O-])c1O)c1cc(Cl)cc(Cl)c1Cl,IC50,68000.0,4.17,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68000.0,4.167491087293763
CHEMBL1682037,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2c(Cl)ccc(Cl)c2Cl)c1O,IC50,30000.0,4.52,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL1682030,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cc(Cl)cc(Cl)c2Cl)c1O,IC50,13000.0,4.89,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL1685075,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccccc2)c1O,IC50,25000.0,4.6,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL1682065,O=C(/C=C/c1cc(Br)cc([N+](=O)[O-])c1O)c1c(Cl)ccc(Cl)c1Cl,IC50,36000.0,4.44,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36000.0,4.443697499232713
CHEMBL1682060,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(Br)c2)c1O,IC50,19000.0,4.72,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL1685080,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(Br)cc2)c1O,IC50,11000.0,4.96,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL1682043,O=C(O)c1cc(F)cc(C(=O)/C=C/c2cc(Cl)cc(Cl)c2Cl)c1O,IC50,15000.0,4.82,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL1682029,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(Cl)c(Cl)c2)c1O,IC50,14000.0,4.85,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL1682027,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cc(Cl)ccc2Cl)c1O,IC50,18000.0,4.75,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL1685082,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(Cl)cc2Cl)c1O,IC50,7000.0,5.16,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL1685076,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccccc2Cl)c1O,IC50,14000.0,4.85,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL1682055,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc3sccc3c2)c1O,IC50,23000.0,4.64,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL1682068,O=C(O)c1cc(Br)cc(C(=O)NCc2ccc(F)cc2)c1O,IC50,15000.0,4.82,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL1682065,O=C(/C=C/c1cc(Br)cc([N+](=O)[O-])c1O)c1c(Cl)ccc(Cl)c1Cl,IC50,21000.0,4.68,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL1682039,O=C(O)c1cc(F)cc(C(=O)/C=C/c2ccc(Cl)cc2)c1O,IC50,17000.0,4.77,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL1682036,O=C(O)c1cc(Cl)cc(C(=O)/C=C/c2cc(Cl)cc(Cl)c2Cl)c1O,IC50,17000.0,4.77,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL1685078,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(Cl)c2)c1O,IC50,9000.0,5.05,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL1685077,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccccc2F)c1O,IC50,32000.0,4.5,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL1682062,N#Cc1cc(Br)cc(C(=O)/C=C/c2c(Cl)ccc(Cl)c2Cl)c1O,IC50,44000.0,4.36,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44000.0,4.356547323513812
CHEMBL1682061,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(F)c2)c1O,IC50,59000.0,4.23,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,59000.0,4.229147988357856
CHEMBL1682056,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccccc2-c2ccco2)c1O,IC50,16000.0,4.8,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL1685080,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(Br)cc2)c1O,IC50,5000.0,5.3,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL1682066,O=Cc1cc(Br)cc(C(=O)NCc2ccc(F)cc2)c1O,IC50,8000.0,5.1,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL1682061,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(F)c2)c1O,IC50,71000.0,4.15,CHEMBL1685114,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,71000.0,4.1487416512809245
CHEMBL1682060,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2cccc(Br)c2)c1O,IC50,18000.0,4.75,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL1682051,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccsc2)c1O,IC50,18000.0,4.75,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL1682055,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc3sccc3c2)c1O,IC50,11000.0,4.96,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL1685079,O=C(O)c1cc(Br)cc(C(=O)/C=C/c2ccc(Cl)cc2)c1O,IC50,12000.0,4.92,CHEMBL1685113,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL1213165,C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c([O-])c3C(=O)N12.[Na+],IC50,2.7,8.57,CHEMBL1692673,Inhibition of strand transfer activity of Human immunodeficiency virus 1 Integrase using [3H]labeled target DNA as substrate after 45 mins by scintillation counting,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.7,8.568636235841012
CHEMBL518520,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c([O-])c(=O)n2C)o1.[K+],IC50,3.3,8.48,CHEMBL1692673,Inhibition of strand transfer activity of Human immunodeficiency virus 1 Integrase using [3H]labeled target DNA as substrate after 45 mins by scintillation counting,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.3,8.481486060122112
CHEMBL1761471,CCc1c(C(=O)c2ccccc2)n(COCc2ccccc2)c(=O)n(O)c1=O,IC50,37000.0,4.43,CHEMBL1763884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL1761472,CCc1c(C(=O)c2ccccc2)n(COCc2ccc(F)cc2)c(=O)n(O)c1=O,IC50,25000.0,4.6,CHEMBL1763884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL1761473,CCc1c(C(=O)c2cc(C)cc(C)c2)n(COCc2ccc(F)cc2)c(=O)n(O)c1=O,IC50,21000.0,4.68,CHEMBL1763884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL1761474,CCc1c(C(=O)c2cc(C)cc(C)c2)n(COCc2ccccc2)c(=O)n(O)c1=O,IC50,41000.0,4.39,CHEMBL1763884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41000.0,4.3872161432802645
CHEMBL1761475,CCc1c(C(=O)c2ccccc2)n(COCCc2ccc(F)cc2)c(=O)n(O)c1=O,IC50,4100.0,5.39,CHEMBL1763884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4100.0,5.3872161432802645
CHEMBL1761476,CCc1c(C(=O)c2cc(C)cc(C)c2)n(COCCc2ccc(F)cc2)c(=O)n(O)c1=O,IC50,7000.0,5.16,CHEMBL1763884,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL1770428,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc(F)cc3)cc2c1=O,IC50,3000.0,5.52,CHEMBL1772515,Inhibition of HIV1 integrase 3' processing activity after 1 hr by gel based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL1770430,O=C(O)/C=C/c1ccc2c(c1)c(=O)c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,8000.0,5.1,CHEMBL1772515,Inhibition of HIV1 integrase 3' processing activity after 1 hr by gel based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL1770431,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(Br)cc2c1=O,IC50,1600.0,5.8,CHEMBL1772515,Inhibition of HIV1 integrase 3' processing activity after 1 hr by gel based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL1770428,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc(F)cc3)cc2c1=O,IC50,50.0,7.3,CHEMBL1772517,Inhibition of HIV1 integrase strand transfer activity after 1 hr by gel based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL1770430,O=C(O)/C=C/c1ccc2c(c1)c(=O)c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,30.0,7.52,CHEMBL1772517,Inhibition of HIV1 integrase strand transfer activity after 1 hr by gel based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL1770431,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(Br)cc2c1=O,IC50,30.0,7.52,CHEMBL1772517,Inhibition of HIV1 integrase strand transfer activity after 1 hr by gel based assay in presence of magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL1773415,CC1CCN(S(=O)(=O)c2cn(Cc3ccc(F)cc3)c3cnc4c(c23)CCN(O)C4=O)CC1,IC50,36.0,7.44,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36.0,7.443697499232712
CHEMBL1773414,O=C1c2ncc3c(c(S(=O)(=O)N4CCCC4)cn3Cc3ccc(F)cc3)c2CCN1O,IC50,22.0,7.66,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22.0,7.657577319177793
CHEMBL1773413,CN(C)S(=O)(=O)c1cn(Cc2ccc(F)cc2)c2cnc3c(c12)CCN(O)C3=O,IC50,13.0,7.89,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL1773412,COCCN(C)S(=O)(=O)c1cn(Cc2ccc(F)cc2)c2cnc3c(c12)CCN(O)C3=O,IC50,66.0,7.18,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,66.0,7.180456064458131
CHEMBL1773411,O=C1c2ncc3c(c(S(=O)(=O)N4CCOCC4)cn3Cc3ccc(F)cc3)c2CCN1O,IC50,43.0,7.37,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43.0,7.366531544420413
CHEMBL1773410,O=C1c2ncc3c(c(CCC(F)(F)F)cn3Cc3ccc(F)cc3)c2CCN1O,IC50,13.0,7.89,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL1773409,O=C1c2ncc3c(c(CCCOC4CCOCC4)cn3Cc3ccc(F)cc3)c2CCN1O,IC50,14.0,7.85,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL1773408,CC(C)(O)CCc1cn(Cc2ccc(F)cc2)c2cnc3c(c12)CCN(O)C3=O,IC50,8.8,8.06,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.8,8.05551732784983
CHEMBL1773407,CC(=O)N(C)CCCc1cn(Cc2ccc(F)cc2)c2cnc3c(c12)CCN(O)C3=O,IC50,14.0,7.85,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL1773406,O=C1c2ncc3c(c(CCCN4CCOCC4)cn3Cc3ccc(F)cc3)c2CCN1O,IC50,13.0,7.89,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL1773405,O=C(O)CCc1cn(Cc2ccc(F)cc2)c2cnc3c(c12)CCN(O)C3=O,IC50,13.0,7.89,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL1773404,O=C1c2ncc3c(c(COCc4ccccc4F)cn3Cc3ccc(F)cc3)c2CCN1O,IC50,16.0,7.8,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16.0,7.795880017344075
CHEMBL1773403,O=C1c2ncc3c(c(COCCCc4ccccn4)cn3Cc3ccc(F)cc3)c2CCN1O,IC50,14.0,7.85,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL1773402,CC(C)OCCOCc1cn(Cc2ccc(F)cc2)c2cnc3c(c12)CCN(O)C3=O,IC50,17.0,7.77,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17.0,7.769551078621726
CHEMBL1773401,O=C1c2ncc3c(c(COCC4CCOCC4)cn3Cc3ccc(F)cc3)c2CCN1O,IC50,14.0,7.85,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL1773324,O=C1c2ncc3c(c(COCc4ccccn4)cn3Cc3ccc(F)cc3)c2CCN1O,IC50,11.0,7.96,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL1773323,O=C1c2ncc3c(c(COCCc4ccccn4)cn3Cc3ccc(F)cc3)c2CCN1O,IC50,12.0,7.92,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL1773322,O=C1c2ncc3c(c(CN4CCC(F)(F)C4)cn3Cc3ccc(F)cc3)c2CCN1O,IC50,11.0,7.96,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL1773321,CN(Cc1cn(Cc2ccc(F)cc2)c2cnc3c(c12)CCN(O)C3=O)CC1CC1,IC50,35.0,7.46,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35.0,7.455931955649724
CHEMBL1773320,COCCN(C)Cc1cn(Cc2ccc(F)cc2)c2cnc3c(c12)CCN(O)C3=O,IC50,26.0,7.58,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26.0,7.585026652029182
CHEMBL1773319,O=C1c2ncc3c(c(CN4CCCCC4)cn3Cc3ccc(F)cc3)c2CCN1O,IC50,15.0,7.82,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL1773318,CN(CCO)Cc1cn(Cc2ccc(F)cc2)c2cnc3c(c12)CCN(O)C3=O,IC50,15.0,7.82,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL1773317,CN(C)Cc1cn(Cc2ccc(F)cc2)c2cnc3c(c12)CCN(O)C3=O,IC50,81.0,7.09,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,81.0,7.0915149811213505
CHEMBL1773316,N#Cc1c(Cn2ccc3c4c(ncc32)C(=O)N(O)CC4)ccc(F)c1Cl,IC50,17.0,7.77,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17.0,7.769551078621726
CHEMBL1773315,N#Cc1cc(F)ccc1Cn1ccc2c3c(ncc21)C(=O)N(O)CC3,IC50,50.0,7.3,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL1773314,O=C1c2ncc3c(ccn3Cc3ncc(F)cc3F)c2CCN1O,IC50,18.0,7.75,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL1773313,O=C1c2ncc3c(ccn3Cc3ccc(F)cn3)c2CCN1O,IC50,32.0,7.5,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32.0,7.494850021680094
CHEMBL1773312,O=C1c2ncc3c(ccn3Cc3ccc(F)cc3)c2CCN1O,IC50,2.9,8.54,CHEMBL1777555,Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.9,8.537602002101044
CHEMBL1774044,O=C1c2c(c3n(c(=O)c2O)CCC3)C(=O)N1Cc1ccc(F)c(Cl)c1,IC50,10900.0,4.96,CHEMBL1775514,Inhibition of HIV1 recombinant integrase strand transfer activity expressed in Escherichia coli after 30 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10900.0,4.962573502059376
CHEMBL1774045,O=C1c2c(c3n(c(=O)c2O)CCCC3)C(=O)N1Cc1ccc(F)c(Cl)c1,IC50,9100.0,5.04,CHEMBL1775514,Inhibition of HIV1 recombinant integrase strand transfer activity expressed in Escherichia coli after 30 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9100.0,5.040958607678906
CHEMBL1774046,O=C1c2c(c3n(c(=O)c2O)CCCCC3)C(=O)N1Cc1ccc(F)c(Cl)c1,IC50,6000.0,5.22,CHEMBL1775514,Inhibition of HIV1 recombinant integrase strand transfer activity expressed in Escherichia coli after 30 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL1774047,O=C1c2c(c3n(c(=O)c2O)CCCCCC3)C(=O)N1Cc1ccc(F)c(Cl)c1,IC50,5400.0,5.27,CHEMBL1775514,Inhibition of HIV1 recombinant integrase strand transfer activity expressed in Escherichia coli after 30 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5400.0,5.267606240177031
CHEMBL1774048,O=C1c2c(c3n(c(=O)c2O)CCCCC3)C(=O)N1Cc1ccc(F)cc1,IC50,10400.0,4.98,CHEMBL1775514,Inhibition of HIV1 recombinant integrase strand transfer activity expressed in Escherichia coli after 30 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10400.0,4.982966660701219
CHEMBL1774049,O=C1c2c(c3n(c(=O)c2O)CCCCC3)C(=O)N1Cc1ccc(F)c(F)c1,IC50,6010.0,5.22,CHEMBL1775514,Inhibition of HIV1 recombinant integrase strand transfer activity expressed in Escherichia coli after 30 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6010.0,5.221125527997261
CHEMBL1774050,O=C1c2c(c3n(c(=O)c2O)CCCCC3)C(=O)N1Cc1cccc(Cl)c1F,IC50,9200.0,5.04,CHEMBL1775514,Inhibition of HIV1 recombinant integrase strand transfer activity expressed in Escherichia coli after 30 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9200.0,5.036212172654444
CHEMBL1774052,O=C1c2c(c3n(c(=O)c2O)CCCCC3)C(=O)N1Cc1cccc2ccccc12,IC50,90500.0,4.04,CHEMBL1775514,Inhibition of HIV1 recombinant integrase strand transfer activity expressed in Escherichia coli after 30 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90500.0,4.043351420794797
CHEMBL551241,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(F)cc1,IC50,5300.0,5.28,CHEMBL1775514,Inhibition of HIV1 recombinant integrase strand transfer activity expressed in Escherichia coli after 30 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5300.0,5.275724130399211
CHEMBL562366,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1ccc(F)c(F)c1,IC50,140.0,6.85,CHEMBL1775514,Inhibition of HIV1 recombinant integrase strand transfer activity expressed in Escherichia coli after 30 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,140.0,6.853871964321762
CHEMBL556473,O=C1c2ccc(O)c(O)c2C(=O)N1Cc1cccc(Cl)c1F,IC50,1700.0,5.77,CHEMBL1775514,Inhibition of HIV1 recombinant integrase strand transfer activity expressed in Escherichia coli after 30 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,4500.0,,CHEMBL1775515,Inhibition of HIV1 recombinant integrase 3'-processing activity expressed in Escherichia coli after 60 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis in presence of cofactor magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4500.0,5.346787486224656
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,4500.0,,CHEMBL1775516,Inhibition of HIV1 recombinant integrase 3'-processing activity expressed in Escherichia coli after 60 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis in presence of cofactor manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4500.0,5.346787486224656
CHEMBL1774045,O=C1c2c(c3n(c(=O)c2O)CCCC3)C(=O)N1Cc1ccc(F)c(Cl)c1,IC50,28000.0,4.55,CHEMBL1775516,Inhibition of HIV1 recombinant integrase 3'-processing activity expressed in Escherichia coli after 60 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis in presence of cofactor manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL1774045,O=C1c2c(c3n(c(=O)c2O)CCCC3)C(=O)N1Cc1ccc(F)c(Cl)c1,IC50,9100.0,5.04,CHEMBL1775517,Inhibition of HIV1 recombinant integrase strand transfer activity expressed in Escherichia coli after 60 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis in presence of cofactor magnesium,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9100.0,5.040958607678906
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,74.0,7.13,CHEMBL1776829,Inhibition of HIV1 recombinant integrase strand transfer activity expressed in Escherichia coli after 60 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis in presence of cofactor manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,74.0,7.130768280269024
CHEMBL1774045,O=C1c2c(c3n(c(=O)c2O)CCCC3)C(=O)N1Cc1ccc(F)c(Cl)c1,IC50,1200.0,5.92,CHEMBL1776829,Inhibition of HIV1 recombinant integrase strand transfer activity expressed in Escherichia coli after 60 mins using [32P]-labeled oligonucleotide as a substrate by densitometric analysis in presence of cofactor manganese,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL1784919,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)c(O)c3O)nc2c1O,IC50,302.0,6.52,CHEMBL1785226,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,302.0,6.51999305704285
CHEMBL36585,COC(=O)c1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O,IC50,100000.0,4.0,CHEMBL1785226,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL316892,Cc1ccc2cccc(O)c2n1,IC50,100000.0,4.0,CHEMBL1785226,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL432775,COc1ccc(/C=C/C(=O)Oc2cccc3ccc(C)nc23)cc1OC,IC50,100000.0,4.0,CHEMBL1785226,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL418303,Cc1ccc2cccc(OC(=O)/C=C/c3ccc(O)c(O)c3)c2n1,IC50,100000.0,4.0,CHEMBL1785226,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL61203,Oc1cccc2ccc(/C=C/c3ccccc3)nc12,IC50,100000.0,4.0,CHEMBL1785226,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL96959,Oc1cccc2ccc(/C=C/c3ccc4cccc(O)c4n3)nc12,IC50,100000.0,4.0,CHEMBL1785226,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL61800,O=[N+]([O-])c1cccc2ccc(/C=C/c3ccc(O)c(O)c3)nc12,IC50,100000.0,4.0,CHEMBL1785226,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL58191,Nc1cccc2ccc(/C=C/c3ccc(O)c(O)c3)nc12,IC50,100000.0,4.0,CHEMBL1785226,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL39823,Cc1ccc2ccc(C(=O)O)c(O)c2n1,IC50,100000.0,4.0,CHEMBL1785226,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1785027,Cc1cc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)ccc1O,IC50,2818.38,5.55,CHEMBL1785226,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2818.38,5.550000451689026
CHEMBL39725,Oc1ccc(/C=C/c2ccc3c(Cl)cc(Cl)c(O)c3n2)cc1O,IC50,100000.0,4.0,CHEMBL1785226,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL293788,CC(=O)Oc1cccc2ccc(/C=C/c3ccccc3)nc12,IC50,100000.0,4.0,CHEMBL1785226,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL97679,Oc1ccc(/C=C/c2ccc3ccccc3n2)cc1O,IC50,100000.0,4.0,CHEMBL1785226,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL58923,CC(=O)Oc1ccc(/C=C/c2ccc3cccc(OC(C)=O)c3n2)cc1OC(C)=O,IC50,100000.0,4.0,CHEMBL1785226,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813133,CCOC(=O)CC(=O)Nc1c(Cl)cccc1Cl,IC50,100000.0,,CHEMBL1816188,Inhibition of HIV1 recombinant integrase 3'-processing and strand transfer activity using 21-mer U5B/U5A duplex oligonucleotides after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813129,Cc1ccc(NC(=O)CC(=O)O)c([N+](=O)[O-])c1,IC50,100000.0,,CHEMBL1816188,Inhibition of HIV1 recombinant integrase 3'-processing and strand transfer activity using 21-mer U5B/U5A duplex oligonucleotides after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813128,CCOC(=O)CC(=O)NCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1816188,Inhibition of HIV1 recombinant integrase 3'-processing and strand transfer activity using 21-mer U5B/U5A duplex oligonucleotides after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1456957,CCOC(=O)CC(=O)Nc1ccc(C)cc1,IC50,50000.0,4.3,CHEMBL1816188,Inhibition of HIV1 recombinant integrase 3'-processing and strand transfer activity using 21-mer U5B/U5A duplex oligonucleotides after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL1813127,CCOC(=O)CC(=O)Nc1ccc2cccc(O)c2n1,IC50,42000.0,4.38,CHEMBL1816188,Inhibition of HIV1 recombinant integrase 3'-processing and strand transfer activity using 21-mer U5B/U5A duplex oligonucleotides after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42000.0,4.376750709602099
CHEMBL1813126,CCOC(=O)CC(=O)Nc1ccc(C(=O)O)cc1,IC50,2000.0,5.7,CHEMBL1816188,Inhibition of HIV1 recombinant integrase 3'-processing and strand transfer activity using 21-mer U5B/U5A duplex oligonucleotides after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,5.0,8.3,CHEMBL1816188,Inhibition of HIV1 recombinant integrase 3'-processing and strand transfer activity using 21-mer U5B/U5A duplex oligonucleotides after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL1682442,Cc1ccc2c(O)c(C(=O)O)ccc2n1,IC50,47000.0,4.33,CHEMBL1816189,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47000.0,4.327902142064283
CHEMBL1813372,O=C(O)c1cccc(OCc2ccc(F)cc2)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813371,O=C(O)c1cccc(OCc2ccccc2)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813373,O=C(O)c1cccc(OCc2ccc3ccccc3c2)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813374,O=C(O)c1ccc(OCc2ccccc2)cc1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813375,O=C(O)c1ccc(OCc2ccc(F)cc2)cc1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813376,O=C(O)c1cc(OCc2ccccc2)ccc1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813377,O=C(O)c1cc(OCc2ccc(F)cc2)ccc1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813378,O=C(O)c1c(O)cccc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813379,O=C(O)c1c(O)cccc1OCc1ccc2ccccc2c1,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813380,O=C(NO)c1cccc(OCc2ccc(F)cc2)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813381,O=C(NO)c1ccc(OCc2ccc(F)cc2)cc1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813382,O=C(NO)c1cc(OCc2ccc(F)cc2)ccc1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813383,O=C(NO)c1c(O)cccc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL252553,O=C(NCc1ccc(F)cc1)c1cccc(O)c1O,IC50,100000.0,4.0,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813385,O=C(NCc1cccc2ccccc12)c1cccc(O)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813386,O=C(NCc1ccc(F)c(F)c1)c1cccc(O)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813493,O=C(NCc1ccc2[nH]ccc2c1)c1cccc(O)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813494,O=C(NCCc1c[nH]c2ccccc12)c1cccc(O)c1O,IC50,100000.0,4.0,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813495,O=C(Nc1ccc2[nH]ccc2c1)c1cccc(O)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813496,O=C(NCc1cccs1)c1cccc(O)c1O,IC50,83000.0,4.08,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,83000.0,4.080921907623926
CHEMBL1813497,O=C(NCc1ccco1)c1cccc(O)c1O,IC50,90000.0,4.05,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL1813498,O=C(NCc1ccc(-c2cccs2)cc1)c1cccc(O)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813499,O=C(NC1CCNCC1)c1cccc(O)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813500,O=C(NC1CCCCC1)c1cccc(O)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813501,O=C(NCC1CCCCC1)c1cccc(O)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813502,CNC(=O)Cc1ccccc1CNC(=O)c1cccc(O)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813503,CNC(=O)c1cc(F)ccc1CNC(=O)c1cccc(O)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813505,CNS(=O)(=O)c1cc(O)c(O)c(C(=O)NCc2ccc(F)cc2)c1,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813506,CC(C)(C)NS(=O)(=O)c1cc(O)c(O)c(C(=O)NCc2ccc(F)cc2)c1,IC50,70000.0,4.16,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL1813507,O=C(NCc1ccco1)c1cc(S(=O)(=O)N2CCCCC2)cc(O)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813508,O=C(NCc1ccc(C(F)(F)F)cc1)c1cc(S(=O)(=O)N2CCCCC2)cc(O)c1O,IC50,89000.0,4.05,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,89000.0,4.050609993355088
CHEMBL1813509,O=C(NCC1CCCCC1)c1cc(S(=O)(=O)N2CCCCC2)cc(O)c1O,IC50,53000.0,4.28,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53000.0,4.275724130399211
CHEMBL1813510,O=C(NCc1cccs1)c1cc(S(=O)(=O)N2CCCCC2)cc(O)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813511,CS(=O)(=O)Nc1cc(O)c(O)c(C(=O)NCc2ccc(F)cc2)c1,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813512,CC(=O)Nc1cc(O)c(O)c(C(=O)NCc2ccc(F)cc2)c1,IC50,55000.0,4.26,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55000.0,4.259637310505756
CHEMBL1813513,N#Cc1cc(O)c(O)c(C(=O)NCc2ccc(F)cc2)c1,IC50,75000.0,4.12,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75000.0,4.1249387366083
CHEMBL1813514,CN(C)Cc1ccc(C(=O)NCc2ccc(F)cc2)c(O)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813515,CN(C)Cc1ccc(C(=O)NCc2ccco2)c(O)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813516,COc1cc(S(=O)(=O)N2CCCCC2)cc(C(=O)NCc2ccco2)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813517,Nc1cccc(C(=O)NCc2ccco2)c1O,IC50,100000.0,,CHEMBL1816562,Inhibition of wild-type HIV1 integrase 3'-processing activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813371,O=C(O)c1cccc(OCc2ccccc2)c1O,IC50,100000.0,,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813372,O=C(O)c1cccc(OCc2ccc(F)cc2)c1O,IC50,100000.0,,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813374,O=C(O)c1ccc(OCc2ccccc2)cc1O,IC50,100000.0,,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813375,O=C(O)c1ccc(OCc2ccc(F)cc2)cc1O,IC50,100000.0,,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813376,O=C(O)c1cc(OCc2ccccc2)ccc1O,IC50,100000.0,,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813377,O=C(O)c1cc(OCc2ccc(F)cc2)ccc1O,IC50,100000.0,,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813378,O=C(O)c1c(O)cccc1OCc1ccc(F)cc1,IC50,100000.0,,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813380,O=C(NO)c1cccc(OCc2ccc(F)cc2)c1O,IC50,100000.0,,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813381,O=C(NO)c1ccc(OCc2ccc(F)cc2)cc1O,IC50,100000.0,4.0,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813382,O=C(NO)c1cc(OCc2ccc(F)cc2)ccc1O,IC50,85000.0,4.07,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,85000.0,4.070581074285707
CHEMBL1813383,O=C(NO)c1c(O)cccc1OCc1ccc(F)cc1,IC50,97000.0,4.01,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,97000.0,4.013228265733755
CHEMBL252553,O=C(NCc1ccc(F)cc1)c1cccc(O)c1O,IC50,35000.0,4.46,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL1813385,O=C(NCc1cccc2ccccc12)c1cccc(O)c1O,IC50,26000.0,4.58,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26000.0,4.585026652029182
CHEMBL1813386,O=C(NCc1ccc(F)c(F)c1)c1cccc(O)c1O,IC50,23000.0,4.64,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL1813493,O=C(NCc1ccc2[nH]ccc2c1)c1cccc(O)c1O,IC50,24000.0,4.62,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL1813494,O=C(NCCc1c[nH]c2ccccc12)c1cccc(O)c1O,IC50,100000.0,4.0,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813495,O=C(Nc1ccc2[nH]ccc2c1)c1cccc(O)c1O,IC50,58000.0,4.24,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58000.0,4.236572006437063
CHEMBL1813496,O=C(NCc1cccs1)c1cccc(O)c1O,IC50,12000.0,4.92,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL1813497,O=C(NCc1ccco1)c1cccc(O)c1O,IC50,15000.0,4.82,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL1813498,O=C(NCc1ccc(-c2cccs2)cc1)c1cccc(O)c1O,IC50,21000.0,4.68,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL1813499,O=C(NC1CCNCC1)c1cccc(O)c1O,IC50,100000.0,,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813500,O=C(NC1CCCCC1)c1cccc(O)c1O,IC50,100000.0,,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813501,O=C(NCC1CCCCC1)c1cccc(O)c1O,IC50,18000.0,4.75,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL1813502,CNC(=O)Cc1ccccc1CNC(=O)c1cccc(O)c1O,IC50,56000.0,4.25,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL1813503,CNC(=O)c1cc(F)ccc1CNC(=O)c1cccc(O)c1O,IC50,100000.0,4.0,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813504,O=C(NCc1ccc(F)cc1)c1cc(S(=O)(=O)N2CCCCC2)cc(O)c1O,IC50,5000.0,5.3,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL1813505,CNS(=O)(=O)c1cc(O)c(O)c(C(=O)NCc2ccc(F)cc2)c1,IC50,44000.0,4.36,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44000.0,4.356547323513812
CHEMBL1813506,CC(C)(C)NS(=O)(=O)c1cc(O)c(O)c(C(=O)NCc2ccc(F)cc2)c1,IC50,8000.0,5.1,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL1813507,O=C(NCc1ccco1)c1cc(S(=O)(=O)N2CCCCC2)cc(O)c1O,IC50,13000.0,4.89,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL1813508,O=C(NCc1ccc(C(F)(F)F)cc1)c1cc(S(=O)(=O)N2CCCCC2)cc(O)c1O,IC50,11000.0,4.96,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL1813509,O=C(NCC1CCCCC1)c1cc(S(=O)(=O)N2CCCCC2)cc(O)c1O,IC50,19000.0,4.72,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL1813510,O=C(NCc1cccs1)c1cc(S(=O)(=O)N2CCCCC2)cc(O)c1O,IC50,44000.0,4.36,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44000.0,4.356547323513812
CHEMBL1813511,CS(=O)(=O)Nc1cc(O)c(O)c(C(=O)NCc2ccc(F)cc2)c1,IC50,34000.0,4.47,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34000.0,4.468521082957745
CHEMBL1813512,CC(=O)Nc1cc(O)c(O)c(C(=O)NCc2ccc(F)cc2)c1,IC50,14000.0,4.85,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL1813513,N#Cc1cc(O)c(O)c(C(=O)NCc2ccc(F)cc2)c1,IC50,22000.0,4.66,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL1813514,CN(C)Cc1ccc(C(=O)NCc2ccc(F)cc2)c(O)c1O,IC50,20000.0,4.7,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1813515,CN(C)Cc1ccc(C(=O)NCc2ccco2)c(O)c1O,IC50,39000.0,4.41,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39000.0,4.4089353929735005
CHEMBL1813516,COc1cc(S(=O)(=O)N2CCCCC2)cc(C(=O)NCc2ccco2)c1O,IC50,100000.0,,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1813517,Nc1cccc(C(=O)NCc2ccco2)c1O,IC50,100000.0,,CHEMBL1816563,Inhibition of wild-type HIV1 integrase strand transfer activity using [32P]-5'-end-labeled 5'-ACTGCTAGAGATTTTCCACAC-3' as substrate after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1909981,O=C(C1=C(O)C(=O)N(c2ccccc2)C1c1ccc([N+](=O)[O-])cc1)c1ccccc1,IC50,44000.0,4.36,CHEMBL1912792,Inhibition of HIV1 integrase-mediated single strand tansfer of viral DNA after 30 mins by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44000.0,4.356547323513812
CHEMBL1909981,O=C(C1=C(O)C(=O)N(c2ccccc2)C1c1ccc([N+](=O)[O-])cc1)c1ccccc1,IC50,89000.0,4.05,CHEMBL1912791,Inhibition of HIV1 integrase-mediated 3' processing of viral DNA after 30 mins by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,89000.0,4.050609993355088
CHEMBL1909980,COc1ccc(CCN2C(=O)C(O)=C(C(=O)c3ccccc3)C2c2ccccc2)cc1,IC50,80000.0,4.1,CHEMBL1912791,Inhibition of HIV1 integrase-mediated 3' processing of viral DNA after 30 mins by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL1909980,COc1ccc(CCN2C(=O)C(O)=C(C(=O)c3ccccc3)C2c2ccccc2)cc1,IC50,45000.0,4.35,CHEMBL1912792,Inhibition of HIV1 integrase-mediated single strand tansfer of viral DNA after 30 mins by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45000.0,4.346787486224656
CHEMBL1909979,COc1ccc(CCN2C(=O)C(O)=C(C(=O)c3ccccn3)C2c2cccc(Cl)c2)cc1,IC50,77000.0,4.11,CHEMBL1912791,Inhibition of HIV1 integrase-mediated 3' processing of viral DNA after 30 mins by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,77000.0,4.113509274827518
CHEMBL1909979,COc1ccc(CCN2C(=O)C(O)=C(C(=O)c3ccccn3)C2c2cccc(Cl)c2)cc1,IC50,40000.0,4.4,CHEMBL1912792,Inhibition of HIV1 integrase-mediated single strand tansfer of viral DNA after 30 mins by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL1909978,CN1C(=O)C(O)=C(C(=O)c2ccccn2)C1c1cccc(Cl)c1,IC50,100000.0,,CHEMBL1912791,Inhibition of HIV1 integrase-mediated 3' processing of viral DNA after 30 mins by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1909978,CN1C(=O)C(O)=C(C(=O)c2ccccn2)C1c1cccc(Cl)c1,IC50,100000.0,,CHEMBL1912792,Inhibition of HIV1 integrase-mediated single strand tansfer of viral DNA after 30 mins by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1909977,COc1ccc(CCN2C(=O)C(O)=C(C(=O)c3ccccc3)C2c2ccc(O)cc2)cc1,IC50,100000.0,,CHEMBL1912791,Inhibition of HIV1 integrase-mediated 3' processing of viral DNA after 30 mins by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1909977,COc1ccc(CCN2C(=O)C(O)=C(C(=O)c3ccccc3)C2c2ccc(O)cc2)cc1,IC50,100000.0,4.0,CHEMBL1912792,Inhibition of HIV1 integrase-mediated single strand tansfer of viral DNA after 30 mins by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1909976,CN1C(=O)C(O)=C(C(=O)c2ccccc2)C1c1cccc(Cl)c1,IC50,100000.0,,CHEMBL1912791,Inhibition of HIV1 integrase-mediated 3' processing of viral DNA after 30 mins by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1909976,CN1C(=O)C(O)=C(C(=O)c2ccccc2)C1c1cccc(Cl)c1,IC50,100000.0,,CHEMBL1912792,Inhibition of HIV1 integrase-mediated single strand tansfer of viral DNA after 30 mins by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1605092,CN1C(=O)C(O)=C(C(=O)c2ccccc2)C1c1ccc([N+](=O)[O-])cc1,IC50,100000.0,,CHEMBL1912791,Inhibition of HIV1 integrase-mediated 3' processing of viral DNA after 30 mins by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1605092,CN1C(=O)C(O)=C(C(=O)c2ccccc2)C1c1ccc([N+](=O)[O-])cc1,IC50,100000.0,,CHEMBL1912792,Inhibition of HIV1 integrase-mediated single strand tansfer of viral DNA after 30 mins by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1909982,CC(C)CN1C(=O)C(O)=C(C(=O)c2ccccc2)C1c1ccccc1,IC50,100000.0,,CHEMBL1912791,Inhibition of HIV1 integrase-mediated 3' processing of viral DNA after 30 mins by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1909982,CC(C)CN1C(=O)C(O)=C(C(=O)c2ccccc2)C1c1ccccc1,IC50,100000.0,,CHEMBL1912792,Inhibition of HIV1 integrase-mediated single strand tansfer of viral DNA after 30 mins by PAGE,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1917872,O=C(NCc1ccc(F)cc1)c1c(O)c2ncccc2[nH]c1=O,IC50,13.0,7.89,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL1917873,CC(C)n1c(=O)c(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc21,IC50,1.0,9.0,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1.0,9.0
CHEMBL1917874,O=C(NCc1ccc(F)cc1)c1c(O)c2ncccc2n(C2CCCC2)c1=O,IC50,6.0,8.22,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL1917875,O=C(NCc1ccc(F)cc1)c1c(O)c2ncc(Cc3ccccc3)cc2[nH]c1=O,IC50,13.0,7.89,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL1917876,O=C(NCc1ccc(F)cc1)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,6.0,8.22,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL1917877,O=C(NCc1ccc(F)cc1Cl)c1c(O)c2ncc(Cc3ccccc3)cc2[nH]c1=O,IC50,35.0,7.46,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35.0,7.455931955649724
CHEMBL1914550,O=C(NCc1ccc(F)cc1C(F)(F)F)c1c(O)c2ncc(Cc3ccccc3)cc2[nH]c1=O,IC50,32.0,7.5,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32.0,7.494850021680094
CHEMBL1914551,COc1ccc(CNC(=O)c2c(O)c3ncc(Cc4ccc(F)cc4)cc3[nH]c2=O)cc1,IC50,7.0,8.15,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL1914552,COc1cccc(CNC(=O)c2c(O)c3ncc(Cc4ccc(F)cc4)cc3[nH]c2=O)c1,IC50,10.0,8.0,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL1914553,COc1ccccc1CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,6.0,8.22,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL1914554,COc1ccc(CNC(=O)c2c(O)c3ncc(Cc4ccc(F)cc4)cc3[nH]c2=O)cc1OC,IC50,8.0,8.1,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL1914555,CC(NC(=O)c1c(O)c2ncc(Cc3ccccc3)cc2[nH]c1=O)c1ccccc1,IC50,20.0,7.7,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL1914556,Cn1c(=O)c(C(=O)NCc2ccc(F)cc2)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,17.0,7.77,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17.0,7.769551078621726
CHEMBL1914557,CCCn1c(=O)c(C(=O)NCc2ccc(F)cc2)c(O)c2ncc(Cc3ccccc3)cc21,IC50,18.0,7.75,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL1914558,O=C(NCc1ccc(F)cc1)c1c(O)c2ncc(Cc3ccccc3)cc2n(CC2CC2)c1=O,IC50,34.0,7.47,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34.0,7.468521082957745
CHEMBL1914559,Nc1ccc(Cn2c(=O)c(C(=O)NCc3ccc(F)cc3)c(O)c3ncc(Cc4ccccc4)cc32)cc1,IC50,28.0,7.55,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28.0,7.552841968657781
CHEMBL1914560,CS(=O)(=O)c1ccc(Cn2c(=O)c(C(=O)NCc3ccc(F)cc3)c(O)c3ncc(Cc4ccccc4)cc32)cc1,IC50,28.0,7.55,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28.0,7.552841968657781
CHEMBL1914561,O=C(NCc1ccc(F)cc1)c1c(O)c2ncc(Cc3ccccc3)cc2n(CCN2CCCC2=O)c1=O,IC50,32.0,7.5,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32.0,7.494850021680094
CHEMBL1914562,O=C(NCc1ccc(F)cc1)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CCN2CCCC2=O)c1=O,IC50,14.0,7.85,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL1914460,CN(C)C(=O)Cn1c(=O)c(C(=O)NCc2ccc(F)cc2)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,4.0,8.4,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL1914563,O=C(NCc1ccc(F)cc1)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)N2CCCCC2)c1=O,IC50,19.0,7.72,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19.0,7.721246399047171
CHEMBL1914564,O=C(NCc1ccc(F)cc1)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)N2CCOCC2)c1=O,IC50,8.0,8.1,CHEMBL1918322,Inhibition of HIV1 integrase strand transfer by biochemical assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL1928158,COc1ccc(/C(O)=C/C(=O)c2nnn(Cc3ccc(F)cc3)c2C)cc1,IC50,54000.0,,CHEMBL1930715,Inhibition of Human immunodeficiency virus 1 integrase-mediated strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54000.0,4.267606240177032
CHEMBL1928157,Cc1c(C(=O)/C=C(\O)c2ccccc2)nnn1Cc1ccc(F)cc1,IC50,59000.0,,CHEMBL1930715,Inhibition of Human immunodeficiency virus 1 integrase-mediated strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,59000.0,4.229147988357856
CHEMBL1928159,COc1ccc(/C(O)=C/C(=O)c2nnn(Cc3ccc(F)cc3)c2C)cc1OC,IC50,50000.0,,CHEMBL1930715,Inhibition of Human immunodeficiency virus 1 integrase-mediated strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL1928160,COc1cc(/C(O)=C/C(=O)c2nnn(Cc3ccc(F)cc3)c2C)cc(OC)c1OC,IC50,47000.0,,CHEMBL1930715,Inhibition of Human immunodeficiency virus 1 integrase-mediated strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47000.0,4.327902142064283
CHEMBL1928161,Cc1c(C(=O)/C=C(\O)c2ccccc2)nnn1Cc1cccc(F)c1,IC50,59000.0,,CHEMBL1930715,Inhibition of Human immunodeficiency virus 1 integrase-mediated strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,59000.0,4.229147988357856
CHEMBL1928162,COc1ccc(/C(O)=C/C(=O)c2nnn(Cc3cccc(F)c3)c2C)cc1,IC50,54000.0,,CHEMBL1930715,Inhibition of Human immunodeficiency virus 1 integrase-mediated strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54000.0,4.267606240177032
CHEMBL1928163,COc1ccc(/C(O)=C/C(=O)c2nnn(Cc3cccc(F)c3)c2C)cc1OC,IC50,50000.0,,CHEMBL1930715,Inhibition of Human immunodeficiency virus 1 integrase-mediated strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL1928164,COc1cc(/C(O)=C/C(=O)c2nnn(Cc3cccc(F)c3)c2C)cc(OC)c1OC,IC50,47000.0,,CHEMBL1930715,Inhibition of Human immunodeficiency virus 1 integrase-mediated strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47000.0,4.327902142064283
CHEMBL1928165,Cc1c(C(=O)/C=C(\O)c2ccc(O)cc2)nnn1Cc1ccc(F)cc1,IC50,56000.0,,CHEMBL1930715,Inhibition of Human immunodeficiency virus 1 integrase-mediated strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL1928166,Cc1c(C(=O)/C=C(\O)c2ccc(O)c(O)c2)nnn1Cc1ccc(F)cc1,IC50,40000.0,4.4,CHEMBL1930715,Inhibition of Human immunodeficiency virus 1 integrase-mediated strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL1928167,Cc1c(C(=O)/C=C(\O)c2cc(O)c(O)c(O)c2)nnn1Cc1ccc(F)cc1,IC50,2600.0,5.58,CHEMBL1930715,Inhibition of Human immunodeficiency virus 1 integrase-mediated strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2600.0,5.585026652029182
CHEMBL1928168,Cc1c(C(=O)/C=C(\O)c2ccc(O)cc2)nnn1Cc1cccc(F)c1,IC50,56000.0,,CHEMBL1930715,Inhibition of Human immunodeficiency virus 1 integrase-mediated strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL1928169,Cc1c(C(=O)/C=C(\O)c2ccc(O)c(O)c2)nnn1Cc1cccc(F)c1,IC50,32000.0,4.5,CHEMBL1930715,Inhibition of Human immunodeficiency virus 1 integrase-mediated strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL1928170,Cc1c(C(=O)/C=C(\O)c2cc(O)c(O)c(O)c2)nnn1Cc1cccc(F)c1,IC50,780.0,6.11,CHEMBL1930715,Inhibition of Human immunodeficiency virus 1 integrase-mediated strand transfer activity after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,780.0,6.107905397309519
CHEMBL2011784,Cc1cn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OCCCCCCNC(=S)Nc3ccc(-c4c5cc(Br)c(=O)c(Br)c-5oc5c(Br)c(O)c(Br)cc45)c(C(=O)O)c3)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3CO)O2)c(=O)[nH]c1=O,IC50,50.0,7.3,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL2011785,Cc1cn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3O)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@@H]3C[C@@H](CO)N(C(=O)CCCCCNC(=O)c4ccc(C(=O)O)c(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c4)C3)O2)c(=O)[nH]c1=O,IC50,320.0,6.5,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,320.0,6.494850021680094
CHEMBL2011786,Cc1cn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3O)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)OCCCCCCNC(=O)c3ccc(C(=O)O)c(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c3)O2)c(=O)[nH]c1=O,IC50,310.0,6.51,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,310.0,6.508638306165727
CHEMBL2011787,Cc1cn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OCCCCCCNC(=S)Nc3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3CO)O2)c(=O)[nH]c1=O,IC50,315.0,6.5,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,315.0,6.501689446210399
CHEMBL2011881,Cc1cn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3O)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)OCCCCCCNC(=O)c3cc(Cl)c(C(=O)O)c(-c4c5cc(Cl)c(=O)c(Cl)c-5oc5c(Cl)c(O)c(Cl)cc45)c3Cl)O2)c(=O)[nH]c1=O,IC50,55.0,7.26,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55.0,7.259637310505756
CHEMBL2011882,Cc1cn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3O)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)OCCCCCCNC(=O)c3cc(Cl)c(-c4c5cc(Cl)c(O)c(Cl)c5nc5c(Cl)c(O)c(Cl)cc45)c(C(=O)O)c3Cl)O2)c(=O)[nH]c1=O,IC50,52.0,7.28,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52.0,7.2839966563652006
CHEMBL2011883,Cc1cn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3O)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)OCCCCCCNC(=O)c3cc(Cl)c(C(=O)O)c(-c4c5cc(Cl)c(=O)cc-5oc5cc(O)c(Cl)cc45)c3Cl)O2)c(=O)[nH]c1=O,IC50,290.0,6.54,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,290.0,6.537602002101044
CHEMBL2011884,COc1cc2c(-c3cc(C(=O)NCCCCCCOP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(=O)[nH]c(N)nc65)C[C@@H]4OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(=O)[nH]c(N)nc65)C[C@@H]4OP(=O)(O)OC[C@H]4O[C@@H](n5cc(C)c(=O)[nH]c5=O)C[C@@H]4OP(=O)(O)OC[C@H]4O[C@@H](n5cc(C)c(=O)[nH]c5=O)C[C@@H]4OP(=O)(O)OC[C@H]4O[C@@H](n5cc(C)c(=O)[nH]c5=O)C[C@@H]4OP(=O)(O)OC[C@H]4O[C@@H](n5cc(C)c(=O)[nH]c5=O)C[C@@H]4OP(=O)(O)OC[C@H]4O[C@@H](n5cc(C)c(=O)[nH]c5=O)C[C@@H]4OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(=O)[nH]c(N)nc65)C[C@@H]4OP(=O)(O)OC[C@H]4O[C@@H](n5cc(C)c(=O)[nH]c5=O)C[C@@H]4OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(=O)[nH]c(N)nc65)C[C@@H]4OP(=O)(O)OC[C@H]4O[C@@H](n5cc(C)c(=O)[nH]c5=O)C[C@@H]4O)ccc3C(=O)O)c3cc(OC)c(=O)c(Cl)c-3oc2c(Cl)c1O,IC50,310.0,6.51,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,310.0,6.508638306165727
CHEMBL2011885,CCCCCCCC/C=C\CCCCCCCC(=O)NCCCOCC(O)COP(=O)(O)O[C@H]1C[C@H](n2cc(C)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cnc3c(=O)[nH]c(N)nc32)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cc(C)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cnc3c(=O)[nH]c(N)nc32)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cc(C)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cc(C)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cc(C)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cc(C)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cc(C)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cnc3c(=O)[nH]c(N)nc32)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cnc3c(=O)[nH]c(N)nc32)O[C@@H]1CO,IC50,200.0,6.7,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL2011886,CCCCCCCC/C=C\CCCCCCCC(=O)NCCCOCC(O)COP(=O)(O)O[C@H]1C[C@H](n2cc(C)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cnc3c(=O)[nH]c(N)nc32)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cc(C)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cnc3c(=O)[nH]c(N)nc32)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cc(C)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cc(C)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cc(C)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cc(C)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cc(C)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cnc3c(=O)[nH]c(N)nc32)O[C@@H]1COP(=O)(O)O[C@H]1C[C@H](n2cnc3c(=O)[nH]c(N)nc32)O[C@@H]1COP(=O)(O)O[C@@H]1C[C@@H](CO)N(C(=O)CCCCCNC(=O)c2ccc(C(=O)O)c(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c2)C1,IC50,20.0,7.7,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL2012007,CCCCCCCC/C=C\CCCCCCCC(=O)NCCCOCC(O)COP(=O)(O)O[C@@H]1C[C@@H](COP(=O)(O)O[C@H]2C[C@H](n3cc(C)c(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O[C@H]2C[C@H](n3cnc4c(=O)[nH]c(N)nc43)O[C@@H]2COP(=O)(O)O[C@H]2C[C@H](n3cc(C)c(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O[C@H]2C[C@H](n3cnc4c(=O)[nH]c(N)nc43)O[C@@H]2COP(=O)(O)O[C@H]2C[C@H](n3cc(C)c(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O[C@H]2C[C@H](n3cc(C)c(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O[C@H]2C[C@H](n3cc(C)c(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O[C@H]2C[C@H](n3cc(C)c(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O[C@H]2C[C@H](n3cc(C)c(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O[C@H]2C[C@H](n3cnc4c(=O)[nH]c(N)nc43)O[C@@H]2COP(=O)(O)O[C@H]2C[C@H](n3cnc4c(=O)[nH]c(N)nc43)O[C@@H]2CO)N(C(=O)CCCCCNC(=O)c2ccc(C(=O)O)c(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c2)C1,IC50,23.0,7.64,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23.0,7.638272163982407
CHEMBL2012008,Cc1cn([C@H]2C[C@H](OP(C)(=O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(C)(=O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(C)(=O)OCCCCCCNC(=S)Nc3ccc(-c4c5cc(Br)c(=O)c(Br)c-5oc5c(Br)c(O)c(Br)cc45)c(C(=O)O)c3)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3CO)O2)c(=O)[nH]c1=O,IC50,100.0,7.0,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL2012009,Cc1cn([C@H]2C[C@H](OP(C)(=O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(C)(=O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OCCCCCCNC(=S)Nc3ccc(-c4c5cc(Br)c(=O)c(Br)c-5oc5c(Br)c(O)c(Br)cc45)c(C(=O)O)c3)[C@@H](COP(C)(=O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3CO)O2)c(=O)[nH]c1=O,IC50,110.0,6.96,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL2012010,Cc1cn([C@H]2C[C@H](OP(C)(=O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(C)(=O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OCCCCCCNC(=S)Nc3ccc(-c4c5cc(Br)c(=O)c(Br)c-5oc5c(Br)c(O)c(Br)cc45)c(C(=O)O)c3)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(C)(=O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3CO)O2)c(=O)[nH]c1=O,IC50,100.0,7.0,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL2012011,Cc1cn([C@H]2C[C@H](OP(=O)(S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(S)OCCCCCCNC(=S)Nc3ccc(-c4c5cc(Br)c(=O)c(Br)c-5oc5c(Br)c(O)c(Br)cc45)c(C(=O)O)c3)[C@@H](COP(=O)(S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3CO)O2)c(=O)[nH]c1=O,IC50,18.0,7.75,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL2012123,Cc1cn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(S)OCCCCCCNC(=S)Nc3ccc(-c4c5cc(Br)c(=O)c(Br)c-5oc5c(Br)c(O)c(Br)cc45)c(C(=O)O)c3)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3CO)O2)c(=O)[nH]c1=O,IC50,20.0,7.7,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL2012124,Cc1cn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OCCCCCCNC(=S)Nc3ccc(-c4c5cc(Br)c(=O)c(Br)c-5oc5c(Br)c(O)c(Br)cc45)c(C(=O)O)c3)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3CO)O2)c(=O)[nH]c1=O,IC50,22.0,7.66,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22.0,7.657577319177793
CHEMBL2012125,Cc1cn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OCCCCCCNC(=S)Nc3ccc(-c4c5cc(Br)c(=O)c(Br)c-5oc5c(Br)c(O)c(Br)cc45)c(C(=O)O)c3)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3CO)O2)c(=O)[nH]c1=O,IC50,24.0,7.62,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24.0,7.619788758288394
CHEMBL2012126,Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O[C@H]3CCO[C@@H]3COP(=O)(O)O[C@H]3CCO[C@@H]3COP(=O)(O)O[C@H]3CCO[C@@H]3COP(=O)(O)O[C@H]3CCO[C@@H]3COP(=O)(O)O[C@H]3CCO[C@@H]3COP(=O)(O)O[C@H]3CCO[C@@H]3COP(=O)(O)O[C@H]3CCO[C@@H]3COP(=O)(O)O[C@H]3CCO[C@@H]3COP(=O)(O)O[C@H]3CCO[C@@H]3COP(=O)(O)O[C@H]3CCO[C@@H]3COP(=O)(O)OCCCCCCNC(=O)c3cc(Cl)c(C(=O)O)c(-c4c5cc(Cl)c(=O)c(Cl)c-5oc5c(Cl)c(O)c(Cl)cc45)c3Cl)O2)c(=O)[nH]c1=O,IC50,1200.0,5.92,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL2012127,Cc1cn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3O)[C@@H](COP(=O)(O)O[C@H]3CCO[C@@H]3COP(=O)(O)O[C@H]3CCO[C@@H]3COP(=O)(O)O[C@H]3CCO[C@@H]3COP(=O)(O)O[C@H]3CCO[C@@H]3COP(=O)(O)O[C@H]3CCO[C@@H]3COP(=O)(O)O[C@H]3CCO[C@@H]3COP(=O)(O)OCCCCCCNC(=O)c3cc(Cl)c(C(=O)O)c(-c4c5cc(Cl)c(=O)c(Cl)c-5oc5c(Cl)c(O)c(Cl)cc45)c3Cl)O2)c(=O)[nH]c1=O,IC50,280.0,6.55,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,280.0,6.552841968657781
CHEMBL2012128,Cc1cn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3OCC[C@@H]3OP(=O)(O)OC[C@H]3OCC[C@@H]3OP(=O)(O)OC[C@H]3OCC[C@@H]3OP(=O)(O)OC[C@H]3OCC[C@@H]3OP(=O)(O)OC[C@H]3OCC[C@@H]3OP(=O)(O)OC[C@H]3OCC[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3O)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)OCCCCCCNC(=O)c3cc(Cl)c(C(=O)O)c(-c4c5cc(Cl)c(=O)c(Cl)c-5oc5c(Cl)c(O)c(Cl)cc45)c3Cl)O2)c(=O)[nH]c1=O,IC50,250.0,6.6,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL2012129,Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCCCCNC(=O)c3cc(Cl)c(C(=O)O)c(-c4c5cc(Cl)c(=O)c(Cl)c-5oc5c(Cl)c(O)c(Cl)cc45)c3Cl)O2)c(=O)[nH]c1=O,IC50,1300.0,5.89,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL2012130,Cc1cn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3O)[C@@H](COP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCCCCNC(=O)c3cc(Cl)c(C(=O)O)c(-c4c5cc(Cl)c(=O)c(Cl)c-5oc5c(Cl)c(O)c(Cl)cc45)c3Cl)O2)c(=O)[nH]c1=O,IC50,250.0,6.6,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL2012131,Cc1cn([C@H]2C[C@H](OP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OCCCOP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3O)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)OCCCCCCNC(=O)c3cc(Cl)c(C(=O)O)c(-c4c5cc(Cl)c(=O)c(Cl)c-5oc5c(Cl)c(O)c(Cl)cc45)c3Cl)O2)c(=O)[nH]c1=O,IC50,310.0,6.51,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,310.0,6.508638306165727
CHEMBL2012378,CO[C@@H]1[C@H](OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](OC)[C@@H]2OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](OC)[C@@H]2OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(=O)[nH]c(N)nc43)[C@H](OC)[C@@H]2OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](OC)[C@@H]2OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(=O)[nH]c(N)nc43)[C@H](OC)[C@@H]2OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](OC)[C@@H]2OP(=O)(O)OCCCCCCNC(=S)Nc2ccc(-c3c4cc(Br)c(=O)c(Br)c-4oc4c(Br)c(O)c(Br)cc34)c(C(=O)O)c2)[C@@H](COP(=O)(O)O[C@H]2[C@@H](OC)[C@H](n3ccc(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O[C@H]2[C@@H](OC)[C@H](n3ccc(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O[C@H]2[C@@H](OC)[C@H](n3cnc4c(=O)[nH]c(N)nc43)O[C@@H]2COP(=O)(O)O[C@H]2[C@@H](OC)[C@H](n3cnc4c(=O)[nH]c(N)nc43)O[C@@H]2CO)O[C@H]1n1ccc(=O)[nH]c1=O,IC50,48.0,7.32,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48.0,7.318758762624412
CHEMBL2012379,CO[C@@H]1[C@H](O)[C@@H](COP(=O)(O)O[C@H]2[C@@H](OC)[C@H](n3cnc4c(=O)[nH]c(N)nc43)O[C@@H]2COP(=O)(O)O[C@H]2[C@@H](OC)[C@H](n3ccc(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O[C@H]2[C@@H](OC)[C@H](n3cnc4c(=O)[nH]c(N)nc43)O[C@@H]2COP(=O)(O)O[C@H]2[C@@H](OC)[C@H](n3ccc(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O[C@H]2[C@@H](OC)[C@H](n3ccc(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O[C@H]2[C@@H](OC)[C@H](n3ccc(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O[C@H]2[C@@H](OC)[C@H](n3ccc(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O[C@H]2[C@@H](OC)[C@H](n3ccc(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O[C@H]2[C@@H](OC)[C@H](n3cnc4c(=O)[nH]c(N)nc43)O[C@@H]2COP(=O)(O)O[C@H]2[C@@H](OC)[C@H](n3cnc4c(=O)[nH]c(N)nc43)O[C@@H]2COP(=O)(O)OCCCCCCNC(=O)c2cc(Cl)c(C(=O)O)c(-c3c4cc(Cl)c(=O)c(Cl)c-4oc4c(Cl)c(O)c(Cl)cc34)c2Cl)O[C@H]1n1ccc(=O)[nH]c1=O,IC50,52.0,7.28,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52.0,7.2839966563652006
CHEMBL2012380,CO[C@@H]1[C@H](O)[C@@H](COP(=O)(S)O[C@H]2[C@@H](OC)[C@H](n3cnc4c(=O)[nH]c(N)nc43)O[C@@H]2COP(=O)(S)O[C@H]2[C@@H](OC)[C@H](n3ccc(=O)[nH]c3=O)O[C@@H]2COP(=O)(S)O[C@H]2[C@@H](OC)[C@H](n3cnc4c(=O)[nH]c(N)nc43)O[C@@H]2COP(=O)(S)O[C@H]2[C@@H](OC)[C@H](n3ccc(=O)[nH]c3=O)O[C@@H]2COP(=O)(S)O[C@H]2[C@@H](OC)[C@H](n3ccc(=O)[nH]c3=O)O[C@@H]2COP(=O)(S)O[C@H]2[C@@H](OC)[C@H](n3ccc(=O)[nH]c3=O)O[C@@H]2COP(=O)(S)O[C@H]2[C@@H](OC)[C@H](n3ccc(=O)[nH]c3=O)O[C@@H]2COP(=O)(S)O[C@H]2[C@@H](OC)[C@H](n3ccc(=O)[nH]c3=O)O[C@@H]2COP(=O)(S)O[C@H]2[C@@H](OC)[C@H](n3cnc4c(=O)[nH]c(N)nc43)O[C@@H]2COP(=O)(S)O[C@H]2[C@@H](OC)[C@H](n3cnc4c(=O)[nH]c(N)nc43)O[C@@H]2COP(=O)(S)OCCCCCCNC(=O)c2cc(Cl)c(C(=O)O)c(-c3c4cc(Cl)c(=O)c(Cl)c-4oc4c(Cl)c(O)c(Cl)cc34)c2Cl)O[C@H]1n1ccc(=O)[nH]c1=O,IC50,19.0,7.72,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19.0,7.721246399047171
CHEMBL2012381,CCCCCCCC/C=C\CCCCCCCC(=O)NCCCOCC(O)COP(=O)(S)O[C@H]1[C@@H](OC)[C@H](n2ccc(=O)[nH]c2=O)O[C@@H]1COP(=O)(S)O[C@H]1[C@@H](OC)[C@H](n2cnc3c(=O)[nH]c(N)nc32)O[C@@H]1COP(=O)(S)O[C@H]1[C@@H](OC)[C@H](n2ccc(=O)[nH]c2=O)O[C@@H]1COP(=O)(S)O[C@H]1[C@@H](OC)[C@H](n2cnc3c(=O)[nH]c(N)nc32)O[C@@H]1COP(=O)(S)O[C@H]1[C@@H](OC)[C@H](n2ccc(=O)[nH]c2=O)O[C@@H]1COP(=O)(S)O[C@H]1[C@@H](OC)[C@H](n2ccc(=O)[nH]c2=O)O[C@@H]1COP(=O)(S)O[C@H]1[C@@H](OC)[C@H](n2ccc(=O)[nH]c2=O)O[C@@H]1COP(=O)(S)O[C@H]1[C@@H](OC)[C@H](n2ccc(=O)[nH]c2=O)O[C@@H]1COP(=O)(S)O[C@H]1[C@@H](OC)[C@H](n2ccc(=O)[nH]c2=O)O[C@@H]1COP(=O)(S)O[C@H]1[C@@H](OC)[C@H](n2cnc3c(=O)[nH]c(N)nc32)O[C@@H]1COP(=O)(S)O[C@H]1[C@@H](OC)[C@H](n2cnc3c(=O)[nH]c(N)nc32)O[C@@H]1COP(=O)(S)OCCCCCCNC(=O)c1cc(Cl)c(C(=O)O)c(-c2c3cc(Cl)c(=O)c(Cl)c-3oc3c(Cl)c(O)c(Cl)cc23)c1Cl,IC50,20.0,7.7,CHEMBL2015879,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity expressed in Escherichia coli using 21-mer DNA and Mg2+ after 2 hrs by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL2018722,COc1ccc(CCNC(=O)C/C(C)=N/NC(=O)c2cc3ccccc3cc2O)cc1OC,IC50,79000.0,4.1,CHEMBL2019571,Inhibition of HIV1 integrase using oligodeoxynucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,79000.0,4.102372908709558
CHEMBL2018722,COc1ccc(CCNC(=O)C/C(C)=N/NC(=O)c2cc3ccccc3cc2O)cc1OC,IC50,38400.0,4.42,CHEMBL2019572,Inhibition of GST-tagged HIV1 integrase and C-terminal His6-tagged HIV1 integrase dimerization after 3 hrs by AlphaScreen-based dimerization assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38400.0,4.4156687756324695
CHEMBL2042382,O=C(O)/C(O)=C/C(=O)c1cc(Cc2ccccc2)cn(Cc2ccccc2)c1=O,IC50,70.0,7.16,CHEMBL2046045,Inhibition of HIV1 integrase-mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL2042548,O=C(O)/C(O)=C/C(=O)c1cc(Cc2ccc(F)cc2F)cn(Cc2ccc(F)cc2F)c1=O,IC50,5.5,8.26,CHEMBL2046045,Inhibition of HIV1 integrase-mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.5,8.259637310505756
CHEMBL2043144,O=C(O)/C(O)=C/C(=O)c1cc(Cc2ccc(F)cc2F)cn(Cc2ccccc2F)c1=O,IC50,6.0,8.22,CHEMBL2046045,Inhibition of HIV1 integrase-mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL2043147,CC(C)OC(=O)/C(O)=C/C(=O)c1cc(Cc2ccc(F)cc2F)cn(Cc2ccccc2F)c1=O,IC50,475.0,,CHEMBL2046045,Inhibition of HIV1 integrase-mediated strand transfer,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,475.0,6.323306390375134
CHEMBL2087233,CC[C@H](C)[C@@H]1NC(=O)[C@H]2CSC(=N2)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC1=O,IC50,39000.0,4.41,CHEMBL2092483,Inhibition of HIV-1 integrase by colorimetry,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39000.0,4.4089353929735005
CHEMBL2171669,CN(C)C(=O)c1[nH]cc(C(=O)NCc2ccc(F)cc2)c(=O)c1O,IC50,540.0,6.27,CHEMBL2175367,Inhibition of HIV1 integrase strand transfer activity using pre-incubation and wash with Mg2+ cofactor by ELISA based microtiter plate integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,540.0,6.267606240177031
CHEMBL2171668,CNC(=O)c1[nH]cc(C(=O)NCc2ccc(F)cc2)c(=O)c1O,IC50,1300.0,5.89,CHEMBL2175367,Inhibition of HIV1 integrase strand transfer activity using pre-incubation and wash with Mg2+ cofactor by ELISA based microtiter plate integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL2171667,NC(=O)c1[nH]cc(C(=O)NCc2ccc(F)cc2)c(=O)c1O,IC50,380.0,6.42,CHEMBL2175367,Inhibition of HIV1 integrase strand transfer activity using pre-incubation and wash with Mg2+ cofactor by ELISA based microtiter plate integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,380.0,6.42021640338319
CHEMBL2171666,O=C(NCCO)c1[nH]cc(C(=O)NCc2ccc(F)cc2)c(=O)c1O,IC50,300.0,6.52,CHEMBL2175367,Inhibition of HIV1 integrase strand transfer activity using pre-incubation and wash with Mg2+ cofactor by ELISA based microtiter plate integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL2171665,COCCNC(=O)c1[nH]cc(C(=O)NCc2ccc(F)cc2)c(=O)c1O,IC50,130.0,6.89,CHEMBL2175367,Inhibition of HIV1 integrase strand transfer activity using pre-incubation and wash with Mg2+ cofactor by ELISA based microtiter plate integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL2171670,COC(=O)c1[nH]cc(C(=O)NCc2ccc(F)cc2)c(=O)c1O,IC50,18.0,7.75,CHEMBL2175367,Inhibition of HIV1 integrase strand transfer activity using pre-incubation and wash with Mg2+ cofactor by ELISA based microtiter plate integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL2171671,O=C(O)c1[nH]cc(C(=O)NCc2ccc(F)cc2)c(=O)c1O,IC50,10.0,8.0,CHEMBL2175367,Inhibition of HIV1 integrase strand transfer activity using pre-incubation and wash with Mg2+ cofactor by ELISA based microtiter plate integration assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL2180472,O=C(/C=C/c1ccccc1O)c1ccc(O)c(O)c1,IC50,3670.0,5.43,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3670.0,5.435333935747911
CHEMBL2180572,NCCNc1c(C(=O)NCc2ccc(F)cc2)nc(Br)c2cccnc12,IC50,100000.0,,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2180571,O=C(NCc1ccc(F)cc1)c1nc(Br)c2cccnc2c1NCCCNc1c(C(=O)NCc2ccc(F)cc2)nc(Br)c2cccnc12,IC50,100000.0,,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2180598,NCCCNc1c(C(=O)NCc2ccc(F)cc2)nc(Br)c2cccnc12,IC50,100000.0,,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2180597,O=C(NCc1ccc(F)cc1)c1nc(Br)c2cccnc2c1NCc1ccc(F)cc1,IC50,100000.0,,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2180594,O=C(NCc1ccc(F)cc1)c1nc(Br)c2cccnc2c1NCc1ccccc1,IC50,100000.0,,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2180593,O=C(NCc1ccc(F)cc1)c1nc(Br)c2cccnc2c1NCCO,IC50,69000.0,4.16,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69000.0,4.161150909262744
CHEMBL2180592,CNc1c(C(=O)NCc2ccc(F)cc2)nc(Br)c2cccnc12,IC50,100000.0,,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2180591,C[C@H](CO)Nc1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,200.0,6.7,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL2180590,C[C@@H](CO)Nc1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,300.0,6.52,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL2180589,O=C(NCc1ccc(F)cc1)c1nc(NCCO)c2cccnc2c1O,IC50,300.0,6.52,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL2180588,O=C(NCc1ccc(F)cc1)c1nc(NCCc2c[nH]c3ccccc23)c2cccnc2c1O,IC50,1000.0,6.0,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL2180587,O=CNCCCCCCNc1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,200.0,6.7,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL2180586,CS(=O)(=O)NCCCCCCN(c1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12)S(C)(=O)=O,IC50,700.0,6.16,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL2180585,CS(=O)(=O)NCCCN(c1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12)S(C)(=O)=O,IC50,700.0,6.16,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL414850,O=C(NCc1ccc(F)cc1)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,300.0,6.52,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,300.0,6.522878745280337
CHEMBL2180601,Cc1ccc(S(=O)(=O)Oc2c(C(=O)NCc3ccc(F)cc3)nc(Br)c3cccnc23)cc1,IC50,31000.0,4.51,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31000.0,4.508638306165727
CHEMBL2180600,CS(=O)(=O)Oc1c(C(=O)NCc2ccc(F)cc2)nc(Br)c2cccnc12,IC50,13000.0,4.89,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL2180599,O=C(NCc1ccc(F)cc1)c1nc(Br)c2cccnc2c1O,IC50,500.0,6.3,CHEMBL2185500,Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL2180572,NCCNc1c(C(=O)NCc2ccc(F)cc2)nc(Br)c2cccnc12,IC50,100000.0,,CHEMBL2185924,Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2180571,O=C(NCc1ccc(F)cc1)c1nc(Br)c2cccnc2c1NCCCNc1c(C(=O)NCc2ccc(F)cc2)nc(Br)c2cccnc12,IC50,100000.0,,CHEMBL2185924,Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2180598,NCCCNc1c(C(=O)NCc2ccc(F)cc2)nc(Br)c2cccnc12,IC50,100000.0,,CHEMBL2185924,Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2180597,O=C(NCc1ccc(F)cc1)c1nc(Br)c2cccnc2c1NCc1ccc(F)cc1,IC50,100000.0,,CHEMBL2185924,Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2180594,O=C(NCc1ccc(F)cc1)c1nc(Br)c2cccnc2c1NCc1ccccc1,IC50,100000.0,,CHEMBL2185924,Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2180593,O=C(NCc1ccc(F)cc1)c1nc(Br)c2cccnc2c1NCCO,IC50,100000.0,,CHEMBL2185924,Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2180592,CNc1c(C(=O)NCc2ccc(F)cc2)nc(Br)c2cccnc12,IC50,100000.0,,CHEMBL2185924,Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2180591,C[C@H](CO)Nc1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,6900.0,5.16,CHEMBL2185924,Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6900.0,5.161150909262744
CHEMBL2180590,C[C@@H](CO)Nc1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,7800.0,5.11,CHEMBL2185924,Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7800.0,5.107905397309519
CHEMBL2180589,O=C(NCc1ccc(F)cc1)c1nc(NCCO)c2cccnc2c1O,IC50,9500.0,5.02,CHEMBL2185924,Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9500.0,5.022276394711152
CHEMBL2180588,O=C(NCc1ccc(F)cc1)c1nc(NCCc2c[nH]c3ccccc23)c2cccnc2c1O,IC50,14000.0,4.85,CHEMBL2185924,Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL2180587,O=CNCCCCCCNc1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12,IC50,6000.0,5.22,CHEMBL2185924,Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL2180586,CS(=O)(=O)NCCCCCCN(c1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12)S(C)(=O)=O,IC50,11000.0,4.96,CHEMBL2185924,Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL2180585,CS(=O)(=O)NCCCN(c1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12)S(C)(=O)=O,IC50,34000.0,4.47,CHEMBL2185924,Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34000.0,4.468521082957745
CHEMBL414850,O=C(NCc1ccc(F)cc1)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,IC50,11000.0,4.96,CHEMBL2185924,Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL2180599,O=C(NCc1ccc(F)cc1)c1nc(Br)c2cccnc2c1O,IC50,14000.0,4.85,CHEMBL2185924,Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear oligonucleotide substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL2180481,Cc1nc2ccccc2c(-c2cc(F)c3c(c2C)CCCO3)c1[C@H](OC(C)(C)C)C(=O)O,IC50,19.0,7.72,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19.0,7.721246399047171
CHEMBL2180479,CCCC(C(=O)O)c1c(C)nc2ccc(Cl)cc2c1-c1ccccc1,IC50,1000.0,6.0,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL1230532,O=C(O)Cc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O,IC50,11650.0,4.93,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11650.0,4.933674074637962
CHEMBL324842,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,IC50,550.0,6.26,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,550.0,6.259637310505756
CHEMBL448816,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OCc6ccccc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,700.0,6.16,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL211369,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,5510.0,5.26,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5510.0,5.2588484011482155
CHEMBL506556,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cccc(C(=O)O)c6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,1140.0,5.94,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1140.0,5.943095148663527
CHEMBL449967,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,9940.0,5.0,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9940.0,5.002613615602687
CHEMBL443663,COc1cccc(CC(NC(=O)CCCC[C@]23CCC(C)(C)C[C@H]2C2=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]2(C)CC3)C(=O)O)c1OC,IC50,3220.0,5.49,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3220.0,5.492144128304169
CHEMBL448797,COc1cc(CC(NC(=O)CCCC[C@]23CCC(C)(C)C[C@H]2C2=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]2(C)CC3)C(=O)O)cc(OC)c1,IC50,1260.0,5.9,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1260.0,5.899629454882437
CHEMBL446573,COc1ccccc1CC(NC(=O)CCCC[C@]12CCC(C)(C)C[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)C(=O)O,IC50,4560.0,5.34,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4560.0,5.341035157335565
CHEMBL301567,CC1(C)CC[C@]2(CCCCC(=O)NC(Cc3ccccc3Cl)C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,650.0,6.19,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,650.0,6.187086643357144
CHEMBL2180478,O=C(NCc1cccc([N+](=O)[O-])c1)c1ccc(OCc2ccccc2)cc1O,IC50,3840.0,5.42,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3840.0,5.415668775632469
CHEMBL243619,O=C(/C=C/c1cccc(O)c1O)c1c(O)cc(O)cc1O,IC50,260.0,6.58,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,260.0,6.585026652029182
CHEMBL2180477,O=C(/C=C/c1cc(F)cc(F)c1)c1ccc(O)cc1O,IC50,1750.0,5.76,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1750.0,5.756961951313706
CHEMBL1935203,O=C(/C=C/c1ccccc1Cl)c1ccc(O)cc1O,IC50,320.0,6.5,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,320.0,6.494850021680094
CHEMBL2180476,O=C(/C=C/c1cc(O)ccc1O)c1ccc(O)cc1O,IC50,3780.0,5.42,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3780.0,5.422508200162775
CHEMBL2180475,O=C(/C=C/c1cccc(O)c1O)c1ccc(O)cc1O,IC50,1700.0,5.77,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL2180474,O=C(/C=C/c1ccccc1O)c1c(O)cc(O)cc1O,IC50,6210.0,5.21,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6210.0,5.20690839982342
CHEMBL2180473,O=C(/C=C/c1ccccc1O)c1cccc(O)c1O,IC50,1610.0,5.79,CHEMBL2185782,Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1610.0,5.79317412396815
CHEMBL2206228,CN(C)S(=O)(=O)c1ccc(-c2c(O)c(O)c3c(c2S(=O)(=O)N(C)C)CN(Cc2ccc(F)c(Cl)c2)C3=O)cc1,IC50,250.0,6.6,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL2206227,CN(C)S(=O)(=O)c1c(O)c(O)c(O)c2c1CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,260.0,6.58,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,260.0,6.585026652029182
CHEMBL2206774,CC(C)c1c(O)c(O)c2c(c1S(=O)(=O)N1CCOCC1)CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,410.0,6.39,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,410.0,6.3872161432802645
CHEMBL2206773,CC(C)c1c(O)c(O)c2c(c1S(=O)(=O)N(C)C)CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,190.0,6.72,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,190.0,6.721246399047171
CHEMBL2206772,CCCCc1c(O)c(O)c2c(c1S(=O)(=O)N(C)C)CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,2300.0,5.64,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2300.0,5.638272163982407
CHEMBL2206771,Cc1c(O)c(O)c2c(c1S(=O)(=O)N(C)C)CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,2800.0,5.55,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL2206770,CN(CC(=O)O)S(=O)(=O)c1cc(O)c(O)c2c1CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,58.0,7.24,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58.0,7.236572006437063
CHEMBL2206769,O=C(O)CNS(=O)(=O)c1cc(O)c(O)c2c1CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,80.0,7.1,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL2206768,O=C1c2c(O)c(O)cc(S(=O)(=O)N3CCOCC3)c2CN1Cc1ccc(F)c(Cl)c1,IC50,47.0,7.33,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47.0,7.327902142064282
CHEMBL2206767,NCCN1CCN(S(=O)(=O)c2cc(O)c(O)c3c2CN(Cc2ccc(F)c(Cl)c2)C3=O)CC1,IC50,190.0,6.72,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,190.0,6.721246399047171
CHEMBL2206766,CN1CCN(S(=O)(=O)c2cc(O)c(O)c3c2CN(Cc2ccc(F)c(Cl)c2)C3=O)CC1,IC50,400.0,6.4,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL2206765,O=C1c2c(O)c(O)cc(S(=O)(=O)NCc3ccccn3)c2CN1Cc1ccc(F)c(Cl)c1,IC50,370.0,6.43,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,370.0,6.431798275933005
CHEMBL2206764,O=C1c2c(O)c(O)cc(S(=O)(=O)NCCN3CCNCC3)c2CN1Cc1ccc(F)c(Cl)c1,IC50,310.0,6.51,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,310.0,6.508638306165727
CHEMBL2206763,O=C1c2c(O)c(O)cc(S(=O)(=O)NCCN3CCOCC3)c2CN1Cc1ccc(F)c(Cl)c1,IC50,320.0,6.5,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,320.0,6.494850021680094
CHEMBL2203322,CN(C)CCCNS(=O)(=O)c1cc(O)c(O)c2c1CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,240.0,6.62,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,240.0,6.619788758288394
CHEMBL2206762,O=C1c2c(O)c(O)cc(S(=O)(=O)NCCCBr)c2CN1Cc1ccc(F)c(Cl)c1,IC50,110.0,6.96,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL2206761,CCN(CC)S(=O)(=O)c1cc(O)c(O)c2c1CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,54.0,7.27,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54.0,7.267606240177031
CHEMBL2206760,CNS(=O)(=O)c1cc(O)c(O)c2c1CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,120.0,6.92,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,120.0,6.920818753952375
CHEMBL2206759,CN(C)S(=O)(=O)c1ccc(-c2cc3c(c(O)c2O)C(=O)N(Cc2ccc(F)c(Cl)c2)C3)cc1,IC50,400.0,6.4,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL2206233,O=C1c2c(cc(O)c(O)c2O)CN1Cc1ccc(F)c(Cl)c1,IC50,1500.0,5.82,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1500.0,5.823908740944319
CHEMBL2206232,O=C1c2c(cc(-c3ccccc3)c(O)c2O)CN1Cc1ccc(F)c(Cl)c1,IC50,870.0,6.06,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,870.0,6.060480747381382
CHEMBL2206231,CC(C)c1cc2c(c(O)c1O)C(=O)N(Cc1ccc(F)c(Cl)c1)C2,IC50,5400.0,5.27,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5400.0,5.267606240177031
CHEMBL2206230,CCCCc1cc2c(c(O)c1O)C(=O)N(Cc1ccc(F)c(Cl)c1)C2,IC50,6800.0,5.17,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6800.0,5.167491087293763
CHEMBL2206228,CN(C)S(=O)(=O)c1ccc(-c2c(O)c(O)c3c(c2S(=O)(=O)N(C)C)CN(Cc2ccc(F)c(Cl)c2)C3=O)cc1,IC50,35200.0,4.45,CHEMBL2215190,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35200.0,4.453457336521869
CHEMBL2206227,CN(C)S(=O)(=O)c1c(O)c(O)c(O)c2c1CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,7600.0,5.12,CHEMBL2215190,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7600.0,5.119186407719209
CHEMBL2206771,Cc1c(O)c(O)c2c(c1S(=O)(=O)N(C)C)CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,49700.0,4.3,CHEMBL2215190,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,49700.0,4.303643611266668
CHEMBL2206770,CN(CC(=O)O)S(=O)(=O)c1cc(O)c(O)c2c1CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,6900.0,5.16,CHEMBL2215190,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6900.0,5.161150909262744
CHEMBL2206769,O=C(O)CNS(=O)(=O)c1cc(O)c(O)c2c1CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,11700.0,4.93,CHEMBL2215190,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11700.0,4.931814138253839
CHEMBL2206768,O=C1c2c(O)c(O)cc(S(=O)(=O)N3CCOCC3)c2CN1Cc1ccc(F)c(Cl)c1,IC50,6800.0,5.17,CHEMBL2215190,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6800.0,5.167491087293763
CHEMBL2206767,NCCN1CCN(S(=O)(=O)c2cc(O)c(O)c3c2CN(Cc2ccc(F)c(Cl)c2)C3=O)CC1,IC50,21200.0,4.67,CHEMBL2215190,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21200.0,4.673664139071248
CHEMBL2206766,CN1CCN(S(=O)(=O)c2cc(O)c(O)c3c2CN(Cc2ccc(F)c(Cl)c2)C3=O)CC1,IC50,23000.0,4.64,CHEMBL2215190,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL2206765,O=C1c2c(O)c(O)cc(S(=O)(=O)NCc3ccccn3)c2CN1Cc1ccc(F)c(Cl)c1,IC50,23000.0,4.64,CHEMBL2215190,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL2206764,O=C1c2c(O)c(O)cc(S(=O)(=O)NCCN3CCNCC3)c2CN1Cc1ccc(F)c(Cl)c1,IC50,19300.0,4.71,CHEMBL2215190,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19300.0,4.714442690992226
CHEMBL2206763,O=C1c2c(O)c(O)cc(S(=O)(=O)NCCN3CCOCC3)c2CN1Cc1ccc(F)c(Cl)c1,IC50,30200.0,4.52,CHEMBL2215190,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30200.0,4.519993057042849
CHEMBL2203322,CN(C)CCCNS(=O)(=O)c1cc(O)c(O)c2c1CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,15900.0,4.8,CHEMBL2215190,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15900.0,4.798602875679548
CHEMBL2206762,O=C1c2c(O)c(O)cc(S(=O)(=O)NCCCBr)c2CN1Cc1ccc(F)c(Cl)c1,IC50,14700.0,4.83,CHEMBL2215190,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14700.0,4.8326826652518236
CHEMBL2206761,CCN(CC)S(=O)(=O)c1cc(O)c(O)c2c1CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,9500.0,5.02,CHEMBL2215190,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9500.0,5.022276394711152
CHEMBL2206760,CNS(=O)(=O)c1cc(O)c(O)c2c1CN(Cc1ccc(F)c(Cl)c1)C2=O,IC50,17500.0,4.76,CHEMBL2215190,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17500.0,4.756961951313706
CHEMBL2206233,O=C1c2c(cc(O)c(O)c2O)CN1Cc1ccc(F)c(Cl)c1,IC50,36000.0,4.44,CHEMBL2215190,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36000.0,4.443697499232713
CHEMBL2206229,Cc1cc2c(c(O)c1O)C(=O)N(Cc1ccc(F)c(Cl)c1)C2,IC50,11500.0,4.94,CHEMBL2215189,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-labeled oligonucleotide a substrate after 30 mins by electrophoretic analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11500.0,4.939302159646388
CHEMBL2216808,O=C(Nc1ccc(O)cc1)C(=S)NN1C(=O)/C(=C\c2cc(I)cc(I)c2O)SC1=S,IC50,3000.0,5.52,CHEMBL2217228,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL2216808,O=C(Nc1ccc(O)cc1)C(=S)NN1C(=O)/C(=C\c2cc(I)cc(I)c2O)SC1=S,IC50,7000.0,5.16,CHEMBL2217215,Inhibition of HIV1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL459074,COc1ccc(C(=O)C2=NS(=O)(=O)c3cc(C)c(Cl)cc3S2)cc1,IC50,12000.0,4.92,CHEMBL3070866,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity using [32P]5'end-labeled linear 21 mer as substrate incubated for 30 min prior to substrate addition measured after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL2297147,CC(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,140.0,6.85,CHEMBL3070866,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity using [32P]5'end-labeled linear 21 mer as substrate incubated for 30 min prior to substrate addition measured after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,140.0,6.853871964321762
CHEMBL2297146,Cc1cc2c(cc1Cl)SC(C(=O)c1ccc(F)cc1)=NS2(=O)=O,IC50,42000.0,4.38,CHEMBL3070866,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity using [32P]5'end-labeled linear 21 mer as substrate incubated for 30 min prior to substrate addition measured after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42000.0,4.376750709602099
CHEMBL2297144,O=S(=O)(/C=C/c1ccc(O)c(O)c1O)CS(=O)(=O)/C=C/c1ccc(O)c(O)c1O,IC50,900.0,6.05,CHEMBL3070866,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity using [32P]5'end-labeled linear 21 mer as substrate incubated for 30 min prior to substrate addition measured after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL2297143,Cc1ccc(-n2ncnc2-c2nc3ccccc3nc2NS(=O)(=O)c2cc(C(=O)Nc3ccccc3)c(Cl)cc2S)cc1,IC50,10000.0,5.0,CHEMBL3070866,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity using [32P]5'end-labeled linear 21 mer as substrate incubated for 30 min prior to substrate addition measured after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL2297149,NNS(=O)(=O)c1cccc(OCC(=O)O)c1,IC50,8700.0,5.06,CHEMBL3070866,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity using [32P]5'end-labeled linear 21 mer as substrate incubated for 30 min prior to substrate addition measured after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8700.0,5.060480747381382
CHEMBL131784,Cc1cc(S(=O)(=O)Nc2nnc3c4scc(C)c4ncn23)c(S)cc1Cl,IC50,4260.0,5.37,CHEMBL3070866,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity using [32P]5'end-labeled linear 21 mer as substrate incubated for 30 min prior to substrate addition measured after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4260.0,5.370590400897282
CHEMBL2297148,O=C1NC(=S)SC1NS(=O)(=O)c1ccc(/N=N/c2ncccn2)cc1,IC50,14120.0,4.85,CHEMBL3070866,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity using [32P]5'end-labeled linear 21 mer as substrate incubated for 30 min prior to substrate addition measured after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14120.0,4.850165303284215
CHEMBL129147,Cc1cc2nc3nc(N)nc(NS(=O)(=O)c4cc(C)c(Cl)cc4S)n3c2cc1C,IC50,7410.0,5.13,CHEMBL3070866,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity using [32P]5'end-labeled linear 21 mer as substrate incubated for 30 min prior to substrate addition measured after 1 hr,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7410.0,5.130181792020672
CHEMBL2315832,CN(CCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(C)c1=O)S(C)(=O)=O,IC50,5.0,8.3,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL2315831,CC(=O)NCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(C)c1=O,IC50,5.0,8.3,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL2315830,Cn1c(=O)c(C(=O)NCCN2CCNC2=O)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,5.0,8.3,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL2315829,Cn1c(=O)c(C(=O)NCCN2CCOCC2)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,13.0,7.89,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL2315828,Cn1c(=O)c(C(=O)NCCCN2CCCC2=O)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,16.0,7.8,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16.0,7.795880017344075
CHEMBL2316128,Cn1c(=O)c(C(=O)NCCCN2CCCC2)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,6.0,8.22,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL2316127,C[C@H](CO)CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(C)c1=O,IC50,4.0,8.4,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL2316126,C[C@@H](CO)CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(C)c1=O,IC50,3.0,8.52,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL2316125,C[C@H](O)CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(C)c1=O,IC50,2.0,8.7,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL2316124,Cn1c(=O)c(C(=O)NC2(CO)CCCC2)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,7.0,8.15,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL2316123,Cn1c(=O)c(C(=O)NC(C)(C)CO)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,6.0,8.22,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL2316122,C[C@@H](CO)NC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(C)c1=O,IC50,4.0,8.4,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL2316121,C[C@H](CO)NC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(C)c1=O,IC50,8.0,8.1,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL2316120,Cn1c(=O)c(C(=O)NCCCO)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,5.0,8.3,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL491347,COCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(C)c1=O,IC50,4.0,8.4,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL2316119,Cn1c(=O)c(C(=O)NCC(F)F)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,5.0,8.3,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL491336,CCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(C)c1=O,IC50,4.0,8.4,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL522802,CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(C)c1=O,IC50,4.0,8.4,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL2316118,CC(C)(CO)CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,4.0,8.4,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL2316117,C[C@@H](O)CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,6.0,8.22,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL2311585,C[C@H](O)CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,3.0,8.52,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL2316116,CC(C)(CO)NC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,3.0,8.52,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL2316115,C[C@@H](CO)NC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,4.0,8.4,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL2316114,C[C@H](CO)NC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,5.0,8.3,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL2316113,CSCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,5.0,8.3,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL2316112,O=C(NC1CCS(=O)(=O)CC1)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,9.0,8.05,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL2316111,CN(CCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O)S(C)(=O)=O,IC50,4.0,8.4,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL2316139,CN1CCN(CCCNC(=O)c2c(O)c3ncc(Cc4ccc(F)cc4)cc3[nH]c2=O)CC1,IC50,11.0,7.96,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL2316138,O=C(NCCCN1CCOCC1)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,8.0,8.1,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL2316137,O=C(NCCN1CCOCC1)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,7.0,8.15,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL2316136,O=C(NCCCN1CCCC1=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,4.0,8.4,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL2316135,O=C(NCCCN1CCCC1)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,23.0,7.64,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23.0,7.638272163982407
CHEMBL2316134,O=C(NCCN1CCCCC1)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,14.0,7.85,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL2316133,O=C(NCCCO)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,11.0,7.96,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL2316132,O=C(NCCO)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,5.0,8.3,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL2316131,CC(C)OCCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,9.0,8.05,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL2316130,CCOCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,9.0,8.05,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL492188,COCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,5.0,8.3,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL2316129,CC(C)CCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,5.0,8.3,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL521793,CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,6.0,8.22,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL491538,NC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2[nH]c1=O,IC50,45.0,7.35,CHEMBL2318645,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45.0,7.346787486224656
CHEMBL2311912,C=CC/N=c1/scc(-c2ccccc2Br)n1/N=C/c1ccccn1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311911,CC/N=c1/scc(-c2cc(OC)ccc2OC)n1/N=C(\C)c1ccco1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311910,COCC/N=c1/scc(-c2cccs2)n1/N=C/c1cc(Br)c(O)c(OC)c1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1976649,COc1ccccc1N1CCN(/N=C/c2ccc(Cl)c([N+](=O)[O-])c2)CC1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311908,Cn1cccc1/C=N/N1CCN(Cc2ccccc2)CC1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311906,C/C(=N\N1CCN(Cc2ccccc2Cl)CC1)c1ccc([N+](=O)[O-])cc1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311904,FC(F)(F)c1ccccc1/C=N/N1CCN(Cc2ccccc2)CC1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311903,Cc1ccc(N/N=C2\Sc3ccccc3C2=O)cc1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311898,CC(=O)c1ccc(/N=N/c2ccc(C[P+](c3ccccc3)(c3ccccc3)c3ccccc3)cc2)cc1.[Br-],IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311897,CN(C)c1ccc(/N=N/c2ccc(Cl)cc2)cc1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311896,c1ccc(/N=N/C(=N/Nc2ccccc2)c2ccccc2)cc1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311893,CCN(CC)c1ccc(/C=C2\CCC(/C=N/N=C/c3cccnc3)=C2N2CCOCC2)cc1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311891,COc1cc(/C=N/Nc2ccc(S(=O)(=O)Nc3ccccc3C(=O)O)cc2[N+](=O)[O-])ccc1O,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311890,COc1ccccc1NS(=O)(=O)c1ccc(N/N=C(\C)c2ccccc2Br)c([N+](=O)[O-])c1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311889,C/C(=N\Nc1ccc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-])c1cc(O)ccc1O,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311888,Oc1ccc(Br)cc1/C=N/Nc1cccc2cccnc12,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311885,Cc1nnc(NN)c2c1[nH]c1ccccc12,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311879,O=C(COc1ccc(Cl)cc1Cl)N/N=C/c1cc(Br)ccc1O,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311877,COc1ccc(O)c(/C=N/NC(=O)c2sc3ccccc3c2O)c1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2094455,O=C(N/N=C/c1c(O)ccc2ccccc12)c1cc[nH]n1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311874,O=C(N/N=C/c1c(O)ccc2ccccc12)c1n[nH]c2c1CCC2,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311872,CCOc1cccc(/C=N/NC(=O)c2n[nH]c3c2CCC3)c1O,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311870,COc1ccc(OC)c(/C=N/NC(=O)c2n[nH]c3c2CCC3)c1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL390195,O=C(N/N=C/c1c(O)ccc2ccccc12)c1ccncc1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311868,O=C(N/N=C/c1ccc(Cl)cc1Cl)c1cnccn1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL569410,O=C(N/N=C/c1ccccc1O)c1cnccn1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL200144,O=C(N/N=C/c1cc(Br)ccc1O)c1cccnc1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL199592,O=C(N/N=C/c1ccc(O)cc1O)c1ccncc1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311866,COc1c(Cl)cc(Cl)cc1/C=N/NC(=O)c1ccncc1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311912,C=CC/N=c1/scc(-c2ccccc2Br)n1/N=C/c1ccccn1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311911,CC/N=c1/scc(-c2cc(OC)ccc2OC)n1/N=C(\C)c1ccco1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311910,COCC/N=c1/scc(-c2cccs2)n1/N=C/c1cc(Br)c(O)c(OC)c1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1976649,COc1ccccc1N1CCN(/N=C/c2ccc(Cl)c([N+](=O)[O-])c2)CC1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311908,Cn1cccc1/C=N/N1CCN(Cc2ccccc2)CC1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311906,C/C(=N\N1CCN(Cc2ccccc2Cl)CC1)c1ccc([N+](=O)[O-])cc1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311904,FC(F)(F)c1ccccc1/C=N/N1CCN(Cc2ccccc2)CC1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311903,Cc1ccc(N/N=C2\Sc3ccccc3C2=O)cc1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311902,O=C1C(O)=Cc2ccccc2/C1=N\Nc1ccc(Cl)cc1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311898,CC(=O)c1ccc(/N=N/c2ccc(C[P+](c3ccccc3)(c3ccccc3)c3ccccc3)cc2)cc1.[Br-],IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311897,CN(C)c1ccc(/N=N/c2ccc(Cl)cc2)cc1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311896,c1ccc(/N=N/C(=N/Nc2ccccc2)c2ccccc2)cc1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311893,CCN(CC)c1ccc(/C=C2\CCC(/C=N/N=C/c3cccnc3)=C2N2CCOCC2)cc1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311891,COc1cc(/C=N/Nc2ccc(S(=O)(=O)Nc3ccccc3C(=O)O)cc2[N+](=O)[O-])ccc1O,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311890,COc1ccccc1NS(=O)(=O)c1ccc(N/N=C(\C)c2ccccc2Br)c([N+](=O)[O-])c1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311889,C/C(=N\Nc1ccc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-])c1cc(O)ccc1O,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311888,Oc1ccc(Br)cc1/C=N/Nc1cccc2cccnc12,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311885,Cc1nnc(NN)c2c1[nH]c1ccccc12,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311879,O=C(COc1ccc(Cl)cc1Cl)N/N=C/c1cc(Br)ccc1O,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311877,COc1ccc(O)c(/C=N/NC(=O)c2sc3ccccc3c2O)c1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2094455,O=C(N/N=C/c1c(O)ccc2ccccc12)c1cc[nH]n1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311874,O=C(N/N=C/c1c(O)ccc2ccccc12)c1n[nH]c2c1CCC2,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311872,CCOc1cccc(/C=N/NC(=O)c2n[nH]c3c2CCC3)c1O,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311870,COc1ccc(OC)c(/C=N/NC(=O)c2n[nH]c3c2CCC3)c1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL390195,O=C(N/N=C/c1c(O)ccc2ccccc12)c1ccncc1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311868,O=C(N/N=C/c1ccc(Cl)cc1Cl)c1cnccn1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL569410,O=C(N/N=C/c1ccccc1O)c1cnccn1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL200144,O=C(N/N=C/c1cc(Br)ccc1O)c1cccnc1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL199592,O=C(N/N=C/c1ccc(O)cc1O)c1ccncc1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311866,COc1c(Cl)cc(Cl)cc1/C=N/NC(=O)c1ccncc1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1597979,CCNc1nc(NCC)nc(C(=O)NN)n1,IC50,100000.0,,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL1597979,CCNc1nc(NCC)nc(C(=O)NN)n1,IC50,100000.0,,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311902,O=C1C(O)=Cc2ccccc2/C1=N\Nc1ccc(Cl)cc1,IC50,100000.0,4.0,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311878,O=C(CP(=O)(c1ccccc1)c1ccccc1)N/N=C/c1cc(Br)cc(Br)c1O,IC50,100000.0,4.0,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311878,O=C(CP(=O)(c1ccccc1)c1ccccc1)N/N=C/c1cc(Br)cc(Br)c1O,IC50,100000.0,4.0,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2311882,COCCN1C(=O)/C(=C\NNC(=O)c2cc(Cl)ccc2O)C(=O)NC1=S,IC50,90000.0,4.05,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL2311881,Cc1occc1C(=O)NN/C=C1/C(=O)N(c2ccccc2Cl)C(=O)c2ccccc21,IC50,90000.0,4.05,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL2311882,COCCN1C(=O)/C(=C\NNC(=O)c2cc(Cl)ccc2O)C(=O)NC1=S,IC50,80000.0,4.1,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL2311887,Cc1sc2ncnc(N/N=C/c3c(O)ccc4ccccc34)c2c1C,IC50,77000.0,4.11,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,77000.0,4.113509274827518
CHEMBL2311881,Cc1occc1C(=O)NN/C=C1/C(=O)N(c2ccccc2Cl)C(=O)c2ccccc21,IC50,75000.0,4.12,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75000.0,4.1249387366083
CHEMBL2094513,Oc1ccc(/C=N/N2CCN(c3ccccc3)CC2)cc1O,IC50,69000.0,4.16,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69000.0,4.161150909262744
CHEMBL2311887,Cc1sc2ncnc(N/N=C/c3c(O)ccc4ccccc34)c2c1C,IC50,52000.0,4.28,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52000.0,4.2839966563652006
CHEMBL2094513,Oc1ccc(/C=N/N2CCN(c3ccccc3)CC2)cc1O,IC50,31000.0,4.51,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31000.0,4.508638306165727
CHEMBL2311873,O=C(N/N=C/c1cc(Br)ccc1O)C1=NNC2CCCCC12,IC50,29000.0,4.54,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,29000.0,4.537602002101044
CHEMBL2311867,COc1cc(Br)cc(/C=N/NC(=O)c2ccccn2)c1O,IC50,17000.0,4.77,CHEMBL2317017,Inhibition of wild type HIV1 integrase 3'-processing activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL2311873,O=C(N/N=C/c1cc(Br)ccc1O)C1=NNC2CCCCC12,IC50,15000.0,4.82,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL2311867,COc1cc(Br)cc(/C=N/NC(=O)c2ccccn2)c1O,IC50,13000.0,4.89,CHEMBL2317016,Inhibition of wild type HIV1 integrase strand transfer activity using 5'-end 32P-labeled linear oligonucleotide as substrate preincubated for 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL2095083,O=C(CC(Sc1cccc2cccnc12)c1ccc(F)cc1)c1cccs1,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325489,O=C(CC(Sc1cccc2cccnc12)c1ccc(OC(F)F)cc1)c1ccco1,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325746,Cc1ccc(S(=O)(=O)NC(=O)Oc2cccc3cccnc23)cc1,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1360037,Oc1ccc(CN2CCN(Cc3ccccc3)CC2)c2cccnc12,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1564403,CCOC(=O)C1CCN(Cc2ccc(O)c3ncccc23)CC1,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1457644,Oc1ccc(CN2CCN(c3ccccc3)CC2)c2cccnc12,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325745,CCOC(=O)C1CCCN(Cc2ccc(O)c3ncccc23)C1,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325744,Oc1ccc(CN2CCN(c3ccccn3)CC2)c2cccnc12,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1505060,CCOC(=O)N1CCN(Cc2ccc(O)c3ncccc23)CC1,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325494,CCN1CCN(Cc2ccc(O)c3ncccc23)CC1,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325493,CN1CCN(Cc2ccc(O)c3ncccc23)CC1,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1519338,Oc1ccc(CN2CCCCC2)c2cccnc12,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1412719,Oc1ccc(CNc2ccccc2Cl)c2cccnc12,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1460823,Cc1ccc(NCc2ccc(O)c3ncccc23)cc1C,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL582653,CCOc1ccc(NCc2ccc(O)c3ncccc23)cc1,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1539727,Cc1cccc(NCc2ccc(O)c3ncccc23)c1,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1486366,Oc1ccc(CNc2ccccc2F)c2cccnc12,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1427004,Cc1cccnc1NCc1ccc(O)c2ncccc12,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1535759,Cc1ccc(NCc2ccc(O)c3ncccc23)cc1,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325492,COc1cccc(NCc2ccc(O)c3ncccc23)c1,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1481390,Cc1cccc(NCc2ccc(O)c3ncccc23)c1C,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1481742,Oc1ccc(CNc2cccc(C(F)(F)F)c2)c2cccnc12,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2094406,Cc1cccc(NCc2ccc(O)c3ncccc23)n1,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325491,Oc1ccc(CNc2ccc(C(F)(F)F)cc2)c2cccnc12,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325490,Oc1ccc(Cc2ccc(O)c3ncccc23)c2cccnc12,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1559622,Cc1ccccc1NCc1ccc(O)c2ncccc12,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1457139,Oc1ccccc1C(Nc1nccs1)c1ccc2cccnc2c1O,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL590927,CCCC(=O)NC(c1ccc(OC)cc1)c1ccc2cccnc2c1O,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL580130,CC(=O)NC(c1ccc(N(C)C)cc1)c1cc(Cl)c2cccnc2c1O,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1361046,CCC(=O)NC(c1ccc(OC)c(OC)c1)c1cc(Cl)c2cccnc2c1O,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL580727,CCC(=O)NC(c1ccco1)c1cc(Cl)c2cccnc2c1O,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325748,COc1ccc(C(NC(C)=O)c2cc([N+](=O)[O-])c3cccnc3c2O)cc1OC,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1369893,CCC(=O)NC(c1cccs1)c1cc([N+](=O)[O-])c2cccnc2c1O,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL591361,CC(=O)NC(c1ccccc1)c1cc(Cl)c2cccnc2c1O,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325747,CCC(=O)NC(c1ccc(OC)cc1)c1cc([N+](=O)[O-])c2cccnc2c1O,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1594475,COc1cccc(C(NC(C)=O)c2ccc3cccnc3c2O)c1,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL602718,CCC(=O)NC(c1ccccc1OC)c1ccc2cccnc2c1O,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1598785,CCCC(=O)NC(c1ccccc1)c1ccc2cccnc2c1O,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1566852,CCOCc1ccc(O)c2ncccc12,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1200596,Oc1c(Cl)cc(Cl)c2cccnc12,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL225164,Oc1ccc(Cl)c2cccnc12,IC50,20000.0,,CHEMBL2327747,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2095083,O=C(CC(Sc1cccc2cccnc12)c1ccc(F)cc1)c1cccs1,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325489,O=C(CC(Sc1cccc2cccnc12)c1ccc(OC(F)F)cc1)c1ccco1,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325746,Cc1ccc(S(=O)(=O)NC(=O)Oc2cccc3cccnc23)cc1,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1360037,Oc1ccc(CN2CCN(Cc3ccccc3)CC2)c2cccnc12,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1564403,CCOC(=O)C1CCN(Cc2ccc(O)c3ncccc23)CC1,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1457644,Oc1ccc(CN2CCN(c3ccccc3)CC2)c2cccnc12,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325745,CCOC(=O)C1CCCN(Cc2ccc(O)c3ncccc23)C1,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325744,Oc1ccc(CN2CCN(c3ccccn3)CC2)c2cccnc12,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1505060,CCOC(=O)N1CCN(Cc2ccc(O)c3ncccc23)CC1,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325494,CCN1CCN(Cc2ccc(O)c3ncccc23)CC1,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325493,CN1CCN(Cc2ccc(O)c3ncccc23)CC1,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1519338,Oc1ccc(CN2CCCCC2)c2cccnc12,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1412719,Oc1ccc(CNc2ccccc2Cl)c2cccnc12,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1460823,Cc1ccc(NCc2ccc(O)c3ncccc23)cc1C,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL582653,CCOc1ccc(NCc2ccc(O)c3ncccc23)cc1,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1539727,Cc1cccc(NCc2ccc(O)c3ncccc23)c1,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1486366,Oc1ccc(CNc2ccccc2F)c2cccnc12,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1427004,Cc1cccnc1NCc1ccc(O)c2ncccc12,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1535759,Cc1ccc(NCc2ccc(O)c3ncccc23)cc1,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325492,COc1cccc(NCc2ccc(O)c3ncccc23)c1,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1481390,Cc1cccc(NCc2ccc(O)c3ncccc23)c1C,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL225164,Oc1ccc(Cl)c2cccnc12,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1200596,Oc1c(Cl)cc(Cl)c2cccnc12,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1566852,CCOCc1ccc(O)c2ncccc12,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1598785,CCCC(=O)NC(c1ccccc1)c1ccc2cccnc2c1O,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL602718,CCC(=O)NC(c1ccccc1OC)c1ccc2cccnc2c1O,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1594475,COc1cccc(C(NC(C)=O)c2ccc3cccnc3c2O)c1,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325747,CCC(=O)NC(c1ccc(OC)cc1)c1cc([N+](=O)[O-])c2cccnc2c1O,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL591361,CC(=O)NC(c1ccccc1)c1cc(Cl)c2cccnc2c1O,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1369893,CCC(=O)NC(c1cccs1)c1cc([N+](=O)[O-])c2cccnc2c1O,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325748,COc1ccc(C(NC(C)=O)c2cc([N+](=O)[O-])c3cccnc3c2O)cc1OC,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL580727,CCC(=O)NC(c1ccco1)c1cc(Cl)c2cccnc2c1O,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1361046,CCC(=O)NC(c1ccc(OC)c(OC)c1)c1cc(Cl)c2cccnc2c1O,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL580130,CC(=O)NC(c1ccc(N(C)C)cc1)c1cc(Cl)c2cccnc2c1O,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL590927,CCCC(=O)NC(c1ccc(OC)cc1)c1ccc2cccnc2c1O,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1457139,Oc1ccccc1C(Nc1nccs1)c1ccc2cccnc2c1O,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1559622,Cc1ccccc1NCc1ccc(O)c2ncccc12,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325490,Oc1ccc(Cc2ccc(O)c3ncccc23)c2cccnc12,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2325491,Oc1ccc(CNc2ccc(C(F)(F)F)cc2)c2cccnc12,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2094406,Cc1cccc(NCc2ccc(O)c3ncccc23)n1,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1481742,Oc1ccc(CNc2cccc(C(F)(F)F)c2)c2cccnc12,IC50,20000.0,,CHEMBL2327748,Inhibition of HIV-1 integrase 3'-processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2396767,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(N)=O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC,IC50,1700.0,5.77,CHEMBL2401273,Inhibition of HIV1 3'-processing activity of integrase F185K/C280S double mutant expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL2396766,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)CCC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,430.0,6.37,CHEMBL2401273,Inhibition of HIV1 3'-processing activity of integrase F185K/C280S double mutant expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,430.0,6.366531544420413
CHEMBL2396853,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)CN1CCN(C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)CC1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,460.0,6.34,CHEMBL2401273,Inhibition of HIV1 3'-processing activity of integrase F185K/C280S double mutant expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,460.0,6.337242168318426
CHEMBL2396852,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)CC1CCN(C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)CC1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,570.0,6.24,CHEMBL2401273,Inhibition of HIV1 3'-processing activity of integrase F185K/C280S double mutant expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,570.0,6.2441251443275085
CHEMBL3037906,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)C1CCCC(CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)C1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,1000.0,6.0,CHEMBL2401273,Inhibition of HIV1 3'-processing activity of integrase F185K/C280S double mutant expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL2396850,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)COCCOCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,1070.0,5.97,CHEMBL2401273,Inhibition of HIV1 3'-processing activity of integrase F185K/C280S double mutant expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1070.0,5.97061622231479
CHEMBL2396849,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)CCCCCCCCCCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,1300.0,5.89,CHEMBL2401273,Inhibition of HIV1 3'-processing activity of integrase F185K/C280S double mutant expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL2396848,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)CCCCCCCCCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,850.0,6.07,CHEMBL2401273,Inhibition of HIV1 3'-processing activity of integrase F185K/C280S double mutant expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,850.0,6.070581074285707
CHEMBL2396847,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)CCCCCCCCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,760.0,6.12,CHEMBL2401273,Inhibition of HIV1 3'-processing activity of integrase F185K/C280S double mutant expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,760.0,6.119186407719209
CHEMBL2396846,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)CCCCCCCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,720.0,6.14,CHEMBL2401273,Inhibition of HIV1 3'-processing activity of integrase F185K/C280S double mutant expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,720.0,6.142667503568731
CHEMBL2396845,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)CCCCCCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,680.0,6.17,CHEMBL2401273,Inhibition of HIV1 3'-processing activity of integrase F185K/C280S double mutant expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,680.0,6.167491087293763
CHEMBL2396844,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)CCCCCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,910.0,6.04,CHEMBL2401273,Inhibition of HIV1 3'-processing activity of integrase F185K/C280S double mutant expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,910.0,6.040958607678906
CHEMBL265887,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,3000.0,5.52,CHEMBL2401273,Inhibition of HIV1 3'-processing activity of integrase F185K/C280S double mutant expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL2396768,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O,IC50,2000.0,5.7,CHEMBL2401273,Inhibition of HIV1 3'-processing activity of integrase F185K/C280S double mutant expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL2396843,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)CCCCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,1500.0,5.82,CHEMBL2401273,Inhibition of HIV1 3'-processing activity of integrase F185K/C280S double mutant expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1500.0,5.823908740944319
CHEMBL2396769,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)CCCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,IC50,3750.0,5.43,CHEMBL2401273,Inhibition of HIV1 3'-processing activity of integrase F185K/C280S double mutant expressed in Escherichia coli BL21 (DE3),CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3750.0,5.425968732272281
CHEMBL2398124,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,25000.0,4.6,CHEMBL2401248,Inhibition of HIV-1 His6-tagged integrase assessed as inhibition of LEDGF/p75-integrase interaction incubated 30 mins prior to flag-tagged LEDGF/p75 addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL2398138,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@](C)(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)c2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)[C@@H](C)O)CCC/C=C\CCC[C@@](C)(C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC1=O,IC50,25000.0,4.6,CHEMBL2401248,Inhibition of HIV-1 His6-tagged integrase assessed as inhibition of LEDGF/p75-integrase interaction incubated 30 mins prior to flag-tagged LEDGF/p75 addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL2398137,CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@@](C)(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)CCC/C=C\CCC[C@@](C)(C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC(=O)[C@H](CC(C)C)NC1=O,IC50,5000.0,5.3,CHEMBL2401248,Inhibition of HIV-1 His6-tagged integrase assessed as inhibition of LEDGF/p75-integrase interaction incubated 30 mins prior to flag-tagged LEDGF/p75 addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL2398136,C=CCCC[C@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@](C)(CCCC=C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,100000.0,,CHEMBL2401248,Inhibition of HIV-1 His6-tagged integrase assessed as inhibition of LEDGF/p75-integrase interaction incubated 30 mins prior to flag-tagged LEDGF/p75 addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2398133,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@](C)(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)CC/C=C/CC[C@@](C)(C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC1=O,IC50,14000.0,4.85,CHEMBL2401248,Inhibition of HIV-1 His6-tagged integrase assessed as inhibition of LEDGF/p75-integrase interaction incubated 30 mins prior to flag-tagged LEDGF/p75 addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL2398132,C=CCC[C@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@](C)(CCC=C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,20000.0,4.7,CHEMBL2401248,Inhibition of HIV-1 His6-tagged integrase assessed as inhibition of LEDGF/p75-integrase interaction incubated 30 mins prior to flag-tagged LEDGF/p75 addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2398128,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@](C)(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)CCC/C=C\CCC[C@@](C)(C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC1=O,IC50,14000.0,4.85,CHEMBL2401248,Inhibition of HIV-1 His6-tagged integrase assessed as inhibition of LEDGF/p75-integrase interaction incubated 30 mins prior to flag-tagged LEDGF/p75 addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL2398127,C=CCCC[C@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@](C)(CCCC=C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,15000.0,4.82,CHEMBL2401248,Inhibition of HIV-1 His6-tagged integrase assessed as inhibition of LEDGF/p75-integrase interaction incubated 30 mins prior to flag-tagged LEDGF/p75 addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL2398126,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCC/C=C\CCC[C@](C)(N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,100000.0,,CHEMBL2401248,Inhibition of HIV-1 His6-tagged integrase assessed as inhibition of LEDGF/p75-integrase interaction incubated 30 mins prior to flag-tagged LEDGF/p75 addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2398125,C=CCCC[C@](C)(N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@](C)(CCC=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,26000.0,4.58,CHEMBL2401248,Inhibition of HIV-1 His6-tagged integrase assessed as inhibition of LEDGF/p75-integrase interaction incubated 30 mins prior to flag-tagged LEDGF/p75 addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26000.0,4.585026652029182
CHEMBL2398124,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,6200.0,5.21,CHEMBL2399084,Inhibition of wild type HIV-1 integrase strand transfer activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6200.0,5.207608310501746
CHEMBL2398138,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@](C)(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)c2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)[C@@H](C)O)CCC/C=C\CCC[C@@](C)(C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC1=O,IC50,6000.0,5.22,CHEMBL2399084,Inhibition of wild type HIV-1 integrase strand transfer activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL2398137,CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@@](C)(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)CCC/C=C\CCC[C@@](C)(C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC(=O)[C@H](CC(C)C)NC1=O,IC50,25000.0,4.6,CHEMBL2399084,Inhibition of wild type HIV-1 integrase strand transfer activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL2398136,C=CCCC[C@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@](C)(CCCC=C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,11000.0,4.96,CHEMBL2399084,Inhibition of wild type HIV-1 integrase strand transfer activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL2398135,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@](C)(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)CCCC/C=C/CCCC[C@@](C)(C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC1=O,IC50,44000.0,4.36,CHEMBL2399084,Inhibition of wild type HIV-1 integrase strand transfer activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44000.0,4.356547323513812
CHEMBL2398134,C=CCCCC[C@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@](C)(CCCCC=C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,43000.0,4.37,CHEMBL2399084,Inhibition of wild type HIV-1 integrase strand transfer activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43000.0,4.366531544420414
CHEMBL2398133,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@](C)(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)CC/C=C/CC[C@@](C)(C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC1=O,IC50,83000.0,4.08,CHEMBL2399084,Inhibition of wild type HIV-1 integrase strand transfer activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,83000.0,4.080921907623926
CHEMBL2398132,C=CCC[C@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@](C)(CCC=C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,68000.0,4.17,CHEMBL2399084,Inhibition of wild type HIV-1 integrase strand transfer activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68000.0,4.167491087293763
CHEMBL2398130,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@]1(C)CCC/C=C/CCC[C@@](C)(C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC1=O,IC50,100000.0,,CHEMBL2399084,Inhibition of wild type HIV-1 integrase strand transfer activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2398129,C=CCCC[C@](C)(NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@](C)(CCCC=C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,100000.0,,CHEMBL2399084,Inhibition of wild type HIV-1 integrase strand transfer activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2398128,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@](C)(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)CCC/C=C\CCC[C@@](C)(C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC1=O,IC50,6000.0,5.22,CHEMBL2399084,Inhibition of wild type HIV-1 integrase strand transfer activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL2398127,C=CCCC[C@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@](C)(CCCC=C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,6000.0,5.22,CHEMBL2399084,Inhibition of wild type HIV-1 integrase strand transfer activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL2398126,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCC/C=C\CCC[C@](C)(N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,19000.0,4.72,CHEMBL2399084,Inhibition of wild type HIV-1 integrase strand transfer activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL2398125,C=CCCC[C@](C)(N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@](C)(CCC=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,15000.0,4.82,CHEMBL2399084,Inhibition of wild type HIV-1 integrase strand transfer activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL2398124,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,17500.0,4.76,CHEMBL2399083,Inhibition of wild type HIV-1 integrase 3' processing activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17500.0,4.756961951313706
CHEMBL2398138,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@](C)(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)c2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)[C@@H](C)O)CCC/C=C\CCC[C@@](C)(C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC1=O,IC50,5000.0,5.3,CHEMBL2399083,Inhibition of wild type HIV-1 integrase 3' processing activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL2398137,CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@@](C)(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)CCC/C=C\CCC[C@@](C)(C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC(=O)[C@H](CC(C)C)NC1=O,IC50,22000.0,4.66,CHEMBL2399083,Inhibition of wild type HIV-1 integrase 3' processing activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL2398136,C=CCCC[C@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@](C)(CCCC=C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,15000.0,4.82,CHEMBL2399083,Inhibition of wild type HIV-1 integrase 3' processing activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL2398135,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@](C)(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)CCCC/C=C/CCCC[C@@](C)(C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC1=O,IC50,48000.0,4.32,CHEMBL2399083,Inhibition of wild type HIV-1 integrase 3' processing activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48000.0,4.318758762624412
CHEMBL2398134,C=CCCCC[C@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@](C)(CCCCC=C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,61000.0,4.21,CHEMBL2399083,Inhibition of wild type HIV-1 integrase 3' processing activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,61000.0,4.214670164989233
CHEMBL2398133,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@](C)(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)CC/C=C/CC[C@@](C)(C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC1=O,IC50,90000.0,4.05,CHEMBL2399083,Inhibition of wild type HIV-1 integrase 3' processing activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL2398132,C=CCC[C@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@](C)(CCC=C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,74000.0,4.13,CHEMBL2399083,Inhibition of wild type HIV-1 integrase 3' processing activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,74000.0,4.130768280269024
CHEMBL2398130,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@]1(C)CCC/C=C/CCC[C@@](C)(C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC1=O,IC50,100000.0,,CHEMBL2399083,Inhibition of wild type HIV-1 integrase 3' processing activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2398129,C=CCCC[C@](C)(NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@](C)(CCCC=C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,100000.0,,CHEMBL2399083,Inhibition of wild type HIV-1 integrase 3' processing activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2398128,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@](C)(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)CCC/C=C\CCC[C@@](C)(C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC1=O,IC50,9000.0,5.05,CHEMBL2399083,Inhibition of wild type HIV-1 integrase 3' processing activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL2398127,C=CCCC[C@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@](C)(CCCC=C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,9000.0,5.05,CHEMBL2399083,Inhibition of wild type HIV-1 integrase 3' processing activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL2398126,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCC/C=C\CCC[C@](C)(N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,53000.0,4.28,CHEMBL2399083,Inhibition of wild type HIV-1 integrase 3' processing activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53000.0,4.275724130399211
CHEMBL2398125,C=CCCC[C@](C)(N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@](C)(CCC=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,IC50,22000.0,4.66,CHEMBL2399083,Inhibition of wild type HIV-1 integrase 3' processing activity after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL2401912,O=C(/C=C(\O)c1cc(Cc2ccc(F)cc2F)cn(Cc2ccccc2F)c1=O)C(=O)N[C@@H]1CCC[C@H]1O,IC50,48.0,7.32,CHEMBL2405961,Inhibition of HIV-1 integrase strand transfer activity after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48.0,7.318758762624412
CHEMBL2403238,C[C@H]1CO[C@@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,IC50,3.0,8.52,CHEMBL2405242,Inhibition of HIV-1 integrase strand transfer activity using [3H]-DNA as substrate preincubated for 60 mins prior to substrate addition measured after 25 to 45 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL1229211,C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,IC50,2.7,8.57,CHEMBL2405242,Inhibition of HIV-1 integrase strand transfer activity using [3H]-DNA as substrate preincubated for 60 mins prior to substrate addition measured after 25 to 45 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.7,8.568636235841012
CHEMBL2403118,C[C@@H]1CCN2C(=O)c3c(O)c(=O)c(C(=O)NCc4ccc(F)cc4)cn3C[C@@H]2O1,IC50,5.0,8.3,CHEMBL2405242,Inhibition of HIV-1 integrase strand transfer activity using [3H]-DNA as substrate preincubated for 60 mins prior to substrate addition measured after 25 to 45 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL2407287,O=C(NCc1ccc(F)cc1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,100000.0,,CHEMBL2411807,Inhibition of HIV1 integrase binding to LEDGF,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2407287,O=C(NCc1ccc(F)cc1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,60.0,7.22,CHEMBL2411985,Inhibition of 3'-processing activity of HIV1 integrase using 32P-5'-TGTGGAAAATCTCTAGCAGT-3' and 5'-ACTGCTAGAGATTTTCCACA-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL2407284,O=C(NCc1ccc(O)cc1O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,2350.0,5.63,CHEMBL2411985,Inhibition of 3'-processing activity of HIV1 integrase using 32P-5'-TGTGGAAAATCTCTAGCAGT-3' and 5'-ACTGCTAGAGATTTTCCACA-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2350.0,5.628932137728263
CHEMBL2407277,COc1ccc(NC(=O)C2C(=O)N(O)C(=O)c3ccccc32)cc1Cl,IC50,1580.0,5.8,CHEMBL2411985,Inhibition of 3'-processing activity of HIV1 integrase using 32P-5'-TGTGGAAAATCTCTAGCAGT-3' and 5'-ACTGCTAGAGATTTTCCACA-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1580.0,5.801342913045577
CHEMBL2407275,CN(C(=O)C1C(=O)N(O)C(=O)c2ccccc21)c1ccccc1,IC50,5600.0,5.25,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5600.0,5.251811972993799
CHEMBL2407274,O=C(NCCc1ccc(O)c(O)c1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,296.0,6.53,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,296.0,6.528708288941061
CHEMBL2407273,COc1ccc(CCNC(=O)C2C(=O)N(O)C(=O)c3ccccc32)cc1OC,IC50,126.0,6.9,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,126.0,6.899629454882437
CHEMBL2407272,O=C(NCCc1ccc(F)cc1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,200.0,6.7,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL2407287,O=C(NCc1ccc(F)cc1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,99.0,7.0,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,99.0,7.00436480540245
CHEMBL2407286,O=C(NCc1ccc(O)c(O)c1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,258.0,6.59,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,258.0,6.58838029403677
CHEMBL2407285,COc1ccc(CNC(=O)C2C(=O)N(O)C(=O)c3ccccc32)cc1OC,IC50,307.0,6.51,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,307.0,6.512861624522813
CHEMBL2407284,O=C(NCc1ccc(O)cc1O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,572.0,6.24,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,572.0,6.242603971206975
CHEMBL2407283,COc1ccc(CNC(=O)C2C(=O)N(O)C(=O)c3ccccc32)c(OC)c1,IC50,254.0,6.59,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,254.0,6.5951662833800615
CHEMBL2407282,COc1ccc(CNC(=O)C2C(=O)N(O)C(=O)c3ccccc32)cc1,IC50,1030.0,5.99,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1030.0,5.987162775294828
CHEMBL2407281,Cc1ccc(CNC(=O)C2C(=O)N(O)C(=O)c3ccccc32)cc1,IC50,84.0,7.08,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,84.0,7.075720713938118
CHEMBL2407280,O=C(NCc1ccccc1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,30.0,7.52,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL2407279,O=C(Nc1ccc(F)cc1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,1120.0,5.95,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1120.0,5.950781977329818
CHEMBL2407278,O=C(Nc1cccc(F)c1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,110.0,6.96,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL2407277,COc1ccc(NC(=O)C2C(=O)N(O)C(=O)c3ccccc32)cc1Cl,IC50,277.0,6.56,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,277.0,6.557520230935552
CHEMBL2407276,O=C(Nc1ccccc1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,730.0,6.14,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,730.0,6.136677139879544
CHEMBL2407289,O=C1NC(=O)C(C(=O)NCc2ccc(F)cc2)c2ccccc21,IC50,79000.0,4.1,CHEMBL2411984,Inhibition of strand transfer activity of HIV1 integrase using pre-cleaved oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,79000.0,4.102372908709558
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,10.0,8.0,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL2407275,CN(C(=O)C1C(=O)N(O)C(=O)c2ccccc21)c1ccccc1,IC50,5210.0,5.28,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5210.0,5.283162276700475
CHEMBL2407274,O=C(NCCc1ccc(O)c(O)c1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,673.0,6.17,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,673.0,6.171984935776023
CHEMBL2407273,COc1ccc(CCNC(=O)C2C(=O)N(O)C(=O)c3ccccc32)cc1OC,IC50,495.0,6.3,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,495.0,6.305394801066431
CHEMBL2407272,O=C(NCCc1ccc(F)cc1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,30.0,7.52,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL2407287,O=C(NCc1ccc(F)cc1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,56.0,7.25,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56.0,7.251811972993799
CHEMBL2407286,O=C(NCc1ccc(O)c(O)c1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,205.0,6.69,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,205.0,6.688246138944246
CHEMBL2407285,COc1ccc(CNC(=O)C2C(=O)N(O)C(=O)c3ccccc32)cc1OC,IC50,235.0,6.63,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,235.0,6.628932137728263
CHEMBL2407284,O=C(NCc1ccc(O)cc1O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,35.0,7.46,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35.0,7.455931955649724
CHEMBL2407283,COc1ccc(CNC(=O)C2C(=O)N(O)C(=O)c3ccccc32)c(OC)c1,IC50,35.0,7.46,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35.0,7.455931955649724
CHEMBL2407282,COc1ccc(CNC(=O)C2C(=O)N(O)C(=O)c3ccccc32)cc1,IC50,1190.0,5.92,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1190.0,5.924453038607469
CHEMBL2407281,Cc1ccc(CNC(=O)C2C(=O)N(O)C(=O)c3ccccc32)cc1,IC50,76.0,7.12,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,76.0,7.119186407719209
CHEMBL2407280,O=C(NCc1ccccc1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,80.0,7.1,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL2407279,O=C(Nc1ccc(F)cc1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,800.0,6.1,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL2407278,O=C(Nc1cccc(F)c1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,10.0,8.0,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL2407277,COc1ccc(NC(=O)C2C(=O)N(O)C(=O)c3ccccc32)cc1Cl,IC50,20.0,7.7,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL2407276,O=C(Nc1ccccc1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,310.0,6.51,CHEMBL2411983,Inhibition of HIV1 integrase overall inhibition using 5'-digoxigenin-labeled 5'-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,310.0,6.508638306165727
CHEMBL1374702,CNC(=O)c1[nH]cnc1C(=O)Nc1ccccn1,IC50,20000.0,,CHEMBL2421043,Inhibition of recombinant His6-tagged HIV-1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1312820,NNC(=O)c1[nH]cnc1C(=O)Nc1ccccn1,IC50,20000.0,,CHEMBL2421043,Inhibition of recombinant His6-tagged HIV-1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1534378,Cc1ccc(NC(=O)c2[nH]cnc2C(=O)NN)cc1,IC50,20000.0,,CHEMBL2421043,Inhibition of recombinant His6-tagged HIV-1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419620,O=C(Nc1ccccc1O)c1nc[nH]c1C(=O)N1CCNCC1,IC50,20000.0,,CHEMBL2421043,Inhibition of recombinant His6-tagged HIV-1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419619,O=C(Nc1ccccc1O)c1nc[nH]c1C(=O)N1CCC(O)CC1,IC50,20000.0,,CHEMBL2421043,Inhibition of recombinant His6-tagged HIV-1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419618,O=C(Nc1ccccc1O)c1nc[nH]c1C(=O)N1CCOCC1,IC50,20000.0,,CHEMBL2421043,Inhibition of recombinant His6-tagged HIV-1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2417573,O=C(Nc1ccccn1)c1nc[nH]c1C(=O)N1CCNCC1,IC50,20000.0,,CHEMBL2421043,Inhibition of recombinant His6-tagged HIV-1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419627,O=C(Nc1ccccn1)c1nc[nH]c1C(=O)N1CCC(O)CC1,IC50,20000.0,,CHEMBL2421043,Inhibition of recombinant His6-tagged HIV-1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419626,O=C(Nc1ccccn1)c1nc[nH]c1C(=O)N1CCOCC1,IC50,20000.0,,CHEMBL2421043,Inhibition of recombinant His6-tagged HIV-1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419625,Nc1ccc(NC(=O)c2nc[nH]c2C(=O)O)cc1,IC50,20000.0,,CHEMBL2421043,Inhibition of recombinant His6-tagged HIV-1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419624,O=C(Nc1ccc([N+](=O)[O-])cc1)c1nc[nH]c1C(=O)O,IC50,20000.0,,CHEMBL2421043,Inhibition of recombinant His6-tagged HIV-1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419623,O=C(Nc1ccccn1)c1nc[nH]c1C(=O)O,IC50,20000.0,,CHEMBL2421043,Inhibition of recombinant His6-tagged HIV-1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419622,COC(=O)c1[nH]cnc1C(=O)Nc1ccc(F)cc1,IC50,20000.0,,CHEMBL2421043,Inhibition of recombinant His6-tagged HIV-1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419621,O=C(NCc1ccc(F)cc1)c1nc[nH]c1C(=O)O,IC50,20000.0,,CHEMBL2421043,Inhibition of recombinant His6-tagged HIV-1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1703922,O=C(Nc1ccc(F)cc1)c1nc[nH]c1C(=O)O,IC50,20000.0,,CHEMBL2421043,Inhibition of recombinant His6-tagged HIV-1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1414893,O=C(Nc1ccccc1)c1nc[nH]c1C(=O)O,IC50,20000.0,,CHEMBL2421043,Inhibition of recombinant His6-tagged HIV-1 integrase 3' strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1374702,CNC(=O)c1[nH]cnc1C(=O)Nc1ccccn1,IC50,20000.0,,CHEMBL2421044,Inhibition of recombinant His6-tagged HIV-1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1312820,NNC(=O)c1[nH]cnc1C(=O)Nc1ccccn1,IC50,20000.0,,CHEMBL2421044,Inhibition of recombinant His6-tagged HIV-1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1534378,Cc1ccc(NC(=O)c2[nH]cnc2C(=O)NN)cc1,IC50,20000.0,,CHEMBL2421044,Inhibition of recombinant His6-tagged HIV-1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419620,O=C(Nc1ccccc1O)c1nc[nH]c1C(=O)N1CCNCC1,IC50,20000.0,,CHEMBL2421044,Inhibition of recombinant His6-tagged HIV-1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419619,O=C(Nc1ccccc1O)c1nc[nH]c1C(=O)N1CCC(O)CC1,IC50,20000.0,,CHEMBL2421044,Inhibition of recombinant His6-tagged HIV-1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419618,O=C(Nc1ccccc1O)c1nc[nH]c1C(=O)N1CCOCC1,IC50,20000.0,,CHEMBL2421044,Inhibition of recombinant His6-tagged HIV-1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2417573,O=C(Nc1ccccn1)c1nc[nH]c1C(=O)N1CCNCC1,IC50,20000.0,,CHEMBL2421044,Inhibition of recombinant His6-tagged HIV-1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419627,O=C(Nc1ccccn1)c1nc[nH]c1C(=O)N1CCC(O)CC1,IC50,20000.0,,CHEMBL2421044,Inhibition of recombinant His6-tagged HIV-1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419626,O=C(Nc1ccccn1)c1nc[nH]c1C(=O)N1CCOCC1,IC50,20000.0,,CHEMBL2421044,Inhibition of recombinant His6-tagged HIV-1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419625,Nc1ccc(NC(=O)c2nc[nH]c2C(=O)O)cc1,IC50,20000.0,,CHEMBL2421044,Inhibition of recombinant His6-tagged HIV-1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419624,O=C(Nc1ccc([N+](=O)[O-])cc1)c1nc[nH]c1C(=O)O,IC50,20000.0,,CHEMBL2421044,Inhibition of recombinant His6-tagged HIV-1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419623,O=C(Nc1ccccn1)c1nc[nH]c1C(=O)O,IC50,20000.0,,CHEMBL2421044,Inhibition of recombinant His6-tagged HIV-1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419622,COC(=O)c1[nH]cnc1C(=O)Nc1ccc(F)cc1,IC50,20000.0,,CHEMBL2421044,Inhibition of recombinant His6-tagged HIV-1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2419621,O=C(NCc1ccc(F)cc1)c1nc[nH]c1C(=O)O,IC50,20000.0,,CHEMBL2421044,Inhibition of recombinant His6-tagged HIV-1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1703922,O=C(Nc1ccc(F)cc1)c1nc[nH]c1C(=O)O,IC50,20000.0,,CHEMBL2421044,Inhibition of recombinant His6-tagged HIV-1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL1414893,O=C(Nc1ccccc1)c1nc[nH]c1C(=O)O,IC50,20000.0,,CHEMBL2421044,Inhibition of recombinant His6-tagged HIV-1 integrase 3' processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442180,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCCN,IC50,20000.0,,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442179,CC(C)(C)OC(=O)NCCCn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,20000.0,,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442198,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCC[N-]S(=O)(=O)C1CC1.[Na+],IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442197,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCC[N-]S(=O)(=O)c1ccccc1.[Na+],IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442196,CCC(=O)NCCCn1c(C(C)(C)C)nc(C(=O)[N-]Cc2ccc(F)cc2)c(O)c1=O.[Na+],IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442195,CC(C)(C)c1nc(C(=O)[N-]Cc2ccc(F)cc2)c(O)c(=O)n1CCCNC(=O)C1CC1.[Na+],IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL259780,CC(C)(C)c1nc(O)c(O)c(C(=O)NCc2ccc(F)cc2)n1,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442194,CC(=O)Nc1ccc(S(=O)(=O)NCCCn2c(C(C)(C)C)nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)cc1,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442193,CC(C)(C)C(=O)NCCCn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442192,Cn1cnc(S(=O)(=O)NCCCn2c(C(C)(C)C)nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)c1,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442191,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCCNC(=O)c1ccco1,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442190,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCCNC(=O)Cc1cccs1,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442189,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCCNC(=O)c1cccs1,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442188,CCS(=O)(=O)NCCCn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442187,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCCNS(=O)(=O)C1CC1,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442186,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCCNS(=O)(=O)c1ccccc1,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442185,CCCC(=O)NCCCn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442184,CCC(=O)NCCCn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442183,CC(=O)NCCCn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442182,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCCNC(=O)c1ccccc1,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442181,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCCNC(=O)C1CC1,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442180,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCCN,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442179,CC(C)(C)OC(=O)NCCCn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,20000.0,,CHEMBL2445699,Inhibition of Human immunodeficiency virus 1 integrase 3'-processing activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442197,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCC[N-]S(=O)(=O)c1ccccc1.[Na+],IC50,20000.0,4.7,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442193,CC(C)(C)C(=O)NCCCn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,20000.0,4.7,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442190,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCCNC(=O)Cc1cccs1,IC50,20000.0,4.7,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442187,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCCNS(=O)(=O)C1CC1,IC50,20000.0,4.7,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442186,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCCNS(=O)(=O)c1ccccc1,IC50,20000.0,4.7,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442185,CCCC(=O)NCCCn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,20000.0,4.7,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2442189,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCCNC(=O)c1cccs1,IC50,14000.0,4.85,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL2442182,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCCNC(=O)c1ccccc1,IC50,13000.0,4.89,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL2442192,Cn1cnc(S(=O)(=O)NCCCn2c(C(C)(C)C)nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)c1,IC50,12000.0,4.92,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL2442198,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCC[N-]S(=O)(=O)C1CC1.[Na+],IC50,9000.0,5.05,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL2442194,CC(=O)Nc1ccc(S(=O)(=O)NCCCn2c(C(C)(C)C)nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)cc1,IC50,8000.0,5.1,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL2442188,CCS(=O)(=O)NCCCn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,7000.0,5.16,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL2442184,CCC(=O)NCCCn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,6000.0,5.22,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL2442195,CC(C)(C)c1nc(C(=O)[N-]Cc2ccc(F)cc2)c(O)c(=O)n1CCCNC(=O)C1CC1.[Na+],IC50,5000.0,5.3,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL2442196,CCC(=O)NCCCn1c(C(C)(C)C)nc(C(=O)[N-]Cc2ccc(F)cc2)c(O)c1=O.[Na+],IC50,4000.0,5.4,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL2442191,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCCNC(=O)c1ccco1,IC50,3000.0,5.52,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL2442181,CC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1CCCNC(=O)C1CC1,IC50,3000.0,5.52,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL259780,CC(C)(C)c1nc(O)c(O)c(C(=O)NCc2ccc(F)cc2)n1,IC50,2000.0,5.7,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL2442183,CC(=O)NCCCn1c(C(C)(C)C)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,2000.0,5.7,CHEMBL2445698,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL2442286,COc1ccc2c(c1)cc(C(=O)CC(=O)C(=O)O)c1ccccc12,IC50,32000.0,4.5,CHEMBL2446201,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL2442285,COc1ccc2c(c1)cc(C(=O)CC(=O)C(=O)O)c1c(F)cccc12,IC50,44000.0,4.36,CHEMBL2446201,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44000.0,4.356547323513812
CHEMBL2442284,O=C(O)C(=O)CC(=O)c1ccc2ccc3c(Cl)cccc3c2c1,IC50,11000.0,4.96,CHEMBL2446201,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL2442283,O=C(O)C(=O)CC(=O)c1ccc2c(ccc3c(Cl)cccc32)c1,IC50,19000.0,4.72,CHEMBL2446201,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL2442282,O=C(O)C(=O)CC(=O)c1ccc2c(ccc3ccc(Cl)cc32)c1,IC50,5000.0,5.3,CHEMBL2446201,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL2442281,O=C(O)C(=O)CC(=O)c1ccc2c(ccc3cc(Cl)ccc32)c1,IC50,12000.0,4.92,CHEMBL2446201,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL2442280,O=C(O)C(=O)CC(=O)c1ccc2ccc3cc(F)ccc3c2c1F,IC50,63000.0,4.2,CHEMBL2446201,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,63000.0,4.200659450546418
CHEMBL2442279,O=C(O)C(=O)CC(=O)c1ccc2ccc3ccccc3c2c1F,IC50,83000.0,4.08,CHEMBL2446201,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,83000.0,4.080921907623926
CHEMBL2442278,O=C(O)C(=O)CC(=O)c1ccc2c(ccc3c(F)cccc32)c1,IC50,35000.0,4.46,CHEMBL2446201,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL2440140,O=C(O)C(=O)CC(=O)c1ccc2ccc3c(F)cccc3c2c1,IC50,11000.0,4.96,CHEMBL2446201,Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL2442286,COc1ccc2c(c1)cc(C(=O)CC(=O)C(=O)O)c1ccccc12,IC50,3000.0,5.52,CHEMBL2446202,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL2442285,COc1ccc2c(c1)cc(C(=O)CC(=O)C(=O)O)c1c(F)cccc12,IC50,6000.0,5.22,CHEMBL2446202,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL2442284,O=C(O)C(=O)CC(=O)c1ccc2ccc3c(Cl)cccc3c2c1,IC50,1200.0,5.92,CHEMBL2446202,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL2442283,O=C(O)C(=O)CC(=O)c1ccc2c(ccc3c(Cl)cccc32)c1,IC50,4000.0,5.4,CHEMBL2446202,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL2442282,O=C(O)C(=O)CC(=O)c1ccc2c(ccc3ccc(Cl)cc32)c1,IC50,1300.0,5.89,CHEMBL2446202,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL2442281,O=C(O)C(=O)CC(=O)c1ccc2c(ccc3cc(Cl)ccc32)c1,IC50,1400.0,5.85,CHEMBL2446202,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1400.0,5.853871964321762
CHEMBL2442280,O=C(O)C(=O)CC(=O)c1ccc2ccc3cc(F)ccc3c2c1F,IC50,8000.0,5.1,CHEMBL2446202,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL2442279,O=C(O)C(=O)CC(=O)c1ccc2ccc3ccccc3c2c1F,IC50,63000.0,4.2,CHEMBL2446202,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,63000.0,4.200659450546418
CHEMBL2442278,O=C(O)C(=O)CC(=O)c1ccc2c(ccc3c(F)cccc32)c1,IC50,4000.0,5.4,CHEMBL2446202,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL2440140,O=C(O)C(=O)CC(=O)c1ccc2ccc3c(F)cccc3c2c1,IC50,3000.0,5.52,CHEMBL2446202,Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL557770,O=C(O)C(=O)CC(=O)c1ccc(NC(=O)c2ccccc2)s1,IC50,1900.0,5.72,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1900.0,5.721246399047171
CHEMBL3087331,O=C(/C=C/c1cccn1Cc1cc(Cl)cc(Cl)c1)CC(=O)C(=O)O,IC50,970.0,6.01,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,970.0,6.013228265733755
CHEMBL3087330,O=C(/C=C/c1cccn1Cc1c(Cl)cccc1Cl)CC(=O)C(=O)O,IC50,170.0,6.77,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,170.0,6.769551078621726
CHEMBL3087329,O=C(/C=C/c1cccn1Cc1ccc(Cl)cc1Cl)CC(=O)C(=O)O,IC50,4900.0,5.31,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4900.0,5.309803919971486
CHEMBL3087328,O=C(/C=C/c1cccn1Cc1cc(F)cc(F)c1)CC(=O)C(=O)O,IC50,1200.0,5.92,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL3087620,O=C(/C=C/c1cccn1Cc1ccc(F)c(F)c1)CC(=O)C(=O)O,IC50,1600.0,5.8,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL3087619,O=C(/C=C/c1cccn1Cc1c(F)cccc1F)CC(=O)C(=O)O,IC50,150.0,6.82,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,150.0,6.823908740944319
CHEMBL3087618,O=C(/C=C/c1cccn1Cc1cc(F)ccc1F)CC(=O)C(=O)O,IC50,52.0,7.28,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52.0,7.2839966563652006
CHEMBL3087617,O=C(/C=C/c1cccn1Cc1ccc(F)cc1F)CC(=O)C(=O)O,IC50,42.0,7.38,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42.0,7.376750709602099
CHEMBL3087616,O=C(/C=C/c1cccn1Cc1cccc(F)c1F)CC(=O)C(=O)O,IC50,59.0,7.23,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,59.0,7.229147988357855
CHEMBL3087338,Cc1cc(C)cc(Cn2cccc2/C=C/C(=O)CC(=O)C(=O)O)c1,IC50,1600.0,5.8,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL3087337,CCOc1ccccc1Cn1cccc1/C=C/C(=O)CC(=O)C(=O)O,IC50,310.0,6.51,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,310.0,6.508638306165727
CHEMBL46032,COc1ccc(Cn2cccc2/C=C/C(=O)CC(=O)C(=O)O)cc1,IC50,4100.0,5.39,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4100.0,5.3872161432802645
CHEMBL3087336,COc1ccccc1Cn1cccc1/C=C/C(=O)CC(=O)C(=O)O,IC50,530.0,6.28,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,530.0,6.275724130399211
CHEMBL3087335,N#Cc1ccc(Cn2cccc2/C=C/C(=O)CC(=O)C(=O)O)cc1,IC50,1700.0,5.77,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL3087334,N#Cc1cccc(Cn2cccc2/C=C/C(=O)CC(=O)C(=O)O)c1,IC50,750.0,6.12,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,750.0,6.1249387366083
CHEMBL3087333,N#Cc1ccccc1Cn1cccc1/C=C/C(=O)CC(=O)C(=O)O,IC50,6000.0,5.22,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL299873,O=C(/C=C/c1cccn1Cc1ccc(Cl)cc1)CC(=O)C(=O)O,IC50,4100.0,5.39,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4100.0,5.3872161432802645
CHEMBL3087332,O=C(/C=C/c1cccn1Cc1cccc(Cl)c1)CC(=O)C(=O)O,IC50,310.0,6.51,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,310.0,6.508638306165727
CHEMBL48573,O=C(/C=C/c1cccn1Cc1ccc(F)cc1)CC(=O)C(=O)O,IC50,26.0,7.58,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26.0,7.585026652029182
CHEMBL3087631,O=C(/C=C/c1cccn1Cc1cccc(F)c1)CC(=O)C(=O)O,IC50,920.0,6.04,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,920.0,6.036212172654444
CHEMBL3087630,O=C(/C=C/c1cccn1Cc1ccccc1F)CC(=O)C(=O)O,IC50,980.0,6.01,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,980.0,6.008773924307505
CHEMBL49363,Cc1ccc(Cn2cccc2/C=C/C(=O)CC(=O)C(=O)O)cc1,IC50,1200.0,5.92,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL3087629,Cc1cccc(Cn2cccc2/C=C/C(=O)CC(=O)C(=O)O)c1,IC50,1300.0,5.89,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL3087628,Cc1ccccc1Cn1cccc1/C=C/C(=O)CC(=O)C(=O)O,IC50,170.0,6.77,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,170.0,6.769551078621726
CHEMBL49201,O=C(/C=C/c1cccn1Cc1ccccc1)CC(=O)C(=O)O,IC50,90.0,7.05,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90.0,7.045757490560675
CHEMBL3087627,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cc(Cl)cc(Cl)c1,IC50,8000.0,5.1,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL3087626,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1c(Cl)cccc1Cl,IC50,1700.0,5.77,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL3087624,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cc(F)cc(F)c1,IC50,490.0,6.31,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,490.0,6.309803919971486
CHEMBL3087623,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(F)c(F)c1,IC50,600.0,6.22,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL3087622,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1c(F)cccc1F,IC50,4000.0,5.4,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL3087621,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cc(F)ccc1F,IC50,450.0,6.35,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,450.0,6.346787486224656
CHEMBL3085796,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(F)cc1F,IC50,1000.0,6.0,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL3087790,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cccc(F)c1F,IC50,530.0,6.28,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,530.0,6.275724130399211
CHEMBL3087789,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cc(C)cc(C)c1,IC50,19000.0,4.72,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19000.0,4.721246399047171
CHEMBL3087788,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccccc1OCC,IC50,12000.0,4.92,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL3087787,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccccc1OC,IC50,23000.0,4.64,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL3087785,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cccc(C#N)c1,IC50,13000.0,4.89,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL3087635,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccccc1C#N,IC50,9000.0,5.05,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL417356,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(Cl)cc1,IC50,42000.0,4.38,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42000.0,4.376750709602099
CHEMBL3087634,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cccc(Cl)c1,IC50,6000.0,5.22,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL3087633,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cccc(F)c1,IC50,11000.0,4.96,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL3087632,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccccc1F,IC50,1000.0,6.0,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL3087792,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cccc(C)c1,IC50,8000.0,5.1,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL3087791,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccccc1C,IC50,32000.0,4.5,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL48381,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccccc1,IC50,15000.0,4.82,CHEMBL3088597,Inhibition of strand transfer activity of recombinant HIV1 integrase using 5'-end-labeled 21-mer double-stranded DNA as substrate after 60 mins by electrochemiluminescent plate-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,120.0,6.92,CHEMBL3101347,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,120.0,6.920818753952375
CHEMBL3099066,CC(C)=CCC1C(C)=CCc2c(O)ccc(O)c21,IC50,11500.0,4.94,CHEMBL3101347,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11500.0,4.939302159646388
CHEMBL3099065,CC(C)=CCC1C(C)=CCc2c1ccc(O)c2O,IC50,11100.0,4.96,CHEMBL3101347,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11100.0,4.954677021213342
CHEMBL3099064,CC(C)=CCCC1=CCc2ccc(O)c(O)c2C1,IC50,13400.0,4.87,CHEMBL3101347,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13400.0,4.872895201635193
CHEMBL3116306,NC(Cc1ccc(Cl)c(Cl)c1)(P(=O)(O)O)P(=O)(O)O,IC50,7000.0,5.16,CHEMBL3119246,Inhibition of HIV-1 integrase N155H mutant expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL34249,O=P(O)(O)C(O)(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,35000.0,4.46,CHEMBL3119246,Inhibition of HIV-1 integrase N155H mutant expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL3116306,NC(Cc1ccc(Cl)c(Cl)c1)(P(=O)(O)O)P(=O)(O)O,IC50,7000.0,5.16,CHEMBL3119247,Inhibition of HIV-1 integrase G140S mutant expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL34249,O=P(O)(O)C(O)(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,35000.0,4.46,CHEMBL3119247,Inhibition of HIV-1 integrase G140S mutant expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL3116306,NC(Cc1ccc(Cl)c(Cl)c1)(P(=O)(O)O)P(=O)(O)O,IC50,7000.0,5.16,CHEMBL3119248,Inhibition of HIV-1 integrase E138K mutant expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL34249,O=P(O)(O)C(O)(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,35000.0,4.46,CHEMBL3119248,Inhibition of HIV-1 integrase E138K mutant expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL3116306,NC(Cc1ccc(Cl)c(Cl)c1)(P(=O)(O)O)P(=O)(O)O,IC50,7000.0,5.16,CHEMBL3116567,Inhibition of HIV-1 integrase E92Q mutant expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL34249,O=P(O)(O)C(O)(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,35000.0,4.46,CHEMBL3116567,Inhibition of HIV-1 integrase E92Q mutant expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL3116307,O=P(O)(O)C(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,6000.0,5.22,CHEMBL3119255,Inhibition of HIV-1 GST-tagged integrase-His6-tagged LEDGF complex expressed in Escherichia coli BL21(DE3) using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mn2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL3116306,NC(Cc1ccc(Cl)c(Cl)c1)(P(=O)(O)O)P(=O)(O)O,IC50,2000.0,5.7,CHEMBL3119255,Inhibition of HIV-1 GST-tagged integrase-His6-tagged LEDGF complex expressed in Escherichia coli BL21(DE3) using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mn2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL3116305,O=P(O)(O)C(O)(Cc1ccc(Cl)cc1)P(=O)(O)O,IC50,8000.0,5.1,CHEMBL3119255,Inhibition of HIV-1 GST-tagged integrase-His6-tagged LEDGF complex expressed in Escherichia coli BL21(DE3) using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mn2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL34249,O=P(O)(O)C(O)(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,4500.0,5.35,CHEMBL3119255,Inhibition of HIV-1 GST-tagged integrase-His6-tagged LEDGF complex expressed in Escherichia coli BL21(DE3) using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mn2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4500.0,5.346787486224656
CHEMBL3116306,NC(Cc1ccc(Cl)c(Cl)c1)(P(=O)(O)O)P(=O)(O)O,IC50,7000.0,5.16,CHEMBL3116560,Inhibition of HIV-1 GST-tagged integrase-His6-tagged LEDGF complex expressed in Escherichia coli BL21(DE3) using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL3116308,O=P(O)(O)C(Cc1ccc(Cl)c(Cl)c1)(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,800.0,6.1,CHEMBL3116561,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B-2/U5A DNA as substrate assessed as inhibition of strand transfer reaction after 2 hrs by PAGE analysis in presence of Mn2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL3116307,O=P(O)(O)C(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,5000.0,5.3,CHEMBL3116561,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B-2/U5A DNA as substrate assessed as inhibition of strand transfer reaction after 2 hrs by PAGE analysis in presence of Mn2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL3116306,NC(Cc1ccc(Cl)c(Cl)c1)(P(=O)(O)O)P(=O)(O)O,IC50,2000.0,5.7,CHEMBL3116561,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B-2/U5A DNA as substrate assessed as inhibition of strand transfer reaction after 2 hrs by PAGE analysis in presence of Mn2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL3116305,O=P(O)(O)C(O)(Cc1ccc(Cl)cc1)P(=O)(O)O,IC50,6000.0,5.22,CHEMBL3116561,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B-2/U5A DNA as substrate assessed as inhibition of strand transfer reaction after 2 hrs by PAGE analysis in presence of Mn2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL34249,O=P(O)(O)C(O)(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,4000.0,5.4,CHEMBL3116561,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B-2/U5A DNA as substrate assessed as inhibition of strand transfer reaction after 2 hrs by PAGE analysis in presence of Mn2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL3116308,O=P(O)(O)C(Cc1ccc(Cl)c(Cl)c1)(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,16000.0,4.8,CHEMBL3116562,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B-2/U5A DNA as substrate assessed as inhibition of strand transfer reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL3116307,O=P(O)(O)C(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,30000.0,4.52,CHEMBL3116562,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B-2/U5A DNA as substrate assessed as inhibition of strand transfer reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL3116306,NC(Cc1ccc(Cl)c(Cl)c1)(P(=O)(O)O)P(=O)(O)O,IC50,3000.0,5.52,CHEMBL3116562,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B-2/U5A DNA as substrate assessed as inhibition of strand transfer reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL3116305,O=P(O)(O)C(O)(Cc1ccc(Cl)cc1)P(=O)(O)O,IC50,42000.0,4.38,CHEMBL3116562,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B-2/U5A DNA as substrate assessed as inhibition of strand transfer reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42000.0,4.376750709602099
CHEMBL34249,O=P(O)(O)C(O)(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,45000.0,4.35,CHEMBL3116562,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B-2/U5A DNA as substrate assessed as inhibition of strand transfer reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45000.0,4.346787486224656
CHEMBL3116308,O=P(O)(O)C(Cc1ccc(Cl)c(Cl)c1)(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,800.0,6.1,CHEMBL3116566,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mn2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL3116307,O=P(O)(O)C(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,5000.0,5.3,CHEMBL3116566,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mn2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL3116306,NC(Cc1ccc(Cl)c(Cl)c1)(P(=O)(O)O)P(=O)(O)O,IC50,2000.0,5.7,CHEMBL3116566,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mn2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL3116305,O=P(O)(O)C(O)(Cc1ccc(Cl)cc1)P(=O)(O)O,IC50,5000.0,5.3,CHEMBL3116566,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mn2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL34249,O=P(O)(O)C(O)(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,5000.0,5.3,CHEMBL3116566,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mn2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL3116308,O=P(O)(O)C(Cc1ccc(Cl)c(Cl)c1)(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,20000.0,4.7,CHEMBL3116563,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3116307,O=P(O)(O)C(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,30000.0,4.52,CHEMBL3116563,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL3116306,NC(Cc1ccc(Cl)c(Cl)c1)(P(=O)(O)O)P(=O)(O)O,IC50,7000.0,5.16,CHEMBL3116563,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL3116305,O=P(O)(O)C(O)(Cc1ccc(Cl)cc1)P(=O)(O)O,IC50,20000.0,4.7,CHEMBL3116563,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL34249,O=P(O)(O)C(O)(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,35000.0,4.46,CHEMBL3116563,Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B/U5A DNA as substrate assessed as inhibition of 3'-processing reaction after 2 hrs by PAGE analysis in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL3116308,O=P(O)(O)C(Cc1ccc(Cl)c(Cl)c1)(Cc1ccc(Cl)c(Cl)c1)P(=O)(O)O,IC50,100000.0,4.0,CHEMBL3116564,Displacement of [32P]-labeled U5B/U5A DNA from HIV-1 integrase expressed in Escherichia coli in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3116305,O=P(O)(O)C(O)(Cc1ccc(Cl)cc1)P(=O)(O)O,IC50,70000.0,4.16,CHEMBL3116564,Displacement of [32P]-labeled U5B/U5A DNA from HIV-1 integrase expressed in Escherichia coli in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL1978342,O=C(c1ccccc1)c1ccc(C(c2c(O)c3ccccc3oc2=O)c2c(O)c3ccccc3oc2=O)cc1,IC50,27000.0,4.57,CHEMBL3130457,Inhibition of HIV-1 integrase 3'-end processing activity preincubated for 30 mins followed by 5'-end 32P-labeled linear double-stranded oligonucleotide addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27000.0,4.568636235841013
CHEMBL1978342,O=C(c1ccccc1)c1ccc(C(c2c(O)c3ccccc3oc2=O)c2c(O)c3ccccc3oc2=O)cc1,IC50,18000.0,4.75,CHEMBL3130456,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by 5'-end 32P-labeled linear double-stranded oligonucleotide addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL477328,O=C(CN1CCCC1)Nc1ccc(Cc2ccc(NC(=O)CN3CCCC3)cc2)cc1,IC50,7290.0,5.14,CHEMBL3130459,Inhibition of HIV-1 integrase binding to viral DNA by SPR-based competitive assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7290.0,5.137272471682025
CHEMBL30922,COC(=O)[C@H](COC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1)NC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1,IC50,3000.0,5.52,CHEMBL3130461,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL30922,COC(=O)[C@H](COC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1)NC(=O)/C=C/c1ccc(OC(C)=O)c(OC(C)=O)c1,IC50,3000.0,5.52,CHEMBL3130460,Inhibition of HIV-1 integrase 3'-end processing activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL3125968,O=C(NCc1ccc(F)cc1F)c1cc2ccccc2n(O)c1=O,IC50,19700.0,4.71,CHEMBL3132334,Inhibition of HIV-1 integrase-mediated strand transfer activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19700.0,4.705533773838407
CHEMBL3125975,O=C(NCc1ccc(F)cc1F)c1c(O)c2cccnc2[nH]c1=O,IC50,7100.0,5.15,CHEMBL3132334,Inhibition of HIV-1 integrase-mediated strand transfer activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7100.0,5.1487416512809245
CHEMBL3125974,O=C(NCc1ccc(F)c(F)c1)c1c(O)c2cccnc2[nH]c1=O,IC50,8100.0,5.09,CHEMBL3132334,Inhibition of HIV-1 integrase-mediated strand transfer activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8100.0,5.0915149811213505
CHEMBL3125973,O=C(NCc1ccc(F)c(Cl)c1)c1c(O)c2cccnc2[nH]c1=O,IC50,7800.0,5.11,CHEMBL3132334,Inhibition of HIV-1 integrase-mediated strand transfer activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7800.0,5.107905397309519
CHEMBL3125972,O=C(NCc1ccc(F)cc1F)c1c(O)c2cccnc2n(O)c1=O,IC50,55.0,7.26,CHEMBL3132334,Inhibition of HIV-1 integrase-mediated strand transfer activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55.0,7.259637310505756
CHEMBL3125971,O=C(NCc1ccc(F)c(F)c1)c1c(O)c2cccnc2n(O)c1=O,IC50,40.0,7.4,CHEMBL3132334,Inhibition of HIV-1 integrase-mediated strand transfer activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL3125970,O=C(NCc1ccc(F)c(Cl)c1)c1c(O)c2cccnc2n(O)c1=O,IC50,27.0,7.57,CHEMBL3132334,Inhibition of HIV-1 integrase-mediated strand transfer activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27.0,7.568636235841012
CHEMBL3125981,O=C(NCc1ccc(F)cc1F)c1cc2cccnc2n(O)c1=O,IC50,41.0,7.39,CHEMBL3132334,Inhibition of HIV-1 integrase-mediated strand transfer activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41.0,7.3872161432802645
CHEMBL3125980,O=C(NCc1ccc(F)c(F)c1)c1cc2cccnc2n(O)c1=O,IC50,17.0,7.77,CHEMBL3132334,Inhibition of HIV-1 integrase-mediated strand transfer activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17.0,7.769551078621726
CHEMBL3125979,O=C(NCc1ccc(F)c(Cl)c1)c1cc2cccnc2n(O)c1=O,IC50,14.0,7.85,CHEMBL3132334,Inhibition of HIV-1 integrase-mediated strand transfer activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL3125978,O=C(NCc1ccc(F)cc1F)c1cc2cccc(O)c2n(O)c1=O,IC50,18000.0,4.75,CHEMBL3132334,Inhibition of HIV-1 integrase-mediated strand transfer activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL3125977,O=C(NCc1ccc(F)c(F)c1)c1cc2cccc(O)c2n(O)c1=O,IC50,780.0,6.11,CHEMBL3132334,Inhibition of HIV-1 integrase-mediated strand transfer activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,780.0,6.107905397309519
CHEMBL3125976,O=C(NCc1ccc(F)c(Cl)c1)c1cc2cccc(O)c2n(O)c1=O,IC50,530.0,6.28,CHEMBL3132334,Inhibition of HIV-1 integrase-mediated strand transfer activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,530.0,6.275724130399211
CHEMBL3125974,O=C(NCc1ccc(F)c(F)c1)c1c(O)c2cccnc2[nH]c1=O,IC50,93000.0,4.03,CHEMBL3132335,Inhibition of HIV-1 integrase-mediated 3'-processing activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,93000.0,4.031517051446065
CHEMBL3125972,O=C(NCc1ccc(F)cc1F)c1c(O)c2cccnc2n(O)c1=O,IC50,1200.0,5.92,CHEMBL3132335,Inhibition of HIV-1 integrase-mediated 3'-processing activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL3125971,O=C(NCc1ccc(F)c(F)c1)c1c(O)c2cccnc2n(O)c1=O,IC50,3600.0,5.44,CHEMBL3132335,Inhibition of HIV-1 integrase-mediated 3'-processing activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3600.0,5.443697499232712
CHEMBL3125970,O=C(NCc1ccc(F)c(Cl)c1)c1c(O)c2cccnc2n(O)c1=O,IC50,4700.0,5.33,CHEMBL3132335,Inhibition of HIV-1 integrase-mediated 3'-processing activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4700.0,5.327902142064282
CHEMBL3125981,O=C(NCc1ccc(F)cc1F)c1cc2cccnc2n(O)c1=O,IC50,6100.0,5.21,CHEMBL3132335,Inhibition of HIV-1 integrase-mediated 3'-processing activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6100.0,5.214670164989233
CHEMBL3125980,O=C(NCc1ccc(F)c(F)c1)c1cc2cccnc2n(O)c1=O,IC50,13600.0,4.87,CHEMBL3132335,Inhibition of HIV-1 integrase-mediated 3'-processing activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13600.0,4.866461091629782
CHEMBL3125979,O=C(NCc1ccc(F)c(Cl)c1)c1cc2cccnc2n(O)c1=O,IC50,9400.0,5.03,CHEMBL3132335,Inhibition of HIV-1 integrase-mediated 3'-processing activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9400.0,5.026872146400301
CHEMBL3125978,O=C(NCc1ccc(F)cc1F)c1cc2cccc(O)c2n(O)c1=O,IC50,43000.0,4.37,CHEMBL3132335,Inhibition of HIV-1 integrase-mediated 3'-processing activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43000.0,4.366531544420414
CHEMBL3125977,O=C(NCc1ccc(F)c(F)c1)c1cc2cccc(O)c2n(O)c1=O,IC50,24000.0,4.62,CHEMBL3132335,Inhibition of HIV-1 integrase-mediated 3'-processing activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL3125976,O=C(NCc1ccc(F)c(Cl)c1)c1cc2cccc(O)c2n(O)c1=O,IC50,17000.0,4.77,CHEMBL3132335,Inhibition of HIV-1 integrase-mediated 3'-processing activity using [32P]-labeled oligonucleotide as substrate after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL595010,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,IC50,4000.0,5.4,CHEMBL3224593,Inhibition of HIV1 recombinant integrase strand transfer activity using precleaved LTR DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL595912,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],IC50,5600.0,5.25,CHEMBL3224593,Inhibition of HIV1 recombinant integrase strand transfer activity using precleaved LTR DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5600.0,5.251811972993799
CHEMBL593913,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],IC50,3500.0,5.46,CHEMBL3224593,Inhibition of HIV1 recombinant integrase strand transfer activity using precleaved LTR DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3500.0,5.455931955649724
CHEMBL561679,CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,IC50,100000.0,,CHEMBL3224592,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL595682,CCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,IC50,100000.0,,CHEMBL3224592,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4298695,CCCCCCCCCCCCCCCCCCPCCCCCCCCCCCCCC.O=S(=O)(NS(=O)(=O)C(F)(F)F)C(F)(F)F,IC50,100000.0,,CHEMBL3224592,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3222013,CCCCCCCC[N+]1(C)CCCC1,IC50,100000.0,,CHEMBL3224592,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3222014,CCCCCCCC[n+]1ccccc1.[Cl-],IC50,100000.0,,CHEMBL3224592,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3222015,CN(C)C(N(C)C)N(C)C.Cc1ccc(S(=O)(=O)O)cc1,IC50,100000.0,,CHEMBL3224592,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL595682,CCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,IC50,100000.0,,CHEMBL3224594,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4298695,CCCCCCCCCCCCCCCCCCPCCCCCCCCCCCCCC.O=S(=O)(NS(=O)(=O)C(F)(F)F)C(F)(F)F,IC50,100000.0,,CHEMBL3224594,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3222013,CCCCCCCC[N+]1(C)CCCC1,IC50,100000.0,,CHEMBL3224594,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3222014,CCCCCCCC[n+]1ccccc1.[Cl-],IC50,100000.0,,CHEMBL3224594,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3222015,CN(C)C(N(C)C)N(C)C.Cc1ccc(S(=O)(=O)O)cc1,IC50,100000.0,,CHEMBL3224594,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL595010,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,IC50,1600.0,5.8,CHEMBL3224592,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL610767,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],IC50,72000.0,4.14,CHEMBL3224592,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,72000.0,4.142667503568732
CHEMBL3186693,CCCCCCCCCCCCCCn1cc[n+](C)c1.[Cl-],IC50,55200.0,4.26,CHEMBL3224592,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55200.0,4.2580609222708015
CHEMBL595912,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],IC50,2500.0,5.6,CHEMBL3224592,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL593913,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],IC50,1700.0,5.77,CHEMBL3224592,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL594772,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,IC50,1700.0,5.77,CHEMBL3224592,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL3222021,CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC.O=C([O-])C(F)(F)F,IC50,6800.0,5.17,CHEMBL3224592,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6800.0,5.167491087293763
CHEMBL3185210,CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC.O=S(=O)([O-])C(F)(F)F,IC50,9000.0,5.05,CHEMBL3224592,Inhibition of HIV1 recombinant integrase 3' processing activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL561679,CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,IC50,6600.0,5.18,CHEMBL3224594,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6600.0,5.180456064458131
CHEMBL595010,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,IC50,1530.0,5.82,CHEMBL3224594,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1530.0,5.815308569182401
CHEMBL610767,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],IC50,36600.0,4.44,CHEMBL3224594,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36600.0,4.436518914605589
CHEMBL3186693,CCCCCCCCCCCCCCn1cc[n+](C)c1.[Cl-],IC50,20200.0,4.7,CHEMBL3224594,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20200.0,4.694648630553377
CHEMBL595912,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],IC50,1300.0,5.89,CHEMBL3224594,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL593913,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],IC50,1100.0,5.96,CHEMBL3224594,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1100.0,5.958607314841775
CHEMBL594772,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,IC50,1400.0,5.85,CHEMBL3224594,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1400.0,5.853871964321762
CHEMBL593914,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,IC50,42000.0,4.38,CHEMBL3224594,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42000.0,4.376750709602099
CHEMBL3222018,C[N+](C)(C)C.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,IC50,38500.0,4.42,CHEMBL3224594,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38500.0,4.414539270491499
CHEMBL3222021,CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC.O=C([O-])C(F)(F)F,IC50,2800.0,5.55,CHEMBL3224594,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL3185210,CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC.O=S(=O)([O-])C(F)(F)F,IC50,6120.0,5.21,CHEMBL3224594,Inhibition of HIV1 recombinant integrase strand transfer activity using [32P]-radiolabeled full-length DNA as substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6120.0,5.213248577854438
CHEMBL3219143,COc1cc(F)ccc1Cn1ccc2c3c(ncc21)C(=O)N(O)CC3,IC50,40.5,7.39,CHEMBL3225000,Inhibition of HIV1 HXB2 full length amino terminal 6-HIs tagged integrase expressed in Escherichia coli using [3H]thymidine-labeled DNA/biotinylated ds-DNA as substrate assessed as inhibition of strand transfer after 50 mins by scintillation proximity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.5,7.392544976785332
CHEMBL3238120,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCNCC3)ccc2c1=O,IC50,24000.0,4.62,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL3238121,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCN(C)CC3)ccc2c1=O,IC50,600.0,6.22,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL3238122,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCN(CC)CC3)ccc2c1=O,IC50,2400.0,5.62,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2400.0,5.619788758288394
CHEMBL3238123,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCN(C(C)=O)CC3)ccc2c1=O,IC50,170.0,6.77,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,170.0,6.769551078621726
CHEMBL3238124,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCOCC3)ccc2c1=O,IC50,2100.0,5.68,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2100.0,5.6777807052660805
CHEMBL3238125,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N(C)C)ccc2c1=O,IC50,2900.0,5.54,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2900.0,5.537602002101044
CHEMBL3238126,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCN(CCCCl)CC3)ccc2c1=O,IC50,1300.0,5.89,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL3238127,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCNCC3)ccc2c1=O,IC50,2000.0,5.7,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL3238128,CN1CCN(c2ccc3c(=O)c(C(=O)/C=C(\O)C(=O)O)cn(Cc4ccc(F)cc4)c3c2)CC1,IC50,100.0,7.0,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL3238129,CCN1CCN(c2ccc3c(=O)c(C(=O)/C=C(\O)C(=O)O)cn(Cc4ccc(F)cc4)c3c2)CC1,IC50,210.0,6.68,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,210.0,6.6777807052660805
CHEMBL3238130,CC(=O)N1CCN(c2ccc3c(=O)c(C(=O)/C=C(\O)C(=O)O)cn(Cc4ccc(F)cc4)c3c2)CC1,IC50,80.0,7.1,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL3238131,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCSCC3)ccc2c1=O,IC50,360.0,6.44,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,360.0,6.443697499232712
CHEMBL3238132,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCOCC3)ccc2c1=O,IC50,80.0,7.1,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL3238133,CN(C)c1ccc2c(=O)c(C(=O)/C=C(\O)C(=O)O)cn(Cc3ccc(F)cc3)c2c1,IC50,150.0,6.82,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,150.0,6.823908740944319
CHEMBL3238134,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCN(CCCCl)CC3)ccc2c1=O,IC50,50.0,7.3,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL204656,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C,IC50,28.0,7.55,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28.0,7.552841968657781
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,87.0,7.06,CHEMBL3240942,Inhibition of HIV1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,87.0,7.060480747381382
CHEMBL3238121,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCN(C)CC3)ccc2c1=O,IC50,56000.0,4.25,CHEMBL3240943,Inhibition of HIV1 integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56000.0,4.251811972993799
CHEMBL3238123,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCN(C(C)=O)CC3)ccc2c1=O,IC50,17000.0,4.77,CHEMBL3240943,Inhibition of HIV1 integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL3238125,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N(C)C)ccc2c1=O,IC50,41000.0,4.39,CHEMBL3240943,Inhibition of HIV1 integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41000.0,4.3872161432802645
CHEMBL3238127,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCNCC3)ccc2c1=O,IC50,65000.0,4.19,CHEMBL3240943,Inhibition of HIV1 integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65000.0,4.187086643357144
CHEMBL3238128,CN1CCN(c2ccc3c(=O)c(C(=O)/C=C(\O)C(=O)O)cn(Cc4ccc(F)cc4)c3c2)CC1,IC50,8500.0,5.07,CHEMBL3240943,Inhibition of HIV1 integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8500.0,5.070581074285707
CHEMBL3238129,CCN1CCN(c2ccc3c(=O)c(C(=O)/C=C(\O)C(=O)O)cn(Cc4ccc(F)cc4)c3c2)CC1,IC50,23000.0,4.64,CHEMBL3240943,Inhibition of HIV1 integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL3238130,CC(=O)N1CCN(c2ccc3c(=O)c(C(=O)/C=C(\O)C(=O)O)cn(Cc4ccc(F)cc4)c3c2)CC1,IC50,8500.0,5.07,CHEMBL3240943,Inhibition of HIV1 integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8500.0,5.070581074285707
CHEMBL3238131,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCSCC3)ccc2c1=O,IC50,30000.0,4.52,CHEMBL3240943,Inhibition of HIV1 integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL3238132,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCOCC3)ccc2c1=O,IC50,13000.0,4.89,CHEMBL3240943,Inhibition of HIV1 integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL3238133,CN(C)c1ccc2c(=O)c(C(=O)/C=C(\O)C(=O)O)cn(Cc3ccc(F)cc3)c2c1,IC50,5100.0,5.29,CHEMBL3240943,Inhibition of HIV1 integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5100.0,5.292429823902063
CHEMBL3238134,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCN(CCCCl)CC3)ccc2c1=O,IC50,4600.0,5.34,CHEMBL3240943,Inhibition of HIV1 integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4600.0,5.337242168318426
CHEMBL204656,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C,IC50,8100.0,5.09,CHEMBL3240943,Inhibition of HIV1 integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8100.0,5.0915149811213505
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,12800.0,4.89,CHEMBL3240943,Inhibition of HIV1 integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12800.0,4.892790030352131
CHEMBL3233021,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(C(F)(F)F)cc2)c2ccc(Cl)cc12,IC50,260.0,6.58,CHEMBL3242251,Inhibition of HIV-1 integrase strand transfer activity using 3'-end biotin labelled oligonucleotide/5'-end digoxigenin labelled oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,260.0,6.585026652029182
CHEMBL3233898,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(C(F)(F)F)cc2)c2ccc(F)cc12,IC50,1550.0,5.81,CHEMBL3242251,Inhibition of HIV-1 integrase strand transfer activity using 3'-end biotin labelled oligonucleotide/5'-end digoxigenin labelled oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1550.0,5.809668301829708
CHEMBL3233902,Cc1cc(C)c(Cn2cc(C(=O)/C=C(\O)C(=O)O)c3cc(F)ccc32)c(C)c1,IC50,2510.0,5.6,CHEMBL3242251,Inhibition of HIV-1 integrase strand transfer activity using 3'-end biotin labelled oligonucleotide/5'-end digoxigenin labelled oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2510.0,5.600326278518962
CHEMBL3233907,COc1ccc2c(c1)c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cc(C)cc(C)c1,IC50,1090.0,5.96,CHEMBL3242251,Inhibition of HIV-1 integrase strand transfer activity using 3'-end biotin labelled oligonucleotide/5'-end digoxigenin labelled oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1090.0,5.962573502059376
CHEMBL3233908,COc1ccc2c(c1)c(C(=O)/C=C(\O)C(=O)O)cn2Cc1c(C)cc(C)cc1C,IC50,420.0,6.38,CHEMBL3242251,Inhibition of HIV-1 integrase strand transfer activity using 3'-end biotin labelled oligonucleotide/5'-end digoxigenin labelled oligonucleotide as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,420.0,6.376750709602099
CHEMBL1422607,Cc1nc2ccc(Cl)cc2c(-c2ccccc2)c1CC(=O)O,IC50,9100.0,5.04,CHEMBL3266568,Inhibition of HIV1 integrase by LTR cleavage assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9100.0,5.040958607678906
CHEMBL3259885,Cc1nc2ccc(Br)cc2c(-c2ccccc2)c1CC(=O)O,IC50,5100.0,5.29,CHEMBL3266568,Inhibition of HIV1 integrase by LTR cleavage assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5100.0,5.292429823902063
CHEMBL1422813,Cc1nc2ccccc2c(-c2ccccc2)c1CC(=O)O,IC50,24000.0,4.62,CHEMBL3266568,Inhibition of HIV1 integrase by LTR cleavage assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL3259886,Cc1ccc(-c2c(CC(=O)O)c(C)nc3ccc(Br)cc23)cc1,IC50,350.0,6.46,CHEMBL3266568,Inhibition of HIV1 integrase by LTR cleavage assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,350.0,6.455931955649724
CHEMBL3259887,Cc1nc2ccc(Br)cc2c(-c2ccc(Cl)cc2)c1CC(=O)O,IC50,270.0,6.57,CHEMBL3266568,Inhibition of HIV1 integrase by LTR cleavage assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,270.0,6.568636235841012
CHEMBL3259888,Cc1nc2ccccc2c(-c2ccc(Cl)cc2)c1CC(=O)O,IC50,3100.0,5.51,CHEMBL3266568,Inhibition of HIV1 integrase by LTR cleavage assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3100.0,5.508638306165727
CHEMBL3259889,Cc1nc2ccc(Br)cc2c(-c2ccc(Cl)cc2)c1C(C)C(=O)O,IC50,310.0,6.51,CHEMBL3266568,Inhibition of HIV1 integrase by LTR cleavage assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,310.0,6.508638306165727
CHEMBL3259890,CCCC(C(=O)O)c1c(C)nc2ccc(Br)cc2c1-c1ccc(Cl)cc1,IC50,77.0,7.11,CHEMBL3266568,Inhibition of HIV1 integrase by LTR cleavage assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,77.0,7.113509274827518
CHEMBL3259891,COC(C(=O)O)c1c(C)nc2ccc(Br)cc2c1-c1ccc(Cl)cc1,IC50,40.0,7.4,CHEMBL3266568,Inhibition of HIV1 integrase by LTR cleavage assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL3259892,CO[C@@H](C(=O)O)c1c(C)nc2ccc(Br)cc2c1-c1ccc(Cl)cc1,IC50,3100.0,5.51,CHEMBL3266568,Inhibition of HIV1 integrase by LTR cleavage assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3100.0,5.508638306165727
CHEMBL3259893,CO[C@H](C(=O)O)c1c(C)nc2ccc(Br)cc2c1-c1ccc(Cl)cc1,IC50,28.0,7.55,CHEMBL3266568,Inhibition of HIV1 integrase by LTR cleavage assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28.0,7.552841968657781
CHEMBL3288813,O=C(NCc1ccc(F)cc1F)c1c(Nc2ccc(-c3ccccc3)cc2)c2cccnc2n(O)c1=O,IC50,52000.0,4.28,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,52000.0,4.2839966563652006
CHEMBL3288814,O=C(NCc1ccc(F)cc1F)c1c(Nc2ccc3c(c2)Cc2ccccc2-3)c2cccnc2n(O)c1=O,IC50,46000.0,4.34,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,46000.0,4.337242168318426
CHEMBL3288815,N#Cc1ccc(-c2ccc(Nc3c(C(=O)NCc4ccc(F)cc4F)c(=O)n(O)c4ncccc34)cc2)cc1,IC50,70000.0,4.16,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL3288816,Nc1ccc(-c2ccc(Nc3c(C(=O)NCc4ccc(F)cc4F)c(=O)n(O)c4ncccc34)cc2)cc1,IC50,80000.0,4.1,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL3288817,O=C(NCc1ccc(F)cc1F)c1c(Nc2ccccc2)c2cccnc2n(O)c1=O,IC50,6900.0,5.16,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6900.0,5.161150909262744
CHEMBL3288818,CNc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,3700.0,5.43,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3700.0,5.431798275933005
CHEMBL3288819,CN(C)c1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,21000.0,4.68,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL3288820,O=C(NCc1ccc(F)cc1F)c1c(N2CCOCC2)c2cccnc2n(O)c1=O,IC50,77000.0,4.11,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,77000.0,4.113509274827518
CHEMBL3288821,O=C(NCc1ccc(F)cc1F)c1c(NC2CCCCCC2)c2cccnc2n(O)c1=O,IC50,13000.0,4.89,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL3288822,O=C(NCc1ccc(F)cc1F)c1c(NCCc2ccccc2)c2cccnc2n(O)c1=O,IC50,8000.0,5.1,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL3288823,O=C(NCc1ccc(F)cc1F)c1c(NCCCCc2ccccc2)c2cccnc2n(O)c1=O,IC50,12000.0,4.92,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL3288824,CCCCCNc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,8200.0,5.09,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8200.0,5.086186147616283
CHEMBL3288825,CC(C)Nc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,1800.0,5.75,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL3288826,NCCNc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,4500.0,5.35,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4500.0,5.346787486224656
CHEMBL3288827,O=C(NCc1ccc(F)cc1F)c1c(NCCO)c2cccnc2n(O)c1=O,IC50,550.0,6.26,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,550.0,6.259637310505756
CHEMBL3288828,CC(=O)OCCNc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,5300.0,5.28,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5300.0,5.275724130399211
CHEMBL3288829,COC(=O)CNc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,710.0,6.15,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,710.0,6.1487416512809245
CHEMBL3288830,COC(=O)[C@H](C)Nc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,7400.0,5.13,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7400.0,5.130768280269024
CHEMBL3288831,COC(=O)[C@@H](C)Nc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,5800.0,5.24,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5800.0,5.236572006437063
CHEMBL3288832,COC(=O)[C@@H](Nc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12)c1ccccc1,IC50,16700.0,4.78,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16700.0,4.777283528852417
CHEMBL3288833,COC(=O)[C@H](Nc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12)c1ccccc1,IC50,13500.0,4.87,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13500.0,4.8696662315049934
CHEMBL3288834,COC(=O)[C@H](CO)Nc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,5800.0,5.24,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5800.0,5.236572006437063
CHEMBL3288835,COC(=O)[C@@H](CO)Nc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,4400.0,5.36,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4400.0,5.356547323513812
CHEMBL3288836,CCOC(=O)[C@@H]1CCCN1c1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,86000.0,4.07,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,86000.0,4.0655015487564325
CHEMBL3288837,Nc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,2500.0,5.6,CHEMBL3295658,Inhibition of 3'-processing activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL3288813,O=C(NCc1ccc(F)cc1F)c1c(Nc2ccc(-c3ccccc3)cc2)c2cccnc2n(O)c1=O,IC50,340.0,6.47,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,340.0,6.468521082957745
CHEMBL3288814,O=C(NCc1ccc(F)cc1F)c1c(Nc2ccc3c(c2)Cc2ccccc2-3)c2cccnc2n(O)c1=O,IC50,840.0,6.08,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,840.0,6.075720713938118
CHEMBL3288815,N#Cc1ccc(-c2ccc(Nc3c(C(=O)NCc4ccc(F)cc4F)c(=O)n(O)c4ncccc34)cc2)cc1,IC50,130.0,6.89,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL3288816,Nc1ccc(-c2ccc(Nc3c(C(=O)NCc4ccc(F)cc4F)c(=O)n(O)c4ncccc34)cc2)cc1,IC50,130.0,6.89,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL3288817,O=C(NCc1ccc(F)cc1F)c1c(Nc2ccccc2)c2cccnc2n(O)c1=O,IC50,18.0,7.75,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL3288818,CNc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,27.0,7.57,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27.0,7.568636235841012
CHEMBL3288819,CN(C)c1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,87.0,7.06,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,87.0,7.060480747381382
CHEMBL3288820,O=C(NCc1ccc(F)cc1F)c1c(N2CCOCC2)c2cccnc2n(O)c1=O,IC50,79.0,7.1,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,79.0,7.102372908709558
CHEMBL3288821,O=C(NCc1ccc(F)cc1F)c1c(NC2CCCCCC2)c2cccnc2n(O)c1=O,IC50,460.0,6.34,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,460.0,6.337242168318426
CHEMBL3288822,O=C(NCc1ccc(F)cc1F)c1c(NCCc2ccccc2)c2cccnc2n(O)c1=O,IC50,50.0,7.3,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL3288823,O=C(NCc1ccc(F)cc1F)c1c(NCCCCc2ccccc2)c2cccnc2n(O)c1=O,IC50,280.0,6.55,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,280.0,6.552841968657781
CHEMBL3288824,CCCCCNc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,24.0,7.62,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24.0,7.619788758288394
CHEMBL3288825,CC(C)Nc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,16.0,7.8,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16.0,7.795880017344075
CHEMBL3288826,NCCNc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,39.0,7.41,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,39.0,7.4089353929735005
CHEMBL3288827,O=C(NCc1ccc(F)cc1F)c1c(NCCO)c2cccnc2n(O)c1=O,IC50,10.0,8.0,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL3288828,CC(=O)OCCNc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,27.0,7.57,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27.0,7.568636235841012
CHEMBL3288829,COC(=O)CNc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,21.0,7.68,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL3288830,COC(=O)[C@H](C)Nc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,17.0,7.77,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17.0,7.769551078621726
CHEMBL3288831,COC(=O)[C@@H](C)Nc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,27.0,7.57,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27.0,7.568636235841012
CHEMBL3288832,COC(=O)[C@@H](Nc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12)c1ccccc1,IC50,10.0,8.0,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL3288833,COC(=O)[C@H](Nc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12)c1ccccc1,IC50,8.2,8.09,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.2,8.086186147616283
CHEMBL3288834,COC(=O)[C@H](CO)Nc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,8.4,8.08,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.4,8.075720713938118
CHEMBL3288835,COC(=O)[C@@H](CO)Nc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,13.0,7.89,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL3288836,CCOC(=O)[C@@H]1CCCN1c1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,310.0,6.51,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,310.0,6.508638306165727
CHEMBL3288837,Nc1c(C(=O)NCc2ccc(F)cc2F)c(=O)n(O)c2ncccc12,IC50,19.0,7.72,CHEMBL3295659,Inhibition of strand transfer activity of HIV-1 integrase using [gamma-32P]-labeled DNA as substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19.0,7.721246399047171
CHEMBL3286442,O=c1nc(NCc2ccc(F)cc2)c2cccnc2n1O,IC50,3160.0,5.5,CHEMBL3293763,Inhibition of recombinant HIV1 integrase bound with donor DNA-SPA beads using [3H] target DNA as substrate assessed as strand transfer activity preincubated for 60 mins followed by substrate addition measured after 25 to 45 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3160.0,5.500312917381596
CHEMBL3290938,O=c1nc(N2CCC(F)(F)CC2)c2cccnc2n1O,IC50,7940.0,5.1,CHEMBL3293763,Inhibition of recombinant HIV1 integrase bound with donor DNA-SPA beads using [3H] target DNA as substrate assessed as strand transfer activity preincubated for 60 mins followed by substrate addition measured after 25 to 45 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7940.0,5.100179497572904
CHEMBL3290939,O=c1nc(NCC2CC2)c2cccnc2n1O,IC50,3900.0,5.41,CHEMBL3293763,Inhibition of recombinant HIV1 integrase bound with donor DNA-SPA beads using [3H] target DNA as substrate assessed as strand transfer activity preincubated for 60 mins followed by substrate addition measured after 25 to 45 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3900.0,5.4089353929735005
CHEMBL3290940,O=c1nc(Nc2ccc(-c3ccccc3)cc2)c2cccnc2n1O,IC50,790.0,6.1,CHEMBL3293763,Inhibition of recombinant HIV1 integrase bound with donor DNA-SPA beads using [3H] target DNA as substrate assessed as strand transfer activity preincubated for 60 mins followed by substrate addition measured after 25 to 45 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,790.0,6.102372908709558
CHEMBL3290941,O=c1nc(NCc2ccc(-c3ccccc3)cc2)c2cccnc2n1O,IC50,630.0,6.2,CHEMBL3293763,Inhibition of recombinant HIV1 integrase bound with donor DNA-SPA beads using [3H] target DNA as substrate assessed as strand transfer activity preincubated for 60 mins followed by substrate addition measured after 25 to 45 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,630.0,6.200659450546418
CHEMBL3290942,O=c1nc(Nc2ccc(-c3ccncc3)cc2)c2cccnc2n1O,IC50,1990.0,5.7,CHEMBL3293763,Inhibition of recombinant HIV1 integrase bound with donor DNA-SPA beads using [3H] target DNA as substrate assessed as strand transfer activity preincubated for 60 mins followed by substrate addition measured after 25 to 45 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1990.0,5.701146923590294
CHEMBL3290943,O=c1nc(NCc2ccc(-c3ccncc3)cc2)c2cccnc2n1O,IC50,1260.0,5.9,CHEMBL3293763,Inhibition of recombinant HIV1 integrase bound with donor DNA-SPA beads using [3H] target DNA as substrate assessed as strand transfer activity preincubated for 60 mins followed by substrate addition measured after 25 to 45 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1260.0,5.899629454882437
CHEMBL3290944,O=c1nc(Nc2ccc(N3CCOCC3)cc2)c2cccnc2n1O,IC50,500.0,6.3,CHEMBL3293763,Inhibition of recombinant HIV1 integrase bound with donor DNA-SPA beads using [3H] target DNA as substrate assessed as strand transfer activity preincubated for 60 mins followed by substrate addition measured after 25 to 45 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL3290945,O=c1nc(NCc2ccc(N3CCOCC3)cc2)c2cccnc2n1O,IC50,1580.0,5.8,CHEMBL3293763,Inhibition of recombinant HIV1 integrase bound with donor DNA-SPA beads using [3H] target DNA as substrate assessed as strand transfer activity preincubated for 60 mins followed by substrate addition measured after 25 to 45 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1580.0,5.801342913045577
CHEMBL3290946,O=c1nc(Nc2ccc(CN3CCOCC3)cc2)c2cccnc2n1O,IC50,1300.0,5.89,CHEMBL3293763,Inhibition of recombinant HIV1 integrase bound with donor DNA-SPA beads using [3H] target DNA as substrate assessed as strand transfer activity preincubated for 60 mins followed by substrate addition measured after 25 to 45 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL3290947,O=c1nc(NCc2cccc(N3CCOCC3)c2)c2cccnc2n1O,IC50,1990.0,5.7,CHEMBL3293763,Inhibition of recombinant HIV1 integrase bound with donor DNA-SPA beads using [3H] target DNA as substrate assessed as strand transfer activity preincubated for 60 mins followed by substrate addition measured after 25 to 45 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1990.0,5.701146923590294
CHEMBL3290948,O=c1nc(NCc2cccc(CN3CCOCC3)c2)c2cccnc2n1O,IC50,15900.0,4.8,CHEMBL3293763,Inhibition of recombinant HIV1 integrase bound with donor DNA-SPA beads using [3H] target DNA as substrate assessed as strand transfer activity preincubated for 60 mins followed by substrate addition measured after 25 to 45 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15900.0,4.798602875679548
CHEMBL3290936,O=C(NCc1ccc(Cl)cc1)c1ncc2cccnc2c1O,IC50,20000.0,4.7,CHEMBL3293762,Inhibition of recombinant HIV1 N-terminal His6-tagged integrase expressed in Escherichia coli using 32P-labeled preprocessed HIV-1 U5 DNA as substrate assessed as strand transfer activity after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3290937,O=C(O)c1ncc2cccnc2c1O,IC50,11000.0,4.96,CHEMBL3293762,Inhibition of recombinant HIV1 N-terminal His6-tagged integrase expressed in Escherichia coli using 32P-labeled preprocessed HIV-1 U5 DNA as substrate assessed as strand transfer activity after 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL8260,O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12,IC50,7500.0,5.12,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7500.0,5.1249387366083
CHEMBL50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288712,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(OCc3ccc(F)cc3)cc(O)c12,IC50,20000.0,4.7,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288713,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(N3CCOCC3)cc(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,8000.0,5.1,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL3288712,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(OCc3ccc(F)cc3)cc(O)c12,IC50,4000.0,5.4,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL3288713,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(N3CCOCC3)cc(O)c12,IC50,20000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,600.0,6.22,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL3288712,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(OCc3ccc(F)cc3)cc(O)c12,IC50,940.0,6.03,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,940.0,6.026872146400301
CHEMBL3288713,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(N3CCOCC3)cc(O)c12,IC50,970.0,6.01,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,970.0,6.013228265733755
CHEMBL3288714,O=c1cc(-c2ccccc2)oc2cc(OCc3ccc(F)cc3)c(O)c(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288946,O=c1cc(-c2ccc(O)cc2)oc2cc(OCc3ccc(F)cc3)cc(O)c12,IC50,80000.0,4.1,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL28,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288943,CC(C)(C)Oc1cc2oc(-c3ccccc3)cc(=O)c2c(O)c1O,IC50,100000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL151,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288944,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(OCc3ccc(F)cc3)cc(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288945,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(N3CCOCC3)cc(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL8260,O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12,IC50,780.0,6.11,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,780.0,6.107905397309519
CHEMBL3288714,O=c1cc(-c2ccccc2)oc2cc(OCc3ccc(F)cc3)c(O)c(O)c12,IC50,7000.0,5.16,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL3288943,CC(C)(C)Oc1cc2oc(-c3ccccc3)cc(=O)c2c(O)c1O,IC50,100000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL151,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,8900.0,5.05,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8900.0,5.050609993355087
CHEMBL3288944,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(OCc3ccc(F)cc3)cc(O)c12,IC50,20000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288945,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(N3CCOCC3)cc(O)c12,IC50,20000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL8260,O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12,IC50,2700.0,5.57,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2700.0,5.568636235841012
CHEMBL3288714,O=c1cc(-c2ccccc2)oc2cc(OCc3ccc(F)cc3)c(O)c(O)c12,IC50,20000.0,,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288943,CC(C)(C)Oc1cc2oc(-c3ccccc3)cc(=O)c2c(O)c1O,IC50,20000.0,,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL151,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,450.0,6.35,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,450.0,6.346787486224656
CHEMBL3288945,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(N3CCOCC3)cc(O)c12,IC50,1600.0,5.8,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL3288947,CC(C)(C)Oc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288948,O=c1cc(-c2ccc(O)cc2)oc2cc(N3CCOCC3)cc(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL117,O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288949,O=c1cc(-c2ccccc2)oc2cc(OCc3ccc(F)cc3)cc(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288950,CC(C)(C)Oc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,IC50,100000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3288951,O=c1cc(-c2ccccc2)oc2cc(N3CCOCC3)cc(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL9352,O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O)cc(O)c21,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288952,O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(OCc3ccc(F)cc3)cc(O)c21,IC50,100000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3288953,CC(C)(C)Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)cc1)CC2=O,IC50,100000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL44,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288954,O=c1c(-c2ccc(O)cc2)coc2cc(OCc3ccc(F)cc3)cc(O)c12,IC50,100000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3288955,CC(C)(C)Oc1cc(O)c2c(=O)c(-c3ccc(O)cc3)coc2c1,IC50,100000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3288956,O=c1c(-c2ccc(O)cc2)coc2cc(N3CCOCC3)cc(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288957,O=c1c(O)c(-c2ccc3c(c2)OC(c2ccccc2)(c2ccccc2)O3)oc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL28,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288946,O=c1cc(-c2ccc(O)cc2)oc2cc(OCc3ccc(F)cc3)cc(O)c12,IC50,35000.0,4.46,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL3288947,CC(C)(C)Oc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1,IC50,20000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288948,O=c1cc(-c2ccc(O)cc2)oc2cc(N3CCOCC3)cc(O)c12,IC50,20000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL117,O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288949,O=c1cc(-c2ccccc2)oc2cc(OCc3ccc(F)cc3)cc(O)c12,IC50,20000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288950,CC(C)(C)Oc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,IC50,50000.0,4.3,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL3288951,O=c1cc(-c2ccccc2)oc2cc(N3CCOCC3)cc(O)c12,IC50,20000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL9352,O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O)cc(O)c21,IC50,20000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288952,O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(OCc3ccc(F)cc3)cc(O)c21,IC50,100000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3288953,CC(C)(C)Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)cc1)CC2=O,IC50,100000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL44,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288954,O=c1c(-c2ccc(O)cc2)coc2cc(OCc3ccc(F)cc3)cc(O)c12,IC50,80000.0,4.1,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80000.0,4.096910013008056
CHEMBL3288955,CC(C)(C)Oc1cc(O)c2c(=O)c(-c3ccc(O)cc3)coc2c1,IC50,70000.0,4.16,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL3288956,O=c1c(-c2ccc(O)cc2)coc2cc(N3CCOCC3)cc(O)c12,IC50,20000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL28,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,IC50,1500.0,5.82,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1500.0,5.823908740944319
CHEMBL3288946,O=c1cc(-c2ccc(O)cc2)oc2cc(OCc3ccc(F)cc3)cc(O)c12,IC50,20000.0,,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288947,CC(C)(C)Oc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1,IC50,20000.0,,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288948,O=c1cc(-c2ccc(O)cc2)oc2cc(N3CCOCC3)cc(O)c12,IC50,1700.0,5.77,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL117,O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12,IC50,1400.0,5.85,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1400.0,5.853871964321762
CHEMBL3288949,O=c1cc(-c2ccccc2)oc2cc(OCc3ccc(F)cc3)cc(O)c12,IC50,20000.0,,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288950,CC(C)(C)Oc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,IC50,20000.0,,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288951,O=c1cc(-c2ccccc2)oc2cc(N3CCOCC3)cc(O)c12,IC50,20000.0,,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL9352,O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O)cc(O)c21,IC50,1700.0,5.77,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL3288953,CC(C)(C)Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)cc1)CC2=O,IC50,20000.0,,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL44,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,IC50,1100.0,5.96,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1100.0,5.958607314841775
CHEMBL3288954,O=c1c(-c2ccc(O)cc2)coc2cc(OCc3ccc(F)cc3)cc(O)c12,IC50,20000.0,,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288955,CC(C)(C)Oc1cc(O)c2c(=O)c(-c3ccc(O)cc3)coc2c1,IC50,20000.0,,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288956,O=c1c(-c2ccc(O)cc2)coc2cc(N3CCOCC3)cc(O)c12,IC50,1700.0,5.77,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1700.0,5.769551078621726
CHEMBL3288957,O=c1c(O)c(-c2ccc3c(c2)OC(c2ccccc2)(c2ccccc2)O3)oc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288957,O=c1c(O)c(-c2ccc3c(c2)OC(c2ccccc2)(c2ccccc2)O3)oc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3286423,O=c1c(OCc2ccc(F)cc2)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288958,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(OCc3ccc(F)cc3)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288959,O=c1c(O)c(-c2ccc(O)c(OCc3ccc(F)cc3)c2)oc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288960,O=c1c(O)c(-c2ccc(OCc3ccc(F)cc3)c(O)c2)oc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294261,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3286423,O=c1c(OCc2ccc(F)cc2)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288958,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(OCc3ccc(F)cc3)c12,IC50,7600.0,5.12,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7600.0,5.119186407719209
CHEMBL3288959,O=c1c(O)c(-c2ccc(O)c(OCc3ccc(F)cc3)c2)oc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3288960,O=c1c(O)c(-c2ccc(OCc3ccc(F)cc3)c(O)c2)oc2cc(O)cc(O)c12,IC50,20000.0,,CHEMBL3294262,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3286423,O=c1c(OCc2ccc(F)cc2)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,380.0,6.42,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,380.0,6.42021640338319
CHEMBL3288958,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(OCc3ccc(F)cc3)c12,IC50,1800.0,5.75,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL3288959,O=c1c(O)c(-c2ccc(O)c(OCc3ccc(F)cc3)c2)oc2cc(O)cc(O)c12,IC50,1800.0,5.75,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL3288960,O=c1c(O)c(-c2ccc(OCc3ccc(F)cc3)c(O)c2)oc2cc(O)cc(O)c12,IC50,1400.0,5.85,CHEMBL3294266,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1400.0,5.853871964321762
CHEMBL3288272,COc1ccc2c(c1)C(=O)N(O)C(=O)C2C(=O)NCc1ccc(F)cc1,IC50,260.0,6.58,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,260.0,6.585026652029182
CHEMBL3288273,COc1ccc2c(C(=O)NCc3ccc(F)cc3)c(O)n(O)c(=O)c2c1,IC50,10.0,8.0,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL3288274,O=C(NCc1ccc(F)cc1)c1c(O)n(O)c(=O)c2ccc([N+](=O)[O-])cc12,IC50,30.0,7.52,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL3288275,Nc1ccc2c(c1)C(=O)N(O)C(=O)C2C(=O)NCc1ccc(F)cc1,IC50,110.0,6.96,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL3288276,O=C(NCc1ccc(F)cc1)C1C(=O)N(O)C(=O)c2cc(F)ccc21,IC50,240.0,6.62,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,240.0,6.619788758288394
CHEMBL3288277,O=C(NCc1ccc(F)cc1)C1C(=O)N(O)C(=O)c2ccc(F)cc21,IC50,240.0,6.62,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,240.0,6.619788758288394
CHEMBL3288278,O=C(NCc1ccc(F)cc1)C1C(=O)N(O)C(=O)c2c(F)cccc21,IC50,880.0,6.06,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,880.0,6.055517327849831
CHEMBL3288279,O=C(NCc1ccc(F)cc1)C1C(=O)N(O)C(=O)c2cc(Cl)ccc21,IC50,140.0,6.85,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,140.0,6.853871964321762
CHEMBL3288280,O=C(NCc1ccc(F)cc1)C1C(=O)N(O)C(=O)c2cc(Br)ccc21,IC50,60.0,7.22,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL3288281,O=C(NCc1ccc(F)cc1)C1C(=O)N(O)C(=O)c2cc(C(F)(F)F)ccc21,IC50,20.0,7.7,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL3288282,N#Cc1ccc2c(C(=O)NCc3ccc(F)cc3)c(O)n(O)c(=O)c2c1,IC50,70.0,7.16,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL3288270,CC(=O)Nc1ccc2c(c1)C(=O)N(O)C(=O)C2C(=O)NCc1ccc(F)cc1,IC50,100.0,7.0,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL3288271,O=C(Nc1ccc2c(c1)C(=O)N(O)C(=O)C2C(=O)NCc1ccc(F)cc1)c1ccccc1,IC50,80.0,7.1,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL3288261,O=C(Nc1ccc2c(c1)C(=O)N(O)C(=O)C2C(=O)NCc1ccc(F)cc1)c1ccccn1,IC50,160.0,6.8,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,160.0,6.795880017344075
CHEMBL3288262,O=C(Cc1ccccc1)Nc1ccc2c(c1)C(=O)N(O)C(=O)C2C(=O)NCc1ccc(F)cc1,IC50,230.0,6.64,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,230.0,6.638272163982407
CHEMBL3288263,O=C(Cc1cccs1)Nc1ccc2c(c1)C(=O)N(O)C(=O)C2C(=O)NCc1ccc(F)cc1,IC50,60.0,7.22,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL3288264,CCCCCCNC(=O)c1c(O)n(O)c(=O)c2cc([N+](=O)[O-])ccc12,IC50,60.0,7.22,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL3286416,O=C(Nc1ccccc1)c1c(O)n(O)c(=O)c2cc([N+](=O)[O-])ccc12,IC50,10.0,8.0,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL3288265,O=C(NCc1ccccc1)c1c(O)n(O)c(=O)c2cc([N+](=O)[O-])ccc12,IC50,10.0,8.0,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL3288266,O=C(Nc1ccc(F)cc1)c1c(O)n(O)c(=O)c2cc([N+](=O)[O-])ccc12,IC50,30.0,7.52,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL3288267,O=C(NCCc1ccc(F)cc1)c1c(O)n(O)c(=O)c2cc([N+](=O)[O-])ccc12,IC50,60.0,7.22,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL3288268,COc1ccc(CNC(=O)c2c(O)n(O)c(=O)c3cc([N+](=O)[O-])ccc23)cc1,IC50,10.0,8.0,CHEMBL3294150,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL3360116,Cn1c(C2CCOCC2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,5.0,8.3,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL3360115,Cn1c(C2(C)CCCS2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,5.0,8.3,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL3360114,Cn1c(C2(C)CCCO2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,5.0,8.3,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL3360113,CSC1COCC1c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,3.0,8.52,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL3360112,Cn1c(C2COCC2O)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,6.0,8.22,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL3360111,Cn1c(C2CCOC2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,4.0,8.4,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL3360110,Cn1c(C2=CCOC2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,19.0,7.72,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19.0,7.721246399047171
CHEMBL3360109,Cn1c(-c2ccco2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,21.0,7.68,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL3360117,Cn1c(C2CCCCO2)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,IC50,10.0,8.0,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL3360118,Cn1c(C2CCOC2)nc(C(=O)NCc2ccc(F)cc2S(C)(=O)=O)c(O)c1=O,IC50,9.0,8.05,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL3360119,CN(C)S(=O)(=O)c1cc(F)ccc1CNC(=O)c1nc(C2CCOC2)n(C)c(=O)c1O,IC50,10.0,8.0,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL3360120,Cn1c(C2CCOC2)nc(C(=O)NCc2ccc(F)cc2N2CCCCS2(=O)=O)c(O)c1=O,IC50,9.0,8.05,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL3360121,Cn1c(C2CCOC2)nc(C(=O)NCc2ccc(F)cc2-n2cncn2)c(O)c1=O,IC50,4.0,8.4,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL3360122,Cc1ncnn1-c1cc(F)ccc1CNC(=O)c1nc(C2CCOC2)n(C)c(=O)c1O,IC50,12.0,7.92,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL3360123,Cc1cnnn1-c1cc(F)ccc1CNC(=O)c1nc(C2CCOC2)n(C)c(=O)c1O,IC50,10.0,8.0,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL3360124,Cn1ncnc1-c1cc(F)ccc1CNC(=O)c1nc(C2CCOC2)n(C)c(=O)c1O,IC50,6.0,8.22,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL3352894,Cn1cnnc1-c1cc(F)ccc1CNC(=O)c1nc(C2CCOC2)n(C)c(=O)c1O,IC50,18.0,7.75,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL3360125,Cn1c(C2CCOC2)nc(C(=O)NCc2ccc(F)cc2N2CCN(C(C)(C)C)S2(=O)=O)c(O)c1=O,IC50,16.0,7.8,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16.0,7.795880017344075
CHEMBL3360126,CN1C(C)(C)CN(c2cc(F)ccc2CNC(=O)c2nc(C3CCOC3)n(C)c(=O)c2O)S1(=O)=O,IC50,10.0,8.0,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL3360127,CN1CCN(c2cc(F)ccc2CNC(=O)c2nc(C3CCOC3)n(C)c(=O)c2O)C1=O,IC50,6.0,8.22,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL3360128,COCCN1CCN(c2cc(F)ccc2CNC(=O)c2nc(C3CCOC3)n(C)c(=O)c2O)C1=O,IC50,3.0,8.52,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL3360129,Cn1c(C2CCOCC2)nc(C(=O)NCc2ccc(F)cc2S(C)(=O)=O)c(O)c1=O,IC50,8.0,8.1,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL3360130,CN(C)S(=O)(=O)c1cc(F)ccc1CNC(=O)c1nc(C2CCOCC2)n(C)c(=O)c1O,IC50,12.0,7.92,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL3360131,Cn1c(C2CCOCC2)nc(C(=O)NCc2ccc(F)cc2N2CCCCS2(=O)=O)c(O)c1=O,IC50,11.0,7.96,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL3360132,Cn1c(C2CCOCC2)nc(C(=O)NCc2ccc(F)cc2-n2cncn2)c(O)c1=O,IC50,6.0,8.22,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL3360133,Cc1ncnn1-c1cc(F)ccc1CNC(=O)c1nc(C2CCOCC2)n(C)c(=O)c1O,IC50,8.0,8.1,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL3360134,Cc1cnnn1-c1cc(F)ccc1CNC(=O)c1nc(C2CCOCC2)n(C)c(=O)c1O,IC50,13.0,7.89,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL3360135,Cn1ncnc1-c1cc(F)ccc1CNC(=O)c1nc(C2CCOCC2)n(C)c(=O)c1O,IC50,9.0,8.05,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL3360136,Cn1c(C2CCOCC2)nc(C(=O)NCc2ccc(F)cc2N2CCN(C(C)(C)C)S2(=O)=O)c(O)c1=O,IC50,17.0,7.77,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17.0,7.769551078621726
CHEMBL3360137,CN1C(C)(C)CN(c2cc(F)ccc2CNC(=O)c2nc(C3CCOCC3)n(C)c(=O)c2O)S1(=O)=O,IC50,6.0,8.22,CHEMBL3373530,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL3353126,COc1cccc2c1c(C(=O)/C=C(\O)C(=O)O)cn2Cc1cc(C)cc(C)c1,IC50,5490.0,5.26,CHEMBL3388739,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5490.0,5.260427655549908
CHEMBL1270993,Cc1cc(C)cc(Cn2cc(C(=O)/C=C(\O)C(=O)O)c3c(O)cccc32)c1,IC50,3500.0,5.46,CHEMBL3388738,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3500.0,5.455931955649724
CHEMBL3310415,COCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)N2CCN(C)CC2)c1=O,IC50,28.0,7.55,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28.0,7.552841968657781
CHEMBL3310414,COCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)N2CCOCC2)c1=O,IC50,7.6,8.12,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.6,8.119186407719209
CHEMBL3310413,COCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)N2CCCCC2)c1=O,IC50,4.7,8.33,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.7,8.327902142064282
CHEMBL3310412,COCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)N2CCCC2)c1=O,IC50,42.0,7.38,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42.0,7.376750709602099
CHEMBL3310411,COCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)NCCN(C)C)c1=O,IC50,45.0,7.35,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45.0,7.346787486224656
CHEMBL3310410,COCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)NCC(F)(F)F)c1=O,IC50,11.0,7.96,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL3310409,COCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)NC(C)C)c1=O,IC50,6.2,8.21,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.2,8.207608310501746
CHEMBL3310098,COCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)NC2CCC2)c1=O,IC50,8.5,8.07,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.5,8.070581074285707
CHEMBL3310097,COCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)NC2CC2)c1=O,IC50,7.3,8.14,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.3,8.136677139879545
CHEMBL3310091,CN(C)C(=O)Cn1c(=O)c(C(=O)NC2(CO)CCCC2)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,23.0,7.64,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23.0,7.638272163982407
CHEMBL3310092,C[C@@H](O)CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)N(C)C)c1=O,IC50,9.2,8.04,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.2,8.036212172654444
CHEMBL3310093,C[C@H](O)CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)N(C)C)c1=O,IC50,4.1,8.39,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.1,8.387216143280265
CHEMBL3310094,CN(C)C(=O)Cn1c(=O)c(C(=O)NCCN2CCOCC2)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,8.6,8.07,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.6,8.065501548756432
CHEMBL3310095,COCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(N)=O)c1=O,IC50,7.7,8.11,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.7,8.113509274827518
CHEMBL3310096,CNC(=O)Cn1c(=O)c(C(=O)NCCOC)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,9.0,8.05,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL3310082,CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)NCCOC)c1=O,IC50,6.8,8.17,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.8,8.167491087293763
CHEMBL3310083,CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)NCCN(C)C)c1=O,IC50,22.0,7.66,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22.0,7.657577319177793
CHEMBL3310084,CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)NOC)c1=O,IC50,5.7,8.24,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.7,8.244125144327509
CHEMBL3310085,CN(C)C(=O)Cn1c(=O)c(C(=O)NC2CC2)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,3.0,8.52,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL3310086,CN(C)C(=O)Cn1c(=O)c(C(=O)NCCO)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,5.7,8.24,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.7,8.244125144327509
CHEMBL3310087,COCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)N(C)C)c1=O,IC50,4.0,8.4,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL3310088,C[C@H](CO)NC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)N(C)C)c1=O,IC50,8.6,8.07,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.6,8.065501548756432
CHEMBL3310089,C[C@@H](CO)NC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)N(C)C)c1=O,IC50,7.1,8.15,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.1,8.148741651280925
CHEMBL3310090,CN(C)C(=O)Cn1c(=O)c(C(=O)NC(C)(C)CO)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,6.5,8.19,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.5,8.187086643357144
CHEMBL3310080,CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)NCC2CC2)c1=O,IC50,8.0,8.1,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL3310081,CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)NCC(F)(F)F)c1=O,IC50,7.1,8.15,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.1,8.148741651280925
CHEMBL3310079,CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)NC(C)(C)C)c1=O,IC50,6.9,8.16,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.9,8.161150909262744
CHEMBL3309906,CCN(CC)C(=O)Cn1c(=O)c(C(=O)NC)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,4.4,8.36,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.4,8.356547323513812
CHEMBL3309907,CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)N2CCCC2)c1=O,IC50,13.0,7.89,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL3310076,CCCNC(=O)Cn1c(=O)c(C(=O)NC)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,9.2,8.04,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.2,8.036212172654444
CHEMBL3310077,CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)NC(C)C)c1=O,IC50,7.8,8.11,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.8,8.10790539730952
CHEMBL3310078,CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)NC2CC2)c1=O,IC50,4.4,8.36,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.4,8.356547323513812
CHEMBL3309905,CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(=O)N(C)C)c1=O,IC50,9.3,8.03,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.3,8.031517051446064
CHEMBL3309268,CCNC(=O)Cn1c(=O)c(C(=O)NC)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,8.2,8.09,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.2,8.086186147616283
CHEMBL3309904,CNC(=O)Cn1c(=O)c(C(=O)NC)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,9.3,8.03,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.3,8.031517051446064
CHEMBL3309903,CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(CC(N)=O)c1=O,IC50,7.6,8.12,CHEMBL3369753,Inhibition of recombinant HIV-1 integrase by strand-transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.6,8.119186407719209
CHEMBL3334637,Cc1ccc(CNC(=O)c2nc(-c3ccc(F)cc3)[nH]c(=O)c2O)cc1C,IC50,500.0,6.3,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL3334636,O=C(NCc1ccc(F)c(F)c1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,1000.0,6.0,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL3334635,O=C(NCc1ccc(Br)cc1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,500.0,6.3,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,500.0,6.301029995663981
CHEMBL3334634,O=C(NCc1ccc(Cl)cc1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,800.0,6.1,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL3334633,O=C(NCc1ccc(F)cc1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,600.0,6.22,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL3334652,O=C(NCc1ccc(F)cc1)c1nc(-c2cccc(F)c2)[nH]c(=O)c1O,IC50,5000.0,5.3,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL3334651,O=C(NCc1ccc(F)cc1)c1nc(-c2ccc(Br)cc2)[nH]c(=O)c1O,IC50,3000.0,5.52,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL3334650,O=C(NCc1ccc(F)cc1)c1nc(-c2ccccc2F)[nH]c(=O)c1O,IC50,16000.0,4.8,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL3334649,O=C(NCc1ccc(F)cc1)c1nc(-c2ccc(Cl)cc2)[nH]c(=O)c1O,IC50,5000.0,5.3,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL3334648,O=C(NCc1ccc(F)cc1)c1nc(Cc2ccc(F)cc2)[nH]c(=O)c1O,IC50,20000.0,,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3334647,O=C(NCc1ccc(F)cc1)c1nc(-c2ccccc2)[nH]c(=O)c1O,IC50,17000.0,4.77,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL385951,O=C(NCc1ccccc1)c1nc(-c2ccccc2)nc(O)c1O,IC50,20000.0,,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3334646,O=C(NCc1cc(F)c(F)c(F)c1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,14000.0,4.85,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL3334645,O=C(NCc1ccc(F)c(Cl)c1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,6000.0,5.22,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL3334644,O=C(NCc1cccc(Cl)c1F)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,13000.0,4.89,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL3334643,O=C(NCc1ccccc1F)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,20000.0,4.7,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3334642,O=C(NCc1cccc(F)c1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,20000.0,4.7,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3334641,O=C(NCc1ccc(O)cc1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,20000.0,,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3334640,O=C(NCc1cccc(Cl)c1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,20000.0,4.7,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3334639,O=C(NCCc1ccc(F)cc1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,17000.0,4.77,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL3334638,COc1ccc(CNC(=O)c2nc(-c3ccc(F)cc3)[nH]c(=O)c2O)cc1,IC50,16000.0,4.8,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL3334637,Cc1ccc(CNC(=O)c2nc(-c3ccc(F)cc3)[nH]c(=O)c2O)cc1C,IC50,16000.0,4.8,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL3334636,O=C(NCc1ccc(F)c(F)c1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,17000.0,4.77,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL3334635,O=C(NCc1ccc(Br)cc1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,11000.0,4.96,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL3334634,O=C(NCc1ccc(Cl)cc1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,9000.0,5.05,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL3334633,O=C(NCc1ccc(F)cc1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,12000.0,4.92,CHEMBL3373171,Inhibition of HIV1 recombinant wild type integrase 3'-processing activity by gel-based assays,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL3334638,COc1ccc(CNC(=O)c2nc(-c3ccc(F)cc3)[nH]c(=O)c2O)cc1,IC50,2000.0,5.7,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL3334639,O=C(NCCc1ccc(F)cc1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,4000.0,5.4,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL3334640,O=C(NCc1cccc(Cl)c1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,1400.0,5.85,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1400.0,5.853871964321762
CHEMBL3334641,O=C(NCc1ccc(O)cc1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,6000.0,5.22,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL3334642,O=C(NCc1cccc(F)c1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,3000.0,5.52,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL3334643,O=C(NCc1ccccc1F)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,7000.0,5.16,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL3334644,O=C(NCc1cccc(Cl)c1F)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,1400.0,5.85,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1400.0,5.853871964321762
CHEMBL3334645,O=C(NCc1ccc(F)c(Cl)c1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,4000.0,5.4,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL3334646,O=C(NCc1cc(F)c(F)c(F)c1)c1nc(-c2ccc(F)cc2)[nH]c(=O)c1O,IC50,8000.0,5.1,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL385951,O=C(NCc1ccccc1)c1nc(-c2ccccc2)nc(O)c1O,IC50,8000.0,5.1,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL3334647,O=C(NCc1ccc(F)cc1)c1nc(-c2ccccc2)[nH]c(=O)c1O,IC50,1000.0,6.0,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL3334648,O=C(NCc1ccc(F)cc1)c1nc(Cc2ccc(F)cc2)[nH]c(=O)c1O,IC50,10000.0,5.0,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL3334649,O=C(NCc1ccc(F)cc1)c1nc(-c2ccc(Cl)cc2)[nH]c(=O)c1O,IC50,2000.0,5.7,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL3334650,O=C(NCc1ccc(F)cc1)c1nc(-c2ccccc2F)[nH]c(=O)c1O,IC50,2000.0,5.7,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL3334651,O=C(NCc1ccc(F)cc1)c1nc(-c2ccc(Br)cc2)[nH]c(=O)c1O,IC50,1000.0,6.0,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL3334652,O=C(NCc1ccc(F)cc1)c1nc(-c2cccc(F)c2)[nH]c(=O)c1O,IC50,1000.0,6.0,CHEMBL3373172,Inhibition of HIV1 recombinant wild type integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,1800.0,5.75,CHEMBL3399229,Inhibition of HIV-1 integrase after 1 hr by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL3397854,COc1c(C(=O)N2CCN(CCCNC(=O)c3ccc(O)c(O)c3)CC2)nc(Cc2ccc(O)cc2)n(C)c1=O,IC50,100000.0,,CHEMBL3399229,Inhibition of HIV-1 integrase after 1 hr by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3397853,COc1c(C(=O)N2CCN(CCCNC(=O)c3ccc(O)c(O)c3)CC2)nc(Cc2ccc(F)cc2)n(C)c1=O,IC50,100000.0,,CHEMBL3399229,Inhibition of HIV-1 integrase after 1 hr by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3397852,COc1c(C(=O)N2CCN(CCCNC(=O)c3ccc(O)c(O)c3)CC2)nc(Cc2ccccc2)n(C)c1=O,IC50,100000.0,,CHEMBL3399229,Inhibition of HIV-1 integrase after 1 hr by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3397851,COc1c(C(=O)N2CCN(CCNC(=O)c3cc(O)c(O)c(O)c3)CC2)nc(Cc2ccc(O)cc2)n(C)c1=O,IC50,700.0,6.16,CHEMBL3399229,Inhibition of HIV-1 integrase after 1 hr by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL3397850,COc1c(C(=O)N2CCN(CCNC(=O)c3cc(O)c(O)c(O)c3)CC2)nc(Cc2ccc(F)cc2)n(C)c1=O,IC50,2500.0,5.6,CHEMBL3399229,Inhibition of HIV-1 integrase after 1 hr by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL3397849,COc1c(C(=O)N2CCN(CCNC(=O)c3cc(O)c(O)c(O)c3)CC2)nc(Cc2ccccc2)n(C)c1=O,IC50,18600.0,4.73,CHEMBL3399229,Inhibition of HIV-1 integrase after 1 hr by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18600.0,4.730487055782084
CHEMBL3397848,COc1c(C(=O)N2CCN(CCCNC(=O)c3cc(O)c(O)c(O)c3)CC2)nc(Cc2ccc(Cl)c(Cl)c2)n(C)c1=O,IC50,22400.0,4.65,CHEMBL3399229,Inhibition of HIV-1 integrase after 1 hr by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22400.0,4.649751981665837
CHEMBL3397847,COc1c(C(=O)N2CCN(CCCNC(=O)c3cc(O)c(O)c(O)c3)CC2)nc(Cc2ccc(C)cc2)n(C)c1=O,IC50,3500.0,5.46,CHEMBL3399229,Inhibition of HIV-1 integrase after 1 hr by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3500.0,5.455931955649724
CHEMBL3397846,COc1c(C(=O)N2CCN(CCCNC(=O)c3cc(O)c(O)c(O)c3)CC2)nc(Cc2ccc(F)cc2)n(C)c1=O,IC50,18900.0,4.72,CHEMBL3399229,Inhibition of HIV-1 integrase after 1 hr by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18900.0,4.723538195826756
CHEMBL3397845,COc1c(C(=O)N2CCN(CCCNC(=O)c3cc(O)c(O)c(O)c3)CC2)nc(Cc2ccc(Cl)cc2)n(C)c1=O,IC50,2400.0,5.62,CHEMBL3399229,Inhibition of HIV-1 integrase after 1 hr by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2400.0,5.619788758288394
CHEMBL3397844,COc1c(C(=O)N2CCN(CCCNC(=O)c3cc(O)c(O)c(O)c3)CC2)nc(Cc2ccccc2)n(C)c1=O,IC50,900.0,6.05,CHEMBL3399229,Inhibition of HIV-1 integrase after 1 hr by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL3414857,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1O,IC50,3800.0,5.42,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3800.0,5.42021640338319
CHEMBL3414858,Cc1ccc(Cc2ccc3c(c2)CC(=O)N(O)C3=O)cc1,IC50,36000.0,4.44,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36000.0,4.443697499232713
CHEMBL3414859,O=C1Cc2cc(Cc3ccc(F)cc3)ccc2C(=O)N1O,IC50,36000.0,4.44,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36000.0,4.443697499232713
CHEMBL3414860,O=C1Cc2cc(Cc3ccc(Cl)cc3)ccc2C(=O)N1O,IC50,4400.0,5.36,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4400.0,5.356547323513812
CHEMBL3414861,O=C1Cc2cc(Cc3ccc(Br)cc3)ccc2C(=O)N1O,IC50,28000.0,4.55,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL3414862,O=C1Cc2cc(Cc3ccc(C(F)(F)F)cc3)ccc2C(=O)N1O,IC50,100000.0,,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3414863,O=C1Cc2cc(Cc3ccc(F)cc3F)ccc2C(=O)N1O,IC50,20000.0,4.7,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3414864,O=C1Cc2cc(Cc3ccc(C4CC4)cc3)ccc2C(=O)N1O,IC50,3800.0,5.42,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3800.0,5.42021640338319
CHEMBL3414865,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1O,IC50,100000.0,,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3414866,O=C1Cc2cc(Cc3ccc(-c4cccs4)cc3)ccc2C(=O)N1O,IC50,100000.0,,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3414867,O=C1Cc2cc(Cc3ccc(-c4ccc(F)cc4)cc3)ccc2C(=O)N1O,IC50,100000.0,,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3414868,N#Cc1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,IC50,100000.0,,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3414869,COc1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,IC50,100000.0,,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3414870,CS(=O)(=O)c1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,IC50,11000.0,4.96,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL3414871,NS(=O)(=O)c1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,IC50,3600.0,5.44,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3600.0,5.443697499232712
CHEMBL3414872,NC(=O)c1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,IC50,9100.0,5.04,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9100.0,5.040958607678906
CHEMBL3414873,O=C1Cc2cc(Cc3ccc(-c4ccc(F)cc4F)cc3)ccc2C(=O)N1O,IC50,100000.0,,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3414874,O=C1Cc2cc(Cc3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)cc3)ccc2C(=O)N1O,IC50,9100.0,5.04,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9100.0,5.040958607678906
CHEMBL3414875,COc1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1F,IC50,100000.0,,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3414876,Cc1ccc(S(=O)(=O)O)cc1.O=C1Cc2cc(Cc3ccc(-c4ccncc4)cc3)ccc2C(=O)N1O,IC50,5700.0,5.24,CHEMBL3418257,Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5700.0,5.2441251443275085
CHEMBL3415839,CCOC(=O)/C(O)=C/C(=O)/C=C/c1ccn(Cc2ccc(F)cc2)c1,IC50,90000.0,4.05,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,90000.0,4.045757490560675
CHEMBL3415838,CCOC(=O)/C(O)=C/C(=O)/C=C/c1cc(-c2ccccc2)cn1Cc1ccc(F)cc1,IC50,2500.0,5.6,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL3415836,CCOC(=O)/C(O)=C/C(=O)/C=C/c1cc(C(=O)c2ccc(F)cc2)cn1-c1ccccc1,IC50,1200.0,5.92,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL3415835,CCOC(=O)/C(O)=C/C(=O)/C=C/c1cc(C(=O)c2ccc(F)cc2)cn1Cc1ccccc1,IC50,4300.0,5.37,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4300.0,5.366531544420413
CHEMBL3415833,CCOC(=O)/C(O)=C/C(=O)c1ccn(Cc2ccc(F)cc2)c1,IC50,1600.0,5.8,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL3415832,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)cc1-c1ccccc1,IC50,420.0,6.38,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,420.0,6.376750709602099
CHEMBL3415840,CCOC(=O)/C(O)=C/C(=O)/C=C/c1cn(Cc2ccc(F)cc2)cc1-c1ccccc1,IC50,21000.0,,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL3415841,CCOC(=O)/C(O)=C/C(=O)c1cccn1Cc1ccc(F)cc1,IC50,510.0,6.29,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,510.0,6.292429823902063
CHEMBL3415842,CCOC(=O)/C(O)=C/C(=O)c1cc(-c2ccccc2)cn1Cc1ccc(F)cc1,IC50,790.0,6.1,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,790.0,6.102372908709558
CHEMBL3415843,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)cc1-c1ccccc1,IC50,22.0,7.66,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22.0,7.657577319177793
CHEMBL3415845,O=C(O)/C(O)=C/C(=O)c1ccn(Cc2ccc(F)cc2)c1,IC50,24.0,7.62,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24.0,7.619788758288394
CHEMBL3415846,N/C(=C\C(=O)c1cn(Cc2ccc(F)cc2)cc1-c1ccccc1)C(=O)O,IC50,43.0,7.37,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43.0,7.366531544420413
CHEMBL3415847,O=C(/C=C(\O)C(=O)O)/C=C/c1cc(C(=O)c2ccc(F)cc2)cn1Cc1ccccc1,IC50,63.0,7.2,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,63.0,7.200659450546418
CHEMBL3415848,O=C(/C=C(\O)C(=O)O)/C=C/c1cc(C(=O)c2ccc(F)cc2)cn1-c1ccccc1,IC50,590.0,6.23,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,590.0,6.229147988357855
CHEMBL3415850,O=C(/C=C(\O)C(=O)O)/C=C/c1cc(-c2ccccc2)cn1Cc1ccc(F)cc1,IC50,66.0,7.18,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,66.0,7.180456064458131
CHEMBL3415851,O=C(/C=C(\O)C(=O)O)/C=C/c1ccn(Cc2ccc(F)cc2)c1,IC50,26000.0,4.58,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26000.0,4.585026652029182
CHEMBL3415852,O=C(/C=C(\O)C(=O)O)/C=C/c1cn(Cc2ccc(F)cc2)cc1-c1ccccc1,IC50,730.0,6.14,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,730.0,6.136677139879544
CHEMBL499273,O=C(O)/C(O)=C/C(=O)c1cccn1Cc1ccc(F)cc1,IC50,57.0,7.24,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57.0,7.2441251443275085
CHEMBL3415853,O=C(O)/C(O)=C/C(=O)c1cc(-c2ccccc2)cn1Cc1ccc(F)cc1,IC50,19.0,7.72,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19.0,7.721246399047171
CHEMBL3415854,O=C(/C=C(\O)c1nc[nH]n1)c1cccn1Cc1ccc(F)cc1,IC50,110.0,6.96,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL3415855,CCOC(=O)/C(O)=C/C(=O)/C=C/c1cccn1Cc1ccc(F)cc1,IC50,98000.0,4.01,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,98000.0,4.008773924307505
CHEMBL3415856,CCOC(=O)/C(O)=C/C(=O)/C=C/c1cccn1Cc1ccc(F)c(F)c1,IC50,600.0,6.22,CHEMBL3418916,Inhibition of HIV-1 integrase strand transfer activity by gel-based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL499273,O=C(O)/C(O)=C/C(=O)c1cccn1Cc1ccc(F)cc1,IC50,80.0,7.1,CHEMBL3418920,Inhibition of HIV-1 HXB2 integrase using 32P-labelled oligonucleotide as substrate after 1 hr by phosphorimager analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL3582058,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc2c1=O,IC50,540.0,6.27,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,540.0,6.267606240177031
CHEMBL2236603,COc1cccc(Cn2cc(C(=O)/C=C(\O)C(=O)O)c(=O)c3ccccc32)c1,IC50,140.0,6.85,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,140.0,6.853871964321762
CHEMBL2236599,O=C(O)/C(O)=C/C(=O)c1cn(Cc2cccc(F)c2)c2ccccc2c1=O,IC50,15.0,7.82,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL2236588,COc1ccccc1Cn1cc(C(=O)/C=C(\O)C(=O)O)c(=O)c2ccccc21,IC50,38.0,7.42,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38.0,7.42021640338319
CHEMBL3582057,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccccc2F)c2ccccc2c1=O,IC50,16.0,7.8,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16.0,7.795880017344075
CHEMBL3582056,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccccc2)c2ccccc2c1=O,IC50,34.0,7.47,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34.0,7.468521082957745
CHEMBL3582054,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)c(Cl)c2)c2c(Cl)cccc2c1=O,IC50,25080.0,4.6,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25080.0,4.6006724678413216
CHEMBL3582053,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)c(Cl)c2)c2ccccc2c1=O,IC50,3100.0,5.51,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3100.0,5.508638306165727
CHEMBL3582052,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cccc(Cl)c2F)c2ccccc2c1=O,IC50,1080.0,5.97,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1080.0,5.96657624451305
CHEMBL3582051,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cc(C)cc(C)c2)c2ccccc2c1=O,IC50,1300.0,5.89,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL3582049,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2c(Cl)cccc2Cl)c2ccccc2c1=O,IC50,32000.0,4.5,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL3582047,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cc(F)cc(F)c2)c2ccccc2c1=O,IC50,11000.0,4.96,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL3582046,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)c(F)c2)c2ccccc2c1=O,IC50,5500.0,5.26,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5500.0,5.259637310505756
CHEMBL2236600,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2c(F)cccc2F)c2ccccc2c1=O,IC50,250.0,6.6,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL3582045,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cc(F)ccc2F)c2ccccc2c1=O,IC50,3700.0,5.43,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3700.0,5.431798275933005
CHEMBL3582044,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2F)c2ccccc2c1=O,IC50,2200.0,5.66,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2200.0,5.657577319177793
CHEMBL3582043,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc([N+](=O)[O-])cc2)c2ccccc2c1=O,IC50,37000.0,,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL3582042,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(OC)cc2)c2ccccc2c1=O,IC50,37000.0,,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL3582041,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(O)cc2)c2ccccc2c1=O,IC50,1400.0,5.85,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1400.0,5.853871964321762
CHEMBL3582040,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc2c1=O,IC50,37000.0,,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL2236602,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cccc(OC)c2)c2ccccc2c1=O,IC50,16000.0,4.8,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL2236598,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cccc(F)c2)c2ccccc2c1=O,IC50,4900.0,5.31,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4900.0,5.309803919971486
CHEMBL2236589,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccccc2OC)c2ccccc2c1=O,IC50,1400.0,5.85,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1400.0,5.853871964321762
CHEMBL3582039,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccccc2F)c2ccccc2c1=O,IC50,280.0,6.55,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,280.0,6.552841968657781
CHEMBL3582038,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccccc2)c2ccccc2c1=O,IC50,700.0,6.16,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL497501,O=C(O)/C(O)=C/C(=O)c1ccc2c(c1)c(=O)c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,12.0,7.92,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL3582082,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc3ccccc3n2)c2ccccc2c1=O,IC50,70000.0,4.16,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70000.0,4.154901959985743
CHEMBL3582080,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc3ccccc3c2)c2ccccc2c1=O,IC50,18000.0,4.75,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18000.0,4.7447274948966935
CHEMBL3582073,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccccc2F)c2c(Cl)cccc2c1=O,IC50,20500.0,4.69,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20500.0,4.688246138944246
CHEMBL3582072,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)c(Cl)c2)c2c(Cl)cccc2c1=O,IC50,9800.0,5.01,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9800.0,5.008773924307505
CHEMBL3582071,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)c(Cl)c2)c2ccccc2c1=O,IC50,21000.0,4.68,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21000.0,4.6777807052660805
CHEMBL3582070,O=C(O)/C(O)=C/C(=O)c1cn(Cc2cccc(Cl)c2F)c2ccccc2c1=O,IC50,1750.0,5.76,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1750.0,5.756961951313706
CHEMBL2236601,O=C(O)/C(O)=C/C(=O)c1cn(Cc2c(F)cccc2F)c2ccccc2c1=O,IC50,700.0,6.16,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL3582061,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc([N+](=O)[O-])cc2)c2ccccc2c1=O,IC50,27000.0,4.57,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27000.0,4.568636235841013
CHEMBL3582060,COc1ccc(Cn2cc(C(=O)/C=C(\O)C(=O)O)c(=O)c3ccccc32)cc1,IC50,28000.0,4.55,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL3582059,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(O)cc2)c2ccccc2c1=O,IC50,37000.0,,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL3582058,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc2c1=O,IC50,22000.0,4.66,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL2236603,COc1cccc(Cn2cc(C(=O)/C=C(\O)C(=O)O)c(=O)c3ccccc32)c1,IC50,4100.0,,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4100.0,5.3872161432802645
CHEMBL2236599,O=C(O)/C(O)=C/C(=O)c1cn(Cc2cccc(F)c2)c2ccccc2c1=O,IC50,4600.0,5.34,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4600.0,5.337242168318426
CHEMBL2236588,COc1ccccc1Cn1cc(C(=O)/C=C(\O)C(=O)O)c(=O)c2ccccc21,IC50,4100.0,,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4100.0,5.3872161432802645
CHEMBL3582057,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccccc2F)c2ccccc2c1=O,IC50,1200.0,5.92,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL3582056,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccccc2)c2ccccc2c1=O,IC50,4000.0,5.4,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL3582052,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cccc(Cl)c2F)c2ccccc2c1=O,IC50,1080.0,5.97,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1080.0,5.96657624451305
CHEMBL2236600,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2c(F)cccc2F)c2ccccc2c1=O,IC50,12300.0,,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12300.0,4.910094888560602
CHEMBL3582043,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc([N+](=O)[O-])cc2)c2ccccc2c1=O,IC50,37000.0,,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL3582042,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(OC)cc2)c2ccccc2c1=O,IC50,37000.0,,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL3582040,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc2c1=O,IC50,37000.0,,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL497501,O=C(O)/C(O)=C/C(=O)c1ccc2c(c1)c(=O)c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,200.0,6.7,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL498713,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(Cl)c(Cl)cc2c1=O,IC50,50000.0,,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50000.0,4.301029995663981
CHEMBL2236598,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2cccc(F)c2)c2ccccc2c1=O,IC50,12300.0,,CHEMBL3583194,Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12300.0,4.910094888560602
CHEMBL3582059,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(O)cc2)c2ccccc2c1=O,IC50,450.0,6.35,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,450.0,6.346787486224656
CHEMBL3582060,COc1ccc(Cn2cc(C(=O)/C=C(\O)C(=O)O)c(=O)c3ccccc32)cc1,IC50,510.0,6.29,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,510.0,6.292429823902063
CHEMBL3582061,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc([N+](=O)[O-])cc2)c2ccccc2c1=O,IC50,640.0,6.19,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,640.0,6.1938200260161125
CHEMBL3582062,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2F)c2ccccc2c1=O,IC50,10.0,8.0,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL3582063,O=C(O)/C(O)=C/C(=O)c1cn(Cc2cc(F)ccc2F)c2ccccc2c1=O,IC50,3200.0,5.5,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3200.0,5.494850021680094
CHEMBL2236601,O=C(O)/C(O)=C/C(=O)c1cn(Cc2c(F)cccc2F)c2ccccc2c1=O,IC50,19.0,7.72,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19.0,7.721246399047171
CHEMBL3582064,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)c(F)c2)c2ccccc2c1=O,IC50,110.0,6.96,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL3582065,O=C(O)/C(O)=C/C(=O)c1cn(Cc2cc(F)cc(F)c2)c2ccccc2c1=O,IC50,220.0,6.66,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,220.0,6.657577319177793
CHEMBL3582066,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(Cl)cc2Cl)c2ccccc2c1=O,IC50,2300.0,5.64,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2300.0,5.638272163982407
CHEMBL3582067,O=C(O)/C(O)=C/C(=O)c1cn(Cc2c(Cl)cccc2Cl)c2ccccc2c1=O,IC50,270.0,6.57,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,270.0,6.568636235841012
CHEMBL3582068,Cc1ccc(Cn2cc(C(=O)/C=C(\O)C(=O)O)c(=O)c3ccccc32)c(C)c1,IC50,7000.0,5.16,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL3582069,Cc1cc(C)cc(Cn2cc(C(=O)/C=C(\O)C(=O)O)c(=O)c3ccccc32)c1,IC50,50.0,7.3,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL3582070,O=C(O)/C(O)=C/C(=O)c1cn(Cc2cccc(Cl)c2F)c2ccccc2c1=O,IC50,18.0,7.75,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL3582071,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)c(Cl)c2)c2ccccc2c1=O,IC50,190.0,6.72,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,190.0,6.721246399047171
CHEMBL3582072,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)c(Cl)c2)c2c(Cl)cccc2c1=O,IC50,96.0,7.02,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,96.0,7.017728766960431
CHEMBL3582073,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccccc2F)c2c(Cl)cccc2c1=O,IC50,130.0,6.89,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,130.0,6.886056647693163
CHEMBL3582076,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc3ccccc3c2)c2ccccc2c1=O,IC50,32000.0,4.5,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL3582077,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccncc2)c2ccccc2c1=O,IC50,14000.0,4.85,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL3582078,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc3ccccc3n2)c2ccccc2c1=O,IC50,3500.0,5.46,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3500.0,5.455931955649724
CHEMBL3582079,O=C(O)/C(O)=C/C(=O)c1cn(CCCCc2ccccc2)c2ccccc2c1=O,IC50,450.0,,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,450.0,6.346787486224656
CHEMBL3582080,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc3ccccc3c2)c2ccccc2c1=O,IC50,450.0,,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,450.0,6.346787486224656
CHEMBL3582081,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccncc2)c2ccccc2c1=O,IC50,16000.0,4.8,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL3582082,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc3ccccc3n2)c2ccccc2c1=O,IC50,400.0,6.4,CHEMBL3583195,Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity using 32P-labeled DNA as substrate after 1 hr by gel-based assay in presence of Mg2+,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL3585685,CCCCn1cc(C(=O)O)c(=O)c2ccc(Oc3ccnc(Nc4ccc(C#N)cc4)n3)cc21,IC50,32490.0,4.49,CHEMBL3588118,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32490.0,4.488250288655017
CHEMBL204656,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C,IC50,1.8,8.74,CHEMBL3588118,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1.8,8.744727494896694
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,2.4,8.62,CHEMBL3598343,Inhibition of His-tagged HIV-1 integrase-mediated 3' processing and strand transfer reactions using 5'-ACAGGCCTAGCACGCGTCG-Biotin-3' annealed with 5'-CGACGCGTGGTAGGCCTGT-Biotin3'/5'-Cy5-ATGTGGAAAATCTCTAGCAGT-3' annealed with 5'-Cy5-TGAGCTCGAGATTTTCCACAT-3' as donar/acceptor DNA substrate preincubated for 1 hr followed by DNA and LEDGF/p75 addition measured after 90 mins by HTRF assay in presence of 300 mM sucrose,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.4,8.619788758288394
CHEMBL1230654,CCC[C@H](C(=O)O)c1c(C)nc2ccc(Cl)cc2c1-c1ccccc1,IC50,6000.0,5.22,CHEMBL3598343,Inhibition of His-tagged HIV-1 integrase-mediated 3' processing and strand transfer reactions using 5'-ACAGGCCTAGCACGCGTCG-Biotin-3' annealed with 5'-CGACGCGTGGTAGGCCTGT-Biotin3'/5'-Cy5-ATGTGGAAAATCTCTAGCAGT-3' annealed with 5'-Cy5-TGAGCTCGAGATTTTCCACAT-3' as donar/acceptor DNA substrate preincubated for 1 hr followed by DNA and LEDGF/p75 addition measured after 90 mins by HTRF assay in presence of 300 mM sucrose,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6000.0,5.221848749616356
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,53.0,7.28,CHEMBL3598342,Inhibition of His-tagged HIV-1 integrase-mediated 3' processing and strand transfer reactions using 5'-ACAGGCCTAGCACGCGTCG-Biotin-3' annealed with 5'-CGACGCGTGGTAGGCCTGT-Biotin3'/5'-Cy5-ATGTGGAAAATCTCTAGCAGT-3' annealed with 5'-Cy5-TGAGCTCGAGATTTTCCACAT-3' as donar/acceptor DNA substrate preincubated for 1 hr followed by DNA and LEDGF/p75 addition measured after 90 mins by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53.0,7.275724130399211
CHEMBL1230654,CCC[C@H](C(=O)O)c1c(C)nc2ccc(Cl)cc2c1-c1ccccc1,IC50,20000.0,4.7,CHEMBL3598342,Inhibition of His-tagged HIV-1 integrase-mediated 3' processing and strand transfer reactions using 5'-ACAGGCCTAGCACGCGTCG-Biotin-3' annealed with 5'-CGACGCGTGGTAGGCCTGT-Biotin3'/5'-Cy5-ATGTGGAAAATCTCTAGCAGT-3' annealed with 5'-Cy5-TGAGCTCGAGATTTTCCACAT-3' as donar/acceptor DNA substrate preincubated for 1 hr followed by DNA and LEDGF/p75 addition measured after 90 mins by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL2180481,Cc1nc2ccccc2c(-c2cc(F)c3c(c2C)CCCO3)c1[C@H](OC(C)(C)C)C(=O)O,IC50,18.0,7.75,CHEMBL3598341,Binding affinity to recombinant HIV-1 integrase catalytic core domain expressed in Escherichia coli assessed as inhibition of interaction with LEDFG/P75 by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL1230654,CCC[C@H](C(=O)O)c1c(C)nc2ccc(Cl)cc2c1-c1ccccc1,IC50,2350.0,5.63,CHEMBL3598341,Binding affinity to recombinant HIV-1 integrase catalytic core domain expressed in Escherichia coli assessed as inhibition of interaction with LEDFG/P75 by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2350.0,5.628932137728263
CHEMBL3259895,Cc1nc2ccc(Br)cc2c(-c2ccc(Cl)cc2)c1[C@H](OC(C)(C)C)C(=O)O,IC50,60.0,7.22,CHEMBL3598341,Binding affinity to recombinant HIV-1 integrase catalytic core domain expressed in Escherichia coli assessed as inhibition of interaction with LEDFG/P75 by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL3597476,COc1ccc2nc(/C=C3\SC(=S)N(C(C(=O)O)C(C)C)C3=O)ccc2c1,IC50,15760.0,4.8,CHEMBL3599803,Inhibition of HIV1 His6-tagged integrase assessed as inhibition of interaction with recombinant flag-tagged LEDGF/p75 incubated for 30 mins prior to substrate addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15760.0,4.802443786846464
CHEMBL3596211,COc1ccc(/C=C2\SC(=S)N(C(C(=O)O)C(C)C)C2=O)cc1,IC50,41280.0,4.38,CHEMBL3599803,Inhibition of HIV1 His6-tagged integrase assessed as inhibition of interaction with recombinant flag-tagged LEDGF/p75 incubated for 30 mins prior to substrate addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41280.0,4.384260311380845
CHEMBL3597545,CCC(C(=O)O)N1C(=O)/C(=C/c2ccc(OC)cc2)SC1=S,IC50,100000.0,,CHEMBL3599803,Inhibition of HIV1 His6-tagged integrase assessed as inhibition of interaction with recombinant flag-tagged LEDGF/p75 incubated for 30 mins prior to substrate addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3597542,COc1ccc(/C=C2\SC(=S)N(CCC(=O)O)C2=O)cc1,IC50,100000.0,,CHEMBL3599803,Inhibition of HIV1 His6-tagged integrase assessed as inhibition of interaction with recombinant flag-tagged LEDGF/p75 incubated for 30 mins prior to substrate addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3597537,CCOc1cc(/C=C2\SC(=S)N(C(C(=O)O)C(C)C)C2=O)ccc1O,IC50,24990.0,4.6,CHEMBL3599803,Inhibition of HIV1 His6-tagged integrase assessed as inhibition of interaction with recombinant flag-tagged LEDGF/p75 incubated for 30 mins prior to substrate addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24990.0,4.60223374387355
CHEMBL3597536,CC(C)C(C(=O)O)N1C(=O)/C(=C/c2ccc(O)cc2)SC1=S,IC50,43750.0,4.36,CHEMBL3599803,Inhibition of HIV1 His6-tagged integrase assessed as inhibition of interaction with recombinant flag-tagged LEDGF/p75 incubated for 30 mins prior to substrate addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43750.0,4.359021942641668
CHEMBL1173791,CC(C)C(C(=O)O)N1C(=O)/C(=C/c2cccc3ccccc23)SC1=S,IC50,18750.0,4.73,CHEMBL3599803,Inhibition of HIV1 His6-tagged integrase assessed as inhibition of interaction with recombinant flag-tagged LEDGF/p75 incubated for 30 mins prior to substrate addition measured after 1 hr by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18750.0,4.726998727936262
CHEMBL2171955,Fc1ccc(Nc2ccc(F)c3ccccc23)cc1,IC50,100000.0,,CHEMBL3615808,Binding affinity to His6-tagged recombinant HIV1 Integrase assessed as inhibition of protein interaction with 3xFLAG-tagged LEDGF/p75 preincubated for 30 mins followed by 3xFLAG-tagged LEDGF/p75 addition measured after 60 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2171961,O=C(O)c1ccc(Nc2ccc(O)c3ccccc23)cc1,IC50,2500.0,5.6,CHEMBL3615808,Binding affinity to His6-tagged recombinant HIV1 Integrase assessed as inhibition of protein interaction with 3xFLAG-tagged LEDGF/p75 preincubated for 30 mins followed by 3xFLAG-tagged LEDGF/p75 addition measured after 60 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL2171964,O=C(O)c1cc(Nc2ccc(O)c3ccccc23)ccc1O,IC50,19120.0,4.72,CHEMBL3615808,Binding affinity to His6-tagged recombinant HIV1 Integrase assessed as inhibition of protein interaction with 3xFLAG-tagged LEDGF/p75 preincubated for 30 mins followed by 3xFLAG-tagged LEDGF/p75 addition measured after 60 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19120.0,4.718512112059919
CHEMBL2171855,COC(=O)c1ccc(Nc2ccc(OC)c3ccccc23)cc1,IC50,34800.0,4.46,CHEMBL3615808,Binding affinity to His6-tagged recombinant HIV1 Integrase assessed as inhibition of protein interaction with 3xFLAG-tagged LEDGF/p75 preincubated for 30 mins followed by 3xFLAG-tagged LEDGF/p75 addition measured after 60 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34800.0,4.458420756053419
CHEMBL2171858,COc1ccc(I)cc1Nc1ccc(OC)c2ccccc12,IC50,28930.0,4.54,CHEMBL3615808,Binding affinity to His6-tagged recombinant HIV1 Integrase assessed as inhibition of protein interaction with 3xFLAG-tagged LEDGF/p75 preincubated for 30 mins followed by 3xFLAG-tagged LEDGF/p75 addition measured after 60 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28930.0,4.5386515663520175
CHEMBL2171865,O=C(O)c1ccc(Nc2ccc3ccccc3c2O)cc1,IC50,70070.0,4.15,CHEMBL3615808,Binding affinity to His6-tagged recombinant HIV1 Integrase assessed as inhibition of protein interaction with 3xFLAG-tagged LEDGF/p75 preincubated for 30 mins followed by 3xFLAG-tagged LEDGF/p75 addition measured after 60 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70070.0,4.154467882506425
CHEMBL2171872,COc1ccc2ccccc2c1Nc1c(OC)ccc2ccccc12,IC50,13760.0,4.86,CHEMBL3615808,Binding affinity to His6-tagged recombinant HIV1 Integrase assessed as inhibition of protein interaction with 3xFLAG-tagged LEDGF/p75 preincubated for 30 mins followed by 3xFLAG-tagged LEDGF/p75 addition measured after 60 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13760.0,4.8613815661005075
CHEMBL3612300,CCOC(=O)c1cn(Cc2ccc(C(=O)OC)cc2)c2ccccc2c1=O,IC50,100000.0,,CHEMBL3615808,Binding affinity to His6-tagged recombinant HIV1 Integrase assessed as inhibition of protein interaction with 3xFLAG-tagged LEDGF/p75 preincubated for 30 mins followed by 3xFLAG-tagged LEDGF/p75 addition measured after 60 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3612301,Cc1ccc(-c2c(C(OC(C)(C)C)C(=O)O)ccc3sc(C)cc23)cc1,IC50,46.0,7.34,CHEMBL3615808,Binding affinity to His6-tagged recombinant HIV1 Integrase assessed as inhibition of protein interaction with 3xFLAG-tagged LEDGF/p75 preincubated for 30 mins followed by 3xFLAG-tagged LEDGF/p75 addition measured after 60 mins by AlphaScreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,46.0,7.337242168318426
CHEMBL3736096,CCOC(=O)c1c(-c2ccc(OC)cc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1-c1ccccc1,IC50,1900.0,5.72,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1900.0,5.721246399047171
CHEMBL3734908,CCOC(=O)c1c(-c2ccc(F)cc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1-c1ccccc1,IC50,2400.0,5.62,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2400.0,5.619788758288394
CHEMBL3735322,CCOC(=O)c1c(-c2ccccc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1-c1ccccc1,IC50,2000.0,5.7,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL3736464,CCOC(=O)c1c(-c2ccc(OC)cc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1C(C)C,IC50,3300.0,5.48,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3300.0,5.481486060122112
CHEMBL3735086,CCOC(=O)c1c(-c2ccc(F)cc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1C(C)C,IC50,3600.0,5.44,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3600.0,5.443697499232712
CHEMBL3735455,CCOC(=O)c1c(-c2ccccc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1C(C)C,IC50,2300.0,5.64,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2300.0,5.638272163982407
CHEMBL3735646,CCOC(=O)c1c(-c2ccc(OC)cc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1CC,IC50,5600.0,5.25,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5600.0,5.251811972993799
CHEMBL3735944,CCOC(=O)c1c(-c2ccc(F)cc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1CC,IC50,1100.0,5.96,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1100.0,5.958607314841775
CHEMBL3736051,CCOC(=O)c1c(-c2ccccc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1CC,IC50,640.0,6.19,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,640.0,6.1938200260161125
CHEMBL3736106,CCOC(=O)c1c(Cc2ccccc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1C,IC50,190.0,6.72,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,190.0,6.721246399047171
CHEMBL3735397,CCOC(=O)c1c(-c2ccc(F)cc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1C,IC50,1300.0,5.89,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL3734837,CCOC(=O)c1c(-c2ccccc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1C,IC50,2400.0,5.62,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2400.0,5.619788758288394
CHEMBL3735286,CCOC(=O)c1c(-c2ccccc2)nc(SCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)nc1-c1ccc(OC)cc1,IC50,23000.0,4.64,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL3735239,CCOC(=O)c1c(-c2ccccc2)nc(SCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)nc1-c1ccc(F)cc1,IC50,22000.0,4.66,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL3735570,CCOC(=O)c1c(-c2ccccc2)nc(SCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)nc1-c1ccccc1,IC50,30000.0,4.52,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL3735583,CCOC(=O)c1c(CC)nc(SCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)nc1-c1ccc(OC)cc1,IC50,30700.0,4.51,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30700.0,4.512861624522814
CHEMBL3735630,CCOC(=O)c1c(CC)nc(SCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)nc1-c1ccc(F)cc1,IC50,29300.0,4.53,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,29300.0,4.533132379645891
CHEMBL3735665,CCOC(=O)c1c(CC)nc(SCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)nc1-c1ccccc1,IC50,21100.0,4.68,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21100.0,4.675717544702307
CHEMBL3735829,CCOC(=O)c1c(-c2ccccc2)nc(=O)n(Cc2ccc(Cc3cccc(C(=O)/C=C(\O)C(=O)O)c3)cc2)c1CC,IC50,22500.0,4.65,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22500.0,4.647817481888637
CHEMBL3736042,CCOC(=O)c1c(-c2cc(C)cc(C)c2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1-c1ccccc1,IC50,16300.0,4.79,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16300.0,4.787812395596042
CHEMBL3736096,CCOC(=O)c1c(-c2ccc(OC)cc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1-c1ccccc1,IC50,17200.0,4.76,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17200.0,4.764471553092451
CHEMBL3734908,CCOC(=O)c1c(-c2ccc(F)cc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1-c1ccccc1,IC50,16600.0,4.78,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16600.0,4.779891911959945
CHEMBL3735322,CCOC(=O)c1c(-c2ccccc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1-c1ccccc1,IC50,18400.0,4.74,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18400.0,4.735182176990463
CHEMBL3736464,CCOC(=O)c1c(-c2ccc(OC)cc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1C(C)C,IC50,19200.0,4.72,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19200.0,4.716698771296451
CHEMBL3735086,CCOC(=O)c1c(-c2ccc(F)cc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1C(C)C,IC50,40000.0,4.4,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40000.0,4.3979400086720375
CHEMBL3735455,CCOC(=O)c1c(-c2ccccc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1C(C)C,IC50,37500.0,4.43,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37500.0,4.425968732272281
CHEMBL3735646,CCOC(=O)c1c(-c2ccc(OC)cc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1CC,IC50,72000.0,4.14,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,72000.0,4.142667503568732
CHEMBL3735944,CCOC(=O)c1c(-c2ccc(F)cc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1CC,IC50,35000.0,4.46,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL3736051,CCOC(=O)c1c(-c2ccccc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1CC,IC50,19100.0,4.72,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19100.0,4.718966632752273
CHEMBL3736106,CCOC(=O)c1c(Cc2ccccc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1C,IC50,16900.0,4.77,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16900.0,4.772113295386326
CHEMBL3735397,CCOC(=O)c1c(-c2ccc(F)cc2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1C,IC50,17400.0,4.76,CHEMBL3738751,Inhibition of recombinant HIV-1 integrase 3'-processing activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17400.0,4.7594507517174005
CHEMBL3736042,CCOC(=O)c1c(-c2cc(C)cc(C)c2)nc(=O)n(Cc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1-c1ccccc1,IC50,1300.0,5.89,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL3735829,CCOC(=O)c1c(-c2ccccc2)nc(=O)n(Cc2ccc(Cc3cccc(C(=O)/C=C(\O)C(=O)O)c3)cc2)c1CC,IC50,850.0,6.07,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,850.0,6.070581074285707
CHEMBL3735665,CCOC(=O)c1c(CC)nc(SCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)nc1-c1ccccc1,IC50,2230.0,5.65,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2230.0,5.651695136951839
CHEMBL3735630,CCOC(=O)c1c(CC)nc(SCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)nc1-c1ccc(F)cc1,IC50,920.0,6.04,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,920.0,6.036212172654444
CHEMBL3735583,CCOC(=O)c1c(CC)nc(SCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)nc1-c1ccc(OC)cc1,IC50,2270.0,5.64,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2270.0,5.6439741428068775
CHEMBL3735570,CCOC(=O)c1c(-c2ccccc2)nc(SCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)nc1-c1ccccc1,IC50,6100.0,5.21,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6100.0,5.214670164989233
CHEMBL3735239,CCOC(=O)c1c(-c2ccccc2)nc(SCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)nc1-c1ccc(F)cc1,IC50,2800.0,5.55,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL3735286,CCOC(=O)c1c(-c2ccccc2)nc(SCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)nc1-c1ccc(OC)cc1,IC50,1200.0,5.92,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,13.0,7.89,CHEMBL3738752,Inhibition of recombinant HIV-1 integrase stand transfer activity expressed in Escherichia coli BL21(DE3) cells using 32P-labeled DNA substrate after 1 hr by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL3741160,COc1ccc(C2=Cc3ccc(F)cc3C(CC(C)=O)N2c2ccc(O)cc2)cc1,IC50,12000.0,4.92,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL3741323,COc1ccc(C2=Cc3ccc([N+](=O)[O-])cc3C(CC(C)=O)N2c2ccc(F)cc2)cc1,IC50,460.0,6.34,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,460.0,6.337242168318426
CHEMBL3740792,COc1ccc(C2=Cc3ccc([N+](=O)[O-])cc3C(CC(C)=O)N2c2ccc(C)cc2)cc1,IC50,600.0,6.22,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,600.0,6.221848749616356
CHEMBL3740311,COc1ccc(C2=Cc3ccc([N+](=O)[O-])cc3C(CC(C)=O)N2c2ccc(C#N)cc2)cc1,IC50,2900.0,5.54,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2900.0,5.537602002101044
CHEMBL3739763,COc1ccc(C2=Cc3ccc([N+](=O)[O-])cc3C(CC(C)=O)N2c2ccc(O)cc2)cc1,IC50,6600.0,5.18,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6600.0,5.180456064458131
CHEMBL3741987,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)CO)N2c2ccc(C)cc2)cc1,IC50,15100.0,4.82,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15100.0,4.82102305270683
CHEMBL3739597,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)CO)N2c2ccc(Cl)cc2)cc1,IC50,17900.0,4.75,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17900.0,4.747146969020107
CHEMBL3739984,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)CO)N2c2ccc(C#N)cc2)cc1,IC50,7600.0,5.12,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7600.0,5.119186407719209
CHEMBL3741049,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)CO)N2c2ccc(O)cc2)cc1,IC50,22100.0,4.66,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22100.0,4.655607726314889
CHEMBL3739970,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)CO)N2c2ccc([N+](=O)[O-])cc2)cc1,IC50,820.0,6.09,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,820.0,6.086186147616283
CHEMBL3741789,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)C(C)O)N2c2ccc(C)cc2)cc1,IC50,10600.0,4.97,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10600.0,4.97469413473523
CHEMBL3742275,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)C(C)O)N2c2ccc(Cl)cc2)cc1,IC50,11800.0,4.93,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11800.0,4.928117992693875
CHEMBL3742037,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)C(C)O)N2c2ccc(F)cc2)cc1,IC50,7900.0,5.1,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7900.0,5.102372908709558
CHEMBL3740456,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)C(C)O)N2c2ccc(C#N)cc2)cc1,IC50,22200.0,4.65,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22200.0,4.653647025549361
CHEMBL3741857,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)C(C)O)N2c2ccc(O)cc2)cc1,IC50,25200.0,4.6,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25200.0,4.598599459218456
CHEMBL3742287,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)C(C)O)N2c2ccc([N+](=O)[O-])cc2)cc1,IC50,5200.0,5.28,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5200.0,5.2839966563652006
CHEMBL3739466,COc1ccc(C2=Cc3ccc(F)cc3C(C[N+](=O)[O-])N2c2ccc(Cl)cc2)cc1,IC50,700.0,6.16,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL3740012,O=[N+]([O-])CC1c2cc([N+](=O)[O-])ccc2C=C(c2ccccc2)N1c1ccc(Cl)cc1,IC50,3100.0,5.51,CHEMBL3744581,Inhibition of HIV-1 integrase strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3100.0,5.508638306165727
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,50.0,7.3,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL3741160,COc1ccc(C2=Cc3ccc(F)cc3C(CC(C)=O)N2c2ccc(O)cc2)cc1,IC50,14000.0,4.85,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL3740056,COc1ccc(C2=Cc3ccc(F)cc3C(CC(C)=O)N2c2ccc(C#N)cc2)cc1,IC50,20000.0,4.7,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL3741323,COc1ccc(C2=Cc3ccc([N+](=O)[O-])cc3C(CC(C)=O)N2c2ccc(F)cc2)cc1,IC50,640.0,6.19,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,640.0,6.1938200260161125
CHEMBL3740792,COc1ccc(C2=Cc3ccc([N+](=O)[O-])cc3C(CC(C)=O)N2c2ccc(C)cc2)cc1,IC50,650.0,6.19,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,650.0,6.187086643357144
CHEMBL3740311,COc1ccc(C2=Cc3ccc([N+](=O)[O-])cc3C(CC(C)=O)N2c2ccc(C#N)cc2)cc1,IC50,2800.0,5.55,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL3739763,COc1ccc(C2=Cc3ccc([N+](=O)[O-])cc3C(CC(C)=O)N2c2ccc(O)cc2)cc1,IC50,7600.0,5.12,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7600.0,5.119186407719209
CHEMBL3741987,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)CO)N2c2ccc(C)cc2)cc1,IC50,14100.0,4.85,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14100.0,4.85078088734462
CHEMBL3739597,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)CO)N2c2ccc(Cl)cc2)cc1,IC50,14900.0,4.83,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14900.0,4.826813731587726
CHEMBL3739984,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)CO)N2c2ccc(C#N)cc2)cc1,IC50,7000.0,5.16,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL3741049,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)CO)N2c2ccc(O)cc2)cc1,IC50,20100.0,4.7,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20100.0,4.696803942579511
CHEMBL3739970,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)CO)N2c2ccc([N+](=O)[O-])cc2)cc1,IC50,46400.0,4.33,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,46400.0,4.333482019445119
CHEMBL3741789,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)C(C)O)N2c2ccc(C)cc2)cc1,IC50,12700.0,4.9,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12700.0,4.896196279044043
CHEMBL3742275,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)C(C)O)N2c2ccc(Cl)cc2)cc1,IC50,10800.0,4.97,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10800.0,4.966576244513051
CHEMBL3742037,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)C(C)O)N2c2ccc(F)cc2)cc1,IC50,8000.0,5.1,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8000.0,5.096910013008056
CHEMBL3740456,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)C(C)O)N2c2ccc(C#N)cc2)cc1,IC50,22000.0,4.66,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL3741857,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)C(C)O)N2c2ccc(O)cc2)cc1,IC50,25000.0,4.6,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL3742287,COc1ccc(C2=Cc3ccc(F)cc3C(CC(=O)C(C)O)N2c2ccc([N+](=O)[O-])cc2)cc1,IC50,5500.0,5.26,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5500.0,5.259637310505756
CHEMBL3739466,COc1ccc(C2=Cc3ccc(F)cc3C(C[N+](=O)[O-])N2c2ccc(Cl)cc2)cc1,IC50,800.0,6.1,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL3740012,O=[N+]([O-])CC1c2cc([N+](=O)[O-])ccc2C=C(c2ccccc2)N1c1ccc(Cl)cc1,IC50,3000.0,5.52,CHEMBL3744582,Inhibition of HIV-1 integrase G140S mutant strand transfer activity preincubated for 30 mins followed by addition of FITC-labelled dsDNA for 1 hr by microplate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3000.0,5.522878745280337
CHEMBL3799805,O=C(O)/C=C/c1ccc2c(c1)CC(=O)N2Cc1ccc2c(c1C(=O)O)OCO2,IC50,5000.0,5.3,CHEMBL3802585,Inhibition of HIV1 integrase using DIG/biotin-tagged annealed U5 LTR sequence oligonucleotides as substrate after 2 hrs by 3-processing strand transfer combined assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL3805355,CCCNC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,1820.0,5.74,CHEMBL3807245,Inhibition of HIV1 integrase using 3'-biotin-labelled and 5'-digoxigenin-labelled oligonucleotide substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1820.0,5.739928612014925
CHEMBL3804900,CC(C)NC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,4430.0,5.35,CHEMBL3807245,Inhibition of HIV1 integrase using 3'-biotin-labelled and 5'-digoxigenin-labelled oligonucleotide substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4430.0,5.3535962737769305
CHEMBL3805930,CCCCNC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,660.0,6.18,CHEMBL3807245,Inhibition of HIV1 integrase using 3'-biotin-labelled and 5'-digoxigenin-labelled oligonucleotide substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,660.0,6.180456064458131
CHEMBL3806031,CCCCN(C)C(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,8660.0,5.06,CHEMBL3807245,Inhibition of HIV1 integrase using 3'-biotin-labelled and 5'-digoxigenin-labelled oligonucleotide substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8660.0,5.062482107982653
CHEMBL3805166,CC(C)(C)NC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,4450.0,5.35,CHEMBL3807245,Inhibition of HIV1 integrase using 3'-biotin-labelled and 5'-digoxigenin-labelled oligonucleotide substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4450.0,5.351639989019068
CHEMBL3805349,CCCCCNC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,650.0,6.19,CHEMBL3807245,Inhibition of HIV1 integrase using 3'-biotin-labelled and 5'-digoxigenin-labelled oligonucleotide substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,650.0,6.187086643357144
CHEMBL3805993,CCCCCCNC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,85.0,7.07,CHEMBL3807245,Inhibition of HIV1 integrase using 3'-biotin-labelled and 5'-digoxigenin-labelled oligonucleotide substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,85.0,7.070581074285707
CHEMBL3805505,CCCCCCCNC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,860.0,6.07,CHEMBL3807245,Inhibition of HIV1 integrase using 3'-biotin-labelled and 5'-digoxigenin-labelled oligonucleotide substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,860.0,6.065501548756432
CHEMBL3805298,CCCCCCCCNC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,9050.0,5.04,CHEMBL3807245,Inhibition of HIV1 integrase using 3'-biotin-labelled and 5'-digoxigenin-labelled oligonucleotide substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9050.0,5.043351420794797
CHEMBL3805756,CCCCCCCCCNC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,6650.0,5.18,CHEMBL3807245,Inhibition of HIV1 integrase using 3'-biotin-labelled and 5'-digoxigenin-labelled oligonucleotide substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6650.0,5.1771783546968955
CHEMBL3805358,O=C(NC1CC1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,2130.0,5.67,CHEMBL3807245,Inhibition of HIV1 integrase using 3'-biotin-labelled and 5'-digoxigenin-labelled oligonucleotide substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2130.0,5.671620396561263
CHEMBL3805999,O=C(NC1CCCC1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,1360.0,5.87,CHEMBL3807245,Inhibition of HIV1 integrase using 3'-biotin-labelled and 5'-digoxigenin-labelled oligonucleotide substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1360.0,5.866461091629782
CHEMBL3805115,O=C(NC1CCCCC1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,700.0,6.16,CHEMBL3807245,Inhibition of HIV1 integrase using 3'-biotin-labelled and 5'-digoxigenin-labelled oligonucleotide substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,700.0,6.154901959985743
CHEMBL3806113,O=C(C1C(=O)N(O)C(=O)c2ccccc21)N1CCCCC1,IC50,8120.0,5.09,CHEMBL3807245,Inhibition of HIV1 integrase using 3'-biotin-labelled and 5'-digoxigenin-labelled oligonucleotide substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8120.0,5.090443970758825
CHEMBL3805355,CCCNC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,1990.0,5.7,CHEMBL3807246,Inhibition of HIV1 integrase strand transfer activity using 5'[digoxigenin]-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCA-3' as substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1990.0,5.701146923590294
CHEMBL3804900,CC(C)NC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,5050.0,5.3,CHEMBL3807246,Inhibition of HIV1 integrase strand transfer activity using 5'[digoxigenin]-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCA-3' as substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5050.0,5.296708621881338
CHEMBL3805930,CCCCNC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,480.0,6.32,CHEMBL3807246,Inhibition of HIV1 integrase strand transfer activity using 5'[digoxigenin]-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCA-3' as substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,480.0,6.318758762624412
CHEMBL3806031,CCCCN(C)C(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,8700.0,5.06,CHEMBL3807246,Inhibition of HIV1 integrase strand transfer activity using 5'[digoxigenin]-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCA-3' as substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8700.0,5.060480747381382
CHEMBL3805166,CC(C)(C)NC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,4460.0,5.35,CHEMBL3807246,Inhibition of HIV1 integrase strand transfer activity using 5'[digoxigenin]-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCA-3' as substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4460.0,5.350665141287858
CHEMBL3805349,CCCCCNC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,530.0,6.28,CHEMBL3807246,Inhibition of HIV1 integrase strand transfer activity using 5'[digoxigenin]-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCA-3' as substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,530.0,6.275724130399211
CHEMBL3805993,CCCCCCNC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,195.0,6.71,CHEMBL3807246,Inhibition of HIV1 integrase strand transfer activity using 5'[digoxigenin]-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCA-3' as substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,195.0,6.709965388637482
CHEMBL3805505,CCCCCCCNC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,1050.0,5.98,CHEMBL3807246,Inhibition of HIV1 integrase strand transfer activity using 5'[digoxigenin]-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCA-3' as substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1050.0,5.978810700930062
CHEMBL3805298,CCCCCCCCNC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,9130.0,5.04,CHEMBL3807246,Inhibition of HIV1 integrase strand transfer activity using 5'[digoxigenin]-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCA-3' as substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9130.0,5.039529222465701
CHEMBL3805756,CCCCCCCCCNC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,6670.0,5.18,CHEMBL3807246,Inhibition of HIV1 integrase strand transfer activity using 5'[digoxigenin]-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCA-3' as substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6670.0,5.175874166083451
CHEMBL3805358,O=C(NC1CC1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,4000.0,5.4,CHEMBL3807246,Inhibition of HIV1 integrase strand transfer activity using 5'[digoxigenin]-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCA-3' as substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL3805999,O=C(NC1CCCC1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,3630.0,5.44,CHEMBL3807246,Inhibition of HIV1 integrase strand transfer activity using 5'[digoxigenin]-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCA-3' as substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3630.0,5.440093374963888
CHEMBL3805115,O=C(NC1CCCCC1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,3360.0,5.47,CHEMBL3807246,Inhibition of HIV1 integrase strand transfer activity using 5'[digoxigenin]-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCA-3' as substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3360.0,5.4736607226101555
CHEMBL3806113,O=C(C1C(=O)N(O)C(=O)c2ccccc21)N1CCCCC1,IC50,9100.0,5.04,CHEMBL3807246,Inhibition of HIV1 integrase strand transfer activity using 5'[digoxigenin]-GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCA-3' as substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9100.0,5.040958607678906
CHEMBL3805993,CCCCCCNC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,510.0,6.29,CHEMBL3807174,Inhibition of HIV1 integrase 3'-processing activity using 5'-ACTGCTAGAGATTTTCCACACTGACTAAAAGGGTC-[biotin]3' as substrate incubated for 1 hr by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,510.0,6.292429823902063
CHEMBL2403116,O=C(NCc1ccc(F)cc1)c1cn2c(c(O)c1=O)C(=O)N1CCCO[C@H]1C2,IC50,2.0,8.7,CHEMBL3808055,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in HIV1 infected human CIP4 cells after 2 days by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL1256978,Cn1c(=O)c(C(=O)NCCO)c(O)c2ncc(Cc3ccc(F)cc3)cc21,IC50,3.0,8.52,CHEMBL3808055,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in HIV1 infected human CIP4 cells after 2 days by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL3805532,O=C1c2c(cc3cc(Cc4cccc(Cl)c4F)cnc3c2O)CN2CCCN12,IC50,16.0,7.8,CHEMBL3808055,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in HIV1 infected human CIP4 cells after 2 days by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16.0,7.795880017344075
CHEMBL3805585,N#Cc1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCCN1C2,IC50,2.2,8.66,CHEMBL3808055,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in HIV1 infected human CIP4 cells after 2 days by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.2,8.657577319177793
CHEMBL3805498,N#Cc1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCC[C@@H]1C2,IC50,7.0,8.15,CHEMBL3808055,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in HIV1 infected human CIP4 cells after 2 days by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL3805132,N#Cc1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCC[C@H]1C2,IC50,14.0,7.85,CHEMBL3808055,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in HIV1 infected human CIP4 cells after 2 days by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL3805269,N#Cc1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCCC[C@H]21,IC50,15.0,7.82,CHEMBL3808055,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in HIV1 infected human CIP4 cells after 2 days by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL3806308,N#Cc1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCCC[C@@H]21,IC50,18.0,7.75,CHEMBL3808055,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in HIV1 infected human CIP4 cells after 2 days by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL3805531,N#Cc1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCC[C@H]21,IC50,5.0,8.3,CHEMBL3808055,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in HIV1 infected human CIP4 cells after 2 days by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL3804966,N#Cc1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCC[C@@H]21,IC50,10.0,8.0,CHEMBL3808055,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in HIV1 infected human CIP4 cells after 2 days by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL3805726,NC(=O)c1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCC[C@@H]1C2,IC50,8.0,8.1,CHEMBL3808055,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in HIV1 infected human CIP4 cells after 2 days by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL3805145,NC(=O)c1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCC[C@H]1C2,IC50,3.0,8.52,CHEMBL3808055,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in HIV1 infected human CIP4 cells after 2 days by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL3806067,NC(=O)c1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCCC[C@H]21,IC50,0.7,9.15,CHEMBL3808055,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in HIV1 infected human CIP4 cells after 2 days by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,0.7,9.154901959985743
CHEMBL3805182,NC(=O)c1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCCC[C@@H]21,IC50,0.6,9.22,CHEMBL3808055,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in HIV1 infected human CIP4 cells after 2 days by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,0.6,9.221848749616356
CHEMBL3805532,O=C1c2c(cc3cc(Cc4cccc(Cl)c4F)cnc3c2O)CN2CCCN12,IC50,136.0,6.87,CHEMBL3808056,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in in HIV1 infected human CIP4 cells after 2 days in presence of 40% human serum albumin by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,136.0,6.866461091629782
CHEMBL3805585,N#Cc1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCCN1C2,IC50,415.0,6.38,CHEMBL3808056,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in in HIV1 infected human CIP4 cells after 2 days in presence of 40% human serum albumin by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,415.0,6.3819519032879075
CHEMBL3805498,N#Cc1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCC[C@@H]1C2,IC50,4540.0,5.34,CHEMBL3808056,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in in HIV1 infected human CIP4 cells after 2 days in presence of 40% human serum albumin by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4540.0,5.342944147142896
CHEMBL3805132,N#Cc1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCC[C@H]1C2,IC50,66.0,7.18,CHEMBL3808056,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in in HIV1 infected human CIP4 cells after 2 days in presence of 40% human serum albumin by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,66.0,7.180456064458131
CHEMBL3805269,N#Cc1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCCC[C@H]21,IC50,457.0,6.34,CHEMBL3808056,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in in HIV1 infected human CIP4 cells after 2 days in presence of 40% human serum albumin by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,457.0,6.34008379993015
CHEMBL3806308,N#Cc1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCCC[C@@H]21,IC50,1280.0,5.89,CHEMBL3808056,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in in HIV1 infected human CIP4 cells after 2 days in presence of 40% human serum albumin by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1280.0,5.892790030352131
CHEMBL3805531,N#Cc1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCC[C@H]21,IC50,294.0,6.53,CHEMBL3808056,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in in HIV1 infected human CIP4 cells after 2 days in presence of 40% human serum albumin by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,294.0,6.531652669587842
CHEMBL3804966,N#Cc1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCC[C@@H]21,IC50,3320.0,5.48,CHEMBL3808056,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in in HIV1 infected human CIP4 cells after 2 days in presence of 40% human serum albumin by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3320.0,5.478861916295964
CHEMBL3805726,NC(=O)c1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCC[C@@H]1C2,IC50,30.0,7.52,CHEMBL3808056,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in in HIV1 infected human CIP4 cells after 2 days in presence of 40% human serum albumin by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30.0,7.522878745280337
CHEMBL3805145,NC(=O)c1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCC[C@H]1C2,IC50,15.0,7.82,CHEMBL3808056,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in in HIV1 infected human CIP4 cells after 2 days in presence of 40% human serum albumin by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL3806067,NC(=O)c1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCCC[C@H]21,IC50,1.0,9.0,CHEMBL3808056,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in in HIV1 infected human CIP4 cells after 2 days in presence of 40% human serum albumin by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1.0,9.0
CHEMBL3805182,NC(=O)c1c2c(c(O)c3ncc(Cc4cccc(Cl)c4F)cc13)C(=O)N1CCCC[C@@H]21,IC50,2.0,8.7,CHEMBL3808056,Inhibition of pseudotype HIV1 integrase strand transfer activity assessed as reduction in viral replication in in HIV1 infected human CIP4 cells after 2 days in presence of 40% human serum albumin by luciferase reporter gene assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL3818730,O=C(O)c1c[nH]cc(O)c1=O,IC50,100000.0,,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3818383,O=C(O)c1cn(-c2ccccc2)cc(O)c1=O,IC50,37000.0,4.43,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL3818308,O=C(O)c1cn(Cc2ccccc2)cc(O)c1=O,IC50,35000.0,4.46,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL3818878,O=C(O)c1cn(Cc2ccc(F)cc2)cc(O)c1=O,IC50,35000.0,4.46,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL3818435,CC(c1ccc(F)cc1)n1cc(O)c(=O)c(C(=O)O)c1,IC50,34000.0,4.47,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34000.0,4.468521082957745
CHEMBL3818266,Cc1cc(Cn2cc(O)c(=O)c(C(=O)O)c2)ccc1F,IC50,100000.0,,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3818407,O=C(O)c1cn(Cc2ccc(F)cc2F)cc(O)c1=O,IC50,100000.0,,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3818416,O=C(O)c1cn(Cc2ccc(Cl)cc2)cc(O)c1=O,IC50,67000.0,4.17,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,67000.0,4.173925197299174
CHEMBL3819540,O=C(O)c1cn(Cc2ccc(Cl)c(Cl)c2)cc(O)c1=O,IC50,36000.0,4.44,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36000.0,4.443697499232713
CHEMBL3818729,O=C(O)c1cn(Cc2ccc(Cl)cc2Cl)cc(O)c1=O,IC50,25000.0,4.6,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL3819579,O=C(O)c1cn(Cc2ccc(F)c(Cl)c2)cc(O)c1=O,IC50,44500.0,4.35,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44500.0,4.351639989019068
CHEMBL3818134,O=C(O)c1cn(Cc2ccc(Br)cc2)cc(O)c1=O,IC50,100000.0,,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3818253,O=C(O)c1cn(Cc2cccc(C(F)(F)F)c2)cc(O)c1=O,IC50,100000.0,,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3818739,O=C(O)c1cn(Cc2ccncc2)cc(O)c1=O,IC50,100000.0,,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3817979,CS(=O)(=O)c1ccc(Cn2cc(O)c(=O)c(C(=O)O)c2)cc1,IC50,100000.0,,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3819151,O=C(O)c1ccc(Cn2cc(O)c(=O)c(C(=O)O)c2)cc1,IC50,100000.0,,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3819610,COc1ccc(Cn2cc(O)c(=O)c(C(=O)O)c2)cc1,IC50,100000.0,,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3818736,O=C(O)c1cn(Cc2cccc3ccccc23)cc(O)c1=O,IC50,23000.0,4.64,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL3818453,CC(c1cccc2ccccc12)n1cc(O)c(=O)c(C(=O)O)c1,IC50,2260.0,5.65,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2260.0,5.645891560852599
CHEMBL3818605,O=C(O)c1cn(CC2(c3ccccc3)CCCC2)cc(O)c1=O,IC50,14000.0,4.85,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL3819415,O=C(O)c1cn(Cc2ccccc2-c2ccccc2)cc(O)c1=O,IC50,17000.0,4.77,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL3818081,O=C(O)c1cn(Cc2ccc(-c3ccccc3)cc2)cc(O)c1=O,IC50,22000.0,4.66,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL3819541,NCc1ccc(-c2ccc(Cn3cc(O)c(=O)c(C(=O)O)c3)cc2)cc1,IC50,7790.0,5.11,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7790.0,5.108462542327436
CHEMBL3818189,O=C(O)c1cn(Cc2ccc(-c3cnc4ccccc4c3)cc2)cc(O)c1=O,IC50,16000.0,4.8,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL3818057,NS(=O)(=O)c1ccc(-c2ccc(Cn3cc(O)c(=O)c(C(=O)O)c3)cc2)cc1,IC50,100000.0,,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3818755,O=C(O)c1cn(Cc2ccc(-c3cccnc3)cc2)cc(O)c1=O,IC50,35000.0,4.46,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL3819452,CCOC(=O)c1cn(Cc2ccc(F)cc2)cc(O)c1=O,IC50,100000.0,,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL3818788,NC(=O)c1cn(Cc2ccc(F)cc2)cc(O)c1=O,IC50,32000.0,4.5,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL3819193,O=C(NCc1ccc(F)cc1F)c1cn(Cc2ccc(F)cc2)cc(O)c1=O,IC50,100000.0,,CHEMBL3820838,Inhibition of full-length HIV-1 integrase F185K/C280S double mutant strand transfer activity expressed in Escherichia coli BL21(DE3) using oligo DNA as substrate preincubated for 10 mins followed by substrate addition incubated for 30 mins by plate reader analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4130102,CC1(C)OCCn2c1nc(C(=O)NCc1ccc(F)cc1N1CCCCS1(=O)=O)c(O)c2=O,IC50,9.0,8.05,CHEMBL4123648,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL4126840,CN(C)S(=O)(=O)c1c(CNC(=O)c2nc3n(c(=O)c2O)CCOC3(C)C)ccc(F)c1F,IC50,10.0,8.0,CHEMBL4123648,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL4128890,CC1(C)OCCn2c1nc(C(=O)NCc1ccc(F)cc1S(C)(=O)=O)c(O)c2=O,IC50,6.0,8.22,CHEMBL4123648,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL4130252,CNC(=O)c1cc(F)ccc1CNC(=O)c1nc2n(c(=O)c1O)CCOC2(C)C,IC50,11.0,7.96,CHEMBL4123648,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL4127923,CC1(C)OCCn2c1nc(C(=O)NCc1ccc(F)cc1N1CCOCC1)c(O)c2=O,IC50,5.0,8.3,CHEMBL4123648,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL4128715,CC1(C)OCCn2c1nc(C(=O)NCc1ccc(F)cc1Cl)c(O)c2=O,IC50,10.0,8.0,CHEMBL4123648,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL4126686,Cc1cc(F)ccc1CNC(=O)c1nc2n(c(=O)c1O)CCOC2(C)C,IC50,2.0,8.7,CHEMBL4123648,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL4127891,CC1(C)OCCn2c1nc(C(=O)NCc1ccc(F)c(Cl)c1)c(O)c2=O,IC50,3.0,8.52,CHEMBL4123648,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL4127663,Cc1cc(CNC(=O)c2nc3n(c(=O)c2O)CCOC3(C)C)ccc1F,IC50,3.0,8.52,CHEMBL4123648,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL4126289,CC1(C)OCCn2c1nc(C(=O)NCc1ccc(F)cc1)c(O)c2=O,IC50,3.0,8.52,CHEMBL4123648,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL4127873,O=C(NCc1ccc(F)cc1N1CCCCS1(=O)=O)c1nc2n(c(=O)c1O)CCCC21CCCC1,IC50,5.0,8.3,CHEMBL4123648,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL4128924,O=C(NCc1ccc(F)cc1S(=O)(=O)N1CCOCC1)c1nc2n(c(=O)c1O)CCCC21CCCC1,IC50,11.0,7.96,CHEMBL4123648,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL4126659,CN(C)S(=O)(=O)c1cc(F)ccc1CNC(=O)c1nc2n(c(=O)c1O)CCCC21CCCC1,IC50,6.0,8.22,CHEMBL4123648,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL4128240,CS(=O)(=O)c1cc(F)ccc1CNC(=O)c1nc2n(c(=O)c1O)CCCC21CCCC1,IC50,4.0,8.4,CHEMBL4123648,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL4126165,Cc1cc(CNC(=O)c2nc3n(c(=O)c2O)CCCC32CCCC2)ccc1F,IC50,2.0,8.7,CHEMBL4123648,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL4129717,O=C(NCc1ccc(F)cc1)c1nc2n(c(=O)c1O)CCCC21CCCC1,IC50,3.0,8.52,CHEMBL4123648,Inhibition of HIV1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL4170599,O=C1Cc2cc(-c3ccccc3)ccc2C(=O)N1O,IC50,2000.0,5.7,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2000.0,5.698970004336019
CHEMBL4159305,O=c1[nH]c2cc(-c3ccccc3)ccc2c(=O)n1O,IC50,11000.0,4.96,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL4171477,Cl.O=C1NC2CN(Cc3ccccc3)CCC2C(=O)N1O,IC50,100000.0,,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL183062,O=c1[nH]c2cc(-c3ccccc3)sc2c(=O)n1O,IC50,4500.0,5.35,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4500.0,5.346787486224656
CHEMBL4170035,O=c1[nH]c2cc(-c3ccc(F)cc3)sc2c(=O)n1O,IC50,17000.0,4.77,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL4162103,O=c1[nH]c2cc(-c3ccc(Cl)cc3)sc2c(=O)n1O,IC50,23000.0,4.64,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23000.0,4.638272163982407
CHEMBL4161705,O=c1[nH]c2sc(-c3ccccc3)cc2c(=O)n1O,IC50,2200.0,5.66,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2200.0,5.657577319177793
CHEMBL4172336,O=c1[nH]c2sc(Cc3ccccc3)cc2c(=O)n1O,IC50,5000.0,5.3,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL4176832,O=c1[nH]c2scc(-c3ccccc3)c2c(=O)n1O,IC50,1300.0,5.89,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL4163088,O=c1[nH]c2scc(-c3ccc(Cl)cc3)c2c(=O)n1O,IC50,2100.0,5.68,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2100.0,5.6777807052660805
CHEMBL361350,O=c1[nH]c2sccc2c(=O)n1O,IC50,35000.0,4.46,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL183792,Cc1csc2[nH]c(=O)n(O)c(=O)c12,IC50,12000.0,4.92,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL4175467,Cc1sc2[nH]c(=O)n(O)c(=O)c2c1C,IC50,8400.0,5.08,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8400.0,5.075720713938118
CHEMBL4175393,Cc1c(C(=O)O)sc2[nH]c(=O)n(O)c(=O)c12,IC50,7900.0,5.1,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7900.0,5.102372908709558
CHEMBL4167025,O=c1[nH]c2c(c(=O)n1O)C1CCCC1S2,IC50,5600.0,5.25,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5600.0,5.251811972993799
CHEMBL4168270,O=c1[nH]c2c(c(=O)n1O)C1CCCCC1S2,IC50,3600.0,5.44,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3600.0,5.443697499232712
CHEMBL4161240,CCN1CCC2c3c([nH]c(=O)n(O)c3=O)SC2C1.Cl,IC50,100000.0,,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4176527,Br.O=c1[nH]c2c(c(=O)n1O)C1CCNCC1S2,IC50,17000.0,4.77,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17000.0,4.769551078621726
CHEMBL4163126,Cl.O=c1[nH]c2c(c(=O)n1O)C1CCN(Cc3ccccc3)CC1S2,IC50,8300.0,5.08,CHEMBL4135244,Inhibition of HIV1 integrase pre-incubated for 10 mins before DNA substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8300.0,5.080921907623926
CHEMBL4167946,COC(=O)c1c(Nc2ccc(-c3cncnc3)cc2)c2nccnc2n(O)c1=O,IC50,1490.0,5.83,CHEMBL4156192,Inhibition of recombinant HIV1 integrase strand transfer activity using biotin-labeled double-stranded HIV-1 LTR U5 donor DNA substrate pretreated for 5 mins followed by substrate addition and measured after 30 mins by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1490.0,5.826813731587726
CHEMBL4160026,COC(=O)c1c(Nc2cccc(-c3cccc(C#N)c3)c2)c2nccnc2n(O)c1=O,IC50,250.0,6.6,CHEMBL4156192,Inhibition of recombinant HIV1 integrase strand transfer activity using biotin-labeled double-stranded HIV-1 LTR U5 donor DNA substrate pretreated for 5 mins followed by substrate addition and measured after 30 mins by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL4173285,COC(=O)c1c(Nc2ccc(-c3cccc(C#N)c3)cc2)c2nccnc2n(O)c1=O,IC50,25000.0,,CHEMBL4156192,Inhibition of recombinant HIV1 integrase strand transfer activity using biotin-labeled double-stranded HIV-1 LTR U5 donor DNA substrate pretreated for 5 mins followed by substrate addition and measured after 30 mins by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL4165371,COC(=O)c1c(Nc2cccc(-c3ccc(C#N)cc3)c2)c2nccnc2n(O)c1=O,IC50,22800.0,4.64,CHEMBL4156192,Inhibition of recombinant HIV1 integrase strand transfer activity using biotin-labeled double-stranded HIV-1 LTR U5 donor DNA substrate pretreated for 5 mins followed by substrate addition and measured after 30 mins by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22800.0,4.642065152999546
CHEMBL4169856,COC(=O)c1c(Nc2ccc(-c3ccc(C#N)cc3)cc2)c2nccnc2n(O)c1=O,IC50,1180.0,5.93,CHEMBL4156192,Inhibition of recombinant HIV1 integrase strand transfer activity using biotin-labeled double-stranded HIV-1 LTR U5 donor DNA substrate pretreated for 5 mins followed by substrate addition and measured after 30 mins by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1180.0,5.928117992693874
CHEMBL4166116,COC(=O)c1c(Nc2cccc(-c3cncnc3)c2)c2nccnc2n(O)c1=O,IC50,10850.0,4.96,CHEMBL4156192,Inhibition of recombinant HIV1 integrase strand transfer activity using biotin-labeled double-stranded HIV-1 LTR U5 donor DNA substrate pretreated for 5 mins followed by substrate addition and measured after 30 mins by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10850.0,4.964570261815452
CHEMBL4176741,COC(=O)c1c(Nc2ccc(-c3ccc(OC)c(OC)c3)cc2)c2nccnc2n(O)c1=O,IC50,25000.0,,CHEMBL4156192,Inhibition of recombinant HIV1 integrase strand transfer activity using biotin-labeled double-stranded HIV-1 LTR U5 donor DNA substrate pretreated for 5 mins followed by substrate addition and measured after 30 mins by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL4162663,COC(=O)c1c(Nc2cccc(-c3ccc(OC)c(OC)c3)c2)c2nccnc2n(O)c1=O,IC50,220.0,6.66,CHEMBL4156192,Inhibition of recombinant HIV1 integrase strand transfer activity using biotin-labeled double-stranded HIV-1 LTR U5 donor DNA substrate pretreated for 5 mins followed by substrate addition and measured after 30 mins by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,220.0,6.657577319177793
CHEMBL4173375,COC(=O)c1c(Nc2cccc3ccccc23)c2nccnc2n(O)c1=O,IC50,25000.0,,CHEMBL4156192,Inhibition of recombinant HIV1 integrase strand transfer activity using biotin-labeled double-stranded HIV-1 LTR U5 donor DNA substrate pretreated for 5 mins followed by substrate addition and measured after 30 mins by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL4159297,COC(=O)c1c(Nc2ccc3ccccc3c2)c2nccnc2n(O)c1=O,IC50,6740.0,5.17,CHEMBL4156192,Inhibition of recombinant HIV1 integrase strand transfer activity using biotin-labeled double-stranded HIV-1 LTR U5 donor DNA substrate pretreated for 5 mins followed by substrate addition and measured after 30 mins by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6740.0,5.17134010346468
CHEMBL4169936,COC(=O)c1c(Nc2ccc(-c3ccccc3)cc2)c2nccnc2n(O)c1=O,IC50,25000.0,,CHEMBL4156192,Inhibition of recombinant HIV1 integrase strand transfer activity using biotin-labeled double-stranded HIV-1 LTR U5 donor DNA substrate pretreated for 5 mins followed by substrate addition and measured after 30 mins by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,200.0,6.7,CHEMBL4156192,Inhibition of recombinant HIV1 integrase strand transfer activity using biotin-labeled double-stranded HIV-1 LTR U5 donor DNA substrate pretreated for 5 mins followed by substrate addition and measured after 30 mins by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,200.0,6.698970004336019
CHEMBL282731,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H](C(=O)O)[C@@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,34.0,7.47,CHEMBL4221348,Inhibition of HIV-1 subtype C integrase in presence of biotinylated DNA by colorimetric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34.0,7.468521082957745
CHEMBL4225194,O=C(O)CC(O)/C=N/c1ccc(O)c(O)c1,IC50,38730.0,4.41,CHEMBL4221348,Inhibition of HIV-1 subtype C integrase in presence of biotinylated DNA by colorimetric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38730.0,4.411952503013917
CHEMBL4228083,O=C(O)CC(O)/C=N/c1cc([N+](=O)[O-])ccc1O,IC50,65110.0,4.19,CHEMBL4221348,Inhibition of HIV-1 subtype C integrase in presence of biotinylated DNA by colorimetric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,65110.0,4.186352304653103
CHEMBL4225205,O=C(O)CC(O)/C=N/c1cc(Cl)cc(Br)c1O,IC50,100000.0,,CHEMBL4221348,Inhibition of HIV-1 subtype C integrase in presence of biotinylated DNA by colorimetric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4225035,O=C(O)CC(O)/C=N/c1cc(Cl)cc(Cl)c1O,IC50,100000.0,,CHEMBL4221348,Inhibition of HIV-1 subtype C integrase in presence of biotinylated DNA by colorimetric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4229270,O=C(O)CC(O)/C=N/c1cc(Br)cc(Br)c1O,IC50,26430.0,4.58,CHEMBL4221348,Inhibition of HIV-1 subtype C integrase in presence of biotinylated DNA by colorimetric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26430.0,4.577902836868289
CHEMBL4227772,O=C(O)CC(O)/C=N/c1ccc(O)c(O)c1O,IC50,3520.0,5.45,CHEMBL4221348,Inhibition of HIV-1 subtype C integrase in presence of biotinylated DNA by colorimetric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3520.0,5.453457336521868
CHEMBL4228494,O=C(O)CC(O)/C=N/c1cccc(O)c1O,IC50,53150.0,4.27,CHEMBL4221348,Inhibition of HIV-1 subtype C integrase in presence of biotinylated DNA by colorimetric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53150.0,4.274496731140684
CHEMBL4225997,O=C(O)CC(O)/C=N/c1ccccc1O,IC50,100000.0,,CHEMBL4221348,Inhibition of HIV-1 subtype C integrase in presence of biotinylated DNA by colorimetric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4226527,CN(C)CCCNC(=O)c1ccc2nc(-c3ccc4nc(CNC(=O)CCCCCCCCCCCC(=O)NCc5nc6ccc(-c7nc8ccc(C(=O)NCCCN(C)C)cc8[nH]7)cc6[nH]5)[nH]c4c3)[nH]c2c1,IC50,60.0,7.22,CHEMBL4223013,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,60.0,7.221848749616356
CHEMBL4282218,O=c1cc(Sc2ccccc2)[nH]c(=O)n1O,IC50,1100.0,5.96,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1100.0,5.958607314841775
CHEMBL4292143,Cc1ccc(Sc2cc(=O)n(O)c(=O)[nH]2)cc1,IC50,2800.0,5.55,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2800.0,5.552841968657781
CHEMBL4284247,CCc1ccc(Sc2cc(=O)n(O)c(=O)[nH]2)cc1,IC50,1300.0,5.89,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL4288722,CCc1ccccc1Sc1cc(=O)n(O)c(=O)[nH]1,IC50,750.0,6.12,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,750.0,6.1249387366083
CHEMBL4280827,O=c1cc(Sc2ccc(C(F)(F)F)cc2)[nH]c(=O)n1O,IC50,10000.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL4291548,O=c1cc(Sc2cccc(C(F)(F)F)c2)[nH]c(=O)n1O,IC50,880.0,6.06,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,880.0,6.055517327849831
CHEMBL4277423,O=c1cc(Sc2ccccc2C(F)(F)F)[nH]c(=O)n1O,IC50,880.0,6.06,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,880.0,6.055517327849831
CHEMBL4281951,O=c1cc(Sc2ccc(F)cc2)[nH]c(=O)n1O,IC50,6800.0,5.17,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6800.0,5.167491087293763
CHEMBL4279266,O=c1cc(Sc2cccc(F)c2)[nH]c(=O)n1O,IC50,490.0,6.31,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,490.0,6.309803919971486
CHEMBL4278477,O=c1cc(Sc2ccccc2F)[nH]c(=O)n1O,IC50,770.0,6.11,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,770.0,6.113509274827518
CHEMBL4289142,O=c1cc(Sc2ccc(Cl)cc2)[nH]c(=O)n1O,IC50,640.0,6.19,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,640.0,6.1938200260161125
CHEMBL4291865,O=c1cc(Sc2cccc(Cl)c2)[nH]c(=O)n1O,IC50,590.0,6.23,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,590.0,6.229147988357855
CHEMBL4288444,O=c1cc(Sc2cccc(Br)c2)[nH]c(=O)n1O,IC50,1200.0,5.92,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL4277795,O=c1cc(Sc2ccccc2Br)[nH]c(=O)n1O,IC50,1100.0,5.96,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1100.0,5.958607314841775
CHEMBL4280139,O=c1cc(Sc2ccc([N+](=O)[O-])cc2)[nH]c(=O)n1O,IC50,3400.0,5.47,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3400.0,5.468521082957745
CHEMBL4288035,O=c1cc(Sc2ccc(O)cc2)[nH]c(=O)n1O,IC50,1600.0,5.8,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1600.0,5.795880017344075
CHEMBL4276707,COc1ccc(Sc2cc(=O)n(O)c(=O)[nH]2)cc1,IC50,3600.0,5.44,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3600.0,5.443697499232712
CHEMBL4284648,COc1cccc(Sc2cc(=O)n(O)c(=O)[nH]2)c1,IC50,2700.0,5.57,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2700.0,5.568636235841012
CHEMBL4286950,COc1ccccc1Sc1cc(=O)n(O)c(=O)[nH]1,IC50,8400.0,5.08,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8400.0,5.075720713938118
CHEMBL4294846,O=c1cc(Sc2cccc3ccccc23)[nH]c(=O)n1O,IC50,790.0,6.1,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,790.0,6.102372908709558
CHEMBL4282781,Cc1ccc(-c2ccc(Sc3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,IC50,1000.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL4294074,O=c1cc(Sc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)[nH]c(=O)n1O,IC50,1000.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL4286171,O=c1cc(Sc2ccc(-c3cccc(C(F)(F)F)c3)cc2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4278928,O=c1cc(Sc2ccc(-c3ccc(F)cc3)cc2)[nH]c(=O)n1O,IC50,1000.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL4289601,O=c1cc(Sc2ccc(-c3cccc(F)c3)cc2)[nH]c(=O)n1O,IC50,1000.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL4282386,O=c1cc(Sc2ccc(-c3ccc(Cl)cc3)cc2)[nH]c(=O)n1O,IC50,1000.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL4292982,O=c1cc(Sc2ccc(-c3ccc(O)cc3)cc2)[nH]c(=O)n1O,IC50,170.0,6.77,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,170.0,6.769551078621726
CHEMBL4285791,COc1ccc(-c2ccc(Sc3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,IC50,100000.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4277847,COc1cccc(-c2ccc(Sc3cc(=O)n(O)c(=O)[nH]3)cc2)c1,IC50,1000.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL4276679,COc1ccc(-c2ccc(Sc3cc(=O)n(O)c(=O)[nH]3)cc2)cc1OC,IC50,330.0,6.48,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,330.0,6.481486060122112
CHEMBL4293481,COc1cc(OC)cc(-c2ccc(Sc3cc(=O)n(O)c(=O)[nH]3)cc2)c1,IC50,100000.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4286262,Cc1cc(-c2ccc(Sc3cc(=O)n(O)c(=O)[nH]3)cc2)ccc1F,IC50,10000.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL4278348,COc1ccc(-c2ccc(Sc3cc(=O)n(O)c(=O)[nH]3)cc2)cc1F,IC50,140.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,140.0,6.853871964321762
CHEMBL4289681,O=c1cc(Sc2cccc(-c3ccc(C(F)(F)F)cc3)c2)[nH]c(=O)n1O,IC50,140.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,140.0,6.853871964321762
CHEMBL4281804,O=c1cc(Sc2cccc(-c3cccc(C(F)(F)F)c3)c2)[nH]c(=O)n1O,IC50,1000.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL4293068,O=c1cc(Sc2cccc(-c3ccc(F)cc3)c2)[nH]c(=O)n1O,IC50,140.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,140.0,6.853871964321762
CHEMBL4285242,O=c1cc(Sc2cccc(-c3cccc(F)c3)c2)[nH]c(=O)n1O,IC50,240.0,6.62,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,240.0,6.619788758288394
CHEMBL4277935,O=c1cc(Sc2cccc(-c3ccc(Cl)cc3)c2)[nH]c(=O)n1O,IC50,1000.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL4288585,O=c1cc(Sc2cccc(-c3ccc(F)c(Cl)c3)c2)[nH]c(=O)n1O,IC50,1000.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL4292590,O=c1cc(Sc2ccccc2-c2ccc(C(F)(F)F)cc2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4281980,O=c1cc(Sc2ccccc2-c2ccc(F)cc2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273393,Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4285821,O=c1cc(Cc2cccc(Br)c2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4277884,O=c1cc(Cc2ccc(Br)cc2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4291139,Cc1cc(-c2cccc(Cc3cc(=O)n(O)c(=O)[nH]3)c2)ccc1F,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4283283,COc1ccc(-c2cccc(Cc3cc(=O)n(O)c(=O)[nH]3)c2)cc1F,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4287728,O=c1cc(Cc2cccc(-c3cc(Cl)cc(C(F)(F)F)c3)c2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4279822,O=c1cc(Cc2cccc(-c3cccc(Cl)c3)c2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4284329,O=c1cc(Cc2cccc(-c3ccc(Cl)cc3)c2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4294970,O=c1cc(Cc2cccc(-c3cccc(F)c3)c2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4280927,O=c1cc(Cc2cccc(-c3cccc(C(F)(F)F)c3)c2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4291563,O=c1cc(Cc2cccc(-c3ccccc3)c2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4277572,Cc1cc(-c2ccc(Cc3cc(=O)n(O)c(=O)[nH]3)cc2)ccc1F,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4285516,COc1ccc(-c2ccc(Cc3cc(=O)n(O)c(=O)[nH]3)cc2)cc1F,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4290770,O=c1cc(Cc2ccc(-c3cc(Cl)cc(C(F)(F)F)c3)cc2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4280134,O=c1cc(Cc2ccc(-c3ccc(Cl)c(F)c3)cc2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4294172,O=c1cc(Cc2ccc(-c3ccc(Cl)cc3Cl)cc2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4283583,O=c1cc(Cc2ccc(-c3ccc(F)cc3F)cc2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4279014,O=c1cc(Cc2ccc(-c3ccc(C(F)(F)F)cc3C(F)(F)F)cc2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4286946,O=c1cc(Cc2ccc(-c3cccc(Cl)c3)cc2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4282486,O=c1cc(Cc2ccc(-c3cccc(F)c3)cc2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4290358,O=c1cc(Cc2ccc(-c3cccc(C(F)(F)F)c3)cc2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4280616,O=c1cc(Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4281820,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4273400,Inhibition of HIV integrase strand transfer activity expressed in Escherichia coli BL21 (DE3) using 5' biotin ATGTGGAAAATCTCTAGCA primer annealed with ACTGCTAGAGATTTTCCACAT 3' Cy5 template preincubated for 10 mins followed by primer/template addition measured after 30 mins by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4280818,Cc1nc2ccc(Br)cc2c(-c2ccc(Cl)cc2)c1C(OC(C)(C)C)C(=O)O,IC50,136.0,6.87,CHEMBL4334399,Inhibition of biotinylated-TAR-RNA binding to HIV1 His6-tagged integrase expressed in Escherichia coli BL21(DE3) preincubated for 2 hrs followed by RNA addition and measured after 2 hrs by Alpha screen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,136.0,6.866461091629782
CHEMBL4544303,CC(C)(C)OC(C(=O)O)c1c(-c2ccc3c(c2)CCCO3)nc(-c2cnn(Cc3ccccc3)c2)c2ccccc12,IC50,210.0,6.68,CHEMBL4334399,Inhibition of biotinylated-TAR-RNA binding to HIV1 His6-tagged integrase expressed in Escherichia coli BL21(DE3) preincubated for 2 hrs followed by RNA addition and measured after 2 hrs by Alpha screen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,210.0,6.6777807052660805
CHEMBL4280818,Cc1nc2ccc(Br)cc2c(-c2ccc(Cl)cc2)c1C(OC(C)(C)C)C(=O)O,IC50,150.0,6.82,CHEMBL4334397,Inhibition of LEDGF/p75 binding to HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,150.0,6.823908740944319
CHEMBL4544303,CC(C)(C)OC(C(=O)O)c1c(-c2ccc3c(c2)CCCO3)nc(-c2cnn(Cc3ccccc3)c2)c2ccccc12,IC50,36700.0,4.43,CHEMBL4334397,Inhibition of LEDGF/p75 binding to HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36700.0,4.43533393574791
CHEMBL4280818,Cc1nc2ccc(Br)cc2c(-c2ccc(Cl)cc2)c1C(OC(C)(C)C)C(=O)O,IC50,150.0,6.82,CHEMBL4334396,Inhibition of LEDGF/p75-dependant HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,150.0,6.823908740944319
CHEMBL4544303,CC(C)(C)OC(C(=O)O)c1c(-c2ccc3c(c2)CCCO3)nc(-c2cnn(Cc3ccccc3)c2)c2ccccc12,IC50,23400.0,4.63,CHEMBL4334396,Inhibition of LEDGF/p75-dependant HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23400.0,4.6307841425898575
CHEMBL4280818,Cc1nc2ccc(Br)cc2c(-c2ccc(Cl)cc2)c1C(OC(C)(C)C)C(=O)O,IC50,120.0,6.92,CHEMBL4334395,Inhibition of LEDGF/p75-independant HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,120.0,6.920818753952375
CHEMBL4450048,CC(C)(C)OC(C(=O)O)c1c(-c2ccc3c(c2)CCCO3)nc(-c2nc3cc(Cl)ccc3[nH]2)c2ccccc12,IC50,810.0,6.09,CHEMBL4334395,Inhibition of LEDGF/p75-independant HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,810.0,6.0915149811213505
CHEMBL4544303,CC(C)(C)OC(C(=O)O)c1c(-c2ccc3c(c2)CCCO3)nc(-c2cnn(Cc3ccccc3)c2)c2ccccc12,IC50,480.0,6.32,CHEMBL4334395,Inhibition of LEDGF/p75-independant HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,480.0,6.318758762624412
CHEMBL4526711,CC(C)(C)OC(C(=O)O)c1c(-c2ccc3c(c2)CCCO3)nc(-c2ccco2)c2ccccc12,IC50,3550.0,5.45,CHEMBL4334395,Inhibition of LEDGF/p75-independant HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3550.0,5.449771646944906
CHEMBL4527313,CC(C)(C)OC(C(=O)O)c1c(-c2ccc3c(c2)CCCO3)nc(-c2ccc3c(c2)CCCO3)c2ccccc12,IC50,1220.0,5.91,CHEMBL4334395,Inhibition of LEDGF/p75-independant HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1220.0,5.913640169325252
CHEMBL4476045,CC(C)(C)OC(C(=O)O)c1c(-c2ccc3c(c2)CCCO3)nc(-c2ccc(-c3ccccc3)cc2)c2ccccc12,IC50,830.0,6.08,CHEMBL4334395,Inhibition of LEDGF/p75-independant HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,830.0,6.080921907623926
CHEMBL4557062,COc1ccc(-c2nc(-c3ccc4c(c3)CCCO4)c(C(OC(C)(C)C)C(=O)O)c3ccccc23)cc1,IC50,1000.0,6.0,CHEMBL4334395,Inhibition of LEDGF/p75-independant HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL4465280,CC(C)(C)OC(C(=O)O)c1c(-c2ccc3c(c2)CCCO3)nc(-c2ccc(C(F)(F)F)cc2)c2ccccc12,IC50,7640.0,5.12,CHEMBL4334395,Inhibition of LEDGF/p75-independant HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7640.0,5.11690664142431
CHEMBL4558950,CC(C)(C)OC(C(=O)O)c1c(-c2ccc3c(c2)CCCO3)nc(-c2cccc(C(=O)O)c2)c2ccccc12,IC50,12300.0,4.91,CHEMBL4334395,Inhibition of LEDGF/p75-independant HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12300.0,4.910094888560602
CHEMBL4454444,CC(C)(C)OC(C(=O)O)c1c(-c2ccc3c(c2)CCCO3)nc(-c2cccc(F)c2)c2ccccc12,IC50,12900.0,4.89,CHEMBL4334395,Inhibition of LEDGF/p75-independant HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12900.0,4.889410289700751
CHEMBL4572060,COc1cccc(-c2nc(-c3ccc4c(c3)CCCO4)c(C(OC(C)(C)C)C(=O)O)c3ccccc23)c1,IC50,1140.0,5.94,CHEMBL4334395,Inhibition of LEDGF/p75-independant HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1140.0,5.943095148663527
CHEMBL4558632,COc1cccc(-c2nc(-c3ccccc3)c(C(OC(C)(C)C)C(=O)O)c3ccccc23)c1,IC50,13800.0,4.86,CHEMBL4334395,Inhibition of LEDGF/p75-independant HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13800.0,4.860120913598763
CHEMBL4470794,CC(C)(C)OC(C(=O)O)c1c(-c2ccc3c(c2)CCCO3)nc(-c2ccccc2)c2ccccc12,IC50,4650.0,5.33,CHEMBL4334395,Inhibition of LEDGF/p75-independant HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4650.0,5.332547047110046
CHEMBL4470920,CC(C)(C)OC(C(=O)O)c1c(-c2ccccc2)nc(-c2ccccc2)c2ccccc12,IC50,10100.0,5.0,CHEMBL4334395,Inhibition of LEDGF/p75-independant HIV1 His/FLAG-tagged integrase expressed in Escherichia coli BL21(DE3) by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10100.0,4.995678626217358
CHEMBL4535359,CC(C)Oc1ccc2cccnc2c1-c1cccc2ccccc12,IC50,100000.0,,CHEMBL4350068,Inhibition of recombinant HIV1 integrase strand transfer activity using biotin-labeled double-stranded HIV1 LTR U5 donor DNA substrate pretreated for 5 mins followed by substrate addition and measured after 30 mins by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4465677,CC(C)Oc1ccc2cccnc2c1-c1cccc2cccnc12,IC50,100000.0,,CHEMBL4350068,Inhibition of recombinant HIV1 integrase strand transfer activity using biotin-labeled double-stranded HIV1 LTR U5 donor DNA substrate pretreated for 5 mins followed by substrate addition and measured after 30 mins by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,1100.0,5.96,CHEMBL4350068,Inhibition of recombinant HIV1 integrase strand transfer activity using biotin-labeled double-stranded HIV1 LTR U5 donor DNA substrate pretreated for 5 mins followed by substrate addition and measured after 30 mins by ELISA,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1100.0,5.958607314841775
CHEMBL4459084,Cc1ccc2oc(=O)c3c(O)cc(=O)oc3c2c1,IC50,9500.0,5.02,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9500.0,5.022276394711152
CHEMBL4440430,Cc1ccc2c(c1)oc(=O)c1c(O)cc(=O)oc12,IC50,41500.0,4.38,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41500.0,4.3819519032879075
CHEMBL4457846,Cc1cccc2c1oc(=O)c1c(O)cc(=O)oc12,IC50,24000.0,4.62,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24000.0,4.619788758288394
CHEMBL4581840,O=c1cc(O)c2c(=O)oc3ccc4ccccc4c3c2o1,IC50,21500.0,4.67,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21500.0,4.667561540084395
CHEMBL4436493,O=c1cc(O)c2c(=O)oc3c4ccccc4ccc3c2o1,IC50,7500.0,5.12,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7500.0,5.1249387366083
CHEMBL4546001,CC(=O)c1c(O)c2c(=O)oc3ccccc3c2oc1=O,IC50,8500.0,5.07,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8500.0,5.070581074285707
CHEMBL4450551,CC(=O)c1c(O)c2c(=O)oc3ccc(C)cc3c2oc1=O,IC50,6450.0,5.19,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6450.0,5.1904402853647325
CHEMBL4569505,CC(=O)c1c(O)c2c(=O)oc3cc(C)ccc3c2oc1=O,IC50,22350.0,4.65,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22350.0,4.650722472532045
CHEMBL4570404,CC(=O)c1c(O)c2c(=O)oc3c(C)cccc3c2oc1=O,IC50,18500.0,4.73,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18500.0,4.732828271596986
CHEMBL4567188,CC(=O)CC(=O)c1c(O)c2c(=O)oc3ccccc3c2oc1=O,IC50,42000.0,4.38,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42000.0,4.376750709602099
CHEMBL4453513,CC(=O)CC(=O)c1c(O)c2c(=O)oc3ccc4ccccc4c3c2oc1=O,IC50,47500.0,4.32,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47500.0,4.323306390375134
CHEMBL4461018,CC(=O)CC(=O)c1c(O)c2c(=O)oc3c4ccccc4ccc3c2oc1=O,IC50,11000.0,4.96,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11000.0,4.958607314841775
CHEMBL4450126,Cc1cc(=O)c2c(=O)oc3c4ccccc4oc(=O)c3c2o1,IC50,14000.0,4.85,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14000.0,4.853871964321762
CHEMBL4465730,O=C(c1ccccc1)c1ccc2c(c1)N=CCC(c1c(O)c3c(=O)oc4ccccc4c3oc1=O)=N2,IC50,20000.0,4.7,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20000.0,4.698970004336019
CHEMBL4467593,Cc1ccc2oc(=O)c3cc(C4=Nc5ccc(C(=O)c6ccccc6)cc5N=CC4)c(=O)oc3c2c1,IC50,100000.0,,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4586578,Cc1cc(-c2c(O)c3c(=O)oc4ccccc4c3oc2=O)nn1-c1ccccc1,IC50,100000.0,,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2180479,CCCC(C(=O)O)c1c(C)nc2ccc(Cl)cc2c1-c1ccccc1,IC50,9000.0,5.05,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9000.0,5.045757490560675
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,58.0,7.24,CHEMBL4363041,Inhibition of LEDGF/p75-dependent full length HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated for 1 hr further incubated for 90 mins with biotin-labeled donor DNA and target DNA by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58.0,7.236572006437063
CHEMBL4459084,Cc1ccc2oc(=O)c3c(O)cc(=O)oc3c2c1,IC50,69000.0,4.16,CHEMBL4363043,Inhibition of subunit exchanging activity of His and Flag-tagged HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells after 2.5 hrs by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,69000.0,4.161150909262744
CHEMBL4436493,O=c1cc(O)c2c(=O)oc3c4ccccc4ccc3c2o1,IC50,57000.0,4.24,CHEMBL4363043,Inhibition of subunit exchanging activity of His and Flag-tagged HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells after 2.5 hrs by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,57000.0,4.2441251443275085
CHEMBL4450551,CC(=O)c1c(O)c2c(=O)oc3ccc(C)cc3c2oc1=O,IC50,56500.0,4.25,CHEMBL4363043,Inhibition of subunit exchanging activity of His and Flag-tagged HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells after 2.5 hrs by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,56500.0,4.247951552180561
CHEMBL4461018,CC(=O)CC(=O)c1c(O)c2c(=O)oc3c4ccccc4ccc3c2oc1=O,IC50,85000.0,4.07,CHEMBL4363043,Inhibition of subunit exchanging activity of His and Flag-tagged HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells after 2.5 hrs by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,85000.0,4.070581074285707
CHEMBL4450126,Cc1cc(=O)c2c(=O)oc3c4ccccc4oc(=O)c3c2o1,IC50,100000.0,,CHEMBL4363043,Inhibition of subunit exchanging activity of His and Flag-tagged HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells after 2.5 hrs by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4465730,O=C(c1ccccc1)c1ccc2c(c1)N=CCC(c1c(O)c3c(=O)oc4ccccc4c3oc1=O)=N2,IC50,100000.0,,CHEMBL4363043,Inhibition of subunit exchanging activity of His and Flag-tagged HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells after 2.5 hrs by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL2180479,CCCC(C(=O)O)c1c(C)nc2ccc(Cl)cc2c1-c1ccccc1,IC50,100000.0,,CHEMBL4363043,Inhibition of subunit exchanging activity of His and Flag-tagged HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells after 2.5 hrs by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,100000.0,,CHEMBL4363043,Inhibition of subunit exchanging activity of His and Flag-tagged HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells after 2.5 hrs by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4462312,O=C(NNC(=O)c1cc2ccccc2oc1=O)c1ccccc1O,IC50,70.0,7.16,CHEMBL4369200,Inhibition of HIV1 subtype C recombinant integrase strand transfer activity preincubated for 45 mins with double-stranded biotinylated donor DNA followed by addition of double stranded FITC-labelled target DNA and measured after 60 mins relative to control,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL4562173,O=C(NNC(=O)c1cc2cc(Br)ccc2oc1=O)c1ccccc1O,IC50,14.0,7.85,CHEMBL4369200,Inhibition of HIV1 subtype C recombinant integrase strand transfer activity preincubated for 45 mins with double-stranded biotinylated donor DNA followed by addition of double stranded FITC-labelled target DNA and measured after 60 mins relative to control,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL4460630,O=C(NNC(=O)c1cc2cc(Cl)ccc2oc1=O)c1ccccc1O,IC50,13.0,7.89,CHEMBL4369200,Inhibition of HIV1 subtype C recombinant integrase strand transfer activity preincubated for 45 mins with double-stranded biotinylated donor DNA followed by addition of double stranded FITC-labelled target DNA and measured after 60 mins relative to control,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL4578898,COc1cccc2cc(C(=O)NNC(=O)c3ccccc3O)c(=O)oc12,IC50,47.0,7.33,CHEMBL4369200,Inhibition of HIV1 subtype C recombinant integrase strand transfer activity preincubated for 45 mins with double-stranded biotinylated donor DNA followed by addition of double stranded FITC-labelled target DNA and measured after 60 mins relative to control,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47.0,7.327902142064282
CHEMBL4471021,CCOc1cccc2cc(C(=O)NNC(=O)c3ccccc3O)c(=O)oc12,IC50,104.0,6.98,CHEMBL4369200,Inhibition of HIV1 subtype C recombinant integrase strand transfer activity preincubated for 45 mins with double-stranded biotinylated donor DNA followed by addition of double stranded FITC-labelled target DNA and measured after 60 mins relative to control,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,104.0,6.982966660701219
CHEMBL4483602,O=C(NNC(=O)c1cc2ccccc2oc1=O)c1cc(Cl)ccc1O,IC50,33.0,7.48,CHEMBL4369200,Inhibition of HIV1 subtype C recombinant integrase strand transfer activity preincubated for 45 mins with double-stranded biotinylated donor DNA followed by addition of double stranded FITC-labelled target DNA and measured after 60 mins relative to control,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33.0,7.481486060122112
CHEMBL4438012,O=C(NNC(=O)c1cc2cc(Br)ccc2oc1=O)c1cc(Cl)ccc1O,IC50,175.0,6.76,CHEMBL4369200,Inhibition of HIV1 subtype C recombinant integrase strand transfer activity preincubated for 45 mins with double-stranded biotinylated donor DNA followed by addition of double stranded FITC-labelled target DNA and measured after 60 mins relative to control,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,175.0,6.756961951313706
CHEMBL4568499,O=C(NNC(=O)c1cc2cc(Cl)ccc2oc1=O)c1cc(Cl)ccc1O,IC50,41.0,7.39,CHEMBL4369200,Inhibition of HIV1 subtype C recombinant integrase strand transfer activity preincubated for 45 mins with double-stranded biotinylated donor DNA followed by addition of double stranded FITC-labelled target DNA and measured after 60 mins relative to control,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41.0,7.3872161432802645
CHEMBL4444865,COc1cccc2cc(C(=O)NNC(=O)c3cc(Cl)ccc3O)c(=O)oc12,IC50,23.0,7.64,CHEMBL4369200,Inhibition of HIV1 subtype C recombinant integrase strand transfer activity preincubated for 45 mins with double-stranded biotinylated donor DNA followed by addition of double stranded FITC-labelled target DNA and measured after 60 mins relative to control,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23.0,7.638272163982407
CHEMBL4463247,CCOc1cccc2cc(C(=O)NNC(=O)c3cc(Cl)ccc3O)c(=O)oc12,IC50,31.0,7.51,CHEMBL4369200,Inhibition of HIV1 subtype C recombinant integrase strand transfer activity preincubated for 45 mins with double-stranded biotinylated donor DNA followed by addition of double stranded FITC-labelled target DNA and measured after 60 mins relative to control,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31.0,7.508638306165727
CHEMBL4455967,COc1ccc(O)c(C(=O)NNC(=O)c2cc3ccccc3oc2=O)c1,IC50,5800.0,5.24,CHEMBL4369200,Inhibition of HIV1 subtype C recombinant integrase strand transfer activity preincubated for 45 mins with double-stranded biotinylated donor DNA followed by addition of double stranded FITC-labelled target DNA and measured after 60 mins relative to control,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5800.0,5.236572006437063
CHEMBL4451590,COc1ccc(O)c(C(=O)NNC(=O)c2cc3cc(Br)ccc3oc2=O)c1,IC50,163.0,6.79,CHEMBL4369200,Inhibition of HIV1 subtype C recombinant integrase strand transfer activity preincubated for 45 mins with double-stranded biotinylated donor DNA followed by addition of double stranded FITC-labelled target DNA and measured after 60 mins relative to control,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,163.0,6.787812395596042
CHEMBL4533364,COc1ccc(O)c(C(=O)NNC(=O)c2cc3cc(Cl)ccc3oc2=O)c1,IC50,605.0,6.22,CHEMBL4369200,Inhibition of HIV1 subtype C recombinant integrase strand transfer activity preincubated for 45 mins with double-stranded biotinylated donor DNA followed by addition of double stranded FITC-labelled target DNA and measured after 60 mins relative to control,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,605.0,6.2182446253475305
CHEMBL4435433,COc1ccc(O)c(C(=O)NNC(=O)c2cc3cccc(OC)c3oc2=O)c1,IC50,901.0,6.04,CHEMBL4369200,Inhibition of HIV1 subtype C recombinant integrase strand transfer activity preincubated for 45 mins with double-stranded biotinylated donor DNA followed by addition of double stranded FITC-labelled target DNA and measured after 60 mins relative to control,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,901.0,6.045275209020938
CHEMBL4459285,CCOc1cccc2cc(C(=O)NNC(=O)c3cc(OC)ccc3O)c(=O)oc12,IC50,592.0,6.23,CHEMBL4369200,Inhibition of HIV1 subtype C recombinant integrase strand transfer activity preincubated for 45 mins with double-stranded biotinylated donor DNA followed by addition of double stranded FITC-labelled target DNA and measured after 60 mins relative to control,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,592.0,6.22767829327708
CHEMBL282731,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H](C(=O)O)[C@@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O,IC50,10.0,8.0,CHEMBL4369200,Inhibition of HIV1 subtype C recombinant integrase strand transfer activity preincubated for 45 mins with double-stranded biotinylated donor DNA followed by addition of double stranded FITC-labelled target DNA and measured after 60 mins relative to control,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,2.0,8.7,CHEMBL4387462,Inhibition of HIV integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL1229211,C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,IC50,0.5,9.3,CHEMBL4387462,Inhibition of HIV integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,0.5,9.301029995663981
CHEMBL3989866,O=C(NCc1c(F)cc(F)cc1F)c1cn2c(c(O)c1=O)C(=O)N1[C@H]3CC[C@H](C3)O[C@@H]1C2,IC50,7.5,8.12,CHEMBL4387462,Inhibition of HIV integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.5,8.1249387366083
CHEMBL4452475,O=c1[nH]c2ccc(NS(=O)(=O)c3ccc4ccccc4c3)cc2c(=O)n1O,IC50,850.0,6.07,CHEMBL4387465,Inhibition of strand transfer activity of HIV1 integrase expressed in Escherichia coli using DNA complexes containing 32P-labeled INT1ST and and non-labeled INT2,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,850.0,6.070581074285707
CHEMBL4585102,Cc1ccc(C(=O)c2cc(=O)n(O)c(=O)[nH]2)cc1,IC50,7200.0,5.14,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7200.0,5.142667503568731
CHEMBL4543258,O=C(c1ccc(C(F)(F)F)cc1)c1cc(=O)n(O)c(=O)[nH]1,IC50,2100.0,5.68,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2100.0,5.6777807052660805
CHEMBL4526907,O=C(c1ccc(F)cc1)c1cc(=O)n(O)c(=O)[nH]1,IC50,4000.0,5.4,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL4458156,COC(=O)c1ccc(C(=O)c2cc(=O)n(O)c(=O)[nH]2)cc1,IC50,13000.0,4.89,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL4475543,Cc1cc(C)cc(C(=O)c2cc(=O)n(O)c(=O)[nH]2)c1,IC50,4900.0,5.31,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4900.0,5.309803919971486
CHEMBL4453588,Cc1ccc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,IC50,10000.0,5.0,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10000.0,5.0
CHEMBL4566382,O=C(c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)c1cc(=O)n(O)c(=O)[nH]1,IC50,100000.0,,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4436114,O=C(c1ccc(-c2ccc(F)cc2)cc1)c1cc(=O)n(O)c(=O)[nH]1,IC50,6700.0,5.17,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6700.0,5.173925197299173
CHEMBL4446400,COC(=O)c1ccc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,IC50,6700.0,5.17,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6700.0,5.173925197299173
CHEMBL4440369,Cc1cc(C)cc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)c1,IC50,3500.0,5.46,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3500.0,5.455931955649724
CHEMBL4452722,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)n(O)c(=O)[nH]1,IC50,2500.0,5.6,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2500.0,5.6020599913279625
CHEMBL4451536,O=C(c1cccc(-c2ccccc2)c1)c1cc(=O)n(O)c(=O)[nH]1,IC50,7100.0,5.15,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7100.0,5.1487416512809245
CHEMBL4572580,COc1ccc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,IC50,100000.0,,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4541401,N#Cc1ccc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,IC50,530.0,6.28,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,530.0,6.275724130399211
CHEMBL4574161,COc1ccc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)cc1OC,IC50,330.0,6.48,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,330.0,6.481486060122112
CHEMBL4537227,Cc1cc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)ccc1F,IC50,4300.0,5.37,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4300.0,5.366531544420413
CHEMBL4559115,O=C(c1ccc(-c2ccc(Cl)c(F)c2)cc1)c1cc(=O)n(O)c(=O)[nH]1,IC50,370.0,6.43,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,370.0,6.431798275933005
CHEMBL4578447,CCOCn1c(C(=O)c2ccc(-c3ccccc3)cc2)cc(=O)n(O)c1=O,IC50,100000.0,,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4555062,CCOCn1c(C(=O)c2cccc(-c3ccccc3)c2)cc(=O)n(O)c1=O,IC50,100000.0,,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4529686,CCOCn1c(C(C#N)c2cc(C)cc(C)c2)cc(=O)n(O)c1=O,IC50,100000.0,,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4466889,CCOCn1c(C(C#N)c2ccc(-c3ccccc3)cc2)cc(=O)n(O)c1=O,IC50,100000.0,,CHEMBL4401325,Inhibition of HIV1 integrase strand transfer activity using 5'-biotinylated oligonucleotide as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4581611,Cn1c(Nc2cccc(-c3ccccc3)c2)cc(=O)n(O)c1=O,IC50,2200.0,5.66,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2200.0,5.657577319177793
CHEMBL4586421,COc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)cc1,IC50,4400.0,5.36,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4400.0,5.356547323513812
CHEMBL4471489,COc1cccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)c1,IC50,4600.0,5.34,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4600.0,5.337242168318426
CHEMBL4440667,Cn1c(Nc2ccc(-c3cccc(C#N)c3)cc2)cc(=O)n(O)c1=O,IC50,30000.0,4.52,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30000.0,4.522878745280337
CHEMBL4473298,Cn1c(Nc2cccc(-c3cccc(C#N)c3)c2)cc(=O)n(O)c1=O,IC50,7100.0,5.15,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7100.0,5.1487416512809245
CHEMBL4437185,Cc1noc(C)c1-c1ccc(Nc2cc(=O)n(O)c(=O)n2C)cc1,IC50,25000.0,4.6,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL4563474,Cn1c(Oc2ccc(-c3ccc(O)cc3)cc2)cc(=O)n(O)c1=O,IC50,12000.0,4.92,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12000.0,4.920818753952375
CHEMBL4472002,Cn1c(Oc2cccc(-c3cccc(O)c3)c2)cc(=O)n(O)c1=O,IC50,7100.0,5.15,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7100.0,5.1487416512809245
CHEMBL4545702,COc1ccc(-c2ccccc2Oc2cc(=O)n(O)c(=O)n2C)cc1,IC50,1000.0,6.0,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1000.0,6.0
CHEMBL4549947,Cc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,IC50,93000.0,4.03,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,93000.0,4.031517051446065
CHEMBL4453169,Cc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)[nH]3)c2)cc1,IC50,44000.0,4.36,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44000.0,4.356547323513812
CHEMBL4280869,COc1cccc(-c2ccc(Nc3cc(=O)n(O)c(=O)[nH]3)cc2)c1,IC50,100000.0,,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4451895,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)[nH]3)c2)cc1,IC50,100000.0,,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4474029,COc1cc(OC)cc(-c2ccc(Nc3cc(=O)n(O)c(=O)[nH]3)cc2)c1,IC50,35000.0,4.46,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL4475877,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)[nH]3)c2)c(OC)c1,IC50,1200.0,5.92,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1200.0,5.920818753952375
CHEMBL4454510,COc1cccc(OC)c1-c1cccc(Nc2cc(=O)n(O)c(=O)[nH]2)c1,IC50,1300.0,5.89,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL4531566,O=c1cc(Nc2cccc(-c3ccc(F)cc3)c2)[nH]c(=O)n1O,IC50,100000.0,,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL50605,O=C(O)C(=O)CC(=O)c1cccn1Cc1ccc(F)cc1,IC50,400.0,6.4,CHEMBL4428286,Inhibition of HIV integrase pre-incubated for 10 mins before addition of oligo-5'-biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3'-Cy5) substrate,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL593,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,IC50,100000.0,,CHEMBL4430967,Inhibition of HIV1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4448648,Cn1c(C(OC(C)(C)C)C(=O)[O-])c(-c2ccc3c(c2)CCCO3)c2ccccc21.[Na+],IC50,28700.0,4.54,CHEMBL4432977,Inhibition of C-terminal FLAG-tagged LEDGF/p75 binding to recombinant full length N-terminal His-tagged HIV1 integrase expressed in Escherichia coli BL21(DE3) cells preincubated with enzyme for 30 mins followed by LEDGF/p75 addition by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28700.0,4.542118103266008
CHEMBL4448648,Cn1c(C(OC(C)(C)C)C(=O)[O-])c(-c2ccc3c(c2)CCCO3)c2ccccc21.[Na+],IC50,900.0,6.05,CHEMBL4432975,Inhibition of recombinant full length C-terminal His-tagged HIV1 integrase A128T mutant expressed in Escherichia coli BL21(DE3) cells assessed as reduction in LEDGF/p75 independent 3' processing activity using 32P-labeled blunt ended 21-mer DNA as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL4448648,Cn1c(C(OC(C)(C)C)C(=O)[O-])c(-c2ccc3c(c2)CCCO3)c2ccccc21.[Na+],IC50,3200.0,5.5,CHEMBL4432972,Inhibition of recombinant full length C-terminal His-tagged HIV1 integrase expressed in Escherichia coli BL21(DE3) cells assessed as reduction in LEDGF/p75 independent 3' processing activity using 32P-labeled blunt ended 21-mer DNA as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3200.0,5.494850021680094
CHEMBL3259891,COC(C(=O)O)c1c(C)nc2ccc(Br)cc2c1-c1ccc(Cl)cc1,IC50,1300.0,5.89,CHEMBL4432973,Inhibition of recombinant full length C-terminal His-tagged HIV1 integrase expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of recombinant C-terminal FLAG-tagged LEDGF/p75-induced integration of viral 32-mer blunt-ended U5 DNA into pBR322 DNA preincubated with enzyme for 30 mins followed by viral and target DNA addition and subsequent addition of LEDGF/p75 after 5 mins measured after 90 mins by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1300.0,5.886056647693163
CHEMBL4513790,COc1ccc(-n2c(C(OC(C)(C)C)C(=O)O)c(C)c3ccccc32)cc1,IC50,100000.0,,CHEMBL4432973,Inhibition of recombinant full length C-terminal His-tagged HIV1 integrase expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of recombinant C-terminal FLAG-tagged LEDGF/p75-induced integration of viral 32-mer blunt-ended U5 DNA into pBR322 DNA preincubated with enzyme for 30 mins followed by viral and target DNA addition and subsequent addition of LEDGF/p75 after 5 mins measured after 90 mins by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4462745,Cn1c(CC(OC(C)(C)C)C(=O)O)c(-c2ccccc2)c2ccccc21,IC50,100000.0,,CHEMBL4432973,Inhibition of recombinant full length C-terminal His-tagged HIV1 integrase expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of recombinant C-terminal FLAG-tagged LEDGF/p75-induced integration of viral 32-mer blunt-ended U5 DNA into pBR322 DNA preincubated with enzyme for 30 mins followed by viral and target DNA addition and subsequent addition of LEDGF/p75 after 5 mins measured after 90 mins by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4573753,COc1ccc(-c2c(C(OC(C)(C)C)C(=O)[O-])n(Cc3ccccc3)c3ccccc23)cc1.[Na+],IC50,59100.0,4.23,CHEMBL4432973,Inhibition of recombinant full length C-terminal His-tagged HIV1 integrase expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of recombinant C-terminal FLAG-tagged LEDGF/p75-induced integration of viral 32-mer blunt-ended U5 DNA into pBR322 DNA preincubated with enzyme for 30 mins followed by viral and target DNA addition and subsequent addition of LEDGF/p75 after 5 mins measured after 90 mins by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,59100.0,4.228412519118745
CHEMBL4460215,Cn1c(C(OC(C)(C)C)C(=O)[O-])c(Cc2ccccc2)c2ccccc21.[Na+],IC50,31300.0,4.5,CHEMBL4432973,Inhibition of recombinant full length C-terminal His-tagged HIV1 integrase expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of recombinant C-terminal FLAG-tagged LEDGF/p75-induced integration of viral 32-mer blunt-ended U5 DNA into pBR322 DNA preincubated with enzyme for 30 mins followed by viral and target DNA addition and subsequent addition of LEDGF/p75 after 5 mins measured after 90 mins by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31300.0,4.504455662453552
CHEMBL4448648,Cn1c(C(OC(C)(C)C)C(=O)[O-])c(-c2ccc3c(c2)CCCO3)c2ccccc21.[Na+],IC50,4500.0,5.35,CHEMBL4432973,Inhibition of recombinant full length C-terminal His-tagged HIV1 integrase expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of recombinant C-terminal FLAG-tagged LEDGF/p75-induced integration of viral 32-mer blunt-ended U5 DNA into pBR322 DNA preincubated with enzyme for 30 mins followed by viral and target DNA addition and subsequent addition of LEDGF/p75 after 5 mins measured after 90 mins by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4500.0,5.346787486224656
CHEMBL4532605,COc1ccc(-c2c(C(OC(C)(C)C)C(=O)[O-])n(C)c3ccccc23)cc1.[Na+],IC50,32000.0,4.5,CHEMBL4432973,Inhibition of recombinant full length C-terminal His-tagged HIV1 integrase expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of recombinant C-terminal FLAG-tagged LEDGF/p75-induced integration of viral 32-mer blunt-ended U5 DNA into pBR322 DNA preincubated with enzyme for 30 mins followed by viral and target DNA addition and subsequent addition of LEDGF/p75 after 5 mins measured after 90 mins by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,32000.0,4.494850021680094
CHEMBL4586384,Cn1c(C(OC(C)(C)C)C(=O)[O-])c(-c2ccccc2)c2ccccc21.[Na+],IC50,44100.0,4.36,CHEMBL4432973,Inhibition of recombinant full length C-terminal His-tagged HIV1 integrase expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of recombinant C-terminal FLAG-tagged LEDGF/p75-induced integration of viral 32-mer blunt-ended U5 DNA into pBR322 DNA preincubated with enzyme for 30 mins followed by viral and target DNA addition and subsequent addition of LEDGF/p75 after 5 mins measured after 90 mins by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44100.0,4.355561410532162
CHEMBL4079475,O=C(NCc1ccccc1)c1c(Nc2ccccc2)[nH]c(=O)n(O)c1=O,IC50,100000.0,,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4083483,O=C(NCc1ccccc1)c1c(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)n(O)c1=O,IC50,100000.0,,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4541705,CNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccccc1,IC50,80.0,7.1,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,80.0,7.096910013008056
CHEMBL4540879,CNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1cccc(F)c1,IC50,250.0,6.6,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,250.0,6.6020599913279625
CHEMBL4566749,CNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccc(F)cc1,IC50,110.0,6.96,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL4546928,CNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1cccc(Cl)c1F,IC50,110.0,6.96,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,110.0,6.958607314841775
CHEMBL4575590,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccccc1,IC50,33.0,7.48,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33.0,7.481486060122112
CHEMBL4594021,CCCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccccc1,IC50,66.0,7.18,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,66.0,7.180456064458131
CHEMBL4525700,CCCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1cccc(Cl)c1F,IC50,58.0,7.24,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,58.0,7.236572006437063
CHEMBL4564306,CC(C)Nc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccccc1,IC50,150.0,6.82,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,150.0,6.823908740944319
CHEMBL4572031,O=C(NCc1ccccc1)c1c(NC2CC2)[nH]c(=O)n(O)c1=O,IC50,210.0,6.68,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,210.0,6.6777807052660805
CHEMBL4583643,CC(C)(C)Nc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccccc1,IC50,81.0,7.09,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,81.0,7.0915149811213505
CHEMBL4530287,Nc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccccc1,IC50,900.0,6.05,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,900.0,6.045757490560675
CHEMBL1229211,C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,IC50,68.0,7.17,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68.0,7.167491087293763
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,650.0,6.19,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,650.0,6.187086643357144
CHEMBL4583283,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1cccc(F)c1,IC50,68.0,7.17,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68.0,7.167491087293763
CHEMBL4560700,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccc(F)cc1,IC50,49.0,7.31,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,49.0,7.309803919971486
CHEMBL4573034,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1cc(F)ccc1F,IC50,68.0,7.17,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,68.0,7.167491087293763
CHEMBL4580966,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccc(F)cc1F,IC50,48.0,7.32,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48.0,7.318758762624412
CHEMBL4538712,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1cc(F)cc(F)c1,IC50,230.0,6.64,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,230.0,6.638272163982407
CHEMBL4562114,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccc(F)c(F)c1,IC50,77.0,7.11,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,77.0,7.113509274827518
CHEMBL4579940,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1cc(F)ccc1Cl,IC50,95.0,7.02,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,95.0,7.022276394711152
CHEMBL4587480,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccc(Cl)c(F)c1,IC50,120.0,6.92,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,120.0,6.920818753952375
CHEMBL4564288,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1cccc(Cl)c1F,IC50,21.0,7.68,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL4550727,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccc(C)c(F)c1,IC50,51.0,7.29,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,51.0,7.292429823902063
CHEMBL4522635,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCCc1ccccc1,IC50,100.0,7.0,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL4593441,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)Nc1ccccc1,IC50,35000.0,4.46,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35000.0,4.455931955649724
CHEMBL4534066,CCNc1[nH]c(=O)n(O)c(=O)c1C(N)=O,IC50,100000.0,,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4538154,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCCCl,IC50,100000.0,,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4584656,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)Oc1ccccc1,IC50,100000.0,,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4588345,CCNc1c(C(=O)NCc2ccc(F)cc2)c(=O)n(O)c(=O)n1C,IC50,100000.0,,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL4576831,CCNc1c(C(=O)N(C)Cc2ccc(F)cc2)c(=O)n(O)c(=O)n1C,IC50,7000.0,5.16,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL4528932,Cn1c(O)c(C(=O)NCc2ccccc2)c(=O)n(O)c1=O,IC50,37000.0,4.43,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37000.0,4.431798275933005
CHEMBL4557888,O=C(NCc1ccc(F)cc1)c1c2n(c(=O)n(O)c1=O)CCCN2,IC50,430.0,6.37,CHEMBL4478444,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli using [32P]-labeled oligonucleotide as substrate after 60 mins by strand transfer activity assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,430.0,6.366531544420413
CHEMBL4639852,CCCCn1cncc1-c1cccc(OC)c1,IC50,30500.0,4.52,CHEMBL4610361,Inhibition of HIV-1 integrase assessed as inhibition of interaction of HIV-1 IN with LEDGF/p75 (unknown origin) preincubated with enzyme for 30 mins followed by further incubation with LEDGF/p75 for 1 hr by Alphascreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,30500.0,4.515700160653214
CHEMBL4642650,CCCCn1cncc1-c1ccc(C(C)(C)C)cc1,IC50,22400.0,4.65,CHEMBL4610361,Inhibition of HIV-1 integrase assessed as inhibition of interaction of HIV-1 IN with LEDGF/p75 (unknown origin) preincubated with enzyme for 30 mins followed by further incubation with LEDGF/p75 for 1 hr by Alphascreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22400.0,4.649751981665837
CHEMBL4638855,COc1cccc(-c2cncn2C2CCCCC2)c1,IC50,21900.0,4.66,CHEMBL4610361,Inhibition of HIV-1 integrase assessed as inhibition of interaction of HIV-1 IN with LEDGF/p75 (unknown origin) preincubated with enzyme for 30 mins followed by further incubation with LEDGF/p75 for 1 hr by Alphascreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21900.0,4.6595558851598815
CHEMBL4645491,CC(C)(C)c1ccc(-c2cncn2C2CCCCC2)cc1,IC50,14600.0,4.84,CHEMBL4610361,Inhibition of HIV-1 integrase assessed as inhibition of interaction of HIV-1 IN with LEDGF/p75 (unknown origin) preincubated with enzyme for 30 mins followed by further incubation with LEDGF/p75 for 1 hr by Alphascreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14600.0,4.835647144215563
CHEMBL4633855,Fc1ccc(-c2cncn2-c2ccc(Br)cc2)cc1,IC50,25100.0,4.6,CHEMBL4610361,Inhibition of HIV-1 integrase assessed as inhibition of interaction of HIV-1 IN with LEDGF/p75 (unknown origin) preincubated with enzyme for 30 mins followed by further incubation with LEDGF/p75 for 1 hr by Alphascreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25100.0,4.600326278518962
CHEMBL4649334,COc1ccc(-c2cncn2-c2ccc(Br)cc2)c(OC)c1,IC50,7000.0,5.16,CHEMBL4610361,Inhibition of HIV-1 integrase assessed as inhibition of interaction of HIV-1 IN with LEDGF/p75 (unknown origin) preincubated with enzyme for 30 mins followed by further incubation with LEDGF/p75 for 1 hr by Alphascreen assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,27.0,7.57,CHEMBL4615840,Inhibition of wild type recombinant HIV1 His6-tagged integrase expressed in Escherichia coli BL21 using 18 nucleotide 3'-biotin labeled DNA acceptor as substrate preincubated for 1 hr followed by substrate addition and further incubated for 90 mins in presence of recombinant LEDGF/p75 by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27.0,7.568636235841012
CHEMBL4642985,CCOC(=O)c1cc(-c2cn(Cc3ccc(F)cc3)cc2-c2ccccc2)n[nH]1,IC50,75000.0,4.12,CHEMBL4615869,"Inhibition of wild type HIV1 subtype B NL4-3 6xHis-tagged integrase expressed in Escherichia coli BL21 (DE3) assessed as inhibition of 3'-processing and strand-transfer reactions using DNA as substrate preincubated with enzyme for 1 hr followed by addition of recombinant 6xHis-tagged LEDGF/p75 expressed in Escherichia coli BL21 (DE3), DNA donor substrate and DNA acceptor substrate and further incubated for 90 mins by HTRF assay",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75000.0,4.1249387366083
CHEMBL4638187,C/C(=N\NC(=O)C(O)C(O)C(=O)N/N=C(\C)c1c(O)c2ccccc2oc1=O)c1c(O)c2ccccc2oc1=O,IC50,3500.0,5.46,CHEMBL4627592,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3500.0,5.455931955649724
CHEMBL4649461,CN(C)CCCNC(=O)c1ccc2nc(-c3ccc4nc(CNC(=O)CCCCN5CCN(CCCCC(=O)NCc6nc7ccc(-c8nc9ccc(C(=O)NCCCN(C)C)cc9[nH]8)cc7[nH]6)CC5)[nH]c4c3)[nH]c2c1,IC50,1100.0,5.96,CHEMBL4628341,Inhibition of recombinant HIV1 integrase expressed in Escherichia coli Rosetta assessed as reduction in 3' end processing activity using [32P]-labelled U5B/U5A DNA as substrate measured after 2 hrs by polyacrylamide gel electrophoresis method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1100.0,5.958607314841775
CHEMBL4649072,CN(C)CCCNC(=O)c1ccc2nc(-c3ccc4nc(CNC(=O)CCN5CCN(CCC(=O)NCc6nc7ccc(-c8nc9ccc(C(=O)NCCCN(C)C)cc9[nH]8)cc7[nH]6)CC5)[nH]c4c3)[nH]c2c1,IC50,2600.0,5.58,CHEMBL4628341,Inhibition of recombinant HIV1 integrase expressed in Escherichia coli Rosetta assessed as reduction in 3' end processing activity using [32P]-labelled U5B/U5A DNA as substrate measured after 2 hrs by polyacrylamide gel electrophoresis method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2600.0,5.585026652029182
CHEMBL4647024,CN(C)CCCNC(=O)c1ccc2nc(-c3ccc4nc(CNC(=O)CCCN5CCN(CCCC(=O)NCc6nc7ccc(-c8nc9ccc(C(=O)NCCCN(C)C)cc9[nH]8)cc7[nH]6)CC5)[nH]c4c3)[nH]c2c1,IC50,1800.0,5.75,CHEMBL4628341,Inhibition of recombinant HIV1 integrase expressed in Escherichia coli Rosetta assessed as reduction in 3' end processing activity using [32P]-labelled U5B/U5A DNA as substrate measured after 2 hrs by polyacrylamide gel electrophoresis method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL4649015,CN1CCN(c2ccc3nc(-c4ccc5nc(CNC(=O)CCCCN6CCN(CCCCC(=O)NCc7nc8ccc(-c9nc%10ccc(N%11CCN(C)CC%11)cc%10[nH]9)cc8[nH]7)CC6)[nH]c5c4)[nH]c3c2)CC1,IC50,3900.0,5.41,CHEMBL4628341,Inhibition of recombinant HIV1 integrase expressed in Escherichia coli Rosetta assessed as reduction in 3' end processing activity using [32P]-labelled U5B/U5A DNA as substrate measured after 2 hrs by polyacrylamide gel electrophoresis method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3900.0,5.4089353929735005
CHEMBL4640673,CN(C)CCCNC(=O)c1ccc2nc(-c3ccc4nc(CNC(=O)CN5CCN(CC(=O)NCc6nc7ccc(-c8nc9ccc(C(=O)NCCCN(C)C)cc9[nH]8)cc7[nH]6)CC5)[nH]c4c3)[nH]c2c1,IC50,2100.0,5.68,CHEMBL4628341,Inhibition of recombinant HIV1 integrase expressed in Escherichia coli Rosetta assessed as reduction in 3' end processing activity using [32P]-labelled U5B/U5A DNA as substrate measured after 2 hrs by polyacrylamide gel electrophoresis method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2100.0,5.6777807052660805
CHEMBL4633363,CN1CCN(c2ccc3nc(-c4ccc5nc(CNC(=O)CN6CCN(CC(=O)NCc7nc8ccc(-c9nc%10ccc(N%11CCN(C)CC%11)cc%10[nH]9)cc8[nH]7)CC6)[nH]c5c4)[nH]c3c2)CC1,IC50,15000.0,,CHEMBL4628341,Inhibition of recombinant HIV1 integrase expressed in Escherichia coli Rosetta assessed as reduction in 3' end processing activity using [32P]-labelled U5B/U5A DNA as substrate measured after 2 hrs by polyacrylamide gel electrophoresis method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL4644631,CN1CCN(c2ccc3nc(-c4ccc5nc(CNC(=O)CCN6CCN(CCC(=O)NCc7nc8ccc(-c9nc%10ccc(N%11CCN(C)CC%11)cc%10[nH]9)cc8[nH]7)CC6)[nH]c5c4)[nH]c3c2)CC1,IC50,7000.0,5.16,CHEMBL4628341,Inhibition of recombinant HIV1 integrase expressed in Escherichia coli Rosetta assessed as reduction in 3' end processing activity using [32P]-labelled U5B/U5A DNA as substrate measured after 2 hrs by polyacrylamide gel electrophoresis method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7000.0,5.154901959985743
CHEMBL4645067,CN1CCN(c2ccc3nc(-c4ccc5nc(CNC(=O)CCCN6CCN(CCCC(=O)NCc7nc8ccc(-c9nc%10ccc(N%11CCN(C)CC%11)cc%10[nH]9)cc8[nH]7)CC6)[nH]c5c4)[nH]c3c2)CC1,IC50,9900.0,5.0,CHEMBL4628341,Inhibition of recombinant HIV1 integrase expressed in Escherichia coli Rosetta assessed as reduction in 3' end processing activity using [32P]-labelled U5B/U5A DNA as substrate measured after 2 hrs by polyacrylamide gel electrophoresis method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9900.0,5.00436480540245
CHEMBL5207303,CC(=O)c1ccc2c(c1)c(=O)c(C(=O)O)cn2Cc1ccc(F)cc1,IC50,100000.0,,CHEMBL5098052,Inhibition of recombinant His-tagged HIV-1 NL4-3 integrase expressed in Escherichia coli BL21 pLys using GTGTGGAAAATCTCTAGCA/ACTGCTAGAGATTTTCCACAC as DNA substrate incubated for 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL5176128,O=C(/C=C/c1ccc2c(c1)c(=O)c(C(=O)O)cn2Cc1ccc(F)cc1)c1ccccc1,IC50,3380.0,5.47,CHEMBL5098052,Inhibition of recombinant His-tagged HIV-1 NL4-3 integrase expressed in Escherichia coli BL21 pLys using GTGTGGAAAATCTCTAGCA/ACTGCTAGAGATTTTCCACAC as DNA substrate incubated for 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3380.0,5.471083299722345
CHEMBL5188823,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccccc3)cc2c1=O,IC50,410.0,6.39,CHEMBL5098052,Inhibition of recombinant His-tagged HIV-1 NL4-3 integrase expressed in Escherichia coli BL21 pLys using GTGTGGAAAATCTCTAGCA/ACTGCTAGAGATTTTCCACAC as DNA substrate incubated for 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,410.0,6.3872161432802645
CHEMBL5197780,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3cccc(Cl)c3Cl)cc2c1=O,IC50,100000.0,,CHEMBL5098052,Inhibition of recombinant His-tagged HIV-1 NL4-3 integrase expressed in Escherichia coli BL21 pLys using GTGTGGAAAATCTCTAGCA/ACTGCTAGAGATTTTCCACAC as DNA substrate incubated for 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL5198940,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc(Cl)c(Cl)c3)cc2c1=O,IC50,3250.0,5.49,CHEMBL5098052,Inhibition of recombinant His-tagged HIV-1 NL4-3 integrase expressed in Escherichia coli BL21 pLys using GTGTGGAAAATCTCTAGCA/ACTGCTAGAGATTTTCCACAC as DNA substrate incubated for 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3250.0,5.488116639021126
CHEMBL5173288,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3cccc4ccccc34)cc2c1=O,IC50,100000.0,,CHEMBL5098052,Inhibition of recombinant His-tagged HIV-1 NL4-3 integrase expressed in Escherichia coli BL21 pLys using GTGTGGAAAATCTCTAGCA/ACTGCTAGAGATTTTCCACAC as DNA substrate incubated for 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL5183730,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc4c(c3)OCO4)cc2c1=O,IC50,100000.0,,CHEMBL5098052,Inhibition of recombinant His-tagged HIV-1 NL4-3 integrase expressed in Escherichia coli BL21 pLys using GTGTGGAAAATCTCTAGCA/ACTGCTAGAGATTTTCCACAC as DNA substrate incubated for 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL5185855,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc(Oc4ccccc4)cc3)cc2c1=O,IC50,100000.0,,CHEMBL5098052,Inhibition of recombinant His-tagged HIV-1 NL4-3 integrase expressed in Escherichia coli BL21 pLys using GTGTGGAAAATCTCTAGCA/ACTGCTAGAGATTTTCCACAC as DNA substrate incubated for 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL5194402,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(C(C)=O)cc2c1=O,IC50,100000.0,,CHEMBL5098052,Inhibition of recombinant His-tagged HIV-1 NL4-3 integrase expressed in Escherichia coli BL21 pLys using GTGTGGAAAATCTCTAGCA/ACTGCTAGAGATTTTCCACAC as DNA substrate incubated for 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL5182942,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3cccc(Cl)c3Cl)cc2c1=O,IC50,50.0,7.3,CHEMBL5098052,Inhibition of recombinant His-tagged HIV-1 NL4-3 integrase expressed in Escherichia coli BL21 pLys using GTGTGGAAAATCTCTAGCA/ACTGCTAGAGATTTTCCACAC as DNA substrate incubated for 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL5191403,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc(Cl)c(Cl)c3)cc2c1=O,IC50,9450.0,5.03,CHEMBL5098052,Inhibition of recombinant His-tagged HIV-1 NL4-3 integrase expressed in Escherichia coli BL21 pLys using GTGTGGAAAATCTCTAGCA/ACTGCTAGAGATTTTCCACAC as DNA substrate incubated for 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9450.0,5.0245681914907365
CHEMBL5207685,CCOC(=O)/C=C/C(=O)/C=C/c1cccn1Cc1ccccc1Cl,IC50,100000.0,,CHEMBL5098052,Inhibition of recombinant His-tagged HIV-1 NL4-3 integrase expressed in Escherichia coli BL21 pLys using GTGTGGAAAATCTCTAGCA/ACTGCTAGAGATTTTCCACAC as DNA substrate incubated for 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,19.0,7.72,CHEMBL5098052,Inhibition of recombinant His-tagged HIV-1 NL4-3 integrase expressed in Escherichia coli BL21 pLys using GTGTGGAAAATCTCTAGCA/ACTGCTAGAGATTTTCCACAC as DNA substrate incubated for 2 hrs by densitometric analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19.0,7.721246399047171
CHEMBL5180773,COC(=O)[C@@]1(C(=O)C(C)=O)C(C)=C(C)C=C2[C@]3(C=O)CC[C@H](OC(C)=O)C(C)(C)[C@H]3CC[C@@]21C,IC50,8.1,8.09,CHEMBL5108710,Inhibition of influenza A virus Neuraminidase using 2-(4-methylumbelliferyl)-a-D-acetylneuraminic acid as substrate incubated for 30 mins by fluorescence based analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.1,8.09151498112135
CHEMBL5184817,C=C1C[C@@H]2[C@@]3(C)CCC(=O)C(C)(C)[C@@H]3C(=O)C[C@@]2(C)[C@@]2(C(=O)OC)C(=O)[C@](C)(O)C(=O)[C@@]12C,IC50,18.0,7.75,CHEMBL5113611,Inhibition of influenza A virus neuraminidase using 2-(4-methylumbelliferyl)-a-D-acetylneuraminic acid as substrate incubated for 30 mins by fluorescence based analysis,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL5189624,COc1cc2c(c(O)c1C)Oc1c(C=O)c(O)cc(C)c1C(=O)O2,IC50,4650.0,5.33,CHEMBL5114441,Inhibition of recombinant HIV-1 subtype C integrase using double-stranded FITC-labelled target DNA as substrate pre-incubated for 45 mins followed by substrate addition measured after 60 mins by strand transfer inhibition assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4650.0,5.332547047110046
CHEMBL505516,CC(=O)N[C@H]1[C@H](O[C@H]2CC[C@]3(C)[C@H]4CC=C5[C@@H]6CC(C)(C)CC[C@]6(C(=O)O)CC[C@@]5(C)[C@]4(C)CC[C@H]3C2(C)C)O[C@H](CO)[C@@H](O)[C@@H]1O,IC50,18300.0,4.74,CHEMBL5114441,Inhibition of recombinant HIV-1 subtype C integrase using double-stranded FITC-labelled target DNA as substrate pre-incubated for 45 mins followed by substrate addition measured after 60 mins by strand transfer inhibition assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18300.0,4.73754891026957
CHEMBL5204422,C/C=C/Oc1cc(C=O)ccc1O,IC50,27000.0,4.57,CHEMBL5128374,Inhibition of Influenza A virus (A/GuangdongSB/01/2009(H1N1)) neuraminidase using 4-MUNANA as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27000.0,4.568636235841013
CHEMBL5204422,C/C=C/Oc1cc(C=O)ccc1O,IC50,28000.0,4.55,CHEMBL5128375,Inhibition of Influenza A virus (A/Guangdong/03/2009(H1N1)) neuraminidase using 4-MUNANA as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,28000.0,4.552841968657781
CHEMBL5204422,C/C=C/Oc1cc(C=O)ccc1O,IC50,25000.0,4.6,CHEMBL5128376,Inhibition of Influenza A virus (A/Guangdong/05/2009(H1N1)) neuraminidase using 4-MUNANA as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by fluorescence assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25000.0,4.6020599913279625
CHEMBL3342478,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2ccc(-c3ccccc3)cc2)[C@H]1NC(C)=O,IC50,2970.0,5.53,CHEMBL5142325,Inhibition of Influenza A virus A/California/04/2009 (H1N1) Neuraminidase H274Y mutant using MUNANA as substrate preincubated for 10 mins followed by substrate addition and measured after 40 mins by fluorescence based microplate reader method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2970.0,5.527243550682788
CHEMBL674,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](N)[C@H]1NC(C)=O,IC50,3560.0,5.45,CHEMBL5142325,Inhibition of Influenza A virus A/California/04/2009 (H1N1) Neuraminidase H274Y mutant using MUNANA as substrate preincubated for 10 mins followed by substrate addition and measured after 40 mins by fluorescence based microplate reader method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3560.0,5.448550002027124
CHEMBL222813,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1NC(=N)N,IC50,2.5,8.6,CHEMBL5142325,Inhibition of Influenza A virus A/California/04/2009 (H1N1) Neuraminidase H274Y mutant using MUNANA as substrate preincubated for 10 mins followed by substrate addition and measured after 40 mins by fluorescence based microplate reader method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.5,8.602059991327963
CHEMBL5201314,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2ccc(-c3cccs3)cc2Cl)[C@H]1NC(C)=O,IC50,3710.0,5.43,CHEMBL5142325,Inhibition of Influenza A virus A/California/04/2009 (H1N1) Neuraminidase H274Y mutant using MUNANA as substrate preincubated for 10 mins followed by substrate addition and measured after 40 mins by fluorescence based microplate reader method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3710.0,5.430626090384954
CHEMBL5200599,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2ccc(-c3cccs3)cc2C)[C@H]1NC(C)=O,IC50,1640.0,5.79,CHEMBL5142325,Inhibition of Influenza A virus A/California/04/2009 (H1N1) Neuraminidase H274Y mutant using MUNANA as substrate preincubated for 10 mins followed by substrate addition and measured after 40 mins by fluorescence based microplate reader method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1640.0,5.785156151952302
CHEMBL5191374,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2ccc(-c3cccs3)cc2OC)[C@H]1NC(C)=O,IC50,510.0,6.29,CHEMBL5142325,Inhibition of Influenza A virus A/California/04/2009 (H1N1) Neuraminidase H274Y mutant using MUNANA as substrate preincubated for 10 mins followed by substrate addition and measured after 40 mins by fluorescence based microplate reader method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,510.0,6.292429823902063
CHEMBL5192262,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2c(C)cc(-c3cccs3)cc2C)[C@H]1NC(C)=O,IC50,100000.0,,CHEMBL5142325,Inhibition of Influenza A virus A/California/04/2009 (H1N1) Neuraminidase H274Y mutant using MUNANA as substrate preincubated for 10 mins followed by substrate addition and measured after 40 mins by fluorescence based microplate reader method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100000.0,4.0
CHEMBL5199263,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2c(F)cc(-c3cccs3)cc2F)[C@H]1NC(C)=O,IC50,4600.0,5.34,CHEMBL5142325,Inhibition of Influenza A virus A/California/04/2009 (H1N1) Neuraminidase H274Y mutant using MUNANA as substrate preincubated for 10 mins followed by substrate addition and measured after 40 mins by fluorescence based microplate reader method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4600.0,5.337242168318426
CHEMBL5174598,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2ccc(-c3cccs3)c(Cl)c2)[C@H]1NC(C)=O,IC50,7100.0,5.15,CHEMBL5142325,Inhibition of Influenza A virus A/California/04/2009 (H1N1) Neuraminidase H274Y mutant using MUNANA as substrate preincubated for 10 mins followed by substrate addition and measured after 40 mins by fluorescence based microplate reader method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7100.0,5.1487416512809245
CHEMBL5197351,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2ccc(-c3ccsc3)cc2Cl)[C@H]1NC(C)=O,IC50,940.0,6.03,CHEMBL5142325,Inhibition of Influenza A virus A/California/04/2009 (H1N1) Neuraminidase H274Y mutant using MUNANA as substrate preincubated for 10 mins followed by substrate addition and measured after 40 mins by fluorescence based microplate reader method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,940.0,6.026872146400301
CHEMBL5192935,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2ccc(-c3ccsc3)cc2C)[C@H]1NC(C)=O,IC50,2290.0,5.64,CHEMBL5142325,Inhibition of Influenza A virus A/California/04/2009 (H1N1) Neuraminidase H274Y mutant using MUNANA as substrate preincubated for 10 mins followed by substrate addition and measured after 40 mins by fluorescence based microplate reader method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2290.0,5.6401645176601125
CHEMBL5196665,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2ccc(-c3ccsc3)cc2OC)[C@H]1NC(C)=O,IC50,1070.0,5.97,CHEMBL5142325,Inhibition of Influenza A virus A/California/04/2009 (H1N1) Neuraminidase H274Y mutant using MUNANA as substrate preincubated for 10 mins followed by substrate addition and measured after 40 mins by fluorescence based microplate reader method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1070.0,5.97061622231479
CHEMBL5196029,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2c(C)cc(-c3ccsc3)cc2C)[C@H]1NC(C)=O,IC50,3720.0,5.43,CHEMBL5142325,Inhibition of Influenza A virus A/California/04/2009 (H1N1) Neuraminidase H274Y mutant using MUNANA as substrate preincubated for 10 mins followed by substrate addition and measured after 40 mins by fluorescence based microplate reader method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3720.0,5.429457060118103
CHEMBL5196288,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2ccc(-c3ccsc3)cc2O)[C@H]1NC(C)=O,IC50,3210.0,5.49,CHEMBL5142325,Inhibition of Influenza A virus A/California/04/2009 (H1N1) Neuraminidase H274Y mutant using MUNANA as substrate preincubated for 10 mins followed by substrate addition and measured after 40 mins by fluorescence based microplate reader method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3210.0,5.493494967595128
CHEMBL3342485,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2ccc(-c3cccs3)cc2)[C@H]1NC(C)=O,IC50,4000.0,5.4,CHEMBL5142325,Inhibition of Influenza A virus A/California/04/2009 (H1N1) Neuraminidase H274Y mutant using MUNANA as substrate preincubated for 10 mins followed by substrate addition and measured after 40 mins by fluorescence based microplate reader method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4000.0,5.3979400086720375
CHEMBL4287425,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2ccc(Sc3ccccc3)cc2)[C@H]1NC(C)=O,IC50,5.57,8.25,CHEMBL5152235,Inhibition of Influenza A virus H1N1 Neuraminidase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.57,8.254144804826272
CHEMBL5187320,CC[C@@H](CCCCc1cn([C@H]2[C@H](O)[C@@H](O)[C@H](n3cc(-c4ccc(-c5cn([C@@H]6O[C@H](CO)[C@@H](n7cc(-c8cc(O)c(-c9cn([C@@H]%10O[C@H](CO)[C@@H](n%11cc(-c%12ccc(-c%13cn([C@@H]%14O[C@H](CO)[C@@H](n%15cc(CCCC[C@H](CC)O[C@@H]%16OC(C(=O)O)=C[C@H](O)[C@H]%16NC(C)=O)nn%15)[C@H](O)[C@H]%14O)nn%13)cc%12)nn%11)[C@H](O)[C@H]%10O)nn9)cc8O)nn7)[C@H](O)[C@H]6O)nn5)cc4)nn3)O[C@@H]2CO)nn1)O[C@@H]1OC(C(=O)O)=C[C@H](N)[C@H]1NC(C)=O,IC50,10600.0,4.97,CHEMBL5167159,Inhibition of Influenza A virus (A/Wisconsin/09/2013(HIN1)) recombinant Neuraminidase using MUNANA as substrate incubated for 60 mins by fluorescence based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10600.0,4.97469413473523
CHEMBL674,CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](N)[C@H]1NC(C)=O,IC50,10.0,8.0,CHEMBL5167159,Inhibition of Influenza A virus (A/Wisconsin/09/2013(HIN1)) recombinant Neuraminidase using MUNANA as substrate incubated for 60 mins by fluorescence based assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL3125978,O=C(NCc1ccc(F)cc1F)c1cc2cccc(O)c2n(O)c1=O,IC50,1800.0,5.75,CHEMBL5237320,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL3125979,O=C(NCc1ccc(F)c(Cl)c1)c1cc2cccnc2n(O)c1=O,IC50,140.0,6.85,CHEMBL5237320,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,140.0,6.853871964321762
CHEMBL3125980,O=C(NCc1ccc(F)c(F)c1)c1cc2cccnc2n(O)c1=O,IC50,170.0,6.77,CHEMBL5237320,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,170.0,6.769551078621726
CHEMBL3125981,O=C(NCc1ccc(F)cc1F)c1cc2cccnc2n(O)c1=O,IC50,410.0,6.39,CHEMBL5237320,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,410.0,6.3872161432802645
CHEMBL3125970,O=C(NCc1ccc(F)c(Cl)c1)c1c(O)c2cccnc2n(O)c1=O,IC50,270.0,6.57,CHEMBL5237320,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,270.0,6.568636235841012
CHEMBL3125971,O=C(NCc1ccc(F)c(F)c1)c1c(O)c2cccnc2n(O)c1=O,IC50,400.0,6.4,CHEMBL5237320,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,400.0,6.3979400086720375
CHEMBL3125972,O=C(NCc1ccc(F)cc1F)c1c(O)c2cccnc2n(O)c1=O,IC50,550.0,6.26,CHEMBL5237320,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,550.0,6.259637310505756
CHEMBL1229211,C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,IC50,0.68,9.17,CHEMBL5237323,Inhibition of HIV-1 integrase Q148K mutant,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,0.68,9.167491087293763
CHEMBL377937,CC1=C[C@H](c2c(O)ccc([C@@H]3CC(=O)c4c(O)cc(O)cc4O3)c2O)[C@@H](C(=O)c2ccc(O)cc2O)[C@H](c2ccc(O)cc2O)C1,IC50,42000.0,4.38,CHEMBL5331907,Inhibition of recombinant HIV-1 LEDGF-dependent full length His-tagged integrase expressed in Escherichia coli BL21 (DE3) by HTRF method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42000.0,4.376750709602099
CHEMBL377937,CC1=C[C@H](c2c(O)ccc([C@@H]3CC(=O)c4c(O)cc(O)cc4O3)c2O)[C@@H](C(=O)c2ccc(O)cc2O)[C@H](c2ccc(O)cc2O)C1,IC50,34000.0,4.47,CHEMBL5331908,Inhibition of recombinant HIV-1 LEDGF-independent full length His-tagged integrase expressed in Escherichia coli BL21 (DE3) by HTRF method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34000.0,4.468521082957745
CHEMBL377937,CC1=C[C@H](c2c(O)ccc([C@@H]3CC(=O)c4c(O)cc(O)cc4O3)c2O)[C@@H](C(=O)c2ccc(O)cc2O)[C@H](c2ccc(O)cc2O)C1,IC50,22000.0,4.66,CHEMBL5331911,Inhibition of recombinant HIV-1 His-tagged LEDGF integrase preincubated for 30 mins followed by FLAG-LEDGF addition and measured after 4 hrs by HTRF method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,22000.0,4.657577319177793
CHEMBL4865520,Cc1c(O)c([N+](=O)[O-])cc2cc(C(=O)Nc3ccc(O)c(C(=O)O)c3)c(=O)oc12,IC50,5000.0,5.3,CHEMBL5331919,Inhibition of HIV-1 integrase strand transfer activity,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5000.0,5.301029995663981
CHEMBL5434992,O=C(N/N=C/c1ccc(O)cc1O)c1cc(O)c(O)c(O)c1,IC50,16000.0,4.8,CHEMBL5331924,Inhibition of recombinant HIV-1 His-tagged LEDGF-dependent integrase preincubated for 1 hr followed by compound addition and measured after 90 mins by HTRF method,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16000.0,4.795880017344075
CHEMBL5439129,CCCCCCC[C@H]1Cc2cc3c(c(O)c2CO1)C(=O)C(=O)C(OC)=C3,IC50,440.0,6.36,CHEMBL5372148,Inhibition of HIV-1 integrase expressed in HEK293T co-transfected with CS-II Luci vector incubated for 48 hrs by Bright-Glo luciferase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,440.0,6.356547323513812
CHEMBL5434329,CCCCCCc1c(OC)cc(=O)oc1C,IC50,15000.0,4.82,CHEMBL5372148,Inhibition of HIV-1 integrase expressed in HEK293T co-transfected with CS-II Luci vector incubated for 48 hrs by Bright-Glo luciferase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15000.0,4.823908740944319
CHEMBL5434231,CCCCCc1cc(O)c(C)c(O)c1C=O,IC50,13000.0,4.89,CHEMBL5372148,Inhibition of HIV-1 integrase expressed in HEK293T co-transfected with CS-II Luci vector incubated for 48 hrs by Bright-Glo luciferase assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13000.0,4.886056647693163
CHEMBL437708,O=C(NCc1ccccc1)c1nc(-c2cccs2)nc(O)c1O,IC50,2600.0,5.58,CHEMBL5391256,Inhibition of HIV-1 integrase G140S/Q148K double mutant,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2600.0,5.585026652029182
CHEMBL3128331,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2nccc3ccccc23)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,IC50,7.0,8.15,CHEMBL5576844,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL3125106,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2ncc(OC)c3ccccc23)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,IC50,2.0,8.7,CHEMBL5576844,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5594789,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2nccc3ccc(Cl)cc23)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,IC50,12.0,7.92,CHEMBL5576844,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL2105735,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2ncc(OC)c3ccc(Cl)cc23)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,IC50,1.0,9.0,CHEMBL5576844,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1.0,9.0
CHEMBL5596283,Cc1ccc2c(c1C(OC(C)(C)C)C(=O)O)[C@]1(CC2)CC[C@@H](C)CC1,IC50,54.0,7.27,CHEMBL5585776,Allosteric inhibition of HIV-1 integrase by ELISA based IN-DNA assembly/Strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54.0,7.267606240177031
CHEMBL5596570,Cc1ccc2c(c1C(OC(C)(C)C)C(=O)O)[C@]1(CCC2)CC[C@@H](C)CC1,IC50,50.0,7.3,CHEMBL5585776,Allosteric inhibition of HIV-1 integrase by ELISA based IN-DNA assembly/Strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL5596955,Cc1ccc2c(c1C(OC(C)(C)C)C(=O)O)[C@]1(CC[C@H](C)CC1)CC2O,IC50,430.0,6.37,CHEMBL5585776,Allosteric inhibition of HIV-1 integrase by ELISA based IN-DNA assembly/Strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,430.0,6.366531544420413
CHEMBL5596874,COC1C[C@]2(CC[C@@H](C)CC2)c2c1ccc(C)c2C(OC(C)(C)C)C(=O)O,IC50,53.0,7.28,CHEMBL5585776,Allosteric inhibition of HIV-1 integrase by ELISA based IN-DNA assembly/Strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,53.0,7.275724130399211
CHEMBL5591004,Cc1ccc2c(c1C(OC(C)(C)C)C(=O)O)[C@]1(CC[C@H](C)CC1)CC2=O,IC50,490.0,6.31,CHEMBL5585776,Allosteric inhibition of HIV-1 integrase by ELISA based IN-DNA assembly/Strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,490.0,6.309803919971486
CHEMBL5277931,Cc1ccc(-c2c([C@H](OC(C)(C)C)C(=O)O)c(C)nc3ccccc23)cc1C,IC50,12.0,7.92,CHEMBL5585776,Allosteric inhibition of HIV-1 integrase by ELISA based IN-DNA assembly/Strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL5597523,CNC(=O)c1cc(C)c(C(OC(C)(C)C)C(=O)O)c2c1CC[C@]21CC[C@@H](C)CC1,IC50,160.0,6.8,CHEMBL5585776,Allosteric inhibition of HIV-1 integrase by ELISA based IN-DNA assembly/Strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,160.0,6.795880017344075
CHEMBL5598287,Cc1cc(C(=O)N(C)C)c2c(c1C(OC(C)(C)C)C(=O)O)[C@]1(CC2)CC[C@@H](C)CC1,IC50,1800.0,5.75,CHEMBL5585776,Allosteric inhibition of HIV-1 integrase by ELISA based IN-DNA assembly/Strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1800.0,5.7447274948966935
CHEMBL5596946,Cc1cc(C(=O)NC(C)C)c2c(c1C(OC(C)(C)C)C(=O)O)[C@]1(CC2)CC[C@@H](C)CC1,IC50,20.0,7.7,CHEMBL5585776,Allosteric inhibition of HIV-1 integrase by ELISA based IN-DNA assembly/Strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL5596381,Cc1cc(C(=O)NCC(C)C)c2c(c1C(OC(C)(C)C)C(=O)O)[C@]1(CC2)CC[C@@H](C)CC1,IC50,5.7,8.24,CHEMBL5585776,Allosteric inhibition of HIV-1 integrase by ELISA based IN-DNA assembly/Strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.7,8.244125144327509
CHEMBL5597609,Cc1cc(C(=O)NC2CCCCC2)c2c(c1C(OC(C)(C)C)C(=O)O)[C@]1(CC2)CC[C@@H](C)CC1,IC50,2.0,8.7,CHEMBL5585776,Allosteric inhibition of HIV-1 integrase by ELISA based IN-DNA assembly/Strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5597978,Cc1cc(C(=O)NC2CCCCCC2)c2c(c1C(OC(C)(C)C)C(=O)O)[C@]1(CC2)CC[C@@H](C)CC1,IC50,1.8,8.74,CHEMBL5585776,Allosteric inhibition of HIV-1 integrase by ELISA based IN-DNA assembly/Strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1.8,8.744727494896694
CHEMBL5596288,Cc1cc(NC(=O)CC(C)C)c2c(c1C(OC(C)(C)C)C(=O)O)[C@]1(CC2)CC[C@@H](C)CC1,IC50,2.2,8.66,CHEMBL5585776,Allosteric inhibition of HIV-1 integrase by ELISA based IN-DNA assembly/Strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.2,8.657577319177793
CHEMBL5597897,Cc1cc(C(=O)NC2CCCCC2)c2c(c1[C@H](OC(C)(C)C)C(=O)O)[C@]1(CC2)CC[C@@H](C)CC1,IC50,1.4,8.85,CHEMBL5585776,Allosteric inhibition of HIV-1 integrase by ELISA based IN-DNA assembly/Strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1.4,8.853871964321762
CHEMBL5597870,Cc1cc(C(=O)NC2CCCCC2)c2c(c1[C@@H](OC(C)(C)C)C(=O)O)[C@]1(CC2)CC[C@@H](C)CC1,IC50,8.3,8.08,CHEMBL5585776,Allosteric inhibition of HIV-1 integrase by ELISA based IN-DNA assembly/Strand transfer assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.3,8.080921907623926
CHEMBL497501,O=C(O)/C(O)=C/C(=O)c1ccc2c(c1)c(=O)c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,70.0,7.16,CHEMBL5611630,Inhibition of HIV-1 integrase catalytic activity incubated for 1 hrs in absence of LEDGF/p75 by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,70.0,7.154901959985743
CHEMBL2236594,O=C(O)/C(O)=C/C(=O)c1ccc2[nH]cc(C(=O)/C=C(\O)C(=O)O)c(=O)c2c1,IC50,3140.0,5.5,CHEMBL5611630,Inhibition of HIV-1 integrase catalytic activity incubated for 1 hrs in absence of LEDGF/p75 by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3140.0,5.503070351926786
CHEMBL5613849,CN(C)c1cc2c(cc1C(=O)/C=C(\O)C(=O)O)c(=O)c(C(=O)/C=C(\O)C(=O)O)cn2Cc1ccc(F)cc1,IC50,181.0,6.74,CHEMBL5611630,Inhibition of HIV-1 integrase catalytic activity incubated for 1 hrs in absence of LEDGF/p75 by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,181.0,6.7423214251308154
CHEMBL5612913,CCOC(=O)/C(O)=C/C(=O)c1ccc2c(c1)c(=O)c(C(=O)/C=C(\O)C(=O)OCC)cn2Cc1ccc(F)cc1,IC50,800.0,6.1,CHEMBL5611630,Inhibition of HIV-1 integrase catalytic activity incubated for 1 hrs in absence of LEDGF/p75 by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,800.0,6.096910013008056
CHEMBL2236593,CCOC(=O)/C(O)=C/C(=O)c1ccc2[nH]cc(C(=O)/C=C(\O)C(=O)OCC)c(=O)c2c1,IC50,2340.0,5.63,CHEMBL5611630,Inhibition of HIV-1 integrase catalytic activity incubated for 1 hrs in absence of LEDGF/p75 by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2340.0,5.630784142589857
CHEMBL5612575,CCOC(=O)/C(O)=C/C(=O)c1cc2c(=O)c(C(=O)/C=C(\O)C(=O)OCC)cn(Cc3ccc(F)cc3)c2cc1N(C)C,IC50,480.0,6.32,CHEMBL5611630,Inhibition of HIV-1 integrase catalytic activity incubated for 1 hrs in absence of LEDGF/p75 by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,480.0,6.318758762624412
CHEMBL5613277,CCOC(=O)/C(O)=C/C(=O)c1cc2c(=O)c(C(=O)/C=C(\O)C(=O)OCC)cn(Cc3ccc(F)cc3)c2cc1N1CCN(C)CC1,IC50,782.0,6.11,CHEMBL5611630,Inhibition of HIV-1 integrase catalytic activity incubated for 1 hrs in absence of LEDGF/p75 by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,782.0,6.106793246940152
CHEMBL5613927,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(C(=O)c3ccc(C(=O)O)cc3)cc2c1=O,IC50,77.0,7.11,CHEMBL5611630,Inhibition of HIV-1 integrase catalytic activity incubated for 1 hrs in absence of LEDGF/p75 by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,77.0,7.113509274827518
CHEMBL5613097,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2ccc(C(=O)c3ccc(C(=O)OCC)cc3)cc2c1=O,IC50,741.0,6.13,CHEMBL5611630,Inhibition of HIV-1 integrase catalytic activity incubated for 1 hrs in absence of LEDGF/p75 by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,741.0,6.130181792020672
CHEMBL5173288,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3cccc4ccccc34)cc2c1=O,IC50,36500.0,4.44,CHEMBL5611630,Inhibition of HIV-1 integrase catalytic activity incubated for 1 hrs in absence of LEDGF/p75 by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36500.0,4.437707135543525
CHEMBL5613833,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc(OCc4ccccc4)cc3)cc2c1=O,IC50,6280.0,5.2,CHEMBL5611630,Inhibition of HIV-1 integrase catalytic activity incubated for 1 hrs in absence of LEDGF/p75 by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6280.0,5.202040356262804
CHEMBL5172754,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3cccc4ccccc34)cc2c1=O,IC50,41900.0,4.38,CHEMBL5611630,Inhibition of HIV-1 integrase catalytic activity incubated for 1 hrs in absence of LEDGF/p75 by HTRF assay,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41900.0,4.377785977033705
CHEMBL499273,O=C(O)/C(O)=C/C(=O)c1cccn1Cc1ccc(F)cc1,IC50,50.0,7.3,CHEMBL5634346,Inhibition of HIV-1 integrase,CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL5800090,Cc1ccc(-c2c(C)c3c(c(C)c2C(OC(C)(C)C)C(=O)O)CN(Cc2ccc(F)cc2)C3)cc1,IC50,35.0,7.46,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,35.0,7.455931955649724
CHEMBL6036968,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2ccc(F)cc2)C3)cc1,IC50,36.0,7.44,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36.0,7.443697499232712
CHEMBL5995049,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2cccc(F)c2F)C3)cc1,IC50,40.0,7.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL5752856,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)NC2CCCCC2)C3)cc1,IC50,33.0,7.48,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,33.0,7.481486060122112
CHEMBL5975753,Cc1ccc(-c2c(C)c3c(c(C)c2C(OC(C)(C)C)C(=O)O)CN(S(=O)(=O)c2cccc4ccccc24)C3)cc1,IC50,42.0,7.38,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42.0,7.376750709602099
CHEMBL5740902,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCCC2)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5769985,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2cccc(F)c2)C3)cc(F)c2c1CCCO2,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5926469,Cc1ccc(-c2c(C)c3c(c(C)c2C(OC(C)(C)C)C(=O)O)CN(Cc2ccccc2)C3)cc1,IC50,98.0,7.01,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,98.0,7.008773924307505
CHEMBL5785946,Cc1ccc(-c2c(C)c3c(c(C)c2C(OC(C)(C)C)C(=O)O)CN(CC2CCCCC2)C3)cc1,IC50,71.0,7.15,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,71.0,7.1487416512809245
CHEMBL5756531,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2ccncc2)C3)cc1,IC50,174.0,6.76,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,174.0,6.7594507517174005
CHEMBL5823260,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(CC2CCOCC2)C3)cc1,IC50,820.0,6.09,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,820.0,6.086186147616283
CHEMBL5918921,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2cccc4ccccc24)C3)cc1,IC50,44.0,7.36,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44.0,7.356547323513812
CHEMBL5808869,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C2CCC(C)(C)CC2)C3)cc1,IC50,118.0,6.93,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,118.0,6.928117992693874
CHEMBL5793999,Cc1ccc(-c2c(C)c3c(c(C)c2C(OC(C)(C)C)C(=O)O)CN(S(C)(=O)=O)C3)cc1,IC50,2133.0,5.67,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2133.0,5.671009144550571
CHEMBL5975753,Cc1ccc(-c2c(C)c3c(c(C)c2C(OC(C)(C)C)C(=O)O)CN(S(=O)(=O)c2cccc4ccccc24)C3)cc1,IC50,62.0,7.21,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,62.0,7.207608310501746
CHEMBL5826672,Cc1ccc(-c2c(C)c3c(c(C)c2C(OC(C)(C)C)C(=O)O)CN(C(=O)OCc2ccccc2)C3)cc1,IC50,1280.0,5.89,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1280.0,5.892790030352131
CHEMBL6041476,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2ccc(Cl)cc2)C3)cc1,IC50,75.0,7.12,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,75.0,7.1249387366083
CHEMBL5952967,COc1ccc(CN2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)cc1,IC50,340.0,6.47,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,340.0,6.468521082957745
CHEMBL6002963,Cc1ccc(CN2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)cc1,IC50,115.0,6.94,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,115.0,6.939302159646388
CHEMBL5771163,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2ccccc2F)C3)cc1,IC50,40.0,7.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL5971684,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2cccc(F)c2)C3)cc1,IC50,20.0,7.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL6047292,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2nc(C)c[nH]2)C3)cc1,IC50,203.0,6.69,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,203.0,6.692503962086787
CHEMBL5883456,COc1cccc(CN2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,12.0,7.92,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL5815397,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(CC(C)C)C3)cc1,IC50,946.0,6.02,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,946.0,6.024108863598207
CHEMBL5835715,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2ccc(Cl)c(Cl)c2)C3)cc1,IC50,54.0,7.27,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,54.0,7.267606240177031
CHEMBL6063303,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2ccc(C(F)(F)F)cc2)C3)cc1,IC50,932.0,6.03,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,932.0,6.030584087646019
CHEMBL5912457,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2cccc(C(F)(F)F)c2)C3)cc1,IC50,94.0,7.03,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,94.0,7.026872146400302
CHEMBL5843007,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2cccc(-c4ccccc4)c2)C3)cc1,IC50,184.0,6.74,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,184.0,6.735182176990463
CHEMBL5979763,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(CC2CCCCC2)C3)cc1,IC50,47.0,7.33,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,47.0,7.327902142064282
CHEMBL6009656,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C2CCCC(c4ccccc4)C2)C3)cc1,IC50,203.0,6.69,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,203.0,6.692503962086787
CHEMBL5985195,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C2CCC[C@@H](C)C2)C3)cc1,IC50,723.0,6.14,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,723.0,6.140861702705469
CHEMBL6053476,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N[C@H]2CC[C@H](C)CC2)C3)cc1,IC50,616.0,6.21,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,616.0,6.210419287835574
CHEMBL6059861,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)NCc2ccccc2)C3)cc1,IC50,86.0,7.07,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,86.0,7.0655015487564325
CHEMBL5896784,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCC2)C3)cc1,IC50,12.0,7.92,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL5916056,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(S(=O)(=O)C2CCCCC2)C3)cc1,IC50,37.0,7.43,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37.0,7.431798275933005
CHEMBL5985195,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C2CCC[C@@H](C)C2)C3)cc1,IC50,723.0,6.14,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,723.0,6.140861702705469
CHEMBL5818646,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(CCCc2cccc(F)c2)C3)cc1,IC50,1230.0,5.91,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1230.0,5.910094888560602
CHEMBL5742907,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(CCc2ccccc2)C3)cc1,IC50,872.0,6.06,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,872.0,6.059483515067432
CHEMBL6012275,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(CC2CCCN2C(=O)OC(C)(C)C)C3)cc1,IC50,3427.0,5.46,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3427.0,5.465085895570133
CHEMBL5828467,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2cccnc2)C3)cc1,IC50,50.0,7.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,50.0,7.301029995663981
CHEMBL5817204,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2ccc(F)cc2F)C3)cc1,IC50,25.0,7.6,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25.0,7.6020599913279625
CHEMBL5776110,CNC(=O)c1cccc(CN2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,937.0,6.03,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,937.0,6.028260409112222
CHEMBL6039684,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2cccc(C(=O)N4CCCCC4)c2)C3)cc1,IC50,3350.0,5.47,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3350.0,5.474955192963154
CHEMBL5747845,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2cccc(Cl)c2)C3)cc1,IC50,43.0,7.37,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,43.0,7.366531544420413
CHEMBL5932052,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2cccc(N4CCOCC4)c2)C3)cc1,IC50,4077.0,5.39,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4077.0,5.389659288547843
CHEMBL5961638,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2cccc(F)c2C)C3)cc1,IC50,44.0,7.36,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44.0,7.356547323513812
CHEMBL5966561,COC(=O)N1Cc2c(C)c(-c3ccc(C)cc3)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,573.0,6.24,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,573.0,6.24184537803261
CHEMBL5805653,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(S(=O)(=O)c2ccc(F)cc2)C3)cc1,IC50,100.0,7.0,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,100.0,7.0
CHEMBL5860782,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(S(=O)(=O)N2CCCCC2)C3)cc1,IC50,29.0,7.54,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,29.0,7.537602002101044
CHEMBL5969443,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(S(=O)(=O)NC(C)C)C3)cc1,IC50,44.0,7.36,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44.0,7.356547323513812
CHEMBL5838125,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(S(=O)(=O)N2CCOCC2)C3)cc1,IC50,18.0,7.75,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL6049915,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2ccc(F)c(F)c2)C3)cc1,IC50,51.0,7.29,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,51.0,7.292429823902063
CHEMBL5912069,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)NC2CCC(C)CC2)C3)cc1,IC50,288.0,6.54,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,288.0,6.5406075122407685
CHEMBL6059861,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)NCc2ccccc2)C3)cc1,IC50,86.0,7.07,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,86.0,7.0655015487564325
CHEMBL5896784,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCC2)C3)cc1,IC50,12.0,7.92,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL5837161,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCOCC2)C3)cc1,IC50,44.0,7.36,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44.0,7.356547323513812
CHEMBL5954600,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)NCC2CCCCC2)C3)cc1,IC50,350.0,6.46,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,350.0,6.455931955649724
CHEMBL5744689,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N(C)C)C3)cc1,IC50,279.0,6.55,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,279.0,6.554395796726403
CHEMBL5774243,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCCCCC2)C3)cc1,IC50,14.0,7.85,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL5895815,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC2)C3)cc1,IC50,38.0,7.42,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38.0,7.42021640338319
CHEMBL5876582,COCCN(C)C(=O)N1Cc2c(C)c(-c3ccc(C)cc3)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,44.0,7.36,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44.0,7.356547323513812
CHEMBL6023799,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)NC(C)(C)C)C3)cc1,IC50,15.0,7.82,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL5821991,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCS(=O)(=O)CC2)C3)cc1,IC50,106.0,6.97,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,106.0,6.97469413473523
CHEMBL5774243,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCCCCC2)C3)cc1,IC50,10.0,8.0,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL5740462,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCC(F)(F)C2)C3)cc1,IC50,6.0,8.22,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL5865980,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N(C)C2CCCCC2)C3)cc1,IC50,55.0,7.26,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,55.0,7.259637310505756
CHEMBL5800362,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC(F)(F)C2)C3)cc1,IC50,8.0,8.1,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL5851830,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCC[C@H]2C)C3)cc1,IC50,14.0,7.85,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL5750362,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)NC2CCC2)C3)cc1,IC50,34.0,7.47,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34.0,7.468521082957745
CHEMBL5974708,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCN(C)CC2)C3)cc1,IC50,276.0,6.56,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,276.0,6.559090917934782
CHEMBL5957222,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCOC[C@H]2C)C3)cc1,IC50,16.0,7.8,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16.0,7.795880017344075
CHEMBL5967785,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2C[C@H](C)O[C@@H](C)C2)C3)cc1,IC50,26.0,7.58,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26.0,7.585026652029182
CHEMBL6053816,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)NCC(C)(C)C)C3)cc1,IC50,21.0,7.68,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL5783516,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CC4CCC(C2)O4)C3)cc1,IC50,34.0,7.47,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,34.0,7.468521082957745
CHEMBL5883440,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCOCC2)C3)cc1,IC50,12.0,7.92,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL6050633,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CC[C@H](O)C2)C3)cc1,IC50,160.0,6.8,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,160.0,6.795880017344075
CHEMBL6059628,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N(C)CC2CCCCC2)C3)cc1,IC50,126.0,6.9,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,126.0,6.899629454882437
CHEMBL5949348,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)NCCOCc2ccccc2)C3)cc1,IC50,231.0,6.64,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,231.0,6.636388020107855
CHEMBL6061525,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCN4CCC[C@@H]4C2)C3)cc1,IC50,381.0,6.42,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,381.0,6.41907502432438
CHEMBL5792510,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC(C)CC2)C3)cc1,IC50,16.0,7.8,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16.0,7.795880017344075
CHEMBL5775790,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CC4CCCC4C2)C3)cc1,IC50,14.0,7.85,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL5825792,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2[C@H]4CC[C@@H]2CC4)C3)cc1,IC50,6.0,8.22,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL5843815,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC(C)(C)CC2)C3)cc1,IC50,11.0,7.96,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL5847509,CC(=O)N1CCN(C(=O)N2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)CC1,IC50,120.0,6.92,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,120.0,6.920818753952375
CHEMBL6047228,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCNCC2)C3)cc1,IC50,1163.0,5.93,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1163.0,5.9344202852715515
CHEMBL6005894,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC[C@@H]2C)C3)cc1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5830108,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2C[C@H](C)OC[C@H]2C)C3)cc1,IC50,18.0,7.75,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL5846156,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC(F)CC2)C3)cc1,IC50,11.0,7.96,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL6055403,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCN(C)C(=O)C2)C3)cc1,IC50,267.0,6.57,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,267.0,6.573488738635424
CHEMBL6032588,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCOC[C@@H]2C)C3)cc1,IC50,13.0,7.89,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL6043580,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC(F)(F)CC2)C3)cc1,IC50,16.0,7.8,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16.0,7.795880017344075
CHEMBL5757229,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCC(C)(C)C2)C3)cc1,IC50,7.0,8.15,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL5746281,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)NCC(F)(F)F)C3)cc1,IC50,44.0,7.36,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44.0,7.356547323513812
CHEMBL5855140,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC(Cc4ccccc4)CC2)C3)cc1,IC50,778.0,6.11,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,778.0,6.109020403010311
CHEMBL5889239,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CC[C@@H](F)C2)C3)cc1,IC50,14.0,7.85,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL5933215,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)NC(C)(C)c2ccccc2)C3)cc1,IC50,144.0,6.84,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,144.0,6.84163750790475
CHEMBL5868100,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC(N4CCOCC4)CC2)C3)cc1,IC50,2296.0,5.64,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2296.0,5.639028116274064
CHEMBL5834936,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N[C@@H](C)C2CCCCC2)C3)cc1,IC50,45.0,7.35,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,45.0,7.346787486224656
CHEMBL5992590,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC(F)(F)C2)C3)cc(F)c2c1CCCO2,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5971201,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCCC2)C3)cc(F)c2c1CCCO2,IC50,3.0,8.52,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL5995588,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCC(F)(F)C2)C3)cc(F)c2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5988149,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(F)c2)C3)cc(F)c2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5797075,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)CC(C)(C)C)C3)cc(F)c2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5808303,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc4c2OCCO4)C3)cc1,IC50,14.0,7.85,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL5962021,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)CN2CCCCC2)C3)cc1,IC50,143.0,6.84,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,143.0,6.844663962534938
CHEMBL6041548,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)C2CCCCC2)C3)cc1,IC50,7.0,8.15,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL5842808,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(F)c2)C3)cc1,IC50,6.0,8.22,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL5962547,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)C(C)(C)C)C3)cc1,IC50,36.0,7.44,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,36.0,7.443697499232712
CHEMBL5894046,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)CC(C)(C)C)C3)cc1,IC50,6.0,8.22,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL5879919,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)C2CCC(F)(F)CC2)C3)cc1,IC50,16.0,7.8,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16.0,7.795880017344075
CHEMBL5754544,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)C2CCCC2)C3)cc1,IC50,29.0,7.54,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,29.0,7.537602002101044
CHEMBL5961293,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)C2CCC(F)(F)C2)C3)cc1,IC50,10.0,8.0,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL5929822,COc1cccc(C(=O)N2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5828561,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc(C)c(F)c2)C3)cc1,IC50,6.0,8.22,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL6065644,COC1CCC(C(=O)N2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)CC1,IC50,31.0,7.51,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31.0,7.508638306165727
CHEMBL5757405,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)CC2CCCCC2)C3)cc1,IC50,17.0,7.77,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17.0,7.769551078621726
CHEMBL5914026,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)C2CC4(CCC4)C2)C3)cc1,IC50,14.0,7.85,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL6003061,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(F)cc(F)c2)C3)cc1,IC50,3.0,8.52,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL5747193,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(F)c2F)C3)cc1,IC50,3.0,8.52,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL5795604,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(F)ccc2C)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5888817,COc1cc(F)cc(C(=O)N2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,3.0,8.52,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL5885577,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(C)cc(F)c2)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5991834,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CNC3)cc1,IC50,1090.0,5.96,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,1090.0,5.962573502059376
CHEMBL5779231,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2cccc4c2OCCO4)C3)cc1,IC50,15.0,7.82,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL5941041,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)OC(C)(C)C)C3)cc1,IC50,13.0,7.89,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL5793750,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(CC(=O)N2CCCCC2)C3)cc1,IC50,318.0,6.5,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,318.0,6.497572880015568
CHEMBL5893619,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=N)N2CCCCC2)C3)cc1,IC50,8539.0,5.07,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8539.0,5.068592986443427
CHEMBL5802219,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)C(=O)N2CCCCC2)C3)cc1,IC50,14.0,7.85,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL6002185,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)C(=O)N2CCOC[C@H]2C)C3)cc1,IC50,41.0,7.39,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41.0,7.3872161432802645
CHEMBL5912845,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=S)N2CCCCC2)C3)cc1,IC50,19.0,7.72,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,19.0,7.721246399047171
CHEMBL5794120,Cc1c2c(c(C)c([C@H](OC(C)(C)C)C(=O)O)c1-c1ccc(Cl)cc1)CN(C(=O)N1CCCCC1)C2,IC50,21.0,7.68,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,21.0,7.6777807052660805
CHEMBL6008575,Cc1c2c(c(C)c([C@H](OC(C)(C)C)C(=O)O)c1-c1ccc(Cl)cc1)CN(C(=O)c1cccc(F)c1)C2,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5994944,Cc1c2c(c(C)c([C@H](OC(C)(C)C)C(=O)O)c1-c1ccc(Cl)cc1)CN(C(=O)C1CCCCC1)C2,IC50,6.0,8.22,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL5832144,Cc1c2c(c(C)c([C@H](OC(C)(C)C)C(=O)O)c1-c1ccc(Cl)cc1)CN(C(=O)CC(C)(C)C)C2,IC50,23.0,7.64,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23.0,7.638272163982407
CHEMBL5791527,Cc1ccc(F)cc1C(=O)N1Cc2c(C)c(-c3cc(F)c4c(c3C)CCCO4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL6010256,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)C2CCCCC2)C3)cc(F)c2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL6058556,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc4c2OCO4)C3)cc(F)c2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL6054601,COc1cccc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1C,IC50,37.0,7.43,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37.0,7.431798275933005
CHEMBL5881560,COc1cc(F)cc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5888152,Cc1c(F)cccc1C(=O)N1Cc2c(C)c(-c3cc(F)c4c(c3C)CCCO4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5955169,Cc1ncccc1C(=O)N1Cc2c(C)c(-c3cc(F)c4c(c3C)CCCO4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,31.0,7.51,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,31.0,7.508638306165727
CHEMBL5958958,COc1cncc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5772643,Cc1ccc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)cc1F,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5753742,Cc1cc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)ccc1F,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5844832,Cc1ccccc1C(=O)N1Cc2c(C)c(-c3cc(F)c4c(c3C)CCCO4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,3.0,8.52,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL5983041,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(Cl)c2)C3)cc(F)c2c1CCCO2,IC50,13.0,7.89,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL5951549,COc1cccc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1F,IC50,9.0,8.05,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL5907716,Cc1cccc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5857804,COc1ccc(F)cc1C(=O)N1Cc2c(C)c(-c3cc(F)c4c(c3C)CCCO4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL6056327,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc4sccc24)C3)cc(F)c2c1CCCO2,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL6031109,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc4c2OCC4)C3)cc(F)c2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5811439,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc4c2OCCO4)C3)cc(F)c2c1CCCO2,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL6059372,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc4c(cnn4C)c2)C3)cc(F)c2c1CCCO2,IC50,8.0,8.1,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL6015441,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccccc2C(C)(C)C)C3)cc(F)c2c1CCCO2,IC50,48.0,7.32,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48.0,7.318758762624412
CHEMBL5753265,COc1cc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)ccc1C,IC50,3.0,8.52,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL6061533,Cc1ccc(C)c(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,3.0,8.52,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL6000500,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccccc2)C3)cc(F)c2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5866997,COc1cccc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5891754,COc1ccc(C)c(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5775384,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc4c2CCC4)C3)cc(F)c2c1CCCO2,IC50,3.0,8.52,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL5796850,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc4c2OC(F)(F)O4)C3)cc(F)c2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5939858,COc1ccccc1C(=O)N1Cc2c(C)c(-c3ccc(C)cc3)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5766070,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc4c2OCC4)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5980791,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc4c2ccn4C)C3)cc1,IC50,108.0,6.97,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,108.0,6.96657624451305
CHEMBL6028189,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc4sccc24)C3)cc1,IC50,27.0,7.57,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,27.0,7.568636235841012
CHEMBL5748845,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc4ccoc24)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5850268,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc4ccccc24)C3)cc(F)c2c1CCCO2,IC50,11.0,7.96,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL5967797,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc4ccoc24)C3)cc(F)c2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5831007,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(F)cc(F)c2)C3)cc(F)c2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL6061709,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc(F)c(Cl)c2)C3)cc(F)c2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL6025033,Cc1c(Cl)cccc1C(=O)N1Cc2c(C)c(-c3cc(F)c4c(c3C)CCCO4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,7.0,8.15,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL5848964,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(F)c(F)c(F)c2)C3)cc(F)c2c1CCCO2,IC50,3.0,8.52,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL5809982,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc(F)cc2)C3)cc(F)c2c1CCCO2,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL6036752,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(F)c(Cl)c(F)c2)C3)cc(F)c2c1CCCO2,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5988742,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(F)c2F)C3)cc(F)c2c1CCCO2,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5791527,Cc1ccc(F)cc1C(=O)N1Cc2c(C)c(-c3cc(F)c4c(c3C)CCCO4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5815196,Cc1cc(F)cc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5854746,COc1ccc(F)c(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5835927,COc1cc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)ccc1F,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5801336,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(F)cc(Cl)c2)C3)cc(F)c2c1CCCO2,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL6050676,Cc1cncc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5773200,COc1ccc(C)cc1C(=O)N1Cc2c(C)c(-c3cc(F)c4c(c3C)CCCO4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5893837,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccccn2)C3)cc(F)c2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL6060815,Cc1ccc(Cl)cc1C(=O)N1Cc2c(C)c(-c3cc(F)c4c(c3C)CCCO4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5922815,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc(F)c(F)c2)C3)cc(F)c2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5992226,COc1ccc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)cc1F,IC50,3.0,8.52,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL5748926,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(Cl)c(F)c(Cl)c2)C3)cc(F)c2c1CCCO2,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL6019128,Cc1ccc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c(C)c1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5837779,Cc1ccc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)cc1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL6042005,Cc1cc(C)cc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5799129,COc1ccc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)cc1C,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5787845,Cc1cccc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1C,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL6062526,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(F)c(F)c(Cl)c2)C3)cc(F)c2c1CCCO2,IC50,11.0,7.96,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL5789224,COc1c(F)cccc1C(=O)N1Cc2c(C)c(-c3cc(F)c4c(c3C)CCCO4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,3.0,8.52,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL5942452,COc1ccc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)cc1,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5803075,Cc1cccc(F)c1C(=O)N1Cc2c(C)c(-c3cc(F)c4c(c3C)CCCO4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5872733,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc(Cl)cc2)C3)cc(F)c2c1CCCO2,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5781328,COc1ccccc1C(=O)N1Cc2c(C)c(-c3cc(F)c4c(c3C)CCCO4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL6065323,COc1cc(C)ccc1C(=O)N1Cc2c(C)c(-c3cc(F)c4c(c3C)CCCO4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,11.0,7.96,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL5939556,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(c2nnc(-c4cccc(F)c4)o2)C3)cc(F)c2c1CCCO2,IC50,387.0,6.41,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,387.0,6.412289034981089
CHEMBL6016749,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(c2nc4ccccc4o2)C3)cc(F)c2c1CCCO2,IC50,124.0,6.91,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,124.0,6.906578314837764
CHEMBL5766789,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(c2nnc(Cc4ccc(F)c(F)c4)o2)C3)cc(F)c2c1CCCO2,IC50,63.0,7.2,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,63.0,7.200659450546418
CHEMBL5934894,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(c2nc4cc(F)ccc4o2)C3)cc(F)c2c1CCCO2,IC50,665.0,6.18,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,665.0,6.1771783546968955
CHEMBL5883650,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCC[C@H]2C)C3)cc(F)c2c1CCCO2,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5871081,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCC(C)(C)CC2)C3)cc(F)c2c1CCCO2,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5902169,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)NCC(C)(C)C)C3)cc(F)c2c1CCCO2,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5909503,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCC2)C3)cc(F)c2c1CCCO2,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5951884,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCOC[C@@H]2C)C3)cc(F)c2c1CCCO2,IC50,23.0,7.64,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,23.0,7.638272163982407
CHEMBL5793357,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)Nc2cccc(F)c2)C3)cc(F)c2c1CCCO2,IC50,14.0,7.85,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL5786808,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC(C)(C)CC2)C3)cc(F)c2c1CCCO2,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5888927,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC[C@@H]2C)C3)cc(F)c2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5947763,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC(F)(F)CC2)C3)cc(F)c2c1CCCO2,IC50,3.0,8.52,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL6032501,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC(C)(C)C2)C3)cc(F)c2c1CCCO2,IC50,3.0,8.52,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL5971978,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)C(=O)N2CCCCC2)C3)cc(F)c2c1CCCO2,IC50,10.0,8.0,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,10.0,8.0
CHEMBL5872593,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(Cc2cccc4c2OCO4)C3)cc(F)c2c1CCCO2,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5950796,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)Oc2ccccc2)C3)cc(F)c2c1CCCO2,IC50,12.0,7.92,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL5767021,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(S(=O)(=O)c2cccc(F)c2)C3)cc(F)c2c1CCCO2,IC50,11.0,7.96,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL5779677,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccccc2C)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL6059993,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(Cl)c2)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5904277,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(F)c2C)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5822355,COc1cc(C(=O)N2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)ccc1C,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5839016,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccnn2C)C3)cc1,IC50,13.0,7.89,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL5933282,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc(C(C)(C)C)cc2)C3)cc1,IC50,44.0,7.36,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,44.0,7.356547323513812
CHEMBL5949866,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(C)c2)C3)cc1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5874553,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(F)cc(Cl)c2)C3)cc1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5802778,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc(C(F)(F)F)cc2)C3)cc1,IC50,14.0,7.85,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL5763221,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)C2CCC2)C3)cc1,IC50,13.0,7.89,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL6033011,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccccc2)C3)cc1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5874290,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(C(C)(C)C)c2)C3)cc1,IC50,111.0,6.96,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,111.0,6.954677021213342
CHEMBL5970458,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)[C@H]2CCOC2)C3)cc1,IC50,37.0,7.43,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,37.0,7.431798275933005
CHEMBL5920655,CCOCCC(=O)N1Cc2c(C)c(-c3ccc(C)cc3)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,148.0,6.83,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,148.0,6.8297382846050425
CHEMBL5763455,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)Cc2cccc(F)c2)C3)cc1,IC50,12.0,7.92,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL5913264,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(OC(C)C)c2)C3)cc1,IC50,26.0,7.58,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26.0,7.585026652029182
CHEMBL5833751,COc1cncc(C(=O)N2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5865545,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cncc(C)c2)C3)cc1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL6034832,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cn(C)cn2)C3)cc1,IC50,67.0,7.17,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,67.0,7.173925197299173
CHEMBL5920369,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2nccn2C)C3)cc1,IC50,940.0,6.03,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,940.0,6.026872146400301
CHEMBL5920369,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2nccn2C)C3)cc1,IC50,16.0,7.8,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16.0,7.795880017344075
CHEMBL5911658,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccn(C)n2)C3)cc1,IC50,121.0,6.92,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,121.0,6.91721462968355
CHEMBL5885583,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)C(C)(C)C(F)(F)F)C3)cc1,IC50,25.0,7.6,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,25.0,7.6020599913279625
CHEMBL5919821,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccccc2C(C)(C)C)C3)cc1,IC50,13.0,7.89,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL5908984,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)C2(C)CCCCC2)C3)cc1,IC50,18.0,7.75,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL6026798,COC1CCCC(C(=O)N2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)C1,IC50,14.0,7.85,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL6026798,COC1CCCC(C(=O)N2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)C1,IC50,26.0,7.58,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,26.0,7.585026652029182
CHEMBL5950510,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc(F)c(C)c2)C3)cc1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5754129,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc(F)cc2F)C3)cc1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5746099,COc1ccc(F)c(C(=O)N2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5885671,COc1ccc(C)c(C(=O)N2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5825205,COc1ccc(C)cc1C(=O)N1Cc2c(C)c(-c3ccc(C)cc3)c([C@H](OC(C)(C)C)C(=O)O)c(C)c2C1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5918141,COc1cc(C(=O)N2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)ccc1F,IC50,3.0,8.52,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL5909166,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc(F)c(Cl)c2)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5874762,COc1cccc(C(=O)N2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1F,IC50,12.0,7.92,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,12.0,7.920818753952375
CHEMBL5827730,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc(F)cc2)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5891226,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc4c(c2)OCCO4)C3)cc1,IC50,13.0,7.89,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL6008065,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc4c(c2)B(O)OC4)C3)cc1,IC50,740.0,6.13,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,740.0,6.130768280269024
CHEMBL5864952,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(B(O)O)c2)C3)cc1,IC50,134.0,6.87,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,134.0,6.872895201635192
CHEMBL5773083,COc1cccc(C(=O)N2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1C,IC50,15.0,7.82,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL5944736,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccnc2C)C3)cc1,IC50,20.0,7.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,20.0,7.698970004336019
CHEMBL6009430,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cnccc2C)C3)cc1,IC50,15.0,7.82,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL6021472,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc(F)c(F)c2)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL6024315,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(F)ccc2F)C3)cc1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL6020080,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(Cl)ccc2C)C3)cc1,IC50,6.0,8.22,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL5876044,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc(Cl)c(F)c2)C3)cc1,IC50,9.0,8.05,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL5907809,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc4c(c2)OCO4)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5859485,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(F)cc(C(N)=O)c2)C3)cc1,IC50,126.0,6.9,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,126.0,6.899629454882437
CHEMBL5785868,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(F)cc(C(=O)O)c2)C3)cc1,IC50,3463.0,5.46,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3463.0,5.460547508450539
CHEMBL5981842,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccnc2)C3)cc1,IC50,14.0,7.85,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL5977190,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cncs2)C3)cc1,IC50,116.0,6.94,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,116.0,6.935542010773082
CHEMBL6061777,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc(Cl)cc2)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5761893,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(Cl)cc(Cl)c2)C3)cc1,IC50,8.0,8.1,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL5999772,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cocn2)C3)cc1,IC50,86.0,7.07,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,86.0,7.0655015487564325
CHEMBL5790398,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccccn2)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5933919,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cnc(-c4ccccc4)o2)C3)cc1,IC50,297.0,6.53,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,297.0,6.527243550682788
CHEMBL6016753,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc4c2OCO4)C3)cc1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5758626,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc(Cl)c(Cl)c2)C3)cc1,IC50,16.0,7.8,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,16.0,7.795880017344075
CHEMBL5934533,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(F)c(Cl)c(Cl)c2)C3)cc1,IC50,14.0,7.85,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL5992271,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(C)c(F)c(F)c2)C3)cc1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL6032986,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(F)c(F)c(F)c2)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5763774,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(F)c(F)c(Cl)c2)C3)cc1,IC50,8.0,8.1,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,8.0,8.096910013008056
CHEMBL5958165,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(Cl)c(F)c(Cl)c2)C3)cc1,IC50,17.0,7.77,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,17.0,7.769551078621726
CHEMBL5790888,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(F)c(Cl)c(F)c2)C3)cc1,IC50,7.0,8.15,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,7.0,8.154901959985743
CHEMBL5820683,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2ccc(C)nc2)C3)cc1,IC50,13.0,7.89,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL5931879,COc1cccc(C(=O)N2Cc3c(C)c(-c4ccc(C)cc4)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c1OC,IC50,48.0,7.32,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,48.0,7.318758762624412
CHEMBL5796044,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cc(F)ccc2F)C3)cc(F)c2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5795132,COc1ccc(C(=O)N2Cc3c(C)c(-c4cc(F)c5c(c4C)CCCO5)c([C@H](OC(C)(C)C)C(=O)O)c(C)c3C2)c(C)c1,IC50,11.0,7.96,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,11.0,7.958607314841775
CHEMBL5950470,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)OCC(C)(C)C)C3)cc1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL6038747,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=S)c2cccc(F)c2)C3)cc1,IC50,15.0,7.82,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL5751839,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(S(=O)(=O)N2CCC(F)(F)C2)C3)cc1,IC50,14.0,7.85,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL5919938,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)NCc2ncccn2)C3)cc1,IC50,2558.0,5.59,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2558.0,5.592099459857365
CHEMBL5937290,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC(C)(C)C2)C3)cc1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5744108,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC[C@H]2C)C3)cc1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5950005,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCC[C@@H]2C)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5879804,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CC[C@H](F)C2)C3)cc1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5856763,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(F)c2)C3)cc(Cl)c2c1CCCO2,IC50,9.0,8.05,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,9.0,8.045757490560675
CHEMBL6056443,Cc1cc(Cl)ccc1-c1c(C)c2c(c(C)c1[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c1cccc(F)c1)C2,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL6005076,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(F)c2)C3)c(O)c1,IC50,42.0,7.38,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,42.0,7.376750709602099
CHEMBL6033530,COc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(F)c2)C3)c(C)c1,IC50,24.0,7.62,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,24.0,7.619788758288394
CHEMBL6018051,Cc1c2c(c(C)c([C@H](OC(C)(C)C)C(=O)O)c1-c1ccc3c4c(ccnc14)CCO3)CN(C(=O)c1cccc(F)c1)C2,IC50,14.0,7.85,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,14.0,7.853871964321762
CHEMBL5851514,Cc1c2c(c(C)c([C@H](OC(C)(C)C)C(=O)O)c1-c1ccc(Cl)c3cccnc13)CN(C(=O)c1cccc(F)c1)C2,IC50,40.0,7.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,40.0,7.3979400086720375
CHEMBL5763292,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(F)c2)C3)cc(F)c2c1NCCO2,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5866940,Cc1c2c(c(C)c([C@H](OC(C)(C)C)C(=O)O)c1C1=CCC(C)(C)CC1)CN(C(=O)c1cccc(F)c1)C2,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5902718,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(F)c2)C3)ccc2c1NCCO2,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5915378,Cc1c2c(c(C)c([C@H](OC(C)(C)C)C(=O)O)c1-c1ccc3c(c1)CCCO3)CN(C(=O)c1cccc(F)c1)C2,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5983898,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(F)c2)C3)ccc2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5873823,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(F)c2)C3)c(Cl)c1,IC50,38.0,7.42,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,38.0,7.42021640338319
CHEMBL5897438,Cc1c2c(c(C)c([C@H](OC(C)(C)C)C(=O)O)c1C1=CCC(C)(C)CC1)CN(C(=O)c1cccc3c1OCO3)C2,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5965350,Cc1c2c(c(C)c([C@H](OC(C)(C)C)C(=O)O)c1-c1ccc(Cl)cc1)CN(C(=O)c1cccc3c1OCO3)C2,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL6031917,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc4c2OCO4)C3)c(Cl)c1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL6062571,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc4c2OCO4)C3)cc(F)c2c1NCCO2,IC50,18.0,7.75,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,18.0,7.7447274948966935
CHEMBL5902718,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(F)c2)C3)ccc2c1NCCO2,IC50,15.0,7.82,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL5860650,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC(F)(F)C2)C3)ccc2c1NCCO2,IC50,6.0,8.22,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,6.0,8.221848749616356
CHEMBL5946364,Cc1c2c(c(C)c([C@H](OC(C)(C)C)C(=O)O)c1-c1ccc3c(c1)CCCO3)CN(C(=O)N1CCC(F)(F)C1)C2,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5898339,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC(F)(F)C2)C3)c(Cl)c1,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5916043,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC(F)(F)C2)C3)cc(F)c2c1NCCO2,IC50,15.0,7.82,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,15.0,7.823908740944319
CHEMBL5834066,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCCC2)C3)c(Cl)c1,IC50,41.0,7.39,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,41.0,7.3872161432802645
CHEMBL5787990,Cc1c2c(c(C)c([C@H](OC(C)(C)C)C(=O)O)c1-c1ccc3c(c1)CCCO3)CN(C(=O)N1CCCCC1)C2,IC50,3.0,8.52,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL5781437,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCCC2)C3)cc(F)c2c1NCCO2,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5885356,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCCC2)C3)ccc2c1NCCO2,IC50,4.0,8.4,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,4.0,8.397940008672037
CHEMBL5987265,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCC(F)(F)C2)C3)ccc2c1CCCO2,IC50,3.0,8.52,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,3.0,8.522878745280337
CHEMBL6018431,Cc1c(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCCC2)C3)ccc2c1CCCO2,IC50,2.0,8.7,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,2.0,8.698970004336019
CHEMBL5834066,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)N2CCCCC2)C3)c(Cl)c1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
CHEMBL5802258,Cc1cc(Cl)ccc1-c1c(C)c2c(c(C)c1C(OC(C)(C)C)C(=O)O)CN(C(=O)N1CCC(F)(F)C1)C2,IC50,13.0,7.89,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL6016861,Cc1cc(Cl)ccc1-c1c(C)c2c(c(C)c1[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)C1CCCCC1)C2,IC50,13.0,7.89,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL6046283,Cc1cc(Cl)ccc1-c1c(C)c2c(c(C)c1[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)CC(C)(C)C)C2,IC50,13.0,7.89,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,13.0,7.886056647693163
CHEMBL5873823,Cc1ccc(-c2c(C)c3c(c(C)c2[C@H](OC(C)(C)C)C(=O)O)CN(C(=O)c2cccc(F)c2)C3)c(Cl)c1,IC50,5.0,8.3,CHEMBL5731565,"Anti-HIV Activity MT4 Assay: Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell line MT-4 based on the method previously described (Hazen et al., 2007, In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV (Hazen et al., In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV, Antimicrob. Agents Chemother. 2007, 51: 3147-3154; and Pauwels et al., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. of Virological Methods 1987, 16: 171-185).",CHEMBL3471,Human immunodeficiency virus type 1 integrase,Human immunodeficiency virus 1,nM,5.0,8.301029995663981
